Citrus Sinensis ID: 047043
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.866 | 0.269 | 0.409 | 9e-57 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.783 | 0.251 | 0.412 | 5e-51 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.888 | 0.270 | 0.390 | 1e-50 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.863 | 0.264 | 0.360 | 2e-46 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.742 | 0.329 | 0.397 | 9e-42 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.780 | 0.519 | 0.372 | 2e-41 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.840 | 0.514 | 0.356 | 1e-40 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.748 | 0.371 | 0.374 | 6e-40 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.716 | 0.321 | 0.392 | 5e-39 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.742 | 0.394 | 0.395 | 6e-39 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 220 bits (561), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 125/305 (40%), Positives = 184/305 (60%), Gaps = 33/305 (10%)
Query: 3 VIIVCIVLRKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI 62
V ++ + RK++ + P + SY D++ AT GF+ N++G+GSFG VYK +
Sbjct: 661 VTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKAL 720
Query: 63 L-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF-----KALV 116
L ++ VA+KV +Q A +SF +ECE L+++ HRNL+K+ ++CS+ DF +AL+
Sbjct: 721 LLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALI 780
Query: 117 LELMPNGSLENWLYSH--------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
E MPNGSL+ WL+ + L LERLNI IDV L+YLH H PI HCD
Sbjct: 781 YEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCD 839
Query: 169 LKPSNILLDENMVARVSDFGISKLLGD-GEDSVTQTMTMA----TIGYMAPVSQLFDILK 223
LKPSN+LLD+++ A VSDFG+++LL E+S ++ A TIGY AP
Sbjct: 840 LKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP--------- 890
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDV 283
++G G S DVYSFG+LL+E FTGK+PT+E+F G +L ++ +LP + D+
Sbjct: 891 ----EYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDI 946
Query: 284 VDANL 288
VD ++
Sbjct: 947 VDESI 951
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 113/274 (41%), Positives = 158/274 (57%), Gaps = 28/274 (10%)
Query: 29 WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFR-SFDS 87
+ R SY + AT GFN +L+G+G FG VYKG+L + VA+KV + F SF
Sbjct: 646 YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR 705
Query: 88 ECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---LDTLERLNI 144
EC++L+ HRNL++I ++CS P F ALVL LMPNGSLE LY Y LD ++ +NI
Sbjct: 706 ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNI 765
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV---- 200
DV + YLHH +S +VHCDLKPSNILLD+ M A V+DFGIS+L+ E++V
Sbjct: 766 CSDVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDD 824
Query: 201 ------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254
T + ++GY+AP ++G S DVYSFGVLL+E +G
Sbjct: 825 SVSFGSTDGLLCGSVGYIAP-------------EYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 255 KKPTDEMFTGEISLKNWVNESLPHALTDVVDANL 288
++PTD + SL ++ P +L +++ L
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL 905
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (509), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 125/320 (39%), Positives = 182/320 (56%), Gaps = 41/320 (12%)
Query: 1 MIVIIVCIVLRKR---SAKIIAPIDLLPVATW-RRTSYLDIQRATEGFNECNLLGTGSFG 56
+IV +C ++++ +A P D + + + SY ++ AT F+ NL+G+G+FG
Sbjct: 665 IIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFG 724
Query: 57 IVYKGILSDGNN-VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-----P 110
V+KG+L N VA+KV L A +SF +ECE + + HRNL+K+ + CS+
Sbjct: 725 NVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGN 784
Query: 111 DFKALVLELMPNGSLENWLY--------SHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
DF+ALV E MP GSL+ WL H+ L E+LNI IDV ALEYLH H
Sbjct: 785 DFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHV-HCHD 843
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLL--GDGEDSVTQTMTM---ATIGYMAPVSQ 217
P+ HCD+KPSNILLD+++ A VSDFG+++LL D E + Q + TIGY AP
Sbjct: 844 PVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP--- 900
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLP 277
++G G S + DVYSFG+LL+E F+GKKPTDE F G+ +L ++ L
Sbjct: 901 ----------EYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILS 950
Query: 278 HAL----TDVVDANLRVSMK 293
++ +D LR+ ++
Sbjct: 951 GCTSSGGSNAIDEGLRLVLQ 970
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 122/338 (36%), Positives = 175/338 (51%), Gaps = 67/338 (19%)
Query: 25 PVAT-WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN-VAIKVFKLQLGRAF 82
PV + + + SY ++ + T GF+ NL+G+G+FG V+KG L N VAIKV L A
Sbjct: 699 PVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAA 758
Query: 83 RSFDSECEVLRNVHHRNLLKIFSSCSNPDF-----KALVLELMPNGSLENWLY------- 130
+SF +ECE L + HRNL+K+ + CS+ DF +ALV E MPNG+L+ WL+
Sbjct: 759 KSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEET 818
Query: 131 -SHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189
+ + L RLNI IDV AL YLH + PI HCD+KPSNILLD+++ A VSDFG+
Sbjct: 819 GNPSRTLGLFARLNIAIDVASALVYLHT-YCHNPIAHCDIKPSNILLDKDLTAHVSDFGL 877
Query: 190 SKLLGDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244
++LL + + TIGY AP ++G G S DVYSF
Sbjct: 878 AQLLLKFDRDTFHIQFSSAGVRGTIGYAAP-------------EYGMGGHPSIMGDVYSF 924
Query: 245 GVLLMETFTGKKPTDEMFTGEISLKNWVNESLP-HALTDVVDANL--------------- 288
G++L+E FTGK+PT+++F ++L ++ +L D+ D +
Sbjct: 925 GIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECL 984
Query: 289 -----------------RVSMKDVAAKLKKIRVKFLYD 309
R+SM + +KL IR F D
Sbjct: 985 TLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 99/249 (39%), Positives = 138/249 (55%), Gaps = 16/249 (6%)
Query: 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVL 92
SY ++ +AT GF++ NLLG G FG VYKGIL DG VA+K K+ G+ R F +E E L
Sbjct: 366 SYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETL 425
Query: 93 RNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
+HHR+L+ I C + D + L+ + + N L L+ LD R+ I L
Sbjct: 426 SRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSVLDWATRVKIAAGAARGL 485
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
YLH I+H D+K SNILL++N ARVSDFG+++L D +T T + T GYM
Sbjct: 486 AYLHE-DCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGTFGYM 543
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD-EMFTGEISLKNW 271
AP ++ S G ++ K DV+SFGV+L+E TG+KP D G+ SL W
Sbjct: 544 AP-------------EYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 590
Query: 272 VNESLPHAL 280
+ HA+
Sbjct: 591 ARPLISHAI 599
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 99/266 (37%), Positives = 150/266 (56%), Gaps = 21/266 (7%)
Query: 29 WRRTSYL-DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDS 87
W R L +++ AT G E N++G G +GIVY+GIL+DG VA+K G+A + F
Sbjct: 138 WGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKV 197
Query: 88 ECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLE---RLNI 144
E EV+ V H+NL+++ C ++ LV + + NG+LE W++ + L R+NI
Sbjct: 198 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNI 257
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
++ + L YLH G +VH D+K SNILLD A+VSDFG++KLLG E S T
Sbjct: 258 ILGMAKGLAYLHEGLEPK-VVHRDIKSSNILLDRQWNAKVSDFGLAKLLGS-ESSYVTTR 315
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD-EMFT 263
M T GY+AP ++ G+++ K D+YSFG+L+ME TG+ P D
Sbjct: 316 VMGTFGYVAP-------------EYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQ 362
Query: 264 GEISLKNWVNESLPHALT-DVVDANL 288
GE +L +W+ + + + +VVD +
Sbjct: 363 GETNLVDWLKSMVGNRRSEEVVDPKI 388
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 102/286 (35%), Positives = 154/286 (53%), Gaps = 22/286 (7%)
Query: 2 IVIIVCIVLRKRSAKII-APIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYK 60
++ +C R R K + API L+ +Y ++ RAT F+E NLLG G FG VYK
Sbjct: 140 LIFFLCKKKRPRDDKALPAPIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYK 199
Query: 61 GILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120
GIL++GN VA+K K+ + + F +E ++ +HHRNL+ + C + LV E +
Sbjct: 200 GILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFV 259
Query: 121 PNGSLENWLYSHNYFLDTLE---RLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD 177
PN +LE + H T+E RL I + L YLH + + I+H D+K +NIL+D
Sbjct: 260 PNNTLE--FHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHE-NCNPKIIHRDIKAANILID 316
Query: 178 ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA 237
A+V+DFG++K+ D V+ T M T GY+AP ++ + G ++
Sbjct: 317 FKFEAKVADFGLAKIALDTNTHVS-TRVMGTFGYLAP-------------EYAASGKLTE 362
Query: 238 KCDVYSFGVLLMETFTGKKPTD-EMFTGEISLKNWVNESLPHALTD 282
K DVYSFGV+L+E TG++P D + SL +W L AL +
Sbjct: 363 KSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEE 408
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 94/251 (37%), Positives = 136/251 (54%), Gaps = 16/251 (6%)
Query: 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVL 92
+Y ++ AT GF + NLLG G FG V+KG+L G VA+K K G+ R F +E +++
Sbjct: 273 TYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDII 332
Query: 93 RNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLA 151
VHHR L+ + C + LV E +PN +LE L+ N ++ RL I +
Sbjct: 333 SRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKG 392
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
L YLH I+H D+K +NILLD N A V+DFG++KL D V+ T M T GY
Sbjct: 393 LAYLHE-DCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVS-TRVMGTFGY 450
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW 271
+AP ++ S G ++ K DV+S+GV+L+E TGK+P D T + +L +W
Sbjct: 451 LAP-------------EYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDW 497
Query: 272 VNESLPHALTD 282
+ AL D
Sbjct: 498 ARPLMARALED 508
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 95/242 (39%), Positives = 136/242 (56%), Gaps = 17/242 (7%)
Query: 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVL 92
+Y ++ AT+GF++ LLG G FG V+KGIL +G +A+K K G+ R F +E E++
Sbjct: 325 TYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVEII 384
Query: 93 RNVHHRNLLKIFSSCSNPDFKA-LVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWL 150
VHHR+L+ + CSN + LV E +PN +LE L+ + +D RL I +
Sbjct: 385 SRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGSAK 444
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
L YLH I+H D+K SNILLD N A+V+DFG++KL D V+ T M T G
Sbjct: 445 GLAYLHE-DCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVS-TRVMGTFG 502
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270
Y+AP ++ S G ++ K DV+SFGV+L+E TG+ P D E SL +
Sbjct: 503 YLAP-------------EYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDMEDSLVD 549
Query: 271 WV 272
W
Sbjct: 550 WA 551
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 102/258 (39%), Positives = 146/258 (56%), Gaps = 25/258 (9%)
Query: 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAF-RSFDSECEVLRN 94
DI + E NE +++G G FG VYK + DG A+K L+L F R F+ E E+L +
Sbjct: 298 DIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRI-LKLNEGFDRFFERELEILGS 356
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
+ HR L+ + C++P K L+ + +P GSL+ L+ LD R+NI+I L Y
Sbjct: 357 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSY 416
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
LHH S I+H D+K SNILLD N+ ARVSDFG++KLL D E +T T+ T GY+AP
Sbjct: 417 LHH-DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-TIVAGTFGYLAP 474
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE-ISLKNW-- 271
++ G + K DVYSFGVL++E +GK+PTD F + +++ W
Sbjct: 475 -------------EYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLK 521
Query: 272 --VNESLPHALTDVVDAN 287
++E P D+VD N
Sbjct: 522 FLISEKRPR---DIVDPN 536
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | ||||||
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.939 | 0.278 | 0.565 | 1e-101 | |
| 224115342 | 252 | predicted protein [Populus trichocarpa] | 0.802 | 1.0 | 0.677 | 1e-100 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.952 | 0.274 | 0.541 | 3e-96 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.936 | 0.288 | 0.533 | 5e-94 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.888 | 0.267 | 0.598 | 1e-92 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.929 | 0.251 | 0.507 | 3e-90 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.888 | 0.286 | 0.575 | 4e-90 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.920 | 0.265 | 0.532 | 2e-89 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.837 | 0.132 | 0.603 | 3e-88 | |
| 359485121 | 1469 | PREDICTED: probable LRR receptor-like se | 0.904 | 0.193 | 0.5 | 5e-88 |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 374 bits (961), Expect = e-101, Method: Compositional matrix adjust.
Identities = 193/341 (56%), Positives = 237/341 (69%), Gaps = 46/341 (13%)
Query: 1 MIVIIVCIVLRKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYK 60
++ + V I R K+ D LP ATWR+ SY ++ RATEGFNE NLLGTGS G VYK
Sbjct: 728 VLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYK 787
Query: 61 GILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120
G LSDG +A+KVF LQL FDSECEVLR + HRNL+KI SSC N DFKAL+LE +
Sbjct: 788 GTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFI 847
Query: 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180
P+GSLE WLYSHNY+LD L+RLNIMIDV ALEYLHHG + P+VHCDLKPSN+L++E+M
Sbjct: 848 PHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHG-CTRPVVHCDLKPSNVLINEDM 906
Query: 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCD 240
VA VSDFGIS+LLG+G D+VTQT+T+ATIGYMAP ++G EGI+S K D
Sbjct: 907 VAHVSDFGISRLLGEG-DAVTQTLTLATIGYMAP-------------EYGLEGIVSVKGD 952
Query: 241 VYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL------------ 288
VYS+G+ LMETFT KKPTD+MF GE+SLKNWV +SLP A+T+V+DANL
Sbjct: 953 VYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKD 1012
Query: 289 -------------------RVSMKDVAAKLKKIRVKFLYDV 310
R+ M+DV L+KI++K+ DV
Sbjct: 1013 CITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115342|ref|XP_002317008.1| predicted protein [Populus trichocarpa] gi|222860073|gb|EEE97620.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 371 bits (953), Expect = e-100, Method: Compositional matrix adjust.
Identities = 181/267 (67%), Positives = 215/267 (80%), Gaps = 15/267 (5%)
Query: 22 DLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRA 81
D +ATWRR S+ +++RAT+GF+E NLLGTGSFG VYKG+ SDG N A+KVF QL A
Sbjct: 1 DFPDLATWRRVSFQELERATDGFDEVNLLGTGSFGSVYKGLFSDGANAAVKVFHTQLEGA 60
Query: 82 FRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER 141
F+SFD ECEVLR++ HRNL+KI +SC N DFKALVLE MPN SLE WLYSHNYFLD L+R
Sbjct: 61 FKSFDVECEVLRSIRHRNLVKIITSCCNIDFKALVLEFMPNWSLEKWLYSHNYFLDLLQR 120
Query: 142 LNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201
LNIMIDV ALEYLHHG+++ +VHCDLKPSNILLDENMVA VSDFGI+KLLG+G S+T
Sbjct: 121 LNIMIDVASALEYLHHGNATL-VVHCDLKPSNILLDENMVAHVSDFGIAKLLGEGH-SIT 178
Query: 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
QTMT+AT+GYMAP ++GSEGI+S K DVYS+G+LLMETFT +KPTDEM
Sbjct: 179 QTMTLATVGYMAP-------------EYGSEGIVSVKGDVYSYGILLMETFTRRKPTDEM 225
Query: 262 FTGEISLKNWVNESLPHALTDVVDANL 288
FTGE +LK WV +SLP A+T + DANL
Sbjct: 226 FTGETNLKLWVKDSLPGAVTQIADANL 252
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 189/349 (54%), Positives = 235/349 (67%), Gaps = 50/349 (14%)
Query: 1 MIVIIVCIVLRK---RSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGI 57
+ V+ I+L++ R AK D L + T RR SY ++Q AT GF E N LG GSFG
Sbjct: 756 VFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGS 815
Query: 58 VYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117
VYKG LSDG +A KVF LQL RAF+SFD+ECEVLRN+ HRNL+KI +SCS P+FKALVL
Sbjct: 816 VYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVL 875
Query: 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD 177
E MPN SLE WLYS +YFL+ L+RLNIM+DV LEYLHHG+ + P+ HCD+KPSN+LL+
Sbjct: 876 EFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGY-TIPMAHCDIKPSNVLLN 934
Query: 178 ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA 237
E+MVA ++DFGISKLLG+ E SV QTMT+ATIGYMAP ++GSEGI+S
Sbjct: 935 EDMVAFLADFGISKLLGE-EGSVMQTMTLATIGYMAP-------------EYGSEGIVSV 980
Query: 238 KCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL--------- 288
+ DVYS+GVLLMETFT KKPTD+MFT ++SLK+WV +SL +T V+DANL
Sbjct: 981 RGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLA 1040
Query: 289 -----------------------RVSMKDVAAKLKKIRVKFLYDVAATS 314
R+ MK V L+KI+ KFL D+ S
Sbjct: 1041 AKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDIRQLS 1089
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 350 bits (898), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 183/343 (53%), Positives = 231/343 (67%), Gaps = 49/343 (14%)
Query: 1 MIVIIVCIVL--RKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIV 58
++V + +V+ R+R K P L A RR SYL++ AT F+E NLLG GSFG V
Sbjct: 686 LVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSV 745
Query: 59 YKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118
Y+G L DG NVA+K+F LQL RAFRSFD+ECE++RN+ HRNL+KI SCSN DFKALVLE
Sbjct: 746 YQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLE 805
Query: 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178
MP GSLE WLYSHNY LD ++R+NIMIDV ALEYLHHG+ S P+VHCDLKPSN+LLDE
Sbjct: 806 YMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPS-PVVHCDLKPSNVLLDE 864
Query: 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAK 238
+MVA V DFGI+KLLG+ E S QT T+ATIGYMAP ++G +G++S K
Sbjct: 865 DMVAHVCDFGIAKLLGENE-SFAQTRTLATIGYMAP-------------EYGLDGLVSTK 910
Query: 239 CDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL---------- 288
DVYSFG++LME T K+PTDEMF GE+SLK V ESLP ++ D+VD+N+
Sbjct: 911 IDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVK 970
Query: 289 ----------------------RVSMKDVAAKLKKIRVKFLYD 309
R++M ++ A+LK I+ +FL D
Sbjct: 971 KEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 345 bits (886), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 179/299 (59%), Positives = 223/299 (74%), Gaps = 20/299 (6%)
Query: 3 VIIVCIVLRKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI 62
V I+ I RKR+ +I LLP+AT +R SY ++++AT+ FNE NLLG GSFG VYKG
Sbjct: 718 VAIIFIRSRKRNMRITE--GLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGT 775
Query: 63 LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS--NPDFKALVLELM 120
SDG++VA+KVF LQ+ AF+SFD ECEVLR + HRNL+KI +SCS N DFKALVLE M
Sbjct: 776 FSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFM 835
Query: 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180
PN SLE WL S +FL+ LERLNIM+DV A+EYLHHG+ + PIVHCDLKPSNILLDENM
Sbjct: 836 PNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGY-AMPIVHCDLKPSNILLDENM 894
Query: 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCD 240
VA V+DFGI+KLLGD E S QT+T+AT+GYMAP ++GSEG++S D
Sbjct: 895 VAHVTDFGIAKLLGD-EHSFIQTITLATVGYMAP-------------EYGSEGVVSTGGD 940
Query: 241 VYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDAN-LRVSMKDVAAK 298
+YSFG+LLMETFT KKPTD+MF EIS+K WV ES+P +T + D + LR+ + +AK
Sbjct: 941 IYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAK 999
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 337 bits (865), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 173/341 (50%), Positives = 230/341 (67%), Gaps = 49/341 (14%)
Query: 1 MIVIIVCIVLRKRSAKIIAP--IDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIV 58
M+ + +++R+R +K AP ++ + RR S+ ++ AT F E N++GTGS G+V
Sbjct: 833 MVFVAFVVLIRRRRSKSKAPAQVNSFHLGKLRRISHQELIYATNYFGEDNMIGTGSLGMV 892
Query: 59 YKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118
++G+LSDG+ VA+KVF L+ AF+SFD+ECE++RN+ HRNL+KI SSCS +FKALVLE
Sbjct: 893 HRGVLSDGSIVAVKVFNLEFQGAFKSFDAECEIMRNIQHRNLVKIISSCSILNFKALVLE 952
Query: 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178
MPNGSLE WLYSHNY L+ ++RLNIMIDV ALEYLHH S P+VHCDLKP+N+LLDE
Sbjct: 953 YMPNGSLEKWLYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHCDLKPNNVLLDE 1012
Query: 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAK 238
MVAR+ DFGISKLL + E S+ QT T+ TIGYMAP ++GSEGI+S +
Sbjct: 1013 EMVARLGDFGISKLLTETE-SMEQTRTLGTIGYMAP-------------EYGSEGIVSTR 1058
Query: 239 CDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL---------- 288
DVYS+G+++METF KKPTDEMF GE++L++WV ESL + +VVD NL
Sbjct: 1059 GDVYSYGIMMMETFARKKPTDEMFGGEVTLRSWV-ESLAGRVMEVVDGNLVRREDQHFGI 1117
Query: 289 ----------------------RVSMKDVAAKLKKIRVKFL 307
R+ MK+V +LKKIR+K L
Sbjct: 1118 KESCLRSIMALALECTTESPRDRIDMKEVVVRLKKIRIKLL 1158
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 337 bits (864), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 172/299 (57%), Positives = 222/299 (74%), Gaps = 20/299 (6%)
Query: 3 VIIVCIVLRKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI 62
V+I+ I RKR+ + LLP+AT R SY ++++AT+ FNE NLLG GSFG VYKGI
Sbjct: 648 VVIIFIRSRKRNRRTTE--GLLPLATLERISYRELEQATDKFNEINLLGKGSFGSVYKGI 705
Query: 63 LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS--NPDFKALVLELM 120
SDG +VA+KVF LQ AF+SFD E EVLR + HRNL+KI +SCS N +FKALVLE M
Sbjct: 706 FSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFM 765
Query: 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180
PN SLE WLYS N+FL+ L+RLNIM+DV A+EYLHHG+++ PIVHCDLKP+NILLDENM
Sbjct: 766 PNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHHGYTT-PIVHCDLKPNNILLDENM 824
Query: 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCD 240
A V+DFGI+KLLGD E S +T+T+AT+GYMAP ++GSEG++S D
Sbjct: 825 AAHVTDFGIAKLLGD-ERSFIRTITLATVGYMAP-------------EYGSEGVVSTGGD 870
Query: 241 VYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDAN-LRVSMKDVAAK 298
VYSFG+L++ETFT +KPTD+MF E+++K WV ESL +T + D N LR+ + ++AK
Sbjct: 871 VYSFGILMIETFTSRKPTDDMFNEEMNMKQWVQESLAGGVTQIADPNLLRIEDEHLSAK 929
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 335 bits (858), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 180/338 (53%), Positives = 224/338 (66%), Gaps = 49/338 (14%)
Query: 1 MIVIIVCIVLRKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYK 60
+ +I V RKR+A + + L ATWRR SY +I +AT GF+ NLLG GS G VY+
Sbjct: 761 LALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYR 820
Query: 61 GILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKALVLE 118
G LSDG N AIKVF LQ AF+SFD+ECEV+ ++ HRNL+KI SSCSN DFKALVLE
Sbjct: 821 GTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLE 880
Query: 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178
+PNGSLE WLYSHNY LD L+RLNIMIDV LA+EYLHHG S P+VHCDLKPSNILLDE
Sbjct: 881 YVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHG-CSTPVVHCDLKPSNILLDE 939
Query: 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAK 238
+ V DFGI+KLL + E+S+ +T T+ATIGYMAP K+ S GI++
Sbjct: 940 DFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAP-------------KYVSNGIVTTS 985
Query: 239 CDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL---------- 288
DVYS+G++LMETFT ++PTDE+F+ E+S+KNWV + L ++T+VVDANL
Sbjct: 986 GDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMA 1045
Query: 289 ----------------------RVSMKDVAAKLKKIRV 304
R+ MKDV LKKI+
Sbjct: 1046 KKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIKT 1083
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 331 bits (849), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 169/280 (60%), Positives = 209/280 (74%), Gaps = 17/280 (6%)
Query: 11 RKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVA 70
RKR+A + + L ATWRR SY +I +AT GF+ NLLG GS G VY+G LSDG N A
Sbjct: 1175 RKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAA 1234
Query: 71 IKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKALVLELMPNGSLENW 128
IKVF LQ AF+SFD+ECEV+ ++ HRNL+KI SSCSN DFKALVLE +PNGSLE W
Sbjct: 1235 IKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERW 1294
Query: 129 LYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188
LYSHNY LD L+RLNIMIDV LA+EYLHHG S P+VHCDLKPSNILLDE+ V DFG
Sbjct: 1295 LYSHNYCLDILQRLNIMIDVALAMEYLHHG-CSTPVVHCDLKPSNILLDEDFGGHVGDFG 1353
Query: 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
I+KLL + E+S+ +T T+ATIGYMAP K+ S GI++ DVYS+G++L
Sbjct: 1354 IAKLLRE-EESIRETQTLATIGYMAP-------------KYVSNGIVTTSGDVYSYGIVL 1399
Query: 249 METFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL 288
METFT ++PTDE+F+ E+S+KNWV + L ++T+VVDANL
Sbjct: 1400 METFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANL 1439
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485121|ref|XP_003633218.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 330 bits (846), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 166/332 (50%), Positives = 220/332 (66%), Gaps = 48/332 (14%)
Query: 11 RKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVA 70
RKR+ + ID+LP R SY +++RAT F+E N+LG GSFG V+KG+L DG NVA
Sbjct: 986 RKRNVTALNSIDVLPSVAHRMISYHELRRATNDFSEANILGVGSFGSVFKGVLFDGTNVA 1045
Query: 71 IKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLY 130
+KV LQ+ AF+SFD+ECEVL V HRNL+K+ SSCSNP+ +ALVL+ MPNGSLE WLY
Sbjct: 1046 VKVLNLQIEGAFKSFDAECEVLVRVRHRNLVKVISSCSNPELRALVLQYMPNGSLEKWLY 1105
Query: 131 SHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190
SHNY L+ +R++IM+DV LALEYLHHG S P+VHCDLKPSN+LLD M+A V DFGI+
Sbjct: 1106 SHNYCLNLFQRVSIMVDVALALEYLHHGQSE-PVVHCDLKPSNVLLDGEMIAHVGDFGIA 1164
Query: 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
K+L + + + TQT T+ T+GY+AP ++GSEG +S + D+YS+GV+L+E
Sbjct: 1165 KILVENK-TATQTKTLGTLGYIAP-------------EYGSEGRVSTRGDIYSYGVMLLE 1210
Query: 251 TFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL---------------------- 288
FT KKPTD MF GE+SL+ WV S+P + +V+D NL
Sbjct: 1211 MFTRKKPTDVMFVGELSLRQWVMTSIPDKIMEVIDGNLLRIEDGRDVIAAQGDLLAIMEL 1270
Query: 289 -----------RVSMKDVAAKLKKIRVKFLYD 309
RV +K+V KL KI+VK ++D
Sbjct: 1271 GLECSREFPEERVDIKEVVVKLNKIKVKQVHD 1302
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.770 | 0.236 | 0.446 | 6.8e-52 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.866 | 0.269 | 0.413 | 1.1e-51 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.834 | 0.259 | 0.428 | 7.7e-51 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.792 | 0.246 | 0.416 | 4.2e-49 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.853 | 0.259 | 0.402 | 2.2e-46 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.808 | 0.259 | 0.419 | 5.1e-46 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.789 | 0.241 | 0.411 | 4e-44 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.735 | 0.460 | 0.413 | 2.8e-43 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.850 | 0.572 | 0.352 | 5.9e-41 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.780 | 0.519 | 0.372 | 2.6e-40 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 6.8e-52, P = 6.8e-52
Identities = 121/271 (44%), Positives = 171/271 (63%)
Query: 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVL 92
SY + +AT+GF NLLG+GSFG VYKG L+ ++VA+KV KL+ +A +SF +ECE L
Sbjct: 697 SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEAL 756
Query: 93 RNVHHRNLLKIFSSCSN-----PDFKALVLELMPNGSLENWLY------SHNYFLDTLER 141
RN+ HRNL+KI + CS+ DFKA+V + MPNGSLE+W++ + L+ R
Sbjct: 757 RNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRR 816
Query: 142 LNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201
+ I++DV AL+YLH H P+VHCD+K SN+LLD +MVA V DFG++++L DG +
Sbjct: 817 VTILLDVACALDYLHR-HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQ 875
Query: 202 Q-TMTMA---TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
Q T +M TIGY AP ++G I S D+YS+G+L++E TGK+P
Sbjct: 876 QSTSSMGFIGTIGYAAP-------------EYGVGLIASTHGDIYSYGILVLEIVTGKRP 922
Query: 258 TDEMFTGEISLKNWVNESLPHALTDVVDANL 288
TD F ++ L+ +V L +TDVVD L
Sbjct: 923 TDSTFRPDLGLRQYVELGLHGRVTDVVDTKL 953
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.1e-51, P = 1.1e-51
Identities = 126/305 (41%), Positives = 185/305 (60%)
Query: 3 VIIVCIVLRKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI 62
V ++ + RK++ + P + SY D++ AT GF+ N++G+GSFG VYK +
Sbjct: 661 VTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKAL 720
Query: 63 L-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF-----KALV 116
L ++ VA+KV +Q A +SF +ECE L+++ HRNL+K+ ++CS+ DF +AL+
Sbjct: 721 LLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALI 780
Query: 117 LELMPNGSLENWLYS------H--NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
E MPNGSL+ WL+ H + L LERLNI IDV L+YLH H PI HCD
Sbjct: 781 YEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCD 839
Query: 169 LKPSNILLDENMVARVSDFGISKLLGD-GEDSVTQTMTMA----TIGYMAPVSQLFDILK 223
LKPSN+LLD+++ A VSDFG+++LL E+S ++ A TIGY AP
Sbjct: 840 LKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP--------- 890
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDV 283
++G G S DVYSFG+LL+E FTGK+PT+E+F G +L ++ +LP + D+
Sbjct: 891 ----EYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDI 946
Query: 284 VDANL 288
VD ++
Sbjct: 947 VDESI 951
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 7.7e-51, P = 7.7e-51
Identities = 128/299 (42%), Positives = 180/299 (60%)
Query: 11 RKRSAKI--IAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN 68
RK + KI AP L + SY D++ AT+GF+ N++G+GSFG V+K +L N
Sbjct: 668 RKNNQKINNSAPFTL--EIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENK 725
Query: 69 -VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF-----KALVLELMPN 122
VA+KV +Q A +SF +ECE L+++ HRNL+K+ ++C++ DF +AL+ E MPN
Sbjct: 726 IVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPN 785
Query: 123 GSLENWLYS------H--NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174
GSL+ WL+ H + L LERLNI IDV L+YLH H PI HCDLKPSNI
Sbjct: 786 GSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNI 844
Query: 175 LLDENMVARVSDFGISKLL--GDGEDSVTQTMTMA---TIGYMAPVSQLFDILKPKNAKF 229
LLD+++ A VSDFG+++LL D E Q + TIGY AP ++
Sbjct: 845 LLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAP-------------EY 891
Query: 230 GSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDANL 288
G G S DVYSFGVL++E FTGK+PT+E+F G +L ++ +LP + D+ D ++
Sbjct: 892 GMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSI 950
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 4.2e-49, P = 4.2e-49
Identities = 118/283 (41%), Positives = 175/283 (61%)
Query: 31 RTSYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSEC 89
+ SY D++ AT GF+ N++G+GSFG V+K +L ++ VA+KV +Q A +SF +EC
Sbjct: 690 KISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAEC 749
Query: 90 EVLRNVHHRNLLKIFSSCSNPDF-----KALVLELMPNGSLENWLYSHNY--------FL 136
E L++ HRNL+K+ ++C++ DF +AL+ E +PNGS++ WL+ L
Sbjct: 750 ESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTL 809
Query: 137 DTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL--G 194
LERLNI+IDV L+YLH H PI HCDLKPSN+LL++++ A VSDFG+++LL
Sbjct: 810 TLLERLNIVIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKF 868
Query: 195 DGEDSVTQTMTMA---TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251
D E + Q + TIGY AP ++G G S DVYSFGVLL+E
Sbjct: 869 DKESFLNQLSSAGVRGTIGYAAP-------------EYGMGGQPSIHGDVYSFGVLLLEM 915
Query: 252 FTGKKPTDEMFTGEISLKNWVNESLPHALTDVVD-ANLRVSMK 293
FTGK+PTDE+F G ++L ++ +LP + ++ D A L + ++
Sbjct: 916 FTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLR 958
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 2.2e-46, P = 2.2e-46
Identities = 124/308 (40%), Positives = 176/308 (57%)
Query: 11 RKRSAKIIAPIDLLPVATWR-RTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN- 68
+K +A P D + + + SY ++ AT F+ NL+G+G+FG V+KG+L N
Sbjct: 678 KKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKL 737
Query: 69 VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-----PDFKALVLELMPNG 123
VA+KV L A +SF +ECE + + HRNL+K+ + CS+ DF+ALV E MP G
Sbjct: 738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797
Query: 124 SLENWLY--------SHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNI 174
SL+ WL H+ L E+LNI IDV ALEYLH H H P+ HCD+KPSNI
Sbjct: 798 SLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHD--PVAHCDIKPSNI 855
Query: 175 LLDENMVARVSDFGISKLLG--DGEDSVTQTMTMA---TIGYMAPVSQLFDILKPKNAKF 229
LLD+++ A VSDFG+++LL D E + Q + TIGY AP ++
Sbjct: 856 LLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP-------------EY 902
Query: 230 GSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALT----DVVD 285
G G S + DVYSFG+LL+E F+GKKPTDE F G+ +L ++ L + + +D
Sbjct: 903 GMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSNAID 962
Query: 286 ANLRVSMK 293
LR+ ++
Sbjct: 963 EGLRLVLQ 970
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.1e-46, P = 5.1e-46
Identities = 110/262 (41%), Positives = 156/262 (59%)
Query: 31 RTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFR-SFDSEC 89
R SY + AT GFN +L+G+G FG VYKG+L + VA+KV + F SF EC
Sbjct: 648 RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKREC 707
Query: 90 EVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---LDTLERLNIMI 146
++L+ HRNL++I ++CS P F ALVL LMPNGSLE LY Y LD ++ +NI
Sbjct: 708 QILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICS 767
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
DV + YLHH +S +VHCDLKPSNILLD+ M A V+DFGIS+L+ E++V+ T
Sbjct: 768 DVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVS---TD 823
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266
++ + + L + ++G S DVYSFGVLL+E +G++PTD +
Sbjct: 824 DSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGS 883
Query: 267 SLKNWVNESLPHALTDVVDANL 288
SL ++ P +L +++ L
Sbjct: 884 SLHEFMKSHYPDSLEGIIEQAL 905
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 460 (167.0 bits), Expect = 4.0e-44, Sum P(2) = 4.0e-44
Identities = 118/287 (41%), Positives = 170/287 (59%)
Query: 25 PVAT-WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN-VAIKVFKLQLGRAF 82
PV + + + SY ++ + T GF+ NL+G+G+FG V+KG L N VAIKV L A
Sbjct: 699 PVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAA 758
Query: 83 RSFDSECEVLRNVHHRNLLKIFSSCSNPDF-----KALVLELMPNGSLENWLY------- 130
+SF +ECE L + HRNL+K+ + CS+ DF +ALV E MPNG+L+ WL+
Sbjct: 759 KSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEET 818
Query: 131 -SHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188
+ + L RLNI IDV AL YLH + H+ PI HCD+KPSNILLD+++ A VSDFG
Sbjct: 819 GNPSRTLGLFARLNIAIDVASALVYLHTYCHN--PIAHCDIKPSNILLDKDLTAHVSDFG 876
Query: 189 ISKLLGDGE-DSVTQTMTMA----TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYS 243
+++LL + D+ + A TIGY AP ++G G S DVYS
Sbjct: 877 LAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP-------------EYGMGGHPSIMGDVYS 923
Query: 244 FGVLLMETFTGKKPTDEMFTGEISLKNWVNESLP--HALTDVVDANL 288
FG++L+E FTGK+PT+++F ++L ++ +L AL D+ D +
Sbjct: 924 FGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQAL-DITDETI 969
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 2.8e-43, P = 2.8e-43
Identities = 110/266 (41%), Positives = 154/266 (57%)
Query: 31 RTSYLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSEC 89
+ SY ++ AT GF+ NL+G+G+F V+KG+L + VA+KV L A +SF +EC
Sbjct: 196 KISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAEC 255
Query: 90 EVLRNVHHRNLLKIFSSCSN-----PDFKALVLELMPNGSLENWLY--------SHNYFL 136
E + + HRNL K+ + CS+ DF+ALV E MP GSL+ WL +H+ L
Sbjct: 256 ESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSL 315
Query: 137 DTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195
E++NI IDV ALEYLH + H P+ HCD+KPSN+LLD+++ A VSDFG+++LL +
Sbjct: 316 TFAEKVNIAIDVASALEYLHVYCHD--PVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYN 373
Query: 196 GEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
++ + TIGY AP ++G S + DVYSFGVLL+E
Sbjct: 374 FDEKTFLNQFSSAGVRGTIGYAAP-------------EYGMGSKPSIQGDVYSFGVLLLE 420
Query: 251 TFTGKKPTDEMFTGEISLKNWVNESL 276
FTGKKPTD F G +L + L
Sbjct: 421 MFTGKKPTDNSFGGGYNLHGYTKSVL 446
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 5.9e-41, P = 5.9e-41
Identities = 103/292 (35%), Positives = 164/292 (56%)
Query: 19 APIDLLPVAT--WRRTSYL-DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFK 75
+P+ LP + W L D++ AT F++ N++G G +G+VY+G L +G+ VA+K
Sbjct: 129 SPLSGLPESHLGWGHWFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKIL 188
Query: 76 LQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS---H 132
LG+A + F E + + +V H+NL+++ C + LV E M NG+LE WL+ H
Sbjct: 189 NHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKH 248
Query: 133 NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192
+ +L R+ ++ AL YLH +VH D+K SNIL+D+ A++SDFG++KL
Sbjct: 249 HGYLTWEARMKVLTGTSKALAYLHEA-IEPKVVHRDIKSSNILIDDRFNAKISDFGLAKL 307
Query: 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252
LGDG+ VT T M T GY+AP ++ + G+++ K DVYSFGVL++E
Sbjct: 308 LGDGKSHVT-TRVMGTFGYVAP-------------EYANTGLLNEKSDVYSFGVLVLEAI 353
Query: 253 TGKKPTDEMF-TGEISLKNWVNESL-PHALTDVVDANLRVSMKDVAAKLKKI 302
TG+ P D E++L W+ + L +V+D N+ V + LK++
Sbjct: 354 TGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAV--RPATRALKRV 403
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
Identities = 99/266 (37%), Positives = 150/266 (56%)
Query: 29 WRRTSYL-DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDS 87
W R L +++ AT G E N++G G +GIVY+GIL+DG VA+K G+A + F
Sbjct: 138 WGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKV 197
Query: 88 ECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLE---RLNI 144
E EV+ V H+NL+++ C ++ LV + + NG+LE W++ + L R+NI
Sbjct: 198 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNI 257
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
++ + L YLH G +VH D+K SNILLD A+VSDFG++KLLG E S T
Sbjct: 258 ILGMAKGLAYLHEG-LEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGS-ESSYVTTR 315
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD-EMFT 263
M T GY+AP ++ G+++ K D+YSFG+L+ME TG+ P D
Sbjct: 316 VMGTFGYVAP-------------EYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQ 362
Query: 264 GEISLKNWVNESLPHALTD-VVDANL 288
GE +L +W+ + + ++ VVD +
Sbjct: 363 GETNLVDWLKSMVGNRRSEEVVDPKI 388
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 314 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.001 | |
| COG3173 | 321 | COG3173, COG3173, Predicted aminoglycoside phospho | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-46
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G FG VY G VAIK+ K + E E+L+ ++H N++K++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ + LV+E GSL++ L + L E L I++ + LEYLH S I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHR 116
Query: 168 DLKPSNILLDE-NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKN 226
DLKP NILLD N +++DFG+SKLL + + + T YMAP ++L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAP-----EVLL--- 166
Query: 227 AKFGSEGIISAKCDVYSFGVLLME 250
+G S K D++S GV+L E
Sbjct: 167 ----GKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-45
Identities = 72/212 (33%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNVHHRNLLKIFS 105
LG GSFG VY G VAIKV K + + R E ++L+ + H N+++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
+ D LV+E G L + L + R + + ALEYLH S IV
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-FYLRQILSALEYLH----SKGIV 119
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
H DLKP NILLDE+ +++DFG+++ L GE T + T YMAP ++L K
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAP-----EVLLGK 171
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
D++S GV+L E TGK P
Sbjct: 172 G--------YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 74/211 (35%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG+GSFG VYK G VA+K+ K + + ++ E +LR + H N++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ D LV+E G L ++L E I + + LEYLH S I+H
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIH 121
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKN 226
DLKP NILLDEN V +++DFG++K L S T T YMAP ++L N
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFV-GTPWYMAP-----EVLLGGN 174
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
K DV+S GV+L E TGK P
Sbjct: 175 G-------YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-43
Identities = 73/219 (33%), Positives = 105/219 (47%), Gaps = 25/219 (11%)
Query: 50 LGTGSFGIVYKGILSDGN-----NVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG VYKG L VA+K K F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
C+ + +V+E M G L ++L + L + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----SKN 122
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+H DL N L+ EN+V ++SDFG+S+ L D D + I +MAP S
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPES------- 174
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
K KF S K DV+SFGVLL E FT G++P M
Sbjct: 175 LKEGKFTS------KSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 74/220 (33%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 50 LGTGSFGIVYKGILSDGN-----NVAIKVFKL-QLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG VYKG L VA+K K + F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 104 FSSCSNPDFKALVLELMPNGSLENWL-YSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
C+ + +V+E MP G L ++L + L + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SK 122
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
+H DL N L+ EN+V ++SDFG+S+ L D D I +MAP S
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYKVKGGKLPIRWMAPES------ 175
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
K KF S K DV+SFGVLL E FT G++P M
Sbjct: 176 -LKEGKFTS------KSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG VYKG L VA+K K F E +++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
C+ + +V E MP G L ++L H L + L + + + +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE----SKN 122
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
VH DL N L+ EN+V ++SDFG+S+ + + + + I +MAP S L D
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES-LKD--- 178
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
G ++K DV+SFGVLL E FT G++P M
Sbjct: 179 ---------GKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-39
Identities = 75/233 (32%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 48 NLLGTGSFGIVYKGILSDGNN----VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLK 102
LG G+FG VYKG L + VA+K K R F E V++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH--------NYFLDTLERLNIMIDVWLALEY 154
+ C+ + LVLE M G L ++L L + L+ I + +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
L S VH DL N L+ E++V ++SDFG+S+ + D + +T I +MAP
Sbjct: 121 LA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
S L D GI ++K DV+SFGVLL E FT G P + E+
Sbjct: 177 ES-LKD------------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 48 NLLGTGSFGIVYKGILSD-GNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIF 104
LLG GSFG VY + D G +A+K +L + + E +L ++ H N+++ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 105 SSCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTLERLNI------MIDVWLALEYLH 156
S + + L LE + GSL + L +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSL-------SSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAP- 214
S IVH D+K +NIL+D + V +++DFG +K LGD E T ++ T +MAP
Sbjct: 119 ----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPE 173
Query: 215 -VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ D++S G ++E TGK P
Sbjct: 174 VIRG---------------EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 69/230 (30%), Positives = 111/230 (48%), Gaps = 21/230 (9%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH 97
+R E F LG+G FG V++G+ + VAIK+ K + F E + L+ + H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLH 156
++L+ +F+ CS + ++ ELM GSL +L S L +++ V + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
+ +H DL NIL+ E++V +V+DFG+++L+ + D + + AP +
Sbjct: 122 EQN----SIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEA 175
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE 265
S G S K DV+SFG+LL E FT G+ P M E
Sbjct: 176 -------------ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G FG VYK G VAIKV KL+ +E ++L+ H N++K + S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E GSL++ L S N L + + ++ LEYLH S I+H D
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRD 123
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K +NILL + ++ DFG+S L D + TM + T +MAP +++ K
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM-VGTPYWMAP-----EVINGKP-- 173
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
K D++S G+ +E GK P
Sbjct: 174 ------YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (287), Expect = 2e-29
Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 43 GFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHR 98
+ LG GSFG VY D VA+KV +L + F E ++L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH--NYFLDTLERLNIMIDVWLALEYLH 156
N++K++ + LV+E + GSLE+ L L E L I+ + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 157 HGHSSAPIVHCDLKPSNILLDEN-MVARVSDFGISKLLGDGEDSVTQTMTMA----TIGY 211
S I+H D+KP NILLD + V ++ DFG++KLL D + + + T GY
Sbjct: 119 ----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---TDEMFTGEISL 268
MA P+ S S+ D++S G+ L E TG P +L
Sbjct: 175 MA----------PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
Query: 269 KNWVNESLPHALTDVVDANLRVSMKDVAAKLKKIRVK 305
K + P + + +N + K + LKK+ K
Sbjct: 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAK 261
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 37/271 (13%)
Query: 50 LGTGSFGIVYKGI-LSDGNN----VAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKI 103
LG+G+FG VYKG+ + +G VAIKV + + A + E V+ +V H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
C + L+ +LMP G L +++ +H + + LN + + + YL
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---- 129
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+VH DL N+L+ +++DFG++KLL E I +MA S L
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH---- 185
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNWVNESLPHALT- 281
I + K DV+S+GV + E T G KP + + EI E LP
Sbjct: 186 ---------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPIC 236
Query: 282 --DV---------VDANLRVSMKDVAAKLKK 301
DV +DA R + K++ + K
Sbjct: 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 49 LLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNVHHRNLLKIFSSC 107
+G G+FG VYKG+L VA+K + L + F E E+L+ H N++K+ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+V+EL+P GSL +L L + L + +D +EYL S +H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHR 117
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N L+ EN V ++SDFG+S+ G +V+ + I + AP + +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-------- 169
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFTG 254
G +++ DV+S+G+LL ETF+
Sbjct: 170 -----GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 49 LLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G FG V G G VA+K K A ++F +E V+ + H NL+++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTL-ERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ +V E M GSL ++L S + TL ++L +DV +EYL VH
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHR 126
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N+L+ E++VA+VSDFG++K E S Q + + AP + L+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAP-----EALR---- 172
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
E S K DV+SFG+LL E ++ G+ P
Sbjct: 173 ----EKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIFSSC 107
LG GS G+VYK G A+K + FR E + LR+ ++K + +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDT-LERLNIMIDVWLALEYLHHGHSSAPIVH 166
++VLE M GSL + L + L + I L+YLH I+H
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI--LKGLDYLHTKRH---IIH 123
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-MATIGYMAPVSQLFDILKPK 225
D+KPSN+L++ +++DFGISK+L E+++ Q T + T+ YM+P
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP----------- 169
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ E S D++S G+ L+E GK P
Sbjct: 170 -ERIQGES-YSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 48 NLLGTGSFGIVYKG-ILSDGNNVAIKVFKL-QLGRAFRSF-DSECEVLRNVHHRNLLKIF 104
+G GSFG VY SDG +K L + R +E ++L+ ++H N++K +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 105 SSCSNPDFKALVLELMPNGSL----ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
S +V+E G L + F + + L+ + + LAL+YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQLCLALKYLH---- 120
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
S I+H D+KP NI L N + ++ DFGISK+L D + +T+ T Y++P +
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVV-GTPYYLSP-----E 173
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+ + K + K D++S G +L E T K P F GE
Sbjct: 174 LCQNKP--------YNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LGTG FG+V G +VAIK+ K + + F E +V+ + H L++++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
+V E M NG L N+L H + L + DV + YL S +H DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDL 126
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM-TMATIGYMAPVSQLFDILKPKNAK 228
N L+D+ +VSDFG+S+ + D D T ++ + + + P L+ +K
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLY-------SK 177
Query: 229 FGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK 269
F S+K DV++FGVL+ E ++ GK P + E K
Sbjct: 178 F------SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 75/235 (31%), Positives = 123/235 (52%), Gaps = 32/235 (13%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN 94
L++Q+ T G ++G G FG V +G + G VA+K K + ++F E V+
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTK 55
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFL-DTLERLNIMIDVWLALE 153
+HH+NL+++ + +V+ELM G+L N+L + L ++ L +DV +E
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YL S +VH DL NIL+ E+ VA+VSDFG++++ G D+ + + + A
Sbjct: 115 YLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTA 165
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS 267
P + K+ KF S+K DV+S+GVLL E F+ G+ P +M E+
Sbjct: 166 PEAL-------KHKKF------SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 69/222 (31%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 50 LGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLLKIFS 105
LG GSFG V D + A+KV K + + + +E +L ++H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPI 164
+ + LVLE P G L + L F + R ++ LALEYLH G I
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSLG-----I 114
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLFDILK 223
++ DLKP NILLD + +++DFG++K L +T T T Y+AP ++L
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP-----EVLL 166
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
D +S GVLL E TGK P F E
Sbjct: 167 --------GKGYGKAVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 74/229 (32%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 50 LGTGSFGIVYKG---ILSDGNN---VAIKVFK-LQLGRAFRSFDSECEVLRNVHHRNLLK 102
LG G+FG V+ G L N+ VA+K K A + F+ E E+L N H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHN---YFLD---------TLERL-NIMIDVW 149
+ C+ D +V E M +G L +L SH FL TL +L I + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+ YL +S VH DL N L+ ++V ++ DFG+S+ + + TM I
Sbjct: 133 SGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+M P S ++ KF +E DV+SFGV+L E FT GK+P
Sbjct: 189 RWMPPESIMY-------RKFTTES------DVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIF 104
+L+G G+FG+VYKG+ L G+ VAIK L+ A +S E ++L+N+ H N++K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI--MIDVWLALEYLHHGHSSA 162
S D ++LE NGSL + F E L + V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESLVAVYVYQVLQGLAYLH----EQ 118
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP-VSQLFDI 221
++H D+K +NIL ++ V +++DFG++ L D S + T +MAP V ++
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPEVIEM--- 173
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
G S D++S G ++E TG P
Sbjct: 174 ----------SG-ASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 49 LLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNVHHRNLLKIFSSC 107
LLG G+FG V+KG L D VA+K K L + + F SE +L+ H N++K+ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ +V+EL+P G ++L L T + + +D + YL S +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHR 117
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N L+ EN V ++SDFG+S+ DG S + + I + AP + +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNY-------- 168
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT 253
G S++ DV+S+G+LL ETF+
Sbjct: 169 -----GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-23
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
+G+G FG+V+ G + VAIK + + + F E +V+ + H L++++ C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
LV E M +G L ++L + L + +DV + YL S+ ++H DL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDL 126
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
N L+ EN V +VSDFG+++ + D D T ++ G PV P+ F
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLD--DQYT-----SSTGTKFPVKW----SSPEVFSF 175
Query: 230 GSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
S+K DV+SFGVL+ E F+ GK P + E+
Sbjct: 176 SK---YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-23
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 29/223 (13%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V+ G + VA+K K + +F E ++++ + H L+++++ CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 110 PDFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ +V E M GSL ++L S L L +++ + + YL S +H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLE----SRNYIH 126
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI--LKP 224
DL NIL+ EN+V +++DFG+++L+ D E Y A F I P
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDE-------------YTAREGAKFPIKWTAP 173
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
+ A +G I K DV+SFG+LL E T G+ P M E+
Sbjct: 174 EAANYGRFTI---KSDVWSFGILLTEIVTYGRVPYPGMTNREV 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-23
Identities = 69/218 (31%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG+G FG+V+ G +VAIK+ + + + F E +V+ + H NL++++ C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
+V E M NG L N+L L T L++ DV A+EYL S +H DL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDL 126
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
N L+ E+ V +VSDFG+++ + D + + T + + P ++FD ++F
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPP--EVFD-----YSRF 178
Query: 230 GSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
S+K DV+SFGVL+ E F+ GK P + E+
Sbjct: 179 ------SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIF 104
N +G G+FG VY + L G +A+K ++Q + E +VL + H NL+K +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL-----ALEYLHHGH 159
+ + + +E G+LE L H LD +I V+ L YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILD-----EHVIRVYTLQLLEGLAYLH--- 116
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM--TMATIGYMAPVSQ 217
S IVH D+KP+NI LD N V ++ DFG + L + ++ + + T YMAP
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
K + D++S G +++E TGK+P E+
Sbjct: 176 TGGKGK---GHGRA-------ADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 41/237 (17%)
Query: 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVF-KLQLGR------AFRSFDSECEVL-RN 94
F ++G GSF V AIK+ K QL + E EVL R
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLTRL 58
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
H ++K++ + + + VLE PNG L ++ LD ++ LALEY
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEY 117
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
LH S I+H DLKP NILLD++M +++DFG +K+L + I
Sbjct: 118 LH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI----- 168
Query: 215 VSQLFDILKPKNAKFGS--------------EGIISAKCDVYSFGVLLMETFTGKKP 257
++ +F S E D+++ G ++ + TGK P
Sbjct: 169 ----DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 32/218 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKL----QLGR-AFRSFDSECEVLRNVHHRNLLK 102
LLG+GSFG VY+G+ L DG+ A+K L Q G+ A + + E +L + H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ D + LEL+P GSL L + F + + RL + L LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLHDRN--- 122
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQLF 219
VH D+K +NIL+D N V +++DFG++K V + + G +MAP
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAP----- 170
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+++ + D++S G ++E TGK P
Sbjct: 171 EVIAQQGGY-------GLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 67/228 (29%), Positives = 119/228 (52%), Gaps = 31/228 (13%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFR----------SFDSECEVLRNVHH 97
L+G G++G VY + ++ G +A+K +L A R + SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
N+++ + ++ ++ LE +P GS+ + L ++ F + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVS 216
S I+H DLK N+L+D + + ++SDFGISK D D+ Q M+M ++ +MAP
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAP-- 179
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP--TDEMF 262
+++ + + SAK D++S G +++E F G++P +E
Sbjct: 180 ---EVIHSYSQGY------SAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-21
Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 38/226 (16%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA---------FRSFDSECEVLRNVHHR 98
L+G+GSFG VY G+ S G +A+K +L A + E +L+ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
N+++ S + D + LE +P GS+ L ++ F +TL R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-------MATIGY 211
+ I+H D+K +NIL+D ++SDFGISK L E + T T ++ +
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGSVFW 178
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
MAP +++K + + K D++S G L++E TGK P
Sbjct: 179 MAP-----EVVK--------QTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 4e-21
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIK----VFK-LQLG-RAFRSFDSECEVLRNVHHRNL 100
+G+G++G+V + G VAIK VF L R R E ++LR++ H N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 101 LK---IFSSCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTLERLN-IMIDVWLALEY 154
+ I S DF + V ELM L + S T + + + + L+Y
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPL--TDDHIQYFLYQILRGLKY 118
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYM 212
LH SA ++H DLKPSNIL++ N ++ DFG+++ + ED +T + T Y
Sbjct: 119 LH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTEYVVTRWYR 173
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
AP +L +L ++ I D++S G + E T K
Sbjct: 174 AP--EL--LLSSSRY---TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 9e-21
Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 53/270 (19%)
Query: 10 LRKRSAKIIAPIDLLPVATWRRTSY-----LDIQRATEGFNE---CNLLGTGSFGIVYKG 61
L +R + P+ L P ++ +S A + +E N +G+G+ G VYK
Sbjct: 34 LPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKV 93
Query: 62 I-LSDGNNVAIKVF--------KLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112
I G A+KV + Q+ R E E+LR+V+H N++K +
Sbjct: 94 IHRPTGRLYALKVIYGNHEDTVRRQICR-------EIEILRDVNHPNVVKCHDMFDHNGE 146
Query: 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172
++LE M GSLE + FL + R + + YLH H IVH D+KPS
Sbjct: 147 IQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIAYLHRRH----IVHRDIKPS 197
Query: 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTM-----TMATIGYMAPVSQLFDILKPKNA 227
N+L++ +++DFG+S++L QTM ++ TI YM+P D+ A
Sbjct: 198 NLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAYMSPERINTDL--NHGA 248
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
G G D++S GV ++E + G+ P
Sbjct: 249 YDGYAG------DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 48 NLLGTGSFGIVYKG---ILSD--GNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLL 101
LG G FG V L D G VA+K RS F+ E E+LR + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 102 KIFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
K C P ++ L++E +P+GSL ++L H ++ L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT-QTMTMATIGYMAPVSQL 218
+H DL NIL++ + ++SDFG++K+L + +D + + I + AP
Sbjct: 130 ----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL- 184
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
S+ DV+SFGV L E FT
Sbjct: 185 ------------RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLLK 102
LG G+FG V KG+ + VA+K K + G+ + F E V+ + H +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ C LV+EL P G L +L + + V + + YL H
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYLESKH--- 115
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT-QTMTMATIGYMAPVSQLFDI 221
VH DL N+LL A++SDFG+S+ LG G D T + + AP +
Sbjct: 116 -FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-- 172
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
G S+K DV+S+GV L E F+ G KP EM E+
Sbjct: 173 -----------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 71/215 (33%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 49 LLGTGSFGIVYK---GILSD--GNNVAIKVFKLQLGRA--FRSFDSECEVLRNVHHRNLL 101
LG G+FG V L D G VA+K KLQ A R F+ E E+L+++ H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 102 KIFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
K C + + LV+E +P GSL ++L H LD + L + +EYL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---- 124
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLL-GDGEDSVTQTMTMATIGYMAPVSQL 218
S VH DL NIL++ ++ DFG++K+L D E + + I + AP S
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL- 183
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
+E S DV+SFGV+L E FT
Sbjct: 184 ------------TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 40/231 (17%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLK 102
LG G+FG VYKG L+ N VAIK K + F E E++ ++ H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMID 147
+ C+ ++ E + +G L +L ++ LD + L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+ +EYL SS VH DL N L+ E + ++SDFG+S+ + + Q+ ++
Sbjct: 133 IAAGMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +M P + L+ KF +E D++SFGV+L E F+ G +P
Sbjct: 189 PVRWMPPEAILY-------GKFTTES------DIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V++G+ ++ VA+K K + F +E ++++ + H L+++++ C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPIVHCD 168
+ +V ELM GSL +L L +L ++ V + YL + +H D
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHRD 128
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
L N+L+ EN + +V+DFG+++++ + + + I + AP + L++ +
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYN-------R 180
Query: 229 FGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
F S K DV+SFG+LL E T G+ P M E+
Sbjct: 181 F------SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIFSSC 107
+G G+FG V+ G L +D VA+K + L ++ F E +L+ H N++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ +V+EL+ G +L + L E + ++ + +EYL H +H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHR 118
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N L+ E V ++SDFG+S+ DG + T M + + AP + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-------- 170
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
G S++ DV+SFG+LL E F+ G P
Sbjct: 171 -----GRYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-20
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 48 NLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
+ LG G +G VY+G+ VA+K K + F E V++ + H NL+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 107 CS-NPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
C+ P F ++ E M G+L ++L N ++ + L + + A+EYL +
Sbjct: 71 CTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN----F 125
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
+H DL N L+ EN + +V+DFG+S+L+ G+ I + AP S ++
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN---- 180
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT 253
KF S K DV++FGVLL E T
Sbjct: 181 ---KF------SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 50 LGTGSFGIVY----KGILSDGNN--VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG V+ +L + + VA+K K A + F E E+L + H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--------------LNIMIDVW 149
+ C+ +V E M +G L +L SH L L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+ YL H VH DL N L+ + +V ++ DFG+S+ + + TM I
Sbjct: 133 SGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+M P S L+ KF +E D++SFGV+L E FT GK+P
Sbjct: 189 RWMPPESILY-------RKFTTES------DIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-19
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 45 NECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
E +LG G++GIVY LS +AIK + R + E + + HRN+++
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI----DVWLALEYLHHGH 159
S S F + +E +P GSL L S L E +I + L+YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYLHDNQ 128
Query: 160 SSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
IVH D+K N+L++ + V ++SDFG SK L G + T+T T T+ YMAP
Sbjct: 129 ----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT-GTLQYMAP---- 178
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+++ +G A D++S G ++E TGK P E+
Sbjct: 179 -EVIDKGPRGYG------APADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V+ G + VAIK K + +F E +V++ + H L+++++ S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 110 -PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMID----VWLALEYLHHGHSSAPI 164
P + +V E M GSL ++L RL ++D + + Y+ +
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN----Y 123
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
VH DL+ +NIL+ EN+V +V+DFG+++L+ D E + Q I + AP + L+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY----- 177
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
G + K DV+SFG+LL E T G+ P M E+
Sbjct: 178 --------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-19
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 49 LLGTGSFGIVYKGILS----DGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKI 103
++G G FG V++GIL VAIK K R F SE ++ H N++++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ ++ E M NG+L+ +L H+ + + + ++ + ++YL S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDG-EDSVTQTMTMATIGYMAPVSQLFDIL 222
VH DL NIL++ N+ +VSDFG+S++L D E + T + I + AP + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--- 184
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
KF S DV+SFG+++ E + G++P +M E+
Sbjct: 185 ----RKFTSAS------DVWSFGIVMWEVMSFGERPYWDMSNHEV 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-19
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 48 NLLGTGSFGIVYKGILSDGNNV-AIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
++G G+FG V D + A+K K + R+ +E +L+ ++H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ S + + LV++L+ G L L F + + + ++ LALEYLH S
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH----SKG 120
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
I+H D+KP NILLDE ++DF I+ + + + T T GYMAP ++L
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS---TSGTPGYMAP-----EVLC 172
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ S D +S GV E GK+P
Sbjct: 173 RQGY--------SVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 43/218 (19%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR-----------AFRSFDSECEVLRNV 95
LG G++ +VYK G VAIK K++LG A R E ++L+ +
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIK--KIKLGERKEAKDGINFTALR----EIKLLQEL 59
Query: 96 HHRN---LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
H N LL +F SN + LV E M LE + + L + + M+ L
Sbjct: 60 KHPNIIGLLDVFGHKSNIN---LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
EYLH S I+H DLKP+N+L+ + V +++DFG+++ G + T + T Y
Sbjct: 116 EYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS--PNRKMTHQVVTRWYR 169
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
AP +L FG+ D++S G + E
Sbjct: 170 AP--ELL---------FGARHYGVG-VDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 81/287 (28%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNV----AIKVFKLQLG-RAFRSFDSE 88
L I + TE +LG+G+FG VYKGI + +G V AIK+ G +A F E
Sbjct: 1 LRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 59
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148
++ ++ H +L+++ C +P + LV +LMP+G L ++++ H + + LN + +
Sbjct: 60 ALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI 118
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL +VH DL N+L+ +++DFG+++LL E
Sbjct: 119 AKGMMYLEERR----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS 267
I +MA + + + KF + + DV+S+GV + E T G KP D + T EI
Sbjct: 175 IKWMA-----LECIHYR--KF------THQSDVWSYGVTIWELMTFGGKPYDGIPTREIP 221
Query: 268 LKNWVNESLPH---ALTDV---------VDANLRVSMKDVAAKLKKI 302
E LP DV +DA+ R K++AA+ ++
Sbjct: 222 DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFRS-FDSECEVLRNVHHRNLLKIFSS 106
+G GSFG V K SDG + K + + SE +LR + H N+++ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 107 CSNPDFKAL--VLELMPNGSLENWL---YSHNYFLDTLERLNIMIDVWLALEYLHHG-HS 160
+ + L V+E G L + +++ I+ + LAL H+
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
++H DLKP+NI LD N ++ DFG++K+LG S +T + T YM+P +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTY-VGTPYYMSP-----E 180
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
L + K D++S G L+ E P
Sbjct: 181 QL--------NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDS---ECEVLRNVHHRNLLKIFS 105
+G G+ +VY I L + VAIK L+ + S D E + + +H N++K ++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI---MIDVWLALEYLH-HGHSS 161
S D LV+ + GSL + + +Y L+ I + +V LEYLH +G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMAPVSQLF 219
+H D+K NILL E+ +++DFG+S L DG D + + T +MAP
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP----- 175
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++++ + K D++SFG+ +E TG P
Sbjct: 176 EVMEQVHG-------YDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 26/251 (10%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNN----VAIKVFKLQLG-RAFRSFDSE 88
L I + TE F + +LG+G+FG VYKG+ + +G VAIK + +A + E
Sbjct: 1 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148
V+ +V + ++ ++ C + L+ +LMP G L +++ H + + LN + +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL +VH DL N+L+ +++DFG++KLLG E
Sbjct: 119 AKGMNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS 267
I +MA S L I + + DV+S+GV + E T G KP D + EIS
Sbjct: 175 IKWMALESIL-------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
Query: 268 LKNWVNESLPH 278
E LP
Sbjct: 222 SILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 39/230 (16%)
Query: 50 LGTGSFGIVYKGI---LSDGNN---VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG V+ LS + VA+K K A + F E E+L N+ H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNIMIDV 148
+ C + D +V E M +G L +L +H L + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL H VH DL N L+ N++ ++ DFG+S+ + + TM
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I +M P S ++ KF +E DV+SFGV+L E FT GK+P
Sbjct: 189 IRWMPPESIMY-------RKFTTES------DVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 69/239 (28%), Positives = 108/239 (45%), Gaps = 42/239 (17%)
Query: 50 LGTGSFGIVYKGILSDGNN---------VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL 100
LG G+FG V+ L++ N VA+K K A + F E E+L N+ H ++
Sbjct: 13 LGEGAFGKVF---LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHN------------YFLDTLERLNIMIDV 148
+K + C D +V E M +G L +L +H L + L+I +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL H VH DL N L+ EN++ ++ DFG+S+ + + TM
Sbjct: 130 AAGMVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
I +M P S ++ KF +E DV+S GV+L E FT GK+P ++ E+
Sbjct: 186 IRWMPPESIMY-------RKFTTES------DVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-18
Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 29/228 (12%)
Query: 37 IQRATEGFNECNLLGTGSFGIVYKGILSDGN----NVAIKVFKLQLGRAFRS-FDSECEV 91
IQR C +G G FG VY+G+ VA+K K + R F E +
Sbjct: 3 IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 92 LRNVHHRNLLKIFSSCS-NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL 150
+R H +++K+ + NP + +V+EL P G L ++L + Y LD + +
Sbjct: 61 MRQFDHPHIVKLIGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
AL YL S VH D+ N+L+ ++ DFG+S+ L D E + I
Sbjct: 119 ALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIK 173
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+MAP S F +F ++ DV+ FGV + E G KP
Sbjct: 174 WMAPESINF-------RRF------TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-18
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 26/217 (11%)
Query: 49 LLGTGSFGIVYKGILSDGN----NVAIKVFK-LQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG GSFG+V +G S VA+K K +L F E ++ ++ H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSA 162
+ +V EL P GSL + L + L + + + + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT-IGYMAPVSQLFDI 221
+H DL NILL + ++ DFG+ + L ED + + AP S
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL---- 172
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ F S DV+ FGV L E FT G++P
Sbjct: 173 ---RTRTF------SHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 50 LGTGSFGIVYKGIL-SDGNNVAIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
LG G FG V + S A+K K + SE E+L +H ++K++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI--MIDVWLALEYLHHGHSSAP 163
+ + + +++E G L L F + R I ++ LA EYLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG---- 113
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQLFDIL 222
I++ DLKP N+LLD N ++ DFG +K L G+ +T T T Y+AP
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAP-------- 161
Query: 223 KPKNAKFGSEGIISAK-----CDVYSFGVLLMETFTGKKPTDEMFTGE 265
E II K D +S G+LL E TG+ P F +
Sbjct: 162 ---------E-IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 48 NLLGTGSFGIVYKGILS----DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLK 102
++G G FG V +G L +VAIK K + F +E ++ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ + ++ E M NGSL+ +L ++ + + ++ + ++YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL----SEM 125
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
VH DL NIL++ N+V +VSDFG+S+ L D E + T I + AP + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--- 182
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
++ DV+SFG+++ E + G++P +M
Sbjct: 183 ----------RKFTSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 43/244 (17%)
Query: 48 NLLGTGSFGIVYKGILS-DGN--NVAIKVFK-LQLGRAFRSFDSECEVLRNV-HHRNLLK 102
+++G G+FG V + ++ DG N AIK+ K R F E EVL + HH N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------------LDTLERLNIMID 147
+ +C N + + +E P G+L ++L L + + L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTM 206
V ++YL S +H DL N+L+ EN+ ++++DFG+S+ GE+ V +TM
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE 265
+ +MA S + + + K DV+SFGVLL E + G P M E
Sbjct: 180 LPVRWMAIESLNYSVY-------------TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226
Query: 266 ISLK 269
+ K
Sbjct: 227 LYEK 230
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G+ G VYK + G VAIK +L+ + E ++++ H N++ + S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E M GSL + + + ++ + + +V LEYLH S ++H D
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRD 141
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K NILL ++ +++DFG + L + ++ + T +MAP +++K K+
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-SV-VGTPYWMAP-----EVIKRKD-- 192
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
K D++S G++ +E G+ P
Sbjct: 193 ------YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFR-SFDSECEVLRNVHHRNLLKIFS 105
++G G+FGIV+ +D V IK + Q+ + R + +EC+VL+ + H N+++ +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ +V+E P G+L ++ N LD L+ + + LAL ++H + I
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLI 122
Query: 165 VHCDLKPSNILLDEN-MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+H DLK NILLD++ MV ++ DFGISK+L + T + T Y++P +L + K
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISP--ELCE-GK 176
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLME 250
P N K D+++ G +L E
Sbjct: 177 PYN----------QKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 53 GSFGIVYKGI-LSDGNNVAIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
G++G V+ S G+ AIKV K + +E ++L ++K++ S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHC 167
LV+E +P G L + L + + + R + ++ LALEYLH +G I+H
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG-----IIHR 117
Query: 168 DLKPSNILLDENMVARVSDFGISKL------LGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
DLKP NIL+D N +++DFG+SK+ + +D + T Y+AP ++
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP-----EV 172
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + D +S G +L E G P
Sbjct: 173 ILGQGHSK--------TVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVFKL-----QLGRAFRSFDSECEVLRNVHHRNLLK 102
LLG G+FG VY D G +A+K + + + + E ++L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ + + ++ +E MP GS+++ L ++ +T+ R + +EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSNM--- 124
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
IVH D+K +NIL D ++ DFG SK L QT+ + G M V+ +
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICSSGTG-MKSVTGTPYWM 174
Query: 223 KPKNAKFGSEGIISA-----KCDVYSFGVLLMETFTGKKP 257
P+ +IS K DV+S G ++E T K P
Sbjct: 175 SPE--------VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 40/286 (13%)
Query: 37 IQRATEGFNECNLLGTGSFGIVYKGI-LSDGNN----VAIKVFKLQLGR-AFRSFDSECE 90
I + TE + LLG+G FG V+KGI + +G++ VAIK + + GR F+
Sbjct: 3 ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61
Query: 91 VLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL 150
+ ++ H ++++ C + LV +L P GSL + + H LD LN + +
Sbjct: 62 AMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 151 ALEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+ YL H +VH +L NILL + + +++DFG++ LL + + I
Sbjct: 121 GMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS- 267
+MA S LF G + + DV+S+GV + E + G +P M E+
Sbjct: 176 KWMALESILF-------------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
Query: 268 -LKNWVNESLPHALT-DV---------VDANLRVSMKDVAAKLKKI 302
L+ + P T DV +D N+R + K++A + ++
Sbjct: 223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG GS+G VYK I G VAIKV + + + E +L+ ++K + S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+V+E GS+ + + N L E I+ LEYLH S +H
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHR 123
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
D+K NILL+E A+++DFG+S L D T+ + T +MAP ++++
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTV-IGTPFWMAP-----EVIQEIG- 175
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ K D++S G+ +E GK P
Sbjct: 176 -------YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 37/230 (16%)
Query: 48 NLLGTGSFGIVYKG----ILSDGNN---VAIKVFKL-QLGRAFRSFDSECEVLRNVHHRN 99
N LG+G+FG VY+G IL G+ VA+K + + + F E ++ N +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYS------HNYFLDTLERLNIMIDVWLALE 153
++K+ C + + +++ELM G L ++L L E L+I +DV
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDE-----NMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
YL H +H DL N L+ E + V ++ DFG+++ + + + +
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP S L +G + + DV+SFGVL+ E T G++P
Sbjct: 177 VRWMAPESLL-------------DGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ-LGRAFRSFD-SECEVLRNVHHRNLLKIF 104
N +G GSFG+V+K + +D A+K L + R R E VL + +++ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI---MIDVWLALEYLHHGHSS 161
S + +V+E NG L L L + I + L L +LH S
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILLGLAHLH----S 119
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
I+H D+K N+ LD ++ D G++KLL D + T+ + T Y++P +L +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTI-VGTPYYLSP--ELCED 175
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269
KP N K DV++ GV+L E TGK P D G + LK
Sbjct: 176 -KPYN----------EKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLK 102
+G G++G+VYK G VAIK KL+ A R E ++L+ ++H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ + LV E M + L + L + + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SH 117
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
I+H DLKP N+L++ V +++DFG+++ G T + T Y AP ++L
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAP-----ELL 170
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMET------FTGKKPTDEMF 262
K S + D++S G + E F GK D++F
Sbjct: 171 --LGDKGYSTPV-----DIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 43/188 (22%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAF-------RSFDSECEVLRNVHHRN-- 99
+G+G++G+V I G VAIK ++ AF R+ E ++LR+ H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNII 67
Query: 100 -LLKIFSSCSNPDFKA--LVLELMPNGSLENWLYSH--------NYFLDTLERLNIMIDV 148
+ I DFK +V++LM + L + ++S YFL L R
Sbjct: 68 AIRDILRP-PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--M 206
L+Y+H SA ++H DLKPSN+L++E+ R+ DFG+++ L MT +
Sbjct: 119 --GLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 207 ATIGYMAP 214
AT Y AP
Sbjct: 173 ATRWYRAP 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-17
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 24/220 (10%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V+ G + VA+K K + SF E ++++ + H L+++++ S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 110 -PDFKALVLELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
P + +V E M GSL ++L L +++ V + Y+ + +H
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHR 126
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL+ +NIL+ + +V +++DFG+++L+ D E + Q I + AP + L+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY-------- 177
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
G + K DV+SFG+LL E T G+ P M E+
Sbjct: 178 -----GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 39/220 (17%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G+G++G VYK ++ G VAIKV KL+ G F E +L+ H N++ F S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI---DVWLALEYLHHGHSSAPIV 165
D +V+E GSL++ +Y L L I + L YLH +
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHETG----KI 123
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT----IG---YMAP-VSQ 217
H D+K +NILL E+ +++DFG+S L T T+A IG +MAP V+
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKSFIGTPYWMAPEVAA 174
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ K G +G KCD+++ G+ +E + P
Sbjct: 175 V-------ERKGGYDG----KCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-17
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V+ G + VAIK K +F E ++++ + H L+ +++ S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 110 PDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
+V E M GSL ++L + +L + +++ + + Y+ + +H D
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN----YIHRD 127
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
L+ +NIL+ +N+V +++DFG+++L+ D E + Q I + AP + L+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY--------- 177
Query: 229 FGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
G + K DV+SFG+LL E T G+ P M E+
Sbjct: 178 ----GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 81/268 (30%), Positives = 121/268 (45%), Gaps = 40/268 (14%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
+G G FG V G GN VA+K K ++F +E V+ + H NL+++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 110 PDFKA-LVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+V E M GSL ++L S L L +DV A+EYL + VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHR 126
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N+L+ E+ VA+VSDFG++K E S TQ + + AP + L+ K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP-----EALREK-- 174
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI------SLKNWVNESLPHAL 280
KF S K DV+SFG+LL E ++ G+ P + ++ K + P +
Sbjct: 175 KF------STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
Query: 281 TDV------VDANLRVSMKDVAAKLKKI 302
DV +DA R S + +L+ I
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 35/227 (15%)
Query: 49 LLGTGSFGIVYKGILS--DGN--NVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLK 102
+LG G FG V +G LS DG+ VA+K KL + F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 103 IF------SSCSNPDFKALVLELMPNGSLENWLYSHN-----YFLDTLERLNIMIDVWLA 151
+ SS ++L M +G L ++L L L M+D+ L
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
+EYL S+ +H DL N +L E+M V+DFG+SK + G+ + + +
Sbjct: 126 MEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+A + L D + ++K DV++FGV + E T G+ P
Sbjct: 182 IA-IESLAD------------RVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 50 LGTGSFGIVYKG-ILSDGNNVAIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G+ G+V K G +A+K +L++ A + E ++L + ++ + +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
N ++ +E M GSL+ L + I + V L YLH H I+H
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHR 125
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
D+KPSNIL++ ++ DFG+S L +S+ +T T YMAP
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFV-GTSSYMAP------------- 168
Query: 228 KFGSEGI----ISAKCDVYSFGVLLMETFTGKKP 257
E I S K D++S G+ L+E TG+ P
Sbjct: 169 ----ERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG+G FG+V+ G VAIK + + F E +V+ + H L++++ C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
+V E M NG L N+L L L++ DV +EYL +H DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS----FIHRDL 126
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
N L+ V +VSDFG+++ + D E + + + + P ++F+ K
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPP--EVFNFSK------ 177
Query: 230 GSEGIISAKCDVYSFGVLLMETFT-GKKP 257
S+K DV+SFGVL+ E FT GK P
Sbjct: 178 -----YSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 50 LGTGSFGIVYKGIL---SDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNVHHRNLLKIFS 105
LG+G+FG V KG+ +VAIKV K + ++ R E E++ + + ++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
C LV+E+ G L +L + + +M V + ++YL + V
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN----FV 117
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT--IGYMAPVSQLFDILK 223
H DL N+LL A++SDFG+SK LG +DS + + + + AP F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFR--- 173
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
KF S++ DV+S+G+ + E F+ G+KP +M E+
Sbjct: 174 ----KF------SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV 207
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 49 LLGTGSFGIVYKGILS----DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
++G G FG V +G L VAIK K + R F SE ++ H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ ++ E M NG+L+++L ++ ++ + ++ + ++YL S
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----SEMN 126
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA---TIGYMAPVSQLFD 220
VH DL NIL++ N+V +VSDFG+S+ L D T T ++ I + AP + +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY- 185
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
KF S DV+S+G+++ E + G++P +M
Sbjct: 186 ------RKFTSAS------DVWSYGIVMWEVMSYGERPYWDM 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 48 NLLGTGSFGIVYKGILS-DG--NNVAIKVFKLQLGRA-FRSFDSECEVLRNV-HHRNLLK 102
+++G G+FG V K + DG + AIK K + R F E EVL + HH N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------------LDTLERLNIMID 147
+ +C + + L +E P+G+L ++L L + + L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTM 206
V ++YL S +H DL NIL+ EN VA+++DFG+S+ G++ V +TM
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 172
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE 265
+ +MA S + + + DV+S+GVLL E + G P M E
Sbjct: 173 LPVRWMAIESLNYSVY-------------TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219
Query: 266 I 266
+
Sbjct: 220 L 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-16
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 50 LGTGSFG--IVYKGILSDGNN------VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNL 100
LG G FG +Y D N VA+K K + G+ S + E +L+ ++H N+
Sbjct: 12 LGEGHFGKVSLYC---YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 101 LKIFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
+K CS K L++E +P GSL ++L H L L L + + YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL--LLFAQQICEGMAYLHSQ 126
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED--SVTQTMTMATIGYMAPVS 216
H +H DL N+LLD + + ++ DFG++K + +G + V + Y A
Sbjct: 127 H----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AV-- 179
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
+ LK + S DV+SFGV L E T
Sbjct: 180 ---ECLKENKFSYAS--------DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-16
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 24/220 (10%)
Query: 49 LLGTGSFGIVYKGILSDGNN----VAIKVFKL-QLGRAFRSFDSECEVLRNVHHRNLLKI 103
++G G FG V G L VAIK K + R F SE ++ H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ +V E M NGSL+ +L H+ ++ + ++ + ++YL S
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDIL 222
VH DL NIL++ N+V +VSDFG+S++L D ++ T I + AP + +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--- 183
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
KF S DV+S+G+++ E + G++P EM
Sbjct: 184 ----RKFTSAS------DVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 7e-16
Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 45/221 (20%)
Query: 50 LGTGSFGIV----YKGILSDGNNVAIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLLK 102
LGTGSFG V +KG G A+K+ + + +E +L+++ H L+
Sbjct: 9 LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
++ S + LV+E +P G L + L F + + R V LALEYLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-QVVLALEYLHSLD--- 121
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQLFDI 221
IV+ DLKP N+LLD + +++DFG +K + T T+ T Y+AP
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYLAP------- 167
Query: 222 LKPKNAKFGSEGIISAK-----CDVYSFGVLLMETFTGKKP 257
E II +K D ++ G+L+ E G P
Sbjct: 168 ----------E-IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 65/224 (29%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 43 GFNECNLLGTGSFGIVYK-GILSDGNNVAIKVFKLQLGRAFRSFDS--ECEVLRNVHHRN 99
F LG GS+G VYK LSD A+K L D+ E +L +V+H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER---LNIMIDVWLALEYLH 156
++ + + + +V+E P G L + + I I + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMA 213
I+H DLK +NILL N + ++ D GISK+L + M IG YMA
Sbjct: 121 ----EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPHYMA 169
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
P ++ K + S K D++S G LL E T P
Sbjct: 170 P-----EVWKGRP--------YSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVHHRNLLK 102
+G G++G VYK G VA+K +++ + A R E ++L+ + H N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 103 ---IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
I +S +V E M + L L S + M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I+H D+K SNIL++ + V +++DFG+++ +S T + T+ Y P
Sbjct: 121 ----ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPP----- 170
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
++L G+ + D++S G +L E F GK
Sbjct: 171 ELL------LGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 25/221 (11%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V+ G ++ VA+K K + ++F E +++ + H L+++++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPIVHCD 168
+ ++ E M GSL ++L S L +L + + + Y+ + +H D
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI--LKPKN 226
L+ +N+L+ E+++ +++DFG+++++ D E Y A F I P+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNE-------------YTAREGAKFPIKWTAPEA 175
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
FGS + K DV+SFG+LL E T GK P M ++
Sbjct: 176 INFGS---FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 48/239 (20%)
Query: 50 LGTGSFGIVYKGI------LSDGNNVAIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLK 102
LG G FG V K + VA+K+ K + R SE +L+ V+H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWL-----------------YSHNYFLDTLERLNIM 145
++ +CS L++E GSL ++L S L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 146 IDVWLA------LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
+ A ++YL + +VH DL N+L+ E ++SDFG+S+ + + +
Sbjct: 128 DLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
V ++ + +MA S LFD I + + DV+SFGVLL E T G P
Sbjct: 184 VKRSKGRIPVKWMAIES-LFD------------HIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 74/266 (27%), Positives = 114/266 (42%), Gaps = 53/266 (19%)
Query: 25 PVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKG-ILSDG--NNVAIKVFKLQLGRA 81
PV W + D+ +G G+FG V K I DG + AIK K +
Sbjct: 2 PVLEWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 49
Query: 82 -FRSFDSECEVL-RNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---- 135
R F E EVL + HH N++ + +C + + L +E P+G+L ++L
Sbjct: 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 109
Query: 136 -----------LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184
L + + L+ DV ++YL S +H DL NIL+ EN VA++
Sbjct: 110 AFAIANSTASTLSSQQLLHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVAKI 165
Query: 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244
+DFG+S+ E V +TM + +MA S + + + DV+S+
Sbjct: 166 ADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVY-------------TTNSDVWSY 209
Query: 245 GVLLMETFT-GKKPTDEMFTGEISLK 269
GVLL E + G P M E+ K
Sbjct: 210 GVLLWEIVSLGGTPYCGMTCAELYEK 235
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 50 LGTGSFGIVYKGILSD------GNNVAIK-VFKLQLGRAFRSFDSECEVLRNVHHRNLLK 102
LG GSFG+VY+G+ VAIK V + R F +E V++ + ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH--------NYFLDTLER-LNIMIDVWLALE 153
+ S +V+ELM G L+++L S TL++ + + ++ +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YL VH DL N ++ E++ ++ DFG+++ + + + + + +MA
Sbjct: 134 YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
P S LK +G+ + K DV+SFGV+L E T
Sbjct: 190 PES-----LK--------DGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 42/229 (18%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG G FG V+ G + VAIK K Q + +F +E +++ + H L+++++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 110 -PDFKALVLELMPNGSLENWLYSHNYFLDTLE----RLNIMID----VWLALEYLHHGHS 160
P + ++ E M NGSL + FL T E +N +ID + + ++ +
Sbjct: 73 EPIY--IITEYMENGSLVD-------FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
+H DL+ +NIL+ E + +++DFG+++L+ D E Y A F
Sbjct: 124 ----IHRDLRAANILVSETLCCKIADFGLARLIEDNE-------------YTAREGAKFP 166
Query: 221 I--LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
I P+ +G+ + K DV+SFG+LL E T G+ P M E+
Sbjct: 167 IKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 34/234 (14%)
Query: 50 LGTGSFGIVYKGILSDGNN---VAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G FG V +G L+ ++ VA+K K+ + F SE ++ H N++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 105 SSC----SNPDFKA--LVLELMPNGSLENWL-YSH----NYFLDTLERLNIMIDVWLALE 153
C + + + ++L M +G L ++L YS +L T + M D+ +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YL SS +H DL N +L+ENM V+DFG+SK + +G+ + + ++A
Sbjct: 127 YL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
+ L D + + K DV+SFGV + E T G+ P + EI
Sbjct: 183 -IESLAD------------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 50 LGTGSFGIVYK-GILSDGNNVAIKVFKLQLGRAFRSFDS----ECEVLRNVHHRNLLKIF 104
+G G+ GIV+K G VA+K K+ L R + E + L+ H ++K+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALK--KVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ LV+E MP L L L + + M + + Y+H + I
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGI 120
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
+H DLKP+N+L+ + V +++DFG+++L E+ + +AT Y AP
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 41/252 (16%)
Query: 49 LLGTGSFGIVYKGILSDG--NNVAIK---VFKLQLGRAFRSFD-------SECEVLR-NV 95
LG+G+FG VYK + N +A+K V G+ R D SE +++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS----HNYFLDTLERL-NIMIDVWL 150
H N+++ + + D +V++L+ L S F T ER+ NI + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIWNIFVQMVL 124
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
AL YLH IVH DL P+NI+L E+ ++DFG++K T + TI
Sbjct: 125 ALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP--TDEMFTGEISL 268
Y P +I+ KN +G K DV++FG +L + T + P + M + +
Sbjct: 179 YSCP-----EIV--KNEPYGE------KADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225
Query: 269 KNWVNESLPHAL 280
V E LP +
Sbjct: 226 VEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 37/260 (14%)
Query: 66 GNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSS-CSNPDFKALVLELMP 121
G+ VAIK+ + F E + ++H N++ + S + P V E +P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DE 178
+L L + L E +M+ V L+ L H+ IVH DLKP NI++
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQG-IVHRDLKPQNIMVSQTGV 117
Query: 179 NMVARVSDFGISKLLGDGEDSVTQTMTMAT--IG---YMAPVSQLFDILKPKNAKFGSEG 233
A+V DFGI LL D+ T+T T +G Y AP QL +P
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP-EQLRG--EP--------- 165
Query: 234 IISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--VNESLP-----HALTDVVDA 286
++ D+Y++G++ +E TG++ EI + V+ SLP H L V+
Sbjct: 166 -VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRK 224
Query: 287 NLRVSMKDVAAKLKKIRVKF 306
L + AA + +F
Sbjct: 225 ALNKDPRQRAASAPALAERF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 74/273 (27%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKV---FKLQL--GRAFRSFDSECEVLRNVHHRNLL 101
+ +G G++G+V G VAIK F+ Q R R E ++LR H N++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 102 KIFSSCSNPDFKA-----LVLELMPNGSLENWLYSHN-------YFLDTLERLNIMIDVW 149
I P F++ +V ELM L + + + YFL + R
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MA 207
L+Y+H SA ++H DLKPSN+LL+ N ++ DFG++++ D T +T +A
Sbjct: 118 -GLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYVA 171
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK------------ 255
T Y AP L N+K ++ I D++S G +L E + +
Sbjct: 172 TRWYRAPEIML-------NSKGYTKAI-----DIWSVGCILAEMLSNRPLFPGKDYLHQL 219
Query: 256 --------KPTDEMFTGEISLK--NWVNESLPH 278
P+ E ISL+ N++ +SLP
Sbjct: 220 NLILGVLGTPSQEDLNCIISLRARNYI-KSLPF 251
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 26/239 (10%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNN----VAIKVFKLQLG-RAFRSFDSE 88
+ I + TE + +LG+G+FG VYKGI + DG N VAIKV + +A + E
Sbjct: 1 MRILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDE 59
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148
V+ V + ++ C + LV +LMP G L +++ + + + + LN + +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL +VH DL N+L+ +++DFG+++LL E
Sbjct: 119 AKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
I +MA L IL + + + DV+S+GV + E T G KP D + EI
Sbjct: 175 IKWMA----LESILHRR---------FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 50 LGTGSFGIVYKGIL-----SDGNNVAIKVFK-LQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG +FG +YKG L VAIK K + + + F E ++ +HH N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHN----------------YFLDTLERLNIMID 147
+ ++ E + G L +L + LD + L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+ +EYL SS VH DL NIL+ E + ++SD G+S+ + + Q ++
Sbjct: 133 IAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I +M P + ++ G S+ D++SFGV+L E F+ G +P
Sbjct: 189 PIRWMPPEAIMY-------------GKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 48 NLLGTGSFGIVYKGILS--DGNN----VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNL 100
LG G+FG VY+G+ DG+ VA+K S F E ++ +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 101 LKIFSSC--SNPDFKALVLELMPNGSLENWLY------SHNYFLDTLERLNIMIDVWLAL 152
+++ P F ++LELM G L+++L L + L DV
Sbjct: 72 VRLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+YL H +H D+ N LL VA+++DFG+++ + M I
Sbjct: 130 KYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
+M P + L +GI ++K DV+SFGVLL E F+
Sbjct: 186 KWMPPEAFL-------------DGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 49/245 (20%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDS--------------ECEVL 92
LG G++G V K G VAIK K+ + D E +++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 93 RNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
+ H N++ + DF LV+++M L+ + ++ + I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKC-ILLQILNGL 132
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG----------DGEDSVTQ 202
LH +H DL P+NI ++ + +++DFG+++ G D +
Sbjct: 133 NVLH----KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 203 TMT--MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
MT + T+ Y AP ++L G+E A D++S G + E TGK
Sbjct: 189 EMTSKVVTLWYRAP-----ELL------MGAEKYHFA-VDMWSVGCIFAELLTGKP---- 232
Query: 261 MFTGE 265
+F GE
Sbjct: 233 LFPGE 237
|
Length = 335 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 49 LLGTGSFGIVY---KGILSDGNNV-AIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLL 101
+LG GSFG V+ K D + A+KV K L++ R+ E ++L V+H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI-MIDVWLALEYLHHGHS 160
K+ + L+L+ + G L L F T E + + ++ LAL++LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELALALDHLH---- 115
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQLF 219
S I++ DLKP NILLDE +++DFG+SK + D + + T+ YMAP
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP----- 167
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+++ + + D +SFGVL+ E TG P
Sbjct: 168 EVVNRRGHTQSA--------DWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 21/152 (13%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-------HRNLL 101
LG G+FG VY G VAIK K + F S++ EC LR V H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLH-HGH 159
K+ D V E M G+L + + + +I+ + L ++H HG
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISK 191
H DLKP N+L+ V +++DFG+++
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 50 LGTGSFGIVY----KGILSDGNNVAIKVFK----LQLGRAFRSFDSECEVLRNVHHRNLL 101
LGTG++G V+ G G A+KV K +Q + +E +VL V L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 102 KIFSSCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALEYLHHGH 159
D K L+L+ + G L LY +F T + + I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ-- 123
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I++ D+K NILLD ++DFG+SK E+ + TI YMAP
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAP----- 175
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++++ GS G A D +S GVL E TG P
Sbjct: 176 EVIRG-----GSGGHDKA-VDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR-----AFRSFDSECEVLRNVHHRNLLK 102
++G G FG VY G L D + I L R F E ++++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 103 IFSSCSNPDFKALV-LELMPNGSLENWLYS--HNYFLDTLERLNIMIDVWLALEYLHHGH 159
+ C + LV L M +G L N++ S HN + L + + V +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL--IGFGLQVAKGMEYL---- 114
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT--IGYMAPVSQ 217
+S VH DL N +LDE+ +V+DFG+++ + D E T A + +MA S
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ KF + K DV+SFGVLL E T P
Sbjct: 175 -------QTQKF------TTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 1e-13
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECE-----------V 91
+ + LG G++G+VYK G VA+K +L D+E E +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISL 51
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA 151
L+ + H N++K+ LV E L+ +L L +IM +
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194
L Y H S I+H DLKP NIL++ + V +++DFG+++ G
Sbjct: 111 LAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 50/224 (22%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG------RAFRSFDSECEVLRNVHHRNLL 101
+LG G++G VY G+ + G +A+K +L + + E ++L+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ +C + + ++ +E +P GS+ + L + + + + YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLHNNC-- 122
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG----YMAPVSQ 217
+VH D+K +N++L N + ++ DFG ++ L T + + ++ +MAP
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP--- 177
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+ +E K D++S G + E TGK P M
Sbjct: 178 ----------EVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 41/272 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQ---LGRAFRSFDSECEVLRNVHHRNLLKIF 104
+GTG+FG V+ + A+KV + + + +E VL+ V H ++++F
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ + F +++E +P G L ++L + F ++ ++ ALEYLH S I
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH----SKEI 122
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQLFDILK 223
V+ DLKP NILLD+ +++DFG +K L D +T T+ T Y+AP
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEV------- 169
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISLKNWVNESLPH 278
S+G A D ++ G+L+ E G P ++ ++ K L
Sbjct: 170 -----IQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDL 223
Query: 279 ALTD------VVDANLRV-SMKDVAAKLKKIR 303
D VVD R+ +MK+ A +K R
Sbjct: 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVFKL-----QLGRAFRSFDSECEVLRNVHHRNLLK 102
LLG G+FG VY +D G +A+K + + + + + E ++L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 103 IFSSCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ +P + L +E MP GS+++ L S+ + + R + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH---- 123
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLL------GDGEDSVTQTMTMATIGYMAP 214
S IVH D+K +NIL D ++ DFG SK L G G SVT T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-----GTPYWMSP 178
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
EG K D++S G ++E T K P E
Sbjct: 179 ------------EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 65/246 (26%), Positives = 116/246 (47%), Gaps = 34/246 (13%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS- 108
LG G FG V+ + VA+K K + +F +E V++ + H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPIVHC 167
P + ++ E M GSL ++L S L +L + + + ++ + +H
Sbjct: 73 EPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHR 126
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI--LKPK 225
DL+ +NIL+ ++V +++DFG+++++ D E Y A F I P+
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE-------------YTAREGAKFPIKWTAPE 173
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI--SLKNWV----NESLPH 278
FGS + K DV+SFG+LLME T G+ P M E+ +L+ E+ P
Sbjct: 174 AINFGS---FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 230
Query: 279 ALTDVV 284
L +++
Sbjct: 231 ELYNIM 236
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDS------ECEVLRNVH 96
F +G GSFG VYK I VAIKV L+ + D E + L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQQEIQFLSQCR 57
Query: 97 HRNLLKIFSSCSNPDFK-ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYL 155
+ K + S K +++E GS + L LD I+ +V L LEYL
Sbjct: 58 SPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYL 114
Query: 156 HHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YM 212
H +H D+K +NILL E +++DFG+S G+ + T + +G +M
Sbjct: 115 H----EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWM 165
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
AP +++K + K D++S G+ +E G+ P
Sbjct: 166 AP-----EVIK--------QSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA------FRSFDSECEVLRNVHHRNLL 101
LGTG+F Y+ + G +A+K + + E ++ ++H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 102 KIF-SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
++ ++C + F L +E M GS+ + L + F + + +N + L YLH
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ- 123
Query: 161 SAPIVHCDLKPSNILLDEN-MVARVSDFGI-----SKLLGDGEDSVTQTMTMATIGYMAP 214
I+H D+K +N+L+D R++DFG +K G GE Q + TI +MAP
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMAP 177
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L+ + +G CDV+S G +++E T K P
Sbjct: 178 -----EVLRGEQ--YGRS------CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
LG G+FG VYK G A K+ +++ F E ++L H N++ ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
+ +++E G+L++ + L + + + AL +LH S ++H D
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRD 128
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK--PKN 226
LK NILL + +++DFG+S T + T +MAP + K P +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKS-TLQKRDTF-IGTPYWMAPEVVACETFKDNPYD 186
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
K D++S G+ L+E + P E+
Sbjct: 187 ----------YKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL 100
E F +G+G++G VYK ++ G AIKV KL+ G F E ++++ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ F S D + +E GSL++ +Y L + + + L YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---- 123
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQ 217
S +H D+K +NILL +N +++DFG+S + + T + IG +MA
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWMA---- 174
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
P+ A +G + CD+++ G+ +E
Sbjct: 175 ------PEVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVFKL-----QLGRAFRSFDSECEVLRNVHHRNLLK 102
LLG G+FG VY D G +A K + + + + + E ++L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 103 IFSSCSNPDFKALV--LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ + K L +E MP GS+++ L ++ +++ R + + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---- 123
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
S IVH D+K +NIL D ++ DFG SK L QT+ M+ G + V+
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICMSGTG-IRSVTGTPY 174
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
+ P+ EG K DV+S G ++E T K P E
Sbjct: 175 WMSPE--VISGEG-YGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 65/251 (25%), Positives = 109/251 (43%), Gaps = 57/251 (22%)
Query: 42 EGFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFK--LQLGRAFRSFD-SECEVLRN 94
+ F ++G G+FG V+ L G A+KV + + R + +E ++L +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
++K++ S + + LV+E MP G L N L + F + R I ++ LAL+
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDS 116
Query: 155 LHH-GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV------------- 200
+H G +H D+KP NIL+D + +++DFG+ K + +D
Sbjct: 117 VHKLGF-----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 201 ---------TQTMTMA--TIG---YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGV 246
Q A T+G Y+AP ++L+ +G E CD +S GV
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAP-----EVLRGTP--YGLE------CDWWSLGV 218
Query: 247 LLMETFTGKKP 257
+L E G P
Sbjct: 219 ILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 42/247 (17%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIF---- 104
LG GS G+V+ + SD VA+K L ++ + E +++R + H N++K++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 105 --SSCSNPDFKAL--------VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
S D +L V E M L N + + RL M + L+Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN-VLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 155 LHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLG-DGEDSVTQTMTMATIGYM 212
+H SA ++H DLKP+N+ ++ E++V ++ DFG+++++ + + T Y
Sbjct: 130 IH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG--EISLKN 270
+P +L +L P N + D+++ G + E TGK +F G E+
Sbjct: 186 SP--RL--LLSPNN--------YTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQ 229
Query: 271 WVNESLP 277
+ ES+P
Sbjct: 230 LILESVP 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 25/213 (11%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
LG G FG V + G A K +L+ + + +E ++L V R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYF-LDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ D LV+ LM G L+ +Y+ + + LE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR----I 116
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
V+ DLKP N+LLD++ R+SD G++ L G+ T GYMAP ++L+
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP-----EVLQ- 167
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ D ++ G L E G+ P
Sbjct: 168 -------GEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 60/244 (24%)
Query: 50 LGTGSFGIVYK----GILSDGNN--VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLK 102
+G G+FG V++ G+L VA+K+ K + ++ F E ++ H N++K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWL--------------------YSHNYF-LDTLER 141
+ C+ L+ E M G L +L N L E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 142 LNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL-------G 194
L I V + YL VH DL N L+ ENMV +++DFG+S+ +
Sbjct: 133 LCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT- 253
D++ I +M P S + ++ +E DV+++GV+L E F+
Sbjct: 189 SENDAI-------PIRWMPPESIFY-------NRYTTES------DVWAYGVVLWEIFSY 228
Query: 254 GKKP 257
G +P
Sbjct: 229 GMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 66/223 (29%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 44 FNECNLLGTGSFGIVY---KGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNV 95
F +LGTG++G V+ K D + A+KV + +Q + +E VL +V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 96 HHRNLLKIFSSCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
L + K L+L+ + G + LY + F + R ++ LALE+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEH 120
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
LH IV+ D+K NILLD ++DFG+SK E T + TI YMAP
Sbjct: 121 LH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAP 175
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+I++ K G G D +S G+L+ E TG P
Sbjct: 176 -----EIIRGK----GGHGKA---VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 40/116 (34%), Positives = 52/116 (44%), Gaps = 28/116 (24%)
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
AL YL I+H D+KPSNILLD N ++ DFGIS L DS+ +T
Sbjct: 119 ALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRP 172
Query: 211 YMAP------VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
YMAP +D+ + DV+S G+ L E TGK P +
Sbjct: 173 YMAPERIDPSARDGYDV----------------RSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 44/127 (34%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
AL YL H ++H D+KPSNILLD + ++ DFGIS L DS +T +
Sbjct: 126 ALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKAKTRSAGCAA 179
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270
YMAP + + P + + I A DV+S G+ L+E TG+ P T L
Sbjct: 180 YMAP-----ERIDPPDPN--PKYDIRA--DVWSLGISLVELATGQFPYKNCKTEFEVLTK 230
Query: 271 WVNESLP 277
+ E P
Sbjct: 231 ILQEEPP 237
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 26/225 (11%)
Query: 50 LGTGSFGIVYKGILS---DGNNVAIKVFKLQLGRAFRSFD--SECEVLRNVHHRNLLKIF 104
LG+G+FG V KG+ VA+K+ K + E V++ + + ++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
C + LV+EL G L +L + + + ++ V + ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEK-NITELVHQVSMGMKYLEETN----F 116
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILK 223
VH DL N+LL A++SDFG+SK LG E+ +T + + AP + + K
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP--ECMNYYK 174
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS 267
S+K DV+SFGVL+ E F+ G+KP M E++
Sbjct: 175 -----------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 47/134 (35%), Positives = 69/134 (51%), Gaps = 15/134 (11%)
Query: 144 IMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203
I + + ALEYLH S ++H D+KPSN+L++ N ++ DFGIS G DSV +T
Sbjct: 108 IAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAKT 161
Query: 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263
+ YMAP + + P+ ++ K DV+S G+ ++E TG+ P D T
Sbjct: 162 IDAGCKPYMAP-----ERINPE----LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212
Query: 264 GEISLKNWVNESLP 277
LK V E P
Sbjct: 213 PFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVFKL-----QLGRAFRSFDSECEVLRNVHHRNLLK 102
LLG G+FG VY +D G +A+K + + + + E ++L+N+ H +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 103 IFSSCSNPDFKALVL--ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ +P+ K L + E MP GS+++ L ++ + + R + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---- 123
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISK------LLGDGEDSVTQTMTMATIGYMAP 214
S IVH D+K +NIL D ++ DFG SK + G G SVT T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-----GTPYWMSP 178
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
EG K DV+S ++E T K P E
Sbjct: 179 ------------EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVF------KLQLGRAFRSFDSECEVLRNVHHRNLL 101
L+G GS+G+V K + G VAIK F K+ A R E +L+ + H NL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ LV E + + L++ L + LD + + +E+ H S
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH----S 118
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
I+H D+KP NIL+ ++ V ++ DFG ++ L + T +AT Y AP
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRWYRAPE------ 170
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254
L + K+G D+++ G L+ E TG
Sbjct: 171 LLVGDTKYGR------AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGR-AFRSFDSECEVLRNVHHRN 99
E F + +G GSFG V+KGI + V AIK+ L+ E VL
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+ K + S +++E + GS + L LD + I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
S +H D+K +N+LL E+ +++DFG++ L D + + + + T +MAP
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAP----- 170
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+++K + +K D++S G+ +E G+ P E+
Sbjct: 171 EVIK--------QSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 67/282 (23%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNV-AIKV--------FKLQLGRAFRSFDSECEVL 92
E E + LG G+ G V K L + + A+K + Q+ R E E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53
Query: 93 RNVHHRNLLKIFSSCSNPDFK--ALVLELMPNGSLENWLYSHNYFLDTLER--------- 141
++ ++K + + + + +E GSL++ +Y +R
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYK-----KVKKRGGRIGEKVL 107
Query: 142 LNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201
I V L YLH S I+H D+KPSNILL ++ DFG+S G+ +S+
Sbjct: 108 GKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLA 160
Query: 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGI----ISAKCDVYSFGVLLMETFTGK-- 255
T T T YMAP E I S DV+S G+ L+E +
Sbjct: 161 GTFT-GTSFYMAP-----------------ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
Query: 256 -KPTDEMFTGEISLKNWVNESLPHALTDVVDANLRVS--MKD 294
P E G I L +++ L D ++ S KD
Sbjct: 203 FPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKD 244
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-12
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 50 LGTGSFGIV----YKGILSDGNN----VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNL 100
LG G FG V Y +G+N VA+K K + G E E+LRN++H N+
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 101 LKIFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
+K C+ L++E +P+GSL+ +L + ++ ++L + + ++YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--- 125
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
S VH DL N+L++ ++ DFG++K + ++ T +
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----------------V 168
Query: 219 FDILKPKNAKFGSEGIISAK----CDVYSFGVLLMETFT 253
D L + E +I +K DV+SFGV L E T
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGR-AFRSFDSECEVLRNVHHRN 99
E F + +G GSFG V+KGI + V AIK+ L+ E VL
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+ K + S +++E + GS + L + + D + ++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 118
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
S +H D+K +N+LL E +++DFG++ L D + + + + T +MAP
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAP----- 170
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
++++ + +K D++S G+ +E G+ P +M
Sbjct: 171 EVIQ--------QSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 45/192 (23%)
Query: 44 FNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFD------SECEVLRNVH 96
+ + +G+G++G V + G VAIK +L R F+S E +L+++
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 97 HRN---LLKIFS-SCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLN------I 144
H N LL +F+ + S DF+ LV LM L N + ++L+ +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFL 123
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
+ + L+Y+H SA I+H DLKPSNI ++E+ ++ DFG+++ D M
Sbjct: 124 VYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-------EM 172
Query: 205 T--MATIGYMAP 214
T +AT Y AP
Sbjct: 173 TGYVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 39/238 (16%)
Query: 49 LLGTGSFGIVYKGILSDGNN----VAIKVFKLQLGRA--FRSFDSECEVLRNVHHRNLLK 102
+LG G FG V + L + VA+K+ K + + F E ++ H N++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 103 IFSSCSNPDFKA------LVLELMPNGSLENWLYSH-------NYFLDTLERLNIMIDVW 149
+ K ++L M +G L +L L TL R MID+
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF--MIDIA 123
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+EYL SS +H DL N +L+ENM V+DFG+SK + G+ + +
Sbjct: 124 SGMEYL----SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
++A S ++ + + DV++FGV + E T G+ P + EI
Sbjct: 180 KWLALESL-------------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDS--ECEVLRNV 95
R+ F + N +G G++GIVY+ + G VA+K ++ R S E +L N+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 96 HHRNL--LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
H N+ LK + D LV+E L + L + + +M+ + L+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YLH I+H DLK SN+LL + +++DFG+++ G +T + T+ Y A
Sbjct: 123 YLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
P ++L G +A D+++ G +L E K
Sbjct: 177 P-----ELL------LGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 44/244 (18%)
Query: 48 NLLGTGSFGIV----YKGILSDGNNVAIKVFKLQLGRAFRSFD---SECEVLRNVHHRNL 100
LGTGSFG V +KG G AIK K + + E +L + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ + S + + +LE + G L L F + + + ++ LA EYLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH---- 135
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQLF 219
S I++ DLKP N+LLD +V+DFG +K + D +T T+ T Y+AP
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAP----- 184
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---------TDEMFTGEISLKN 270
++++ K D ++ GVLL E G P +++ G + N
Sbjct: 185 EVIQSKGH--------GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN 236
Query: 271 WVNE 274
W +
Sbjct: 237 WFDG 240
|
Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 45 NECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
E N++ G G YKG S N + V ++ + S SE + + H N++K+
Sbjct: 693 KEENVISRGKKGASYKG-KSIKNGMQFVVKEINDVNSIPS--SEIADMGKLQHPNIVKLI 749
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
C + L+ E + +L L + L R I I + AL +LH S +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLH-CRCSPAV 804
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
V +L P I++D + L T T + Y+AP ++ +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETR-----ET 852
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW 271
K+ I+ K D+Y FG++L+E TGK P D F S+ W
Sbjct: 853 KD--------ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 44 FNECNLLGTGSFGIVYK-GILSDGNNVAIKVFKLQLGRAFRSFD-----SECEVLRNVHH 97
F +LG G FG V + + G A K KL+ R + +E ++L V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLH 156
R ++ + + D LVL LM G L+ +Y+ N D + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
IV+ DLKP NILLD+ R+SD G++ + +GE T + T+GYMAP
Sbjct: 120 ----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAP-- 170
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+++K + F D + G L+ E GK P
Sbjct: 171 ---EVVKNERYTFSP--------DWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 58/254 (22%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN-----VAIKVFK-----LQLGRAFRS 84
+ I R + +LL G+FG ++ GIL D V +K K +Q+
Sbjct: 1 IAISR--DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL---- 54
Query: 85 FDSECEVLRNVHHRNLLKIFSSCS-NPDFKALVLELMPNGSLENWLYSHNYF-------L 136
E +L + H+N+L I C + + ++ M G+L+ +L L
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 137 DTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK----- 191
T + +++ I + + YLH ++H D+ N ++DE + +++D +S+
Sbjct: 115 STQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170
Query: 192 ---LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
LGD E+ + +MA S + N ++ S DV+SFGVLL
Sbjct: 171 DYHCLGDNENR--------PVKWMALESLV-------NKEYSSAS------DVWSFGVLL 209
Query: 249 METFT-GKKPTDEM 261
E T G+ P E+
Sbjct: 210 WELMTLGQTPYVEI 223
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV----AIKVFK----LQLGRAFRSFDSECEVLRNV 95
F +LGTG++G V+ G++ A+KV K +Q + +E +VL ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 96 HHRNLLKIFSSCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALE 153
L D K L+L+ + G L L F + + I ++ LALE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF--KEQEVQIYSGEIVLALE 119
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
+LH I++ D+K NILLD N ++DFG+SK + E + TI YMA
Sbjct: 120 HLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMA 174
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
P DI++ G +G D +S GVL+ E TG P
Sbjct: 175 P-----DIVR------GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 47/242 (19%)
Query: 50 LGTGSFGIVY------------KGILSDGNN-----VAIKVFKLQLGRAFR-SFDSECEV 91
LG G FG V+ K + N VA+KV + R F E ++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMID---- 147
L + N+ ++ C+ +++E M NG L +L H L + +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 148 VWLALE------YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201
+++A + YL S VH DL N L+ +N +++DFG+S+ L +
Sbjct: 133 LYMATQIASGMRYL----ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT--GKKPTD 259
Q I +MA S L KF + K DV++FGV L E T ++P +
Sbjct: 189 QGRAPLPIRWMAWESVLLG-------KF------TTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 260 EM 261
+
Sbjct: 236 HL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 70/297 (23%), Positives = 122/297 (41%), Gaps = 59/297 (19%)
Query: 32 TSYLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSE 88
TSYL++++ LG GS+ VYKGI +G VA+KV ++ G F + E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-RE 53
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148
+L+ + H N++ + + V E M + L ++ H L M +
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQL 112
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
L Y+H H I+H DLKP N+L+ +++DFG+++ + +QT
Sbjct: 113 LRGLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQT----- 159
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK------------ 256
Y + V L+ +P + G+ S+ D++ G + +E G+
Sbjct: 160 --YSSEVVTLW--YRPPDVLLGATD-YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214
Query: 257 ---------PTDEMFTGEISLKN----WVNESLPHALTDVVDANLRV-SMKDVAAKL 299
PT++ + G L N W P L V R +D+A+++
Sbjct: 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQM 271
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 67/281 (23%), Positives = 110/281 (39%), Gaps = 51/281 (18%)
Query: 42 EGFNECNLLGTGSFGIVY----KGILSDGNN--VAIKVF-KLQLGRAFRSFDSECEVLRN 94
E LG G FG V+ KGI +G V +K K + F E ++ R
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWL--------YSHNYFLDTLERLNIMI 146
+ H+N++++ C + ++LE G L+ +L L T +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM-- 204
+ L +++L + VH DL N L+ +VS +SK D
Sbjct: 125 QIALGMDHLSNAR----FVHRDLAARNCLVSSQREVKVSLLSLSK------DVYNSEYYK 174
Query: 205 ---TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP--- 257
+ + ++AP + E S K DV+SFGVL+ E FT G+ P
Sbjct: 175 LRNALIPLRWLAPEAVQ-------------EDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221
Query: 258 -TDEMFTGEI---SLKNWVNESLPHALTDVVDANLRVSMKD 294
+DE + L+ V E P L ++ V+ KD
Sbjct: 222 LSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKD 262
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIF-- 104
++G G++G VYK G VAIK+ + E +LR +H N+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 105 ----SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLN------IMIDVWLALEY 154
+ N D LV+EL GS+ + + +RL I+ + L Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---Y 211
LH ++H D+K NILL +N ++ DFG+S L DS T IG +
Sbjct: 129 LHENK----VIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DS-TLGRRNTFIGTPYW 179
Query: 212 MAP-VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
MAP V I + + A+ DV+S G+ +E GK P +M
Sbjct: 180 MAPEV-----IACDEQP----DASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 44/231 (19%)
Query: 50 LGTGSFGIVY----KGI---LSDGNN--------VAIKVFKLQLGRAFRS-FDSECEVLR 93
LG G FG V+ +G+ L +G VA+K+ + + + R+ F E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWL--------YSHNYFLDTLERLNIM 145
+ + N++++ C + D ++ E M NG L +L ++H + ++ N++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 146 ---IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202
+ + ++YL +S VH DL N L+ + +++DFG+S+ L G+ Q
Sbjct: 133 YMAVQIASGMKYL----ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
+ I +MA S L G + DV++FGV L E FT
Sbjct: 189 GRAVLPIRWMAWESILL-------------GKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGN--NVAIKVF---KLQLGRAFRSFDSECEVLRNVH 96
E FN LGTGSFG V + + VAIK F K+ + SE ++L ++
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
H + ++ S + + LVLE + G +L + F + + + L EYL
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIFEYLQ 148
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPV 215
S IV+ DLKP N+LLD++ +++DFG +K++ T+T T+ T Y+AP
Sbjct: 149 ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYIAP- 197
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
L ++ K A D ++ G+ + E G P
Sbjct: 198 EILLNVGHGKAA------------DWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 37/232 (15%)
Query: 40 ATEGFNECNLLGTGSFGIVY----KGILSD--GNNVAIKVFKLQLGRAFR-SFDSECEVL 92
A E LG GSFG+VY KG++ D VAIK R F +E V+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 93 R--NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS-----HNYFLDTLERLNIM 145
+ N HH ++++ S +++ELM G L+++L S N + L M
Sbjct: 64 KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 146 I----DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201
I ++ + YL ++ VH DL N ++ E+ ++ DFG+++ + + +
Sbjct: 122 IQMAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
+ + +M+P S LK +G+ + DV+SFGV+L E T
Sbjct: 178 GGKGLLPVRWMSPES-----LK--------DGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLL 101
F + +G GSFG VYKGI + V AIK+ L+ E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ + S +++E + GS + L L+ I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH----S 119
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
+H D+K +N+LL E +++DFG++ L D + + + + T +MAP ++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAP-----EV 172
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+K F K D++S G+ +E G+ P ++
Sbjct: 173 IKQSAYDF--------KADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 44 FNECNLLGTGSFGIV------YKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH 97
F + +LG G FG V G + + K K + G + +E ++L V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL--NEKQILEKVNS 59
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLH 156
R ++ + + D LVL LM G L+ +Y + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
IV+ DLKP NILLD++ R+SD G++ + +G+ T + T+GYMAP
Sbjct: 120 QER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAP-- 170
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+++K + F D ++ G LL E G+ P
Sbjct: 171 ---EVVKNERYTFSP--------DWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 50 LGTGSFGIVYKGI---LSDGN---NVAIKVFKLQLGRAFR-SFDSECEVLRNV-HHRNLL 101
LG G+FG V + LS + VA+K+ K + R + SE +++ ++ +H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHS 160
+ +C+ ++ E G L N+L FL + L+ V + +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL----A 158
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
S +H DL N+LL + ++ DFG+++ + + + V + + +MAP S +F+
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES-IFN 217
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
+ + + DV+S+G+LL E F+
Sbjct: 218 ------------CVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 75/239 (31%), Positives = 116/239 (48%), Gaps = 62/239 (25%)
Query: 50 LGTGSFGIVYKGILSD---GNNVAIK-VFKLQLGRAFR-SFDS-----ECEVLRNV-HHR 98
LG G++GIV+K I D VA+K +F AFR + D+ E L+ + H
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFD-----AFRNATDAQRTFREIMFLQELGDHP 67
Query: 99 N---LLKIFSSCSNPDFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLAL 152
N LL + + ++ D LV E M E L++ N D +R IM + AL
Sbjct: 68 NIVKLLNVIKAENDKDI-YLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKAL 120
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT-QTMT--MATI 209
+Y+H S ++H DLKPSNILL+ + +++DFG+++ L + E++ +T +AT
Sbjct: 121 KYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 210 GYMAPVSQLFDILKPKNAKFGS----EGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264
Y AP +IL GS +G+ D++S G +L E GK +F G
Sbjct: 177 WYRAP-----EIL------LGSTRYTKGV-----DMWSVGCILGEMLLGKP----LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 37 IQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAF----RS----FDSE 88
+Q E ++ ++G G+FG V + + KV+ ++L F RS F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLV----RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLN--IMI 146
+++ + ++++F + + + +V+E MP G L N + NY D E+
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTA 149
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
+V LAL+ +H S ++H D+KP N+LLD++ +++DFG + D V +
Sbjct: 150 EVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAV 204
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
T Y++P ++LK + G +G +CD +S GV L E G P
Sbjct: 205 GTPDYISP-----EVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 49 LLGTGSFGIV-YKGILSDGNNVAIKVFKLQ------LGRAFRSFDSECEVLRNVHHRNLL 101
+LG+G+ G V +SDG A+KV ++ RA +E L N +++
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA----QAEVCCLLNCDFFSIV 94
Query: 102 K-----IFSSCSNPD---FKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWL 150
K NP+ ALVL+ G L + S N E + I V L
Sbjct: 95 KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG-EDSVTQTMTMATI 209
A+ ++H H ++H D+K +NILL N + ++ DFG SK+ D V +T T
Sbjct: 155 AVHHVHSKH----MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTP 209
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259
Y+AP +I + K S K D++S GVLL E T K+P D
Sbjct: 210 YYVAP-----EIWRRKP--------YSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEV-----LRNVHH 97
+ L+G G++G VY+G + G VA+K+ L D + EV LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQP 61
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
N+ K + S +++E GS+ + + + I+ +V +AL+Y+H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIHK 119
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV-- 215
++H D+K +NIL+ ++ DFG++ LL S T T +MAP
Sbjct: 120 ----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFV-GTPYWMAPEVI 173
Query: 216 --SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ +D K D++S G+ + E TG P
Sbjct: 174 TEGKYYD----------------TKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 58/254 (22%), Positives = 104/254 (40%), Gaps = 52/254 (20%)
Query: 53 GSFGIVY--KGILSDGNNVAIKVFKLQLGRAFRSFDSECEVL------RNVHHR----NL 100
G+FG VY K + G+ AIKV K ++ +V + + +
Sbjct: 7 GAFGSVYLAKKRST-GDYFAIKVLKKS------DMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
K++ S + D+ LV+E + G + + + + + + +V L +E LH
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLHQRG- 117
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
I+H D+KP N+L+D+ +++DFG+S+ + + V T Y+AP + L
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETIL-- 166
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISLK-NW--- 271
G D +S G ++ E G P D +F +S + NW
Sbjct: 167 ---------GVGDD--KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE 215
Query: 272 VNESLPHALTDVVD 285
V E D+++
Sbjct: 216 VKEFCSPEAVDLIN 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 36 DIQRAT--EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVL 92
DI R + +G+G++G VYK L G A+K+ KL+ G F E ++
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 93 RNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
+ H N++ F S + + + +E GSL++ +Y L L+ + + L
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGL 119
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-----MA 207
YLH S +H D+K +NILL +N +++DFG++ +T T+ +
Sbjct: 120 AYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIG 168
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
T +MA P+ A G + CD+++ G+ +E
Sbjct: 169 TPYWMA----------PEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 21/222 (9%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKL--QLGRAFRS-FDSECEVLRNVHH 97
E F ++G G+FG V L + + V A+K+ L RA + F E +VL N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLH 156
+ + + + + + LV++ G L L + + + R + ++ +A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAIDSVH 119
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS-KLLGDGEDSVTQTMTMATIGYMAPV 215
H VH D+KP NIL+D N R++DFG KL+ DG +V ++ + T Y++P
Sbjct: 120 QLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISP- 172
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++ ++ K+G E CD +S GV + E G+ P
Sbjct: 173 -EILQAMEDGKGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 30/197 (15%)
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
PD +L+LM G L L H F + R ++ L LE++H+ +V+ DL
Sbjct: 69 PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF----VVYRDL 123
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
KP+NILLDE+ R+SD G++ + ++ T GYMAP ++L+ A
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP-----EVLQKGTA-- 172
Query: 230 GSEGIISAKCDVYSFGVLLMETFTGKKP------TDEMFTGEISLKNWVNESLPHALTDV 283
+ D +S G +L + G P D+ ++L VN LP + +
Sbjct: 173 -----YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFSPE 225
Query: 284 VDANLR-VSMKDVAAKL 299
+ + L + +DV+ +L
Sbjct: 226 LKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G GS GIV G VA+K L+ + +E ++R+ HH N++ +++S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E + G+L + + +H ++ + + + V AL YLH + ++H D
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLH----NQGVIHRD 143
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP--VSQLFDILKPKN 226
+K +ILL + ++SDFG + ++ + + T +MAP +S+L
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAPEVISRL-------- 193
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G+E D++S G++++E G+ P
Sbjct: 194 -PYGTE------VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 44 FNECNLLGTGSFGIVYK-GILSDGNNVAIKVFKLQLGR-AFRSFDS----ECEVLRNVHH 97
F + +LG G FG V + + G A K +L+ R R +S E ++L V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLH 156
+ ++ + + D LVL +M G L+ +Y+ N + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
+ V+ DLKP NILLD+ R+SD G++ + +GE + + T+GYMAP
Sbjct: 120 REN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAP-- 170
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L N ++ D + G L+ E G+ P
Sbjct: 171 ---EVL--NNQRYTLSP------DYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAF-RSFDSECEVLRNVHHRNLLKIFSSC 107
LG G+ G VYK L +A+KV L + + SE E+L ++ + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ ++ E M GSL+ + + L I + V L YL S I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW----SLKILHR 119
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
D+KPSN+L++ ++ DFG+S L +S+ +T + T YMAP +
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY-VGTNAYMAPERISGE------- 168
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268
GI S DV+S G+ ME G+ P ++ + SL
Sbjct: 169 ---QYGIHS---DVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 48/244 (19%)
Query: 50 LGTGSFGIVYK----GILSDGNN----VAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRN 99
LG G FG V G+ + N VA+K+ K + SE E+++ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWL---------YSHNYFLDTLERLNI------ 144
++ + +C+ +++E G+L +L Y +N E+L+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
V +EYL +S +H DL N+L+ E+ V +++DFG+++ + + T
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT--GKK----PT 258
+ +MAP LFD I + + DV+SFGVLL E FT G P
Sbjct: 202 GRLPVKWMAP-EALFD------------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248
Query: 259 DEMF 262
+E+F
Sbjct: 249 EELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 28/230 (12%)
Query: 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAF----RS----FDS 87
D++ E + ++G G+FG V + KV+ ++L F RS F
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 88 ECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMID 147
E +++ + ++++F + + + +V+E MP G L N + NY + +
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAE 150
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
V LAL+ +H S +H D+KP N+LLD++ +++DFG + + E V +
Sbjct: 151 VVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVG 205
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
T Y++P ++LK + G +G +CD +S GV L E G P
Sbjct: 206 TPDYISP-----EVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 61/243 (25%), Positives = 111/243 (45%), Gaps = 46/243 (18%)
Query: 49 LLGTGSFGIVYKGILSDGNN------VAIKVFKLQ-LGRAFRSFDSECEVLRNV-HHRNL 100
LG G+FG V K +N VA+K+ K + SE E+++ + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSH-------NYFL-----DTLERLNIM--- 145
+ + C+ +V+E +G+L ++L + + +TL + +++
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
V +E+L +S +H DL N+L+ E+ V +++DFG+++ + + T
Sbjct: 139 YQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP-----TD 259
+ +MAP LFD + + + DV+SFGVLL E FT G P +
Sbjct: 195 RLPVKWMAP-EALFD------------RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241
Query: 260 EMF 262
E+F
Sbjct: 242 ELF 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRS------FDSECEVLRNVHHRNLLKI 103
+G G FG V G G + A V K +L RA + F E + R ++H N+L+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVK-EL-RASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFL------DTLERLNIMIDVWLALEYLHH 157
C LVLE P G L+N+L S+ + D L+R+ +V L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQ 118
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP--V 215
+H DL N L ++ ++ D+G++ + +T+ + ++AP V
Sbjct: 119 AD----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
L PK+ + K +++S GV + E FT
Sbjct: 175 EIRGQDLLPKD--------QTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 21/148 (14%)
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
PD + +L+LM G L L H F + R ++ L LE++H+ +V+ DL
Sbjct: 69 PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF----VVYRDL 123
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
KP+NILLDE+ R+SD G++ + ++ T GYMAP ++L+ K +
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP-----EVLQ-KGVAY 173
Query: 230 GSEGIISAKCDVYSFGVLLMETFTGKKP 257
S D +S G +L + G P
Sbjct: 174 DSSA------DWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 56/233 (24%)
Query: 41 TEGFNECNLLGTGSFGIV--YKGILSDGNNVAIKV----FKLQL--GRAFRSFDSECEVL 92
T + + +G G+FG+V + L+ G NVAIK F + R +R E ++L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR----ELKLL 63
Query: 93 RNVHHRNLL---KIFSSCSNPDFKALVLELMPNGSLENWLYSH-------NYFLDTLERL 142
+++ H N++ IF S + V EL+ L L S YFL + R
Sbjct: 64 KHLRHENIISLSDIFISPLEDIY--FVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILR- 119
Query: 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202
L+Y+H SA +VH DLKPSNIL++EN ++ DFG++++ +D
Sbjct: 120 --------GLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDP-QM 162
Query: 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
T ++T Y AP L K+ E D++S G + E GK
Sbjct: 163 TGYVSTRYYRAPEIML------TWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 31/180 (17%)
Query: 49 LLGTGSFGIVYKGILSD-GNNVAIKVFKLQLG------RAFRSFDSECEVLRNVHHRNLL 101
++G G++G+V K G VAIK FK A R E +VLR + H N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER-------LNIMIDVWLALEY 154
+ + LV E Y L+ LE + +W L+
Sbjct: 64 NLKEAFRRKGRLYLVFE-----------YVERTLLELLEASPGGLPPDAVRSYIWQLLQA 112
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
+ + HS I+H D+KP NIL+ E+ V ++ DFG ++ L S T +AT Y AP
Sbjct: 113 IAYCHSHN-IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAP 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 44 FNECNLLGTGSFGIVYK-GILSDGNNVAIKVFKLQLGR-AFRSFDS----ECEVLRNVHH 97
F +LG G FG V + + G A K KL+ R R ++ E +L V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLH 156
R ++ + + D LVL +M G L+ +Y+ N D + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
IV+ DLKP NILLD+ R+SD G++ + +GE T + T+GYMAP
Sbjct: 120 RER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAP-- 170
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+++ + F D + G L+ E G+ P
Sbjct: 171 ---EVINNEKYTFSP--------DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G+ G VY I ++ G VAIK LQ +E V+R H N++ S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E + GSL + + +D + + + ALE+LH ++H D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ----VIHRD 140
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K NILL + +++DFG + E S TM + T +MAP +++ K
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAP-----EVVTRK--A 191
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G K D++S G++ +E G+ P
Sbjct: 192 YGP------KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 72/242 (29%), Positives = 115/242 (47%), Gaps = 50/242 (20%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGR------AFRSFDSECE 90
+R + F+ +G G++G VYK D G VA+K +L + A R E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58
Query: 91 VLRNVHHRN---LLKIFSSCSNP-DFKA------LVLELMPN---GSLENWL--YSHNYF 135
+LR ++HRN L +I + + DFK LV E M + G LE+ L +S ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 136 LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195
+++L ++ L Y H + +H D+K SNILL+ +++DFG+++L +
Sbjct: 119 KSFMKQL---LE---GLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLY-N 167
Query: 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
E+S T + T+ Y +P G E A DV+S G +L E FT K
Sbjct: 168 SEESRPYTNKVITLWY-----------RPPELLLGEERYGPA-IDVWSCGCILGELFT-K 214
Query: 256 KP 257
KP
Sbjct: 215 KP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 50 LGTGSFGIV-YKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G GS GIV + S G VA+K L+ + +E ++R+ H N++++++S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E + G+L + + +H ++ + + + V AL LH + ++H D
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLKALSVLH----AQGVIHRD 141
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP--VSQLFDILKPKN 226
+K +ILL + ++SDFG + ++ + + T +MAP +S+L
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPELISRL-------- 191
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G E D++S G++++E G+ P
Sbjct: 192 -PYGPE------VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 43/234 (18%)
Query: 50 LGTGSFGIVYK----GILSDGNN----VAIKVFKLQ-LGRAFRSFDSECEVLRNV-HHRN 99
LG G FG V GI D N VA+K+ K + SE E+++ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-----NYFLDTL----------ERLNI 144
++ + +C+ +++E G+L +L + +Y DT + ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
V +EYL +S +H DL N+L+ E+ V +++DFG+++ + + + T
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP LFD + + + DV+SFGVLL E FT G P
Sbjct: 196 GRLPVKWMAP-EALFD------------RVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 24/151 (15%)
Query: 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174
L+LE + G L L F++ + ++ LALE+LH I++ DLKP NI
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLALEHLHQ----QGIIYRDLKPENI 131
Query: 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGI 234
LLD +++DFG+ K E +VT T TI YMAP +IL + G
Sbjct: 132 LLDAQGHVKLTDFGLCK-ESIHEGTVTHTFC-GTIEYMAP-----EIL----MRSGHGKA 180
Query: 235 ISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+ D +S G L+ + TG P FT E
Sbjct: 181 V----DWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVA---IKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G G F +VYK I L DG VA +++F++ +A + E ++L+ + H N++K +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTL--ERL--NIMIDVWLALEYLHHGHSS 161
S + +VLEL G L + H L ER + + ALE++H S
Sbjct: 70 SFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----S 124
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT----MATIGYMAPVSQ 217
I+H D+KP+N+ + V ++ D G+ + ++T + T YM+P
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS------SKTTAAHSLVGTPYYMSP--- 175
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP--TDEM 261
+ + F K D++S G LL E + P D+M
Sbjct: 176 --ERIHENGYNF--------KSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 65/233 (27%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLL 101
F L+G G++G VYKG + G AIKV + G E +L+ HHRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66
Query: 102 KIFSSC--SNP----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA---- 151
+ + NP D LV+E GS+ + + + + N + + W+A
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------TKGNTLKEEWIAYICR 118
Query: 152 --LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-MAT 208
L L H H ++H D+K N+LL EN ++ DFG+S L + +V + T + T
Sbjct: 119 EILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGT 174
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+MAP D F K D++S G+ +E G P +M
Sbjct: 175 PYWMAPEVIACDENPDATYDF--------KSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 50 LGTGSFGIVYKG-ILSDGNNVAIKVFKLQLGRAF---RSFDSECEVLRNVHHRNLLKIFS 105
+G G FG V G + S + V +L++ + F E + R++ H NLL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYF------LDTLERLNIMIDVWLALEYLHHGH 159
C+ LV+E P G L+ +L S TL+R+ ++ L L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
+H DL N LL ++ ++ D+G+S + VT + ++AP +L
Sbjct: 121 ----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP--ELV 174
Query: 220 D-----ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
D +L K +V+S GV + E F G +P
Sbjct: 175 DEVHGNLLVVDQTKES---------NVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-----HHRNLLKI 103
+G G++G VYK DG+ A+K+ D E E N+ +H N++K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 104 FSSCSNPDFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLN------IMIDVWLAL 152
+ D LVLEL GS+ + L +RL+ I+ L L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGL 141
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
++LH+ I+H D+K +NILL ++ DFG+S L + + ++ T +M
Sbjct: 142 QHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWM 195
Query: 213 AP----VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
AP Q +D A+CDV+S G+ +E G P +M
Sbjct: 196 APEVIACEQQYDY------------SYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 67/259 (25%), Positives = 111/259 (42%), Gaps = 36/259 (13%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G G +G V+ D G VA+K K L R +E ++L L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
+ + ++ L +E +P G L ++ L M +++ A++ LH +
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHE----LGYI 123
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
H DLKP N L+D + +++DFG+SK + +SV + + YMAP ++L+ K
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAP-----EVLRGK 173
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISLKNWVNESLPHAL 280
F D +S G +L E G P +E + +LK W E+L +
Sbjct: 174 GYDFT--------VDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYW-KETLQRPV 221
Query: 281 TDVVDANLRVSMKDVAAKL 299
D NL D+ KL
Sbjct: 222 YDDPRFNLSDEAWDLITKL 240
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 44/262 (16%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR------AFRSFDSECEV 91
R+ + + + N + G++G+VY+ G VA+K K++ + + R E +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINI 57
Query: 92 LRNVHHRNLLKIFSSC--SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVW 149
L + H N++ + SN D +V+E + + L++ + + E +M+ +
Sbjct: 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+ +LH I+H DLK SN+LL+ + ++ DFG+++ G TQ + T+
Sbjct: 117 SGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TL 170
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYS----FGVLLMET--FTGKKPTDEMFT 263
Y AP +L G S D++S F LL + F GK D++
Sbjct: 171 WYRAP--ELL---------LG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218
Query: 264 -----GEISLKNWVN-ESLPHA 279
G + K W LP A
Sbjct: 219 IFKLLGTPTEKIWPGFSELPGA 240
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 38/217 (17%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G GS GIV S G VA+K L+ + +E ++R+ H N+++++SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLN------IMIDVWLALEYLHHGHSSA 162
D +V+E + G+L + + T R+N + + V AL +LH +
Sbjct: 87 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIATVCLAVLKALSFLH----AQ 134
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP--VSQLFD 220
++H D+K +ILL + ++SDFG + ++ + + T +MAP +S+L
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPEVISRL-- 190
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G+E D++S G++++E G+ P
Sbjct: 191 -------PYGTE------VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 64/276 (23%), Positives = 108/276 (39%), Gaps = 80/276 (28%)
Query: 49 LLGTGSFGIVYKGIL------SDGNNVAIKVFKL-QLGRAFRSFDSECEVLRNV-HHRNL 100
+LG G+FG V + S N VA+K+ K ++ SE ++L ++ +H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 101 LKIFSSCSNPDFKALVL-ELMPNGSLENWLYSHNYF-----------------LDTLERL 142
+ + +C+ P+ +V+ E G+L N+L + F + R+
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 143 NIMI-----DVWLALEYLHHGHSSAPI--------------------------------- 164
+ I V + S+ P
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 165 --VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
+H DL NILL EN V ++ DFG+++ + D V + + +MAP S +FD
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES-IFD-- 250
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ + + DV+SFGVLL E F+ G P
Sbjct: 251 ----------KVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 21/224 (9%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
LG G+FG VYK + G A KV + + + E E+L +H ++K+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
+++E P G+++ + + L + I + AL+YLH S I+H D
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRD 135
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQLFDILKPK 225
LK N+LL + +++DFG+S ++ T + IG +MAP + + +K
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269
+ K D++S G+ L+E + P E+ + LK
Sbjct: 191 PYDY--------KADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 58/246 (23%), Positives = 97/246 (39%), Gaps = 39/246 (15%)
Query: 57 IVYKGILSDGNNVAIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLLKIFS----SCSN 109
+YKGI + V I+ FK ++E + LR + N+LKI+ +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
+L+LE G L L L +L++ ID L L+ +++ P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK-YTNKP--YKNL 149
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA--PVSQLFDILKPKNA 227
+ L+ EN K++ G + + + + +M L DI
Sbjct: 150 TSVSFLVTEN--------YKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT- 200
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS---LKNWVNESL----PHAL 280
I D+YS GV+L E FTGK P + + T EI + + L P +
Sbjct: 201 ------IKD---DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI 251
Query: 281 TDVVDA 286
+V+A
Sbjct: 252 KCIVEA 257
|
Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 28/196 (14%)
Query: 69 VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLEN 127
VA+K+ + + R+ F E +++ + N++++ + C D ++ E M NG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 128 WLYSHNY----------FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD 177
+L H + + + + ++YL SS VH DL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVG 164
Query: 178 ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA 237
+N +++DFG+S+ L G+ Q + I +M+ S L G +
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-------------GKFTT 211
Query: 238 KCDVYSFGVLLMETFT 253
DV++FGV L E T
Sbjct: 212 ASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 50 LGTGSFGIVYKGILSD------GNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLK 102
LG GSFG+VY+G D VA+K R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYS--------HNYFLDTL-ERLNIMIDVWLALE 153
+ S +V+ELM +G L+++L S TL E + + ++ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YL ++ VH DL N ++ + ++ DFG+++ + + + + + +MA
Sbjct: 134 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
P S LK +G+ + D++SFGV+L E +
Sbjct: 190 PES-----LK--------DGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 50 LGTGSFGIVYK-GILSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
LG G FG V + + G A K +L+ + + E +L VH R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 106 SCSNPDFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ LV+ +M G L +Y+ N + LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLFDI 221
I++ DLKP N+LLD + R+SD G++ L DG+ ++T A T G+MAP ++
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAP-----EL 168
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
L+ + F D ++ GV L E + P
Sbjct: 169 LQGEEYDFS--------VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 48/244 (19%)
Query: 50 LGTGSFGIVYK----GILSD----GNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRN 99
LG G FG V GI D VA+K+ K + SE E+++ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWL---------YSHNYFLDTLERLNI------ 144
++ + +C+ +++E G+L +L YS++ E++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
V +EYL +S +H DL N+L+ EN V +++DFG+++ + + + T
Sbjct: 143 TYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT--GKK----PT 258
+ +MAP LFD + + + DV+SFGVL+ E FT G P
Sbjct: 199 GRLPVKWMAP-EALFD------------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245
Query: 259 DEMF 262
+E+F
Sbjct: 246 EELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 57/230 (24%)
Query: 50 LGTGSFGIVYKGILSDGNN-VAIKVFKLQLGRAFRS-FDS-----ECEVLRNVHHRNLLK 102
+G G++GIV S+ N VAIK ++ AF + D+ E ++LR++ H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK----KIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 103 IFSSCSNPDFKA-----LVLELM---------PNGSLENWLYSH-NYFLDTLERLNIMID 147
I P +A +V ELM + +L + H YFL L R
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSD---DHCQYFLYQLLR------ 119
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
L+Y+H SA ++H DLKPSN+LL+ N ++ DFG+++ + D +T+ +
Sbjct: 120 ---GLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVV 170
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
T Y AP L +++ DV+S G + E G+KP
Sbjct: 171 TRWYRAPELLL------NCSEYT------TAIDVWSVGCIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 49 LLGTGSFGIVYKGILSDGNN----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
+LGTG FG + +G L + VAI + + R F +E L H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ + +V E M NG+L+++L H L + + ++ + ++YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL----SEMG 127
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
VH L +L++ ++V ++S F +L D +++ TM+ + A
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWA---------A 176
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
P+ ++ S+ DV+SFG+++ E + G++P +M
Sbjct: 177 PEAIQYHH---FSSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 49 LLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSECE-VLRNV-----HHRNLL 101
+LG GSFG V L N AIK K + D EC V R V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDV--VLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIM-IDVWLALEYLHHGHS 160
+F + + V+E + G L + S F R ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF--DEARARFYAAEIICGLQFLH---- 113
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISK--LLGDGEDSVTQTMTMATIGYMAPVSQL 218
I++ DLK N+LLD++ +++DFG+ K + G+G+ S T Y+AP
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST----FCGTPDYIAP---- 165
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+IL K K+ + D +SFGVLL E G+ P DE+F
Sbjct: 166 -EIL--KGQKY------NESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 64/227 (28%), Positives = 95/227 (41%), Gaps = 36/227 (15%)
Query: 49 LLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSECEVLRN------VHHRNLL 101
+LG GSFG V L + V AIKV K + + D +C + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDV--ILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHS 160
+ D V+E + G L + F + R +V LAL +LH HG
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG-- 116
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
+++ DLK NILLD +++DFG+ K G T T T Y+AP +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFC-GTPDYIAP-----E 166
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
IL + ++G D ++ GVL+ E G+ P D++F
Sbjct: 167 IL--QELEYG------PSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 43/231 (18%)
Query: 50 LGTGSFGIVYKGILS--DGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-----HHRNLLK 102
+G G++G V+K +L+ +G+ A+K+ D E E N+ H N++K
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 103 IFSSCSNPDFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL---ALEY 154
+ D K LVLEL GS+ + + FL ER+ I ++ AL
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMG 136
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
L H H + I H D+K +NILL ++ DFG+S L + + ++ T +MAP
Sbjct: 137 LQHLHVNKTI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAP 193
Query: 215 ----VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
Q D A+CDV+S G+ +E G P ++
Sbjct: 194 EVIACEQQLD------------STYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK---VFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G G F VY+ L DG VA+K +F L +A E ++L+ ++H N++K ++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVW-------LALEYLHHG 158
S + +VLEL G L + H +RL VW ALE++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSR-MIKH---FKKQKRLIPEKTVWKYFVQLCSALEHMH-- 123
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPV 215
S ++H D+KP+N+ + V ++ D G+ + S T + +G YM+P
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSP- 175
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + F K D++S G LL E + P
Sbjct: 176 ----ERIHENGYNF--------KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 49 LLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSECE-VLRNV-----HHRNLL 101
+LG GSFG V+ L N AIK K + D EC V + V H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
++ + + V+E + G L + S + F D ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH----S 114
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISK--LLGDGEDSVTQTMTMATIGYMAPVSQLF 219
IV+ DLK NILLD + +++DFG+ K +LGD + T T T Y+AP
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFC-GTPDYIAP----- 165
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+IL + K+ + D +SFGVLL E G+ P
Sbjct: 166 EILLGQ--KYNTS------VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 66/231 (28%), Positives = 94/231 (40%), Gaps = 43/231 (18%)
Query: 50 LGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G+FG VY+ D + A+KV + A + EV + RN+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 109 NP-------DFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
+P F+ LV + M G L L F + + I ++ LALE+LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
IV+ DLKP NILLD + DFG+SK + D+ T T Y+AP
Sbjct: 114 KYD----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
L E + D +S GVL+ E G P T +M+
Sbjct: 168 LL------------DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY 206
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 62/242 (25%)
Query: 50 LGTGSFGIV----YKGILSDGNNVAIK----VF--KLQLGRAFRSFDSECEVLRNVH-HR 98
LG G++GIV S+ VAIK VF K+ RA R E ++LR+ H+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 99 NLLKIFS-SCSNPD-FKALVL--ELM---------PNGSLENWLYSHNYFLDTLERLNIM 145
N+ ++ P F L L ELM L + + F+ +
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF--QSFIYQILC---- 116
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
L+Y+H SA ++H DLKP N+L++ + ++ DFG+++ + MT
Sbjct: 117 -----GLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 206 --MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263
+AT Y AP L + ++ I DV+S G +L E G+KP +F
Sbjct: 168 EYVATRWYRAPEIML------SFQSY-TKAI-----DVWSVGCILAE-LLGRKP---VFK 211
Query: 264 GE 265
G+
Sbjct: 212 GK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 18/107 (16%)
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
+E+L +S +H DL NILL EN V ++ DFG+++ + D V + + +
Sbjct: 186 MEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
MAP S +FD + + + DV+SFGVLL E F+ G P
Sbjct: 242 MAPES-IFD------------KVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNVHHRNLLKIFSSC 107
LG G+ G V K + G +A KV + + R E +++ ++ + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPIVH 166
N + + +E M GSL+ +E L I + V L YL++ H I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMH 127
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKN 226
D+KPSNIL++ ++ DFG+S G+ +S+ T + T YM+P
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSP------------ 171
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
+ + K DV+S G+ ++E GK P
Sbjct: 172 ERIQGGK-YTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS-KLLGDGEDSVTQTMTMAT 208
LA+ +H H VH D+KP N+LLD N R++DFG K+ DG +V ++ + T
Sbjct: 113 LAIHSIHQLH----YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGT 166
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
Y++P ++ ++ K+G E CD +S GV + E G+ P
Sbjct: 167 PDYISP--EILQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 20/223 (8%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK---LQLGRAFRSFDSECEVLRNVHHRN 99
F+ +L+G G FG V ++ A+KV K L F+ E ++L +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA--LEYLHH 157
+ ++ + + D LV+E P G L + L + D M +LA + +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD-----EDMAQFYLAELVLAIHS 117
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
H VH D+KP N+L+D +++DFG + L V + + T Y+AP
Sbjct: 118 VHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP--- 172
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
++L N +G +CD +S GV+ E G+ P E
Sbjct: 173 --EVLTTMNG--DGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 8e-09
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA------FRSFDSECEVLRNV- 95
+ E +G G++G VYK L+ G VA+K ++ L R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 96 --HHRNLLKIFSSCSNPDFK-----ALVLELMPNGSLENWLYSH-NYFLDTLERLNIMID 147
H N++++ C P LV E + + L +L L ++M
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+ +++LH S IVH DLKP NIL+ + +++DFG++++ + T +
Sbjct: 116 LLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVV 168
Query: 208 TIGYMAP 214
T+ Y AP
Sbjct: 169 TLWYRAP 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 50 LGTGSFGIVY--KGILSDGNNVAIKVFKLQLGRAFRSFDSECEV--LRNVHHRNLLKIFS 105
+G GSFG +Y K SD + IK L S+ EV L + H N++ F+
Sbjct: 8 IGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 106 SCSNPDFKALVLELMPNGSLENWL-YSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
S +V+E G L + + L+ + + L L+++H I
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKI 122
Query: 165 VHCDLKPSNILLDEN-MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL- 222
+H D+K NI L +N MVA++ DFGI++ L D + + T + T Y++P +I
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAYT-CVGTPYYLSP-----EICQ 175
Query: 223 -KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+P N K D++S G +L E T K P
Sbjct: 176 NRPYN----------NKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-09
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 49 LLGTGSFG-IVYKGILSDGNNVAIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLLKIF 104
LLG G+FG ++ + G A+K+ K ++ A +E VL+N H L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
S D V+E + G L L F + R ++ AL+YLH G I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK----I 116
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI----GYMAPVSQLFD 220
V+ DLK N++LD++ +++DFG+ K + +T TM T Y+AP +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAP-----E 165
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+L+ + +G D + GV++ E G+ P
Sbjct: 166 VLEDND--YGR------AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 58/232 (25%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIK----VFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
++G GS+G+V I G VAIK VF+ + A R E ++LR + H ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRIL-REIKLLRLLRHPDIVEI 64
Query: 104 FSSCSNP---DFKAL--VLELMPNGSLENWLYS------------HNYFLDTLERLNIMI 146
P +FK + V ELM E+ L+ H +FL L R
Sbjct: 65 KHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL-LGDGEDSVTQTMT 205
AL+Y+H +A + H DLKP NIL + + ++ DFG++++ D ++ T
Sbjct: 115 ----ALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 206 MATIGYMAP--VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+AT Y AP F +K+ + D++S G + E TGK
Sbjct: 167 VATRWYRAPELCGSFF-------SKY------TPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 58/183 (31%), Positives = 91/183 (49%), Gaps = 38/183 (20%)
Query: 50 LGTGSFGIV---YKGILSDGNNVAIKVFKLQ--------LGRAFRSFDSECEVLRNVHHR 98
+G+G+ GIV Y + G NVAIK KL RA+R +++ V+H+
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIK--KLSRPFQNVTHAKRAYREL----VLMKLVNHK 75
Query: 99 N---LLKIFSSCSN-PDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL-A 151
N LL +F+ + +F+ LV+ELM N LD ER++ ++ L
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDH-ERMSYLLYQMLCG 130
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
+++LH SA I+H DLKPSNI++ + ++ DFG+++ G S T + T Y
Sbjct: 131 IKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 183
Query: 212 MAP 214
AP
Sbjct: 184 RAP 186
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA---FRSFDSECEVL-RNVHHRNLLKIF 104
+G GSFG V +DG A+KV + + + +E VL +NV H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
S D VL+ + G L L F + R ++ AL YLH S I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH----SLNI 117
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
++ DLKP NILLD ++DFG+ K + T + T Y+AP
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)
Query: 50 LGTGSFGIV----YKGILSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKI 103
+G GS+G V ++ +DG IK L+ R ++ + E ++L + H N++
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 104 FSSCSNPD-FKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSS 161
S D +V+ G L + L L + + + + +AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQL 218
I+H DLK N+ L + +V D GI+++L + D M IG YM+P +L
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-----MASTLIGTPYYMSP--EL 173
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
F KP N K DV++ G + E T K
Sbjct: 174 FSN-KPYN----------YKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNV-AIKVF-KLQLGR----AFRSFDSEC 89
++ E F+ ++G G+FG V V A+K+ K ++ + AF F E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEER 94
Query: 90 EVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIM--ID 147
+++ + + ++++ + + + +V+E MP G L N + NY D E+ +
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAE 150
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
V LAL+ +H S +H D+KP N+LLD++ +++DFG + D V +
Sbjct: 151 VVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVG 205
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
T Y++P ++LK + G +G +CD +S GV L E G P
Sbjct: 206 TPDYISP-----EVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 21/163 (12%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQ-------LGRAFRSFDSECEVLRNV 95
F + LLG G G V+ L + A+KV + + R +E E+L +
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATL 58
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWL--YSHNYFLDTLERLNIMIDVWLALE 153
H L +++S + LV++ P G L L + + R +V LALE
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALE 117
Query: 154 YLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195
YLH G IV+ DLKP NILL E+ +SDF +SK
Sbjct: 118 YLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 50 LGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G++G VYK + A+K +L+L + F E ++L ++ + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFL-----DTLERLNIMIDVWLALEYLHHGHSSA 162
+ +E M GSL+ LY+ D L R I V L++L H+
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEHN-- 123
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQLF 219
I+H D+KP+N+L++ N ++ DFG+S G+ S+ +T IG YMAP
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT----NIGCQSYMAP----- 170
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ +K + + DV+S G+ ++E G+ P
Sbjct: 171 ERIKSGGPN--QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 25/151 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFD-----SECEVLRNV-HHRNLLK 102
+G G+F V K G AIK K + F+S + E + LR + H N+L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 103 ----IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-H 157
+F + ALV ELM + +L + L + M + +L+++H +
Sbjct: 63 LIEVLFDRKTGR--LALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFG 188
G I H D+KP NIL+ ++++ +++DFG
Sbjct: 120 G-----IFHRDIKPENILIKDDIL-KLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK---VFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G G F VY+ L D VA+K +F++ +A + E ++L+ ++H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVW-------LALEYLHHG 158
S + +VLEL G L + YF +RL VW A+E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMI---KYF-KKQKRLIPERTVWKYFVQLCSAVEHMH-- 123
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPV 215
S ++H D+KP+N+ + V ++ D G+ + S T + +G YM+P
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSP- 175
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP--TDEM 261
+ + F K D++S G LL E + P D+M
Sbjct: 176 ----ERIHENGYNF--------KSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 2e-08
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G+ G VY I ++ G VAIK LQ +E V+R + N++ S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E + GSL + + +D + + + AL++LH S ++H D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH----SNQVIHRD 140
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K NILL + +++DFG + E S TM + T +MAP +++ K
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAP-----EVVTRK--A 191
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G K D++S G++ +E G+ P
Sbjct: 192 YGP------KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS-KLLGDGEDSVTQTMTMAT 208
LA++ +H VH D+KP N+LLD+N R++DFG +LL DG +V + + T
Sbjct: 113 LAIDSVHQLG----YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGT 166
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
Y++P +IL+ G G +CD +S GV + E G+ P
Sbjct: 167 PDYISP-----EILQAMEDGKGRYG---PECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 42/232 (18%)
Query: 50 LGTGSFGIVYKGIL------SDGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLL- 101
LG FG VYKG L VAIK K + R F E + + H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 102 ------------KIFSSCSNPDFKALVLELMPN---GSLENWLYSHNYFLDTLERLNIMI 146
IFS CS+ D ++ P+ GS ++ + L+ + ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD-DKTVKSTLEPADFVHIVT 131
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
+ +E+L SS +VH DL N+L+ + + ++SD G+ + + + ++
Sbjct: 132 QIAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I +M+P + ++ G S D++S+GV+L E F+ G +P
Sbjct: 188 LPIRWMSPEAIMY-------------GKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIKVF----------KLQLGRAFRSFDSECEVLRNVHHR 98
+G GS+G+V+K + G VAIK F K+ A R E +L+ + H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI----ALR----EIRMLKQLKHP 60
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
NL+ + LV E + ++ N L + + I+ A+ + H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-- 117
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
+H D+KP NIL+ + ++ DFG +++L D T +AT Y AP
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 50/240 (20%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNN-VAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNL 100
F ++G G++G+V K + VAIK FK + E ++LR + N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 101 LKIFSSCSNPDFKALV-----------LELMPNGSLENWLYSHNYFLDTLERLNIMIDVW 149
+++ + LV LE MPNG + S+ Y L
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------------- 109
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
++ +H H + IVH D+KP N+L+ N V ++ DFG ++ L +G ++ T +AT
Sbjct: 110 --IKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATR 165
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME------TFTGKKPTDEMFT 263
Y +P L A +G D++S G +L E F G+ D++FT
Sbjct: 166 WYRSPELLL-------GAPYGK------AVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 38/202 (18%)
Query: 69 VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLEN 127
VA+K+ + + R+ F E ++L + N++++ C + D ++ E M NG L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 128 WLYSHNYFLDTLER-------------------LNIMIDVWLALEYLHHGHSSAPIVHCD 168
+L S ++ D E L++ + + ++YL SS VH D
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHRD 163
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
L N L+ EN+ +++DFG+S+ L G+ Q + I +MA L
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------- 214
Query: 229 FGSEGIISAKCDVYSFGVLLME 250
G + DV++FGV L E
Sbjct: 215 ----GKFTTASDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 64/218 (29%), Positives = 87/218 (39%), Gaps = 29/218 (13%)
Query: 50 LGTGSFGIVYKGILSDGNN-VAIKVFKL---QLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G GSFG VY N VAIK Q ++ E L+ + H N ++ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 106 SCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
C + A LV+E GS + L H L +E I L YLH S
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHER 136
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP-VSQLFDILK 223
+H D+K NILL E +++DFG + L+ V T +MAP V D
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMD--- 187
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
EG K DV+S G+ +E K P M
Sbjct: 188 --------EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 49 LLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSEC-----EVLRNVH-HRNLL 101
+LG GSFG V L G A+KV K + + D EC +L H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+++ PD V+E + G L + F + R ++ AL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH----D 114
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDG-EDSVTQTMTMATIGYMAPVSQLFD 220
I++ DLK N+LLD +++DFG+ K +G + T + T Y+AP +
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAP-----E 166
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTG----EISLKNW 271
IL+ E + D ++ GVLL E G P D++F E+ W
Sbjct: 167 ILQ--------EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 218
Query: 272 VNE 274
+++
Sbjct: 219 LSQ 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 64/233 (27%), Positives = 92/233 (39%), Gaps = 40/233 (17%)
Query: 44 FNECNLLGTGSFGIV----YKGILSDGNNVAIKVFKLQ--LGR-AFRSFDSE---CEVLR 93
F +LG G FG V YK G AIK K + R S E E
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
+ H L+ +F+ D V+E G L ++ H + V L L+
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQ 115
Query: 154 YLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
YLH + IV+ DLK N+LLD +++DFG+ K G G T T T ++
Sbjct: 116 YLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFC-GTPEFL 168
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
AP ++L +E + D + GVL+ E G+ P F G+
Sbjct: 169 AP-----EVL--------TETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 30/79 (37%), Positives = 49/79 (62%), Gaps = 7/79 (8%)
Query: 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSN 173
LV+E + G +++ L+ + YF + + I +V LAL+YLH HG I+H DLKP N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHG-----IIHRDLKPDN 134
Query: 174 ILLDENMVARVSDFGISKL 192
+L+ +++DFG+SK+
Sbjct: 135 MLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 63/218 (28%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 50 LGTGSFGIVYKGILSDGNN-VAIKVFKL---QLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G GSFG VY S N VA+K Q ++ E + L+ + H N ++ +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-YK 87
Query: 106 SCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
C + A LV+E GS + L H L +E I L YLH S +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNM 142
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP-VSQLFDILK 223
+H D+K NILL E +++DFG + V T +MAP V D
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMD--- 193
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
EG K DV+S G+ +E K P M
Sbjct: 194 --------EGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 48/144 (33%), Positives = 68/144 (47%), Gaps = 21/144 (14%)
Query: 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSN 173
LV+ LM G L+ +Y+ +ER+ I + LH H S IV+ D+KP N
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERV-IHYSAQITCGILHLH---SMDIVYRDMKPEN 125
Query: 174 ILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEG 233
+LLD+ R+SD G++ L DG+ T T T GYMAP +ILK E
Sbjct: 126 VLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAP-----EILK--------EE 169
Query: 234 IISAKCDVYSFGVLLMETFTGKKP 257
S D ++ G + E G+ P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 55/184 (29%), Positives = 94/184 (51%), Gaps = 31/184 (16%)
Query: 36 DIQRA-TEGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLR 93
DI R+ + + N++G GSFG+VY+ I D VAIK K+ ++ + E +++
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYK--NRELLIMK 114
Query: 94 NVHHRNLLKI----FSSCSNPD----FKALVLELMPNGSLENWL--YSHN-----YFLDT 138
N++H N++ + ++ C + F +V+E +P ++ ++ Y+ N FL
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 139 LERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLGDGE 197
L + AL Y+H S I H DLKP N+L+D N ++ DFG +K L G+
Sbjct: 174 LYSYQLC----RALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 198 DSVT 201
SV+
Sbjct: 226 RSVS 229
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 50 LGTGSFGIVYKGILSDGNNVA---IKVFK------LQLGRAFRSFDSECEVLRNVHHRNL 100
LG GSFG VY ++ D VA +KV K L ++ + E ++L + H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI---MIDVWLALEYLHH 157
+K +S D ++ E L+ L + TL + I + L + Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
I+H DLK NI L N++ ++ DFG+S+LL D T T T T YM+P
Sbjct: 125 RR----ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT-TFT-GTPYYMSP--- 174
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
+ LK + +K D++S G +L E
Sbjct: 175 --EALKHQG--------YDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G+ G VY + ++ G VAI+ LQ +E V+R + N++ S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E + GSL + + +D + + + ALE+LH S ++H D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K NILL + +++DFG + E S TM + T +MAP +++ K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAP-----EVVTRK--A 192
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G K D++S G++ +E G+ P
Sbjct: 193 YGP------KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 49 LLGTGSFG-IVYKGILSDGNNVAIKVFK----LQLGRAFRSFDSECEVLRNVHHRNLLKI 103
++G GSFG ++ SDG+ A+KV + L+ +L+N+ H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
S + VL+ + G L L FL+ R +V A+ YLH S
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH----SLN 116
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
I++ DLKP NILLD ++DFG+ K G + T T T Y+AP
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFC-GTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 42 EGFNECNLLGTGSFGIVYK-GILSDGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRN 99
+ F + LG G+ G+V K G +A K+ L++ A R+ E +VL +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ + + + ++ +E M GSL+ L + + + I V L YL H
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-KVSIAVLRGLAYLREKH 123
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I+H D+KPSNIL++ ++ DFG+S G DS+ + + T YM+P
Sbjct: 124 Q---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSP----- 171
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ L+ + S + D++S G+ L+E G+ P
Sbjct: 172 ERLQGTH--------YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 50 LGTGSFG--IVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS 105
LG G+FG +Y+ D + V K L + R +E +L + H N++ ++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 106 SCSNPDFKALVLELMPNGSL-ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ + + +E G+L + + + L + + A+ Y+H A I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGI 122
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
+H D+K NI L + + ++ DFGISK+LG E S+ +T+ + T YM+P ++ +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSP-----ELCQG 175
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKK 256
F K D+++ G +L E T K+
Sbjct: 176 VKYNF--------KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHR 98
+ + + LG GS+ VYKG +G VA+KV +LQ G F + E +L+ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHA 63
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
N++ + + LV E + + L ++ H L + + L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
+ I+H DLKP N+L+ + +++DFG+++ S T + + T+ Y P
Sbjct: 123 Y----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPP 172
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRN 99
+ F + + LG G+ G+V+K G +A K+ L++ A R+ E +VL +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ + + + ++ +E M GSL+ L + + + I V L YL H
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 123
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I+H D+KPSNIL++ ++ DFG+S G DS+ + + T YM+P
Sbjct: 124 K---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSP----- 171
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ L+ + S + D++S G+ L+E G+ P
Sbjct: 172 ERLQGTH--------YSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 23/189 (12%)
Query: 73 VFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH 132
+K + R + ++ ++ R L +S + V E + E
Sbjct: 112 PYKTKDARFRQGKSGYGDISEDLKRR--LDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169
Query: 133 NYFLD--TLERLNIM-IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189
+ + TLE L V +E+L +S +H DL NILL EN V ++ DFG+
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGL 225
Query: 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLM 249
++ + D V + + +MAP +FD + + + DV+SFGVLL
Sbjct: 226 ARDIYKDPDYVRKGDARLPLKWMAP-ETIFD------------RVYTIQSDVWSFGVLLW 272
Query: 250 ETFT-GKKP 257
E F+ G P
Sbjct: 273 EIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 53/241 (21%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVH 96
F + +G G++G+VYK G VA+K +L A R E +L+ ++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
H N++K+ + LV E + + L+ F+D I + L YL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLP--LIKSYLF 107
Query: 157 ---------HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
H H ++H DLKP N+L++ +++DFG+++ G T T +
Sbjct: 108 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVV 162
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET------FTGKKPTDEM 261
T+ Y AP +IL G + S D++S G + E F G D++
Sbjct: 163 TLWYRAP-----EIL------LGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210
Query: 262 F 262
F
Sbjct: 211 F 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VFK--LQLGRAFRSFDSECEVLRNVHHRNLLK 102
+G G+FG+V+ DG VA+K VF+ + R FR E ++L H N+L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63
Query: 103 IFSSCSNPD---FKAL--VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
P F+ + V ELM L + S ++ + + L+YLH
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH- 120
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
SA I+H D+KP N+L++ N V ++ DFG+++ + + ++S T + T Y AP
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAP--- 173
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+IL GS SA D++S G + E +
Sbjct: 174 --EIL------MGSRHYTSA-VDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 56/175 (32%), Positives = 82/175 (46%), Gaps = 20/175 (11%)
Query: 49 LLGTGSFGIVYKGILS----DGNNVAIKVFKLQL---GRAFRSFDSECEVL-RNVHHRNL 100
++G GSFG K +L+ DG A+KV + ++ + + +E VL +NV H L
Sbjct: 2 VIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ + S + VL+ + G L L F + R ++ AL YLH
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---- 113
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG-EDSVTQTMTMATIGYMAP 214
S IV+ DLKP NILLD ++DFG+ K +G S T T T Y+AP
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 59/244 (24%), Positives = 107/244 (43%), Gaps = 48/244 (19%)
Query: 50 LGTGSFGIVYK----GILSDGNN----VAIKVFKLQ-LGRAFRSFDSECEVLRNV-HHRN 99
LG G FG V + GI + VA+K+ K + SE E+++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-----NYFLDTLER----------LNI 144
++ + C+ +++E G+L +L + +Y D + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
V +EYL S +H DL N+L+ E+ V +++DFG+++ + D + +
Sbjct: 140 AYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT--GKK----PT 258
+ +MAP LFD + + + DV+SFG+L+ E FT G P
Sbjct: 196 GRLPVKWMAP-EALFD------------RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242
Query: 259 DEMF 262
+E+F
Sbjct: 243 EELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 36/227 (15%)
Query: 49 LLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSEC-----EVLRNV-HHRNLL 101
+LG GSFG V L + + A+KV K + + D EC VL H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDV--ILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHS 160
++ S D V+E + G L + F + R ++ L L++LH G
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHERG-- 116
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
I++ DLK N+LLD +++DFG+ K G T T T Y+AP +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC-GTPDYIAP-----E 166
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
IL S D ++ GVLL E G+ P DE+F
Sbjct: 167 IL--------SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 120 MPNGSLENWLYSHNYF--LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD 177
+ ++N L S + L TL+ L+ V +E+L +S VH DL N+LL
Sbjct: 217 SNDSEVKN-LLSDDGSEGLTTLDLLSFTYQVARGMEFL----ASKNCVHRDLAARNVLLA 271
Query: 178 ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA 237
+ + ++ DFG+++ + + V++ T + +MAP S +FD + +
Sbjct: 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES-IFD------------NLYTT 318
Query: 238 KCDVYSFGVLLMETFT-GKKP-----TDEMFTGEISLKNWVNESLP-HALTDVVD 285
DV+S+G+LL E F+ G P D F +I K+ + P HA +V D
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI--KSGYRMAKPDHATQEVYD 371
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 22/180 (12%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFD----SECEVLRNVHHRNLLKIF 104
+G G+FG V+K VA+K K+ + F E ++L+ + H N++ +
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 105 SSCSNP-----DFKA---LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
C +K LV E + L L + N E +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMAP 214
I+H D+K +NIL+ ++ + +++DFG+++ ++S T + T+ Y P
Sbjct: 137 ----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-07
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G G+ G V+ I ++ G VAIK LQ +E V++ + + N++ S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
D +V+E + GSL + + +D + + + ALE+LH ++H D
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ----VIHRD 140
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K N+LL + +++DFG + E S TM + T +MAP +++ K
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAP-----EVVTRK--A 191
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+G K D++S G++ +E G+ P
Sbjct: 192 YGP------KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLL 101
F ++G G++G VYKG + G AIKV + E +L+ HHRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 102 KIF------SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA---- 151
+ S + D LV+E GS+ + + + + N + + W+A
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN--------TKGNALKEDWIAYICR 128
Query: 152 --LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-MAT 208
L L H H+ ++H D+K N+LL EN ++ DFG+S L + +V + T + T
Sbjct: 129 EILRGLAHLHAHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGT 184
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+MAP ++ + +A + + D++S G+ +E G P +M
Sbjct: 185 PYWMAP--EVIACDENPDATY------DYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKL---QLGRAFRSFDSECEVLRNVHHRN 99
F + +G GSFG VY N V AIK Q ++ E + L+ + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ + C + A ++ GS + L H L +E I L YLH
Sbjct: 87 SIE-YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--- 142
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
S ++H D+K NILL E +++DFG + + V T +MAP
Sbjct: 143 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAP----- 190
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+++ + EG K DV+S G+ +E K P M
Sbjct: 191 EVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 50 LGTGSFGIVYKGILSDGNN--VAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLLK 102
LG G++ VYKG + VA+K L A R E +++ + H N+++
Sbjct: 8 LGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVR 62
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYF--LDTLERLNIMIDVWLALEYLHHGHS 160
+ + LV E M + L+ ++ +H LD + + + + H
Sbjct: 63 LHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR- 120
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
++H DLKP N+L+++ +++DFG+++ G + T + + T+ Y AP D
Sbjct: 121 ---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAP-----D 170
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264
+L GS S D++S G ++ E TG+ +F G
Sbjct: 171 VL------LGSR-TYSTSIDIWSVGCIMAEMITGRP----LFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 50 LGTGSFGIVYK------GILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG VYK G+L+ A KV + + E ++L + H N++K+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ + +++E G+++ + L + + AL YLH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---- 123
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQLFD 220
I+H DLK NIL + +++DFG+S +++ T + IG +MAP + +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269
K + + K DV+S G+ L+E + P E+ + LK
Sbjct: 179 TSKDRPYDY--------KADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 49/209 (23%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 50 LGTGSFGIV-YKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G GS GIV G VA+K+ L+ + +E ++R+ H+N+++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
+ +++E + G+L + + L+ + + V AL YLH S ++H D
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLH----SQGVIHRD 142
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAK 228
+K +ILL + ++SDFG + +D + + T +MAP +
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAP-------------E 187
Query: 229 FGSEGIISAKCDVYSFGVLLMETFTGKKP 257
S + D++S G++++E G+ P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 25/222 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKL---QLGRAFRSFDSECEVLRNVHHRN 99
F++ +G GSFG VY + V AIK Q ++ E L+ + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ + C + A ++ GS + L H L +E + L YLH
Sbjct: 77 TIQ-YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
S ++H D+K NILL E + ++ DFG + ++ V T +MAP
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAP----- 180
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
+++ + EG K DV+S G+ +E K P M
Sbjct: 181 EVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 40/149 (26%), Positives = 59/149 (39%), Gaps = 14/149 (9%)
Query: 47 CNLLGTGSFG--IVYKGILSDGNN-VAIKVFKL--QLGRAFRSFDSECEVLRNVHHRNLL 101
L+G IV+ N VA+K L + E R + H N+L
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL---NIMIDVWLALEYLHHG 158
+S +V LM GS E+ L +H F + L L I+ DV AL+Y+H
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDF 187
+H +K S+ILL + +S
Sbjct: 121 G----FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 49 LLGTGSFGIVYKGIL----SDGNNVAIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLL 101
LLG G+FG K IL + G A+K+ K ++ A +E VL+N H L
Sbjct: 2 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ S D V+E G L L F + R ++ AL+YLH S
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH---SE 114
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDG-EDSVTQTMTMATIGYMAPVSQLFD 220
+V+ DLK N++LD++ +++DFG+ K +G +D T T Y+AP +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAP-----E 166
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+L+ + +G D + GV++ E G+ P
Sbjct: 167 VLEDND--YGR------AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 12/171 (7%)
Query: 49 LLGTGSFG-IVYKGILSDGNNVAIKVFKLQL---GRAFRSFDSECEVL-RNVHHRNLLKI 103
++G GSFG ++ ++ A+KV + + + + SE VL +NV H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
S D VL+ + G L L FL+ R ++ AL YLH S
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH----SLN 116
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
IV+ DLKP NILLD ++DFG+ K + E + T + T Y+AP
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR-----AFRSFDSECEVLRNV 95
E + + + LG G++ V+KG N VA+K +L+ A R E +L+N+
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNL 60
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI-MIDVWLALEY 154
H N++ + LV E + + L+ +L + L ++ + I M + L Y
Sbjct: 61 KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
H I+H DLKP N+L++E +++DFG+++ ++ T Y
Sbjct: 119 CHK----RKILHRDLKPQNLLINEKGELKLADFGLAR-----------AKSVPTKTYSNE 163
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264
V L+ +P + GS S D++ G +L E TG+ MF G
Sbjct: 164 VVTLW--YRPPDVLLGSTE-YSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 41/219 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSF------DSECEVLRNVHHRN--- 99
+G+G++G V VA+K +L R F+S E +L+++ H N
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 100 LLKIFS-SCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
LL +F+ + S +F LV LM L N + + ++ L + + L+Y+H
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFL--IYQLLRGLKYIH 135
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
SA I+H DLKPSN+ ++E+ R+ DFG+++ D T +AT Y AP
Sbjct: 136 ----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEI 186
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
L N ++ + D++S G ++ E GK
Sbjct: 187 ML-------NWMHYNQTV-----DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 32/180 (17%)
Query: 50 LGTGSFGIV---YKGILSDGNNVAIKVF------KLQLGRAFRSFDSECEVLRNVHHRN- 99
+G+G+ GIV Y +L NVAIK + RA+R E +++ V+H+N
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 78
Query: 100 --LLKIFSSCSN-PDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
LL +F+ + +F+ LV+ELM N LD ++ + +++
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
LH SA I+H DLKPSNI++ + ++ DFG+++ G S T + T Y AP
Sbjct: 135 LH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 50/232 (21%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLK 102
+G G++G+VYKG G VA+K +L+ A R E +L+ + H N++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH------ 156
+ L+ E + S++ Y LD+L +D L YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL---SMDLKKY-----LDSL-PKGQYMDAELVKSYLYQILQGI 114
Query: 157 ---HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
H ++H DLKP N+L+D V +++DFG+++ G T + T+ Y A
Sbjct: 115 LFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRA 169
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
P ++L GS S D++S G + E T KKP +F G+
Sbjct: 170 P-----EVL------LGSP-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSF------DSECEVLRNVHHRN--- 99
+G+G++G V G VA+K +L R F+S E +L+++ H N
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80
Query: 100 LLKIFS-SCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
LL +F+ + S +F LV LM L N + D ++ L + + L+Y+H
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH 137
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
SA I+H DLKPSN+ ++E+ ++ DFG+++ D T +AT Y AP
Sbjct: 138 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEI 188
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
L N ++ + D++S G ++ E TG+
Sbjct: 189 ML-------NWMHYNQTV-----DIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 40/187 (21%)
Query: 94 NVH-----HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148
VH + N +K++ S + L+++ + +G L + L L E I+ +
Sbjct: 60 MVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQL 118
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMV-ARVSDFGISKLLGDGEDSVTQTMTMA 207
AL LH + I+H D+K N+L D + D+G+ K++G T +
Sbjct: 119 VEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDG 168
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF-----GVLLMETFTGKKPTDEMF 262
T+ Y +P E I D SF GVL E TGK P E
Sbjct: 169 TLDYFSP-----------------EKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 263 TGEISLK 269
E+ L+
Sbjct: 211 DEELDLE 217
|
Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 38/220 (17%)
Query: 49 LLGTGSFGIVYKGIL----SDGNNVAIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLL 101
LLG G+FG K IL + G A+K+ + ++ A +E VL+N H L
Sbjct: 2 LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ + D V+E G L L F + R ++ ALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH----S 113
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI----GYMAPVSQ 217
+V+ D+K N++LD++ +++DFG+ K + ++ TM T Y+AP
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAP--- 164
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L+ + +G D + GV++ E G+ P
Sbjct: 165 --EVLEDND--YGR------AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 51/232 (21%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKV----FKLQL--GRAFRSFDSECEVLRN 94
+ + + +G+G++G V + G VAIK F+ +L RA+R E +L++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 95 VHHRN---LLKIFSSCSNPD-FKALVLELMP-NGSLENWLYSHNYFLDTLERLNIMIDVW 149
+ H N LL +F+ + D F L +MP G+ L H + +R+ ++
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYL-VMPFMGTDLGKLMKHEKLSE--DRIQFLVYQM 127
Query: 150 L-ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
L L+Y+H +A I+H DLKP N+ ++E+ ++ DFG+++ D E T + T
Sbjct: 128 LKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSE----MTGYVVT 178
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIIS-----AKCDVYSFGVLLMETFTGK 255
Y AP E I++ D++S G ++ E TGK
Sbjct: 179 RWYRAP-----------------EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 42 EGFNECNLLGTGSFG---IVYKGILSDGNNVAIKVF-------KLQLGRAFRSFDSECEV 91
E F+ ++G G+FG +V K G A+K K QL +E +V
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHV----KAERDV 54
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA 151
L ++ ++ S + + L++E +P G L L ++ F + + R M + LA
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLA 113
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190
+E +H +H D+KP NIL+D ++SDFG+S
Sbjct: 114 IEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 50/224 (22%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRS--FDS----ECEVLRNVHHRN-- 99
+G+G++G V I G VAIK +L R F+S F E +L+++ H N
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77
Query: 100 -LLKIFSSC-SNPDFKALVLELMPNGSLE-NWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
LL +F+S S +F+ L +MP + + H D ++ L + + L+Y+H
Sbjct: 78 GLLDVFTSAVSGDEFQDFYL-VMPYMQTDLQKIMGHPLSEDKVQYL--VYQMLCGLKYIH 134
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
SA I+H DLKP N+ ++E+ ++ DFG+++ D E T + T Y AP
Sbjct: 135 ----SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAE----MTGYVVTRWYRAP-- 183
Query: 217 QLFDILKPKNAKFGSEGIIS-----AKCDVYSFGVLLMETFTGK 255
E I++ D++S G ++ E TGK
Sbjct: 184 ---------------EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 63/227 (27%), Positives = 92/227 (40%), Gaps = 39/227 (17%)
Query: 50 LGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSECE-------VLRNVHHRNLL 101
+G GSFG V + D + A+K + +A SE VL V+ ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR----KAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ S +P+ LVL + G L + L F + R ++ ALE LH
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH----K 111
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
+++ DLKP NILLD + DFG+ KL + +D T Y+AP L
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLL--- 166
Query: 222 LKPKNAKFGSEGIISAKC-DVYSFGVLLMETFTGKKP-----TDEMF 262
G K D ++ GVLL E TG P +EM+
Sbjct: 167 -----------GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 20/114 (17%)
Query: 144 IMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203
I I V L YL H I+H D+KPSNIL++ ++ DFG+S G DS+ +
Sbjct: 104 ISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 157
Query: 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ T YM+P + L+ G+ + + D++S G+ L+E G+ P
Sbjct: 158 F-VGTRSYMSP-----ERLQ------GTHYTVQS--DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 32/161 (19%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVHHRNLLK 102
LG G+FG VYK + G VA+K + + A R E ++L+ + H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 103 IF---------SSCSNPDFKALVLELMP---NGSLENWLYSHNYFLDTLERLNIMIDVWL 150
+ S +V M +G LEN + L + M+ +
Sbjct: 72 LIDMAVERPDKSKRKRGSV-YMVTPYMDHDLSGLLEN----PSVKLTESQIKCYMLQLLE 126
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191
+ YLH H I+H D+K +NIL+D + +++DFG+++
Sbjct: 127 GINYLHENH----ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 34/181 (18%)
Query: 50 LGTGSFGIV---YKGILSDGNNVAIKVF------KLQLGRAFRSFDSECEVLRNVHHRN- 99
+G+G+ GIV Y IL NVAIK + RA+R E +++ V+H+N
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 100 --LLKIFS-SCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALE 153
LL +F+ S +F+ + V+ELM N LD ER++ ++ + ++
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDH-ERMSYLLYQMLCGIK 140
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
+LH SA I+H DLKPSNI++ + ++ DFG+++ G S T + T Y A
Sbjct: 141 HLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 193
Query: 214 P 214
P
Sbjct: 194 P 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 38/228 (16%)
Query: 49 LLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRN------VHHRNLL 101
+LG GSFG V L G A+K K + D EC ++ + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDV--VLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
++ + + V+E + G L + F D ++ L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH----S 114
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISK--LLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I++ DLK N++LD + +++DFG+ K + GD S T Y+AP
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAP----- 165
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+IL+ F D +SFGVLL E G+ P DE+F
Sbjct: 166 EILQGLKYTF--------SVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 49 LLGTGSFGIVYKGIL----SDGNNVAIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLL 101
LLG G+FG K IL + G A+K+ K ++ A +E VL+N H L
Sbjct: 2 LLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ S D V+E G L L F + R ++ AL YLH S
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH----S 113
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
+V+ DLK N++LD++ +++DFG+ K D T T Y+AP
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 41/250 (16%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQ---LGRAFRSFDSECEVLRNVHHRN 99
F + LG G+FG V D + A+K + + L +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+++++ S + D V++ +P G + + L F + L R I ++ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGI---------SKLLGDGEDSVTQTMTMATIG 210
+H D+KP NIL+D + +++DFG+ SK G+ +M +
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 211 YMAPVSQLFDILKP-------------KNAKFGSEGIISAK----------CDVYSFGVL 247
+ D LKP ++ G+ I+ + CD +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 248 LMETFTGKKP 257
L E G+ P
Sbjct: 238 LYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVF-------KLQLG--RAFRSFDSECEVLR 93
F ++G G+FG V D ++ A+K K Q+ RA R ++L
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAER------DILA 56
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
+ ++K++ S + ++ L++E +P G + L + F + R I + LA++
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAID 115
Query: 154 YLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191
+H G+ +H D+KP N+LLD ++SDFG+
Sbjct: 116 SIHKLGY-----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 36/227 (15%)
Query: 50 LGTGSFGIVYKGILSDGNN-VAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLK 102
+G G++G+VYK N +A+K +L+ A R E +L+ + H N+++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIVR 65
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ + LV E + + L+ + S F RL I ++ L + + HS
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP-RL-IKTYLYQILRGIAYCHSHR 122
Query: 163 PIVHCDLKPSNILLDENMVA-RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
++H DLKP N+L+D A +++DFG+++ G T T + T+ Y AP +I
Sbjct: 123 -VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--PVRTFTHEVVTLWYRAP-----EI 174
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMET------FTGKKPTDEMF 262
L GS S D++S G + E F G DE+F
Sbjct: 175 L------LGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 50 LGTGSFGIVYKG--ILSDGNNVAIKVFKLQLGRAFRSFDS--ECEVLRNVH---HRNLLK 102
+G G++G V+K + + G VA+K ++Q G + E VLR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 103 IFSSC--SNPDFKA---LVLELMPNGSLENWL-YSHNYFLDTLERLNIMIDVWLALEYLH 156
+F C S D + LV E + + L +L + T ++M + L++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
S +VH DLKP NIL+ + +++DFG++++ + T + T+ Y AP
Sbjct: 128 ----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 180
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
L + + D++S G + E F +KP
Sbjct: 181 LL-------------QSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQ------LGRAFRSFDSECEVLRNVHHRNLLK 102
+G G++G V+K VA+K +L A R E +L+ + H+N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
++ + LV E + L+ + S N +D + M + L + H +
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--- 119
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLG 194
++H DLKP N+L+++N +++DFG+++ G
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG GS+ VYKG G VA+K +L+ G F + E +L+++ H N++ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLHDI 71
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
LV E + + L+ ++ L + + L Y H ++H
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR----VLH 126
Query: 167 CDLKPSNILLDENMVARVSDFGISK 191
DLKP N+L+ E +++DFG+++
Sbjct: 127 RDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 37/206 (17%)
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++K++ S + D V++ +P G + + L F + L R I ++ A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--- 118
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGI---------SKLLGDGEDSVTQTMTMATIG 210
+H D+KP NIL+D + +++DFG+ SK G+ +M +
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE- 176
Query: 211 YMAPVSQLFDILKPKNAK----------FGSEGIISAK----------CDVYSFGVLLME 250
+ L+ + + G+ I+ + CD +S GV+L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 251 TFTGKKPTDEMFTGEISLK--NWVNE 274
G+ P E LK NW
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETT 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 42 EGFNECNLLGTGSFGIVYKG--ILSDGNNVAIKVFKLQLGR-----AFRSFDSECEVLRN 94
E + + + LG G++ VYKG L+D N VA+K +L+ A R E +L++
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR----EVSLLKD 60
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
+ H N++ + LV E + + L+ +L +++ N+ + ++ L
Sbjct: 61 LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRG 116
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
L++ H ++H DLKP N+L++E +++DFG+++ + T + + T+ Y P
Sbjct: 117 LNYCHRRK-VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPP 173
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
DIL GS S + D++ G + E TG+
Sbjct: 174 -----DIL------LGSTD-YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 18/127 (14%)
Query: 136 LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195
LDT + L+ V + +L +S +H DL NILL + ++ DFG+++ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-G 254
+ V + + +MAP S +F + + + DV+S+G+LL E F+ G
Sbjct: 267 DSNYVVKGNARLPVKWMAPES-IF------------NCVYTFESDVWSYGILLWEIFSLG 313
Query: 255 KKPTDEM 261
P M
Sbjct: 314 SSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 49 LLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLLKIF 104
++G GS+ V L + + A+KV K +L D +E V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 105 SSCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
SC + LV+E + G L + + R ++ +AL +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE----RG 116
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKL-LGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
I++ DLK N+LLD + +++D+G+ K LG G+ T + T Y+AP +IL
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAP-----EIL 168
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259
+ + F D ++ GVL+ E G+ P D
Sbjct: 169 RGEEYGF--------SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 59/239 (24%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEV-----LRNVHHRNLLKI 103
+G G++G VYK G+ VA+K ++Q + EV L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 104 FSSCS-----------------NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI 146
C+ + D + L+ +P L +T++ L M
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTY-LDKVPPPGLP---------AETIKDL--MR 115
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
L++LH + IVH DLKP NIL+ +++DFG++++ + T +
Sbjct: 116 QFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVV 168
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
T+ Y AP L + + D++S G + E F +KP +F G
Sbjct: 169 VTLWYRAPEVLL-------------QSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 49/162 (30%), Positives = 88/162 (54%), Gaps = 27/162 (16%)
Query: 44 FNECNLLGTGSFGIVYKGILSD-GNNVAIKVF------KLQLGRAFRSFDSECEVLRNVH 96
+ + +G+G+ GIV + G NVA+K + RA+R E +L+ V+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVN 78
Query: 97 HRN---LLKIFS-SCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVW 149
H+N LL +F+ S +F+ LV+ELM + +L ++ LD ER++ ++ +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDH-ERMSYLLYQML 133
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191
+++LH SA I+H DLKPSNI++ + ++ DFG+++
Sbjct: 134 CGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 18/142 (12%)
Query: 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180
P + + L + + L ++ + V +E+L +S VH DL N+L+ E
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL----ASKNCVHRDLAARNVLICEGK 276
Query: 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCD 240
+ ++ DFG+++ + + +++ T + +MAP S +F+ L + D
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES-IFNNL------------YTTLSD 323
Query: 241 VYSFGVLLMETFT-GKKPTDEM 261
V+SFG+LL E FT G P E+
Sbjct: 324 VWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 21/114 (18%)
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL-LGDGEDSVTQTMT 205
++ LAL +LH I++ DLK N+LLD +++D+G+ K + G+ T +
Sbjct: 104 EISLALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTF 156
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259
T Y+AP +IL+ ++ F D ++ GVL+ E G+ P D
Sbjct: 157 CGTPNYIAP-----EILRGEDYGF--------SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 14/94 (14%)
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
+H D+ N+LL + VA++ DFG+++ + + + V + + +MAP S +FD
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES-IFDC--- 289
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ + + DV+S+G+LL E F+ GK P
Sbjct: 290 ---------VYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 49 LLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFD---SECEVLRNVHHRNLLKIF 104
++G GS+ V L + A+KV K +L D +E V + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 105 SSCSNPDFKAL-VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
SC + + V+E + G L + + R ++ LAL YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHE----RG 116
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKL-LGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
I++ DLK N+LLD +++D+G+ K L G+ T + T Y+AP +IL
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP-----EIL 168
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259
+ ++ F D ++ GVL+ E G+ P D
Sbjct: 169 RGEDYGF--------SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 48/195 (24%), Positives = 77/195 (39%), Gaps = 50/195 (25%)
Query: 51 GTGSFGIVYKGIL---SDGNNVAIKVFKLQLGR-------AFRSFDSECEVLRNVHHRNL 100
G G++G VYK DG AIK FK + A R E +LR + H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 101 LKIFSSCSNPDFKA--LVLELMPNGSLE--NWLYSHNYFLDTLERLNIMID-------VW 149
+ + K+ L+ + + + + + I +W
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK---------RVSIPPSMVKSLLW 115
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILL----DENMVARVSDFGISKLLGD------GEDS 199
L +H+ HS+ ++H DLKP+NIL+ E V ++ D G+++L D
Sbjct: 116 QILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 200 VTQTMTMATIGYMAP 214
V + TI Y AP
Sbjct: 175 V-----VVTIWYRAP 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 60/250 (24%), Positives = 98/250 (39%), Gaps = 49/250 (19%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNV-AIKVF-------KLQLG--RAFRSFDSECEV 91
E F ++G G+FG V D +V A+K+ K Q+G RA R E +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA 151
L ++K+F S + L++E +P G + L + + + I V LA
Sbjct: 61 LW------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LA 113
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
++ +H +H D+KP N+LLD ++SDFG L G +T + +
Sbjct: 114 IDSIHQ----LGFIHRDIKPDNLLLDSKGHVKLSDFG----LCTGLKKAHRTEFYRNLNH 165
Query: 212 MAPVSQLFDILKPKN--------------AKFGSEGIISAK----------CDVYSFGVL 247
P F + K + G+ I+ + CD +S GV+
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 248 LMETFTGKKP 257
+ E G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 50 LGTGSFGIVYKGI---LSDGNN-----VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLL 101
LG G+F ++KGI + D V +KV SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ C D +V E + GSL+ +L + ++ +L + + AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----D 118
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT---QTMTMATIGYMAPVSQL 218
+ H ++ N+LL + + K L D S+T + + + I ++ P
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLERIPWVPPEC-- 175
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254
I P+N +S D +SFG L E F+G
Sbjct: 176 --IENPQN--------LSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 71/244 (29%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLK 102
+G G++G+VYK G VA+K +L+ A R E +L+ ++H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDT-LERL-----NIMIDVWLALEYLH 156
+ +V EN LY FLD L++ +D L YL+
Sbjct: 63 LLD---------VVHS-------ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 157 ---------HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV---TQTM 204
H H ++H DLKP N+L+D +++DFG+++ G V T T
Sbjct: 107 QLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG-----VPVRTYTH 158
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET------FTGKKPT 258
+ T+ Y AP +IL ++ S + D++S G + E F G
Sbjct: 159 EVVTLWYRAP-----EIL--LGSRQYSTPV-----DIWSIGCIFAEMVNRRPLFPGDSEI 206
Query: 259 DEMF 262
D++F
Sbjct: 207 DQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 4/43 (9%)
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192
LALEYLH + IVH DLKP N+L+ +++DFG+SK+
Sbjct: 112 LALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 50 LGTGSFGIVYKGIL----SDGNNVAIK---VFKLQLGRAFRSFDSECEVLRNVHHRNLLK 102
+G GSFG K IL DG IK + K+ + E VL N+ H N+++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQ 63
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER-LNIMIDVWLALEYLHHGHSS 161
S +V++ G L + + L ++ L+ + + LAL+++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----D 119
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQL 218
I+H D+K NI L ++ ++ DFGI+++L T + IG Y++P
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSP---- 170
Query: 219 FDIL--KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+I +P N K D+++ G +L E T K
Sbjct: 171 -EICENRPYN----------NKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQ--LGR-AFRSFDSECEVLRNVHHRN 99
F + LG G+FG V D + + A+K + + L R +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++K++ S + D V++ +P G + + L F + L R I ++ LA+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGI 189
+H D+KP NIL+D + +++DFG+
Sbjct: 119 -KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 42/227 (18%)
Query: 50 LGTGSFGIVYKGIL---SDGNN--------VAIKVFKLQLGRAFRSFDSECEVLRNVHHR 98
LG G+F +YKG+L SD + V +KV R +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
+L+K++ C + +V E + G L+ +L+ + +L++ + AL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 159 HSSAPIVHCDLKPSNILL-----DENMV--ARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
+VH ++ NIL+ +E V ++SD GI + E+ V + I +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPW 170
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+AP + + D +SFG L+E + G++P
Sbjct: 171 IAP--ECIRNGQASLTIAA---------DKWSFGTTLLEICSNGEEP 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 22/125 (17%)
Query: 83 RSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF--LDTLE 140
++ E ++L+ + HR ++ + + K+ V +MP Y + F +D
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSG 180
Query: 141 RLN----IMIDVWL--ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194
L I I L AL YLH I+H D+K NI LDE A + DFG + L
Sbjct: 181 PLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 195 DGEDS 199
D+
Sbjct: 237 AHPDT 241
|
Length = 392 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 64/241 (26%), Positives = 94/241 (39%), Gaps = 52/241 (21%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV----AIKVFKLQLGRAFRSFDSEC-----EVLRN 94
FN +LG GSFG K +L++ AIK+ K + + D EC VL
Sbjct: 2 FNFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLAL 56
Query: 95 VHHRNLLKIFSSC-SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
L SC D V+E + G L Y + + + V+ A E
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAE 109
Query: 154 ------YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+LH S I++ DLK N++LD +++DFG+ K T+T
Sbjct: 110 IAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFC-G 163
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
T Y+AP + +P D ++FGVLL E G+ P DE+F
Sbjct: 164 TPDYIAPEIIAY---QPYG----------KSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210
Query: 263 T 263
Sbjct: 211 Q 211
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 87 SECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL----ENWLYSHNYFLDTLERL 142
SE L H ++K F + D L++E G L + L H F + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202
+ + LAL+ +H S ++H DLK +NI L + ++ DFG SK D
Sbjct: 174 -LFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ T Y+AP ++ + K S K D++S GV+L E T +P
Sbjct: 229 SSFCGTPYYLAP-----ELWERKR--------YSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 56/242 (23%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV----AIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
FN +LG GSFG K +L++ AIK+ K + + D EC + V R
Sbjct: 2 FNFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDV--VIQDDDVECTM---VEKRV 53
Query: 100 L--------LKIFSSC-SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL 150
L L SC D V+E + G L + F + + ++ +
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-HAVFYAAEIAI 112
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
L +LH S I++ DLK N++LD +++DFG+ K + D VT T
Sbjct: 113 GLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPD 166
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAK-----CDVYSFGVLLMETFTGKKP-----TDE 260
Y+AP II+ + D ++FGVLL E G+ P DE
Sbjct: 167 YIAP------------------EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
Query: 261 MF 262
+F
Sbjct: 209 LF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 60/252 (23%), Positives = 91/252 (36%), Gaps = 73/252 (28%)
Query: 49 LLGTGSFGIVYKGILSD---GNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLK 102
L+G G G VY D VA+K + L + F E ++ ++ H ++
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--------------------- 141
++S CS+ D V MP Y Y L +L +
Sbjct: 67 VYSICSDGD---PVYYTMP--------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 142 LNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED--- 198
L+I + +EY+H S ++H DLKP NILL + D+G + E+
Sbjct: 116 LSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 199 --------SVTQTMT-----MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFG 245
+MT + T YMAP L G S D+Y+ G
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-----------GVPA--SESTDIYALG 218
Query: 246 VLLMETFTGKKP 257
V+L + T P
Sbjct: 219 VILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 22/48 (45%), Positives = 29/48 (60%), Gaps = 6/48 (12%)
Query: 143 NIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189
NIM D+ LEY+H HG I H D+KP NI++D N + D+GI
Sbjct: 130 NIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 44/198 (22%), Positives = 83/198 (41%), Gaps = 45/198 (22%)
Query: 88 ECEVLRNVHHRNLLKIFSSCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTLER---L 142
E V+R + H+N+++ N + L ++E G L + +E +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 143 NIMIDVWLALEYLHH---GHSSAPIVHCDLKPSNILLDENM-----------------VA 182
+I + AL Y H+ G + ++H DLKP NI L + +A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 183 RVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQLFDILKPKNAKFGSEGIISAKC 239
++ DFG+SK +G ++M + +G Y +P ++L + + K
Sbjct: 182 KIGDFGLSKNIG------IESMAHSCVGTPYYWSP-----ELLLHETKSYDD------KS 224
Query: 240 DVYSFGVLLMETFTGKKP 257
D+++ G ++ E +GK P
Sbjct: 225 DMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 42 EGFNECNLLGTGSFGIVYKG--ILSDGNNVAIKVFKLQLGR-----AFRSFDSECEVLRN 94
E + + LG G++ V+KG L++ N VA+K +L+ A R E +L++
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR----EVSLLKD 60
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
+ H N++ + LV E + + L+ ++ + + N+ I ++ L
Sbjct: 61 LKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCG---NIMSMHNVKIFLYQILRG 116
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
L + H ++H DLKP N+L++E +++DFG+++ ++ T Y
Sbjct: 117 LAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLAR-----------AKSVPTKTYSNE 164
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
V L+ +P + GS S + D++ G + E +G+
Sbjct: 165 VVTLW--YRPPDVLLGSSE-YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 75/267 (28%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSE---CEVLRNVHHRNLLKIFS 105
+G G++G VYK + G VA+K +L++ D E LR + +LL++ S
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEM-------DEEGIPPTALREI---SLLQMLS 58
Query: 106 SC------------SNPDFKA---LVLELMPNGSLENWLYSH----NYFLDTLERLNIMI 146
+ K LV E + + L+ ++ S+ L + M
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 147 DVWLALEYLH-HGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTM 204
+ + + H HG ++H DLKP N+L+D + + +++D G+ + S T +
Sbjct: 118 QLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK--------- 255
T+ Y AP ++L GS S D++S G + E +
Sbjct: 173 V--TLWYRAP-----EVL------LGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218
Query: 256 -----------KPTDEMFTGEISLKNW 271
PT++++ G L++W
Sbjct: 219 QQLLHIFKLLGTPTEQVWPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 46/215 (21%), Positives = 83/215 (38%), Gaps = 27/215 (12%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN------VHHRNLLKI 103
+G G FG V + VA V K +L +A S + E L+ + H N+L+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVK-EL-KANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFL---DTLERLNIMIDVWLALEYLHHGHS 160
C LV E G L+++L + L + ++ + ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP--VSQL 218
+H DL N L ++ +V D+GI + T+ + ++AP V +
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 219 FD-ILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252
++ + K +V++ GV L E F
Sbjct: 177 HGGLITAEQTKPS---------NVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 9/152 (5%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFK---LQLGRAFRSFDSECEVLRNVHH 97
+ F ++G G+FG V D G+ A+K+ + + +E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
++K+F S + L++E +P G + L + + + I V LA++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIHQ 119
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189
+H D+KP N+LLD ++SDFG+
Sbjct: 120 ----LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 34/231 (14%)
Query: 44 FNECNLLGTGSFG-IVYKGILSDGNNVAIKVFKLQLGRAFRSFDSEC-----EVLRNVHH 97
FN +LG GSFG ++ AIK+ K + + D EC VL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALQDK 59
Query: 98 RNLLKIFSSC-SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
L SC D V+E + G L + F + + + ++ + L +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLFFLH 118
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
I++ DLK N++LD +++DFG+ K D VT T Y+AP
Sbjct: 119 R----RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP-- 170
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+I+ + +G D +++GVLL E G+ P DE+F
Sbjct: 171 ---EIIAYQ--PYGKS------VDWWAYGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 41/191 (21%), Positives = 65/191 (34%), Gaps = 34/191 (17%)
Query: 11 RKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVA 70
KR ++IA + + V R EG+ LGT + + + +G V
Sbjct: 68 EKREYRVIAALLDVDVPVPR-----AFGLCGEGY-----LGTPFYVMEWV----EGEVVW 113
Query: 71 IKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLY 130
+ LGR F + L +H I + PD L W
Sbjct: 114 SALPPESLGRQFALDAL-ADFLAELH-----SI-DAAGLPDPGKPNAY--RGRQLARW-- 162
Query: 131 SHNYFLDTLERLNIMIDVWLALE-YLHHGHSSAP-----IVHCDLKPSNILLDENMVARV 184
Y E L I + L +L + +VH D +P N+++D V
Sbjct: 163 DDEYRRAKKE-LGGRIPLADRLIKWLEA-NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGV 220
Query: 185 SDFGISKLLGD 195
D+ ++ LGD
Sbjct: 221 LDWELAT-LGD 230
|
Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 44 FNECNLLGTGSFG--IVYKGILSDGNNVAIKVFKLQLGRAFRSFDS---ECEVLRNVHHR 98
+N ++G GSFG ++ + + SD A+K +++L ++ + + E +L + H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSD-QKYAMK--EIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFL---DTLERLNIMIDVWLALEYL 155
N++ S +V+E G L + L DT+ L + + L ++++
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCLGVQHI 116
Query: 156 HHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV 215
H ++H D+K NI L +N ++ DFG ++LL T Y P
Sbjct: 117 HEKR----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYVGTPYYVP- 168
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++++ + N K D++S G +L E T K P
Sbjct: 169 PEIWENMPYNN-----------KSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 40/154 (25%), Positives = 63/154 (40%), Gaps = 18/154 (11%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSS 106
+G G VY I G VA+K +L GR +FR + L + H + L +
Sbjct: 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRL--GRTSFRKVKRNRDYLADKEHGSWLYVSRL 154
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNY------FLDTLERLNIMIDV-------WLALE 153
+ +F+AL L P G + N +++ +E + +DV LE
Sbjct: 155 AAEREFEALQ-RLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILE 213
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187
+ + IVH DL NIL+ E+ V D+
Sbjct: 214 EVRKAYRRG-IVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.72 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.68 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.4 | |
| PLN02236 | 344 | choline kinase | 97.22 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.08 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.49 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.86 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.82 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.74 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.28 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.26 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.18 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.92 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.84 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=339.02 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=204.5
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccH-------HHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR-------AFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.... ......+|+++|++++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 66789999999999999999999 678999999999765311 2334579999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC---CcEEEEeee
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN---MVARVSDFG 188 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~---~~ikl~Dfg 188 (314)
..|+||||+.||+|.+++-.++. +.+.....++.||+.|+.||| ++||+||||||+|||++.+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999988765 888889999999999999999 9999999999999999765 679999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch---
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--- 265 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--- 265 (314)
+|...+.. ....+.+||+.|.|||++..+ ....+..++|+|||||++|-+|+|.+||.......
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~k----------g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~ 391 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASK----------GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK 391 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecC----------CeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence 99987533 245568999999999987532 11223358999999999999999999998654322
Q ss_pred -------hhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 266 -------ISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 266 -------~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
+.+....+..+++...+++ ||..||++.|.+. |+|++..
T Consensus 392 eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~------hpW~~~~ 443 (475)
T KOG0615|consen 392 EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN------HPWFKDA 443 (475)
T ss_pred HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc------Chhhhcc
Confidence 2223334556666555554 9999999999887 7887754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=344.52 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=204.8
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.+|...+.||+|||+.||.++. .+|+.||+|++.+.. ..+.+...+|+++.++|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999996 789999999998742 445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+|+.++|..++++.+ .++|.++..++.||+.||.||| +++|+|||||..|+|++++.++||+|||+|+.+..++
T Consensus 98 ELC~~~sL~el~Krrk-~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-PLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhcC-CCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999998554 4999999999999999999999 9999999999999999999999999999999987543
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-----hhh
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-----NWV 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-----~~~ 272 (314)
. .+.+.+|||.|+|||++. ....+..+||||+||+||.||.|++||+...-.+.-.. ...
T Consensus 173 E--rk~TlCGTPNYIAPEVl~-------------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLN-------------KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM 237 (592)
T ss_pred c--ccceecCCCcccChhHhc-------------cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc
Confidence 3 345578999999997763 44567789999999999999999999997543322111 123
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
+..++...+++| ||.+|||+.+++. |+|++
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~------h~Ff~ 273 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD------HPFFK 273 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhc------CHhhh
Confidence 344555555554 9999999999987 66663
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=325.57 Aligned_cols=238 Identities=29% Similarity=0.488 Sum_probs=198.6
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeec--ccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
...++|++.+.||.|+||+||+|++ +++..||||.+.+. ..+..+.+..|+.+|+.++|||||.+++++.+++.+|+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 3568999999999999999999995 47899999999877 45566778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC------CcEEEEeeec
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN------MVARVSDFGI 189 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~------~~ikl~Dfg~ 189 (314)
|||||.||+|.+++.+.+. +++..+..++.||+.|+++|| +++|+||||||+|||++.. -.+||+|||+
T Consensus 87 VMEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999998875 899999999999999999999 9999999999999999754 4589999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
++.+.... .....+|++-|+|||++. ...|+.|+|+||+|+++|+|++|..||+.....+....
T Consensus 162 AR~L~~~~---~a~tlcGSplYMAPEV~~-------------~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~ 225 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGSPLYMAPEVIM-------------SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY 225 (429)
T ss_pred hhhCCchh---HHHHhhCCccccCHHHHH-------------hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 99886433 345678999999997764 56788899999999999999999999997766655433
Q ss_pred hhhh--------ccCCchhhhhc------cccCCCCHHHHHH
Q 047043 270 NWVN--------ESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 270 ~~~~--------~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.... ..+++.+.+++ ++.+|-++.+.+.
T Consensus 226 ~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 226 IKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred HhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 2222 22233333333 6667766666554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=319.19 Aligned_cols=237 Identities=26% Similarity=0.366 Sum_probs=199.8
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc-eeEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF-KALVL 117 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 117 (314)
..+.+.++.||+|..|+||+++++ +++.+|+|++.... ....+++.+|+++++.++||+||.+||.|.+... +.++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 346788899999999999999965 79999999996553 3456889999999999999999999999999884 99999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++|+|.+++...+. ++|..+.+++.+++.||.|||. ..+|+||||||+|+|+++.|.+||||||.+..+.+.
T Consensus 158 EYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999999987755 9999999999999999999994 489999999999999999999999999998887543
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch---hhhhh-h--
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE---ISLKN-W-- 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~---~~~~~-~-- 271 (314)
......||..|+|||.+ .+..|+.++||||||+.++|+.+|+.||....... ..+.. +
T Consensus 233 ---~a~tfvGT~~YMsPERi-------------~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERI-------------SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred ---hcccccccccccChhhh-------------cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 33456799999999554 57789999999999999999999999998752211 11111 1
Q ss_pred -----hhc-cCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 -----VNE-SLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 -----~~~-~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.+. .+++.++.++ ||..||++.+++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122 3666677766 99999999999983
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=315.49 Aligned_cols=231 Identities=29% Similarity=0.380 Sum_probs=194.8
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
-.++|++++.||+|+||+||+++ ..+++.+|+|++++.. ....+...+|..+|..++||+|++++..|++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 36789999999999999999999 4579999999998763 3346778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|+||+.||.|...+++.+. ++|..+..+++.|+.||.||| +.||+||||||+|||+|.+|+++|+|||++.....
T Consensus 103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999998765 899999999999999999999 99999999999999999999999999999986544
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
.+. .....+||++|+|||++. +..|+.++|.||||+++|+|++|..||.............
T Consensus 178 ~~~--~t~tfcGT~eYmAPEil~-------------~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~ 242 (357)
T KOG0598|consen 178 DGD--ATRTFCGTPEYMAPEILL-------------GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL 242 (357)
T ss_pred CCC--ccccccCCccccChHHHh-------------cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC
Confidence 322 233468999999997764 5588999999999999999999999998765433322211
Q ss_pred --hhccCCchhhhhc------cccCCC
Q 047043 272 --VNESLPHALTDVV------DANLRV 290 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rp 290 (314)
.+...+...++++ ||.+|-
T Consensus 243 ~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1222444455544 888885
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=327.60 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=217.1
Q ss_pred hhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 34 YLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
.+.+......+..++.||+|.||.||+|+++...+||+|.++.... ....|.+|+.+|++|+|++||++++++..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 4555556677888999999999999999997777999999987632 236788999999999999999999999998899
Q ss_pred eEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 114 ALVLELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
++||||++.|+|.++++. .+..+...+...++.||++||+||+ ++++|||||...||||+++..+||+|||+++.
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999999999997 5667899999999999999999999 99999999999999999999999999999996
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhh----
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS---- 267 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~---- 267 (314)
..++... ......-+..|.|||.+. ...++.+|||||||++|+||+| |+.||.++.+.++-
T Consensus 353 ~~d~~Y~-~~~~~kfPIkWtAPEa~~-------------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le 418 (468)
T KOG0197|consen 353 IGDDEYT-ASEGGKFPIKWTAPEALN-------------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE 418 (468)
T ss_pred cCCCcee-ecCCCCCCceecCHHHHh-------------hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 5443322 233334577899997764 5668899999999999999999 99999998876652
Q ss_pred --hhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 268 --LKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 268 --~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.+...+..||+.+.+++ +|.+|||+..+...+.++....
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 23345677898888877 9999999999999999887643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.94 Aligned_cols=252 Identities=30% Similarity=0.464 Sum_probs=209.1
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC-ceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-FKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 116 (314)
......+.+.+|+|+||+||+|.+.....||+|++.... ....+.+.+|+.+|.+++||||++++|++.... .+.+|
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 345566667799999999999998544449999998653 222568999999999999999999999999887 79999
Q ss_pred EEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-eeecCCCCCceEecCCC-cEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLHHGHSSAP-IVHCDLKPSNILLDENM-VARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~-i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~ 193 (314)
|||+++|+|.+++.. .+..++...+..++.|++.||+||| .++ |+||||||+|+|++.++ ++||+|||+++..
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999988 4667999999999999999999999 888 99999999999999997 9999999999876
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
.... .......||..|+|||++.. . ...++.++||||||+++|||++|..||............
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~---------~--~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRG---------E--KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcC---------C--CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 4422 12223569999999988752 1 667899999999999999999999999998764332222
Q ss_pred ----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 271 ----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
..+..+++.+..++ ||..||++.+++..+..+......
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 12334666666665 999999999999999998876654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=309.26 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=197.6
Q ss_pred HHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeec-ccccCC-
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS-SCSNPD- 111 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~- 111 (314)
.+....+|++++.||+|.||+||++. ..+|..+|.|-++-.. ....+....|+.+|++|+||||+++++ .+...+
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 34556789999999999999999999 5689999999987553 345567889999999999999999998 454444
Q ss_pred ceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 112 FKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
-++++||+|.+|+|...++. .+..++|..+|+++.|++.||.++|+.-...-+.||||||.|||++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 48999999999999998864 456799999999999999999999953323459999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
+++.+..... ......|||.|++||.+ .+.+|+++|||||+||++|||+.-..||.+..--++.-
T Consensus 174 L~r~l~s~~t--fA~S~VGTPyYMSPE~i-------------~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~ 238 (375)
T KOG0591|consen 174 LGRFLSSKTT--FAHSLVGTPYYMSPERI-------------HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK 238 (375)
T ss_pred hHhHhcchhH--HHHhhcCCCcccCHHHH-------------hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH
Confidence 9998865422 33456799999999665 57789999999999999999999999998753222211
Q ss_pred hh-------hhhccCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 269 KN-------WVNESLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 269 ~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
.. ..+..++..++.++ ||.+||+.-.++..+
T Consensus 239 KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 239 KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 11 11234455555554 999999854444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=324.51 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=208.5
Q ss_pred HHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (314)
..-.++|...+.||.|+|++|++|+ ..+++.||||++.+.. .........|-+.|.+| .||+|+++|-.|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3456789999999999999999999 5689999999998763 22335566789999999 79999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
+|+|+||+++|+|.++|.+.+. +++.-+..++.+|++||+||| .+|||||||||+|||+|.+++++|+|||.+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999999876 999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCCCc-----------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 193 LGDGEDS-----------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 193 ~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+...... .......||..|.+||++ .....+..+|+|+|||++|+|+.|..||.+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-------------~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-------------NDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHh-------------cCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 7543222 011346899999999776 4566788999999999999999999999985
Q ss_pred ccch-----hhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 262 FTGE-----ISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 262 ~~~~-----~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
..-. ..+....++.+++..++++ ||.+|+|..+|-+ |+||..+
T Consensus 291 NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~------HpFF~~V 344 (604)
T KOG0592|consen 291 NEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA------HPFFEGV 344 (604)
T ss_pred cHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh------CcccccC
Confidence 4322 2233334567777777765 9999999988877 6666544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=322.40 Aligned_cols=246 Identities=25% Similarity=0.390 Sum_probs=201.0
Q ss_pred HHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc----c-HHHHHHHHHHHHHHhCC-CCCcceeecccccC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL----G-RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNP 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~----~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 110 (314)
....++|++.+.||.|+||+|+.|. ..+++.||+|+++.+. . .....+.+|+.+++.+. ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4567899999999999999999999 5579999999877641 1 23456668999999998 99999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEeeec
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDFGI 189 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Dfg~ 189 (314)
+.+|+||||+.||+|.+++... ..+.|..+.+++.|+++|++|+| .+||+||||||+|++++.+ +++||+|||+
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~-g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNK-GRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999999984 45899999999999999999999 9999999999999999999 9999999999
Q ss_pred ceecC-CCCCcceeecccceeeeecCccccccccccCcccCCCCC-CCCcccceehhhHHHHHHhcCCCCCCccccchh-
Q 047043 190 SKLLG-DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEG-IISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI- 266 (314)
Q Consensus 190 ~~~~~-~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~- 266 (314)
+.... ... .-...+||+.|+|||++.. .. +-+.++||||+|+++|.|++|..||+.......
T Consensus 168 s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~------------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~ 232 (370)
T KOG0583|consen 168 SAISPGEDG---LLKTFCGSPAYAAPEVLSG------------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY 232 (370)
T ss_pred ccccCCCCC---cccCCCCCcccCCHHHhCC------------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence 98773 221 2344679999999988752 12 335789999999999999999999998543322
Q ss_pred --------hhhhhh-hccCCchhhhhc--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 267 --------SLKNWV-NESLPHALTDVV--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 267 --------~~~~~~-~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
..+.+. ...+...++.++ ||..|+++.++++ ++|++.
T Consensus 233 ~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~------h~w~~~ 280 (370)
T KOG0583|consen 233 RKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE------HPWFQK 280 (370)
T ss_pred HHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh------Chhhcc
Confidence 222233 222333444444 9999999999986 566554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=298.02 Aligned_cols=241 Identities=28% Similarity=0.371 Sum_probs=200.6
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..+|+.++.||.|+||+|.+++.+ +|..+|+|+++++. .++.+...+|..+|+.++||+++++++.|.+.+++|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 568999999999999999999954 79999999998764 35667788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||++||.|.+++++.++ +++..+..++.|++.|++||| +++|++|||||+|||+|++|.+||+|||++....+.
T Consensus 123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999998876 999999999999999999999 999999999999999999999999999999987543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
..+.+|||.|+|||++ ....+..++|.||||+++|||+.|..||-........... .
T Consensus 198 -----T~TlCGTPeYLAPEii-------------~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEII-------------QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK 259 (355)
T ss_pred -----EEEecCCccccChHHh-------------hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc
Confidence 3456899999999776 4667888999999999999999999999875553321111 1
Q ss_pred hhccCCchhhhhc------cccCC-----CCHHHHHHHHHhhhhheeeee
Q 047043 272 VNESLPHALTDVV------DANLR-----VSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~R-----pt~~~~~~~l~~~~~~~~~~~ 310 (314)
.+..++..+++++ |-.+| ....|+.. |+|++.+
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~------H~wF~~v 303 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKN------HPWFKGV 303 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCcccccc------Ccccccc
Confidence 2344555555554 55555 34444443 6666654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.53 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=204.0
Q ss_pred HHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
...+.|++.+.||.|..+.||+|+ ...+..||||++..+. ....+.+.+|+..++.++||||++++..|..++.+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 456899999999999999999999 4578999999998764 34468899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 117 LELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|.|+.+|++.+++... ...++|..+..++.++++||.||| ++|.+|||||+.||||+++|.|+|+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999864 334899999999999999999999 99999999999999999999999999997766644
Q ss_pred CCC-ccee-ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--
Q 047043 196 GED-SVTQ-TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 196 ~~~-~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-- 271 (314)
.+. .... ....||++|+|||+++. ....|+.|+||||||+++.||.+|+.||..+.+...-+...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q-----------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQ-----------QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhh-----------cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 332 2222 45679999999998542 45568999999999999999999999998876544322211
Q ss_pred -------------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 -------------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 -------------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
....++..+++++ ||.+|||+.++++
T Consensus 248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1223344455544 9999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=306.69 Aligned_cols=245 Identities=29% Similarity=0.421 Sum_probs=197.8
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC--ceeEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD--FKALVL 117 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 117 (314)
..+|...+.||+|.||.||++.. ++|...|+|..........+.+.+|+.+|.+++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 56788999999999999999994 469999999988775444677899999999999999999999854444 688999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeecceecCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDG 196 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~~~~~ 196 (314)
||+++|+|.+++.+.+..+++..+..+..|++.||+||| ++|++|+||||+|||++. ++.+||+|||++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999987656999999999999999999999 999999999999999999 799999999998877531
Q ss_pred -CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc-ccchhhhhh----
Q 047043 197 -EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM-FTGEISLKN---- 270 (314)
Q Consensus 197 -~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~-~~~~~~~~~---- 270 (314)
..........||+.|+|||++.. +.....++|||||||++.||+||..||... ......+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~------------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRN------------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred cccccccccccCCccccCchhhcC------------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 11112234569999999987641 223346899999999999999999999873 221111111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
..+..++...++++ ||..|||+.+++++...
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 23344555555555 99999999999996543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.73 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=201.9
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
-.++|++++.||+|+||.||+|+ ..+|..+|+|++++.. ..+......|-.+|...++|++|++|..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46789999999999999999999 5589999999998764 3456778889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||++||++..++.+.+. +++..+..++.+++.|++-|| +.|++||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999998876 899999999999999999999 99999999999999999999999999999854421
Q ss_pred C-----------------------CCc---ce-------------------eecccceeeeecCccccccccccCcccCC
Q 047043 196 G-----------------------EDS---VT-------------------QTMTMATIGYMAPVSQLFDILKPKNAKFG 230 (314)
Q Consensus 196 ~-----------------------~~~---~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~ 230 (314)
. ... .. .....|||.|+|||++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll------------ 361 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL------------ 361 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh------------
Confidence 0 000 00 01236999999997764
Q ss_pred CCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh---------hccCCchhhhhc-----cccCCCC---HH
Q 047043 231 SEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV---------NESLPHALTDVV-----DANLRVS---MK 293 (314)
Q Consensus 231 ~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~---------~~~~~~~l~~ll-----dp~~Rpt---~~ 293 (314)
+..|+..+|.||||||+||||.|-+||....+.+.-..... ...++....++| ||..|-. +.
T Consensus 362 -~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 362 -GKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAE 440 (550)
T ss_pred -cCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHH
Confidence 55688899999999999999999999998776654322221 223444455554 8888864 55
Q ss_pred HHHHHHHhhhhheeeee
Q 047043 294 DVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 294 ~~~~~l~~~~~~~~~~~ 310 (314)
||-+ |+||+.+
T Consensus 441 EIK~------HPfF~~v 451 (550)
T KOG0605|consen 441 EIKK------HPFFKGV 451 (550)
T ss_pred HHhc------CCccccC
Confidence 6555 7777654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=320.58 Aligned_cols=239 Identities=25% Similarity=0.358 Sum_probs=200.9
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..+-|++.+.||.|+.|.|-+|+ ..+|+..|||++.+.. ......+.+|+-+|+.+.|||++++|++|+++..+|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 46789999999999999999999 5699999999998762 2345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+.||++||-|.+++...+. +++.++.++++||+.|+.|+| ..+++||||||+|+++|..+++||+|||+|..-..
T Consensus 90 vlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999988876 889999999999999999999 99999999999999999999999999999886432
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh-----hh
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-----KN 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-----~~ 270 (314)
...-.+.+|+++|.|||+++ ...+-+.++||||.|+|+|.||+|+.||++.+...+-+ .-
T Consensus 165 ---gklLeTSCGSPHYA~PEIV~------------G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 165 ---GKLLETSCGSPHYAAPEIVS------------GRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF 229 (786)
T ss_pred ---CccccccCCCcccCCchhhc------------CCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc
Confidence 22445678999999998876 33444678999999999999999999999654332211 11
Q ss_pred hhhccCCch----hhhhc--cccCCCCHHHHHHH
Q 047043 271 WVNESLPHA----LTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ~~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~ 298 (314)
..+..++.. ++.++ ||..|.|.+|++++
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 123445554 44444 99999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=301.61 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=205.2
Q ss_pred hHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
+.-....+|++.+.||+|.+|+|-+|. ++.|+.||||.++++. ....-.+++|+++|..|+||||+.+|++|++++
T Consensus 47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 344567899999999999999999999 7899999999998763 345667899999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.+.+||||..+|.|+|++...+. +++..+..++.||++|+.|+| +++++|||||.+|||+|.|+++||.|||++.
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhh
Confidence 99999999999999999998876 999999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh--
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-- 269 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-- 269 (314)
.+.+.. .-+..+|++-|.+||++. ..++-++.+|-||||+++|.|..|.+||++..-.....+
T Consensus 202 ly~~~k---fLqTFCGSPLYASPEIvN------------G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs 266 (668)
T KOG0611|consen 202 LYADKK---FLQTFCGSPLYASPEIVN------------GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS 266 (668)
T ss_pred hhcccc---HHHHhcCCcccCCccccC------------CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh
Confidence 875543 345578999999997763 334447789999999999999999999998543332111
Q ss_pred --hhhhccCCc----hhhhhc--cccCCCCHHHHHHH
Q 047043 270 --NWVNESLPH----ALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 270 --~~~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
.+..+.-|. .++.++ +|..|-|+.|+..+
T Consensus 267 ~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 267 RGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 122222233 455554 99999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=312.99 Aligned_cols=237 Identities=26% Similarity=0.382 Sum_probs=201.7
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
....|...+.||+|+.|.||.|+ ..+++.||+|.+........+.+.+|+.+|+..+|+|||.+++.+..++.+++|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 35679999999999999999999 56899999999988765556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++||+|.|.+.... ++|.++..++.+++.||+||| .+||+|||||.+||+++.+|.+||+|||++..+.....
T Consensus 351 ym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred ecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999997765 899999999999999999999 99999999999999999999999999999998866543
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc-chhhh-------hh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT-GEISL-------KN 270 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~-~~~~~-------~~ 270 (314)
.+....||+.|+|||++ ....|+.++||||||+++.||+-|+.||-.... ..+.+ ..
T Consensus 425 --KR~TmVGTPYWMAPEVv-------------trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVV-------------TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL 489 (550)
T ss_pred --ccccccCCCCccchhhh-------------hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc
Confidence 45567899999999654 577789999999999999999999999864221 11111 00
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
-.++.++..++++| |+.+|+++.++++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12344555555554 9999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=288.93 Aligned_cols=203 Identities=24% Similarity=0.314 Sum_probs=178.4
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|+.+..+|.|++|.||+++++ +|+.||||.+....+ ...+-..+|+++|+++.|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57999999999999999999955 799999999865432 334456799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
||+. ++.+.+......++...+.++++|++.|+.|+| +++++||||||+||+|+.+|.+||||||+|+.+..++.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 9966 888888887777999999999999999999999 99999999999999999999999999999998875433
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
. -.....|..|.|||.+. ....|+.++||||+||++.||++|...|.+..+
T Consensus 157 ~--YTDYVATRWYRaPELLv------------GDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 157 N--YTDYVATRWYRAPELLV------------GDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred h--hhhhhhhhhccChhhhc------------ccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 2 33467899999998765 457889999999999999999999998876544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.11 Aligned_cols=254 Identities=25% Similarity=0.437 Sum_probs=210.2
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..+....++..+.+.||+|.||+||+|+|. | .||||++.... +++.+.|++|+..+++-+|.||+-|.|++.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444556778899999999999999999962 2 49999998774 4678899999999999999999999999998877
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+|+.+|.|.+|+.++......++....+.|+.|++.||.||| .++|+|+|||..|||+.++++|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceee
Confidence 8999999999999999877777999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh------
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI------ 266 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~------ 266 (314)
-..-..........|...|+|||+++ ....-+|++.+||||||+++|||++|..||.......+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIR----------mqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr 607 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIR----------MQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR 607 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHh----------hcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc
Confidence 43322222333445788899999986 23466889999999999999999999999983222211
Q ss_pred ----hhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 267 ----SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 267 ----~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.........+++.+++++ ++++||++.+++..|..+...
T Consensus 608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111223456676666665 999999999999988877663
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=308.59 Aligned_cols=203 Identities=27% Similarity=0.371 Sum_probs=178.9
Q ss_pred HHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCC-CCCcceeecccccCC-cee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPD-FKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~ 114 (314)
..-++|.+++.||.|.||.||+|+ ..++..||||..+.... .....-.+|+..|++++ ||||+++++++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456899999999999999999999 55799999999876642 22233468999999998 999999999998877 999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||++ .+|+++++.+++.+++..+..|+.||+.||+|+| ++|+.|||+||+|||+..+..+||+|||+|+...
T Consensus 87 fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEecccccccccc
Confidence 9999995 5999999998999999999999999999999999 9999999999999999999999999999999875
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
... .-.....|..|+|||+++ ..+.|+.+.||||+||+++|+.+-+..|.+.
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLL------------rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLL------------RSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred cCC---CcchhhhcccccchHHhh------------hccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 432 233456899999999887 6888999999999999999999988888764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=300.52 Aligned_cols=260 Identities=43% Similarity=0.692 Sum_probs=208.8
Q ss_pred cccceehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccc
Q 047043 28 TWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107 (314)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (314)
....++|.++....++|.....||+|+||.||+|...++..||||.+.........+|.+|+.++.+++|||+++++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 67779999999999999999999999999999999888899999987765432145699999999999999999999999
Q ss_pred ccCC-ceeEEEEecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 108 SNPD-FKALVLELMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 108 ~~~~-~~~lv~e~~~~~sL~~~i~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
.+.+ ...+|+||++.|+|.+.+..... .+++....+|+.++|.||+|||+.- ...|+|||||++|||+|++...||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 59999999999999999987654 6899999999999999999999622 2259999999999999999999999
Q ss_pred eeecceecCCCCCcceeecc-cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc-c
Q 047043 186 DFGISKLLGDGEDSVTQTMT-MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF-T 263 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~-~ 263 (314)
|||++........ ..... .||.+|+|||+. ..+..+.++||||||+++.|+++|+.|.+... .
T Consensus 220 DFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~-------------~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYA-------------STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred CccCcccCCcccc--ceeeecCCCCccCChhhh-------------ccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 9999965432111 11112 699999999654 45778899999999999999999998877543 1
Q ss_pred chhhhhh-------------hhhccC-----C--chhhhhc---------cccCCCCHHHHHHHHHhhh
Q 047043 264 GEISLKN-------------WVNESL-----P--HALTDVV---------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 264 ~~~~~~~-------------~~~~~~-----~--~~l~~ll---------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.+..+.. ++++.+ + ..+..+. +|..||++.++++.|+.+.
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1211222 223222 2 2233322 8899999999988885543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=310.90 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=197.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|.+.+.||+|.||.||+|+. .+.+.||+|.+.+.. .+..+.+.+|+++++.++||||+.+++.|++...+++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6899999999999999999994 489999999997764 3456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+.| +|..++...+. ++|+.+..++.|+++||.||| +++|.|+|+||.||+++.+|.+|+||||+++.++...
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 9976 99999987765 899999999999999999999 9999999999999999999999999999998776532
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----hh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----VN 273 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~ 273 (314)
.......|||-|+|||.. .+.+|+..+|+|||||++||+++|++||-....-...-... .+
T Consensus 155 -~vltsikGtPlYmAPElv-------------~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELV-------------EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP 220 (808)
T ss_pred -eeeeeccCcccccCHHHH-------------cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc
Confidence 223334599999999654 58889999999999999999999999996533222111111 11
Q ss_pred ccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 274 ESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 274 ~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
...+..+.++ + ||.+|.|+.+++.+
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2333444444 4 99999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.00 Aligned_cols=204 Identities=28% Similarity=0.399 Sum_probs=180.4
Q ss_pred hcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC--CceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 115 (314)
.+.|+.++.||+|.||.||+|+ ..+|+.||+|.++.+. .....-..+|+.+|++|+||||+++.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4679999999999999999999 6689999999998875 23345567899999999999999999987665 79999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|+||++. +|.-++...+-.+++.++..++.||+.||+|+| ..|+.|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999975 999999887778999999999999999999999 99999999999999999999999999999998765
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
..... -...+-|..|.|||+++ ....|+.++|+||.|||+.||++|+..|++..
T Consensus 271 ~~~~~-~T~rVvTLWYRpPELLL------------G~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 271 SGSAP-YTSRVVTLWYRPPELLL------------GATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred CCCcc-cccceEEeeccChHHhc------------CCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 54332 34466899999999876 56678999999999999999999999998744
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=277.53 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=209.0
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc----
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN---- 109 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 109 (314)
.++....++|++.+.||.|||+.||+++ ..++..+|+|.+.....+..+...+|++.-++++|||+++++++...
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3445567899999999999999999999 66899999999988876777888999999999999999999988643
Q ss_pred -CCceeEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEecCCCcEE
Q 047043 110 -PDFKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 110 -~~~~~lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~~~~~ik 183 (314)
+...|++++|...|+|.+.+... +..++|.++.+++.++++||.+|| ... ++|+||||.||++.+.+.++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH----~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH----EKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh----ccCCcccccCCCcceeEecCCCceE
Confidence 34689999999999999998753 456899999999999999999999 666 99999999999999999999
Q ss_pred EEeeecceecCCCCCcce-------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCC
Q 047043 184 VSDFGISKLLGDGEDSVT-------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK 256 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~ 256 (314)
|.|||+++...-.-.... ......|..|+|||.+ ....+...+.++|||||||++|.|+.|..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf----------~vk~~~ti~ertDIWSLGCtLYa~mf~~s 239 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELF----------NVKSHCTITERTDIWSLGCTLYAMMFGES 239 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchhe----------ecccCcccccccchhhhhHHHHHHHHcCC
Confidence 999999887632111100 1123579999999998 45567778999999999999999999999
Q ss_pred CCCccccch--h-------hhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 257 PTDEMFTGE--I-------SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 257 Pf~~~~~~~--~-------~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
||+...... + +...+....+++.+.+++ ||.+||++.+++..++.+.
T Consensus 240 Pfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 240 PFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 998643211 1 222233445777777765 9999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=277.81 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=181.0
Q ss_pred cCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.+|...+.+|+|.||.||+|+ .++|+.||||.++....+ .-....+|+..|+.++|+||+.+.++|.+.+++.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578899999999999999999 678999999999876432 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++. +|+..++.....++..++..++.+++.|++||| .+.|.||||||.|++|+++|.+||+|||+++.++....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9965 999999988888999999999999999999999 99999999999999999999999999999999987655
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
...+. .-|..|.|||.+. ....|+..+||||.||++.||+.|..-|.+..+
T Consensus 157 ~~~~~--V~TRWYRAPELLf------------Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 157 IQTHQ--VVTRWYRAPELLF------------GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred ccccc--eeeeeccChHHhc------------cchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 44433 6789999998765 567789999999999999999999888776543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=302.68 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=194.1
Q ss_pred HhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccC-
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP- 110 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 110 (314)
..++|++.+.||.|+||.||+|.+ .+++.||+|.++... ......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 357899999999999999999973 235689999987543 23446788999999999 899999999987764
Q ss_pred CceeEEEEecCCCCHHHHHhhcC---------------------------------------------------------
Q 047043 111 DFKALVLELMPNGSLENWLYSHN--------------------------------------------------------- 133 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~--------------------------------------------------------- 133 (314)
..++++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46889999999999999987531
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeeccccee
Q 047043 134 ----YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209 (314)
Q Consensus 134 ----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~ 209 (314)
..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++................++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23667788999999999999999 8999999999999999999999999999987654322222222334567
Q ss_pred eeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh-------hhccCCchhh
Q 047043 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-------VNESLPHALT 281 (314)
Q Consensus 210 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~ 281 (314)
.|+|||.+. +..++.++|||||||++|+|++ |..||......+...... .+..+++.+.
T Consensus 241 ~y~aPE~~~-------------~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 241 KWMAPESIF-------------DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred cccCcHHhh-------------cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 899997653 4557889999999999999997 999998754322111111 1223444455
Q ss_pred hhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 282 DVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 282 ~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+++ ||..||++.++++.|+.+..+
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 544 999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.45 Aligned_cols=203 Identities=25% Similarity=0.376 Sum_probs=171.7
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||.|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999954 789999999875432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++ ++|.+++......+++..+..++.|++.||+||| +.|++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 995 6888888776666889999999999999999999 99999999999999999999999999999875432221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......+++.|+|||++. ....++.++|||||||++|+|++|..||....
T Consensus 159 --~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 159 --TYSNEVVTLWYRPPDVLL------------GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred --cCCCCcccCCCCChHHHc------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 122345789999998753 23456778999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=295.66 Aligned_cols=239 Identities=27% Similarity=0.351 Sum_probs=193.9
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999954 79999999997542 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 99999999999987654 889999999999999999999 9999999999999999999999999999987654321
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hh
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WV 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~ 272 (314)
....|++.|+|||.+. +..++.++|||||||++|+|++|..||............ ..
T Consensus 156 -----~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 217 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQ-------------SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF 217 (291)
T ss_pred -----ccccCChhhcCHHHHc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC
Confidence 1235899999997753 445678999999999999999999999875433221111 11
Q ss_pred hccCCchhhhh----c--cccCCCC-----HHHHHHHHHhhhhheeee
Q 047043 273 NESLPHALTDV----V--DANLRVS-----MKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 273 ~~~~~~~l~~l----l--dp~~Rpt-----~~~~~~~l~~~~~~~~~~ 309 (314)
+..++..++++ + ||.+||+ +.|+++ |+|+..
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~------h~~~~~ 259 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN------HRWFKS 259 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc------CccccC
Confidence 22334444444 4 9999995 888775 666643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=300.98 Aligned_cols=234 Identities=27% Similarity=0.319 Sum_probs=190.9
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 57899999999999999999995 478999999997642 23446688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|.+++...+. +++..+..++.|++.||+||| ++|++|+||||+||+++.++.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999987654 789999999999999999999 999999999999999999999999999998876432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
. ....||+.|+|||.+. +..++.++|||||||++|+|++|..||............ .
T Consensus 172 ~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 233 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQ-------------SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK 233 (329)
T ss_pred c-----ceecCChhhcCHHHHc-------------CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC
Confidence 2 1245899999997753 445678999999999999999999999764432211110 0
Q ss_pred hhccCCc----hhhhhc--cccCCCC-----HHHHHH
Q 047043 272 VNESLPH----ALTDVV--DANLRVS-----MKDVAA 297 (314)
Q Consensus 272 ~~~~~~~----~l~~ll--dp~~Rpt-----~~~~~~ 297 (314)
.+..++. .+..++ ||.+||+ +.+++.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122333 344444 9999986 677776
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.13 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=191.7
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999954 68999999998653 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999999999976654 889999999999999999999 99999999999999999999999999999876543
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh--hhh----
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL--KNW---- 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~--~~~---- 271 (314)
......||+.|+|||.+ .+..++.++|||||||++|+|++|..||......+... ..+
T Consensus 154 ---~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 217 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVL-------------RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217 (333)
T ss_pred ---ccCCcccCccccChhHh-------------cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc
Confidence 12234589999999765 34467889999999999999999999998654432211 100
Q ss_pred hh-------ccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 272 VN-------ESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 272 ~~-------~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
.. ..++..+.++ + +|..||++.+++++
T Consensus 218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0224444444 3 88999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.43 Aligned_cols=234 Identities=24% Similarity=0.323 Sum_probs=193.6
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (314)
....++|+.++.||+|.||+|++|.. .+++.+|||++++.. ....+....|.+++... +||.+++++..|++.+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34567899999999999999999995 478999999999874 34567788899998877 59999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
+|+||||+.||++..++. . ..+++..+..++..++.||.||| ++||+|||||.+|||+|.+|++||+|||++..
T Consensus 444 l~fvmey~~Ggdm~~~~~-~-~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-T-DVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEe-c-ccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999544433 2 33899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh---
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK--- 269 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~--- 269 (314)
....+. ...+.+|||.|+|||++ .+..|+.++|.|||||+|||||.|..||.+...+++-..
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil-------------~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVL-------------TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhh-------------ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 643332 45567899999999665 577899999999999999999999999998655544322
Q ss_pred ------hhhhccCCchhhhhc--cccCCCCH
Q 047043 270 ------NWVNESLPHALTDVV--DANLRVSM 292 (314)
Q Consensus 270 ------~~~~~~~~~~l~~ll--dp~~Rpt~ 292 (314)
.+.+.+.-+.++.++ +|..|-..
T Consensus 583 d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222233333555666 88888644
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.60 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=196.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|..+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999995 4799999999986532 24456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+....+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999887556899999999999999999999 9999999999999999999999999999998765433
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
.. ......+|+.|+|||++... .......++.++|||||||++|+|++|..||.............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTM-------NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred ce-eeecccCCccccCHHHhccc-------cccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 22 22234689999999886421 11124567889999999999999999999997654322111100
Q ss_pred ---hhccCCchhhhhc-----cccCCCCHHHHHH
Q 047043 272 ---VNESLPHALTDVV-----DANLRVSMKDVAA 297 (314)
Q Consensus 272 ---~~~~~~~~l~~ll-----dp~~Rpt~~~~~~ 297 (314)
....++..+.+++ +|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCCCCHHHHHHHHHHccChhhCCCHHHHhC
Confidence 0113444444444 9999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.49 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=192.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|..++..++||+|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999995 478999999997642 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999987654 899999999999999999999 9999999999999999999999999999987543211
Q ss_pred Cc---------------------------------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehh
Q 047043 198 DS---------------------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244 (314)
Q Consensus 198 ~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~sl 244 (314)
.. .......||+.|+|||++. +..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------------~~~~~~~~DvwSl 222 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-------------QTGYNKLCDWWSL 222 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-------------CCCCCCchhhhhh
Confidence 00 0011246899999997753 4457789999999
Q ss_pred hHHHHHHhcCCCCCCccccchhhhhhh-------hh--ccCCchhhhhc-----cc---cCCCCHHHHHHHHHhhhhhee
Q 047043 245 GVLLMETFTGKKPTDEMFTGEISLKNW-------VN--ESLPHALTDVV-----DA---NLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 245 G~il~~ll~g~~Pf~~~~~~~~~~~~~-------~~--~~~~~~l~~ll-----dp---~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
||++|+|++|..||......+...... .+ ..+++.+++++ +| ..||++.|+++ |+|+
T Consensus 223 Gvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~------hp~f 296 (363)
T cd05628 223 GVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT------NPFF 296 (363)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC------CCCC
Confidence 999999999999998654433211111 11 12344455544 33 45689999876 5565
Q ss_pred ee
Q 047043 308 YD 309 (314)
Q Consensus 308 ~~ 309 (314)
+.
T Consensus 297 ~~ 298 (363)
T cd05628 297 EG 298 (363)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=301.31 Aligned_cols=238 Identities=25% Similarity=0.401 Sum_probs=193.8
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|.+++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999954 79999999998653 134466888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.+ .+++..+..++.|++.||+||| ..|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999998764 4899999999999999999999 9999999999999999999999999999987664432
Q ss_pred C---------------------------cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHH
Q 047043 198 D---------------------------SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250 (314)
Q Consensus 198 ~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ 250 (314)
. ........||+.|+|||.+. +..++.++|||||||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-------------GTPYGLECDWWSLGVILYE 222 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHc-------------CCCCCCceeeEecchhhhh
Confidence 0 01122346899999997753 4467889999999999999
Q ss_pred HhcCCCCCCccccchhhhhhhh---------hccCCchhhhh----c-cccCCCC-HHHHHH
Q 047043 251 TFTGKKPTDEMFTGEISLKNWV---------NESLPHALTDV----V-DANLRVS-MKDVAA 297 (314)
Q Consensus 251 ll~g~~Pf~~~~~~~~~~~~~~---------~~~~~~~l~~l----l-dp~~Rpt-~~~~~~ 297 (314)
|++|..||.............. ...+++.+.++ + ||..||+ +.++++
T Consensus 223 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~ 284 (350)
T cd05573 223 MLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284 (350)
T ss_pred hccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhc
Confidence 9999999987553322111110 11134444444 4 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.07 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=172.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||.|+||.||+|+. .+++.||+|.++.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46799999999999999999995 4789999999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++ +|.+++...+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9975 999998876666889999999999999999999 99999999999999999999999999999876533221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......+++.|+|||.+. ....++.++|||||||++|+|++|..||....
T Consensus 159 --~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLL------------GSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred --cccCceecccccChHHhc------------CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122345789999997653 23456788999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=294.37 Aligned_cols=230 Identities=24% Similarity=0.294 Sum_probs=185.0
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 579999999998653 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceee
Q 047043 124 SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203 (314)
Q Consensus 124 sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~ 203 (314)
+|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~ 153 (323)
T cd05571 81 ELFFHLSRERV-FSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--ccc
Confidence 99999876654 899999999999999999999 99999999999999999999999999998875322211 122
Q ss_pred cccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCCc
Q 047043 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLPH 278 (314)
Q Consensus 204 ~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~~ 278 (314)
...||+.|+|||++ .+..++.++|||||||++|+|++|..||............ ..+..++.
T Consensus 154 ~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 220 (323)
T cd05571 154 TFCGTPEYLAPEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP 220 (323)
T ss_pred ceecCccccChhhh-------------cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Confidence 34689999999765 3456788999999999999999999999764332211111 11223444
Q ss_pred hhhhh----c--cccCCC-----CHHHHHH
Q 047043 279 ALTDV----V--DANLRV-----SMKDVAA 297 (314)
Q Consensus 279 ~l~~l----l--dp~~Rp-----t~~~~~~ 297 (314)
.+.++ + ||.+|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 44444 4 999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=300.14 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=192.2
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.|++++.||+|+||+||+|+. .+++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999994 578999999997642 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++.+.+. +++..+..++.|++.||.||| ..|++||||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999987654 889999999999999999999 99999999999999999999999999998754311000
Q ss_pred c---------------------------------------------ceeecccceeeeecCccccccccccCcccCCCCC
Q 047043 199 S---------------------------------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEG 233 (314)
Q Consensus 199 ~---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~ 233 (314)
. .......||+.|+|||.+. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------------~~ 223 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-------------RK 223 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-------------CC
Confidence 0 0001235899999997753 44
Q ss_pred CCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh---------hccCCchhhhhc--------cccCCCCHHHHH
Q 047043 234 IISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV---------NESLPHALTDVV--------DANLRVSMKDVA 296 (314)
Q Consensus 234 ~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~---------~~~~~~~l~~ll--------dp~~Rpt~~~~~ 296 (314)
.++.++|||||||++|+|++|..||......+....... ...++..+.+++ ++..||++.+++
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 577899999999999999999999987554332221110 112344444443 455699999998
Q ss_pred HHHHhhhhheeee
Q 047043 297 AKLKKIRVKFLYD 309 (314)
Q Consensus 297 ~~l~~~~~~~~~~ 309 (314)
+ |+|+..
T Consensus 304 ~------hp~f~~ 310 (381)
T cd05626 304 A------HPFFSE 310 (381)
T ss_pred c------CcccCC
Confidence 7 566554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=299.13 Aligned_cols=238 Identities=24% Similarity=0.403 Sum_probs=190.7
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||.|+||.||+|+. .+++.||+|+++... ......+.+|+++++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999995 479999999998642 234456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999987654 899999999999999999999 9999999999999999999999999999987653211
Q ss_pred Ccc------------------------------------eeecccceeeeecCccccccccccCcccCCCCCCCCcccce
Q 047043 198 DSV------------------------------------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDV 241 (314)
Q Consensus 198 ~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv 241 (314)
... ......||+.|+|||++. ...++.++||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di 222 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-------------QTGYNKECDW 222 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-------------CCCCCCeeee
Confidence 100 001135899999997753 4457889999
Q ss_pred ehhhHHHHHHhcCCCCCCccccchhhhhh--h-------hhccCCchhhhhc-----cccCCCC---HHHHHH
Q 047043 242 YSFGVLLMETFTGKKPTDEMFTGEISLKN--W-------VNESLPHALTDVV-----DANLRVS---MKDVAA 297 (314)
Q Consensus 242 ~slG~il~~ll~g~~Pf~~~~~~~~~~~~--~-------~~~~~~~~l~~ll-----dp~~Rpt---~~~~~~ 297 (314)
|||||++|+|++|..||......+..... + ....+++.+++++ +|.+|++ +.++++
T Consensus 223 wSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKS 295 (364)
T ss_pred ecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhc
Confidence 99999999999999999865433221110 0 0112344444444 8999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=300.04 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=191.4
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.|++++.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999994 578999999997642 2345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++|+|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999877654 789999999999999999999 89999999999999999999999999998753311000
Q ss_pred ---------------------------------------------cceeecccceeeeecCccccccccccCcccCCCCC
Q 047043 199 ---------------------------------------------SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEG 233 (314)
Q Consensus 199 ---------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~ 233 (314)
........||+.|+|||++. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------------~~ 223 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-------------RT 223 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-------------CC
Confidence 00001235899999997653 44
Q ss_pred CCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---------hhccCCchhhhhc-----cccCCCC---HHHHH
Q 047043 234 IISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---------VNESLPHALTDVV-----DANLRVS---MKDVA 296 (314)
Q Consensus 234 ~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---------~~~~~~~~l~~ll-----dp~~Rpt---~~~~~ 296 (314)
.++.++|||||||++|+|++|..||......+...... ....+++...+++ +|.+|++ +.+++
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIK 303 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHh
Confidence 57789999999999999999999998754433221111 0123444444444 8888887 77666
Q ss_pred HHHHhhhhheeee
Q 047043 297 AKLKKIRVKFLYD 309 (314)
Q Consensus 297 ~~l~~~~~~~~~~ 309 (314)
. |+|++.
T Consensus 304 ~------hp~f~~ 310 (382)
T cd05625 304 A------HPFFKT 310 (382)
T ss_pred c------CCCcCC
Confidence 4 566554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.59 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=194.9
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeeccc--------------HHHHHHHHHHHHHHhCCCCC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG--------------RAFRSFDSECEVLRNVHHRN 99 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ 99 (314)
.+-.+..++|++.+.||+|.||.|-+|+ ..+++.||||++.+... ...+...+|+.+|++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 4445678999999999999999999999 45799999999965421 12356789999999999999
Q ss_pred cceeecccccC--CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec
Q 047043 100 LLKIFSSCSNP--DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD 177 (314)
Q Consensus 100 i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~ 177 (314)
||+++++..+. +.+|||+|||..|.+...= .....+++.++++++.+++.||+||| .+||+||||||+|+|++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEc
Confidence 99999999874 6899999999888775532 12223899999999999999999999 99999999999999999
Q ss_pred CCCcEEEEeeecceecCCCC---CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC
Q 047043 178 ENMVARVSDFGISKLLGDGE---DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254 (314)
Q Consensus 178 ~~~~ikl~Dfg~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g 254 (314)
++|.+||+|||.+..+.... ....-....|||.|+|||.... .......+.+.||||+||++|+|+.|
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~---------~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG---------GNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC---------CCCccccchhhhhhhhhhhHHHhhhc
Confidence 99999999999988763221 1111123579999999998652 11244557789999999999999999
Q ss_pred CCCCCccccchhhhhhh-----hh--ccCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 255 KKPTDEMFTGEISLKNW-----VN--ESLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 255 ~~Pf~~~~~~~~~~~~~-----~~--~~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
+.||-+...-+..-... .+ +.+.+.++++| ||.+|.+..|+..+.
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 99998755433322211 11 12334455554 999999999998743
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=297.39 Aligned_cols=243 Identities=22% Similarity=0.312 Sum_probs=192.1
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456899999999999999999995 478999999997532 1233457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++.... +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999887543 788899999999999999999 89999999999999999999999999999877643
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
.... ......||+.|+|||.+.. ......++.++|||||||++|+|++|..||.............
T Consensus 195 ~~~~-~~~~~~gt~~y~aPE~~~~---------~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05596 195 NGMV-RCDTAVGTPDYISPEVLKS---------QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred CCcc-cCCCCCCCcCeECHHHhcc---------CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence 2211 1223468999999988642 1224457889999999999999999999998654322111110
Q ss_pred ---hh--ccCCchhhh----hc--cccC--CCCHHHHHHH
Q 047043 272 ---VN--ESLPHALTD----VV--DANL--RVSMKDVAAK 298 (314)
Q Consensus 272 ---~~--~~~~~~l~~----ll--dp~~--Rpt~~~~~~~ 298 (314)
.+ ..++..+++ ++ +|.. |+++.+++.+
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01 123444444 44 6666 9999998773
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=296.76 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=193.9
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|..+++.++||||+++++.+.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999954 68899999997532 2233557789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++... .+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999998754 3789999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
... .......||+.|+|||++.. ......++.++|+|||||++|+|++|..||.............
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~---------~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKS---------QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhc---------cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 221 11234568999999988742 1223457789999999999999999999998654322111110
Q ss_pred ---hh--ccCCchhhhhc-----ccc---CCCCHHHHHHHHHhhhhheeee
Q 047043 272 ---VN--ESLPHALTDVV-----DAN---LRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ---~~--~~~~~~l~~ll-----dp~---~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.+ ..++..+++++ ++. .|+++.++++ |+|++.
T Consensus 265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~------hp~~~~ 309 (370)
T cd05621 265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ------HPFFKN 309 (370)
T ss_pred ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc------CcccCC
Confidence 01 12344444444 232 3789998887 566654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=298.13 Aligned_cols=239 Identities=26% Similarity=0.385 Sum_probs=188.6
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|+.++.||.|+||.||+|++ .+++.||+|++..... .....+.+|+++++.++|+||+++++++.+.+.++++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 467889999999999999999995 4799999999975533 34467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+.. ...+..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++.......
T Consensus 152 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 152 EFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred ecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999986532 2567788899999999999999 8999999999999999999999999999987664322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-hh-------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS-LK------- 269 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~-~~------- 269 (314)
. ......||..|+|||.+.. ....+...+.++|||||||++|+|++|..||......+.. ..
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 292 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINT--------DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ 292 (353)
T ss_pred c--cccccccCccccCcccccc--------ccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC
Confidence 1 1123468999999987642 1223344567899999999999999999999743322211 00
Q ss_pred -hhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 270 -NWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 270 -~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
......++..+.+++ ||.+||++.|+++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011223444444544 9999999999998
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=296.80 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=206.2
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc-eeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF-KALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 116 (314)
-++|+.++.+|+|+||.+++++++ ++..+++|.+.... ....+...+|..++++++||||+.+.+.|+.++. ++++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368999999999999999999955 68899999998764 3344577899999999999999999999998887 9999
Q ss_pred EEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 117 LELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|+||+||++.+.+.+.+ ..+++..+.+|+.|++.|+.||| ++.|.|||||+.|||++.++.|+|+|||++..+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998654 77899999999999999999999 89999999999999999999999999999998866
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
... ......||+.|++||++ .+.+|+.++|||||||++|||++-+.+|....-........
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil-------------~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~ 223 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEIL-------------SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY 223 (426)
T ss_pred chh--hhheecCCCcccCHHHh-------------CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC
Confidence 531 23446799999999665 57789999999999999999999999999866554433332
Q ss_pred --hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 --VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.+..++..++.++ +|..||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3456666777666 99999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=273.93 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=200.6
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|-||.||+|+ .+++--||+|++-+.. ...-..+.+|+++-..|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 36889999999999999999999 5678899999987653 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++||.+.|++...++.. ...+++...+.+..|++.|+.|+| .++++||||||+|+|++.++.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999843 234899999999999999999999 9999999999999999999999999999887542
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-----hh
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS-----LK 269 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~-----~~ 269 (314)
...+...+||..|++| |+..+...+..+|+|++|++.||++.|..||.....++.. ..
T Consensus 176 ----~~kR~tlcgt~dyl~p-------------Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPP-------------EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred ----CCCceeeecccccCCH-------------hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence 3356668899999999 5556778889999999999999999999999987644331 12
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
...++.++...+++| +|.+|....|++++
T Consensus 239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 223456666677766 77777777777663
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=295.34 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=194.2
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-C-CCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-D-GNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~-~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++.+.||.|+||.||+|.++ + +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 45678999999999999999999843 3 3689999987542 23445678899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999999987654 899999999999999999999 999999999999999999999999999998865
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
.... ....||+.|+|||++. +..++.++|||||||++|+|++|..||............
T Consensus 182 ~~~~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 182 DTRT-----YTLCGTPEYIAPEILL-------------NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred CCCc-----ceecCChhhcCHHHHh-------------CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 4321 2245899999997763 345678999999999999999999999875432211111
Q ss_pred --hhhccCCc----hhhhhc--cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 271 --WVNESLPH----ALTDVV--DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 --~~~~~~~~----~l~~ll--dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
..+..+++ .++.++ ||.+|+ +++++++ |+|+.+
T Consensus 244 ~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~------hp~f~~ 289 (340)
T PTZ00426 244 IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE------HPWFGN 289 (340)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc------CCCcCC
Confidence 11223343 444444 888884 7888876 566554
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.48 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=206.0
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccc----
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCS---- 108 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---- 108 (314)
..+.....++++.+.|..|||+.||+|... .|..||+|.+-.......+..++|+++|++|. |+|||.+++...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 344455678999999999999999999954 45999999887776677889999999999997 999999999321
Q ss_pred --c-CCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 109 --N-PDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 109 --~-~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
. .-.++|.||||+||+|-|++.++ ...+++.++++|+.|+++|+++||.. +..|+|||||-+||||+.+|.+||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEe
Confidence 1 23567999999999999999854 34499999999999999999999943 344999999999999999999999
Q ss_pred EeeecceecCCCCCcce-------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 185 SDFGISKLLGDGEDSVT-------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
||||.++.-........ .-...-|+.|+|||.+ +...+.++++|+|||+|||+||-||....|
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI----------Dlysg~pI~eKsDIWALGclLYkLCy~t~P 257 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI----------DLYSGLPIGEKSDIWALGCLLYKLCYFTTP 257 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH----------hhhcCCCCcchhHHHHHHHHHHHHHHhCCC
Confidence 99998875432221100 0123469999999998 566788999999999999999999999999
Q ss_pred CCcccc-----chhhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 258 TDEMFT-----GEISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 258 f~~~~~-----~~~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
|+.... +.+.++. .+.+++.++++| ||.+||++-++++.+.++...
T Consensus 258 Fe~sg~laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 258 FEESGKLAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cCcCcceeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 997632 2222222 145666666665 999999999999999988764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=300.36 Aligned_cols=238 Identities=23% Similarity=0.329 Sum_probs=189.5
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.+|++++.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999994 579999999987542 223456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999999987654 789999999999999999999 9999999999999999999999999999875331100
Q ss_pred Cc-----------------------------------------ceeecccceeeeecCccccccccccCcccCCCCCCCC
Q 047043 198 DS-----------------------------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIIS 236 (314)
Q Consensus 198 ~~-----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 236 (314)
.. .......||+.|+|||++ .+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~ 222 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-------------LRTGYT 222 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-------------cCCCCC
Confidence 00 000123589999999765 345577
Q ss_pred cccceehhhHHHHHHhcCCCCCCccccchhhhhhh---------hhccCCchhhhhc-----cccCCC---CHHHHHH
Q 047043 237 AKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---------VNESLPHALTDVV-----DANLRV---SMKDVAA 297 (314)
Q Consensus 237 ~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---------~~~~~~~~l~~ll-----dp~~Rp---t~~~~~~ 297 (314)
.++|||||||++|+|++|..||......+...... ....++..+.+++ +|..|+ ++.++++
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKA 300 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhC
Confidence 89999999999999999999998765433211111 0112344444433 999999 8888886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.85 Aligned_cols=235 Identities=25% Similarity=0.347 Sum_probs=188.2
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++|++++++++.+.+.+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378889999999999999994 5899999999875431 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+.+... ...+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999887653 335889999999999999999999 8999999999999999999999999999988754322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--hhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--SLK------ 269 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--~~~------ 269 (314)
. .....||..|+|||.+ .+..++.++|||||||++|+|++|..||........ ...
T Consensus 157 ~---~~~~~g~~~y~aPE~~-------------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVI-------------NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED 220 (285)
T ss_pred e---ecCCCCCCCccCHhhh-------------cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc
Confidence 1 1234589999999765 345678899999999999999999999986433211 000
Q ss_pred -hhhhccCCchhhhhc------cccCCCC-----HHHHHH
Q 047043 270 -NWVNESLPHALTDVV------DANLRVS-----MKDVAA 297 (314)
Q Consensus 270 -~~~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~ 297 (314)
...+..++..+.+++ ||.+||+ +.++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111233455444444 9999987 677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=283.89 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=197.3
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..+.|++++.||+|.-|+||+++. .++..+|+|++.+.. .....+...|-+||+.++||.++.+|..|+..+..++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 456799999999999999999994 467999999998764 2345667789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+||+|..+.+++ +..+++..+..++.+++-||+||| ..|||+|||||+||||.++|++.|+||+++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999875 567999999999999999999999 9999999999999999999999999999764431
Q ss_pred CC--------------------------------CCc----------------------ceeecccceeeeecCcccccc
Q 047043 195 DG--------------------------------EDS----------------------VTQTMTMATIGYMAPVSQLFD 220 (314)
Q Consensus 195 ~~--------------------------------~~~----------------------~~~~~~~~t~~y~aPE~~~~~ 220 (314)
-. ... .......||-+|+|||++
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI--- 307 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI--- 307 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee---
Confidence 00 000 001123689999999776
Q ss_pred ccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh-h------ccCCchhhhhc------ccc
Q 047043 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV-N------ESLPHALTDVV------DAN 287 (314)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~-~------~~~~~~l~~ll------dp~ 287 (314)
.+..-+.++|.|+||+++|||+.|..||.+..+.+.-..... + +.++..++++| ||.
T Consensus 308 ----------~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 308 ----------RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred ----------ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 455567799999999999999999999998766553222111 1 12334455554 999
Q ss_pred CCCC----HHHHHHHHHhhhhheeee
Q 047043 288 LRVS----MKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 288 ~Rpt----~~~~~~~l~~~~~~~~~~ 309 (314)
.|-. +.||-+ |++++-
T Consensus 378 kRlg~~rGA~eIK~------HpFF~g 397 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR------HPFFEG 397 (459)
T ss_pred hhhccccchHHhhc------CccccC
Confidence 9987 666655 555554
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.76 Aligned_cols=230 Identities=24% Similarity=0.299 Sum_probs=184.3
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 579999999998652 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceee
Q 047043 124 SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203 (314)
Q Consensus 124 sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~ 203 (314)
+|..++...+ .+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 153 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence 9998887655 4899999999999999999999 89999999999999999999999999998875322211 122
Q ss_pred cccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----hhccCCc
Q 047043 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----VNESLPH 278 (314)
Q Consensus 204 ~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~~~~~~ 278 (314)
...||+.|+|||++ .+..++.++|||||||++|+|++|..||............. .+..+++
T Consensus 154 ~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 220 (323)
T cd05595 154 TFCGTPEYLAPEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 220 (323)
T ss_pred cccCCcCcCCcccc-------------cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 34589999999765 34567889999999999999999999997654332211111 1233444
Q ss_pred hhhhhc------cccCCC-----CHHHHHH
Q 047043 279 ALTDVV------DANLRV-----SMKDVAA 297 (314)
Q Consensus 279 ~l~~ll------dp~~Rp-----t~~~~~~ 297 (314)
.+.+++ ||.+|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 444444 888887 7777776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=289.62 Aligned_cols=208 Identities=25% Similarity=0.328 Sum_probs=175.4
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|..+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 5799999999999999999995 479999999997532 223455788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999876666899999999999999999999 9999999999999999999999999999987654332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.. ......||+.|+|||++... ......++.++|||||||++|+|++|..||....
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAM--------EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred Cc-cccceeccccccCHHHHhhc--------cccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 21 11224589999999887421 1123456789999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.35 Aligned_cols=199 Identities=26% Similarity=0.361 Sum_probs=172.5
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||+|+||.||+++.+ ++..+|+|++.... ......+.+|+++++.++||||+++++++.+.+..+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999954 78899999998653 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++..... +++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999977554 8899999999999999999993 2469999999999999999999999999987653321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.....++..|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 159 ---~~~~~g~~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ---ANSFVGTRSYMSPERL-------------QGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---cccCCCCcCcCCHhHh-------------cCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 1224589999999765 345578899999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.46 Aligned_cols=237 Identities=26% Similarity=0.330 Sum_probs=186.5
Q ss_pred CccccceeeecCceEEEEEEe----CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 43 GFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
+|++.+.||+|+||.||+++. .+++.||+|+++... ......+..|..+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999984 258899999997542 22345677899999999 589999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++..+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999876554 889999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch--hhhh-h
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--ISLK-N 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--~~~~-~ 270 (314)
...... ......||+.|+|||.+. ....++.++|||||||++|+|++|..||....... .... .
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 222 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIR------------GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhc------------CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence 332221 112345899999998753 12335778999999999999999999997432211 1111 0
Q ss_pred ------hhhccCCchhhhh----c--cccCCC-----CHHHHHH
Q 047043 271 ------WVNESLPHALTDV----V--DANLRV-----SMKDVAA 297 (314)
Q Consensus 271 ------~~~~~~~~~l~~l----l--dp~~Rp-----t~~~~~~ 297 (314)
..+..++..+.++ + ||.+|| +++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 223 ILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1122344444444 4 999999 6777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.61 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=190.8
Q ss_pred hcCccccceeeecCceEEEEEEeCC-----------------CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSD-----------------GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 102 (314)
.++|++.+.||+|+||.||+|.+.+ +..||+|++.... ......+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997432 3369999988653 234467889999999999999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCe
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHN------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i 164 (314)
+++++.+.+..+++|||+++++|.+++.... ..+++..+..++.|++.||.||| +.|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i 159 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNF 159 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCc
Confidence 9999999999999999999999999986532 23567788999999999999999 8999
Q ss_pred eecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehh
Q 047043 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244 (314)
Q Consensus 165 ~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~sl 244 (314)
+|+||||+||+++.++.+||+|||++..+.............++..|+|||.+. ...++.++|||||
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~sl 226 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-------------MGKFTTASDVWAF 226 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-------------cCCCCchhhhHHH
Confidence 999999999999999999999999987664432222222334577899997653 4457889999999
Q ss_pred hHHHHHHhc--CCCCCCccccchhhhh-------------hhhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 245 GVLLMETFT--GKKPTDEMFTGEISLK-------------NWVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 245 G~il~~ll~--g~~Pf~~~~~~~~~~~-------------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
|+++|+|++ +..||........... ...++.+++.+.+++ ||..|||+.++.+.|+
T Consensus 227 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 227 GVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 999999986 6678876543322100 001233455555554 9999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.32 Aligned_cols=204 Identities=26% Similarity=0.394 Sum_probs=172.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++++.||.|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999994 579999999987542 234466788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999976544 889999999999999999999 9999999999999999999999999999986432110
Q ss_pred Cc------------c---------------------------------eeecccceeeeecCccccccccccCcccCCCC
Q 047043 198 DS------------V---------------------------------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSE 232 (314)
Q Consensus 198 ~~------------~---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~ 232 (314)
.. . ......||+.|+|||++. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~ 222 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-------------Q 222 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-------------c
Confidence 00 0 000135899999997753 4
Q ss_pred CCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 233 GIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 233 ~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
..++.++|||||||++|+|++|..||.....
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=284.62 Aligned_cols=202 Identities=25% Similarity=0.317 Sum_probs=169.5
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999964 68899999997643 2334667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++++.+..+ ......+++..+..++.|++.||.||| ..|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9988666544 443445899999999999999999999 99999999999999999999999999999887643221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
. ......+++.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~-------------~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 156 A-NYTEYVATRWYRSPELLL-------------GAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred c-cccccccccccCCcHHHc-------------CCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 112245889999997653 3456789999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=293.89 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=193.3
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
......++|++.+.||+|+||.||+|+.+ +++.+|+|++.... ......+.+|..+++.++||||+++++.+.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999954 78999999987532 223345778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..++||||+++++|.+++.... +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999987643 788899999999999999999 9999999999999999999999999999988
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~ 271 (314)
........ ......||+.|+|||++.. ......++.++|||||||++|+|++|..||.............
T Consensus 191 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~---------~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 191 KMNKEGMV-RCDTAVGTPDYISPEVLKS---------QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (371)
T ss_pred EcCcCCcc-cccCcccCccccCHHHHhc---------cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 76433211 1223568999999988752 1223457889999999999999999999998644322111100
Q ss_pred ---------hhccCCchhhhhc-----cccC---CCCHHHHHHH
Q 047043 272 ---------VNESLPHALTDVV-----DANL---RVSMKDVAAK 298 (314)
Q Consensus 272 ---------~~~~~~~~l~~ll-----dp~~---Rpt~~~~~~~ 298 (314)
....++..+++++ +|.. |+++.+++++
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 261 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1123455555544 3333 6788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=294.14 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=192.3
Q ss_pred hcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (314)
.++|++.+.||+|+||.||+|.+ .++..||+|+++... ......+.+|+.+++.+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999973 235689999987543 23446688899999999 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcC-----------------------------------------------------------
Q 047043 113 KALVLELMPNGSLENWLYSHN----------------------------------------------------------- 133 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~----------------------------------------------------------- 133 (314)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 134 ---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 134 ---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
..+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 13677889999999999999999 89999999999999999999999999999887644322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------ 271 (314)
........++..|+|||.+ .+..++.++||||||+++|+|++ |..||.............
T Consensus 270 ~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESI-------------FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336 (375)
T ss_pred ccccCCCCCCcceeChhHh-------------cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC
Confidence 2222223356679999664 34567889999999999999997 899997654332211111
Q ss_pred -hhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 272 -VNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 272 -~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
.+...+..+.+++ ||.+||++.++++.+++
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1122333444444 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=288.26 Aligned_cols=231 Identities=25% Similarity=0.310 Sum_probs=184.9
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999995 479999999998642 234466788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceee
Q 047043 124 SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203 (314)
Q Consensus 124 sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~ 203 (314)
+|.+.+...+ .+++..+..++.||+.||+||| ++|++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 153 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMK 153 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccc
Confidence 9998887654 4899999999999999999999 89999999999999999999999999999875322211 122
Q ss_pred cccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCCc
Q 047043 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLPH 278 (314)
Q Consensus 204 ~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~~ 278 (314)
...||+.|+|||.+ .+..++.++|||||||++|+|++|..||............ ..+..++.
T Consensus 154 ~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 220 (328)
T cd05593 154 TFCGTPEYLAPEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSA 220 (328)
T ss_pred cccCCcCccChhhh-------------cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCH
Confidence 34689999999765 3445778999999999999999999999764432221111 11223444
Q ss_pred hhhh----hc--cccCCC-----CHHHHHHH
Q 047043 279 ALTD----VV--DANLRV-----SMKDVAAK 298 (314)
Q Consensus 279 ~l~~----ll--dp~~Rp-----t~~~~~~~ 298 (314)
.+.+ ++ ||.+|+ ++.+++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4444 44 999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.26 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=193.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++++.||+|+||.||+|.. .+++.||+|+++... ......+.+|..++..++||+|+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 479999999997542 234567788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999977654 899999999999999999999 9999999999999999999999999999886543211
Q ss_pred Cc---------------------------------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehh
Q 047043 198 DS---------------------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244 (314)
Q Consensus 198 ~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~sl 244 (314)
.. .......||+.|+|||++ .+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-------------~~~~~~~~~DiwSl 222 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-------------MQTGYNKLCDWWSL 222 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-------------cCCCCCCcceeccc
Confidence 00 000123589999999775 34557789999999
Q ss_pred hHHHHHHhcCCCCCCccccchhhhhhh-------hhc--cCCchhhhhc-----cccCCCC---HHHHHHHHHhhhhhee
Q 047043 245 GVLLMETFTGKKPTDEMFTGEISLKNW-------VNE--SLPHALTDVV-----DANLRVS---MKDVAAKLKKIRVKFL 307 (314)
Q Consensus 245 G~il~~ll~g~~Pf~~~~~~~~~~~~~-------~~~--~~~~~l~~ll-----dp~~Rpt---~~~~~~~l~~~~~~~~ 307 (314)
||++|+|++|..||............. .++ .+++.+++++ ||..|++ +.++++ |+|+
T Consensus 223 Gvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~------hp~f 296 (360)
T cd05627 223 GVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKS------HPFF 296 (360)
T ss_pred cceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhc------CCCC
Confidence 999999999999998755433211111 111 2344455444 8888885 455554 7776
Q ss_pred eee
Q 047043 308 YDV 310 (314)
Q Consensus 308 ~~~ 310 (314)
+.+
T Consensus 297 ~~~ 299 (360)
T cd05627 297 EGV 299 (360)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=281.68 Aligned_cols=235 Identities=25% Similarity=0.287 Sum_probs=191.2
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeeccccc----CCceeEEEEec
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSN----PDFKALVLELM 120 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 120 (314)
..||.|+++.||+|.. +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 788999999976532 225678899999999999999999998866 45788999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++|+|.+++.+.+ .+++.....++.|++.|+.+|| + .+++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH----~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY----KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH----hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999998755 4788999999999999999999 5 589999999999999999999999999987654321
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-------hh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-------WV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-------~~ 272 (314)
....++..|+|||.+.. ....++.++|||||||++|+|++|..||......+..... ..
T Consensus 178 ---~~~~~~~~y~aPE~~~~-----------~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLND-----------IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhh-----------ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 12457889999987531 1246788999999999999999999999876543321111 11
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
+..+++.+++++ ||..|||+.++++.|+++..
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 224555566665 99999999999999998754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=286.52 Aligned_cols=228 Identities=26% Similarity=0.308 Sum_probs=182.6
Q ss_pred eeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++.+.+.+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999954 68899999997542 23445677899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecc
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~ 205 (314)
.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 153 (312)
T cd05585 81 FHHLQREGR-FDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTF 153 (312)
T ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccc
Confidence 999977554 899999999999999999999 99999999999999999999999999999875432211 12234
Q ss_pred cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCCchh
Q 047043 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLPHAL 280 (314)
Q Consensus 206 ~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~~~l 280 (314)
.||+.|+|||++ .+..++.++|||||||++|+|++|..||............ ..+..++..+
T Consensus 154 ~gt~~y~aPE~~-------------~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (312)
T cd05585 154 CGTPEYLAPELL-------------LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDA 220 (312)
T ss_pred cCCcccCCHHHH-------------cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHH
Confidence 589999999765 3455788999999999999999999999765433221111 1123344444
Q ss_pred hhhc------cccCCCC---HHHHHH
Q 047043 281 TDVV------DANLRVS---MKDVAA 297 (314)
Q Consensus 281 ~~ll------dp~~Rpt---~~~~~~ 297 (314)
++++ ||.+||+ +.+++.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 5544 9999975 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=290.39 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=208.2
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH---HHHHHHHHHHHHHhCC-CCCcceeecccccCC
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR---AFRSFDSECEVLRNVH-HRNLLKIFSSCSNPD 111 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 111 (314)
...+...|++.+.||+|.||.||.+.. .+|+.+|+|++++.... ......+|+.+|++++ ||||+.+++.+++.+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 355677899999999999999999995 46999999999876532 3457889999999998 999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC----CCcEEEEee
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE----NMVARVSDF 187 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~----~~~ikl~Df 187 (314)
.+++|||++.||.|.+.+... . ++|..+..++.|++.++.||| ..|++||||||+|+++.. ++.++++||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999999999877 3 899999999999999999999 999999999999999953 347999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++...... ......+||+.|+|||++ ....|+..+||||+|+++|.|++|..||.........
T Consensus 184 Gla~~~~~~---~~~~~~~Gtp~y~APEvl-------------~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~ 247 (382)
T KOG0032|consen 184 GLAKFIKPG---ERLHTIVGTPEYVAPEVL-------------GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF 247 (382)
T ss_pred CCceEccCC---ceEeeecCCccccCchhh-------------cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence 999987652 234557899999999654 5578899999999999999999999999876643332
Q ss_pred ---------hhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 268 ---------LKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 268 ---------~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
+.....+.+++..++++ ||..|+|+.++++ |+|+...
T Consensus 248 ~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~------HpWi~~~ 299 (382)
T KOG0032|consen 248 LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ------HPWIKSI 299 (382)
T ss_pred HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc------CccccCC
Confidence 22223455566666655 9999999999999 6887654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=292.43 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=194.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CC-----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SD-----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||+|.+ .. +..||+|.++... ......+.+|+++++.+ +|+||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 466899999999999999999983 22 3579999997653 33446688999999999 8999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcC----------------------------------------------------------
Q 047043 112 FKALVLELMPNGSLENWLYSHN---------------------------------------------------------- 133 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~---------------------------------------------------------- 133 (314)
..+++|||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 134 -----------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 134 -----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
..+++..+.+++.|++.||.||| ++|++||||||+||+++.++.++|+|||++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13677889999999999999999 899999999999999999999999999998766443222222
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh-------hhc
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-------VNE 274 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-------~~~ 274 (314)
....++..|+|||++ ....++.++|||||||++|+|++ |..||............. .+.
T Consensus 272 ~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
T cd05106 272 GNARLPVKWMAPESI-------------FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPD 338 (374)
T ss_pred cCCCCccceeCHHHh-------------cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCC
Confidence 223356679999765 34557889999999999999997 999998754432211111 112
Q ss_pred cCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 275 ~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.++..+.+++ ||..||++.++++.++++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2344455544 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.53 Aligned_cols=241 Identities=23% Similarity=0.283 Sum_probs=194.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CC-CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...|.+.+.||+|++|.||+|.. .+ ++.|++|.+..........+.+|+.+++.++||||+++++++..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 34499999999999999999984 34 67899998766655555677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 119 LMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 119 ~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|+++++|.+++... ...+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+..
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999987542 334789999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
...........||+.|+|||++ .+..++.++|||||||++|+|++|..||......+......
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 288 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELW-------------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288 (478)
T ss_pred ccccccccccCCCccccCHhHh-------------CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 3322223334689999999765 34567889999999999999999999998654433211111
Q ss_pred --hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 --VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.+..++..+.+++ ||..||++.+++.+
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1223444454444 99999999998753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=288.53 Aligned_cols=233 Identities=25% Similarity=0.327 Sum_probs=183.5
Q ss_pred ccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHH---HhCCCCCcceeecccccCCceeEE
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVL---RNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
|++.+.||+|++|.||+|.. .+++.||+|+++... ......+..|.+++ ..++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999995 479999999998642 22345566666665 456799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|...+... .+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999887653 4899999999999999999999 999999999999999999999999999987653222
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
.. ......|++.|+|||.+ .+..++.++|||||||++|+|++|..||......+..... .
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T cd05589 155 GD--RTSTFCGTPEFLAPEVL-------------TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219 (324)
T ss_pred CC--cccccccCccccCHhHh-------------cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 11 12335689999999765 3455788999999999999999999999875433321111 1
Q ss_pred hhccCCch----hhhhc--cccCCC-----CHHHHHH
Q 047043 272 VNESLPHA----LTDVV--DANLRV-----SMKDVAA 297 (314)
Q Consensus 272 ~~~~~~~~----l~~ll--dp~~Rp-----t~~~~~~ 297 (314)
.+..++.. +..++ ||.+|| ++.++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12234444 44444 999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=279.51 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=195.0
Q ss_pred hcCccccceeeecCceEEEEEEeC----CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|.++ .+..|++|.++.... .....+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999999842 366899999886532 334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++......+++..++.++.|++.||+||| ++|++|+||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999876556899999999999999999999 99999999999999999999999999997654322
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhh------
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISL------ 268 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~------ 268 (314)
... .......++..|+|||.+ .+..++.++|||||||++|++++ |..||......+...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~ 225 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAI-------------QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF 225 (266)
T ss_pred cch-hcccCCCCceeecCHHHH-------------hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence 111 111122356789999765 34567889999999999999775 999998755432111
Q ss_pred hhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 269 KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 269 ~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
....+..++..+.+++ +|..||++.++.+.+.++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112334555555554 999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=289.38 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=172.0
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||.|+||.||++.+. ++..+++|.++... ......+.+|+++++.++||||+++++++.+.+..+++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999954 78899999987653 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++...+. +++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999987654 7899999999999999999993 2579999999999999999999999999887553321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.....++..|+|||.+ .+..++.++|+|||||++|+|++|..||...
T Consensus 159 ---~~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERL-------------QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHh-------------cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1223588899999765 3445778899999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=271.60 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=209.5
Q ss_pred hhhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--------cHHHHHHHHHHHHHHhCC-CCCccee
Q 047043 34 YLDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--------GRAFRSFDSECEVLRNVH-HRNLLKI 103 (314)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~-h~~i~~~ 103 (314)
...-+.....|+..+.||+|..+.|-++. .++|+.+++|++.... .+..+.-..|+.+|+++. ||+|+++
T Consensus 9 ~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l 88 (411)
T KOG0599|consen 9 KDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDL 88 (411)
T ss_pred hhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence 44556678899999999999999999988 4588999999986432 123345567999999985 9999999
Q ss_pred ecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEE
Q 047043 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ik 183 (314)
.++++....+++|+|.++.|.|.|++...-. ++|....+++.|+.+|++||| ...|+||||||+||+++++.+++
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceE
Confidence 9999999999999999999999999987644 899999999999999999999 99999999999999999999999
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc---
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE--- 260 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~--- 260 (314)
|+|||+++.+..+.. -...+|||+|+|||.+.++- ....+.|+..+|+|++|+++|.|+.|..||-.
T Consensus 164 isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m-------~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSM-------YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred EeccceeeccCCchh---HHHhcCCCcccChhheeeec-------ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 999999998866543 34478999999999998642 22455688899999999999999999999964
Q ss_pred ------cccchhhhhhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 261 ------MFTGEISLKNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 261 ------~~~~~~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+..++....+.++++..++++ ||..|.|+++.++
T Consensus 234 mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 223445555555566777777765 9999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.37 Aligned_cols=238 Identities=26% Similarity=0.404 Sum_probs=204.6
Q ss_pred hcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...|+.++.||+|.||.||+|. ..+++.||+|++..+.. ....++.+|+.++.+++++||.++|+.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3468888999999999999999 56899999999998753 346788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
||.||++.+.+...+. +++..+..++.+++.|+.||| ..+.+|+|||+.||++..+|.+||+|||.+..+.....
T Consensus 92 y~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999987664 588889999999999999999 99999999999999999999999999999988755432
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh------hhhhh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS------LKNWV 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~------~~~~~ 272 (314)
......||+.|+|||++ ....|+.++||||||++++||.+|..|+....+..+- .+-..
T Consensus 167 --rr~tfvGTPfwMAPEVI-------------~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L 231 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVI-------------KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL 231 (467)
T ss_pred --ccccccccccccchhhh-------------ccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc
Confidence 33567899999999665 4567889999999999999999999999887664331 12222
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
...++..+++++ ||..||++.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 336677777776 99999999999984
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=289.19 Aligned_cols=243 Identities=24% Similarity=0.329 Sum_probs=189.4
Q ss_pred ceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+.+ +++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 68999999998642 23345667788888776 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++.+.+. +++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 g~L~~~i~~~~~-l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (320)
T cd05590 81 GDLMFHIQKSRR-FDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TT 153 (320)
T ss_pred chHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cc
Confidence 999998877654 899999999999999999999 99999999999999999999999999998875422211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~ 277 (314)
....||+.|+|||++. +..++.++|||||||++|+|++|..||............ ..+..++
T Consensus 154 ~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (320)
T cd05590 154 STFCGTPDYIAPEILQ-------------EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220 (320)
T ss_pred cccccCccccCHHHHc-------------CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 2346899999997653 445678899999999999999999999875443321111 1122234
Q ss_pred ch----hhhhc--cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 278 HA----LTDVV--DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 278 ~~----l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.. ++.++ ||.+||++.++...-+.+.|+|+...
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 44 44444 99999999554444444557777543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=275.19 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=176.9
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHH--HHHHHHHHHHHHhCCCCCcceeeccccc--CCcee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA--FRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 114 (314)
-.+.|+.+..|+.|.||.||+|+ .++++.||+|.++.+.... --...+|+.+|.+++|||||.+-.+.+. -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 46789999999999999999999 4589999999998775321 1234689999999999999999988765 45799
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+|||||+. +|..++.+.+..+.+.++..++.|++.|+.||| .+.|+|||||++|++++..|.+||+|||+|+.++
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999976 999999998878999999999999999999999 9999999999999999999999999999999987
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.+... .....-|..|.|||+++ ....|+.+.|+||+|||+.||+++...|.+.
T Consensus 229 sp~k~--~T~lVVTLWYRaPELLL------------G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 229 SPLKP--YTPLVVTLWYRAPELLL------------GAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred CCccc--CcceEEEeeecCHHHhc------------CCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 76332 23346799999999876 5667899999999999999999999988753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=281.06 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=202.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++.+.||.|++|.||++.. .++..+++|.+..........+.+|+++++.++|||++++++.+..+...+++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46799999999999999999995 47899999999877666667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++...+..+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999999876666899999999999999999999 89999999999999999999999999998765533221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------- 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-------- 271 (314)
......+++.|+|||.+.. +......++.++|+||||+++|+|++|..||.............
T Consensus 159 -~~~~~~~~~~y~~PE~~~~--------~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVAC--------ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred -ccceeecchhhcCHHHHhh--------cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 1223457889999988653 22234557789999999999999999999998754332111110
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.+..++..+.+++ +|..||++.++++ ++|+++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~~ 268 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK------HPFVSDQ 268 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhc------Chhhccc
Confidence 1122344444444 9999999999977 5666543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=277.23 Aligned_cols=243 Identities=30% Similarity=0.478 Sum_probs=199.8
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
..+|++.+.||.|++|.||+|..+.+..+++|.+..........+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46799999999999999999997778999999998776555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++++|.+++... +..+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999763 345789999999999999999999 899999999999999999999999999988765432211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~ 272 (314)
.....++..|+|||.. ....++.++|+||||+++|+|++ |..||......+..... ..
T Consensus 161 --~~~~~~~~~~~~PE~~-------------~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05148 161 --SSDKKIPYKWTAPEAA-------------SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC 225 (261)
T ss_pred --ccCCCCceEecCHHHH-------------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC
Confidence 1123457789999764 34456788999999999999998 89999875543321111 11
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
+..+++.+.+++ ||..|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 234455555554 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=286.30 Aligned_cols=230 Identities=25% Similarity=0.281 Sum_probs=183.1
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCC-CCcceeecccccCCceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHH-RNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 117 (314)
+|++.+.||+|+||.||+|+. .+++.||+|+++... ......+..|.+++..+.| ++|+.+++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999995 468899999998642 2344567788999998876 56888999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999876654 789999999999999999999 8999999999999999999999999999886532211
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hh
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WV 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~ 272 (314)
. ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......+..... ..
T Consensus 156 ~--~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 220 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEII-------------AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220 (324)
T ss_pred C--ceeeecCCccccChhhh-------------cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1 12234689999999765 3455778999999999999999999999865443221111 11
Q ss_pred hccCCch----hhhhc--cccCCCCH
Q 047043 273 NESLPHA----LTDVV--DANLRVSM 292 (314)
Q Consensus 273 ~~~~~~~----l~~ll--dp~~Rpt~ 292 (314)
+..++.. ++.++ ||.+|++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2234443 44444 99999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=287.19 Aligned_cols=230 Identities=24% Similarity=0.292 Sum_probs=183.6
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|.++++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 579999999998652 223456678999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 124 SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 124 sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
+|.+++...+. +++..+..++.|++.||.||| + .|++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH----~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (325)
T cd05594 81 ELFFHLSRERV-FSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TM 153 (325)
T ss_pred cHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cc
Confidence 99998876553 899999999999999999999 6 7999999999999999999999999999875432211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~ 277 (314)
....||+.|+|||++ .+..++.++|||||||++|+|++|..||............ ..+..++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 220 (325)
T cd05594 154 KTFCGTPEYLAPEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS 220 (325)
T ss_pred ccccCCcccCCHHHH-------------ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 234589999999775 3456778999999999999999999999765432221111 1122344
Q ss_pred chhhh----hc--cccCCC-----CHHHHHH
Q 047043 278 HALTD----VV--DANLRV-----SMKDVAA 297 (314)
Q Consensus 278 ~~l~~----ll--dp~~Rp-----t~~~~~~ 297 (314)
..+.+ ++ ||.+|+ ++.++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 44444 44 999996 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.57 Aligned_cols=208 Identities=25% Similarity=0.325 Sum_probs=174.9
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999954 68899999987532 223345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.+..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999876556899999999999999999999 9999999999999999999999999999987653322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
. .......||+.|+|||++... ......++.++|||||||++|+|++|..||....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAM--------EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred c-ceecccccCccccCHHHHhcc--------ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 2 122234689999999887421 1123457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=279.29 Aligned_cols=244 Identities=31% Similarity=0.469 Sum_probs=195.2
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
.++|.+.+.||+|++|.||+|... ++..|++|.++..... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457999999999999999999853 2578999999765443 457889999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 114 ALVLELMPNGSLENWLYSHN-------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~-------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
+++|||+++++|.+++...+ ..+++..+..++.|++.|+.+|| ++|++|+||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCC
Confidence 99999999999999997542 23678889999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~ 259 (314)
.++|+|||++................++..|+|||.+ .+..++.++||||||+++|+|++ |..||.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-------------MYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhh-------------ccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 9999999998765332221112233457889999664 35567889999999999999998 999997
Q ss_pred ccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 260 EMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 260 ~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
.....+..... ..+..++..+.+++ ||..||++.|+++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 227 GLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 65443321111 11223445555544 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.54 Aligned_cols=231 Identities=25% Similarity=0.318 Sum_probs=183.6
Q ss_pred cceeeecCceEEEEEEe----CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 47 CNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++.||+|+||.||+++. .+++.||+|+++... ......+.+|+++++.++||||+++++.+.+++..+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 46899999999999984 257899999997542 2233557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++.+.+. +.+..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 81 YLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999999877654 788889999999999999999 89999999999999999999999999999875432221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVN 273 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~ 273 (314)
......||+.|+|||++. +..++.++|||||||++|+|++|..||............ ..+
T Consensus 156 --~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 220 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILM-------------RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP 220 (323)
T ss_pred --cccccCCCccccChhhcc-------------CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 122345899999997653 344678899999999999999999999875432211111 112
Q ss_pred ccCCchhhh----hc--cccCCC-----CHHHHHH
Q 047043 274 ESLPHALTD----VV--DANLRV-----SMKDVAA 297 (314)
Q Consensus 274 ~~~~~~l~~----ll--dp~~Rp-----t~~~~~~ 297 (314)
+.++..+.+ ++ ||.+|| ++.++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 334444444 44 999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=288.37 Aligned_cols=193 Identities=26% Similarity=0.337 Sum_probs=164.6
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999995 478999999998642 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++.+.+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 g~L~~~~~~~~~-l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (329)
T cd05588 81 GDLMFHMQRQRK-LPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence 999998876544 899999999999999999999 99999999999999999999999999998864322111 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
....||+.|+|||++ .+..++.++|+|||||++|+|++|..||+.
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 154 STFCGTPNYIAPEIL-------------RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHH-------------cCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 234689999999765 345677899999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.23 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=196.5
Q ss_pred hcCccccceeeecCceEEEEEEeC-CC-----CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DG-----NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
.++|++.+.||.|++|.||+|... .+ ..|++|.++... ......+.+|++.++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468999999999999999999843 23 579999987553 23456788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 114 ALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
+++|||+++++|.+++.... ..+++..+..++.|++.||+||| ..|++|+||||+||+++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGE 159 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcC
Confidence 99999999999999997642 34778889999999999999999 899999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCC
Q 047043 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~P 257 (314)
++.++|+|||++................+++.|+|||.+ .+..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~sDv~slG~il~el~~~g~~p 226 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-------------LYGKFTTESDIWSFGVVLWEIFSYGLQP 226 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHh-------------ccCcCchhhhHHHHHHHHHHHHcCCCCC
Confidence 999999999998765433222222334567889999764 34557789999999999999998 9999
Q ss_pred CCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 258 TDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 258 f~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
|......+..... ..+..++..+.+++ ||..||++.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 227 YYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 9875543332111 12234556566655 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.50 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=198.4
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..+|.+.+.||.|+||.||++... ++..+++|.+..........+.+|++++++++|||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357899999999999999999842 24568999887665555677899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 115 LVLELMPNGSLENWLYSHN------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
++|||+++++|.+++...+ ..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcE
Confidence 9999999999999987543 24889999999999999999999 8999999999999999999999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~ 261 (314)
+|+|||++................++..|+|||.+ .+..++.++|+||||+++|+|++ |..||...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-------------MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHh-------------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998765433222122223457789999765 34557789999999999999998 99999765
Q ss_pred ccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 262 FTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 262 ~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
...+..... ..+..++..+.+++ ||.+|||+.++.+.++.+...
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 227 SNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 543321111 11223444555554 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.77 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=196.0
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC----eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN----NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..+|++.+.||+|+||.||+|.+. +++ .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999853 444 48999987543 23456788999999999999999999998875 467
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++||+++|+|.+++......+++..++.++.|++.||+||| +.|++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 899999999999999887666889999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
.............+..|+|||.+ ....++.++||||||+++|+|++ |..||+.....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~-------------~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~ 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESI-------------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 227 (316)
T ss_pred CCCcceeccCCccceeecChHHh-------------ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC
Confidence 44332222223356789999765 34567889999999999999997 99999875443321110
Q ss_pred ---hhhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhhe
Q 047043 271 ---WVNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 271 ---~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
..+..++..+.++ + +|..||++.+++..+..+....
T Consensus 228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0112233334433 3 9999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=274.80 Aligned_cols=244 Identities=26% Similarity=0.438 Sum_probs=196.4
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++.+.||+|++|.||+|...+++.|++|.++... .....+.+|+.++++++|||++++++++...+..+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 356799999999999999999997677889999987653 2346688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++.... ..+++..+..++.|++.|+.+|| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997643 45889999999999999999999 89999999999999999999999999999887653211
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------h
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------W 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~ 271 (314)
. .......+..|+|||.+ .+..++.++|+||||+++|+|++ |..||............ .
T Consensus 159 ~-~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 224 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAA-------------LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP 224 (261)
T ss_pred c-ccCCCcCceeccCcccc-------------ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1 11112234579999654 34567889999999999999999 99999875543321111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
....++..+.+++ +|.+||++.++.+.|+.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1223444455544 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=286.88 Aligned_cols=202 Identities=26% Similarity=0.352 Sum_probs=166.7
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----Ccee
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-----DFKA 114 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 114 (314)
+|++.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 689999999999999999995 479999999987532 23345678899999999999999999987533 3579
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|||+. ++|.+++...+. +++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 699998876554 899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 195 DGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 195 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
..... .......+|+.|+|||++.. ....++.++|||||||++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGS-----------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhc-----------cccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 22211 11223468999999987531 1245778999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.57 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=196.9
Q ss_pred hcCccccceeeecCceEEEEEEeCC----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSD----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|.++. ...|++|.++... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4679999999999999999999642 4579999987653 3344678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++......+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999876656899999999999999999999 89999999999999999999999999999987753
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~---- 270 (314)
...........++..|+|||.+ .+..++.++||||||+++|+|++ |..||............
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~-------------~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAI-------------AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225 (266)
T ss_pred cccceeccCCCCCccccChhhh-------------ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence 2222222223346789999765 34456789999999999999998 99999765443321111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
..+..+++.+.+++ +|..||++.++++.++++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223445555544 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=283.43 Aligned_cols=203 Identities=22% Similarity=0.365 Sum_probs=171.3
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||.|+||.||+|+.+ +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367999999999999999999954 788999999875532 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++ +|.+++...+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 9965 899888776666889999999999999999999 89999999999999999999999999999876533221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......+++.|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 160 --~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLL------------GSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred --ccccccccccccCCHHHh------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122345788999998753 23456789999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=289.04 Aligned_cols=193 Identities=26% Similarity=0.336 Sum_probs=163.8
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... ......+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 478999999998642 23445677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|...+...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~~~~~~~-l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (329)
T cd05618 81 GDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence 999988876544 899999999999999999999 89999999999999999999999999998875322211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||..
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 154 STFCGTPNYIAPEIL-------------RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHH-------------cCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 234689999999765 345677899999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.94 Aligned_cols=230 Identities=26% Similarity=0.288 Sum_probs=182.8
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... ......+..|.+++..+ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999995 468899999998652 23345567788888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+.+.+.+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05591 81 GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT 153 (321)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence 999998876654 889999999999999999999 99999999999999999999999999998875432221 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----hhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----VNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~~~~~ 277 (314)
....||+.|+|||++ .+..++.++|||||||++|+|++|..||............. .+..++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 220 (321)
T cd05591 154 TTFCGTPDYIAPEIL-------------QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLS 220 (321)
T ss_pred cccccCccccCHHHH-------------cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 234589999999765 34457889999999999999999999998755433221111 112233
Q ss_pred c----hhhhhc--cccCCC-------CHHHHHH
Q 047043 278 H----ALTDVV--DANLRV-------SMKDVAA 297 (314)
Q Consensus 278 ~----~l~~ll--dp~~Rp-------t~~~~~~ 297 (314)
. .+..++ ||.+|| ++.++++
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 3 444444 999999 7777775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.08 Aligned_cols=243 Identities=21% Similarity=0.341 Sum_probs=193.6
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..++|++.+.||+|+||.||+|.. .+++.|++|++..........+.+|+.+++.++|||++++++.+...+..+++||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 356899999999999999999995 5789999999986654555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++...+ .+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 87 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999887654 4799999999999999999999 89999999999999999999999999999886643211
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh---------h
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL---------K 269 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~---------~ 269 (314)
......++..|+|||.+.. .....++.++|+|||||++|+|++|..||.......... .
T Consensus 162 --~~~~~~~~~~y~~PE~~~~----------~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAV----------EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229 (267)
T ss_pred --ccCccccCccccCHhHccc----------ccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC
Confidence 1122357888999987531 123446778999999999999999999986543221110 0
Q ss_pred hh-hhccCCchhhhh----c--cccCCCCHHHHHHHH
Q 047043 270 NW-VNESLPHALTDV----V--DANLRVSMKDVAAKL 299 (314)
Q Consensus 270 ~~-~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l 299 (314)
.. ....++..+.++ + +|..||++.++++++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 011233444444 4 999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=277.33 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=198.9
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.+.|++++.||.|++|.||+|+. .+++.+++|.+..........+.+|+.+++.++|||++++++.+..++..+++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 46799999999999999999995 46899999999877666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|..++.+....+++..+..++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 9999999888765556899999999999999999999 99999999999999999999999999998765432211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------- 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-------- 271 (314)
......++..|+|||.+.. .......++.++|+|||||++|+|++|..||.............
T Consensus 166 -~~~~~~~~~~y~aPE~~~~--------~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMC--------ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred -ccceecCCccccCceeecc--------ccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 1223457888999988642 11123456789999999999999999999997654322111110
Q ss_pred hhccCCch----hhhhc--cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 272 VNESLPHA----LTDVV--DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 ~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.+..++.. +..++ ||..||++.++++ ++|+..+
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~~ 275 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE------HPFVSSV 275 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc------Ccccccc
Confidence 01122333 44444 9999999999976 5666543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.93 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=194.3
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..++|++.+.||.|+||.||+|.. .+++.|++|+++.........+.+|+.+++.++||||+++++.+...+..+++||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 456899999999999999999994 5799999999987655555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++...+. +++.++..++.|++.|+.||| ..|++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 87 FCGGGSLQDIYHVTGP-LSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred ccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999999876654 899999999999999999999 89999999999999999999999999999876643211
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh----hhhh-
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK----NWVN- 273 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~----~~~~- 273 (314)
......++..|+|||.+. ......++.++|+|||||++|+|++|..||........... ....
T Consensus 162 --~~~~~~~~~~y~aPE~~~----------~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAA----------VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229 (267)
T ss_pred --ccccccCcccccChhhhc----------cccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC
Confidence 122345889999998753 11244567899999999999999999999865432221110 0000
Q ss_pred -----ccCCc----hhhhhc--cccCCCCHHHHHHH
Q 047043 274 -----ESLPH----ALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 274 -----~~~~~----~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
..++. .+..++ +|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 12333 344444 99999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=273.10 Aligned_cols=236 Identities=29% Similarity=0.450 Sum_probs=187.3
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
+.||+|+||.||+|.. .+++.+++|.+..... .....+.+|+++++.++||||+++++++...+..+++|||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4689999999999995 4799999998875432 3446788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecc
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~ 205 (314)
.+++...+..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999876656899999999999999999999 899999999999999999999999999988754332111111112
Q ss_pred cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh------hhhhccCCc
Q 047043 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK------NWVNESLPH 278 (314)
Q Consensus 206 ~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~------~~~~~~~~~ 278 (314)
..+..|+|||.+ .+..++.++|+||||+++|+|++ |..||........... ...+..++.
T Consensus 157 ~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (252)
T cd05084 157 QIPVKWTAPEAL-------------NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPD 223 (252)
T ss_pred CCceeecCchhh-------------cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCH
Confidence 235679999765 34457788999999999999997 9999976544322111 112223344
Q ss_pred hhhhhc------cccCCCCHHHHHHHHH
Q 047043 279 ALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 279 ~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
.+.+++ +|.+||++.++++.++
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 444443 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.45 Aligned_cols=247 Identities=28% Similarity=0.335 Sum_probs=195.9
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.+.....++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+..+..++|+|++++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455678999999999999999999994 579999999997653 234466788999999999999999988764322
Q ss_pred --------ceeEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 112 --------FKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 112 --------~~~lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
.++++|||+++|+|.+++... ...+++..+..++.|++.||.||| +.|++||||||+||+++.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCC
Confidence 367999999999999998653 345889999999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.+||+|||++..+.............||+.|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-------------~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW-------------RRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHh-------------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999998776433222222345689999999765 345678899999999999999999999986
Q ss_pred cccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 261 MFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 261 ~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
....+..... ..+..+++.+.+++ ||.+||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 248 ENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 5433221111 12234455555544 99999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=273.81 Aligned_cols=244 Identities=25% Similarity=0.439 Sum_probs=196.8
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++++.||.|++|.||+|...+++.|++|.+.... .....+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 457899999999999999999997778889999887543 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++... +..++...+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998754 345788899999999999999999 89999999999999999999999999999987644321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------ 271 (314)
. ......++..|+|||.. ....++.++||||||+++|+|++ |..||.............
T Consensus 159 ~-~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 224 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAI-------------NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224 (261)
T ss_pred e-ccCCCccceecCCHHHh-------------ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1 11223356789999764 34456778999999999999998 999997654433211110
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
....++..+.+++ +|..||+++++.+.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1123444454444 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.79 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=201.0
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.+.+-|.+.+.||+|-|+.|-+|++. +|..||||++.+.... ....+.+|++.|+.++|||||++|++..++..+|+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 45678999999999999999999954 8999999999875422 33567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe-cCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL-DENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili-~~~~~ikl~Dfg~~~~~~ 194 (314)
|+|.-.+|+|.++|.+....+.|..+.++++||+.|+.|+| +.-++||||||+|+.+ ..-|.+||+|||++..+.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH----qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH----QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh----hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999999998777999999999999999999999 8889999999999865 688999999999998775
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--------
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-------- 266 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-------- 266 (314)
.+. .-...+|+..|.|||+++. ..+-.+++||||||||+|.|.+|+.||+..++.+.
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLG------------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK 235 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLG------------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK 235 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhc------------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc
Confidence 543 3445789999999988752 22335689999999999999999999998665443
Q ss_pred -hhhhhhhccCCchhhhhc--cccCCCCHHHHHH
Q 047043 267 -SLKNWVNESLPHALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 267 -~~~~~~~~~~~~~l~~ll--dp~~Rpt~~~~~~ 297 (314)
..+..+..+|.+.+..|+ ||++|-+.++|..
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 222233334444444444 9999999999886
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=273.03 Aligned_cols=240 Identities=26% Similarity=0.360 Sum_probs=191.2
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||.|+||.||++.++++..+++|.+..... ....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 357899999999999999999987888899998875432 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++......+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999999765555889999999999999999999 899999999999999999999999999988765332211
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------hh
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------VN 273 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~~ 273 (314)
......++..|+|||.+ .+..++.++|+||||+++|+|++ |..||......+...... .+
T Consensus 157 ~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVF-------------NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223 (256)
T ss_pred ccCCCCCchhhCChhhc-------------ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 11122345679999764 34457789999999999999999 899997654332211110 11
Q ss_pred ccCCchhhh----hc--cccCCCCHHHHHHHH
Q 047043 274 ESLPHALTD----VV--DANLRVSMKDVAAKL 299 (314)
Q Consensus 274 ~~~~~~l~~----ll--dp~~Rpt~~~~~~~l 299 (314)
...+..+.+ ++ +|..||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 222333334 34 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.88 Aligned_cols=226 Identities=27% Similarity=0.327 Sum_probs=177.1
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHH-HHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECE-VLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||+||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 479999999997642 122234444444 45778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++...+ .+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TT 153 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cc
Confidence 99999887655 4889999999999999999999 89999999999999999999999999998865422211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-----hhhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-----NWVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-----~~~~~~~~ 277 (314)
....||+.|+|||++ .+..++.++|||||||++|+|++|..||......+.... ....+.++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (323)
T cd05575 154 STFCGTPEYLAPEVL-------------RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNIS 220 (323)
T ss_pred ccccCChhhcChhhh-------------cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 234589999999765 345578899999999999999999999986543322111 11223344
Q ss_pred chhhh----hc--cccCCCCHH
Q 047043 278 HALTD----VV--DANLRVSMK 293 (314)
Q Consensus 278 ~~l~~----ll--dp~~Rpt~~ 293 (314)
..+.+ ++ ||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 44444 44 999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=282.23 Aligned_cols=208 Identities=23% Similarity=0.313 Sum_probs=175.0
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999954 78899999987532 223345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999875556899999999999999999999 9999999999999999999999999999987664432
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.. ......||+.|+|||.+... ......++.++||||||+++|+|++|..||....
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 TV-QSSVAVGTPDYISPEILQAM--------EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ce-eeccccCCcccCCHHHHhcc--------ccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 21 12234689999999876421 1112456789999999999999999999997644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=274.74 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=198.8
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
+-|++.+.||.|++|.||++.. .++..+++|.+..........+.+|+++++.++|||++++++.+..++..++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 3478899999999999999995 468889999987665556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|..++.+....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 999999988765556899999999999999999999 89999999999999999999999999998876533211
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------h
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--------V 272 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--------~ 272 (314)
......++..|+|||.+.. .......++.++|+|||||++|+|++|..||............. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMC--------ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ 230 (282)
T ss_pred ccccccccccccCHhhccc--------cCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCC
Confidence 1223457889999988642 11234567789999999999999999999998654332211110 1
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
+..++..+.+++ ||..||++.++++ ++|++..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~~ 268 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ------HPFVTVN 268 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc------CCCEecc
Confidence 223444555554 9999999998876 6666543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=287.39 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=195.5
Q ss_pred HhcCccccceeeecCceEEEEEEeC-C-----CCeEEEEEeeeccc-HHHHHHHHHHHHHHhCC-CCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-D-----GNNVAIKVFKLQLG-RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 111 (314)
..++|++.+.||.|+||.||+|... . +..||+|.++.... .....+.+|+.+++++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4678999999999999999999842 2 34699999975432 34467889999999995 999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcC----------------------------------------------------------
Q 047043 112 FKALVLELMPNGSLENWLYSHN---------------------------------------------------------- 133 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~---------------------------------------------------------- 133 (314)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe
Q 047043 134 -------------------------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL 176 (314)
Q Consensus 134 -------------------------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili 176 (314)
..+++..+..++.|++.||.||| ..+++|+||||+||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill 270 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEE
Confidence 13677788999999999999999 8999999999999999
Q ss_pred cCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CC
Q 047043 177 DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GK 255 (314)
Q Consensus 177 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~ 255 (314)
+.++.++|+|||++................++..|+|||.+ .+..++.++||||||+++|+|++ |.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-------------FDNLYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh-------------cCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999998866433222222234467789999765 34457789999999999999997 99
Q ss_pred CCCCccccchhhhhh-------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 256 KPTDEMFTGEISLKN-------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 256 ~Pf~~~~~~~~~~~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.||............ ..+..++..+.+++ ||..||++.++.+.++.+..
T Consensus 338 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 338 TPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 999875433221111 11233455555554 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=286.51 Aligned_cols=242 Identities=22% Similarity=0.283 Sum_probs=186.3
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... ......+.+|..++.++ +||+|+.+++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 478899999998653 23445677899998888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|..++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~~~~~~~-l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (327)
T cd05617 81 GDLMFHMQRQRK-LPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT 153 (327)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence 999998876554 899999999999999999999 89999999999999999999999999998875322211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc------hhhhhhh-----
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG------EISLKNW----- 271 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~------~~~~~~~----- 271 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||...... +......
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (327)
T cd05617 154 STFCGTPNYIAPEIL-------------RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220 (327)
T ss_pred ecccCCcccCCHHHH-------------CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC
Confidence 234689999999765 3456788999999999999999999999643211 1111111
Q ss_pred -hhccCCchh----hhhc--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 272 -VNESLPHAL----TDVV--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 -~~~~~~~~l----~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.+..++..+ ..++ ||.+|+++.+....-+...|+|+..
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 122233334 4444 9999998653333333445666554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=284.08 Aligned_cols=229 Identities=24% Similarity=0.334 Sum_probs=179.5
Q ss_pred ceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+.+ +|+.||+|.++... .........|.+++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999954 78999999998652 22334566777777755 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 g~L~~~i~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (316)
T cd05620 81 GDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RA 153 (316)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ce
Confidence 999999876544 889999999999999999999 89999999999999999999999999998864322111 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----hhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----VNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~~~~~ 277 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||............. .+..++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (316)
T cd05620 154 STFCGTPDYIAPEIL-------------QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWIT 220 (316)
T ss_pred eccCCCcCccCHHHH-------------cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 334689999999765 34567889999999999999999999998654332211110 111233
Q ss_pred c----hhhhhc--cccCCCCHH-HHH
Q 047043 278 H----ALTDVV--DANLRVSMK-DVA 296 (314)
Q Consensus 278 ~----~l~~ll--dp~~Rpt~~-~~~ 296 (314)
. .+..++ ||.+||++. +++
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3 344444 999999984 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=273.03 Aligned_cols=241 Identities=27% Similarity=0.401 Sum_probs=192.7
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||.|++|.||+|.++.+..+|+|.++.... ....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 357899999999999999999976667799998875432 2356889999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++......+++..++.++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 999999999876556899999999999999999999 89999999999999999999999999998876543321 1
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------hh
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------VN 273 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~~ 273 (314)
......++..|.|||.. .+..++.++||||||+++|+|++ |..||............. ..
T Consensus 157 ~~~~~~~~~~y~~pe~~-------------~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVL-------------LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223 (256)
T ss_pred ecCCCccChhhCCHHHH-------------hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC
Confidence 11122356679999765 34457789999999999999998 999998655433211111 11
Q ss_pred ccCCchhhhh----c--cccCCCCHHHHHHHHH
Q 047043 274 ESLPHALTDV----V--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 274 ~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~ 300 (314)
...+..+.++ + +|.+||++.++++.++
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2233344444 3 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.49 Aligned_cols=228 Identities=29% Similarity=0.331 Sum_probs=181.8
Q ss_pred cceeeecCceEEEEEEe----CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 47 CNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
++.||+|+||.||+++. .+|+.+|+|+++.... .....+..|++++++++||||+++++++.+.+..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999984 3588999999986532 23345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++.+... +++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 81 RGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999999876543 899999999999999999999 89999999999999999999999999999876533211
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhcc
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNES 275 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~ 275 (314)
......|++.|+|||.+. +..++.++|||||||++|+|++|..||............ ..+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~-------------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~ 220 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVN-------------RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF 220 (318)
T ss_pred ceecccCChhhcCHHHHc-------------CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 122346899999997653 345678999999999999999999999865433221111 11223
Q ss_pred CCchhhhhc------cccCCCCHHH
Q 047043 276 LPHALTDVV------DANLRVSMKD 294 (314)
Q Consensus 276 ~~~~l~~ll------dp~~Rpt~~~ 294 (314)
++..+.+++ ||..||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 444444444 9999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=282.87 Aligned_cols=230 Identities=26% Similarity=0.313 Sum_probs=183.3
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999998652 23345667788888877 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+.+.+.+. +++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~~~~~~~-l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (318)
T cd05570 81 GDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT 153 (318)
T ss_pred CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence 999998877654 899999999999999999999 99999999999999999999999999998865322211 11
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~ 277 (314)
....|++.|+|||.+ .+..++.++|+|||||++|+|++|..||............ ..+..++
T Consensus 154 ~~~~g~~~y~aPE~~-------------~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (318)
T cd05570 154 STFCGTPDYIAPEIL-------------SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLS 220 (318)
T ss_pred cceecCccccCHHHh-------------cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 224589999999765 3456788999999999999999999999865433221111 1122344
Q ss_pred chhhh----hc--cccCCCCH-----HHHHH
Q 047043 278 HALTD----VV--DANLRVSM-----KDVAA 297 (314)
Q Consensus 278 ~~l~~----ll--dp~~Rpt~-----~~~~~ 297 (314)
..+.+ ++ ||.+||++ .++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 44444 44 99999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=276.54 Aligned_cols=235 Identities=28% Similarity=0.373 Sum_probs=188.5
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.|++.+.||.|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++.+.+++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999995 4789999999875421 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888654 345899999999999999999999 8999999999999999999999999999987654322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--hhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--SLK------ 269 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--~~~------ 269 (314)
. .....|+..|+|||.+ .+..++.++||||+|+++|+|++|..||........ ...
T Consensus 157 ~---~~~~~~~~~y~aPE~~-------------~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVV-------------KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED 220 (285)
T ss_pred c---cccccCCCCccCcHHh-------------cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc
Confidence 1 1234588999999765 345577889999999999999999999986433211 000
Q ss_pred -hhhhccCCchhhhhc------cccCCC-----CHHHHHH
Q 047043 270 -NWVNESLPHALTDVV------DANLRV-----SMKDVAA 297 (314)
Q Consensus 270 -~~~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~ 297 (314)
...+..++..+.+++ ||..|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011223555555554 999999 7778766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=281.41 Aligned_cols=230 Identities=26% Similarity=0.354 Sum_probs=179.7
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... .........|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999998653 12234445566666654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 999999876654 899999999999999999999 8999999999999999999999999999987653322 122
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~ 277 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||............ ..+..++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (316)
T cd05592 154 STFCGTPDYIAPEIL-------------KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWIS 220 (316)
T ss_pred ccccCCccccCHHHH-------------cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 334689999999765 3445778999999999999999999999875443221111 1122234
Q ss_pred ch----hhhhc--cccCCCCHH-HHHH
Q 047043 278 HA----LTDVV--DANLRVSMK-DVAA 297 (314)
Q Consensus 278 ~~----l~~ll--dp~~Rpt~~-~~~~ 297 (314)
.. +..++ ||.+||+.. ++++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 33 44444 999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.48 Aligned_cols=230 Identities=24% Similarity=0.266 Sum_probs=182.9
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
+|++.+.||+|+||.||+|+.. +++.||+|+++... ......+..|..++..+ +|++++++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999954 68899999998653 22334556677777776 5899999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+.+...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999876654 889999999999999999999 8999999999999999999999999999987543221
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----h
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----V 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~ 272 (314)
. ......||+.|+|||++ .+..++.++|||||||++|+|++|..||............. .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 220 (323)
T cd05616 156 V--TTKTFCGTPDYIAPEII-------------AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 220 (323)
T ss_pred C--ccccCCCChhhcCHHHh-------------cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 1 12234689999999765 34567889999999999999999999998755433211111 1
Q ss_pred hccCCchhhh----hc--cccCCCCH
Q 047043 273 NESLPHALTD----VV--DANLRVSM 292 (314)
Q Consensus 273 ~~~~~~~l~~----ll--dp~~Rpt~ 292 (314)
+..++..+.+ ++ ||..|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2234444444 44 99999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=276.58 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=197.2
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|.+.+.||+|++|.||+++.. ++..+++|.++.........+.+|+++++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356889999999999999999842 34568899887665555567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC
Q 047043 115 LVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN 179 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~ 179 (314)
++|||+++++|.+++...+ ..+++..++.++.|++.|++||| .+|++|+||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccC
Confidence 9999999999999997542 23788899999999999999999 9999999999999999999
Q ss_pred CcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCC
Q 047043 180 MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPT 258 (314)
Q Consensus 180 ~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf 258 (314)
+.++|+|||++................++..|+|||.+ .+..++.++||||||+++|+|++ |..||
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-------------MYRKFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHh-------------ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999998765433222222234467889999764 34557789999999999999998 99998
Q ss_pred Cccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 259 DEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 259 ~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
......+..... .....++..+.+++ ||..||++.++++.++.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 227 FQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 765443321100 01123344454544 99999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=289.37 Aligned_cols=249 Identities=33% Similarity=0.467 Sum_probs=204.5
Q ss_pred HhcCccccceeeecCceEEEEEEeCC--C---CeEEEEEeeec---ccHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSD--G---NNVAIKVFKLQ---LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~--~---~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
..++-...+.||.|+||.||+|+.+. + ..||+|..+.+ ......++.+|++++++++||||+++||+.....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34555666999999999999999532 2 23899998853 2566788999999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.+++|||+|+||+|.+++++.+..++..+...++.+.+.||+||| +++++||||..+|+|++.++.+||+|||++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999999998777999999999999999999999 9999999999999999999999999999977
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~ 270 (314)
.-..... ......-+..|+|||.+ ..+.++.++|||||||++||+++ |..||.+....+.....
T Consensus 311 ~~~~~~~--~~~~~klPirWLAPEtl-------------~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 311 AGSQYVM--KKFLKKLPIRWLAPETL-------------NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred CCcceee--ccccccCcceecChhhh-------------ccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 5431111 11112357889999665 45588999999999999999999 89999998776554333
Q ss_pred -------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 271 -------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 271 -------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
..+...|..+..++ ||..||++.++.+.++.+.....
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 12334444444444 99999999999999999887654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=287.37 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=167.6
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC-----cee
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-----FKA 114 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (314)
+|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999995 579999999986532 233467889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|||+. ++|.+.+...+ .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 58888876554 4899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.... .......++..|+|||.+. ....++.++|||||||++|+|++|..||....
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILM------------GSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHc------------CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 3221 1222345788999998753 22346788999999999999999999997643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=278.31 Aligned_cols=238 Identities=34% Similarity=0.545 Sum_probs=187.1
Q ss_pred cccceeeecCceEEEEEEeC-----CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 45 NECNLLGTGSFGIVYKGILS-----DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 45 ~~~~~lg~G~~g~V~~a~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++.+.||.|.||.||+|.+. .+..|+||.++.... +....+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999954 256899999966433 346889999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+++|+||+++||+++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 99999999999887 556899999999999999999999 8999999999999999999999999999998773332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------ 270 (314)
.............|+|||.+. ...++.++||||||+++||+++ |..||......+.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~-------------~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~ 224 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLK-------------DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL 224 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHH-------------HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET
T ss_pred ccccccccccccccccccccc-------------cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 222333345677899998764 2337889999999999999999 78999877544421111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
..+..++..+.+++ ||.+||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12233455555555 999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=273.52 Aligned_cols=213 Identities=26% Similarity=0.360 Sum_probs=183.1
Q ss_pred cceehhhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEee--ecccHHHHHHHHHHHHHHhCCCCCcceeecc
Q 047043 30 RRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFK--LQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106 (314)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (314)
....+.+.......|..++.||.|++|.|..|. ..+|+.||||.+. .+.....++..+|+.+++.++|+||+.++++
T Consensus 10 ~~~~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di 89 (359)
T KOG0660|consen 10 DYEVFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI 89 (359)
T ss_pred EEEeeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence 345566777888889989999999999999999 4589999999887 4444566788899999999999999999998
Q ss_pred ccc-----CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc
Q 047043 107 CSN-----PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV 181 (314)
Q Consensus 107 ~~~-----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ 181 (314)
+.. -+.+|+|+|++ +.+|...++..+. +++..+..++.|++.||.|+| +.+++||||||+|++++.+..
T Consensus 90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCD 163 (359)
T ss_pred cccccccccceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCC
Confidence 754 46789999999 5588888877654 899999999999999999999 899999999999999999999
Q ss_pred EEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
+||+|||+|+...........+....|..|.|||+.. ....|+.+.||||.|||+.||++|+.-|.+
T Consensus 164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll------------~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLL------------NSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred EEeccccceeeccccCcccchhcceeeeeecCHHHHh------------ccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 9999999999886542222234567899999998875 567789999999999999999999998875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=272.13 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=194.7
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++.+.||.|++|.||+|.. ++++.|++|.++... .....+.+|+++++.++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 46789999999999999999995 468899999987553 3346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++... ...+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998764 344788999999999999999999 89999999999999999999999999999876643221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh------hh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK------NW 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~------~~ 271 (314)
. .......+..|+|||.+ .+..++.++||||||+++|+|++ |..||......+.... ..
T Consensus 160 ~-~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESL-------------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225 (263)
T ss_pred e-ccCCCCCccccCCHHHh-------------ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 1 11112345679999754 34557788999999999999998 9999976443322111 11
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
.+..++..+.+++ ||..||++.++++.++.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1233444455544 999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=275.58 Aligned_cols=200 Identities=28% Similarity=0.417 Sum_probs=163.0
Q ss_pred cCccccceeeecCceEEEEEEe-C-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhC---CCCCcceeecccc-----c
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-S-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNV---HHRNLLKIFSSCS-----N 109 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 109 (314)
.+|++.+.||+|+||.||+|+. . +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999995 3 467899999875432 1223455677777665 6999999999874 3
Q ss_pred CCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 110 PDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
....+++||+++ ++|.+++... ...+++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456889999996 5999988754 334789999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
++....... ......+|+.|+|||.+. +..++.++|||||||++|+|++|..||....
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~-------------~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLL-------------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHh-------------CCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 987654331 222345899999997753 3456789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=301.31 Aligned_cols=248 Identities=30% Similarity=0.451 Sum_probs=210.4
Q ss_pred hcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
..+-+..+.||.|+||+||+|+. ++.+.||||.++..... ...+|++|++++..++|||||+++|+|..++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45567788999999999999993 23568999999987655 678999999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 114 ALVLELMPNGSLENWLYSHN-------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~-------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
++|+||+..|+|.+|+.... ..++..+.+.++.|||.||.||- ++..|||||..+|+||.++-
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccce
Confidence 99999999999999998642 12788899999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~ 259 (314)
.|||+|||+++..-..+..+......-+.+|+|||.++ .++++.+|||||+||++||+++ |..||-
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------------y~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------------YGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------------cCcccchhhhhhhhhhhhhhhccccCccc
Confidence 99999999987653333333333456789999997764 6778999999999999999999 999999
Q ss_pred ccccchhhhh------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 260 EMFTGEISLK------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 260 ~~~~~~~~~~------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+..+.++-.. .-.++.+|..+.+++ .|.+||+++||-..|+.....
T Consensus 708 glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 708 GLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 9887765221 224567888888887 999999999999999876544
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.26 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=205.4
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.++.-.++|++++.||+|+||.|.+++. .+++-||+|++.+-. .....-|.+|-++|...+.+.|++++-.|++.+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4445578999999999999999999995 579999999997631 234467889999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
++|+||||++||+|..++.+.+ .+++.-+..++..|+.||.-|| +.|+|||||||+|||+|..|++||+|||.+-
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999999988 6999999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCC-CCCCcccceehhhHHHHHHhcCCCCCCccccc------
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSE-GIISAKCDVYSFGVLLMETFTGKKPTDEMFTG------ 264 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~-~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~------ 264 (314)
.+..++.. ......|||.|++||++. .+..+ +.|+..+|.||+||++|||+.|..||-...-.
T Consensus 224 km~~dG~V-~s~~aVGTPDYISPEvLq---------s~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI 293 (1317)
T KOG0612|consen 224 KMDADGTV-RSSVAVGTPDYISPEVLQ---------SQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI 293 (1317)
T ss_pred hcCCCCcE-EeccccCCCCccCHHHHH---------hhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence 88765543 345578999999999987 33344 78999999999999999999999999653211
Q ss_pred -----hhhhhhhhhccCCchhhhhc-----cccCCCC---HHHHHH
Q 047043 265 -----EISLKNWVNESLPHALTDVV-----DANLRVS---MKDVAA 297 (314)
Q Consensus 265 -----~~~~~~~~~~~~~~~l~~ll-----dp~~Rpt---~~~~~~ 297 (314)
...++ ....+|+..+++| +|..|-. +.|+..
T Consensus 294 m~hk~~l~FP--~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 294 MNHKESLSFP--DETDVSEEAKDLIEALLCDREVRLGRNGIEDIKN 337 (1317)
T ss_pred hchhhhcCCC--cccccCHHHHHHHHHHhcChhhhcccccHHHHHh
Confidence 12222 1133566556655 8888877 888776
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=270.82 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=194.7
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||.|+||.||+|+. .+++.|++|.++... ......+.+|+++++.++|||++++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6899999999999999999995 479999999876432 234456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 118 ELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 118 e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988853 2344788999999999999999999 9999999999999999999999999999887764
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--- 271 (314)
.... ......++..|+|||.+. +..++.++|+||||+++|+|++|..||.............
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~-------------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIH-------------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222 (267)
T ss_pred chhH--HHhcCCCCccccChhhhc-------------cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc
Confidence 3221 112235788899997653 3446778999999999999999999986543221111111
Q ss_pred ------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 272 ------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 272 ------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
....++..+.+++ +|..||++.++++.++.++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1123344455544 9999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.47 Aligned_cols=230 Identities=27% Similarity=0.345 Sum_probs=180.1
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+. .+++.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 468899999998652 22334556677777754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++..... +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (316)
T cd05619 81 GDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT 153 (316)
T ss_pred CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence 999999876543 789999999999999999999 89999999999999999999999999998875422211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~ 277 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||......+..... ..+..++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (316)
T cd05619 154 CTFCGTPDYIAPEIL-------------LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLT 220 (316)
T ss_pred eeecCCccccCHHHH-------------cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Confidence 234589999999765 3455788999999999999999999999865433221111 0112233
Q ss_pred chhhh----hc--cccCCCCHH-HHHH
Q 047043 278 HALTD----VV--DANLRVSMK-DVAA 297 (314)
Q Consensus 278 ~~l~~----ll--dp~~Rpt~~-~~~~ 297 (314)
..+++ ++ ||.+||++. ++..
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 33444 44 999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=271.52 Aligned_cols=239 Identities=29% Similarity=0.432 Sum_probs=192.0
Q ss_pred cCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecC
Q 047043 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
.+|++.+.||.|++|.||++.++++..+++|.+..... ....+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 56899999999999999999977777899999875422 23467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 122 ~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
+++|.+++......+++..+..++.|++.|++||| +.|++|+||||+||+++.++.++|+|||.+....+.... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 99999999876556899999999999999999999 899999999999999999999999999988765432211 1
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhhc
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVNE 274 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~ 274 (314)
.....++..|+|||.+ .+..++.++|+||||+++|+|++ |..||......+..... ..+.
T Consensus 158 ~~~~~~~~~y~~Pe~~-------------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05059 158 SQGTKFPVKWAPPEVF-------------DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224 (256)
T ss_pred cCCCCCCccccCHHHh-------------ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 1112234579999765 34557789999999999999998 89999765443321111 1122
Q ss_pred cCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 275 SLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 275 ~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
.++..+.+++ +|..|||+.++++.+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3455555554 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=288.83 Aligned_cols=193 Identities=23% Similarity=0.307 Sum_probs=164.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++++.||.|+||.||+|.. .+++.||+|.... ..+.+|+++++.++||||+++++++......++++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999994 5799999996432 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+. ++|..++..... +++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++.........
T Consensus 165 ~~-~~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKRN-IAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 95 689888876543 789999999999999999999 899999999999999999999999999998654322111
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||-
T Consensus 239 -~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 239 -KYYGWAGTIATNAPELL-------------ARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred -ccccccCccCCCChhhh-------------cCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 12234689999999765 34567889999999999999999998753
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=276.53 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=199.3
Q ss_pred HHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.+++.++|||++++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999743 24579999886543 233356778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 112 FKALVLELMPNGSLENWLYSHN---------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
..+++|||+++++|.+++...+ ...+...+..++.|++.||.||| ++|++|+||||+||+++.++.+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcE
Confidence 9999999999999999997532 22456778899999999999999 9999999999999999999999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~ 261 (314)
+|+|||++................++..|+|||.. .+..++.++|+|||||++|+|++ |..||...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~-------------~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-------------KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHh-------------ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999988765332221111222356779999664 34557889999999999999998 78899775
Q ss_pred ccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 262 FTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 262 ~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
...+..... ..+..++..+++++ ||..||++.++++.++...++++..+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 543321111 11223344455544 99999999999999999988887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=289.58 Aligned_cols=241 Identities=28% Similarity=0.417 Sum_probs=201.8
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++....++-||+|+.|.||+|+. .++.||||.++. .-..++.-|++|+||||+.|.|+|...-.+++||||
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 344445567799999999999996 456789986542 223478889999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
|+.|.|...++..+. ++......|..+||.||.||| .+.|+|||||.-||||+.+..|||+|||-+....+..
T Consensus 194 Ca~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-- 266 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-- 266 (904)
T ss_pred cccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--
Confidence 999999999987665 778888999999999999999 9999999999999999999999999999887765432
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-------hhhhhh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-------SLKNWV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-------~~~~~~ 272 (314)
.+....||..|+|||++ .+.+.+.|+|||||||++||||||..||.+.....+ .+...+
T Consensus 267 -TkMSFaGTVaWMAPEvI-------------rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 267 -TKMSFAGTVAWMAPEVI-------------RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV 332 (904)
T ss_pred -hhhhhhhhHhhhCHHHh-------------hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC
Confidence 33446799999999555 677888999999999999999999999987554332 444556
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
+..+|+.++-++ -|-.||+|++++.++++.-.+++.-
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~ 375 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST 375 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence 778888666555 8899999999999999988877653
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=272.23 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=190.7
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC----eEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN----NVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||.|+||.||+|.+. +++ .+++|.+..... .....+..|+..++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 368899999999999999999953 455 477777754322 334667788888999999999999998764 4567
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++||+++++|.+++......+++..+..++.|++.||+||| +.|++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 899999999999999876666899999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
............++..|+|||.+ ....++.++||||||+++|++++ |..||.............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~-------------~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESI-------------LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227 (279)
T ss_pred CCCcccccCCCCCcccccCHHHh-------------ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 33222222234467789999665 34557889999999999999998 999998754432211100
Q ss_pred ----hhccCCchhhh----hc--cccCCCCHHHHHHHHHhhhh
Q 047043 272 ----VNESLPHALTD----VV--DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ----~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..++..+.+ ++ ||..||++.|+++.+..+..
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11122333333 33 99999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=270.04 Aligned_cols=204 Identities=25% Similarity=0.390 Sum_probs=175.1
Q ss_pred hcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCC-cceeecccccCC-----
Q 047043 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRN-LLKIFSSCSNPD----- 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 111 (314)
...|+.++.||.|++|+||+|+ ..+|+.||+|.++.+..+ .-....+|+-+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5678889999999999999999 558999999999877442 2345678999999999999 999999998877
Q ss_pred -ceeEEEEecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 112 -FKALVLELMPNGSLENWLYSHN---YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 112 -~~~lv~e~~~~~sL~~~i~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
.+++|+||+. .+|..++.... ..++...+..++.||+.||+||| +++|+||||||.||+|+++|.+||+||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeecc
Confidence 8899999995 59999998765 34777899999999999999999 999999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
|++..+.-+... ......|..|.|||++. ....|+...||||+|||+.||+++...|.+..+
T Consensus 165 GlAra~~ip~~~--yt~evvTlWYRaPEvLl------------Gs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 165 GLARAFSIPMRT--YTPEVVTLWYRAPEVLL------------GSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred chHHHhcCCccc--ccccEEEeeccCHHHhc------------CCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 999866533332 33457899999998865 344688999999999999999999999876543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.74 Aligned_cols=239 Identities=26% Similarity=0.355 Sum_probs=191.5
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-----HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
++|++.+.||.|++|.||.|.. .+++.+++|.+..... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999994 5799999999875421 234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
++|++++++|.+.+...+. +++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999877654 789999999999999999999 99999999999999999999999999999876533
Q ss_pred CCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh----
Q 047043 196 GEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---- 270 (314)
...... .....++..|+|||.+. +..++.++||||||+++|+|++|..||............
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVIS-------------GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 223 (263)
T ss_pred cccccccccCCCcCccccCcceec-------------cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC
Confidence 211110 02234778899997753 344778999999999999999999999765433221111
Q ss_pred ---hhhccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 271 ---WVNESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ---~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
..+..++..+.++ + +|..|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1222344444444 4 89999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=271.76 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=195.3
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++.+.||.|++|.||+|.. .+++.+++|++..........+.+|+++++.++|||++++++.+.+.+.++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46899999999999999999995 46889999999877655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++......+++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999998876455899999999999999999999 89999999999999999999999999998876543211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------- 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-------- 271 (314)
......++..|+|||.+.. .....++.++|+||||+++|+|++|..||.............
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~----------~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAV----------ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcc----------cccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc
Confidence 1223457888999977531 112366789999999999999999999997654322111100
Q ss_pred ------hhccCCchhhhhc--cccCCCCHHHHHH
Q 047043 272 ------VNESLPHALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 272 ------~~~~~~~~l~~ll--dp~~Rpt~~~~~~ 297 (314)
.+..+.+.+..++ +|..|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112223444444 9999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=281.41 Aligned_cols=202 Identities=26% Similarity=0.359 Sum_probs=168.9
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccC--
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-- 110 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 110 (314)
..+...++|++.+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 4456678999999999999999999994 5788999999875432 2345677899999999999999999987543
Q ss_pred ----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 111 ----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 111 ----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcC
Confidence 4568999987 77998887643 3899999999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
||++....... ....+|+.|+|||.+. ....++.++|||||||++|+|++|..||...
T Consensus 162 fg~~~~~~~~~-----~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 162 FGLARQADDEM-----TGYVATRWYRAPEIML------------NWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred CccceecCCCc-----CCccccccccCchHhc------------CCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99988654321 2245889999998753 2245778999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=274.87 Aligned_cols=195 Identities=29% Similarity=0.453 Sum_probs=165.5
Q ss_pred CccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccC-----CceeEE
Q 047043 43 GFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-----DFKALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 116 (314)
.|+-.+.+|+|+||.||.|. ..+++.||||..-.+. +.-.+|+++|+.+.||||+++.-+|... -+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 57888999999999999999 5578999999876552 2234699999999999999998877532 145589
Q ss_pred EEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEeeeccee
Q 047043 117 LELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDFGISKL 192 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Dfg~~~~ 192 (314)
|||+| .+|.+.++. .+..++...+.-+.+||..||+||| ..||+||||||.|+|+|.+ |.+||||||+|..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99996 499999884 2455888889999999999999999 9999999999999999965 8999999999999
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+..++.. .....|..|+|||.+. ....|+.+.||||.||++.||+.|+.-|.+.
T Consensus 176 L~~~epn---iSYicSRyYRaPELif------------ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIF------------GATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHc------------CccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 8766544 3356889999998876 5678999999999999999999999999764
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=273.84 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=191.8
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++++.||+|++|.||++... +++.|++|.++... ......+.+|++++++++||||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999954 79999999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 120 MPNGSLENWLYSH--NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 120 ~~~~sL~~~i~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
+++++|..++... ...+++..+..++.|++.|+.|||+ +.|++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988764 2358999999999999999999993 3699999999999999999999999999887653321
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh--hhh-----
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS--LKN----- 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~--~~~----- 270 (314)
.....++..|+|||.+... .......++.++|+|||||++|+|++|..||......... ...
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~-------~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSG-------GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred ----cccCCCccCccCcchhcCC-------CCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 2224578889999876421 1113345678999999999999999999999754332211 111
Q ss_pred --hhhccCCchhhh----hc--cccCCCCHHHHHH
Q 047043 271 --WVNESLPHALTD----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 271 --~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~ 297 (314)
..+..++..+.+ ++ +|..||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112233444444 44 9999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=275.45 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=195.9
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN 109 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (314)
....++|++.+.||+|++|.||++... ....+++|.+.... ......+.+|+++++.+ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 345678999999999999999999853 23579999987643 33446688899999999 79999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 110 PDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
+...+++|||+++++|.+++... ...+++..+..++.|++.|++||| +.|++|+||||+||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Ni 163 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNV 163 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeE
Confidence 99999999999999999998642 245788999999999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT- 253 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~- 253 (314)
+++.++.++|+|||++..+.............++..|+|||.. .+..++.++|||||||++|+|++
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-------------FDRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh-------------ccCCcCcccceeehhhHHHHHhcC
Confidence 9999999999999998866443221112222345679999754 34557789999999999999997
Q ss_pred CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 254 GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
|..||......+..... ..+..++..+.+++ ||..|||+.++++.++.+.
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 231 GGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99998765433221111 11223344444444 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=276.61 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=171.5
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||.|+||.||+|+. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46799999999999999999995 4789999999875432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++ ++|.+++...+..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 996 5999988876666899999999999999999999 99999999999999999999999999998876533221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......+++.|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 160 --~~~~~~~~~~y~~PE~~~------------~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILL------------GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred --cccccceeecccCcHHHh------------CCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122235788999998753 23346778999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=284.26 Aligned_cols=235 Identities=26% Similarity=0.290 Sum_probs=179.3
Q ss_pred eeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhC---CCCCcceeecccccCCceeEEEEecCC
Q 047043 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNV---HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 50 lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
||+|+||.||+|+. .+++.||+|++..... ........|..++... .||+|+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999995 4799999999975421 2223344566666654 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~~~~~-~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 153 (330)
T cd05586 81 GELFWHLQKEGR-FSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT 153 (330)
T ss_pred ChHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence 999998876554 899999999999999999999 89999999999999999999999999999865422211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------hhhccC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------WVNESL 276 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~~~~~~ 276 (314)
....||..|+|||.+. ....++.++|||||||++|+|++|..||......+..... .....+
T Consensus 154 ~~~~gt~~y~aPE~~~------------~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 221 (330)
T cd05586 154 NTFCGTTEYLAPEVLL------------DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVL 221 (330)
T ss_pred cCccCCccccCHHHHc------------CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence 2346899999998753 2234678899999999999999999999765433221111 011123
Q ss_pred Cch----hhhhc--cccCCCC----HHHHHHHHHhhhhheeee
Q 047043 277 PHA----LTDVV--DANLRVS----MKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 277 ~~~----l~~ll--dp~~Rpt----~~~~~~~l~~~~~~~~~~ 309 (314)
++. ++.++ ||.+||+ +.++++ |+|+++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~------h~~~~~ 258 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE------HPFFAD 258 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc------CccccC
Confidence 443 44444 9999984 555544 666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=281.57 Aligned_cols=230 Identities=27% Similarity=0.302 Sum_probs=178.4
Q ss_pred ceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHH-HHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSEC-EVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+.+ +++.||+|++..... .....+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 688999999976421 1223333343 356778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++...+. +.+..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~ 153 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT 153 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence 999999877554 788899999999999999999 99999999999999999999999999999875432221 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-----hhhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-----NWVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-----~~~~~~~~ 277 (314)
....||+.|+|||++ .+..++.++|||||||++|+|++|..||......+.... ....+.++
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (325)
T cd05602 154 STFCGTPEYLAPEVL-------------HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 220 (325)
T ss_pred ccccCCccccCHHHH-------------cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCC
Confidence 234689999999765 345677899999999999999999999986543322111 11123445
Q ss_pred chhhhh----c--cccCCCCHHHHHH
Q 047043 278 HALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 278 ~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
..+.++ + ||.+||++.+.+.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 544444 4 9999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.01 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=203.2
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeec--ccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...|+++++||+||.++||++...+.+.+|+|.+... .......+.+|+..|.+|+ |.+|+++++|-..+..+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4579999999999999999999767677777765433 3456788999999999995 899999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||- ..+|..++.+.........+..++.||+.++.++| ..||||.||||.|+++- .|.+||+|||.|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 975 45999999987765665688999999999999999 99999999999999884 4699999999999887777
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhc---
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNE--- 274 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~--- 274 (314)
....+..-+||..|++||.+....... ......-+.++++||||||||+|+|+.|+.||....+....+..+..+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~--~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSR--ENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccc--cCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 777777788999999999987544331 112223357889999999999999999999999876555544444433
Q ss_pred -cCCc---------hhhhhc--cccCCCCHHHHHHH
Q 047043 275 -SLPH---------ALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 275 -~~~~---------~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
.+++ .++.|+ ||.+||+..+++++
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2222 344555 99999999999983
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=291.42 Aligned_cols=198 Identities=27% Similarity=0.407 Sum_probs=161.0
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc--------CC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN--------PD 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~ 111 (314)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+|+.+++.++||||+++++++.. ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999995 478999999886542 234569999999999999999887532 22
Q ss_pred ceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEee
Q 047043 112 FKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDF 187 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Df 187 (314)
.++++|||+++ +|.+++.. .+..+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 46789999975 78777653 3445899999999999999999999 89999999999999998665 6999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
|++..+..... .....+|+.|+|||++. ....++.++|||||||++|+|++|..||.+..
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELML------------GATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhc------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986643322 12245789999998753 23457889999999999999999999997643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=273.81 Aligned_cols=235 Identities=25% Similarity=0.319 Sum_probs=184.4
Q ss_pred eeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||+|+||+||++.. .+++.||+|.+..... .....+..|+++++.++|+||+++++++...+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999995 4789999999875432 2335667899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 126 ENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 126 ~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
.+.+.. ....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 988753 2345899999999999999999999 89999999999999999999999999999876543322 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch--hhhh-------hhhh
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--ISLK-------NWVN 273 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--~~~~-------~~~~ 273 (314)
....||+.|+|||.+ .+..++.++|+||||+++|+|++|..||....... .... ...+
T Consensus 155 ~~~~g~~~y~aPE~~-------------~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 221 (280)
T cd05608 155 KGYAGTPGFMAPELL-------------QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP 221 (280)
T ss_pred cccCCCcCccCHHHh-------------cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc
Confidence 234588999999765 34567789999999999999999999997643211 1100 0112
Q ss_pred ccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 274 ESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
..++..+.+++ ||.+|| ++.++++ |+|+..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~------h~~~~~ 262 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT------HPLFRD 262 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc------Chhhhc
Confidence 33455555544 999999 5666666 566544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=279.02 Aligned_cols=230 Identities=24% Similarity=0.270 Sum_probs=182.4
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (314)
+|+..+.||+|+||.||+|+. .+++.||+|+++... ......+..|.+++..+. |++++++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478889999999999999995 479999999998642 223355677888888875 577889999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999877654 899999999999999999999 8999999999999999999999999999887543221
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----h
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----V 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~ 272 (314)
. ......||+.|+|||++. +..++.++|+|||||++|+|++|..||............. .
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 220 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIA-------------YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220 (323)
T ss_pred c--cccCccCCccccCHHHHc-------------CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 1 122345899999997653 4457789999999999999999999998765432211111 1
Q ss_pred hccCCchhhh----hc--cccCCCCH
Q 047043 273 NESLPHALTD----VV--DANLRVSM 292 (314)
Q Consensus 273 ~~~~~~~l~~----ll--dp~~Rpt~ 292 (314)
+..++..+.+ ++ +|..|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 2234444444 44 89999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.90 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=192.5
Q ss_pred hcCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||+|+||.||+|.. .++..+++|.++... ......+.+|+++++.++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 36789999999999999999983 245789999987543 234467888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 115 LVLELMPNGSLENWLYSHN----------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
++|||+++++|.+++.... ..+++..+..++.|++.||.||| ++|++|+||||+||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcC
Confidence 9999999999999985321 23678889999999999999999 899999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCC
Q 047043 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~P 257 (314)
++.++|+|||++................++..|+|||.+ .+..++.++|+||||+++|+|++ |..|
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~il~el~~~g~~p 226 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-------------MYGKFSSDSDIWSFGVVLWEIFSFGLQP 226 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHh-------------ccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 999999999998766433222222333456789999764 34557889999999999999998 9999
Q ss_pred CCccccchhhhh------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 258 TDEMFTGEISLK------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 258 f~~~~~~~~~~~------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
|........... ...+..++..+.+++ ||..||++.++.+.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 227 YYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 976543221110 011233445555544 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=274.02 Aligned_cols=243 Identities=28% Similarity=0.397 Sum_probs=194.0
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..+|...+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.+++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999732 35678999887665556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 115 LVLELMPNGSLENWLYSHN--------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~--------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
++|||+++++|.+++...+ ..+++..+..++.|++.|++||| +.|++|+||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCC
Confidence 9999999999999987643 24788999999999999999999 99999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~ 259 (314)
.++|+|||++................+++.|+|||.+ .+..++.++|||||||++|+|++ |..||.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-------------LYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHh-------------ccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999998765432211112223356789999764 34557889999999999999998 999997
Q ss_pred ccccchhhhh------hhhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 260 EMFTGEISLK------NWVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 260 ~~~~~~~~~~------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
.....+.... ...+..++..+.+++ ||.+||++.++++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 227 QLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 6543322111 111234555555554 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=280.50 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=192.5
Q ss_pred HhcCccccceeeecCceEEEEEEe-C-----CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccccc-C
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-S-----DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN-P 110 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 110 (314)
..++|++.+.||.|+||.||+|.. . +++.||+|.++... ......+..|+.+++++ +|+||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 356899999999999999999973 2 34789999987543 23345677899999999 79999999998764 4
Q ss_pred CceeEEEEecCCCCHHHHHhhcC---------------------------------------------------------
Q 047043 111 DFKALVLELMPNGSLENWLYSHN--------------------------------------------------------- 133 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~--------------------------------------------------------- 133 (314)
...+++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 67889999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceee
Q 047043 134 ---YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210 (314)
Q Consensus 134 ---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 210 (314)
..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+.............++..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 14688889999999999999999 89999999999999999999999999999887643322222223345678
Q ss_pred eecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh-------hhhccCCchhhh
Q 047043 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN-------WVNESLPHALTD 282 (314)
Q Consensus 211 y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-------~~~~~~~~~l~~ 282 (314)
|+|||.+ .+..++.++|||||||++|+|++ |..||......+..... ..+..+++.+.+
T Consensus 241 y~aPE~~-------------~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 241 WMAPESI-------------FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred ccCcHHh-------------cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 9999764 34567889999999999999997 99999764332211111 111223333344
Q ss_pred h----c--cccCCCCHHHHHHHHHhhhhh
Q 047043 283 V----V--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 283 l----l--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+ + +|..||++.+++++|+.+.+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3 3 999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=271.05 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=193.9
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCC----eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGN----NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||.|+||.||+|.+ .+++ .||+|+++... ......+.+|..+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 46799999999999999999984 3555 48999987543 23456788899999999999999999998764 467
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++|++++|+|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..+.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 899999999999999876556899999999999999999999 8999999999999999999999999999988765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
............++..|+|||.. .+..++.++|||||||++|+|++ |..||+............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESI-------------LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227 (279)
T ss_pred cccceeecCCCccchhhCCHHHh-------------ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 43222111222346779999764 34457889999999999999998 999997654432211110
Q ss_pred ----hhccCCchhhh----hc--cccCCCCHHHHHHHHHhhhhhe
Q 047043 272 ----VNESLPHALTD----VV--DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 272 ----~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.+..++..+.+ ++ ||..||++.++++.+..+....
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11223333334 34 9999999999999988876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=286.01 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=207.0
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
+.-.+.|.+.+.||+|.|+.|.+|++ .++..||||++++... ...+.+.+|+++|+.++||||++++++.+.+..+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34567899999999999999999994 5899999999987642 33456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+.+|.+.+++.+.+. ..+..+...+.|+++|++|+| +++++|||||++|++++.+.++||+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999999887 556899999999999999999 9999999999999999999999999999999886
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--------
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-------- 266 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-------- 266 (314)
... .-...+|++.|.|||++. ...+.++.+|+||+|+++|.|+.|..||++..-.+.
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~------------g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFN------------GKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK 271 (596)
T ss_pred ccc---cccccCCCCCccChHhhc------------CcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee
Confidence 443 334578999999998865 223557789999999999999999999997543332
Q ss_pred -hhhhhhhccCCchhhhhc--cccCCCCHHHHHHH
Q 047043 267 -SLKNWVNESLPHALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 267 -~~~~~~~~~~~~~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
+.......+|...++++| +|..|++.+++.+.
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 344445667778888885 99999999999874
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.74 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=196.1
Q ss_pred hcCccccceeeecCceEEEEEEeCC----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSD----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|.+.+.||.|++|.||+|...+ ...|++|.+.... ....+.+.+|+.+++.++|||++++++++.+. ..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 4578999999999999999998532 3478999987664 34556788999999999999999999998764 5679
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++.+....+++..+..++.|++.|+.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999999876656899999999999999999999 89999999999999999999999999999876644
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~---- 270 (314)
.... ......++..|+|||.+ ....++.++||||||+++|++++ |..||......+.....
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESI-------------NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred ccce-ecCCCCccccccChhhh-------------ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 3211 11122345679999654 34456789999999999999986 99999876544322111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..++..+.+++ +|..|||+.++++.++.++.+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12234455555544 999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=271.46 Aligned_cols=239 Identities=24% Similarity=0.314 Sum_probs=186.5
Q ss_pred eeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||+|+||.||+++. .+|+.+|+|.+..... ........|.++++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999995 4799999999865321 1223455699999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeec
Q 047043 126 ENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204 (314)
Q Consensus 126 ~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~ 204 (314)
.+++...+ ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 98886543 34788899999999999999999 9999999999999999999999999999987764332 1223
Q ss_pred ccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch---hhhhhh-------hhc
Q 047043 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE---ISLKNW-------VNE 274 (314)
Q Consensus 205 ~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~---~~~~~~-------~~~ 274 (314)
..++..|+|||.+. +..++.++|||||||++|+|++|..||....... ...... ...
T Consensus 154 ~~~~~~y~aPE~~~-------------~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (277)
T cd05607 154 RAGTNGYMAPEILK-------------EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ 220 (277)
T ss_pred cCCCCCccCHHHHc-------------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc
Confidence 45889999997653 3447889999999999999999999997532211 100111 112
Q ss_pred cCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 275 ~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.+++.+++++ ||.+||+++|.++.. +.|+|++..
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~--~~h~~f~~~ 260 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP--RKHEFFKTI 260 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhh--hcChhhcCC
Confidence 3455555554 999999998776433 357777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.81 Aligned_cols=242 Identities=26% Similarity=0.445 Sum_probs=192.5
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++.+.||+|++|.||+|...++..+++|.++.... ....+.+|+.+++.++|++++++++++.. +..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4568999999999999999999977788899999876533 23568899999999999999999998854 567899999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++... ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998764 344789999999999999999999 89999999999999999999999999999877644321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------ 271 (314)
. ......++..|+|||.+ .+..++.++|+||||+++|+|++ |..||......+......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAA-------------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223 (260)
T ss_pred c-cccCCCCCccccChHHH-------------hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1 11122355679999764 34557789999999999999999 899997754433211111
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
.+...+..+.+++ +|.+|||+.++.+.+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223344444444 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.73 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=190.5
Q ss_pred hcCccccceeeecCceEEEEEEeCC---------------CCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSD---------------GNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIF 104 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~---------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (314)
.++|++.+.||+|+||.||+++... ...||+|.++.... .....+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987431 22589999876532 3345788999999999999999999
Q ss_pred cccccCCceeEEEEecCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCc
Q 047043 105 SSCSNPDFKALVLELMPNGSLENWLYSHN-----------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSN 173 (314)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~N 173 (314)
+++...+..+++|||+++++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhh
Confidence 99999999999999999999999986532 13678889999999999999999 8999999999999
Q ss_pred eEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 174 ILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 174 ili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
|+++.++.++|+|||++................++..|+|||.. .+..++.++|+||||+++|+|++
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-------------LLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh-------------ccCCcCchhhHHHHHHHHHHHHH
Confidence 99999999999999998765433222122223457789999664 34557889999999999999987
Q ss_pred --CCCCCCccccchhhhh-------------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 254 --GKKPTDEMFTGEISLK-------------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 254 --g~~Pf~~~~~~~~~~~-------------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
+..||........... ...++.+++.+.+++ ||.+||++.++++.|++
T Consensus 227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 227 LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred cCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 7788876543321110 001223445555544 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=273.11 Aligned_cols=244 Identities=24% Similarity=0.405 Sum_probs=190.5
Q ss_pred HhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|++|.||.|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999742 25679999886542 2344568889999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEE
Q 047043 113 KALVLELMPNGSLENWLYSHN---------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ik 183 (314)
.+++|||+++++|.+++.+.. ..++...+..++.|++.|+.||| +.|++|+||||+||+++.++.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999987532 12467788999999999999999 89999999999999999999999
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMF 262 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~ 262 (314)
|+|||++................++..|+|||.+ .+..++.++||||||+++|+|++ |..||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-------------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHh-------------hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999988755332221111123457789999765 34557889999999999999998 789997654
Q ss_pred cchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 263 TGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 263 ~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
........ ..+..++..+.+++ ||..||++.|+++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 227 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 43221110 11223444444444 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=268.37 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=194.5
Q ss_pred HHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...++|++.+.||+|+||.||+|..++++.|++|.+..... ....+.+|+.+++.++|+|++++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34678999999999999999999987889999999876543 2357889999999999999999999874 456899999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
++++++|.+++... +..+++.++..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999998753 345788999999999999999999 8999999999999999999999999999987764322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------ 270 (314)
.. ......++..|+|||.+ ....++.++||||||+++|++++ |..||......+.....
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~-------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAI-------------NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM 222 (260)
T ss_pred cc-cccCCcccccccCHHHh-------------ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC
Confidence 11 11223356789999654 34557789999999999999998 99999866543321111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
..+..++..+.+++ +|..||++.++++.++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 11223344444444 999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.39 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=196.8
Q ss_pred HHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...++|++.+.||.|++|.||+|..++++.+++|.+..... ....+.+|+.+++.++|+|++++++++.+....+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 35678999999999999999999977778899999886532 23678899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
++++++|.+++.... ..+++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999997643 45889999999999999999999 8999999999999999999999999999987764322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------ 270 (314)
.. .......+..|+|||.+ .+..++.++|+||||+++|++++ |..||............
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAA-------------NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM 223 (261)
T ss_pred hh-hhhccCCCccccCHHHh-------------ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 11 11122345679999654 34557789999999999999998 99999765543221111
Q ss_pred hhhccCCchhhhh----c--cccCCCCHHHHHHHHHhh
Q 047043 271 WVNESLPHALTDV----V--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 ~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~ 302 (314)
..+...+..+.++ + +|..||++.++.+.++.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 1122334444444 3 999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=292.37 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=214.0
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.+-|+++..||-|+||+||+|..+ ++-.-|.|++.....+...++.-|++||..+.||+|+++++.+...+.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 456899999999999999999955 5667789999888888889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
|.||-....+-.-+..+++.++..++.|+++||.||| ++.|+|||||.-|||++.+|.++|+|||.+..... ..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 9999999998888888999999999999999999999 99999999999999999999999999998765422 22
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh-------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV------- 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~------- 272 (314)
......+|||.|+|||+.++ +.....+|+.++||||||+++.+|..+.+|-.......+-+....
T Consensus 185 qkRDsFIGTPYWMAPEVvmC--------ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMC--------ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred hhhccccCCcccccchheee--------ccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 23456789999999999998 677889999999999999999999999999877655443322211
Q ss_pred -----hccCCchhhhhc--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 273 -----NESLPHALTDVV--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 273 -----~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
...+++.|+.++ ||..||++.++++ |+|+.+
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~------Hpfv~~ 294 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK------HPFVQN 294 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh------Cccccc
Confidence 124555666666 9999999999988 666654
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=269.23 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=194.1
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC---eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN---NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|..+ ++. .|++|.++... ......+..|+.+++.++||||+++++++.++...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 456899999999999999999954 343 69999987653 3445778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++......+++.++..++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999876666899999999999999999999 89999999999999999999999999998876543
Q ss_pred CCCcceeecc---cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh-
Q 047043 196 GEDSVTQTMT---MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 196 ~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~- 270 (314)
.......... ..+..|+|||.+ ....++.++||||||+++|++++ |..||............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~-------------~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAI-------------AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred CccccccccccCCCcceeecCHhHh-------------ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 2221111111 124579999764 34557789999999999999886 99999765443221110
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
..+..++..+.+++ +|.+||++.+++..++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223444555544 999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.84 Aligned_cols=237 Identities=28% Similarity=0.406 Sum_probs=192.6
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++.+.+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588889999999999999995 478999999987542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++... +..+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999765 455889999999999999999999 89999999999999999999999999999887654322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------h
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------V 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------~ 272 (314)
......+++.|+|||.. .+..++.++|+||||+++++|++|..||............. .
T Consensus 157 --~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08529 157 --FANTIVGTPYYLSPELC-------------EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221 (256)
T ss_pred --hhhccccCccccCHHHh-------------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 12233578889999765 34456789999999999999999999998765433211111 1
Q ss_pred hccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 273 NESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ~~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
...++..+.++ + +|..||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11334444444 3 99999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.43 Aligned_cols=243 Identities=24% Similarity=0.359 Sum_probs=195.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|++|.||+|.. .+++.+++|.+.... ......+.+|+.+++.++|||++++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 6799999999999999999994 589999999886532 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 118 ELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 118 e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||+++++|.+++.. ....+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998864 2345789999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh----
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---- 270 (314)
..... .....++..|+|||.. .+..++.++|+||||+++|+|++|..||............
T Consensus 158 ~~~~~--~~~~~~~~~~~ape~~-------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T cd08229 158 SKTTA--AHSLVGTPYYMSPERI-------------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222 (267)
T ss_pred cCCcc--cccccCCcCccCHHHh-------------cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc
Confidence 33211 1224578889999765 3445677899999999999999999999754332111111
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.....++..+++++ ||..|||+.++++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11122444455544 9999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=265.96 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=195.3
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||.|++|.||+|... +++.|++|.++... ......+.+|+++++.++|++++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999965 89999999887432 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 118 ELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 118 e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||+++++|.+++... +..+++..+..++.+++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988642 344789999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh----
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---- 270 (314)
..... .....++..|.|||.+ .+..++.++|+||||+++|+|++|..||............
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERI-------------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222 (267)
T ss_pred CCCcc--cceecCCccccCHHHh-------------ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc
Confidence 32211 1223578889999764 3445778999999999999999999998653321111100
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.....++..+.+++ +|..||++.++++.++.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11113444444444 9999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.31 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=193.6
Q ss_pred CccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999842 124688888875532 345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCC
Q 047043 116 VLELMPNGSLENWLYSHN-----------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~ 172 (314)
++||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhh
Confidence 999999999999986421 23678889999999999999999 899999999999
Q ss_pred ceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 173 Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
||++++++.++|+|||++................++..|+|||.. .+..++.++||||||+++|+|+
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-------------~~~~~~~~~Di~slG~~l~el~ 223 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-------------FDHIYTTQSDVWSFGVLLWEIV 223 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-------------ccCCcchHhHHHHHHHHHHHHH
Confidence 999999999999999998765433222122223456789999764 3445778999999999999999
Q ss_pred c-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 253 T-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 253 ~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+ |..||............ ..+..++..+.+++ +|.+||++.++++.++++.++
T Consensus 224 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 224 TLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 8 99999865443321110 11223444444444 999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=270.21 Aligned_cols=245 Identities=29% Similarity=0.429 Sum_probs=191.0
Q ss_pred cCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc--cCCcee
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS--NPDFKA 114 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 114 (314)
.+|++++.||+|+||.||++.. .++..|++|.++.........+.+|+++++.++|||++++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4789999999999999999974 257899999988766566678899999999999999999999764 345788
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++||+++++|.+++......+++..+..++.|++.||+||| ..|++|+||||+||+++.++.++|+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999876556899999999999999999999 8999999999999999999999999999988764
Q ss_pred CCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch--------
Q 047043 195 DGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE-------- 265 (314)
Q Consensus 195 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~-------- 265 (314)
....... .....++..|+|||.. .+..++.++|+||||+++|+|++|..|+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESL-------------TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHh-------------ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence 3322111 1112234569999764 34457789999999999999999877654321100
Q ss_pred ---h---hhhhh--------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 266 ---I---SLKNW--------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 266 ---~---~~~~~--------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
. ..... ....++..+.+++ +|..|||+.++++.++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0 00000 1123444455554 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.82 Aligned_cols=236 Identities=33% Similarity=0.504 Sum_probs=191.7
Q ss_pred ceeeecCceEEEEEEeC-C---CCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS-D---GNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||.|+||.||+|... . +..+++|.++..... ....+.+|++.++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46899999999999954 3 889999999876543 367888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 123 GSLENWLYSH--------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 123 ~sL~~~i~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|.+++... ...+++..++.++.|++.||++|| ++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999876 456899999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
............++..|+|||.+. ...++.++||||||+++|+|++ |..||............
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 223 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLK-------------DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223 (262)
T ss_pred cccccccccCCCcCccccCHHHhc-------------cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 433222223345788899997653 3367889999999999999999 69999876443221111
Q ss_pred ---hhhccCCchhhhh----c--cccCCCCHHHHHHHHH
Q 047043 271 ---WVNESLPHALTDV----V--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 271 ---~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~ 300 (314)
..+..++..+.++ + +|..||++.++++.++
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122334444444 4 9999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=267.54 Aligned_cols=242 Identities=29% Similarity=0.451 Sum_probs=192.7
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||.|++|.||+|.+.+...|++|.++.... ....+.+|+++++.++||||+++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 467999999999999999999976666799999886432 23568889999999999999999998754 5578999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++++|.+++.+. +..+++..+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999764 344788999999999999999999 899999999999999999999999999998766443221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------V 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~ 272 (314)
......++..|+|||.. .+..++.++|+||||+++|+|++ |..||............. .
T Consensus 159 -~~~~~~~~~~y~~PE~~-------------~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAA-------------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224 (262)
T ss_pred -cccCCcccceecCHhHh-------------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC
Confidence 11223466789999654 34557889999999999999999 888998765433211110 1
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
...++..+.+++ ||..||++.++.+.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 223444444444 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=272.36 Aligned_cols=235 Identities=31% Similarity=0.478 Sum_probs=188.6
Q ss_pred ccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHH--HHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAF--RSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
|++.+.||+|+||.||+++.. +++.+|+|++........ ....+|+.++++++||||+++++++.+.+..+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999954 577899999988753322 23356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++...+. +++..+..++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNKP-LSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NE 153 (260)
T ss_dssp TTEBHHHHHHHHSS-BBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TS
T ss_pred cccccccccccccc-ccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc--cc
Confidence 99999999984443 899999999999999999999 899999999999999999999999999998764221 11
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc--chhhhhhh----h--
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT--GEISLKNW----V-- 272 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~--~~~~~~~~----~-- 272 (314)
......++..|.|||... .+..++.++|+||||+++|+|++|..||..... ........ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQ------------QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS 221 (260)
T ss_dssp EBSSSSSSGGGSCHHHHT------------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH
T ss_pred cccccccccccccccccc------------ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc
Confidence 233456888999997753 366778899999999999999999999987621 11111100 0
Q ss_pred --------hccCCchhhhhc--cccCCCCHHHHHH
Q 047043 273 --------NESLPHALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 273 --------~~~~~~~l~~ll--dp~~Rpt~~~~~~ 297 (314)
...+.+.+..++ ||.+||++.++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 022233444444 9999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.23 Aligned_cols=199 Identities=25% Similarity=0.314 Sum_probs=165.8
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC----
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD---- 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 111 (314)
...++|++.+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4578999999999999999999995 479999999986542 234466778999999999999999999886543
Q ss_pred --ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 112 --FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 112 --~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
..+++|||+++ +|.+.+.. .+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 56899999965 67766643 2788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+....... ......+|+.|+|||.+ .+..++.++|||||||++|+|++|..||...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~-------------~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVI-------------LGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhc-------------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 87543221 12234578999999765 3456778999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=278.98 Aligned_cols=228 Identities=27% Similarity=0.326 Sum_probs=177.5
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHH-HHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECE-VLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||.|+||.||+|+. .+|+.+|+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 479999999997652 122234444544 46678999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|...+.+.+ .+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT 153 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence 99998887654 4899999999999999999999 89999999999999999999999999998865322211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----hhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----VNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~~~~~ 277 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||......+...... ..+..+
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (325)
T cd05604 154 TTFCGTPEYLAPEVI-------------RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGAS 220 (325)
T ss_pred ccccCChhhCCHHHH-------------cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCC
Confidence 234589999999765 34557789999999999999999999998654332211111 122233
Q ss_pred c----hhhhhc--cccCCCCHHHH
Q 047043 278 H----ALTDVV--DANLRVSMKDV 295 (314)
Q Consensus 278 ~----~l~~ll--dp~~Rpt~~~~ 295 (314)
. .+++++ +|.+||++++.
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCC
Confidence 3 455555 89999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=269.61 Aligned_cols=242 Identities=28% Similarity=0.369 Sum_probs=196.3
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++.+.||.|++|.||+|.. .+++.+++|.+.... ......+.+|+++++.++|+|++++++.+.++...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4799999999999999999995 478999999997654 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999998765 4899999999999999999999 89999999999999999999999999999887754321
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------hh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------VN 273 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------~~ 273 (314)
......++..|+|||.+. +..++.++||||||+++|+|++|..||............. ..
T Consensus 154 -~~~~~~~~~~y~~PE~~~-------------~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIK-------------QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE 219 (274)
T ss_pred -ccccccCCccccChhhhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc
Confidence 122345788899997653 3447889999999999999999999997654322211100 11
Q ss_pred cc-CCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 274 ES-LPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 274 ~~-~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.. ++..+.+++ +|.+|||++++++ ++|+...
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~------~~~~~~~ 257 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK------HKFIKKA 257 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh------ChhhcCC
Confidence 11 444444444 9999999999988 5665543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=272.66 Aligned_cols=198 Identities=23% Similarity=0.377 Sum_probs=167.1
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||.|++|.||+|.. .+|+.+++|.++.... .....+.+|+++++.++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999995 4799999999876432 1224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++ ++|.+++...+..+++..+..++.|++.||.||| ..|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 96 5898888765556899999999999999999999 899999999999999999999999999998765432221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
.....++..|+|||.+. ....++.++|||||||++|+|++|..||.
T Consensus 156 --~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 156 --YSAEVVTLWYRPPDVLF------------GAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred --cCCCccccCCcChHHHh------------CCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 12235688899998753 23346778999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=269.58 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=172.6
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||.|++|.||+|.. .+|+.|++|.+.... ......+.+|+.+++.++|||++++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999995 478999999998654 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+ +++|.+++......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 99999999776666899999999999999999999 89999999999999999999999999999887654322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.......++..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 RLYSHQVATRWYRAPELLY------------GARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CccccccCcccccCceeee------------ccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 1122345888999998753 2344677999999999999999998888654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.16 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=194.6
Q ss_pred hcCccccceeeecCceEEEEEEeC--------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS--------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP 110 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (314)
.++|.+.+.||+|+||.||+|+.. +...+|+|.++... ......+.+|+.+++.+ +|||++++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 468999999999999999999842 23469999998653 33456788899999999 799999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceE
Q 047043 111 DFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNIL 175 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nil 175 (314)
+..+++|||+++++|.+++.... ..++..++..++.|++.||.||| ++|++|+||||+||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil 172 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL 172 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheE
Confidence 99999999999999999997642 23778889999999999999999 899999999999999
Q ss_pred ecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-C
Q 047043 176 LDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-G 254 (314)
Q Consensus 176 i~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g 254 (314)
++.++.++|+|||.+................++..|+|||.+ .+..++.++|+||||+++|+|++ |
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-------------FDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh-------------ccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999998765432211111112245679999764 34557789999999999999998 8
Q ss_pred CCCCCccccchhhhh------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 255 KKPTDEMFTGEISLK------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 255 ~~Pf~~~~~~~~~~~------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..||......+.... ...+..++..+.+++ +|..||++.++++.++.+...
T Consensus 240 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 240 GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 899876443322111 011223444555544 899999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=269.38 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=189.2
Q ss_pred cCc-cccceeeecCceEEEEEEe-----CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeeccccc--CCc
Q 047043 42 EGF-NECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDF 112 (314)
Q Consensus 42 ~~y-~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 112 (314)
++| ++.+.||.|+||+||++.. .++..||+|.++.... .....+.+|+++++.++|||++++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8999999999999988652 3577899999986533 344677889999999999999999998754 346
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|||+++++|.+++.... +++..+..++.|++.|+.||| ++|++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 789999999999999987643 899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-----
Q 047043 193 LGDGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI----- 266 (314)
Q Consensus 193 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~----- 266 (314)
......... .....++..|+|||... ...++.++||||||+++|+|++|..||........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~-------------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 223 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLK-------------ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP 223 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhc-------------ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc
Confidence 643322111 12233566799997652 34567899999999999999999999864321100
Q ss_pred --------hhhh--------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 267 --------SLKN--------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 267 --------~~~~--------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.... ..+..++..+.+++ +|..||+++++++.++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 224 KQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 01223445555554 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=271.45 Aligned_cols=200 Identities=25% Similarity=0.398 Sum_probs=168.3
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||.|++|.||+|.. .+++.|++|.++.... .....+.+|+.+++.++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999995 4799999999875432 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 120 MPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 120 ~~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
++ ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58988886532 45899999999999999999999 9999999999999999999999999999987654332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
. ......+++.|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLL------------GSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred c--cccCCcccccccChHHhc------------CCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 122335688899998653 2234677899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=270.45 Aligned_cols=235 Identities=26% Similarity=0.362 Sum_probs=188.2
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++|++++++++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478889999999999999995 579999999987542 1223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++...+ ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999886543 34889999999999999999999 8999999999999999999999999999887654322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-----h----h
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-----S----L 268 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-----~----~ 268 (314)
. .....|+..|+|||.+ .+..++.++|+||||+++|+|++|..||........ . .
T Consensus 157 ~---~~~~~g~~~y~aPE~~-------------~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVV-------------KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 220 (285)
T ss_pred c---ccCCCCCccccChHHH-------------cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh
Confidence 1 1234689999999765 345577899999999999999999999986432110 0 1
Q ss_pred hhhhhccCCchhhhhc------cccCCCC-----HHHHHH
Q 047043 269 KNWVNESLPHALTDVV------DANLRVS-----MKDVAA 297 (314)
Q Consensus 269 ~~~~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~ 297 (314)
.......++..+.+++ ||..||| +.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112233555555544 9999999 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=265.45 Aligned_cols=238 Identities=30% Similarity=0.474 Sum_probs=194.8
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||.|++|.||+|.. .|+.|++|.++.... ....+.+|+.+++.++|+|++++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 56899999999999999999996 478899999987644 4577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++++|.+++.... ..+++..+..++.|++.|+.||| ..|++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999997654 25899999999999999999999 99999999999999999999999999999876632211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh------hhh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK------NWV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~------~~~ 272 (314)
....+..|.|||.+ ....++.++|+||||+++|++++ |..||......+.... ...
T Consensus 158 ----~~~~~~~~~ape~~-------------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEAL-------------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA 220 (256)
T ss_pred ----cCCCcccccCchhh-------------cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 22345679999654 34456778999999999999997 9999976544332111 111
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
+..+++.+.+++ +|..||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 223445455544 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=265.86 Aligned_cols=242 Identities=29% Similarity=0.438 Sum_probs=187.7
Q ss_pred ccccceeeecCceEEEEEEeC-C---CCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC------
Q 047043 44 FNECNLLGTGSFGIVYKGILS-D---GNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD------ 111 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~---~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 111 (314)
|.+.+.||+|+||.||.|... + +..||+|.++... ......+.+|++.++.++|||++++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999853 2 3679999987653 234567889999999999999999999876544
Q ss_pred ceeEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 112 FKALVLELMPNGSLENWLYSH-----NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
..++++||+++++|..++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECC
Confidence 378999999999999988543 235789999999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccch
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE 265 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~ 265 (314)
||++.................+..|+|||.. .+..++.++|||||||++|+|++ |..||......+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-------------~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-------------ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhc-------------ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9998866433222111222346679999654 34557789999999999999999 899997654433
Q ss_pred hhhhhh------hhccCCchhhh----hc--cccCCCCHHHHHHHHHhh
Q 047043 266 ISLKNW------VNESLPHALTD----VV--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 266 ~~~~~~------~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~ 302 (314)
...... .+..++..+.+ ++ ||.+||++.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 211110 12233444444 44 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=271.77 Aligned_cols=249 Identities=28% Similarity=0.437 Sum_probs=195.2
Q ss_pred cCccccceeeecCceEEEEEEeC-CCC--eEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGN--NVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 116 (314)
++|++.+.||.|+||.||+|..+ ++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 68999999999999999999854 443 47888877432 33446788899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc
Q 047043 117 LELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV 181 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ 181 (314)
+||+++++|.+++.+.. ..+++..+..++.|++.|++||| +.|++|+||||+||+++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCe
Confidence 99999999999997532 24788899999999999999999 899999999999999999999
Q ss_pred EEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCc
Q 047043 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDE 260 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~ 260 (314)
++|+|||++...... ........+..|+|||.. ....++.++|||||||++|+|++ |..||..
T Consensus 158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESL-------------NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred EEECCcCCCccccce---eccCCCCcCccccCchhh-------------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999987543211 011112234569999654 34557789999999999999997 9999977
Q ss_pred cccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 261 MFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 261 ~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.......... ..+..++..+.+++ +|..||++.++++.++.+...+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 222 MTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 5543321111 11223555555554 99999999999999999888765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=268.27 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccC------C
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP------D 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~ 111 (314)
..++|++.+.||.|++|.||+|.. .+++.+++|++..... ....+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 458999999999999999999995 4688999999886643 346788999999999 699999999998654 4
Q ss_pred ceeEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 112 FKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
..+++|||+++++|.+++... +..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999988653 355899999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
++........ ......++..|+|||.+..+ ......++.++||||||+++|+|++|..||..........
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 228 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACD--------EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhccc--------ccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH
Confidence 8876543221 12234588899999876421 1224557789999999999999999999997643322211
Q ss_pred hhhh--------hccCCchhhhh----c--cccCCCCHHHHHH
Q 047043 269 KNWV--------NESLPHALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 269 ~~~~--------~~~~~~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
.... ...+++.++++ + ||..|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 11133344444 4 9999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.87 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=193.5
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (314)
.|.+.....++|++++.||.|+||.||+|... ++..+++|++.... ......+..|+.+++.++||||++++++|.+
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 45666778899999999999999999999954 68899999987542 2345678899999999999999999998854
Q ss_pred --CCceeEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC---CCCCeeecCCCCCceEecC---
Q 047043 110 --PDFKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGH---SSAPIVHCDLKPSNILLDE--- 178 (314)
Q Consensus 110 --~~~~~lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~---~~~~i~H~dlkp~Nili~~--- 178 (314)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.. ...+|+|+||||+|||++.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45789999999999999998753 245899999999999999999999311 0145999999999999964
Q ss_pred --------------CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehh
Q 047043 179 --------------NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244 (314)
Q Consensus 179 --------------~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~sl 244 (314)
.+.++|+|||++..+..... .....+|+.|+|||++.. ....++.++|||||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~g-----------e~~~~s~KSDVWSL 229 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLH-----------ETKSYDDKSDMWAL 229 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhc-----------cCCCCCchhHHHHH
Confidence 23489999999876543221 223468999999987641 23457789999999
Q ss_pred hHHHHHHhcCCCCCCccccchhhhhhh------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 245 GVLLMETFTGKKPTDEMFTGEISLKNW------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 245 G~il~~ll~g~~Pf~~~~~~~~~~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
||++|+|++|..||............. ....++..+.++| +|..||++.+++.
T Consensus 230 G~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 230 GCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999999999997644322211111 1122334444444 9999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.41 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=194.2
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
......+|++++.||.|++|.||++.. .+++.|++|.+..........+.+|+.+++.++|||++++++.+..++..++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 345568999999999999999999995 5799999999986654455678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++.+. .+++..+..++.|++.+|.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 94 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred eecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999998654 3788899999999999999999 89999999999999999999999999998876543
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN----- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~----- 270 (314)
... ......+++.|+|||.. .+..++.++|+||||+++|++++|..||............
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~ 232 (297)
T cd06656 168 EQS--KRSTMVGTPYWMAPEVV-------------TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (297)
T ss_pred Ccc--CcCcccCCccccCHHHH-------------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC
Confidence 221 12234578899999765 3455678999999999999999999999764332111000
Q ss_pred ---hhhccCCchhhh----hc--cccCCCCHHHHHH
Q 047043 271 ---WVNESLPHALTD----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 271 ---~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~ 297 (314)
..+..++..+++ ++ +|..||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012234444444 44 8999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=269.39 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=190.9
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccC------C
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP------D 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~ 111 (314)
..+.|++.+.||.|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++.+ +|+|++++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 467899999999999999999994 478999999987653 2335678899999988 699999999988642 4
Q ss_pred ceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 112 FKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
..+++|||+++++|.+++... ...+++..+..++.|++.|++||| +++++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 678999999999999998864 345889999999999999999999 899999999999999999999999999998
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
........ ......++..|+|||.+... ......++.++|+|||||++|+|++|..||............
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~--------~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACD--------ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccc--------cCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 76533211 12234588899999876421 112445788999999999999999999999764432221111
Q ss_pred -------hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 -------WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 -------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.....++..+.+++ +|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11123444444444 9999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=272.14 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=194.6
Q ss_pred HHhcCccccceeeecCceEEEEEEe-C-----CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-S-----DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (314)
...++|++.+.||+|+||.||++.. . ++..+|+|.++... ......+.+|+.+++++ +||||+++++.+...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3446799999999999999999973 1 34579999887543 33446788999999999 799999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
+..+++|||+++++|.+++.... ..+++.++..++.|++.||.||| +++++|+||||+||+++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999997643 34799999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISL 268 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~ 268 (314)
+................++..|+|||.+ ....++.++||||||+++|+|++ |..||......+...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~ 254 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESI-------------FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhh-------------ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH
Confidence 8766443222122223457789999754 34557789999999999999998 999997654332211
Q ss_pred hhh-------hhccCCch----hhhhc--cccCCCCHHHHHHHHHhh
Q 047043 269 KNW-------VNESLPHA----LTDVV--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 269 ~~~-------~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~l~~~ 302 (314)
... .+...+.. +..++ +|..||++.++++.+.++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111 11123333 44444 899999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=270.47 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=192.7
Q ss_pred hcCccccceeeecCceEEEEEEeCC-----------------CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSD-----------------GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 102 (314)
.++|++.+.||+|+||.||+|.... +..|++|.+.... ......+.+|+++++.++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999988432 2458999987654 234567889999999999999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCC
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHN----------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~ 172 (314)
+++++..+...+++||++++++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchh
Confidence 9999999999999999999999999987654 24789999999999999999999 899999999999
Q ss_pred ceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 173 Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
||+++.++.++|+|||++................++..|+|||.+. +..++.++||||||+++|+|+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~~l~el~ 226 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-------------LGKFTTKSDVWAFGVTLWEIL 226 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-------------cCCCCccchhhhhHHHHHHHH
Confidence 9999999999999999987654332222223344677899997653 345788999999999999998
Q ss_pred c--CCCCCCccccchhhhh--h-----------hhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 253 T--GKKPTDEMFTGEISLK--N-----------WVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 253 ~--g~~Pf~~~~~~~~~~~--~-----------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
+ |..||........-.. . ..+..++..+.+++ ||.+|||+.++++.|+
T Consensus 227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 227 TLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 8 7788876543322000 0 01122344555554 9999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=265.15 Aligned_cols=237 Identities=22% Similarity=0.289 Sum_probs=191.4
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
+|++.+.||.|++|.||++... +++.+++|.++... ......+.+|+.+++.++|+|++++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999954 78999999987542 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++++|.+++... +..+++..+..++.|++.||.+|| ++|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988653 445789999999999999999999 99999999999999999999999999999876643322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------hhh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------WVN 273 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~~~ 273 (314)
......+++.|+|||.. .+..++.++|+||||+++|+|++|..||............ ..+
T Consensus 156 -~~~~~~~~~~~~aPE~~-------------~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (255)
T cd08219 156 -YACTYVGTPYYVPPEIW-------------ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP 221 (255)
T ss_pred -ccccccCCccccCHHHH-------------ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 12234578889999765 3445778899999999999999999999865432221111 112
Q ss_pred ccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 274 ESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 274 ~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
..++..+.++ + ||..||++.+++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2334444444 4 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=270.58 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=195.9
Q ss_pred eehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeeccc--
Q 047043 32 TSYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSC-- 107 (314)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-- 107 (314)
.+++.+....++|++.+.||+|++|.||+|.. .+++.+++|+++.... ....+.+|+.+++.+ +|||++++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45666777889999999999999999999995 4688999998875422 235677899999998 699999999987
Q ss_pred ---ccCCceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc
Q 047043 108 ---SNPDFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV 181 (314)
Q Consensus 108 ---~~~~~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ 181 (314)
.+++..+++|||+++++|.+++.. .+..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCC
Confidence 345678999999999999998753 2345788999999999999999999 899999999999999999999
Q ss_pred EEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
++|+|||++........ ......++..|+|||.+.. +......++.++|||||||++|+|++|..||...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--------~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIAC--------EQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEEccCCceeecccCCC--ccccccCCCcccChhhhch--------hhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999876543211 1223458899999988642 1122455788999999999999999999998765
Q ss_pred ccchhhhh--h-----h-hhccCCchhhhh----c--cccCCCCHHHHHHHH
Q 047043 262 FTGEISLK--N-----W-VNESLPHALTDV----V--DANLRVSMKDVAAKL 299 (314)
Q Consensus 262 ~~~~~~~~--~-----~-~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l 299 (314)
........ . . .+..++..+.++ + ||..||++.+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 233 HPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred chhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 43221110 0 0 111223334444 4 999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=265.69 Aligned_cols=245 Identities=22% Similarity=0.411 Sum_probs=202.3
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
...++|++.+.||+|.|+.|+++.+ .+|+.+++|++.... ....+.+.+|+++-+.|+||||+++.+.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 4567899999999999999999984 579999999987553 3356889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---CCCcEEEEeeeccee
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISKL 192 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~---~~~~ikl~Dfg~~~~ 192 (314)
|+|++.|++|-.-|-.. ..++|..+...+.||+++|.|+| .+||+|||+||+|+++. ....+||+|||++..
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999998666554 33789999999999999999999 99999999999999995 344689999999999
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh------
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI------ 266 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~------ 266 (314)
+.+.. .-....|||.|+|||++ ...+|+..+|||+.|+++|-|+.|..||.+.....+
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvv-------------rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~ 226 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVL-------------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA 226 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHh-------------hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 87433 23346799999999665 577889999999999999999999999988544332
Q ss_pred ---hhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 267 ---SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 267 ---~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
......++.+++..++++ ||.+|.|+.|.+. |+|+.+.
T Consensus 227 g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~------HpWi~~r 273 (355)
T KOG0033|consen 227 GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK------HPWICNR 273 (355)
T ss_pred cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC------Cchhcch
Confidence 222223456666666655 9999999988776 7777654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=268.80 Aligned_cols=230 Identities=23% Similarity=0.318 Sum_probs=185.2
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|++++++++|||++++++.+...+..+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4789999999999999999994 578999999987653 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|..+. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999986542 2688899999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-----hhh-h---
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-----SLK-N--- 270 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-----~~~-~--- 270 (314)
.....++..|+|||.+. +..++.++|+||||+++|+|++|..||........ ... .
T Consensus 150 --~~~~~~~~~y~aPE~~~-------------~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 214 (279)
T cd06619 150 --AKTYVGTNAYMAPERIS-------------GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214 (279)
T ss_pred --ccCCCCChhhcCceeec-------------CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc
Confidence 22346888999997653 44577899999999999999999999975432111 000 0
Q ss_pred -----hhhccCCchhhhh----c--cccCCCCHHHHHH
Q 047043 271 -----WVNESLPHALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 271 -----~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
......+..+.++ + +|..||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011233334444 4 9999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.09 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=190.5
Q ss_pred hcCccccceeeecCceEEEEEEeC-----------------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-----------------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-----------------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 102 (314)
.++|++.+.||.|+||.||++++. ++..+|+|.++... ......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998632 23468999987653 234467889999999999999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCC
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHN----------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~ 172 (314)
+++++.+.+..+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.|++|+||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATR 159 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChh
Confidence 9999999999999999999999999987642 23567789999999999999999 899999999999
Q ss_pred ceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 173 Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
||+++.++.++|+|||++..+.............++..|+|||.. ....++.++|+|||||++|+|+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-------------~~~~~~~~~DiwSlG~~l~el~ 226 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-------------LLGKFTTASDVWAFGVTLWEIL 226 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-------------hcCCccchhhhhHHHHHHHHHH
Confidence 999999999999999998765432221112223346779999654 3445788999999999999999
Q ss_pred c--CCCCCCccccchhhhh--h-----------hhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 253 T--GKKPTDEMFTGEISLK--N-----------WVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 253 ~--g~~Pf~~~~~~~~~~~--~-----------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
+ |..||......+.... . ..+..++..+.+++ ||.+||++.++.+.|++
T Consensus 227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 227 TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 8 7789876543322110 0 01223445555554 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.13 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=192.9
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
..+|++.+.||.|+||.||+|... +++.||+|.++.... .....+.+|..++..++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 346889999999999999999842 257899999986543 2346688899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 114 ALVLELMPNGSLENWLYSH---------------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
++++||+++++|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFD 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecC
Confidence 9999999999999998532 123678889999999999999999 899999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCC
Q 047043 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~P 257 (314)
++.+||+|||++................+++.|+|||.+ .+..++.++||||||+++|+|++ |..|
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~~l~el~~~g~~p 226 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-------------MYGKFSIDSDIWSYGVVLWEVFSYGLQP 226 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHH-------------hcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 999999999998766433222222233457789999765 34456788999999999999998 8889
Q ss_pred CCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 258 TDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 258 f~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
|......+..... ..+..+++.+.+++ +|..||++.++++.|+.
T Consensus 227 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 227 YCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8775443321111 11234555555554 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=264.81 Aligned_cols=237 Identities=32% Similarity=0.464 Sum_probs=189.7
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccc-ccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC-SNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 119 (314)
.++|++.+.||+|++|.||++.. .+..+++|.++... ..+.+.+|+.+++.++|++++++++++ ..++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46899999999999999999986 47889999987543 345788999999999999999999875 456678999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++...+ ..+++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 99999999987654 34788999999999999999999 99999999999999999999999999998876543221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhh------hhh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISL------KNW 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~------~~~ 271 (314)
....+..|+|||.. ....++.++|||||||++|+|++ |..||.......... ...
T Consensus 158 -----~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05082 158 -----TGKLPVKWTAPEAL-------------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 219 (256)
T ss_pred -----CCccceeecCHHHH-------------ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 12345679999765 34457789999999999999997 999987644322211 011
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
....++..+.+++ +|..|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1233445555554 999999999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=272.57 Aligned_cols=237 Identities=23% Similarity=0.349 Sum_probs=192.7
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...+|++.+.||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|||++++++.+...+..++++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345699999999999999999994 5799999999876654455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|..++... .+++.++..++.|++.|+++|| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999988654 3789999999999999999999 89999999999999999999999999998876543221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------- 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------- 271 (314)
......++..|+|||.+ .+..++.++|+|||||++|+|++|..||.............
T Consensus 171 --~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVV-------------TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (296)
T ss_pred --cCCCcCCCccccCcchh-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc
Confidence 11223578899999764 34456778999999999999999999998754422211110
Q ss_pred -hhccCCchhhhh----c--cccCCCCHHHHHH
Q 047043 272 -VNESLPHALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 272 -~~~~~~~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
.+..++..+.++ + ||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122344444444 4 9999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=266.07 Aligned_cols=237 Identities=24% Similarity=0.388 Sum_probs=189.7
Q ss_pred CccccceeeecCceEEEEEEeCCCCeEEEEEeeecc------cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
+|.+.+.||.|+||.||+|...+++.+|+|.++... .+....+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 588999999999999999997789999999987542 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
+||+++++|.+++.+.+. +++..+..++.|++.|++||| +.|++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999977554 789999999999999999999 899999999999999999999999999988765321
Q ss_pred CC----cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh---
Q 047043 197 ED----SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK--- 269 (314)
Q Consensus 197 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~--- 269 (314)
.. ........++..|+|||.+ .+..++.++|+||||+++|+|++|..||...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~-------------~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 222 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVI-------------NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA 222 (265)
T ss_pred cccccccccccccCCCccccChhhh-------------cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh
Confidence 11 1111123478889999664 344567889999999999999999999976543221111
Q ss_pred -----hhhhccCCchhhh----hc--cccCCCCHHHHHH
Q 047043 270 -----NWVNESLPHALTD----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 270 -----~~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~ 297 (314)
...+..++..+.+ ++ +|..||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0122234444444 44 9999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=268.04 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=196.3
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC----eEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN----NVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||+|+||.||+|.++ +|. .+++|.++.... .....+.+|+.+++.++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 468999999999999999999953 443 589998876543 344678899999999999999999999887 7888
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|||+++++|.+++......+++..+..++.|++.|++||| ++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999999876666899999999999999999999 8999999999999999999999999999988765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhhh-
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNWV- 272 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~~- 272 (314)
............++..|+|||.+ ....++.++|+||||+++|++++ |..||......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESI-------------LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred CcccceecCCCcccccccCHHHh-------------hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 33322222222245679999654 34556789999999999999998 9999987654432211111
Q ss_pred -----hccCCchh----hhhc--cccCCCCHHHHHHHHHhhhhhe
Q 047043 273 -----NESLPHAL----TDVV--DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 273 -----~~~~~~~l----~~ll--dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
+..++..+ .+++ ||..||++.++++.++.+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 11223333 3333 9999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=266.55 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=194.1
Q ss_pred hcCccccceeeecCceEEEEEEeC-CC---CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DG---NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|.+. ++ ..+++|.++... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 467999999999999999999853 33 378999887543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++......+++.++..++.|++.|+.+|| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999876666899999999999999999999 99999999999999999999999999999876644
Q ss_pred CCCccee-ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 196 GEDSVTQ-TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 196 ~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
....... ....++..|+|||.+ .+..++.++|+||||+++|++++ |..||......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~-------------~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAI-------------AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225 (267)
T ss_pred ccceeeecCCCccceeecCHhHh-------------ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence 3221111 112235679999665 34557889999999999999886 99999765433211110
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
.....++..+.+++ +|..||++.++++.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11122344444444 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=269.31 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=190.0
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
.++|.+.+.||+|++|.||+|.+. ++..|++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999953 456889998875432 2335688899999999999999999999998899
Q ss_pred eEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEEE
Q 047043 114 ALVLELMPNGSLENWLYSHN------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VARV 184 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ikl 184 (314)
+++|||+++++|.+++...+ ..+++..+..++.|++.|++||| +++++|+||||+||+++.++ .++|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999997653 24788999999999999999999 89999999999999998654 5899
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcccc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFT 263 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~ 263 (314)
+|||++.................+..|+|||.+ .+..++.++|||||||++|+|++ |..||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF-------------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHH-------------hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999998766332211111122335679999765 34557889999999999999997 9999987554
Q ss_pred chhhhhh------hhhccCCchhhhh----c--cccCCCCHHHHHHHHH
Q 047043 264 GEISLKN------WVNESLPHALTDV----V--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 264 ~~~~~~~------~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~ 300 (314)
....... ..+..++..+.++ + +|..||++.+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 228 QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3321111 1122344444444 3 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=273.08 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=169.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++.+.||+|+||.||++.+ .++..+++|.++.... .....+.+|++++++++||||+++++++.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4799999999999999999995 4788999999876532 3445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++.+.+. +++..+..++.|++.||.|||+ .++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh---hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 999999999987644 8899999999999999999993 2689999999999999999999999999876543221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.....++..|+|||.. .+..++.++|+||||+++|+|++|..||..
T Consensus 155 --~~~~~~~~~~~aPE~~-------------~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 --ANSFVGTRSYMSPERL-------------QGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred --cccCCCCcCccChhHh-------------cCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1234578899999764 344567889999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=273.24 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=194.1
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
......+|++.+.||+|++|.||+|.. .+++.+++|.+..........+.+|+.+++.+.|||++++++.+..+...++
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 344567999999999999999999994 5789999999987655555778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++... .+++.++..++.|++.||+||| ..|++|+||||+||+++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999999998653 3788999999999999999999 89999999999999999999999999998776533
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
... ......+++.|+|||.+ .+..++.++|||||||++|+|++|..||.............
T Consensus 169 ~~~--~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (296)
T cd06654 169 EQS--KRSTMVGTPYWMAPEVV-------------TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (296)
T ss_pred ccc--ccCcccCCccccCHHHH-------------cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC
Confidence 221 11224578899999764 34456789999999999999999999997654322111110
Q ss_pred ----hhccCCchhhhh----c--cccCCCCHHHHHH
Q 047043 272 ----VNESLPHALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 272 ----~~~~~~~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
.+..++..+.++ + ||..||++.+++.
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 122344444444 4 9999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=265.48 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=193.7
Q ss_pred HHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...++|++.+.||+|+||.||++....+..+++|.+.... .....+.+|+++++.++|+|++++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3467899999999999999999997677789999887542 234678889999999999999999999887 77899999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++.+. +..++...+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999764 344788889999999999999999 8999999999999999999999999999987664322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------ 270 (314)
.. ......++..|+|||.+ ....++.++|+||||+++|++++ |..||............
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAI-------------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 222 (260)
T ss_pred cc-cccCCcccccccCHhHh-------------ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Confidence 11 12223356779999765 34557789999999999999998 99999875443221110
Q ss_pred hhhccCCchhhh----hc--cccCCCCHHHHHHHHHhh
Q 047043 271 WVNESLPHALTD----VV--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 ~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~ 302 (314)
......+..+.+ ++ +|..||++.++.+.|+.+
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111233344444 44 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=279.29 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=194.6
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCC-CCCcceeecccc
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVH-HRNLLKIFSSCS 108 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 108 (314)
.....++|.+.+.||+|+||.||+|++. .+..||+|+++... ......+.+|++++..+. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3445668999999999999999999842 34589999997653 233457889999999997 999999999999
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHN------------------------------------------------------- 133 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~------------------------------------------------------- 133 (314)
..+..++||||+++|+|.+++.+.+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986532
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCC
Q 047043 134 ------------------------------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKP 171 (314)
Q Consensus 134 ------------------------------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp 171 (314)
..++...+..++.|++.||.||| +.|++|+||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp 267 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAA 267 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCc
Confidence 12566678889999999999999 89999999999
Q ss_pred CceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 172 SNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 172 ~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
+||+++.++.++|+|||++................++..|+|||.+ .+..++.++||||||+++|+|
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwslGvil~e~ 334 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-------------FNNLYTTLSDVWSFGILLWEI 334 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh-------------cCCCCCcHhHHHHHHHHHHHH
Confidence 9999999999999999998765332221122223467889999765 344567889999999999999
Q ss_pred hc-CCCCCCccccchhhhhhh-------hhccCCchhhhh----c--cccCCCCHHHHHHHHHhhh
Q 047043 252 FT-GKKPTDEMFTGEISLKNW-------VNESLPHALTDV----V--DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 252 l~-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~ 303 (314)
++ |..||......+...... .+..++..+.++ + +|..||++++++..|+.+.
T Consensus 335 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 335 FTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 98 889997654333211111 122334444444 4 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=267.75 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=192.5
Q ss_pred HhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||.|+||.||+|..+ ++..|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4578999999999999999999853 23689999987553 2344568889999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEE
Q 047043 113 KALVLELMPNGSLENWLYSHN---------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ik 183 (314)
.+++|||+++++|.+++.... ..+++..+..++.|++.|+.||| +.|++|+||||+||+++.++.++
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEE
Confidence 999999999999999986532 23577889999999999999999 99999999999999999999999
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMF 262 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~ 262 (314)
|+|||++................++..|+|||.+ ....++.++||||||+++|++++ |..||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-------------KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHH-------------hcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999998765433221122233467889999765 34457789999999999999998 999997654
Q ss_pred cchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 263 TGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 263 ~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
........ ..+..++..+.+++ +|..|||+.++++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 33221111 11233444444544 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=270.64 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=195.9
Q ss_pred HHhcCccccceeeecCceEEEEEEeC--------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccc
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS--------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCS 108 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|++. ++..+++|.++... ......+.+|+.+++.+ +||||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44678999999999999999999731 24479999987543 34456788999999999 8999999999999
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCc
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSN 173 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~N 173 (314)
.....+++|||+++++|.+++.+.. ..++...+..++.|++.||.||| ++|++|+||||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~N 167 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARN 167 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccce
Confidence 9999999999999999999997642 23677788999999999999999 8999999999999
Q ss_pred eEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 174 ILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 174 ili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
|+++.++.++|+|||.+................++..|+|||.+ .+..++.++||||||+++|+|++
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-------------FDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-------------ccCCCCchhhHHHHHHHHHHHHc
Confidence 99999999999999998876443222222223456789999764 34557889999999999999998
Q ss_pred -CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 254 -GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 254 -g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
|..||......+..... ..+..++..+.+++ +|..||++.++++.|+++..
T Consensus 235 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 235 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 88898765443321111 11223444555544 89999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=262.22 Aligned_cols=236 Identities=31% Similarity=0.501 Sum_probs=188.4
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHH
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLE 126 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 126 (314)
+.||.|++|.||++....++.|++|.++..... ....+.+|++++++++|+||+++++++.+.+..+++|||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999655999999998765433 4567889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeeccc
Q 047043 127 NWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206 (314)
Q Consensus 127 ~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~ 206 (314)
+++......+++..+..++.+++.++.+|| +++++|+||+|+||+++.++.++|+|||.+................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999776556889999999999999999999 8999999999999999999999999999887654222111111223
Q ss_pred ceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------hhccCCch
Q 047043 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------VNESLPHA 279 (314)
Q Consensus 207 ~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~~~~~~~~ 279 (314)
.+..|+|||.+ .+..++.++|+||||+++|+|++ |..||............. .+..++..
T Consensus 157 ~~~~y~~PE~~-------------~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (251)
T cd05041 157 IPIKWTAPEAL-------------NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEE 223 (251)
T ss_pred ceeccCChHhh-------------ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 46679999764 34457889999999999999998 889987654332211111 12233444
Q ss_pred hhhhc------cccCCCCHHHHHHHHH
Q 047043 280 LTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 280 l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
+.+++ +|..||++.++++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 44443 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=269.10 Aligned_cols=203 Identities=24% Similarity=0.317 Sum_probs=170.1
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||.|++|.||+|..+ +++.|++|.+..... ...+.+.+|+.+++.++|||++++++++..++..+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999954 699999999875432 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|..++.... .+++..+..++.|++.+|+||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999877777665443 4899999999999999999999 89999999999999999999999999999887654321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
......++..|+|||.+. ....++.++|+||||+++|+|++|..||.....
T Consensus 156 --~~~~~~~~~~~~aPE~~~------------~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 156 --DYTDYVATRWYRAPELLV------------GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred --cccCcccccccCCHHHHh------------CCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 112234678899998753 223467789999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=269.47 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=169.8
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-----HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
+|++.+.||.|++|.||+|.. .+++.|++|.++.... .....+..|+++++.++|+|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588899999999999999995 4789999999976532 2335567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+ +++|.+++......+++..+..++.|+++||.||| .+|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 88999999876545899999999999999999999 899999999999999999999999999998876543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
... .....++..|.|||.+. ....++.++|+|||||++|+|++|..||....
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 156 NRK--MTHQVVTRWYRAPELLF------------GARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred Ccc--ccccccceeeeCHHHHh------------CCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 221 12234678899998653 23456778999999999999999988876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=274.94 Aligned_cols=226 Identities=26% Similarity=0.307 Sum_probs=175.0
Q ss_pred ceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHH-HHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECE-VLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 689999999976421 22233444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|...+.... .+++..+..++.|++.||.||| ..|++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TT 153 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cc
Confidence 99998887654 3789999999999999999999 89999999999999999999999999998875322211 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLP 277 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~ 277 (314)
....||+.|+|||.+ .+..++.++|||||||++|+|++|..||............ ..+...+
T Consensus 154 ~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVL-------------RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKT 220 (321)
T ss_pred ccccCCcccCCHHHh-------------cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 234689999999765 3445778999999999999999999999775432221111 1122233
Q ss_pred chhhh----hc--cccCCCCHH
Q 047043 278 HALTD----VV--DANLRVSMK 293 (314)
Q Consensus 278 ~~l~~----ll--dp~~Rpt~~ 293 (314)
..+.+ ++ ||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 33444 44 899998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=267.65 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=193.5
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccc--
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCS-- 108 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 108 (314)
+........+.|++.+.||.|+||.||+|.. .+++.+++|++.... .....+..|+.+++.+ +|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3344445668999999999999999999995 578999999987653 3345678899999988 6999999999885
Q ss_pred ----cCCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEE
Q 047043 109 ----NPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 109 ----~~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ik 183 (314)
..+..+++|||+++++|.+++... ...+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEE
Confidence 346789999999999999998764 344788889999999999999999 89999999999999999999999
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
|+|||++........ ......++..|+|||.+.. +......++.++|+|||||++|+|++|..||.....
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~--------~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIAC--------DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCc--------ccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 999998875532211 1122457889999987642 112245677899999999999999999999976543
Q ss_pred chhhhh-------hhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 264 GEISLK-------NWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 264 ~~~~~~-------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...... ......++..+.+++ ||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 MRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 221111 111123444444444 9999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=268.93 Aligned_cols=235 Identities=25% Similarity=0.349 Sum_probs=187.3
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.|+..+.||.|+||+||.|.. .+++.+|+|.+..... .....+.+|+++++.++|++++++++.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 477889999999999999995 5789999999875431 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999888654 335899999999999999999999 8999999999999999999999999999887653322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--hhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--SLK------ 269 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--~~~------ 269 (314)
. .....++..|+|||.+ .+..++.++|+||||+++|+|++|..||........ ...
T Consensus 157 ~---~~~~~g~~~~~aPE~~-------------~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVL-------------NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET 220 (285)
T ss_pred c---ccCCCCCcCccChHHh-------------cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc
Confidence 1 1234589999999765 345677899999999999999999999986533211 110
Q ss_pred -hhhhccCCchhhhhc------cccCCCC-----HHHHHH
Q 047043 270 -NWVNESLPHALTDVV------DANLRVS-----MKDVAA 297 (314)
Q Consensus 270 -~~~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~ 297 (314)
......++..+.+++ ||.+||+ +.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011233444444444 9999999 666666
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=265.68 Aligned_cols=242 Identities=28% Similarity=0.435 Sum_probs=185.9
Q ss_pred ccccceeeecCceEEEEEEeC-CCC--eEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc------CCc
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGN--NVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN------PDF 112 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~--~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 112 (314)
|.+.+.||+|+||.||+|... ++. .+|+|.++... ......+..|..+++.++||||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999999954 343 68999887542 3445678889999999999999999987632 235
Q ss_pred eeEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 113 KALVLELMPNGSLENWLYSH-----NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
.+++|||+++++|.+++... ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCC
Confidence 68999999999999887432 234789999999999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~ 266 (314)
|++................+++.|+|||.. .+..++.++||||||+++|+|++ |..||........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-------------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESL-------------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHc-------------cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 998876443221112223456789999654 45567889999999999999999 8899976544322
Q ss_pred hhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 267 SLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 267 ~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
.... .....+++.+.+++ ||..|||+.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 11223445455544 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=283.60 Aligned_cols=198 Identities=23% Similarity=0.255 Sum_probs=167.9
Q ss_pred HhcCccccceeeecCceEEEEEEeC---CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS---DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
...+|++++.||.|+||.||++... ++..|++|.+... ....+|+++++.++||||+++++.+......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4567999999999999999999742 4678999987654 2346799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
||++. ++|.+++...+ .+++..+..++.|++.||.||| .+|++||||||+||+++.++.++|+|||++......
T Consensus 165 ~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSG-PLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99985 68998885443 4899999999999999999999 899999999999999999999999999998776544
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
..........||+.|+|||++ ....++.++|||||||++|+|++|..||.+.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELL-------------ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccccccccCccCHhHh-------------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 332223345689999999765 3455778999999999999999999998653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=267.35 Aligned_cols=231 Identities=23% Similarity=0.337 Sum_probs=180.4
Q ss_pred ceeeecCceEEEEEEeCC-------------CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 48 NLLGTGSFGIVYKGILSD-------------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
+.||.|+||.||+|...+ ...+++|++..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998422 2258999887665555567888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc-------EEEEee
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV-------ARVSDF 187 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~-------ikl~Df 187 (314)
++|||+++++|..++......+++..+..++.|++.||+||| +.|++|+||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999988776556899999999999999999999 999999999999999976654 899999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh-cCCCCCCccccchh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF-TGKKPTDEMFTGEI 266 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll-~g~~Pf~~~~~~~~ 266 (314)
|++...... ....++..|+|||.+. ....++.++|||||||++|+|+ +|..||......+.
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVE------------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred CCCccccCc------ccccccccccChhhhc------------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 987654321 1234678899997643 2455778899999999999997 58899876433221
Q ss_pred hhh-h---hh----hccCCchhhhhc--cccCCCCHHHHHHHHH
Q 047043 267 SLK-N---WV----NESLPHALTDVV--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 267 ~~~-~---~~----~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~ 300 (314)
... . .. ...+.+.+..++ ||.+||++.++++.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 0 00 111223344444 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=270.26 Aligned_cols=240 Identities=27% Similarity=0.356 Sum_probs=193.8
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||.|++|.||++.. .+++.+++|.++... .+....+.+|+++++.++||||+++++++.+++..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999995 478999999987542 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 99999999999987654 899999999999999999999 899999999999999999999999999998776443
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-----hhh
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-----NWV 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-----~~~ 272 (314)
.....+++.|+|||.+. +...+.++|+||||+++|+|++|..||........... ...
T Consensus 155 ----~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 217 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIIL-------------SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF 217 (290)
T ss_pred ----CCCCCCCccccChhhhc-------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC
Confidence 12235788999997653 33567789999999999999999999976543221111 112
Q ss_pred hccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeeee
Q 047043 273 NESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~~ 310 (314)
+..++..+++++ ||..|+ +++|+++ ++|+..+
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~ 260 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN------HPWFAGI 260 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc------CcccccC
Confidence 233444444444 899998 7777765 5666544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=297.62 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=190.2
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||.||+|.. .+++.||+|.++... .....++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999995 479999999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 118 ELMPNGSLENWLYSH----------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 118 e~~~~~sL~~~i~~~----------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
||++|++|.+++... ....+...+..++.|++.||+||| +.|++||||||+||+++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEec
Confidence 999999999988642 122455678899999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCc----------------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 188 GISKLLGDGEDS----------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 188 g~~~~~~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
|++......... .......||+.|+|||.+ .+..++.++|||||||++|+|
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-------------~g~~~S~kSDIWSLGVILyEL 224 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-------------LGVPASESTDIYALGVILYQM 224 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh-------------cCCCCCcHhHHHHHHHHHHHH
Confidence 998766211100 001123589999999764 355678899999999999999
Q ss_pred hcCCCCCCccccchhhhhhhh--------hccCCchhhhh----c--cccCCC-CHHHHHHHHHhh
Q 047043 252 FTGKKPTDEMFTGEISLKNWV--------NESLPHALTDV----V--DANLRV-SMKDVAAKLKKI 302 (314)
Q Consensus 252 l~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~l~~l----l--dp~~Rp-t~~~~~~~l~~~ 302 (314)
++|..||.............. ...++..+.++ + ||.+|| +++++.+.++..
T Consensus 225 LTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 225 LTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred HHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999976433322111110 11344444444 3 999996 566666666655
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=264.04 Aligned_cols=235 Identities=28% Similarity=0.399 Sum_probs=188.2
Q ss_pred ceeeecCceEEEEEEeCC--C--CeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILSD--G--NNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||.|++|.||+|.+.+ + ..|++|.++.... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999532 3 2689999987765 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 123 GSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 123 ~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
++|.+.+.+.. ..+++..++.++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999998765 45899999999999999999999 89999999999999999999999999999887654322111
Q ss_pred -eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh-------hh
Q 047043 202 -QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN-------WV 272 (314)
Q Consensus 202 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-------~~ 272 (314)
.....++..|+|||.+ ....++.++||||||+++|+|++ |..||......+..... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~-------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESL-------------RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222 (257)
T ss_pred cccCCCCCceecCHHHh-------------cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC
Confidence 1123467789999764 34557889999999999999998 99999765433321111 01
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
+..++..+.+++ +|.+||++.++++.+.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 223444444444 9999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=274.69 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=189.6
Q ss_pred hcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccccc-CC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN-PD 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 111 (314)
.++|++.+.||+|+||.||+|.+ .+++.||+|.++... ......+.+|+.++..+ +|||++++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 246789999997643 23446788899999999 68999999998754 45
Q ss_pred ceeEEEEecCCCCHHHHHhhcC----------------------------------------------------------
Q 047043 112 FKALVLELMPNGSLENWLYSHN---------------------------------------------------------- 133 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~---------------------------------------------------------- 133 (314)
..+++|||+++++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 7789999999999999986531
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecc
Q 047043 134 --------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205 (314)
Q Consensus 134 --------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~ 205 (314)
..++...+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12567778899999999999999 899999999999999999999999999998765332221122223
Q ss_pred cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh-------hhccCC
Q 047043 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-------VNESLP 277 (314)
Q Consensus 206 ~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-------~~~~~~ 277 (314)
.++..|+|||.+ .+..++.++||||||+++|+|++ |..||............. .+..++
T Consensus 242 ~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (343)
T cd05103 242 RLPLKWMAPETI-------------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308 (343)
T ss_pred CCCcceECcHHh-------------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence 356779999764 34457789999999999999996 999997643321111111 111233
Q ss_pred chhhhh----c--cccCCCCHHHHHHHHHhhhh
Q 047043 278 HALTDV----V--DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 278 ~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~ 304 (314)
+.+.++ + ||.+||++.+++++++.+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 333333 3 99999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=268.71 Aligned_cols=198 Identities=26% Similarity=0.396 Sum_probs=160.9
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhC---CCCCcceeeccccc-----CC
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNV---HHRNLLKIFSSCSN-----PD 111 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 111 (314)
+|++.+.||+|+||.||+|+. .+++.||+|.++.... .......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999995 4799999999875421 1123445667666655 69999999998754 34
Q ss_pred ceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 112 FKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
..+++||+++ ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 48988887643 34899999999999999999999 899999999999999999999999999998
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
........ .....++..|+|||.+. +..++.++|||||||++|+|++|..||...
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~-------------~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLL-------------QSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCccc---CCCccccccccCchHhh-------------CCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 76543221 12235788999997653 445788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=264.10 Aligned_cols=243 Identities=26% Similarity=0.448 Sum_probs=191.6
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++.+.||.|++|.||+|....+..+++|.+..... ....+.+|+++++.++|||++++++++.. +..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 3467999999999999999999976667799998875432 23567889999999999999999998754 567899999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++... ...+++..+..++.|++.||+||| +.|++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999999764 334788999999999999999999 89999999999999999999999999999876643321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------ 271 (314)
. ......++..|+|||.. .+..++.++|+||||+++|+|++ |..||......+......
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~-------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAA-------------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223 (260)
T ss_pred c-ccCCCccchhhCCHHHh-------------ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1 11223356779999654 34557789999999999999999 999998765433211110
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
.+..++..+.+++ ||.+||++.++.+.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1122344444444 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=264.60 Aligned_cols=236 Identities=29% Similarity=0.370 Sum_probs=193.9
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++.+.||.|++|.||+|... +++.+++|.++.... ...+.+|+++++.++|||++++++.+.+....++++|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 368999999999999999999965 588999999876633 57889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++...+..+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999999876667899999999999999999999 89999999999999999999999999999887644321
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------- 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-------- 271 (314)
......++..|+|||.+. +..++.++||||||+++|+|++|..||.............
T Consensus 155 -~~~~~~~~~~y~~PE~~~-------------~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQ-------------EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS 220 (256)
T ss_pred -ccccccCCccccCHHHHh-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCC
Confidence 122234788899997653 3457789999999999999999999997654322211100
Q ss_pred hhccCCchhhh----hc--cccCCCCHHHHHH
Q 047043 272 VNESLPHALTD----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 272 ~~~~~~~~l~~----ll--dp~~Rpt~~~~~~ 297 (314)
.+..++..+.+ ++ ||..||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11223334444 44 9999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=265.25 Aligned_cols=242 Identities=22% Similarity=0.303 Sum_probs=181.1
Q ss_pred ceeeecCceEEEEEEeC---CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 48 NLLGTGSFGIVYKGILS---DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+.||+|+||.||+|... ....+++|.+..... .....+.+|+..++.++||||+++++.+.+....+++|||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 35899999999999743 245788887764432 33456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 124 SLENWLYSHNY----FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 124 sL~~~i~~~~~----~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+|.+++..... ..++..+..++.|++.|++||| ++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999976432 2457778899999999999999 899999999999999999999999999987653322111
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh--------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN-------- 270 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-------- 270 (314)
.......++..|+|||...... .......++.++|||||||++|+|++ |..||....+.+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRG------QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230 (269)
T ss_pred eccCCCCCcccccCHHHHhhcc------ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence 1112233567799998864211 01123456789999999999999998 88898765443221110
Q ss_pred ---hhhccCCchhhhhc-----cccCCCCHHHHHHHH
Q 047043 271 ---WVNESLPHALTDVV-----DANLRVSMKDVAAKL 299 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll-----dp~~Rpt~~~~~~~l 299 (314)
.....++..+.+++ ||..||++.++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELL 267 (269)
T ss_pred CCCcccccCCHHHHHHHHHHhcCcccccCHHHHHHHh
Confidence 01123333333332 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=269.92 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=169.8
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||.|++|.||+|..+ +++.|++|.+..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 478999999999999999999954 789999999875432 122446689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++ +|.+++...+..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9975 999988876666899999999999999999999 89999999999999999999999999998865432211
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......++..|+|||... ....++.++||||||+++|+|++|..||....
T Consensus 159 --~~~~~~~~~~~~aPE~~~------------~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLL------------GSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred --cccccccccccCCcHHhh------------cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 112234678899997653 23446778999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=274.23 Aligned_cols=202 Identities=20% Similarity=0.260 Sum_probs=165.2
Q ss_pred cccceeeec--CceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 45 NECNLLGTG--SFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 45 ~~~~~lg~G--~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++++.||+| ++++||++. ..+|+.||+|.++... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 356789999 788999999 4589999999997653 23445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++... ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999999754 334889999999999999999999 89999999999999999999999999986544322111
Q ss_pred cc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 199 SV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 199 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.. ......++..|+|||.+.. ....++.++|||||||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQ-----------NLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhc-----------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 00 1122346778999987641 1235778999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=270.48 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=190.4
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC--eEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN--NVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|.++ ++. .+++|.++... ......+.+|++++.++ +|||++++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468899999999999999999954 555 45777665432 23446788899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 116 VLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
+|||+++++|.+++...+ ..+++..+..++.|++.|++||| +.|++|+||||+||+++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCC
Confidence 999999999999997542 24788999999999999999999 99999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~ 259 (314)
.++|+|||++...... ........+..|+|||.+ ....++.++||||||+++|+|++ |..||.
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESL-------------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred cEEeCccccCcccchh---hhcccCCCcccccCHHHH-------------hccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999987532111 011112245679999764 34456789999999999999998 999997
Q ss_pred ccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 260 EMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 260 ~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
.....+..... ..+..++..+.+++ +|..||++.++++.+..+...-.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 226 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 65433221111 01112334444443 99999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.77 Aligned_cols=236 Identities=25% Similarity=0.424 Sum_probs=185.4
Q ss_pred eeeecCceEEEEEEeC---CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCC
Q 047043 49 LLGTGSFGIVYKGILS---DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGS 124 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s 124 (314)
.||.|+||.||+|.+. .+..||+|++..... .....+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999753 355799999876543 334668899999999999999999998864 46789999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce-ee
Q 047043 125 LENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT-QT 203 (314)
Q Consensus 125 L~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~-~~ 203 (314)
|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++........... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999866556899999999999999999999 89999999999999999999999999999876543322111 11
Q ss_pred cccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhhccC
Q 047043 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVNESL 276 (314)
Q Consensus 204 ~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~~ 276 (314)
...++..|+|||.. ....++.++||||||+++|++++ |..||......+..... ..+..+
T Consensus 157 ~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05115 157 AGKWPLKWYAPECI-------------NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAEC 223 (257)
T ss_pred CCCCCcccCCHHHH-------------ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence 12235689999764 34456789999999999999996 99999876554322111 112234
Q ss_pred Cchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 277 PHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 277 ~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
++.+.+++ +|.+||++.++.+.++.+
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 44555544 899999999999988765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=268.23 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=196.6
Q ss_pred HhcCccccceeeecCceEEEEEEeCC-----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeeccccc-CCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSD-----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-PDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 112 (314)
..++|++.+.||+|+||.||.|.+.. +..|++|.+.... ......+.+|+.+++.++|||++++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999654 6789999887543 3445678899999999999999999998665 567
Q ss_pred eeEEEEecCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 113 KALVLELMPNGSLENWLYSHN-------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
.+++++++++++|.+++.... ..+++..++.++.|++.||+||| +++++|+||||+||+++.++.++|+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEEC
Confidence 889999999999999987642 34789999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTG 264 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~ 264 (314)
|||++..+.............++..|+|||.+ .+..++.++||||||+++|++++ |..||......
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~-------------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 226 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESL-------------VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHH-------------hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH
Confidence 99998765433221111223456779999765 34457789999999999999998 99999865433
Q ss_pred hhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 265 EISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 265 ~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+..... .....+++.+.+++ ||..|||+.++++.|+.+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 227 EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 221100 01123455555554 999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=268.82 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=192.5
Q ss_pred HhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||.|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|||++++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3578999999999999999999853 467899999876543 344678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCC
Q 047043 113 KALVLELMPNGSLENWLYSHN---------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKP 171 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~---------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp 171 (314)
.++++||+++++|.+++.... ..+++..++.++.|++.||+||| ..|++|+||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p 158 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLAT 158 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccH
Confidence 999999999999999987431 23678889999999999999999 89999999999
Q ss_pred CceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 172 SNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 172 ~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
+||+++.++.++|+|||++.................+..|+|||.+ .+..++.++|||||||++|+|
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~il~el 225 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-------------FYNRYTTESDVWAYGVVLWEI 225 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-------------hcCCCCchhHHHHHHHHHHHH
Confidence 9999999999999999988765332211112222346679999654 345678899999999999999
Q ss_pred hc-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 252 FT-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 252 l~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
++ |..||......+..... ..+..++..+.+++ ||..||++.|++..|++
T Consensus 226 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 226 FSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 97 88898765433321110 01223444455544 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=267.49 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=194.5
Q ss_pred cCccccceeeecCceEEEEEEeC-----CCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeeccccc--CCce
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-----DGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 113 (314)
+.|++.+.||+|+||.||+|.+. ++..+|+|.++..... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57888999999999999999842 3678999999876543 56789999999999999999999999877 6688
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++......+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999999877656899999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-----
Q 047043 194 GDGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS----- 267 (314)
Q Consensus 194 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~----- 267 (314)
........ .....++..|+|||.. ....++.++|+||||+++|+|++|..||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~-------------~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 226 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECL-------------RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHH-------------ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc
Confidence 53322111 1112345669999764 3345778899999999999999999998654322210
Q ss_pred --------hhhh--------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 268 --------LKNW--------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 268 --------~~~~--------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.... .+..++..+.+++ +|..||++.|+++.++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0000 1122334444444 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=261.37 Aligned_cols=237 Identities=23% Similarity=0.316 Sum_probs=192.5
Q ss_pred CccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|+.++.||.|++|.|+.++ ..+++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58999999999999999999 4578999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++.+. +..+++..+..++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999765 445899999999999999999999 89999999999999999999999999999876644321
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------h
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------V 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------~ 272 (314)
......+++.|.|||.. .+..++.++|+||||+++|+|++|..||......+...... .
T Consensus 157 --~~~~~~~~~~y~ape~~-------------~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELC-------------QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV 221 (256)
T ss_pred --cccccCCCccccCHhhc-------------CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 12234578999999764 34456778999999999999999999997644333211111 1
Q ss_pred hccCCchhhh----hc--cccCCCCHHHHHHH
Q 047043 273 NESLPHALTD----VV--DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ~~~~~~~l~~----ll--dp~~Rpt~~~~~~~ 298 (314)
...++..+.+ ++ +|..||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1223344444 44 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=260.86 Aligned_cols=235 Identities=31% Similarity=0.479 Sum_probs=187.4
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHH
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLE 126 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 126 (314)
+.||+|++|.||+|...+++.+++|.+..... .....+.+|+++++.++|||++++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999977888999999876543 33356888999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeeccc
Q 047043 127 NWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206 (314)
Q Consensus 127 ~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~ 206 (314)
+++......+++..+..++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++........ .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ 155 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence 998776556889999999999999999999 99999999999999999999999999998865432211 1111223
Q ss_pred ceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhhccCCch
Q 047043 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVNESLPHA 279 (314)
Q Consensus 207 ~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~ 279 (314)
++..|+|||.+ ....++.++||||||+++|++++ |..||............ ..+..++..
T Consensus 156 ~~~~y~aPE~~-------------~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (250)
T cd05085 156 IPIKWTAPEAL-------------NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD 222 (250)
T ss_pred CcccccCHHHh-------------ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 45679999764 34456788999999999999998 99999765433221111 112234444
Q ss_pred hhhhc------cccCCCCHHHHHHHHH
Q 047043 280 LTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 280 l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
+.+++ +|..||++.++.+.+.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 54444 9999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=263.38 Aligned_cols=240 Identities=29% Similarity=0.368 Sum_probs=188.9
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.+.......||+|+||.||+|.. .++..|++|.+..........+.+|+.+++.++|+||+++++++..++..++++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 34455556899999999999994 46889999998877666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeecceecCCC
Q 047043 120 MPNGSLENWLYSHNYFL--DTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDG 196 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~--~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~~~~~ 196 (314)
+++++|.+++......+ ++..+..++.|++.|++||| ..|++|+||||+||+++. ++.++|+|||.+......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999998654335 78889999999999999999 899999999999999976 679999999988765432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------- 269 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------- 269 (314)
.. ......++..|+|||.+.. ....++.++|+||||+++|+|++|..||...........
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~-----------~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDK-----------GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI 229 (268)
T ss_pred CC--ccccCCCCccccChhhhcc-----------ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc
Confidence 21 1122347889999987531 123367789999999999999999999976433221110
Q ss_pred -hhhhccCCch----hhhhc--cccCCCCHHHHHH
Q 047043 270 -NWVNESLPHA----LTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 270 -~~~~~~~~~~----l~~ll--dp~~Rpt~~~~~~ 297 (314)
...+..+++. +.+++ +|..|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1112234444 44444 8999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.65 Aligned_cols=244 Identities=24% Similarity=0.400 Sum_probs=189.7
Q ss_pred cCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccC--Cce
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (314)
.-|++++.||+|+||.||++.. .++..|++|.++... ......+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478999999999999999973 257889999987553 34456788999999999999999999988764 678
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++.+....+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 8999999999999999776555899999999999999999999 999999999999999999999999999998866
Q ss_pred CCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc---------
Q 047043 194 GDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT--------- 263 (314)
Q Consensus 194 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~--------- 263 (314)
....... ......++..|+|||.. .+..++.++||||||+++|+|+++..|+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~-------------~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECL-------------IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT 226 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHh-------------ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc
Confidence 4332211 11223466779999754 345577899999999999999997766432110
Q ss_pred -chhhhh-----------hhhhccCCchhhhh----c--cccCCCCHHHHHHHHHhh
Q 047043 264 -GEISLK-----------NWVNESLPHALTDV----V--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 264 -~~~~~~-----------~~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~ 302 (314)
++.... ......++..+.++ + +|.+||++.++++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 227 HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000 00122344444444 4 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=278.20 Aligned_cols=200 Identities=24% Similarity=0.306 Sum_probs=167.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC----
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP---- 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (314)
....++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 34678999999999999999999994 478999999987542 23446678899999999999999999987543
Q ss_pred --CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 111 --DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 111 --~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357899999964 78877753 2788899999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
++....... ......+|..|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~-------------~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVI-------------LGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHH-------------hCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 987654321 12234588999999775 3455788999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=261.00 Aligned_cols=237 Identities=23% Similarity=0.350 Sum_probs=188.9
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc-CCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-PDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 118 (314)
+|++.+.||.|++|.||++.. .+++.+++|.+.... ....+.+.+|+++++.++|+|++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999995 468899999987543 2345678889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++... +..+++.++..++.+++.++++|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998764 345899999999999999999999 8999999999999999999999999999987764322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------h
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------W 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~ 271 (314)
. ......+++.|+|||.. .+..++.++|+||||+++++|++|..||............ .
T Consensus 157 ~--~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd08223 157 D--MASTLIGTPYYMSPELF-------------SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP 221 (257)
T ss_pred C--ccccccCCcCccChhHh-------------cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 2 12234578899999764 3456778899999999999999999999764432221111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.+..+++.+.+++ +|..||++.+++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1123344444444 99999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=261.11 Aligned_cols=237 Identities=29% Similarity=0.452 Sum_probs=186.9
Q ss_pred ceeeecCceEEEEEEe-CCC---CeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDG---NNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|.+ ..+ ..+++|.+..... .....+.+|+.+++.+.|||++++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4689999999999984 232 6899999886643 34567889999999999999999999876 4567899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce-
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT- 201 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~- 201 (314)
++|.+++.+.. .+++..+..++.|++.|+.+|| ..|++|+||||+||+++.++.++|+|||++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998765 4899999999999999999999 89999999999999999999999999999876644322111
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhhc
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVNE 274 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~ 274 (314)
.....++..|+|||.+ .+..++.++||||||+++|+|++ |..||......+..... ..+.
T Consensus 155 ~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd05060 155 TTAGRWPLKWYAPECI-------------NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE 221 (257)
T ss_pred ccCccccccccCHHHh-------------cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCC
Confidence 1111234679999654 34557889999999999999998 99999876543321111 1223
Q ss_pred cCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 275 ~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.++..+.+++ +|..||++.++++.++.+.
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 3445555554 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.06 Aligned_cols=198 Identities=25% Similarity=0.356 Sum_probs=159.5
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC------CCcceeecccccC-C
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH------RNLLKIFSSCSNP-D 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~ 111 (314)
..++|++.+.||+|+||.||+|.. .+++.||||+++... ........|+.++..++| ++++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 457899999999999999999995 478899999997532 223445667777776643 4588888888764 4
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCC----------
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENM---------- 180 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~---------- 180 (314)
..+++|+++ +++|.+++.+.+. +++..+..++.|++.||.||| . .||+||||||+||+++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~yLH----~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGP-FSHRHLAQIIFQTGVALDYFH----TELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 678899988 7799998877654 899999999999999999999 6 5999999999999998665
Q ss_pred ------cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC
Q 047043 181 ------VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254 (314)
Q Consensus 181 ------~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g 254 (314)
.+||+|||.+..... ......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~-------------~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVV-------------LGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred cCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHh-------------hcCCCCcHHHHHHHHHHHHHHHhC
Confidence 499999998753221 12234689999999775 345678899999999999999999
Q ss_pred CCCCCccc
Q 047043 255 KKPTDEMF 262 (314)
Q Consensus 255 ~~Pf~~~~ 262 (314)
..||+...
T Consensus 342 ~~pf~~~~ 349 (467)
T PTZ00284 342 KLLYDTHD 349 (467)
T ss_pred CCCCCCCC
Confidence 99997543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=262.69 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=181.7
Q ss_pred ceeeecCceEEEEEEeC---CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 48 NLLGTGSFGIVYKGILS---DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+.||+|+||.||+|.+. ++..+++|.++.... .....+.+|+.+++.++||||+++++.+.+....+++|||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999853 345789998876542 23356888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 124 SLENWLYSHN----YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 124 sL~~~i~~~~----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+|.+++.... ...++..+..++.|++.|++||| +.|++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999987532 23566778889999999999999 899999999999999999999999999988654322211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh-------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------- 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------- 271 (314)
.......++..|+|||.+.... .......++.++|+||||+++|+|++ |..||......+......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVH------GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230 (269)
T ss_pred ecCCCcCCcccccCHhHhcccc------ccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence 1122234678899998864110 00112346789999999999999996 999997654433211110
Q ss_pred hhc----cCCchhhhhc-----cccCCCCHHHHHHHHH
Q 047043 272 VNE----SLPHALTDVV-----DANLRVSMKDVAAKLK 300 (314)
Q Consensus 272 ~~~----~~~~~l~~ll-----dp~~Rpt~~~~~~~l~ 300 (314)
..+ ..++.+.+++ +|.+|||+.++...|.
T Consensus 231 ~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 011 1233333333 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.47 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=211.2
Q ss_pred hcCccccceeeecCceEEEEEEeC--CCC----eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS--DGN----NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~--~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
...-+..+.||+|.||.||.|... .+. .||+|.++... .....+|.+|..+|+.++||||++++|++-+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345567778999999999999943 343 38888887654 34568899999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 114 ALVLELMPNGSLENWLYSH------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
++++||+.+|+|..+|+.. ...++..+...++.|+|.|+.||+ +++.|||||..+|+|++....+||+||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999987 667899999999999999999999 999999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~ 266 (314)
|+|+-.-+...........-+..|+|||.+. .+.++.++|||||||++||+++ |..||....+.++
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~-------------d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v 913 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLK-------------DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV 913 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHh-------------hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence 9998443332222222235678899997764 5778999999999999999999 9999998776554
Q ss_pred hh------hhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 267 SL------KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 267 ~~------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
-. +...+..||+.+.+++ +|.+||++.++++.+..+....+..
T Consensus 914 ~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 914 LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 22 3345677888888877 9999999999999998888766544
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=264.02 Aligned_cols=241 Identities=25% Similarity=0.392 Sum_probs=192.6
Q ss_pred cCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
++|++.+.||.|+||.||+|+.+ +.+.+++|.+...... ....+.+|++++++++|+|++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67999999999999999999953 2457999988765443 4577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 115 LVLELMPNGSLENWLYSHN--------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~--------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
++|||+++++|.+++.... ..+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999997654 14789999999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccch
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE 265 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~ 265 (314)
||++........ .......++..|+|||.+ .+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAV-------------QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred cccccccCcccc-cccCCceeEEeecChhhh-------------ccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 998764432211 112223467889999764 23446778999999999999998 888997654433
Q ss_pred hhhhh-------hhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 266 ISLKN-------WVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 266 ~~~~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
..... .....++..+.+++ +|..||++.++++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 21111 11234555555554 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.90 Aligned_cols=245 Identities=26% Similarity=0.455 Sum_probs=193.2
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC---eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN---NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|+..+.||+|++|.||+|..+ +++ .+++|.++... ......+.+|+++++.++|||++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999954 443 68999887653 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++......+++.++..++.|++.|++||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999876556899999999999999999999 89999999999999999999999999999876643
Q ss_pred CCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 196 GEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 196 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
...... ......+..|+|||.+ ....++.++||||||+++|+|++ |..||......+......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~ 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAI-------------AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHh-------------hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence 222111 1112234579999764 34456789999999999999997 999997654332211110
Q ss_pred ----hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 272 ----VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ----~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
....++..+.+++ +|..||++.++++.++++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122344444443 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=265.94 Aligned_cols=243 Identities=22% Similarity=0.386 Sum_probs=193.4
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCC---CCCcceeecccccCCceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVH---HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.|+..+.||.|++|.||+|.. .+++.+++|.++... ......+.+|+.+++.+. |||++++++++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999995 579999999987643 334466788999999986 999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++... .+++..+..++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998654 4889999999999999999999 9999999999999999999999999999988765433
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh-------hh
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-------KN 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-------~~ 270 (314)
. ......++..|+|||.+. .+..++.++|+||||+++|+|++|..||.......... ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVIT------------EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPR 221 (277)
T ss_pred c--ccccccCCcceeCHHHhc------------cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCC
Confidence 1 122345888999997653 23456779999999999999999999997654322111 01
Q ss_pred hhhccCCchhhh----hc--cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 271 WVNESLPHALTD----VV--DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 271 ~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
.....++..+.+ ++ ||..||++.+++. ++|+++..
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~------~~~~~~~~ 262 (277)
T cd06917 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLK------SKWIKAHS 262 (277)
T ss_pred CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh------ChHhhccc
Confidence 111123334444 44 9999999999987 56665543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.52 Aligned_cols=237 Identities=28% Similarity=0.439 Sum_probs=188.9
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---------HHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---------RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
+|.+.+.||.|++|.||.|.. .+++.+++|.+..... +....+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588899999999999999995 4688999998865321 233567889999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|||+++++|.+++...+. +++..+..++.|++.||.+|| ++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC-ccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999999977644 788999999999999999999 89999999999999999999999999998876
Q ss_pred cCCCCCc----ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 193 LGDGEDS----VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 193 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
....... .......++..|+|||.+ .+..++.++|+||||+++|+|++|..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~-------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVV-------------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHh-------------ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence 6422111 011123478889999764 34456778999999999999999999998754322111
Q ss_pred h--h----hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 269 K--N----WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 269 ~--~----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
. . ..+..++..+.+++ ||..||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 1 11223444444444 8999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.33 Aligned_cols=235 Identities=28% Similarity=0.447 Sum_probs=185.4
Q ss_pred eeeecCceEEEEEEe---CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCC
Q 047043 49 LLGTGSFGIVYKGIL---SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
.||+|+||.||+|.+ .++..+++|+++... ......+.+|+.+++.++||||+++++++.. +..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999964 357889999987553 2345678899999999999999999998864 4668999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce-e
Q 047043 124 SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT-Q 202 (314)
Q Consensus 124 sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~-~ 202 (314)
+|.+++.... .+++..+..++.|++.|+.+|| ++|++|+||||+||+++.++.++|+|||++........... .
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997654 4899999999999999999999 89999999999999999999999999999877644322111 1
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhhcc
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVNES 275 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~ 275 (314)
....++..|+|||.+ ....++.++|+||||+++|+|++ |..||......+..... ..+..
T Consensus 156 ~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 222 (257)
T cd05116 156 THGKWPVKWYAPECM-------------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222 (257)
T ss_pred CCCCCCccccCHhHh-------------ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 112245789999764 34456778999999999999998 99999875443221110 12234
Q ss_pred CCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 276 LPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 276 ~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
++..+.+++ ||..||++.++.+.|+.+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 555566655 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.97 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=193.5
Q ss_pred hcCccccceeeecCceEEEEEEeC--------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS--------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP 110 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (314)
.++|.+.+.||+|+||.||+|... ....+++|.++... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 468999999999999999999741 24468999887543 34456788899999999 699999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceE
Q 047043 111 DFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNIL 175 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nil 175 (314)
+..+++|||+++++|.+++.... ..++...+..++.|++.||.||| ++|++|+||||+||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil 166 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVL 166 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEE
Confidence 99999999999999999997532 24778889999999999999999 899999999999999
Q ss_pred ecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-C
Q 047043 176 LDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-G 254 (314)
Q Consensus 176 i~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g 254 (314)
++.++.++|+|||.+................++..|+|||.+ .+..++.++||||||+++|+|++ |
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~DiwslG~~l~el~~~g 233 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-------------FDRVYTHQSDVWSFGILMWEIFTLG 233 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHH-------------ccCCcCccchhhHHHHHHHHHHhCC
Confidence 999999999999998765432211111112244679999765 34557889999999999999999 8
Q ss_pred CCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 255 KKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 255 ~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..||......+..... ..+..++..+.+++ +|..||++.++++.++.+...
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 234 GSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 9999765433221110 11223344444443 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=267.98 Aligned_cols=203 Identities=24% Similarity=0.379 Sum_probs=168.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||+|++|.||+|.. .+++.|++|.++..... ....+.+|+.+++.++|+||+++++++.+++..++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 47899999999999999999994 57899999998765322 22356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+. +++.+.+......+.+..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 995 6888877665555788889999999999999999 89999999999999999999999999998875433211
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......++..|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 159 --~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLL------------GATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred --CCCCccccccccCCceee------------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 112234688899997653 12346678999999999999999999997544
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=269.85 Aligned_cols=195 Identities=22% Similarity=0.285 Sum_probs=157.2
Q ss_pred cceeeecCceEEEEEEeC---CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc--CCceeEEEEecC
Q 047043 47 CNLLGTGSFGIVYKGILS---DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFKALVLELMP 121 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 121 (314)
.+.||+|+||.||+|+.+ +++.+|+|.++.... ...+.+|+.+++.++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999954 467899999875432 2456789999999999999999998854 456889999985
Q ss_pred CCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe----cCCCcEEEEeeec
Q 047043 122 NGSLENWLYSH--------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL----DENMVARVSDFGI 189 (314)
Q Consensus 122 ~~sL~~~i~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili----~~~~~ikl~Dfg~ 189 (314)
++|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5888887532 124788999999999999999999 9999999999999999 4567899999999
Q ss_pred ceecCCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 190 SKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 190 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
+......... .......+|+.|+|||++. ....++.++||||+||++|+|++|..||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLL------------GARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHc------------CCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9876433211 1122346799999998754 234577899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=262.49 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=186.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-----cHHHHHHHHHHHHHHhCCCCCcceeecccccC--Cce
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (314)
++|++.+.||+|+||.||.+.. .++..|++|.+.... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999995 468999999886432 23456788899999999999999999988763 567
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++.+.+. +++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999876644 788889999999999999999 899999999999999999999999999988765
Q ss_pred CCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-
Q 047043 194 GDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 194 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~- 271 (314)
....... ......++..|+|||.+. +..++.++|+||||+++|+|++|..||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVIS-------------GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223 (265)
T ss_pred ccccccccccccCCCCccccChhhhc-------------CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc
Confidence 3211110 111234788899997653 3446789999999999999999999997653222111111
Q ss_pred ------hhccCCc----hhhhhc-cccCCCCHHHHHH
Q 047043 272 ------VNESLPH----ALTDVV-DANLRVSMKDVAA 297 (314)
Q Consensus 272 ------~~~~~~~----~l~~ll-dp~~Rpt~~~~~~ 297 (314)
.+..++. .+.+++ +|..||++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLR 260 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHhc
Confidence 1122233 333333 9999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=267.19 Aligned_cols=201 Identities=27% Similarity=0.381 Sum_probs=168.9
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||.|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++|||++++++++.+++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999964 689999998865432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|..+...... +++..+..++.|++.|+.||| +.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9998888877654433 899999999999999999999 89999999999999999999999999999876644322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
. .....++..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 156 ~--~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 156 V--YTDYVATRWYRAPELLV------------GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred c--cCcccceeeccCcHHhc------------cccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 1 12235788899997753 2344667899999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.98 Aligned_cols=240 Identities=27% Similarity=0.435 Sum_probs=191.5
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
..+|++.+.||.|++|.||+|.+.++..+++|.++.... ....+.+|+++++.++||+++++++++......+++|||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 357899999999999999999976788899998875432 2256788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++......+++..+..++.|++.++++|| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999999876555889999999999999999999 899999999999999999999999999988765432211
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhh
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVN 273 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~ 273 (314)
......++..|+|||.+ .+..++.++|+||||+++|+|++ |..||............ ..+
T Consensus 157 ~~~~~~~~~~~~aPe~~-------------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05112 157 SSTGTKFPVKWSSPEVF-------------SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP 223 (256)
T ss_pred ccCCCccchhhcCHhHh-------------ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC
Confidence 11222356789999764 34457788999999999999998 99999865433221111 111
Q ss_pred ccCCchhhh----hc--cccCCCCHHHHHHHH
Q 047043 274 ESLPHALTD----VV--DANLRVSMKDVAAKL 299 (314)
Q Consensus 274 ~~~~~~l~~----ll--dp~~Rpt~~~~~~~l 299 (314)
...++.+.+ ++ +|..||++.++++.+
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 223344444 44 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=260.16 Aligned_cols=235 Identities=29% Similarity=0.419 Sum_probs=190.7
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-----cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+++++.++|+|++++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888899999999999999965 79999999987643 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
+||+++++|.+++.+.+. +++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS-FPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999977653 789999999999999999999 899999999999999999999999999988765433
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
. ......++..|+|||.+. ....++.++|+||||+++|+|++|..||............
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~------------~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 220 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIA------------QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220 (258)
T ss_pred c---cccccCCCcceeCHHHhc------------CCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC
Confidence 2 122345788899997753 1114778899999999999999999999765432221111
Q ss_pred -hhhccCCchhhh----hc--cccCCCCHHHHHH
Q 047043 271 -WVNESLPHALTD----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 271 -~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~ 297 (314)
..+..++..+.+ ++ +|..||++.+++.
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112233344444 44 9999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=264.95 Aligned_cols=234 Identities=28% Similarity=0.371 Sum_probs=190.0
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
+|++.+.||.|+||.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++.+.+++..++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999954 79999999997643 2345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+.+++|.+++... ..+++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999776 34889999999999999999999 8999999999999999999999999999887664432
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc---hhh-----hhh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG---EIS-----LKN 270 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~---~~~-----~~~ 270 (314)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||...... ... ...
T Consensus 155 --~~~~~~~~~~y~~PE~~~-------------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLC-------------RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV 219 (258)
T ss_pred --cccccCCChhhcCHHHHc-------------ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc
Confidence 122345788899997653 333678999999999999999999999875531 110 011
Q ss_pred hhhccCCchhhhh----c--cccCCCCH--HHHHH
Q 047043 271 WVNESLPHALTDV----V--DANLRVSM--KDVAA 297 (314)
Q Consensus 271 ~~~~~~~~~l~~l----l--dp~~Rpt~--~~~~~ 297 (314)
..+..++..+.++ + ||.+||++ +|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1222344444444 4 99999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=266.23 Aligned_cols=231 Identities=23% Similarity=0.346 Sum_probs=180.2
Q ss_pred ceeeecCceEEEEEEeC-CC-------CeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 48 NLLGTGSFGIVYKGILS-DG-------NNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+.||.|+||.||+|..+ .+ ..+++|.+........+.+.+|..+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46899999999999853 23 34888888766555567788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc--------EEEEeeecce
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV--------ARVSDFGISK 191 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~--------ikl~Dfg~~~ 191 (314)
+++++|.+++...+..+++..+..++.|++.|++||| ++|++|+||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999877666899999999999999999999 999999999999999987664 6999999876
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC-CCCCCccccchhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-KKPTDEMFTGEISLKN 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-~~Pf~~~~~~~~~~~~ 270 (314)
..... ....++..|+|||.+. ....++.++||||||+++|+|++| ..||............
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~ 218 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIE------------NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY 218 (258)
T ss_pred ccCCc------hhccccCCccCchhcc------------CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH
Confidence 54321 2234678899997653 224467889999999999999998 4666554332211110
Q ss_pred ----hhhccCCc----hhhhhc--cccCCCCHHHHHHHHH
Q 047043 271 ----WVNESLPH----ALTDVV--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 271 ----~~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~l~ 300 (314)
..+...+. .+..++ ||..|||++++++.|+
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11112222 344444 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=277.17 Aligned_cols=199 Identities=25% Similarity=0.308 Sum_probs=166.1
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP----- 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (314)
...++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4678999999999999999999994 478999999987542 23446677899999999999999999987543
Q ss_pred -CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 111 -DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 111 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
...+++|||+++ ++.+.+.. .+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357899999965 77776653 3788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+....... ......+|..|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~-------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVI-------------LGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHH-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87654322 12234588999999765 3445778999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=264.44 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=194.2
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|+..+.||.|++|.||++..+ +++.+++|.+.... ......+.+|+++++.++||||+++++.+..++..++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47899999999999999999954 78999999987664 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++......+++..+..++.|++.|+++|| + .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999876456899999999999999999999 7 9999999999999999999999999998866533211
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc---chh-hhhhhh--
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT---GEI-SLKNWV-- 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~---~~~-~~~~~~-- 272 (314)
. ...++..|+|||.+. +..++.++|+||||+++|+|++|..||..... ... ......
T Consensus 157 ~----~~~~~~~y~~PE~~~-------------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd06605 157 K----TFVGTSSYMAPERIQ-------------GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219 (265)
T ss_pred h----cccCChhccCHHHHc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence 1 145788899997653 34678899999999999999999999976421 111 111110
Q ss_pred -----hcc-CCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 273 -----NES-LPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 273 -----~~~-~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
... ++..+.+++ ||.+|||+.+++. ++|++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~------~~~~~~ 262 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE------HPFIKK 262 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh------Cchhhc
Confidence 111 344455444 9999999999986 666654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.57 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=192.6
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCC----eEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGN----NVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|+..+.||+|+||.||+|.+ .++. .+++|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 46789999999999999999985 3554 578888876533 2334678899999999999999999998764 457
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++||+++|+|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEcccccccccc
Confidence 899999999999999876656889999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
............++..|+|||.+ .+..++.++||||||+++|+|++ |..||.............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-------------~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 227 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECI-------------HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 227 (303)
T ss_pred CcccccccCCCccccccCCHHHh-------------ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 33222222223456789999654 35567889999999999999997 999997654332211100
Q ss_pred ----hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 272 ----VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 272 ----~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.+..++..+.+++ +|..||++.++++.++.+....
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1112333344333 9999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=261.99 Aligned_cols=240 Identities=26% Similarity=0.392 Sum_probs=193.2
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++.+.||.|++|.||+|.. .++..+++|++.... ......+.+|++.++.++|+|++++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 5799999999999999999995 468899999987543 33557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 120 MPNGSLENWLYSH--NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 120 ~~~~sL~~~i~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
+++++|.+++... ...+++..+..++.|++.|+++|| +.|++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999764 235899999999999999999999 9999999999999999999999999999887765433
Q ss_pred Ccc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh---
Q 047043 198 DSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV--- 272 (314)
Q Consensus 198 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~--- 272 (314)
... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||..............
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~------------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQ------------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224 (267)
T ss_pred cccccccccccCChhhcChHHHcc------------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC
Confidence 221 1223457889999987541 23567889999999999999999999976543221111100
Q ss_pred --------hccCCchhhhhc------cccCCCCHHHHHH
Q 047043 273 --------NESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 273 --------~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+++.+.+++ ||..||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 013344444443 8999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=263.79 Aligned_cols=239 Identities=25% Similarity=0.348 Sum_probs=183.9
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHH-HHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEV-LRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||+|+||.||+|.. .+|+.||+|.++.... .....+..|... ++..+|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999995 4799999999876532 222344455554 556689999999999999999999999
Q ss_pred ecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 119 LMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 119 ~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
|++ ++|.+++.. .+..+++..++.++.|++.|++||| ++ +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 588888764 2345899999999999999999999 66 99999999999999999999999999987654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--- 271 (314)
... ......++..|+|||.+.. ......++.++|+|||||++|+|++|..||.............
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~---------~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (283)
T cd06617 156 DSV---AKTIDAGCKPYMAPERINP---------ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223 (283)
T ss_pred ccc---ccccccCCccccChhhcCC---------cccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence 321 1122357888999987631 1112446788999999999999999999997543321111111
Q ss_pred -----hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 -----VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 -----~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
....+++.+.+++ +|..||++.++++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123455555544 9999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=261.80 Aligned_cols=238 Identities=26% Similarity=0.348 Sum_probs=187.3
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-----cHHHHHHHHHHHHHHhCCCCCcceeeccccc--CCce
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 113 (314)
.+|+..+.||+|++|.||+|.. .++..|++|.+.... .+....+.+|+.+++.++|||++++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4799999999999999999995 478999999886432 2344678889999999999999999998765 4677
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++++||+++++|.+++...+. +++..++.++.|++.||++|| +++++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999999977654 789999999999999999999 899999999999999999999999999988765
Q ss_pred CCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-
Q 047043 194 GDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 194 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~- 271 (314)
...... .......++..|+|||.+ .+..++.++|+|||||++|+|++|..||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~ 223 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVI-------------SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (266)
T ss_pred ccccccCCccccCCccccccCHHHh-------------CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 321111 111123478889999765 34456789999999999999999999998654322111111
Q ss_pred ------hhccCCchhhhhc-----cccCCCCHHHHHH
Q 047043 272 ------VNESLPHALTDVV-----DANLRVSMKDVAA 297 (314)
Q Consensus 272 ------~~~~~~~~l~~ll-----dp~~Rpt~~~~~~ 297 (314)
.+..+++.+++++ +|..||+++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 QPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCCchhcCHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1122334444433 9999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.50 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=192.0
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccC--
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP-- 110 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 110 (314)
.++....++|++.+.||+|++|.||++.. .+++.+++|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 45555688999999999999999999995 578999999987542 2235677899999988 799999999988643
Q ss_pred ---CceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 111 ---DFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 111 ---~~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
+..+++|||+++++|.+++.. .+..+++..++.++.|++.||.+|| ..|++|+||||+||+++.++.++|
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEE
Confidence 468999999999999998863 3345899999999999999999999 899999999999999999999999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~ 264 (314)
+|||++........ ......++..|+|||.+... ......++.++|+|||||++|+|++|..||......
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACE--------QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCC--------CCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99998876543221 11223578889999876421 112234678999999999999999999999875432
Q ss_pred hhhhhhh--------hhccCCch----hhhhc--cccCCCCHHHHHHH
Q 047043 265 EISLKNW--------VNESLPHA----LTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 265 ~~~~~~~--------~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~ 298 (314)
....... ....++.. +.+++ +|..||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2211110 01122233 34444 99999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.31 Aligned_cols=229 Identities=22% Similarity=0.295 Sum_probs=178.5
Q ss_pred eeeecCceEEEEEEeC-C------------------------CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCccee
Q 047043 49 LLGTGSFGIVYKGILS-D------------------------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~~-~------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 103 (314)
.||+|+||.||+|... + ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999731 1 13588998876655555678889999999999999999
Q ss_pred ecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---
Q 047043 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM--- 180 (314)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~--- 180 (314)
++++......++||||+++++|..++......+++..+..++.|++.||+||| +.|++|+||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998776556899999999999999999999 89999999999999997543
Q ss_pred ----cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh-cCC
Q 047043 181 ----VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF-TGK 255 (314)
Q Consensus 181 ----~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll-~g~ 255 (314)
.++++|||.+...... ....++..|+|||.+. ....++.++||||||+++|+|+ +|.
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~------------~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVP------------GGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhc------------CCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 4899999987543221 1124677899997653 2355788999999999999984 799
Q ss_pred CCCCccccchhhhh----hhhhccCCc----hhhhhc--cccCCCCHHHHHHHH
Q 047043 256 KPTDEMFTGEISLK----NWVNESLPH----ALTDVV--DANLRVSMKDVAAKL 299 (314)
Q Consensus 256 ~Pf~~~~~~~~~~~----~~~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~l 299 (314)
.||......+.... ...+...+. .+..++ +|.+||++.++++.|
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 220 VPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99976544332111 011111222 334444 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.47 Aligned_cols=190 Identities=22% Similarity=0.293 Sum_probs=161.2
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++..+...+++||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999954 6889999975433 234689999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+. ++|.+++......+++..+..++.|++.||.||| ..|++||||||+||+++.++.++|+|||++.......
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 95 5999988776666899999999999999999999 8999999999999999999999999999887532221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
......||..|+|||++ .+..++.++|||||||++|+|+++..|
T Consensus 212 -~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVL-------------ARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred -ccccccccccccCCeec-------------CCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 12234589999999765 345578899999999999999985544
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=258.73 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=196.7
Q ss_pred ceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEEecCCCCH
Q 047043 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
+.||.|+++.|--+. ..+|..+|||++.+...-...+..+|++++.+++ |+||++++++|++...+|+|||.+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 479999999999998 7799999999999886656678889999999996 99999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEEEEeeecceecCCCCC----
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VARVSDFGISKLLGDGED---- 198 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ikl~Dfg~~~~~~~~~~---- 198 (314)
...|.+... ++|.++..+..+++.||.||| .+||.||||||+|||-.+.+ -+|||||++..-......
T Consensus 164 LshI~~~~~-F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 164 LSHIQKRKH-FNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 999988765 899999999999999999999 99999999999999986444 489999998755422111
Q ss_pred -cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc--------------
Q 047043 199 -SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT-------------- 263 (314)
Q Consensus 199 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~-------------- 263 (314)
.+.-...+|+.+|+|||+..- -+.....|+.+.|.||||+++|-||.|..||.+.-.
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~--------fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDV--------FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred CCccccCcccchhhcchhHHhh--------hccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 111234678999999998742 234566789999999999999999999999976432
Q ss_pred ----------chhhhhhhhhccCCchhhhhccccCCCCHHHHHHHHHhhhhheeeee
Q 047043 264 ----------GEISLKNWVNESLPHALTDVVDANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 264 ----------~~~~~~~~~~~~~~~~l~~lldp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
+...++..-+..++...++++..-.--.+.+.+...+-+-|+|+...
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 22233333445566666666633333445555555555556766543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=260.58 Aligned_cols=238 Identities=32% Similarity=0.491 Sum_probs=190.5
Q ss_pred ccccceeeecCceEEEEEEeC-CC----CeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DG----NNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
+++.+.||.|+||.||++... ++ ..|++|.++..... ....+.+|+++++.++|+|++++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467889999999999999954 34 88999999766433 5678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 118 ELMPNGSLENWLYSHNYF-LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~-~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|++++++|.+++...... +++..+..++.|++.|+++|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999765544 899999999999999999999 899999999999999999999999999998776543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK------ 269 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~------ 269 (314)
...... ...++..|+|||.+ ....++.++|+||||+++|+|++ |..||...........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~-------------~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESL-------------KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR 222 (258)
T ss_pred cccccc-cCCCcccccChHHh-------------ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 221111 22367889999654 34567789999999999999998 8899876443222111
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
......++..+.+++ ||..|||+.++++.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111223444444444 999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=281.71 Aligned_cols=194 Identities=21% Similarity=0.246 Sum_probs=164.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..+|.+.+.||+|+||.||+|.+ .+++.|++|.... ..+.+|++++++++|+||+++++++..+...+++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34799999999999999999995 4688999996332 3456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+. ++|.+++......+++..+..++.|++.||.||| ..|++|+||||+||+++.++.++|+|||++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 6999988776556899999999999999999999 899999999999999999999999999998766433222
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCC
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT 258 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf 258 (314)
.......||..|+|||++ .+..++.++|||||||++|||++|..|+
T Consensus 317 ~~~~~~~GT~~Y~APE~~-------------~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVL-------------AGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHH-------------cCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 222234589999999765 3455788999999999999999877553
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=257.99 Aligned_cols=236 Identities=27% Similarity=0.452 Sum_probs=191.0
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|+..+.||.|++|.||+|.. .+++.+++|.+.... ......+.+|+++++.++|||++++++.+..++..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999995 478999999987652 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEeeecceecCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDFGISKLLGDGE 197 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Dfg~~~~~~~~~ 197 (314)
+++++|.+++... +..+++..+..++.+++.++++|| ++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999764 344789999999999999999999 8999999999999999855 467999999988765432
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
.. ....++..|+|||.. ....++.++||||||+++|+|++|..||+............
T Consensus 157 ~~---~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd08220 157 KA---YTVVGTPCYISPELC-------------EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP 220 (256)
T ss_pred cc---cccccCCcccCchhc-------------cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC
Confidence 21 224578899999764 34456788999999999999999999998754433222111
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
....++..+.+++ +|..|||+.+++++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1223444444544 99999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=258.76 Aligned_cols=236 Identities=26% Similarity=0.356 Sum_probs=193.3
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++.+.||.|++|.||+|... +++.|++|.+..... .....+.+|+..+..++|+|++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999954 699999999887644 4457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+++.... .+++..+..++.|++.|+.+|| . .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999998764 4899999999999999999999 8 9999999999999999999999999999887644322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc--chhhhhhh-----
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT--GEISLKNW----- 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~--~~~~~~~~----- 271 (314)
. .....++..|+|||.. ....++.++|+||||+++|+|++|..||..... ........
T Consensus 156 ~--~~~~~~~~~y~~pE~~-------------~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERI-------------QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220 (264)
T ss_pred c--ccceeecccccCHhhh-------------CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC
Confidence 1 1223578889999764 344678899999999999999999999977642 11101110
Q ss_pred --hhcc-CCchhhhhc------cccCCCCHHHHHH
Q 047043 272 --VNES-LPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 --~~~~-~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.... ++..+.+++ +|..||++.++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1122 444455544 8999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.96 Aligned_cols=237 Identities=24% Similarity=0.381 Sum_probs=190.1
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.+.|+..+.||.|++|.||+|.. .+++.||+|.++... ......+.+|+++++.++|||++++++.+..++..++|||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 35688889999999999999985 468899999987543 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++... .+++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 83 YLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999988653 3789999999999999999999 89999999999999999999999999999876543221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------hh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------WV 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~~ 272 (314)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||............ ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 221 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIK-------------QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL 221 (277)
T ss_pred --hhhcccCcccccCHHHhC-------------cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCC
Confidence 112234788899997653 445678999999999999999999998764433211110 01
Q ss_pred hccCCchhhh----hc--cccCCCCHHHHHHH
Q 047043 273 NESLPHALTD----VV--DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ~~~~~~~l~~----ll--dp~~Rpt~~~~~~~ 298 (314)
...++..+.+ ++ +|..||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223333444 44 99999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=265.13 Aligned_cols=202 Identities=24% Similarity=0.340 Sum_probs=169.8
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccC--CceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 115 (314)
.++|++.+.||.|++|.||+|..+ +++.+++|.++..... ....+.+|+.++++++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999954 6899999999765322 223566899999999999999999998776 89999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||++ ++|.+++......+++..+..++.|++.||+||| .+|++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999996 4999998876656899999999999999999999 89999999999999999999999999998887654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
... ......++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLL------------GAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Ccc--ccccccccccccCchhhc------------CCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 112234788899997653 2233577899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=268.51 Aligned_cols=204 Identities=26% Similarity=0.366 Sum_probs=168.9
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccC--Ccee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 114 (314)
..++|++.+.||.|++|.||+|.. .+|+.||+|.++..... ......+|+.++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 357899999999999999999995 47999999999765321 123456799999999999999999998654 5689
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+. ++|.+++......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999996 4899988876566899999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
..... .....++..|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~------------~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLL------------GCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CccCC--CCcccccccccChhhhc------------CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43211 12233577899997653 23456789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=262.26 Aligned_cols=240 Identities=26% Similarity=0.407 Sum_probs=189.2
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc----------HHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG----------RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
+|.+.+.||.|++|.||+|.. .+++.+++|.++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999994 4789999998864311 12346778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..+++|||+++++|.+++...+ .+++..+..++.|++.|+.+|| ++|++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999998765 4889999999999999999999 8999999999999999999999999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh--
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-- 269 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-- 269 (314)
...............++..|+|||.+.. ....++.++|+||||+++|++++|..||...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 225 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHS-----------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG 225 (272)
T ss_pred cccccccccccccccCCccccCHHHhcc-----------ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh
Confidence 6543221111222347888999987541 113467889999999999999999999975433211110
Q ss_pred ---------hhhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 270 ---------NWVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 270 ---------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
......++..+.+++ +|..||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 011123455555544 99999999998873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.11 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=192.9
Q ss_pred HhcCccccceeeecCceEEEEEEeC--------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccccc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS--------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN 109 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (314)
...+|++.+.||+|+||.||+|.+. .+..+++|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3457999999999999999999742 12368999887543 33456788999999999 79999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 110 PDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
.+..++++||+++++|.+++.+.. ..++..++..++.|++.||+||| .+|++|+||||+||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Ni 165 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNV 165 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceE
Confidence 999999999999999999987532 23667788999999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT- 253 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~- 253 (314)
+++.++.++|+|||++................++..|+|||.+ .+..++.++||||||+++|+|++
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-------------FDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-------------ccCCcCchhhhHHHHHHHHHHHhc
Confidence 9999999999999998766443222122222345679999765 34557788999999999999998
Q ss_pred CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 254 GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
|..||......+..... ..+..++..+.+++ +|..||++.++++.++.+.
T Consensus 233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 233 GGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 88999775443321111 11122333444443 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=259.74 Aligned_cols=240 Identities=28% Similarity=0.427 Sum_probs=183.3
Q ss_pred ceeeecCceEEEEEEeC----CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccc-cCCceeEEEEecC
Q 047043 48 NLLGTGSFGIVYKGILS----DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCS-NPDFKALVLELMP 121 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 121 (314)
+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|..+++.++|||++++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 23579999885432 344567888999999999999999999764 4566889999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc--
Q 047043 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-- 199 (314)
Q Consensus 122 ~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~-- 199 (314)
+++|.+++.+.....++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999876555778888999999999999999 899999999999999999999999999998755332110
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------V 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~ 272 (314)
.......++..|+|||.. .+..++.++||||||+++|+|++ |..||......+...... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESL-------------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ 223 (262)
T ss_pred cccccCcCCccccChhHh-------------ccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 011123356789999754 34457789999999999999999 566776544332211111 1
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
+..++..+.+++ +|..||++.++++.++.+..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 222344455544 99999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=264.44 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=191.6
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...|+..+.||.|++|.||.|... +++.||+|.++... ......+.+|+.+++.+.|||++++++.+.+.+..+++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 456889999999999999999954 68899999988653 3445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 83 YLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999998754 3788999999999999999999 89999999999999999999999999999876643221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------hh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------WV 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~~ 272 (314)
......++..|+|||.. .+..++.++|+||||+++|+|++|..||............ ..
T Consensus 157 --~~~~~~~~~~y~apE~~-------------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 221 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVI-------------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL 221 (277)
T ss_pred --ccccccCcccccCHhHh-------------ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCC
Confidence 12223578889999764 3445678999999999999999999999865433221110 11
Q ss_pred hccCCc----hhhhhc--cccCCCCHHHHHHH
Q 047043 273 NESLPH----ALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ~~~~~~----~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
...++. .+..++ +|..||++.+++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112233 344444 99999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=268.97 Aligned_cols=239 Identities=27% Similarity=0.355 Sum_probs=189.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||.|++|.||+|.. .+++.+++|.+..... .....+.+|+++++.++||||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999995 4699999999976532 24567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 118 ELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 118 e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
||+.+++|.+++... +..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998754 345899999999999999999999 899999999999999999999999999987655322
Q ss_pred CCcc---------------------------eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHH
Q 047043 197 EDSV---------------------------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLM 249 (314)
Q Consensus 197 ~~~~---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~ 249 (314)
.... ......|+..|+|||... +..++.++||||||+++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------------~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-------------GDGHGSAVDWWTLGILLY 223 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-------------CCCCCchHHHHHHHHHHH
Confidence 1100 011235788899997653 445678999999999999
Q ss_pred HHhcCCCCCCccccchhhhhhh-----h--hccCCchhhhh----c--cccCCCC----HHHHHH
Q 047043 250 ETFTGKKPTDEMFTGEISLKNW-----V--NESLPHALTDV----V--DANLRVS----MKDVAA 297 (314)
Q Consensus 250 ~ll~g~~Pf~~~~~~~~~~~~~-----~--~~~~~~~l~~l----l--dp~~Rpt----~~~~~~ 297 (314)
+|++|..||............. . ...++..++++ + ||..||+ +.+++.
T Consensus 224 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 224 EMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999999997654332111100 0 11134444444 4 9999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=257.84 Aligned_cols=237 Identities=23% Similarity=0.340 Sum_probs=190.8
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||+|+||.+|.+.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999994 578999999987542 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++++|.+.+... ...+++..+..++.|++.|+.+|| ++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999998764 334789999999999999999999 89999999999999999999999999998876643221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------h
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------V 272 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------~ 272 (314)
. .....++..|+|||.. .+..++.++|+||||+++++|++|..||......+...... .
T Consensus 157 ~--~~~~~~~~~~~~pe~~-------------~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08218 157 L--ARTCIGTPYYLSPEIC-------------ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV 221 (256)
T ss_pred h--hhhccCCccccCHHHh-------------CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC
Confidence 1 1123478889999764 34456778999999999999999999997644332211111 1
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
+..++..+.+++ +|..||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 223344444443 99999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.56 Aligned_cols=235 Identities=22% Similarity=0.361 Sum_probs=187.4
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
+.|.....||.|+||.||++.. .++..|++|.+..........+.+|+.+++.++|+|++++++.+..++..+++|||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 4445456799999999999995 478999999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++... .+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 102 ~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 102 EGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 999999987543 3789999999999999999999 89999999999999999999999999998875533221
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--hhhhhh------
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--SLKNWV------ 272 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--~~~~~~------ 272 (314)
......++..|+|||.. .+..++.++|+||||+++|+|++|..||........ ......
T Consensus 174 ~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVI-------------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240 (292)
T ss_pred cCceeecCccccCHHHH-------------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccc
Confidence 11234578899999765 344567799999999999999999999976433221 111111
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHH
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+++.+.+++ ||.+|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112344444443 9999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=265.12 Aligned_cols=237 Identities=24% Similarity=0.291 Sum_probs=185.7
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||.|+||.||++..+ +++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999954 68899999987653 223456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIGA-LPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999999977654 889999999999999999999 8999999999999999999999999999875321100
Q ss_pred C-------------cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc
Q 047043 198 D-------------SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264 (314)
Q Consensus 198 ~-------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~ 264 (314)
. ........++..|+|||.+ ....++.++|+||||+++|+|++|..||.+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI-------------LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhc-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0 0011123467889999764 3455778999999999999999999999765433
Q ss_pred hhhhhhh--------hhccCCchhhhhc------cccCCCCHHHHH
Q 047043 265 EISLKNW--------VNESLPHALTDVV------DANLRVSMKDVA 296 (314)
Q Consensus 265 ~~~~~~~--------~~~~~~~~l~~ll------dp~~Rpt~~~~~ 296 (314)
+...... ....++..+.+++ ||.+||+..++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 268 (305)
T cd05609 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAF 268 (305)
T ss_pred HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHH
Confidence 2211111 0113455455554 999999864333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=262.69 Aligned_cols=200 Identities=24% Similarity=0.382 Sum_probs=167.5
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|+.++.||.|++|.||+|.. .+++.|++|.++... ......+.+|++++++++|||++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 588999999999999999995 479999999987543 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+. ++|.+++... +..+++..+..++.|++.|++||| ..|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5898888653 345789999999999999999999 89999999999999999999999999998876543221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
. .....++..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 156 ~--~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILL------------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred c--cccccccccccCCeEEe------------cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 12234678899998753 2234577899999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=258.77 Aligned_cols=237 Identities=23% Similarity=0.372 Sum_probs=187.9
Q ss_pred CccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc------cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 43 GFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
+|+..+.||+|++|.||++. ..+++.+++|+++... ......+.+|+.+++.++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999 4579999999987543 1235678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~~ 194 (314)
++||+++++|.+++.+.+. +++..+..++.|++.||++|| ++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999999976553 789999999999999999999 89999999999999998776 59999999987764
Q ss_pred CCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-hhh-h
Q 047043 195 DGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-SLK-N 270 (314)
Q Consensus 195 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~~~-~ 270 (314)
..... .......++..|+|||.+. +..++.++|+||||+++|+|++|..||........ ... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~-------------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 222 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLR-------------GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222 (268)
T ss_pred cccccCCccccccccccceeCHhHhc-------------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH
Confidence 33111 1112235788999997653 34567789999999999999999999975332111 100 0
Q ss_pred --------hhhccCCchhhh----hc--cccCCCCHHHHHH
Q 047043 271 --------WVNESLPHALTD----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 271 --------~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~ 297 (314)
..+..++..+.+ ++ +|..||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111223343444 44 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=265.50 Aligned_cols=194 Identities=22% Similarity=0.294 Sum_probs=156.3
Q ss_pred ceeeecCceEEEEEEeC---CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc--cCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS---DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS--NPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|+.+ ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999954 457899998875432 245778999999999999999999874 4567889999986
Q ss_pred CCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe----cCCCcEEEEeeecc
Q 047043 123 GSLENWLYSH--------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL----DENMVARVSDFGIS 190 (314)
Q Consensus 123 ~sL~~~i~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili----~~~~~ikl~Dfg~~ 190 (314)
++|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888877532 224788899999999999999999 8999999999999999 46678999999999
Q ss_pred eecCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 191 KLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 191 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.......... ......+|+.|+|||.+. ....++.++|||||||++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLL------------GARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhc------------CCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 8764432211 122345789999998753 234567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=258.33 Aligned_cols=235 Identities=31% Similarity=0.495 Sum_probs=187.2
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||+|+||.||.+.. +++.+++|.++... ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 46799999999999999999875 67889999987653 235788899999999999999999998764 468999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++++|.+++.... ..+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999997653 34789999999999999999999 9999999999999999999999999999887643221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~ 272 (314)
.....+..|+|||.+ .+..++.++|+||||+++|+|++ |..||......+..... ..
T Consensus 155 ---~~~~~~~~y~~pe~~-------------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (254)
T cd05083 155 ---DNSKLPVKWTAPEAL-------------KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP 218 (254)
T ss_pred ---CCCCCCceecCHHHh-------------ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC
Confidence 112245679999754 34557789999999999999997 99999765443321111 01
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
...++..+.+++ +|..||++.++++.++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 223444444444 89999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.70 Aligned_cols=240 Identities=27% Similarity=0.400 Sum_probs=191.7
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||+|++|.||++.. .+++.|++|.++.... .....+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 689999999999999999994 4789999999987644 3667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++..... +++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcCC-CChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999877543 788899999999999999999 899999999999999999999999999998876543221
Q ss_pred ce--eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-hhhhh-----
Q 047043 200 VT--QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-SLKNW----- 271 (314)
Q Consensus 200 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~~~~~----- 271 (314)
.. .....++..|+|||.+.. .....++.++||||||++++++++|..||........ .....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~----------~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITG----------GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccC----------CCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC
Confidence 11 112457888999987631 1123477899999999999999999999976532211 11000
Q ss_pred -hhc--cCCc----hhhhhc--cccCCCCHHHHHH
Q 047043 272 -VNE--SLPH----ALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 272 -~~~--~~~~----~l~~ll--dp~~Rpt~~~~~~ 297 (314)
.+. .++. .+.+++ +|..||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011 1133 344444 9999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.49 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=189.0
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccc----
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCS---- 108 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 108 (314)
.+......+|+.++.||+||||.||+++.+ +|+.||||.|.... ......+.+|+..+++|+|||+|++|..|.
T Consensus 472 r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 472 RQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred cchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 333578899999999999999999999965 89999999998763 345677889999999999999999986320
Q ss_pred --------------------------------------------------------------------------c-----
Q 047043 109 --------------------------------------------------------------------------N----- 109 (314)
Q Consensus 109 --------------------------------------------------------------------------~----- 109 (314)
+
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ----------------------------C--------CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Q 047043 110 ----------------------------P--------DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153 (314)
Q Consensus 110 ----------------------------~--------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~ 153 (314)
+ ..+|+-||||+..++.+++..+...-.....|.++++|++||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 0 2356789999887777777665532256789999999999999
Q ss_pred HHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC----------C------CCCcceeecccceeeeecCccc
Q 047043 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG----------D------GEDSVTQTMTMATIGYMAPVSQ 217 (314)
Q Consensus 154 ~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~----------~------~~~~~~~~~~~~t~~y~aPE~~ 217 (314)
|+| +.|++||||||.|||+++++.|||+|||+++... . .......+...||.-|.|||++
T Consensus 712 YIH----~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIH----DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHH----hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999 9999999999999999999999999999998721 0 0111123345799999999887
Q ss_pred cccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhccCCch--------------hhhh
Q 047043 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHA--------------LTDV 283 (314)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------l~~l 283 (314)
. ......|+.|+|+||||++++||+ .||+........+.......+|.. ++.+
T Consensus 788 ~----------~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 788 S----------DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred c----------ccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 4 222347999999999999999999 567654444443333333333332 3333
Q ss_pred c--cccCCCCHHHHHH
Q 047043 284 V--DANLRVSMKDVAA 297 (314)
Q Consensus 284 l--dp~~Rpt~~~~~~ 297 (314)
+ ||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 4 9999999999986
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=264.99 Aligned_cols=240 Identities=25% Similarity=0.300 Sum_probs=190.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
......|++.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34457799999999999999999995 478999999986432 23446788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++|+||+. +++.+.+......+++..+..++.|++.||.||| ..|++|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999996 5888887765556899999999999999999999 899999999999999999999999999988654
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
... ....++..|+|||.+.. .....++.++||||||+++|+|++|..||............
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~----------~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 229 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILA----------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (307)
T ss_pred CCC------CCccCCccccCceeeec----------cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC
Confidence 322 12347788999987631 12345778999999999999999999999765432211110
Q ss_pred ----hhhccCCchh----hhhc--cccCCCCHHHHHHH
Q 047043 271 ----WVNESLPHAL----TDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ----~~~~~~~~~l----~~ll--dp~~Rpt~~~~~~~ 298 (314)
.....+++.+ .+++ +|..||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111233334 4444 99999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=275.21 Aligned_cols=200 Identities=29% Similarity=0.373 Sum_probs=172.0
Q ss_pred HHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-C-----CCcceeecccccC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-H-----RNLLKIFSSCSNP 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~ 110 (314)
..+.-+|++.+.||+|.||.|.+|. .++++.||||+++.. ....++-..|+.+|..++ | -|+|+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3345589999999999999999999 678999999999977 445567778999999986 3 4899999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC--CcEEEEee
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN--MVARVSDF 187 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~--~~ikl~Df 187 (314)
+.+++|+|.+ ..+|+++++.++ ..++...+..++.||+.||.+|| +.||||+||||+|||+.+. ..+|++||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEec
Confidence 9999999998 569999998764 34889999999999999999999 9999999999999999643 47999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
|+++....... ..+-+..|.|||++ .+.+|+.+.||||||||+.||++|.+.|.+.
T Consensus 336 GSSc~~~q~vy-----tYiQSRfYRAPEVI-------------LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 336 GSSCFESQRVY-----TYIQSRFYRAPEVI-------------LGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccccCCcce-----eeeeccccccchhh-------------ccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 99987654332 34567789999655 6889999999999999999999998877653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=259.14 Aligned_cols=236 Identities=30% Similarity=0.457 Sum_probs=182.3
Q ss_pred ceeeecCceEEEEEEeC-CCC--eEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS-DGN--NVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||.|+||.||+|..+ ++. .+++|.++... ......+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999954 454 46888877432 33446788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 123 GSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 123 ~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
++|.+++.... ..+++..+..++.|++.|++||| +.|++|+||||+||+++.++.++|+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEECCC
Confidence 99999987532 23678899999999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~ 266 (314)
|++....... .......+..|+|||.+ ....++.++|+||||+++|+|++ |..||......+.
T Consensus 157 gl~~~~~~~~---~~~~~~~~~~y~apE~~-------------~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~ 220 (270)
T cd05047 157 GLSRGQEVYV---KKTMGRLPVRWMAIESL-------------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220 (270)
T ss_pred CCccccchhh---hccCCCCccccCChHHH-------------ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH
Confidence 9875322110 11112235679999764 34456789999999999999997 9999976543321
Q ss_pred hhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 267 SLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 267 ~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.... ..+..++..+.+++ +|..||++.++++.|+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1110 01122334444443 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=263.48 Aligned_cols=239 Identities=25% Similarity=0.342 Sum_probs=192.2
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...++|++.+.||+|+||.||++.. .+++.|++|.+..........+.+|+.+++.++|||++++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3457999999999999999999994 478899999987654455577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++.+.. +++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999999987643 788899999999999999999 9999999999999999999999999999877654332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
. ......+++.|+|||... ...++.++|+||||+++|++++|..||.............
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~-------------~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVT-------------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234 (293)
T ss_pred c--ccccccCChhhcCchhhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCC
Confidence 2 122345788899997643 3456789999999999999999999997654322111000
Q ss_pred --hhccCCch----hhhhc--cccCCCCHHHHHHH
Q 047043 272 --VNESLPHA----LTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 272 --~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~ 298 (314)
....++.. +.+++ +|..||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123333 44444 99999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=266.20 Aligned_cols=203 Identities=24% Similarity=0.323 Sum_probs=166.7
Q ss_pred CccccceeeecCceEEEEEEe-C--CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccC--Ccee
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-S--DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKA 114 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 114 (314)
+|++.+.||+|++|.||+|.. . +++.||+|.+.... ......+.+|+.+++.++|||++++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 588999999999999999995 3 58899999998732 33345678899999999999999999999887 7899
Q ss_pred EEEEecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC----CCcEEEEe
Q 047043 115 LVLELMPNGSLENWLYSH----NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE----NMVARVSD 186 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~----~~~ikl~D 186 (314)
+||||+++ ++.+.+... ...+++..++.++.|++.||+||| +.+++|+||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999964 777776532 225789999999999999999999 899999999999999998 89999999
Q ss_pred eecceecCCCCC-cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 187 FGISKLLGDGED-SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 187 fg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
||++........ ........++..|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLL------------GARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHh------------CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999886644322 11122335788899998653 23346778999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=265.54 Aligned_cols=208 Identities=22% Similarity=0.319 Sum_probs=169.1
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCC--
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-- 111 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (314)
.....++|++.+.||.|++|.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 445678899999999999999999995 4799999998865432 12234567999999999999999999876543
Q ss_pred ------ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 112 ------FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 112 ------~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
..+++|||+. ++|.+.+...+..+++..++.++.|++.||+||| +.|++|+||+|+||+++.++.++|+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEEC
Confidence 4589999995 5898888776656899999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 186 DFGISKLLGDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 186 Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
|||++......... .......++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL------------GERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhc------------CCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99998766433221 1112335678899998653 2233567899999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=262.38 Aligned_cols=201 Identities=21% Similarity=0.320 Sum_probs=164.4
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCC-CCCcceeecccccCCc-----
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDF----- 112 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 112 (314)
++|++.+.||.|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.+. |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999995 4799999999875432 12356778999999995 6999999998876555
Q ss_pred eeEEEEecCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEee
Q 047043 113 KALVLELMPNGSLENWLYSHN----YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDF 187 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Df 187 (314)
.+++|||+++ +|.+++.... ..+++..+..++.|++.||.||| ..|++|+||+|+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999975 8988876532 34789999999999999999999 899999999999999998 889999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
|.+..+...... .....+++.|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 156 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 156 GLGRAFSIPVKS--YTHEIVTLWYRAPEVLL------------GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred ccceecCCCccc--cCCcccccCCCChHHhh------------CCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 988765332211 11234678899998653 2344678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=264.76 Aligned_cols=237 Identities=21% Similarity=0.319 Sum_probs=188.8
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
...|+....||.|+||.||+|.. .+++.|++|.++.........+.+|+.+++.++|||++++++.+..++..++++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 34566677899999999999995 47899999999765444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++... .+++..+..++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 100 LQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-
Confidence 9999999987653 3789999999999999999999 89999999999999999999999999998865533221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--------W 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--------~ 271 (314)
......++..|+|||.+. +..++.++||||||+++|+|++|..||......+..... .
T Consensus 173 -~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVIS-------------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK 238 (297)
T ss_pred -cccceecCccccCHHHHc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCcc
Confidence 122345888999997653 345678999999999999999999999754322211000 0
Q ss_pred hhccCCchhhh----hc--cccCCCCHHHHHHH
Q 047043 272 VNESLPHALTD----VV--DANLRVSMKDVAAK 298 (314)
Q Consensus 272 ~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~ 298 (314)
....++..+.+ ++ +|.+||++.+++++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11123333444 44 99999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.22 Aligned_cols=241 Identities=19% Similarity=0.237 Sum_probs=177.3
Q ss_pred eeeecCceEEEEEEeCCC---CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCC
Q 047043 49 LLGTGSFGIVYKGILSDG---NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGS 124 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s 124 (314)
.||+|+||.||+++..++ ..+++|.++... ......+.+|+.+++.++|||++++++.+.+....+++|||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999984333 345667665443 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 125 LENWLYSHN---YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 125 L~~~i~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
|.+++.+.. ...++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999997642 23566778899999999999999 89999999999999999999999999998754322111111
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh---------
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW--------- 271 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~--------- 271 (314)
.....++..|+|||...... .......++.++||||||+++|+|++ |..||......+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFH------GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhccccc------CccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence 22345788899998764210 01123346789999999999999996 677887544322111100
Q ss_pred --hhccCCchhhhh----c-cccCCCCHHHHHHHH
Q 047043 272 --VNESLPHALTDV----V-DANLRVSMKDVAAKL 299 (314)
Q Consensus 272 --~~~~~~~~l~~l----l-dp~~Rpt~~~~~~~l 299 (314)
....+++.+.++ + +|.+||++.++++.|
T Consensus 232 ~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 PQLELPYSERWYEVLQFCWLSPEKRATAEEVHRLL 266 (268)
T ss_pred CccCCCCcHHHHHHHHHHhhCcccCCCHHHHHHHh
Confidence 011223333333 3 999999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=259.25 Aligned_cols=234 Identities=27% Similarity=0.388 Sum_probs=187.4
Q ss_pred eeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||.|++|.||+|.. .+++.+++|++..... .....+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999995 4689999999976431 3446788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecc
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~ 205 (314)
.+++.+... +++..+..++.|++.||.||| ++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRGL-FDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999987644 789999999999999999999 8999999999999999999999999999988765432 11223
Q ss_pred cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh-hhh--------hhccC
Q 047043 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-KNW--------VNESL 276 (314)
Q Consensus 206 ~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-~~~--------~~~~~ 276 (314)
.++..|+|||.+ ....++.++|+||||+++|+|++|..||.......... ... .+...
T Consensus 153 ~~~~~~~~PE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEII-------------LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHh-------------cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCccc
Confidence 578889999764 34456788999999999999999999998765211111 111 11222
Q ss_pred Cchhhh----hc--cccCCCC-----HHHHHHHHHhhhhheeeee
Q 047043 277 PHALTD----VV--DANLRVS-----MKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 277 ~~~l~~----ll--dp~~Rpt-----~~~~~~~l~~~~~~~~~~~ 310 (314)
++.+.+ ++ +|..||+ +.|+++ ++|+++.
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~ 258 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK------HKWFNGF 258 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc------ChhhhCC
Confidence 334444 44 9999999 788877 7777654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.78 Aligned_cols=236 Identities=29% Similarity=0.409 Sum_probs=193.2
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecC
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
+|++.+.||+|++|.||++... +++.+++|.+..........+.+|+++++.++|++++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5888999999999999999954 789999999987755566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 122 ~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
+++|.+++......+++..+..++.|++.++.+|| ..|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999999876556899999999999999999999 89999999999999999999999999998877654321
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------h--h
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------V--N 273 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------~--~ 273 (314)
.....++..|+|||... +..++.++|+||||+++|+|++|..||............. . .
T Consensus 154 ~~~~~~~~~~~~PE~~~-------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVIN-------------GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP 220 (253)
T ss_pred ccceecCCcccCHHHHc-------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcc
Confidence 22345788899997653 3336789999999999999999999998653222111100 0 1
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..++..+.+++ ||..|||+.+++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11134444444 99999999999873
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.24 Aligned_cols=201 Identities=24% Similarity=0.411 Sum_probs=168.8
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
+|++.+.||.|++|.||+|... +|+.|++|.++.... .....+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999964 789999999876532 23356678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 121 PNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 121 ~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
++ +|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 8998887643 45899999999999999999999 89999999999999999999999999998875533221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......++..|++||.+. ....++.++|+||||+++|+|++|..||....
T Consensus 156 --~~~~~~~~~~y~~PE~~~------------~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLL------------GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred --ccccccccccccChHHhc------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234678899997653 23346778999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=253.76 Aligned_cols=237 Identities=28% Similarity=0.401 Sum_probs=194.1
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccC--CceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 117 (314)
+|...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+.++++++|||++++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5788899999999999999954 799999999977643 4567888999999999999999999999988 8999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|++++++|.+++.... .+++..++.++.|++.+++||| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998765 5899999999999999999999 8999999999999999999999999999988775543
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh--------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-------- 269 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-------- 269 (314)
.........++..|.|||.+. ....+.++|+||||+++|+|++|..||....+......
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~-------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIR-------------GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhhc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC
Confidence 211122345788999997643 34478899999999999999999999987552111111
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+...+..+.+++ +|..||++.+++.
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 112233444555554 9999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=263.15 Aligned_cols=237 Identities=25% Similarity=0.330 Sum_probs=190.5
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||+|++|.||++.. .+++.|++|++.... ......+.+|+++++.++||||+++++.+...+..+++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46899999999999999999995 468999999987653 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++...+. +++..+..++.+++.++.|||+ ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGGP-IPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred cCCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999998876543 8899999999999999999993 3689999999999999999999999999876543221
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch----------hhh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE----------ISL 268 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~----------~~~ 268 (314)
.....++..|+|||.+ .+..++.++|+|||||++|++++|..||....... ...
T Consensus 159 ---~~~~~~~~~~~aPE~~-------------~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd06620 159 ---ADTFVGTSTYMSPERI-------------QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222 (284)
T ss_pred ---cCccccCcccCCHHHH-------------ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence 1224588999999764 34467789999999999999999999998644320 000
Q ss_pred hhhh--------hccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 269 KNWV--------NESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 269 ~~~~--------~~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
.... ...++..+.++ + ||..||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111 11134444444 4 99999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=259.97 Aligned_cols=231 Identities=26% Similarity=0.288 Sum_probs=190.7
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.-++|+.++.||+|.||+|.+++ ..+++.+|+|+++++. ......-..|-++|+..+||.+..+--.|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 35689999999999999999999 5589999999998874 3344556679999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||..||.|.-.+.+... +++.....+...|++||.||| +.+|++||||.+|.++|.+|++||+|||++..--.
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999988877654 899999999999999999999 89999999999999999999999999999876422
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-hhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS-LKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~-~~~---- 270 (314)
.+ ......+|||+|+|||++ ....|+.++|.|.+|+++|||++|+.||-....+.+- +-.
T Consensus 321 ~g--~t~kTFCGTPEYLAPEVl-------------eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~ 385 (516)
T KOG0690|consen 321 YG--DTTKTFCGTPEYLAPEVL-------------EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL 385 (516)
T ss_pred cc--ceeccccCChhhcCchhh-------------ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc
Confidence 22 234567899999999554 5677899999999999999999999999764433221 111
Q ss_pred hhhccCCchhhhhc------cccCCC
Q 047043 271 WVNESLPHALTDVV------DANLRV 290 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rp 290 (314)
..+..+++..+.++ ||.+|-
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12334455555554 999985
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.73 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=167.4
Q ss_pred ccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
|++.+.||.|++|.||+|.. .+|..|++|.+..... .....+.+|+++++.++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78889999999999999995 4799999999876532 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+ ++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 69999887654 34899999999999999999999 899999999999999999999999999998765432211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.....++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 156 --~~~~~~~~~~~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 --YTHEVVTLWYRAPEILL------------GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred --cCccccccCCCCCceee------------cCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234678899997653 2334677899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.82 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=195.5
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
+...+.|++.+.||.|++|.||.|... +++.+++|+++.... ....+.+|+++++.++|+|++++++.+...+..+++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 446678999999999999999999965 789999999987644 456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
+||+++++|.+++......+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999999887545899999999999999999999 899999999999999999999999999987655432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
.. ......++..|+|||.+ .+..++.++|+||||+++|+|++|..||.............
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~-------------~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVI-------------KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP 234 (286)
T ss_pred hh--hhccccCCcccCCHhHh-------------cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 21 11223477889999764 34456789999999999999999999998654322111110
Q ss_pred ---hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 ---VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
....++..+.+++ +|..||++.++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112445555554 8999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.34 Aligned_cols=229 Identities=23% Similarity=0.365 Sum_probs=179.3
Q ss_pred ceeeecCceEEEEEEeC-CC----------CeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 48 NLLGTGSFGIVYKGILS-DG----------NNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~-~~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
+.||+|+||.||+|... ++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999964 33 25788887665433 5778899999999999999999999888 778999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-------cEEEEeeec
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-------VARVSDFGI 189 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-------~ikl~Dfg~ 189 (314)
|||+++++|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++ .++|+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999999876656899999999999999999999 89999999999999998877 799999998
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISL 268 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~ 268 (314)
+..... .....++..|+|||.+.. ....++.++||||||+++|+|++ |..||......+...
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~-----------~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~ 217 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRN-----------GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER 217 (259)
T ss_pred cccccc------ccccccCCCccChhhhcC-----------CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH
Confidence 876543 112346677999977531 11467889999999999999999 688887654322111
Q ss_pred hhhhh--------ccCCchhhhhc--cccCCCCHHHHHHHH
Q 047043 269 KNWVN--------ESLPHALTDVV--DANLRVSMKDVAAKL 299 (314)
Q Consensus 269 ~~~~~--------~~~~~~l~~ll--dp~~Rpt~~~~~~~l 299 (314)
..... ..+.+.+..++ +|..||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 218 FYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11001 11222344444 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=278.40 Aligned_cols=232 Identities=28% Similarity=0.376 Sum_probs=195.2
Q ss_pred eeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHH
Q 047043 49 LLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLEN 127 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 127 (314)
.||+|.+|+||-|+. .++..+|||-+.....+..+.+.+|+...++++|.|||+++|.+..+..+-++||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999995 4677899999998888888999999999999999999999999999889999999999999999
Q ss_pred HHhhcCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-CCCcEEEEeeecceecCCCCCcceeec
Q 047043 128 WLYSHNYFL--DTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTM 204 (314)
Q Consensus 128 ~i~~~~~~~--~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-~~~~ikl~Dfg~~~~~~~~~~~~~~~~ 204 (314)
+++..=+++ .|.++..+..||++||.||| .+.|+|||||-+|++|+ -.|.+||+|||-+..+..-.+ ....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET 735 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence 998764445 78888999999999999999 99999999999999996 678999999998887754332 3445
Q ss_pred ccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh--------hhhhccC
Q 047043 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK--------NWVNESL 276 (314)
Q Consensus 205 ~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~--------~~~~~~~ 276 (314)
.-||..|+|||++. .....|+.++|||||||++.||.||++||-.+......+- ..+++.+
T Consensus 736 FTGTLQYMAPEvID-----------qG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVID-----------QGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEEL 804 (1226)
T ss_pred cccchhhhChHhhc-----------cCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHH
Confidence 56999999998864 2455688899999999999999999999987655433221 1234445
Q ss_pred Cchhhhhc------cccCCCCHHHHHH
Q 047043 277 PHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 277 ~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
++..++++ ||++||++++++.
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 55555555 9999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=259.75 Aligned_cols=237 Identities=28% Similarity=0.482 Sum_probs=184.8
Q ss_pred ceeeecCceEEEEEEeCC-------CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 48 NLLGTGSFGIVYKGILSD-------GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+.||+|++|.||+|..++ +..+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2578999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-----cEEEEeee
Q 047043 120 MPNGSLENWLYSH------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-----VARVSDFG 188 (314)
Q Consensus 120 ~~~~sL~~~i~~~------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-----~ikl~Dfg 188 (314)
+++++|.+++... ...+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++ .++|+|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999998753 233678899999999999999999 89999999999999999877 89999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEIS 267 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~ 267 (314)
++................++..|+|||.+. +..++.++||||||+++|+|++ |..||......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~ 223 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLL-------------DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHc-------------cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence 987654332222222234567899997653 4457889999999999999998 99999765433321
Q ss_pred hh------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHh
Q 047043 268 LK------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKK 301 (314)
Q Consensus 268 ~~------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~ 301 (314)
.. ...+..++..+.+++ +|..||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 224 QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 011223444444444 99999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=277.11 Aligned_cols=200 Identities=34% Similarity=0.470 Sum_probs=171.7
Q ss_pred cCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC------ce
Q 047043 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD------FK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 113 (314)
..|..-+.||+|+||.||+++ ..+|+.||||.++... ....+....|++++++++|||||+++++-++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 567788899999999999999 5689999999998742 345678889999999999999999999876543 55
Q ss_pred eEEEEecCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec--CCC--cEEEEee
Q 047043 114 ALVLELMPNGSLENWLYS--HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD--ENM--VARVSDF 187 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~--~~~--~ikl~Df 187 (314)
.++||||+||+|...+.+ +...+++.++..++.+++.||.||| .+||+||||||.||++. .+| -.||+||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 799999999999999975 2345999999999999999999999 99999999999999984 223 3699999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
|.|+.++++. ......||..|++||..- ..++|+..+|.|||||++|++.||..||..
T Consensus 169 G~Arel~d~s---~~~S~vGT~~YLhPel~E------------~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNS---LFTSLVGTEEYLHPELYE------------RQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCC---eeeeecCchhhcChHHHh------------hccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999987665 344567999999997652 157889999999999999999999999864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.21 Aligned_cols=244 Identities=25% Similarity=0.280 Sum_probs=197.8
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 116 (314)
+.++.+.+..||.|..|.|++++ ..+|...|||...... .+...++...++++...+ +|+||+.+|+|......++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 45567788899999999999999 4579999999987653 455677888888887764 89999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
||.+ ..-++.++.+....++|..+.++...+++||.||-+ ++|++|||+||+|||+|..|.+||||||.+..+.+.
T Consensus 170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9988 446667777767779999999999999999999997 889999999999999999999999999999887543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhh---
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN--- 273 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~--- 273 (314)
..+....|.+.|+|||.+.. .....|+.++||||||++++||.||..||.+...+-..+....+
T Consensus 246 ---kAhtrsAGC~~YMaPERidp----------~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 246 ---KAHTRSAGCAAYMAPERIDP----------PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred ---cccccccCCccccCccccCC----------CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence 34555679999999988742 24678999999999999999999999999885443332222221
Q ss_pred ------ccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 274 ------ESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 274 ------~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
..+++.+.+++ |+..||...+++++--
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 12555555554 9999999999988543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=258.04 Aligned_cols=240 Identities=28% Similarity=0.365 Sum_probs=186.4
Q ss_pred eeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||.|++|.||+++.. +++.+++|++..... .....+.+|+++++.++|||++++++.+..++..++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 699999999976533 3456788899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC------c
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED------S 199 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~------~ 199 (314)
.+++.+.+ .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998765 4899999999999999999999 99999999999999999999999999998775433211 1
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----hhc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----VNE 274 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-----~~~ 274 (314)
.......++..|+|||... ....+.++|+||||+++|++++|..||............. .+.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~-------------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVIL-------------GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE 222 (265)
T ss_pred ccccCcccCccccCHHHhc-------------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc
Confidence 1122345778899997653 3336778999999999999999999997654433211110 011
Q ss_pred c--CCchhhh----hc--cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 275 S--LPHALTD----VV--DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 275 ~--~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
. ++..+.+ ++ +|..|||+.++.+. +.++|+++.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~---l~~~~~~~~ 263 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI---KNHPFFKGI 263 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHH---hcCccccCC
Confidence 1 1344444 44 99999999444432 227777643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.61 Aligned_cols=242 Identities=25% Similarity=0.303 Sum_probs=188.9
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeeccccc--CCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 117 (314)
++|+..+.||.|++|.||++.. .+++.+++|.+..... .....+.+|+++++.++||||+++++++.. .+.++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4789999999999999999995 4789999999886533 345678899999999999999999998754 45789999
Q ss_pred EecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 118 ELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 118 e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||+++++|.+++.. ....+++..+..++.|++.||+||| ..|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988653 3345788999999999999999999 8999999999999999999999999999887553
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc---chhhhhhh
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT---GEISLKNW 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~---~~~~~~~~ 271 (314)
.... ....++..|+|||.+ .+..++.++||||||+++|+|++|..||..... ........
T Consensus 157 ~~~~----~~~~~~~~y~~pE~~-------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (287)
T cd06621 157 NSLA----GTFTGTSFYMAPERI-------------QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219 (287)
T ss_pred cccc----ccccCCccccCHHHh-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH
Confidence 3221 123467889999664 345577899999999999999999999986521 11111111
Q ss_pred h--------h----------ccCCchhhhhc--cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 272 V--------N----------ESLPHALTDVV--DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 ~--------~----------~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
. . +.+.+.+..++ +|..|||+.|+++ ++|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~------~~~~~~~ 272 (287)
T cd06621 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE------HPWIKAQ 272 (287)
T ss_pred HhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh------Ccccccc
Confidence 0 0 01112333444 9999999999888 5666543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=252.68 Aligned_cols=237 Identities=27% Similarity=0.400 Sum_probs=193.7
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||.|++|.||++.. ++++.+++|.+..... .....+.+|+++++.++|||++++++.+..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588999999999999999995 4789999999986532 4556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 120 MPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 120 ~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
+++++|.+.+... +..+++..+..++.+++.|+++|| +.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999999875 356899999999999999999999 899999999999999999999999999998876543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
. .......+++.|+|||.. .+..++.++|+||+|+++++|++|..||.............
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~-------------~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELC-------------QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP 221 (258)
T ss_pred c--ceecceeeeecccChhHh-------------ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC
Confidence 2 122334688899999764 34446778999999999999999999997654332211111
Q ss_pred -hhccCCchhhh----hc--cccCCCCHHHHHHH
Q 047043 272 -VNESLPHALTD----VV--DANLRVSMKDVAAK 298 (314)
Q Consensus 272 -~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~ 298 (314)
.+..++..+.+ ++ +|..|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11233444444 44 99999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=267.63 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=165.6
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----Cc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-----DF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 112 (314)
..++|++.+.||.|++|.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999994 579999999986432 23446677899999999999999999876543 35
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++++|++. ++|.+.+... .+++..+..++.|++.||++|| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 789999996 4888877543 3899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 193 LGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 193 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
........ ......++..|+|||.+. ....++.++||||||+++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIML------------NSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhh------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 54322111 112245788999997643 234567889999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=270.73 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=213.7
Q ss_pred cccceehhhHHHHhcCccccceeeecCceEEEEEEeC---CC--CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcc
Q 047043 28 TWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILS---DG--NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLL 101 (314)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~---~~--~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~ 101 (314)
..+.++.......++.....+.||.|.||.||.|... .| -.||||..+.+. ....+.|..|.-+|++++||||+
T Consensus 375 ty~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIi 454 (974)
T KOG4257|consen 375 TYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHII 454 (974)
T ss_pred cccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchh
Confidence 3333343444445556667788999999999999842 23 368999998854 45578899999999999999999
Q ss_pred eeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc
Q 047043 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV 181 (314)
Q Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ 181 (314)
+++|+|.+. ..++|||.++.|.|..+++.+...++......++.||+.||+||| +...+||||...||++.+...
T Consensus 455 kLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 455 KLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQC 529 (974)
T ss_pred heeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcce
Confidence 999999874 568999999999999999998888999999999999999999999 899999999999999999999
Q ss_pred EEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCc
Q 047043 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDE 260 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~ 260 (314)
+||+|||+++.+.+...... ....-+..|+|||.+ ....++.++|||.|||++||+++ |..||++
T Consensus 530 VKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESI-------------NfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESI-------------NFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred eeecccchhhhccccchhhc-cccccceeecCcccc-------------chhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 99999999998876544333 233467789999765 45567889999999999999988 9999998
Q ss_pred cccchhhh------hhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 261 MFTGEISL------KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 261 ~~~~~~~~------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+.++-. +.-.++.||..+..++ ||.+||++.++.+.|.+++++
T Consensus 596 vkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 596 VKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 77655422 2335677888777665 999999999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.09 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=169.8
Q ss_pred ccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC--CceeEEEE
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKALVLE 118 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 118 (314)
|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+|++++++++... ...++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 778999999999999999955 68999999998763 33446678899999999999999999999887 89999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++ +|.+++......+++..++.++.|++.|+++|| ..|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 999988776556899999999999999999999 89999999999999999999999999999887654432
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
. ......++..|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~------------~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 156 A-DYTNRVITLWYRPPELLL------------GATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred c-cccccccccccCCceeeE------------ccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 122234678899998653 22346778999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=257.53 Aligned_cols=197 Identities=25% Similarity=0.330 Sum_probs=163.1
Q ss_pred ccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCC-CCCcceeecccccC--CceeEEEE
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNP--DFKALVLE 118 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 118 (314)
|++.+.||.|++|.||+|.. .+++.+++|.++.... .......+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999994 4789999999876421 12233456888888885 99999999999887 88999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++ +++.+.+......+++..+..++.|++.||.||| ..|++|+||+|+||+++. +.++|+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 5888888765556899999999999999999999 899999999999999999 9999999999876643322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
. ....++..|+|||... .+..++.++|+|||||++|+|++|..||...
T Consensus 155 ~---~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 155 Y---TEYISTRWYRAPECLL------------TDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred c---CCCCCCcccCChhHhh------------cCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 1 1234788899997643 2345677899999999999999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=260.80 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=191.8
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..+.|+..+.||+|+||.||+++. .++..+++|.+.... .+....+.+|+++++.++|||++++++++.+++..++
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 345588999999999999999995 478999999987432 2344678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++ ++.+.+......+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9999964 888887765566899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
. ....++..|+|||.+.. .....++.++|||||||++|+|++|..||.............
T Consensus 178 ~------~~~~~~~~y~aPE~~~~----------~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~ 241 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILA----------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241 (317)
T ss_pred c------ccccCCccccChhhhhc----------CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC
Confidence 1 12357888999987531 123446789999999999999999999987654332211111
Q ss_pred ---hhccCCchhhh----hc--cccCCCCHHHHHHHHHhh
Q 047043 272 ---VNESLPHALTD----VV--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 272 ---~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~l~~~ 302 (314)
....+++.+++ ++ +|..||++.+++++...+
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 11223334444 44 899999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.43 Aligned_cols=202 Identities=27% Similarity=0.335 Sum_probs=168.9
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||+|++|.||+|..+ +++.|++|.++... ......+.+|+++++.++|+|++++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999954 68899999987542 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|++++.+..+..+ ...+++..++.++.|++.|+.||| ..|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9987666555444 344899999999999999999999 89999999999999999999999999999887654432
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.. .....++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 156 ~~-~~~~~~~~~~~~PE~~~------------~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 156 SP-LTDYVATRWYRAPELLV------------GDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cc-ccCcccccCCcCCchhc------------CCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 12245788899997754 1226778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=256.99 Aligned_cols=236 Identities=25% Similarity=0.398 Sum_probs=189.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+-|+..+.||.|+||.||+|.. .++..+|+|.+.... ......+.+|+.+++.++|||++++++.+..++..+++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4588899999999999999985 478899999987543 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++.+. .+++..+..++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999988654 3789999999999999999999 99999999999999999999999999998876543211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------hhh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------WVN 273 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~~~ 273 (314)
......++..|+|||... ...++.++|+|||||++|+|++|..||............ ...
T Consensus 157 -~~~~~~~~~~y~~PE~~~-------------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIK-------------QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE 222 (277)
T ss_pred -hhccccCCccccChhhhc-------------cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCC
Confidence 112235788899997642 345677899999999999999999999765432211110 111
Q ss_pred ccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 274 ESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 274 ~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
..++..+.++ + +|..||++.+++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2233444444 3 99999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=256.41 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=186.5
Q ss_pred hhhHHHHhcCcccccee--eecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeeccccc
Q 047043 34 YLDIQRATEGFNECNLL--GTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN 109 (314)
Q Consensus 34 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (314)
..+.....++|++.+.+ |.|+||.||++.. .++..+++|.+........ |......+ +|||++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455667888888887 9999999999994 5789999999876432111 22222222 79999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeee
Q 047043 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFG 188 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg 188 (314)
.+..++||||+++++|.+++.... .+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999998765 5899999999999999999999 89999999999999999888 99999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
++....... ...++..|+|||.+ .+..++.++|+||||+++|+|++|..||..........
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~-------------~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKI-------------KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhh-------------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 887654321 23478889999765 34456778999999999999999999998554333211
Q ss_pred hhh---------hhccCCchhhhh----c--cccCCCC-HHHHHHHHHhhhhheeee
Q 047043 269 KNW---------VNESLPHALTDV----V--DANLRVS-MKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 269 ~~~---------~~~~~~~~l~~l----l--dp~~Rpt-~~~~~~~l~~~~~~~~~~ 309 (314)
..+ ....++..+.++ + +|..||+ ++++++ |+|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~------h~~~~~ 267 (267)
T PHA03390 217 ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK------HPFLKI 267 (267)
T ss_pred HHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc------CCcccC
Confidence 111 111244444444 4 9999996 588886 777653
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=253.78 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=188.3
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccc--cCCceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCS--NPDFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 117 (314)
+|++.+.||.|++|.||+|.. .+++.+++|.++... ......+.+|+++++.++|||++++++.+. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999994 578999999987542 334567888999999999999999999775 345678999
Q ss_pred EecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 118 ELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGH-SSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 118 e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~-~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
||+++++|.+++... +..+++..++.++.|++.||.+||..+ .+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998763 445889999999999999999999210 0367999999999999999999999999998876
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
..... ......+++.|+|||.+ .+..++.++|+||||+++++|++|..||............
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~-------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 225 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQL-------------NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG 225 (265)
T ss_pred cCCcc--cccccccCCCccChhhh-------------cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence 54321 12224578899999765 3444778899999999999999999999875432211110
Q ss_pred ---hhhccCCchhhh----hc--cccCCCCHHHHHHH
Q 047043 271 ---WVNESLPHALTD----VV--DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ---~~~~~~~~~l~~----ll--dp~~Rpt~~~~~~~ 298 (314)
..+..++..+.+ ++ +|..||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233344444 44 99999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=259.96 Aligned_cols=201 Identities=23% Similarity=0.373 Sum_probs=165.9
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||.|++|.||+|..+ +++.|++|.+..... .....+.+|+++++.++|||++++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 67999999999999999999954 789999999865432 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~~~~~ 196 (314)
|++ ++|.+.+.... ..+++..+..++.|++.||+||| ++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 58888876543 33678889999999999999999 899999999999999985 567999999998765332
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.. ......++..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~------------~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILL------------GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cc--ccccCceeecccCHHHHh------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 112234688899998653 2345677899999999999999999999754
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=254.17 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=187.7
Q ss_pred CccccceeeecCceEEEEEEeC--CCCeEEEEEeeecc----------cHHHHHHHHHHHHHHh-CCCCCcceeeccccc
Q 047043 43 GFNECNLLGTGSFGIVYKGILS--DGNNVAIKVFKLQL----------GRAFRSFDSECEVLRN-VHHRNLLKIFSSCSN 109 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~--~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 109 (314)
.|++.+.||.|++|.||++..+ .++.+++|.+.... ......+.+|+.++.. ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4889999999999999999954 47889999886432 2234556778887765 689999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 110 PDFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
.+..+++|||+++++|.+++.. .+..+++..++.++.|++.++.+||+ ..|++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998753 34458999999999999999999993 36899999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||.+....... ......++..|+|||.+ .+..++.++|+||||+++|+|++|..||........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~-------------~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~ 221 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIV-------------KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhh-------------cCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence 99988764432 22334578889999765 344567899999999999999999999976433221
Q ss_pred hhhh-------hhhccCCchhhhh----c--cccCCCCHHHHHHHHH
Q 047043 267 SLKN-------WVNESLPHALTDV----V--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 267 ~~~~-------~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~ 300 (314)
.... .....++..+.++ + ||..||++.|+.+.++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1110 0111334444444 4 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=264.34 Aligned_cols=203 Identities=26% Similarity=0.366 Sum_probs=168.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc----CCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN----PDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 113 (314)
.++|++.+.||.|++|.||+|.. .+++.|++|.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999994 479999999987643 2334567789999999999999999998753 4578
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++||||+. ++|.+++...+. +++..+..++.|++.||.||| .+|++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 589998876554 899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 194 GDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 194 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
...... .......++..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~------------~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLL------------SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cccCcCCCcccccccccccccChHHhc------------CCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 432211 1112345788899998753 2234678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=251.31 Aligned_cols=235 Identities=29% Similarity=0.443 Sum_probs=192.3
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|+++++.++|||++++++++.+++..+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999954 688999999987643 4567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++...+ .+++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999998764 4899999999999999999999 999999999999999999999999999998877543321
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------hh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------VN 273 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------~~ 273 (314)
.....++..|+|||... +..++.++|+||||+++|+|++|..||............. .+
T Consensus 156 --~~~~~~~~~y~~pe~~~-------------~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (254)
T cd06627 156 --DASVVGTPYWMAPEVIE-------------MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP 220 (254)
T ss_pred --ccccccchhhcCHhhhc-------------CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCC
Confidence 12235788899997642 3336788999999999999999999997654322211111 12
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHH
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+++.+.+++ +|..||++.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 23444444444 9999999999886
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.87 Aligned_cols=204 Identities=28% Similarity=0.392 Sum_probs=168.0
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeec--ccHHHHHHHHHHHHHHhC-CCCCcceeeccccc--CCc
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN--PDF 112 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 112 (314)
.+.++|++.+.||+|++|.||+|... +++.+++|.+... .......+..|+.+++++ +||||+++++++.. ...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45788999999999999999999954 6889999987543 223345677899999999 99999999998764 346
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||++ ++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 899999996 5999988765 4788899999999999999999 89999999999999999999999999998876
Q ss_pred cCCCCCc---ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 193 LGDGEDS---VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 193 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
....... .......++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILL------------GSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccccCcchhcccccccccCceeee------------ccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 6433221 1222345788999998653 2345677899999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=256.89 Aligned_cols=235 Identities=22% Similarity=0.334 Sum_probs=187.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.+|...+.||.|++|.||++.. .+++.+++|.++.........+.+|+.+++.++|||++++++++...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3456668999999999999995 578999999987654444566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++... .+++..+..++.|++.|+++|| ++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 99 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 99 EGGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 999999998773 3889999999999999999999 89999999999999999999999999998765433221
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh--hhhh------h
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS--LKNW------V 272 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~--~~~~------~ 272 (314)
......++..|+|||.. .+..++.++|+||||+++|+|++|..||......... .... .
T Consensus 171 ~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVI-------------SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN 237 (285)
T ss_pred ccccccCCccccCHHHh-------------cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcc
Confidence 12234588899999764 3445678999999999999999999998754322110 0000 0
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHH
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...++..+.+++ +|..||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111344444444 9999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=253.25 Aligned_cols=238 Identities=24% Similarity=0.333 Sum_probs=187.9
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeec-----ccHHHHHHHHHHHHHHhCCCCCcceeecccccC--Cce
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ-----LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (314)
.+|++.+.||+|++|.||+|.. .++..|++|.+... .......+.+|++++++++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999994 57999999987542 123456788999999999999999999998664 467
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++++||+++++|.+++...+. +++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999887654 789999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--
Q 047043 194 GDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-- 270 (314)
Q Consensus 194 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-- 270 (314)
...... .......++..|+|||.+. +..++.++|+||||+++|+|++|..||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 223 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVIS-------------GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (264)
T ss_pred ccccccCccccccCCcccccCHhhhc-------------CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc
Confidence 321111 1112235788899997653 345677899999999999999999999865433221111
Q ss_pred -----hhhccCCchhhhhc-----cccCCCCHHHHHH
Q 047043 271 -----WVNESLPHALTDVV-----DANLRVSMKDVAA 297 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll-----dp~~Rpt~~~~~~ 297 (314)
..+..+++.+.+++ ++..||++.+++.
T Consensus 224 ~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~ 260 (264)
T cd06653 224 QPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhc
Confidence 12233444444444 8899999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=266.82 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=203.3
Q ss_pred ceehhhHHHH-hcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeec
Q 047043 31 RTSYLDIQRA-TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFS 105 (314)
Q Consensus 31 ~~~~~~~~~~-~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (314)
||.|++.+.. .+.|+..+.||+||||.|+-+. ..+|+.+|+|.+.+..- .-.....+|-.+|.+++.+.||.+--
T Consensus 173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 4566666553 4568999999999999999999 55899999998765431 11244678999999999999999999
Q ss_pred ccccCCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 106 SCSNPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
.+++++.+++|+..++||+|.-.|.+.+ +.++++.+..++.+|+.||++|| ..+||+|||||+|||+|+.|++.|
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEe
Confidence 9999999999999999999999888764 45899999999999999999999 999999999999999999999999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~ 264 (314)
+|+|+|..+.+... .....||.+|+|||++. ++.|+...|.|||||++|+|+.|+.||.+....
T Consensus 329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~-------------ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQ-------------NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred eccceEEecCCCCc---cccccCcccccCHHHHc-------------CCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 99999998866543 34457999999997764 455899999999999999999999999864321
Q ss_pred ----hh-----hhhhhhhccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeeee
Q 047043 265 ----EI-----SLKNWVNESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 265 ----~~-----~~~~~~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~~ 310 (314)
++ ......++.+++..+++. ||.+|- ++.++.+ |++++++
T Consensus 393 vk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~------HpfFk~l 452 (591)
T KOG0986|consen 393 VKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE------HPFFKDL 452 (591)
T ss_pred hhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh------CcccccC
Confidence 21 111223456666555544 887775 4445544 5666554
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=255.27 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=185.5
Q ss_pred ccccceeeecCceEEEEEEeC----CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC------
Q 047043 44 FNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD------ 111 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 111 (314)
|.+.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+++++.++|||++++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678889999999999999842 46889999987643 334567888999999999999999999876432
Q ss_pred ceeEEEEecCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 112 FKALVLELMPNGSLENWLYSH-----NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
..+++++|+++++|.+++... ...++...+..++.|++.|++||| +.|++|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECc
Confidence 236888999999999887532 124688899999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccch
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE 265 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~ 265 (314)
||++................+++.|++||.. ....++.++||||||+++|+|++ |..||......+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-------------~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESL-------------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHH-------------hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 9998765432211111122345678999654 34456788999999999999999 889987654433
Q ss_pred hhhhhh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 266 ISLKNW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 266 ~~~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
...... .+..++..+.+++ +|..||++.++++.++.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 224 IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 211111 1122334444444 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=256.71 Aligned_cols=228 Identities=25% Similarity=0.361 Sum_probs=174.6
Q ss_pred eeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHH---hCCCCCcceeecccccCCceeEEEEecC
Q 047043 49 LLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLR---NVHHRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
.||+|+||.||++.. .+++.+|+|.+..... .......++..+++ ...||+++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 4689999999875421 11122334443333 3479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 122 ~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
+++|.+++...+. +++..+..++.|++.||.||| ..|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 9999998876654 899999999999999999999 8999999999999999999999999999887554322
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-hhh-------hhhh
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-SLK-------NWVN 273 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~~~-------~~~~ 273 (314)
.....++..|+|||... .+..++.++|+|||||++|+|++|..||........ ... ...+
T Consensus 152 ~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd05633 152 PHASVGTHGYMAPEVLQ------------KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP 219 (279)
T ss_pred ccCcCCCcCccCHHHhc------------CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCc
Confidence 12235889999997643 234567889999999999999999999975432211 111 1122
Q ss_pred ccCCchhhhhc------cccCCC-----CHHHHHH
Q 047043 274 ESLPHALTDVV------DANLRV-----SMKDVAA 297 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rp-----t~~~~~~ 297 (314)
..++..+.+++ ||.+|| +++++++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 33444444444 899998 5887766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=256.21 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=169.8
Q ss_pred ccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
|++.+.||.|++|.||+|.. .+++.+++|.++..... ....+.+|+++++.++|++++++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999995 47899999998765322 3467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++ ++.+++......+++..+..++.|++.|+.+|| ..|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence 65 999888776556899999999999999999999 89999999999999999999999999999887754331
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......++..|.|||.+. ....++.++|+||||+++|+|++|..||....
T Consensus 154 ~~~~~~~~~~~~~PE~~~------------~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 PYTHYVVTRWYRAPELLL------------GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cccCccCcccccCcHHHh------------cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234778899997753 22357889999999999999999999996543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=256.98 Aligned_cols=234 Identities=26% Similarity=0.353 Sum_probs=182.6
Q ss_pred eeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||.|+||+||+|.. .+|+.|++|.+.... ......+.+|+++++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999994 478999999987542 12334567899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeec
Q 047043 126 ENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204 (314)
Q Consensus 126 ~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~ 204 (314)
.+++.+.. ..+++..+..++.|++.|+.||| ..|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 99987654 34899999999999999999999 8999999999999999999999999999887654321 1122
Q ss_pred ccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc----hh-----hhhhhhhcc
Q 047043 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG----EI-----SLKNWVNES 275 (314)
Q Consensus 205 ~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~----~~-----~~~~~~~~~ 275 (314)
..++..|+|||... +..++.++|+||||+++|+|++|..||...... .. ......+..
T Consensus 154 ~~~~~~y~~PE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQ-------------GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhc-------------CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCcc
Confidence 34778899997643 334778899999999999999999999764321 10 001112223
Q ss_pred CCchhhhh----c--cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 276 LPHALTDV----V--DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 276 ~~~~l~~l----l--dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
+++.+.++ + ||..|| ++.++++ ++|++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~------h~~~~~ 259 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE------HPLFKD 259 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh------Chhhhc
Confidence 44444444 4 999999 6666665 555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=257.35 Aligned_cols=238 Identities=27% Similarity=0.428 Sum_probs=191.0
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 116 (314)
++|++.+.||+|++|.||+|.. .+++.|++|++.... ......+.+|.+++++++ ||||+++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999995 479999999987632 233466788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
||++++++|.+++.+.+ .+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998765 4899999999999999999999 999999999999999999999999999988766433
Q ss_pred CCc------------------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCC
Q 047043 197 EDS------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT 258 (314)
Q Consensus 197 ~~~------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf 258 (314)
... .......++..|+|||.. ....++.++|+||||++++++++|..||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-------------~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-------------NEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHh-------------CCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 211 112223467889999764 3344778999999999999999999999
Q ss_pred Cccccchhh-----hhhhhhccCCc----hhhhhc--cccCCCCH----HHHHH
Q 047043 259 DEMFTGEIS-----LKNWVNESLPH----ALTDVV--DANLRVSM----KDVAA 297 (314)
Q Consensus 259 ~~~~~~~~~-----~~~~~~~~~~~----~l~~ll--dp~~Rpt~----~~~~~ 297 (314)
......... .....+..+++ .+..++ +|.+||++ .++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 865432111 01111223333 444454 99999999 77776
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=258.17 Aligned_cols=206 Identities=28% Similarity=0.373 Sum_probs=169.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCC---
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD--- 111 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 111 (314)
....++|++.+.||.|++|.||+|..+ +++.|++|.++.... .....+.+|+++++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346788999999999999999999964 689999999976532 22345678999999999999999999887654
Q ss_pred -------ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 112 -------FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 112 -------~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
..++++||+++ ++.+.+......+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 888887765556899999999999999999999 899999999999999999999999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+|||.+......... ......++..|+|||.+. ....++.++|||||||++|+|++|..||...
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~------------~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLL------------GEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhc------------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998766443221 111223577899998653 2234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=262.97 Aligned_cols=202 Identities=27% Similarity=0.358 Sum_probs=167.2
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----C
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-----D 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 111 (314)
+.++|.+.+.||.|++|.||+|.. .+++.|++|.++... ......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 456899999999999999999994 579999999987532 23345677899999999999999999987644 3
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..++++||+. ++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 5799999995 69998887654 4899999999999999999999 8999999999999999999999999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
....... ......++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKGD--FMTEYVVTRWYRAPELLL------------NCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCcc--cccccccccCccChHHHh------------cCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 6543221 112235788899998753 1234678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=259.06 Aligned_cols=238 Identities=25% Similarity=0.300 Sum_probs=188.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..+.|...+.||.|++|.||+|.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++.+.+..++
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 344578888899999999999995 478999999987542 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+. +++.+++......+++..+..++.|++.++.||| ..|++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 999995 5888888766656899999999999999999999 89999999999999999999999999998764322
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh------
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------ 269 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------ 269 (314)
.....++..|+|||.+. ......++.++||||||+++|+|++|..||...........
T Consensus 174 ------~~~~~~~~~y~aPE~~~----------~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~ 237 (313)
T cd06633 174 ------ANSFVGTPYWMAPEVIL----------AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS 237 (313)
T ss_pred ------CCCccccccccChhhcc----------ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence 12245788899998753 11234577899999999999999999999876543221111
Q ss_pred -hhhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 270 -NWVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 270 -~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
......++..+++++ +|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223344444444 89999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=251.66 Aligned_cols=235 Identities=28% Similarity=0.369 Sum_probs=190.3
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||.|++|.||++.. .+++.+++|.+.... ......+.+|+++++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999984 478999999987643 23445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 120 MPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 120 ~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
+++++|.+++.+. +..+++..++.++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998662 344789999999999999999999 999999999999999999999999999998776543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
......++..|+|||.. .+..++.++|+||||+++|+|++|..||.............
T Consensus 157 ----~~~~~~~~~~~~~Pe~~-------------~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVW-------------KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP 219 (256)
T ss_pred ----CcccccCCccccCHHHH-------------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 11224578889999764 34556778999999999999999999998765433221111
Q ss_pred -hhccCCc----hhhhhc--cccCCCCHHHHHHH
Q 047043 272 -VNESLPH----ALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 272 -~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
....++. .+.+++ +|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112333 344444 89999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=272.33 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=200.6
Q ss_pred hcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeec---ccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQ---LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
...|..++.||.|+||.||-|+ ..+.+-||||...-. ..+...++..|++.|+++.|||++.+-+++......++|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 3458889999999999999999 557889999987543 235568899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||| -|+-.|++.-...++.+..+..++.+.+.||+||| +.+.+|||||.-||++++.|.|||+|||.+......
T Consensus 105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9999 45999999887777999999999999999999999 999999999999999999999999999998865432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
...+|||.|+|||+++ ....+.|+-++||||||++..||.-+++|+-.++....-...
T Consensus 180 ------nsFvGTPywMAPEVIL----------AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP 243 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVIL----------AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 243 (948)
T ss_pred ------hcccCCccccchhHhe----------eccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC
Confidence 3357999999999985 445677888999999999999999999997665433211111
Q ss_pred -hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 -WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 -~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.....-++.+++++ -|..|||..+++.+.-..|++
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 11222333455554 789999999999876666543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=256.61 Aligned_cols=243 Identities=24% Similarity=0.302 Sum_probs=186.9
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (314)
...++|++.+.||+|++|.||+|.++ +++.|++|.++... ......+..|+.++... .||||+++++++.++...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34678999999999999999999965 59999999997643 22334556677766666 49999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+|||+. +++.+++......+++..+..++.|++.|++||| . +|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK----EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999984 5888887765556899999999999999999999 5 699999999999999999999999999987654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV-- 272 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~-- 272 (314)
.... .....++..|+|||.+.. ....+.++.++|+||||+++|+|++|..||..............
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~---------~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDP---------PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCC---------CCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence 3221 122346788999987641 11134577899999999999999999999976332211111111
Q ss_pred -------hccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 273 -------NESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 273 -------~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
...+++.+.+++ ||..||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 012344444444 99999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=278.25 Aligned_cols=244 Identities=26% Similarity=0.436 Sum_probs=209.9
Q ss_pred CccccceeeecCceEEEEEEeC-C---CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-D---GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...+.+.||.|.||+|+.|+.+ . ...||||.++... .++..+|..|+.||-+++||||+++.|+....+...+|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3467789999999999999954 3 3479999998765 456788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||++.|+|+.|++.+...++..++.-|++.|+.||.||. +.++|||||...||||+++..+|++|||+++.+.++.
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999998877999999999999999999999 9999999999999999999999999999999875544
Q ss_pred Cc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchh------hhh
Q 047043 198 DS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI------SLK 269 (314)
Q Consensus 198 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~------~~~ 269 (314)
.. .......-+.+|+|||.+ ...+++.+|||||+|++|||.++ |+.||-++.+.++ ..+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAI-------------a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR 852 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAI-------------AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR 852 (996)
T ss_pred CccccccCCccceeecChhHh-------------hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC
Confidence 22 112222236789999554 57788999999999999999988 9999999887665 333
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.-.+..||..|.+++ |...||.+.+|+..|+++.
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 335567888888887 9999999999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=262.93 Aligned_cols=202 Identities=25% Similarity=0.386 Sum_probs=165.5
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccC---------
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--------- 110 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 110 (314)
.++|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+++++.++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 47899999999999999999995 57999999998776555567788999999999999999999876543
Q ss_pred -----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-CCCcEEE
Q 047043 111 -----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARV 184 (314)
Q Consensus 111 -----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-~~~~ikl 184 (314)
...+++|||++ ++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++ .++.++|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 5898887643 3789999999999999999999 89999999999999997 4567899
Q ss_pred EeeecceecCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 185 SDFGISKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+|||.+.......... ......++..|+|||.+. ....++.++|||||||++|+|++|..||...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL------------SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHh------------CccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987653321111 112234688899998653 2334677899999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=267.89 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=206.7
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHH-HHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+....+.+.||+|-||.|.+++...+.+||+|.++...... ..+|..|+++|.+|+||||+.++++|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44578899999999999999997678999999999876444 47899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSHNYFL-DTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~-~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
++.|+|.+++..+.... .......++.||++||+||. +.+++||||.+.|+|++.++++||+|||.++.+-....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999874333 45566789999999999999 89999999999999999999999999999986654444
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc--CCCCCCccccchhhhh-------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT--GKKPTDEMFTGEISLK------- 269 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~--g~~Pf~~~~~~~~~~~------- 269 (314)
........-+.+|+|||.+. .++++.++|+|+||+++||+++ .+.||.++.++.....
T Consensus 693 y~vqgr~vlpiRwmawEsil-------------lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~ 759 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESIL-------------LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD 759 (807)
T ss_pred eeeecceeeeeeehhHHHHH-------------hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence 44455566789999997764 6778999999999999999866 8899998776554211
Q ss_pred ------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 270 ------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 270 ------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
...+..|++.+.+++ |..+||+++++-..|++.-
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 113456777777766 8899999999998887653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.52 Aligned_cols=236 Identities=25% Similarity=0.381 Sum_probs=188.4
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|++.+.||.|++|.||++.. .++..+++|.+.... ......+.+|+++++.++|+|++++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999995 468999999987642 12345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecceecCCCC
Q 047043 120 MPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLGDGE 197 (314)
Q Consensus 120 ~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~~~~~ 197 (314)
+++++|.+++.... ..+++..+..++.|++.|+.||| ..+++|+||+|+||++++++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999987643 34789999999999999999999 89999999999999998876 46999999887664332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
.. .....+++.|.|||.. ....++.++|+||||+++++|++|..||.............
T Consensus 157 ~~--~~~~~~~~~~~ape~~-------------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEIC-------------QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP 221 (257)
T ss_pred cc--ccccCCCccccCHHHH-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC
Confidence 11 1223578889999764 33456789999999999999999999997654332221111
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+.++..+.+++ +|.+|||+.|+++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1223344444443 8999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.51 Aligned_cols=234 Identities=25% Similarity=0.363 Sum_probs=178.0
Q ss_pred eeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHH---HHHhCCCCCcceeecccccCCceeEEEEecC
Q 047043 49 LLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECE---VLRNVHHRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
.||.|+||.||+|.. .+++.||+|.+..... ........|.. .+....||+++.+++.+...+..+++|||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999995 5789999999875421 11112333333 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 122 ~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
+++|.+++...+ .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999887654 4899999999999999999999 8999999999999999999999999999887553321
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-hh-h------hhhh
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-SL-K------NWVN 273 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~~-~------~~~~ 273 (314)
.....|+..|+|||.+. .+..++.++|+||+|+++|+|++|..||........ .. . ...+
T Consensus 152 ~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQ------------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219 (278)
T ss_pred CcCcCCCcCCcCcHHhc------------CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC
Confidence 12345889999997753 233477889999999999999999999976532111 00 0 0112
Q ss_pred ccCCchhhh----hc--cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 274 ESLPHALTD----VV--DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 274 ~~~~~~l~~----ll--dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
..++..+.+ ++ +|..|| ++.++++ ++|++.
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~------~~~~~~ 260 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------HPFFRS 260 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh------CccccC
Confidence 223444444 44 899999 9999986 555544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=262.48 Aligned_cols=200 Identities=25% Similarity=0.329 Sum_probs=167.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC----
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP---- 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (314)
....++|++.+.||+|++|.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|||++++++++...
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 35678999999999999999999994 579999999986532 23345677899999999999999999987543
Q ss_pred --CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 111 --DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 111 --~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
...++||||+. ++|.+.+... +++..+..++.|++.||+||| ..|++|+||||+||+++.++.++|+|||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35789999995 5888877643 788999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
++........ .....++..|+|||.+ .+..++.++|||||||++|+|++|..||...
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~-------------~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVI-------------LGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHH-------------hCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 9987643321 1223578889999765 3455778999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=276.49 Aligned_cols=201 Identities=19% Similarity=0.237 Sum_probs=157.0
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC--CCCeEEEEEe--------------ee---cccHHHHHHHHHHHHHHhCCCC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS--DGNNVAIKVF--------------KL---QLGRAFRSFDSECEVLRNVHHR 98 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vaiK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ 98 (314)
....++|++++.||+|+||+||++..+ ++...+.|.+ .+ ........+.+|+++++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 445689999999999999999998742 2222222211 10 0112345678999999999999
Q ss_pred CcceeecccccCCceeEEEEecCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHN----YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 99 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
||+++++++.+.+..|++++++. ++|.+++.... .......+..++.|++.||.||| .+|++||||||+||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NI 298 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENI 298 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHE
Confidence 99999999999999999999984 58888775432 12345677889999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g 254 (314)
|++.++.+||+|||++..+...... ......||..|+|||++ .+..++.++|||||||++|+|++|
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvil~ell~~ 364 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEIL-------------AGDGYCEITDIWSCGLILLDMLSH 364 (501)
T ss_pred EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhh-------------cCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999999876543221 12234689999999765 345678899999999999999998
Q ss_pred CCC
Q 047043 255 KKP 257 (314)
Q Consensus 255 ~~P 257 (314)
..+
T Consensus 365 ~~~ 367 (501)
T PHA03210 365 DFC 367 (501)
T ss_pred CCC
Confidence 754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=262.44 Aligned_cols=206 Identities=24% Similarity=0.341 Sum_probs=167.6
Q ss_pred HHhcCcccc-ceeeecCceEEEEEEe-CCCCeEEEEEeeecccHH--------------HHHHHHHHHHHHhCCCCCcce
Q 047043 39 RATEGFNEC-NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRA--------------FRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 39 ~~~~~y~~~-~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~ 102 (314)
.+.++|..+ +.||.|++|.||+|.. .+++.||+|.++...... ...+.+|+++++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 456788765 6799999999999995 479999999987543211 114678999999999999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
+++++..++..+++|||+. ++|.+++..... +++..+..++.|++.||++|| +.|++|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCE
Confidence 9999999999999999996 599998876543 899999999999999999999 9999999999999999999999
Q ss_pred EEEeeecceecCCCCC------------cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHH
Q 047043 183 RVSDFGISKLLGDGED------------SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ 250 (314)
+|+|||.+........ ........++..|+|||.+. ....++.++|+|||||++|+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM------------GAEKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcc------------cCCCCCcHHHHHHHHHHHHH
Confidence 9999999876641110 00111234677899997653 22345778999999999999
Q ss_pred HhcCCCCCCccc
Q 047043 251 TFTGKKPTDEMF 262 (314)
Q Consensus 251 ll~g~~Pf~~~~ 262 (314)
|++|..||....
T Consensus 227 l~tg~~p~~~~~ 238 (335)
T PTZ00024 227 LLTGKPLFPGEN 238 (335)
T ss_pred HHhCCCCCCCCC
Confidence 999999997544
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=256.16 Aligned_cols=241 Identities=19% Similarity=0.246 Sum_probs=174.4
Q ss_pred HhcCccccceeeecCceEEEEEEeC-C---CCeEEEEEeeecccHHH-----------HHHHHHHHHHHhCCCCCcceee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-D---GNNVAIKVFKLQLGRAF-----------RSFDSECEVLRNVHHRNLLKIF 104 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~---~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~ 104 (314)
..++|++.+.||+|+||.||+|.+. + +..+++|+......... .....+...+..++|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3468999999999999999999954 3 45677776543321110 1112233445566899999999
Q ss_pred cccccCC----ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 105 SSCSNPD----FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 105 ~~~~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
+.+.... ..+++++++. .++.+.+..... .++..+..++.|++.||+||| +.+++||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKC-KNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhcc-CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCC
Confidence 8765443 3467788773 477777665432 578889999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCc-----ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCC
Q 047043 181 VARVSDFGISKLLGDGEDS-----VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~ 255 (314)
.++|+|||++..+...... .......||+.|+|||.. .+..++.++|||||||++|+|++|.
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-------------~~~~~~~~~DiwSlG~~l~el~~g~ 230 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-------------NGACVTRRGDLESLGYCMLKWAGIK 230 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh-------------CCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999876432211 111223589999999654 4566789999999999999999999
Q ss_pred CCCCccccchh-------hh-h-----hhhhccCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 256 KPTDEMFTGEI-------SL-K-----NWVNESLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 256 ~Pf~~~~~~~~-------~~-~-----~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
.||........ .. . ....+.++..+.+++ +|.+||++.++.+.+
T Consensus 231 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 231 LPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99987632111 00 1 111233455555554 999999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=264.07 Aligned_cols=202 Identities=26% Similarity=0.382 Sum_probs=168.8
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
+.+...++|++.+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+.+++.++|||++++++++...+.
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34556789999999999999999999954 68899999987532 2334567789999999999999999998866554
Q ss_pred ------eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 113 ------KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 113 ------~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
.++++|++ +++|.+++... .+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 66999988763 3899999999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
||++....... ....++..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 162 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~------------~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 162 FGLARHTDDEM-----TGYVATRWYRAPEIML------------NWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccccccc-----cCCcccccccCHHHHh------------CCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99988664321 2234678899998753 1225678899999999999999999999653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=250.02 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=197.5
Q ss_pred ccceehhhHHHHhcCccccc-eeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeec
Q 047043 29 WRRTSYLDIQRATEGFNECN-LLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFS 105 (314)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~-~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 105 (314)
...+++ .-..+.++|.+-. .||-|-.|.|-.+.+ .+|+++|+|++.-. ...++|++..-.. .|||||.+++
T Consensus 49 ~~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~Iid 122 (400)
T KOG0604|consen 49 ESDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIID 122 (400)
T ss_pred hhhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeeh
Confidence 334444 3334667887765 699999999999995 48999999997643 4556788876666 5999999999
Q ss_pred cccc----CCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---
Q 047043 106 SCSN----PDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD--- 177 (314)
Q Consensus 106 ~~~~----~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~--- 177 (314)
++++ ..++.+|||.++||.|.+.++.++ ..++|.++..++.||..|+.||| ..+|.||||||+|+|..
T Consensus 123 VyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~ 198 (400)
T KOG0604|consen 123 VYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTS 198 (400)
T ss_pred hhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCC
Confidence 8764 468889999999999999998764 46899999999999999999999 99999999999999995
Q ss_pred CCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 178 ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 178 ~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
.|..+||+|||++....... .-...+-|+.|.|||++ ....|+...|+||+||++|-|++|..|
T Consensus 199 ~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevl-------------g~eKydkscdmwSlgVimYIlLCGyPP 262 (400)
T KOG0604|consen 199 PNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVL-------------GPEKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_pred CCcceEecccccccccCCCc---cccCCcccccccCHHHh-------------CchhcCCCCCccchhHHHHHhhcCCCc
Confidence 45578999999998765432 23456789999999554 566789999999999999999999999
Q ss_pred CCccc-------------cchhhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 258 TDEMF-------------TGEISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 258 f~~~~-------------~~~~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
|-... .+...++..-++.+++..++++ +|.+|.|+.+++. |+|+.+.
T Consensus 263 FYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~------hpwi~~~ 328 (400)
T KOG0604|consen 263 FYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD------HPWINQY 328 (400)
T ss_pred ccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc------Cchhccc
Confidence 95432 2333444445566777666665 8888888888877 6666543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=260.20 Aligned_cols=203 Identities=23% Similarity=0.340 Sum_probs=168.9
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.+++.+.++|++++.||.|++|.||+|. ..++..||+|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 3556678899999999999999999999 4579999999986432 223456788999999999999999999887543
Q ss_pred ------ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 112 ------FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 112 ------~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
..+++||++ +++|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 358999998 67998887643 3899999999999999999999 9999999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
|||++....... ....+++.|+|||.+. ....++.++|+||||+++|++++|..||...
T Consensus 161 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 161 DFGLARQTDSEM-----TGYVVTRWYRAPEVIL------------NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ecccccccccCc-----cccccCCcccCHHHHh------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999887653321 1234688899998753 1234677899999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=257.52 Aligned_cols=205 Identities=23% Similarity=0.334 Sum_probs=166.3
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccC-------
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNP------- 110 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 110 (314)
.++|++.+.||.|++|.||+|.. .+++.+++|.+...... ......+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 58999999999999999999995 47899999998754321 223567899999999999999999987443
Q ss_pred -CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 111 -DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 111 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
...++++||+. +++...+......+++..+..++.|+++||+||| ..|++|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 35689999986 4788877765556899999999999999999999 89999999999999999999999999998
Q ss_pred ceecCCCCCcce---------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 190 SKLLGDGEDSVT---------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 190 ~~~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
+........... .....+++.|+|||.+. ....++.++||||||+++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL------------GERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhh------------CCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 876543221111 11234677899997653 234467789999999999999999999975
Q ss_pred cc
Q 047043 261 MF 262 (314)
Q Consensus 261 ~~ 262 (314)
..
T Consensus 230 ~~ 231 (311)
T cd07866 230 KS 231 (311)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.44 Aligned_cols=238 Identities=26% Similarity=0.332 Sum_probs=184.9
Q ss_pred CccccceeeecCceEEEEEEe----CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 43 GFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
+|++.+.||.|+||.||.|+. .+|+.||+|+++... ....+.+.+|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999985 368899999997542 22346678899999999 589999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 999999999999999987654 789999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch--hhhhhh
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--ISLKNW 271 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--~~~~~~ 271 (314)
...... ......++..|+|||.... ....++.++||||||+++|+|++|..||....... ......
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 223 (290)
T cd05613 156 HEDEVE-RAYSFCGTIEYMAPDIVRG-----------GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223 (290)
T ss_pred cccccc-ccccccCCcccCChhhccC-----------CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH
Confidence 432211 1122347888999987531 12345678999999999999999999996432111 111110
Q ss_pred -------hhccCCchhhhh----c--cccCCC-----CHHHHHH
Q 047043 272 -------VNESLPHALTDV----V--DANLRV-----SMKDVAA 297 (314)
Q Consensus 272 -------~~~~~~~~l~~l----l--dp~~Rp-----t~~~~~~ 297 (314)
.+..++..+.++ + ||..|| ++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 ILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 112234444444 3 899997 7777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=260.81 Aligned_cols=203 Identities=26% Similarity=0.368 Sum_probs=167.7
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC-
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP- 110 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 110 (314)
.+++...++|++.+.||+|+||.||+|. ..+++.||+|.++... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4567788999999999999999999999 4579999999987542 22345677899999999999999999987532
Q ss_pred -----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 111 -----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 111 -----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
+..+++++++ +++|.+++... .+++..+..++.|++.|+.||| +.|++|+||||+||+++.++.++|+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888877 77998887654 3889999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
|||++...... .....++..|+|||... ....++.++|||||||++|+|++|..||...
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~------------~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIML------------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHh------------CccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99988764322 12234788899998653 2234677899999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=255.75 Aligned_cols=240 Identities=24% Similarity=0.296 Sum_probs=189.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeec---ccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ---LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..+.|...+.||.|++|.||+|+. .+++.+++|.+... .......+.+|+++++.++|+|++++++++...+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 445688889999999999999995 46889999988643 22344567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+. +++.+.+...+..+++..+..++.|++.|+.||| ..|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 999996 5888887665556899999999999999999999 89999999999999999999999999998876532
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh------
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------ 269 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------ 269 (314)
. ....++..|+|||.+.. .....++.++|||||||++|+|++|..||...........
T Consensus 168 ~------~~~~~~~~y~aPE~~~~----------~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILA----------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231 (308)
T ss_pred c------ccccCCccccCHHHHhh----------cccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC
Confidence 2 12347888999987531 1233467789999999999999999999876543222111
Q ss_pred -hhhhccCCchhh----hhc--cccCCCCHHHHHHHHH
Q 047043 270 -NWVNESLPHALT----DVV--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 270 -~~~~~~~~~~l~----~ll--dp~~Rpt~~~~~~~l~ 300 (314)
......++..+. +++ +|..||++.+++++..
T Consensus 232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111123444444 444 9999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=249.08 Aligned_cols=235 Identities=23% Similarity=0.300 Sum_probs=179.0
Q ss_pred ceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHH-HhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVL-RNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||.|++|.||+|.. .+++.||+|.++.... .....+..|..++ ...+|+|++++++.+..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999995 5789999999875421 1223334444444 345899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++...+. +++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 999999977654 789999999999999999999 89999999999999999999999999998775432 1
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---------hhh
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---------WVN 273 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---------~~~ 273 (314)
....++..|+|||... +..++.++||||||+++|+|++|..||............ ...
T Consensus 151 ~~~~~~~~y~~pe~~~-------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETIL-------------GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhc-------------CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence 2234778899997653 334678999999999999999999999765443321110 011
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
..++..+.+++ +|..||++.++.+ .+.|+|+++
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~---~l~~~~~~~ 256 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQE---IKSHPFFKS 256 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHH---HHcChHhhc
Confidence 23445544544 9999997654433 233566654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=255.86 Aligned_cols=233 Identities=22% Similarity=0.342 Sum_probs=184.5
Q ss_pred ccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
|+....||.|++|.||++.. .+++.|++|.+..........+.+|+.+++.++|+|++++++.+...+..+++|||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 34457799999999999995 57999999998655444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
++|.+++... .+++..+..++.|++.+++||| ..|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 102 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~ 173 (292)
T cd06657 102 GALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR 173 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cc
Confidence 9999977543 3789999999999999999999 89999999999999999999999999998776543221 12
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-h-hhhhh------hc
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-S-LKNWV------NE 274 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~-~~~~~------~~ 274 (314)
....++..|+|||.. .+..++.++|+||+|+++|+|++|..||........ . ..... ..
T Consensus 174 ~~~~~~~~y~~pE~~-------------~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06657 174 KSLVGTPYWMAPELI-------------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLH 240 (292)
T ss_pred cccccCccccCHHHh-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcc
Confidence 234578889999764 334567799999999999999999999975432211 0 00000 11
Q ss_pred cCCchhhhh----c--cccCCCCHHHHHH
Q 047043 275 SLPHALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 275 ~~~~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
.++..+.++ + +|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 233334443 3 9999999999888
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=269.75 Aligned_cols=238 Identities=25% Similarity=0.398 Sum_probs=185.7
Q ss_pred cccceeeecCceEEEEEEe-CCCCeEEEEEeeec----ccHHHHHHHHHHHHHHhCCCCCcceeecccccCC--ceeEEE
Q 047043 45 NECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ----LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD--FKALVL 117 (314)
Q Consensus 45 ~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 117 (314)
+.-..||+|+|-+||+|.. .+|-.||=-.++.. .++..+++..|+.+|+.|+||||+++|++|.+.. ++.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3445799999999999995 35666543322221 2455688999999999999999999999998755 478999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeecceecCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDG 196 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~~~~~ 196 (314)
|.+..|+|..++.+.+. .+...+..|+.||+.||.|||+. ...|+|||||.+||||+. -|.|||+|+|+|+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999998876 88889999999999999999964 567999999999999974 589999999999987543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhccC
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESL 276 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~ 276 (314)
. ....+|||.|+|||.. ...|+..+||||||+++.||.|+..||..-.+...-.+.......
T Consensus 200 ~----aksvIGTPEFMAPEmY--------------EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMY--------------EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred c----cceeccCccccChHHH--------------hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 2 2226799999999774 256888999999999999999999999876665554444443333
Q ss_pred Cc------------hhhhhc-cccCCCCHHHHHHHHHhhhhheeee
Q 047043 277 PH------------ALTDVV-DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 277 ~~------------~l~~ll-dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
|+ .+..|| ....||++.|+++ ++||..
T Consensus 262 P~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~------d~Ff~~ 301 (632)
T KOG0584|consen 262 PAALSKVKDPEVREFIEKCLATKSERLSAKELLK------DPFFDE 301 (632)
T ss_pred HHHhhccCCHHHHHHHHHHhcCchhccCHHHHhh------Chhhcc
Confidence 33 333333 4456777777766 566544
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=249.77 Aligned_cols=198 Identities=25% Similarity=0.338 Sum_probs=166.1
Q ss_pred ccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEEec
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
|++.+.||.|++|.||+|... +++.|++|.+..... .......+|+..++.++ |+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999954 688999999875432 12234456889999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++|.+.+.... ..+++..+..++.|++.+|.||| ++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 779999887654 45899999999999999999999 89999999999999999999999999999886644322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.....++..|+|||.+. ....++.++|+||||+++++|++|..||...
T Consensus 155 --~~~~~~~~~~~aPE~~~------------~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --YTDYVSTRWYRAPEILL------------RSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --cCCCCCcccccCceeee------------cCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 12234788899997653 2345678999999999999999999998654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=258.74 Aligned_cols=203 Identities=24% Similarity=0.343 Sum_probs=165.8
Q ss_pred hhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 34 YLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
...++...++|.+.+.||.|++|.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 86 (342)
T cd07879 7 NKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA 86 (342)
T ss_pred hhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence 344556678999999999999999999995 479999999987542 22335677899999999999999999988654
Q ss_pred ------CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 111 ------DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 111 ------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
...++++||+. .+|.+... ..+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred ccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEE
Confidence 34589999985 47776542 24789999999999999999999 899999999999999999999999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+|||++....... ....++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPEVIL------------NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChhhhc------------CccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987543221 1234688899997753 2234678899999999999999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.84 Aligned_cols=209 Identities=26% Similarity=0.290 Sum_probs=178.5
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhC-CCCCcceeecccccCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (314)
..-..+|..+..||+|+||+|.+|+. .+.+.+|||+++++.- ...+--..|-++|... +.|.+++++.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 44567899999999999999999995 4788999999987642 2223344566777665 57899999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
+|+||||+.||+|.-.+++-+. +.|+.+..++..|+-||-+|| ++||++||||.+||+++.+|++||.|||++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999999998876 889999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
---+. ......+|||.|+|||++. ..+|+.++|.||+|+++|||+.|+.||++....++
T Consensus 500 ni~~~--~TTkTFCGTPdYiAPEIi~-------------YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 500 NIFDG--VTTKTFCGTPDYIAPEIIA-------------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred cccCC--cceeeecCCCcccccceEE-------------ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 43222 2345578999999998775 45678899999999999999999999999765554
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=250.56 Aligned_cols=199 Identities=29% Similarity=0.404 Sum_probs=168.6
Q ss_pred ccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
|+..+.||+|++|.||+|... +++.+++|.+.... ......+..|+.+++.++|+|++++++++.+....++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999954 69999999998753 233466778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
+ ++|.+++.+....+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 5999999876455899999999999999999999 89999999999999999999999999998876643322
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
......++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~aPE~~~------------~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 TYTHEVVTLWYRAPEILL------------GSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ccCccccCcCcCChHHhc------------CCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 112234567799997753 2235677899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=257.34 Aligned_cols=202 Identities=27% Similarity=0.366 Sum_probs=169.7
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC-----cee
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-----FKA 114 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (314)
+|++.+.||.|++|.||+|.. .+++.|++|.+.... ......+.+|+.+++.++|||++++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999995 469999999987653 334567889999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|||++ ++|.+++.... .+++..+..++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||.+....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 58988887655 5899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 195 DGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 195 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
..... .......++..|+|||.+.. ...++.++|+||||+++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLS------------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccccccccccccccCcCCceeeec------------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 43210 11222357888999977641 2267789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.29 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=199.0
Q ss_pred CCcccceehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHh--CCCCCccee
Q 047043 26 VATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN--VHHRNLLKI 103 (314)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~ 103 (314)
+.+.+..+.+-.+.+.++..+.+.||+|.||+||+|+| .|+.||||+|..... +.+.+|.++.+. |+|+||+.|
T Consensus 195 SGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhh
Confidence 34444455566677888999999999999999999999 789999999987633 677888888875 499999999
Q ss_pred ecccccC----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc----CCCCCCeeecCCCCCceE
Q 047043 104 FSSCSNP----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH----GHSSAPIVHCDLKPSNIL 175 (314)
Q Consensus 104 ~~~~~~~----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~----~~~~~~i~H~dlkp~Nil 175 (314)
++.-..+ .+++||++|++.|||.|++.+.. ++.....+++..+++||+|||. .+++..|.|||||..||+
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 9875433 37899999999999999998844 8899999999999999999992 224777999999999999
Q ss_pred ecCCCcEEEEeeecceecCCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 176 LDENMVARVSDFGISKLLGDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 176 i~~~~~ikl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
|..++.+.|+|+|+|.......+. .......||.+|+|||++...+ +.+ -..--..+||||||.++||+..
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti-n~~------~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI-NMK------HFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhc-Chh------hhhhhhHHHHHHHHHHHHHHHH
Confidence 999999999999999887554222 2234567999999999986321 111 1112236899999999999976
Q ss_pred C----------CCCCCccccchhhhhhhh--------hccCCc-------------hhhhhc--cccCCCCHHHHHHHHH
Q 047043 254 G----------KKPTDEMFTGEISLKNWV--------NESLPH-------------ALTDVV--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 254 g----------~~Pf~~~~~~~~~~~~~~--------~~~~~~-------------~l~~ll--dp~~Rpt~~~~~~~l~ 300 (314)
+ ..||-+..+.+-++.... .+.+|+ ..+++. +|..|-|+--+-+.+.
T Consensus 422 Rc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 422 RCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred HhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 3 346665544433222221 122222 122222 8888888888888887
Q ss_pred hhh
Q 047043 301 KIR 303 (314)
Q Consensus 301 ~~~ 303 (314)
++.
T Consensus 502 ~l~ 504 (513)
T KOG2052|consen 502 KLS 504 (513)
T ss_pred HHh
Confidence 765
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=255.39 Aligned_cols=193 Identities=25% Similarity=0.267 Sum_probs=157.1
Q ss_pred CceEEEEEEe-CCCCeEEEEEeeec--ccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHHHHh
Q 047043 54 SFGIVYKGIL-SDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLY 130 (314)
Q Consensus 54 ~~g~V~~a~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~ 130 (314)
++|.||.++. .+++.||+|.++.. .......+.+|+++++.++|+||+++++++...+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455555552 37999999999765 23456788999999999999999999999999999999999999999999987
Q ss_pred hc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc-----ceeec
Q 047043 131 SH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-----VTQTM 204 (314)
Q Consensus 131 ~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~-----~~~~~ 204 (314)
.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||+.+......... .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 64 344789999999999999999999 899999999999999999999999999988765332111 01122
Q ss_pred ccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 205 ~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
..++..|+|||.+.. ....++.++|+|||||++|+|++|..||...
T Consensus 168 ~~~~~~y~aPE~~~~-----------~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 168 SVKNLPWLSPEVLQQ-----------NLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccCHHHhcC-----------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 346778999987641 1234677899999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=255.66 Aligned_cols=200 Identities=19% Similarity=0.280 Sum_probs=160.8
Q ss_pred ceeeec--CceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTG--SFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G--~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
..||+| ++|+||+|++ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999995 479999999987543 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 123 GSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 123 ~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
+++.+++.... ..+++..+..++.|++.||+||| ++|++|+||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987642 34789999999999999999999 89999999999999999999999999975543321111100
Q ss_pred -----eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 202 -----QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 202 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.....++..|+|||.+.. ....++.++|||||||++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQ-----------DLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccccCccCccChhhhcC-----------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 011124566999987531 12346789999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=251.83 Aligned_cols=240 Identities=25% Similarity=0.321 Sum_probs=183.4
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4677788999999999999995 478999999987543 234466788999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHHh---h-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 119 LMPNGSLENWLY---S-HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 119 ~~~~~sL~~~i~---~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++. +++.++.. . ....+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 46655432 1 23458999999999999999999993 3599999999999999999999999999987654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--- 271 (314)
.... .....++..|+|||.+... ....++.++||||||+++|+|++|..||.............
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 226 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPS----------ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG 226 (288)
T ss_pred cCCc---cccccCccCccCHHHhccc----------cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC
Confidence 3221 1223478889999876411 12467889999999999999999999997643211111110
Q ss_pred --------hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 --------VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 --------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
....++..+.+++ ||..|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112444444544 99999999999884
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=254.34 Aligned_cols=237 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.+-|.+++.||.|++|.||+|.+ .+|+.+|||....+ ...+.+..|+.+++++.+|++|++||.+-....+++||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 34588999999999999999995 47999999988776 4568899999999999999999999998888899999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
|..|++.+.++.++..+++..+..++.+.+.||+||| ...-+|||||.-||+++.+|..||.|||.+..+.+. -
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 9999999999988888999999999999999999999 788899999999999999999999999999877532 2
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh------------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI------------S 267 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~------------~ 267 (314)
..+...+||+.|+|||++. .-.|+.+.||||||++..||..|+.||.+..+... .
T Consensus 184 AKRNTVIGTPFWMAPEVI~-------------EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIE-------------EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK 250 (502)
T ss_pred HhhCccccCcccccHHHHH-------------HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC
Confidence 2345578999999998774 33477789999999999999999999987654322 1
Q ss_pred hhhhhhccCCchhhhhc--cccCCCCHHHHHHH
Q 047043 268 LKNWVNESLPHALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 268 ~~~~~~~~~~~~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
-+..-...+.+.++.++ .|.+|-|+-+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11122234445566665 88888888777763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=254.98 Aligned_cols=201 Identities=27% Similarity=0.371 Sum_probs=166.7
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc-CCc
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-PDF 112 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 112 (314)
+..+.++|++.+.||.|+||.||+|.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678999999999999999999994 479999999886432 2234667789999999999999999998865 567
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++++||+ +++|.+++... .+++..+..++.|+++||.||| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999998 56898887643 3788889999999999999999 89999999999999999999999999998875
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
..... ....++..|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~~------------~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIML------------TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCCCc-----CCCcccccccCceeee------------ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43221 1234677899997643 2245678999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=243.37 Aligned_cols=228 Identities=32% Similarity=0.384 Sum_probs=182.0
Q ss_pred eeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCH
Q 047043 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 50 lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
||.|++|.||++... +++.+++|++..... .....+..|+++++.++|||++++++.+..++..+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999954 689999999876532 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecc
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~ 205 (314)
.+++..... +++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (250)
T cd05123 81 FSHLSKEGR-FSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF 153 (250)
T ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence 999987654 899999999999999999999 89999999999999999999999999998877643321 12234
Q ss_pred cceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hhhccCCchh
Q 047043 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WVNESLPHAL 280 (314)
Q Consensus 206 ~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~~~~~~~~l 280 (314)
.++..|+|||... +...+.++|+||||+++|++++|..||............ ..+..++..+
T Consensus 154 ~~~~~~~~Pe~~~-------------~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 220 (250)
T cd05123 154 CGTPEYLAPEVLL-------------GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEA 220 (250)
T ss_pred cCCccccChHHhC-------------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence 5788899997653 334677899999999999999999999765432211111 1222334444
Q ss_pred hhh----c--cccCCCCH---HHHHH
Q 047043 281 TDV----V--DANLRVSM---KDVAA 297 (314)
Q Consensus 281 ~~l----l--dp~~Rpt~---~~~~~ 297 (314)
.++ + ||..||++ .++++
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 444 4 99999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=260.78 Aligned_cols=202 Identities=27% Similarity=0.460 Sum_probs=171.5
Q ss_pred hcCcccc--ceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNEC--NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~--~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..-|++. +.||+|.||+||-|+ .++|+.||||++.+.. .+.-..+++|+.+|+++.||+||.+-..|++.+..++
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 3346655 479999999999999 5689999999998653 2334778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC---CcEEEEeeecce
Q 047043 116 VLELMPNGSLENWL-YSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN---MVARVSDFGISK 191 (314)
Q Consensus 116 v~e~~~~~sL~~~i-~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~---~~ikl~Dfg~~~ 191 (314)
|||.+.| +..+.| .+...++++.....+..||+.||.||| .++|+|+||||+||++.+. ..+||||||+++
T Consensus 641 VMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 641 VMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred Eehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeecccccee
Confidence 9999955 666655 445566999999999999999999999 8999999999999999654 369999999999
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
..++.. .+....|||.|+|||++. +..|...-|+||.|+|+|--++|..||+...+
T Consensus 716 iIgEks---FRrsVVGTPAYLaPEVLr-------------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 716 IIGEKS---FRRSVVGTPAYLAPEVLR-------------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred ecchhh---hhhhhcCCccccCHHHHh-------------hccccccccceeeeEEEEEEecccccCCCccc
Confidence 986543 345567999999997664 56677889999999999999999999986544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.52 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=216.8
Q ss_pred CCcccceehhhHHHHhcCccccceeeecCceEEEEEEeCC-CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceee
Q 047043 26 VATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104 (314)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (314)
..+.....++.+.....+.....+||.|.+|.||.|.|+. .--||||.++.+. ....+|..|+.+|+.+.|||+|+++
T Consensus 251 tvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 251 TVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred ceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHh
Confidence 3444555667888888899999999999999999999864 5679999998774 3468899999999999999999999
Q ss_pred cccccCCceeEEEEecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEE
Q 047043 105 SSCSNPDFKALVLELMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ik 183 (314)
++|...-.+|+|+||+..|+|.++++..++ .++.-..+.|+.||.+||+||. ++..+||||...|+||..+..+|
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEE
Confidence 999999999999999999999999987653 3566677899999999999999 89999999999999999999999
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMF 262 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~ 262 (314)
+.|||+++.+..+... .+....-+..|.|||.+. .-.++.++|||+|||++||+.| |..||.+..
T Consensus 406 vADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLA-------------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLA-------------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred eeccchhhhhcCCcee-cccCccCcccccCccccc-------------ccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 9999999988654322 333334567799997764 3346789999999999999998 999998865
Q ss_pred cchh------hhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 263 TGEI------SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 263 ~~~~------~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
-..+ .++..-++.||+.+.+++ .|.+||++.|+-+.++.+.+.
T Consensus 472 lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 472 LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 4332 223334677888877776 999999999999998877654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=253.93 Aligned_cols=201 Identities=26% Similarity=0.319 Sum_probs=162.4
Q ss_pred CccccceeeecCceEEEEEEe-CC--CCeEEEEEeeecc--cHHHHHHHHHHHHHHhC-CCCCcceeeccccc----CCc
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SD--GNNVAIKVFKLQL--GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN----PDF 112 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 112 (314)
+|++.+.||.|+||.||++.. .+ +..||+|.+.... ......+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588999999999999999994 35 7899999987532 22345677899999999 59999999987432 246
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++++++. ++|.+.+.... .+++..+..++.|++.||.||| ..|++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899885 69999886554 4899999999999999999999 99999999999999999999999999999886
Q ss_pred cCCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 193 LGDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 193 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
....... .......++..|+|||... ....++.++|+||||+++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------------~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIML------------SFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cccccccccccccCcccCccccCcHHHh------------CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 6432211 1112235788999997643 2245678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=246.10 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=162.6
Q ss_pred ccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhC---CCCCcceeecccccCCc-----
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNV---HHRNLLKIFSSCSNPDF----- 112 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 112 (314)
|++.+.||.|++|.||+|+.+ +++.+++|.++.... .....+.+|+.+++.+ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999965 589999999975432 2224455677777665 59999999999987766
Q ss_pred eeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 113 KALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.+++||++++ +|.+++.... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999964 8998887643 35899999999999999999999 8999999999999999999999999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
........ ....++..|+|||.+ .+..++.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~-------------~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVL-------------LQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCccc---ccccccccccChHHh-------------ccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 76443221 122467889999765 34456788999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=249.07 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=189.6
Q ss_pred CccccceeeecCceEEEEEEe----CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 43 GFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
+|++.+.||.|++|.||++.. .++..|++|+++... ......+.+|+.++..+ +||+++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999984 257889999987542 22345678899999999 599999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++||||+++++|.+++...+ .+++..+..++.|++.+|.||| ..|++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987654 3789999999999999999999 899999999999999999999999999988765
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc--hhhhh-h
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG--EISLK-N 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~--~~~~~-~ 270 (314)
...... ......++..|+|||.... .....+.++|+||||+++|+|++|..||...... ..... .
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 223 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRG-----------GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcC-----------CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH
Confidence 433211 1122347889999987531 1223567899999999999999999999642211 00100 0
Q ss_pred ------hhhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 271 ------WVNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 271 ------~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
..+..++..+.++ + ||..|||+.++.+. +.+.|+++.+
T Consensus 224 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~---l~~~~~~~~~ 273 (288)
T cd05583 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEI---KNHPFFQGID 273 (288)
T ss_pred HHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHH---hcCcccccCC
Confidence 1112234444444 4 99999998877664 4456665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.44 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=194.3
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..=+|.-...||.|.||.||.|. ..+|...|+|-++... .+....+.+|..++..++|||++++||+-.+.+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34467888899999999999999 5689999999887653 34556788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
||||.+|+|.+.+...+- .+|.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999876553 667777788899999999999 999999999999999999999999999999887654
Q ss_pred CCcc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---
Q 047043 197 EDSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--- 271 (314)
Q Consensus 197 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--- 271 (314)
.... .-+...||+.|+|||++... .+..-..+.|||||||++.||.||+.||..+.++-.-+-..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t----------~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGT----------KGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG 1457 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhccc----------ccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc
Confidence 2111 12345799999999997521 22223457899999999999999999998866543222111
Q ss_pred ----hhccCCc----hhhhhc--cccCCCCHHHHHHH
Q 047043 272 ----VNESLPH----ALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 272 ----~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
++..+++ .+..|+ ||..|=++.+++++
T Consensus 1458 h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1222333 344455 99999888777763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=262.89 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=203.9
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC--CCC--eEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeeccccc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS--DGN--NVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSN 109 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (314)
++.-...++....++||+|.||.|++|.|. .|+ .||||.++..... ...+|.+|+.+|.+|+|+|++++||+..+
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 444445667788899999999999999975 244 7899999877543 77899999999999999999999999888
Q ss_pred CCceeEEEEecCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 110 PDFKALVLELMPNGSLENWLYS-HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~-~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
....+|+|.++.|+|.+.+.+ ....+-......++.||+.||.||. .+++|||||...|+++.....|||+|||
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeeccc
Confidence 556799999999999999987 4455778889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCCcceee-cccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccch-
Q 047043 189 ISKLLGDGEDSVTQT-MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE- 265 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~- 265 (314)
+++.++..+...... ...-...|+|||.+ ....++.++|||++||++|||++ |+.||-+.....
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsL-------------rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESL-------------RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHh-------------ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 999987765544322 22346679999765 56778899999999999999999 899998754322
Q ss_pred -----hhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 266 -----ISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 266 -----~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
...+...++.|++.+.+++ +|.+||||.+|.+.+-
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2222334567888887776 9999999999986543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=241.62 Aligned_cols=235 Identities=25% Similarity=0.320 Sum_probs=181.0
Q ss_pred CccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-----cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
+|.+.+.||+|++|.||++... .+..+++|+.+... ......+..|+.+++.++|||++++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999954 45556666665321 12234566788999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+||+++++|.+++.. .+..+++..++.++.|++.|+.||| +.|++|+||+|+||+++. +.++|+|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999998864 2345899999999999999999999 899999999999999975 56999999988766
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
...... .....+++.|+|||.. .+..++.++|+||||+++|+|++|..||............
T Consensus 156 ~~~~~~--~~~~~~~~~~~~pe~~-------------~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd08222 156 MGSCDL--ATTFTGTPYYMSPEAL-------------KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG 220 (260)
T ss_pred CCCccc--ccCCCCCcCccCHHHH-------------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence 433221 1223477889999764 2344667899999999999999999999754332221111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+..++..+.+++ +|..||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01223344444444 9999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.55 Aligned_cols=240 Identities=26% Similarity=0.397 Sum_probs=184.1
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
+.......|...+.||+|+||.||+|+. .++..||+|.++.... ....|++.+++++||||+++++++.+.+..+
T Consensus 684 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 4444566788889999999999999995 5789999998865422 2234688899999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+++++|.+++.. +++..+.+++.|++.|++|||+.. ..+++||||||+||+++.++..++. ++......
T Consensus 760 lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999963 788899999999999999999432 4589999999999999988887775 55443321
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh----
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---- 270 (314)
.. ....+++.|+|||++ .+..++.++|||||||++|||++|+.||+...........
T Consensus 834 ~~------~~~~~t~~y~aPE~~-------------~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 894 (968)
T PLN00113 834 TD------TKCFISSAYVAPETR-------------ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY 894 (968)
T ss_pred cC------CCccccccccCcccc-------------cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHH
Confidence 11 122578899999664 4556788999999999999999999998643322111111
Q ss_pred ---------hhhccC--------------Cchhhhhc--cccCCCCHHHHHHHHHhhhh
Q 047043 271 ---------WVNESL--------------PHALTDVV--DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 271 ---------~~~~~~--------------~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~ 304 (314)
+.++.+ -+.+..++ ||.+||++.|+++.++.+..
T Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 111111 01122333 99999999999999998865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=259.53 Aligned_cols=229 Identities=27% Similarity=0.333 Sum_probs=187.5
Q ss_pred hcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...|+....+|.|+|+.|..+. ..+++..++|++.... .+-.+|..++... +||||+++++.+.++...|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5679999999999999999999 4578899999998762 2344567666555 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe-cCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL-DENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili-~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
.+.|+-+.+.+..... +. ..+..|+++|+.|+.||| .+|++||||||+|||+ ++.++++|+|||.+......
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988888876553 33 677789999999999999 9999999999999999 68999999999999877554
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh-h---
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV-N--- 273 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~-~--- 273 (314)
....+-|..|.|||+ .....|++++|+||||+++|+||+|..||..-..+..-..... +
T Consensus 470 ----~~tp~~t~~y~APEv-------------l~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEV-------------LAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS 532 (612)
T ss_pred ----hcccchhhcccChhh-------------hccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc
Confidence 222456888999955 4577899999999999999999999999987655522222221 1
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHH
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+++..++++ ||.+||++.++..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 45666666665 9999999999988
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=258.23 Aligned_cols=207 Identities=24% Similarity=0.352 Sum_probs=181.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEeCCCC-eEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILSDGN-NVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~-~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
+....+++.+..||.||||.|=++..+... .+|+|++++.. .++.+....|-++|..+++|+|+++|..|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 345667888899999999999999965433 48999988764 34556778899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+.||-|-||.|...++..+. +++..+..++..+++|++||| .+||++|||||+|.+++.+|-+||.|||++...
T Consensus 496 YmLmEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999999988876 899999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
+... .....+|||+|.|||+++ +...+.++|.||||+++|||++|.+||.+..+..
T Consensus 571 ~~g~---KTwTFcGTpEYVAPEIIL-------------nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 571 GSGR---KTWTFCGTPEYVAPEIIL-------------NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred ccCC---ceeeecCCcccccchhhh-------------ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 7654 345578999999998875 3344678999999999999999999999866543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=239.82 Aligned_cols=212 Identities=20% Similarity=0.197 Sum_probs=165.1
Q ss_pred cCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHHHHhh
Q 047043 53 GSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS 131 (314)
Q Consensus 53 G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~ 131 (314)
|.+|.||+++. .+++.+|+|.++... ...+|...+....||||+++++++.+.+..+++|||+++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999994 579999999987652 233445555556799999999999999999999999999999999876
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeee
Q 047043 132 HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211 (314)
Q Consensus 132 ~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 211 (314)
... +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ~~~-l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 79 FLN-IPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred hcC-CCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 554 899999999999999999999 8999999999999999999999999999876554321 112356679
Q ss_pred ecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-hhhhhhhccCCc----hhhhhc--
Q 047043 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-SLKNWVNESLPH----ALTDVV-- 284 (314)
Q Consensus 212 ~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~~----~l~~ll-- 284 (314)
+|||.. ....++.++|+||+|+++|+|++|..|+........ ......+..++. .+..++
T Consensus 149 ~aPE~~-------------~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 149 CAPEVG-------------GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred cCCccc-------------CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccC
Confidence 999653 345567889999999999999999988764322111 001112233444 444444
Q ss_pred cccCCCCH
Q 047043 285 DANLRVSM 292 (314)
Q Consensus 285 dp~~Rpt~ 292 (314)
||.+||++
T Consensus 216 dp~~R~~~ 223 (237)
T cd05576 216 NPTERLGA 223 (237)
T ss_pred CHHHhcCC
Confidence 99999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=257.45 Aligned_cols=210 Identities=23% Similarity=0.348 Sum_probs=178.1
Q ss_pred cCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.-|-.++.||-|+||+|.+++ ..+...+|+|.+++.. ..+......|-+||...+++.+|++|-.|++++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347788899999999999999 5567789999988763 234566778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
+|++||++..++.+.+- +.|..+..+..++..|+++.| +.|.+||||||+|||||.+|+|||+|||+++-+....
T Consensus 709 dYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999998876 888999999999999999999 9999999999999999999999999999987652111
Q ss_pred Ccc----------------------------------------eeecccceeeeecCccccccccccCcccCCCCCCCCc
Q 047043 198 DSV----------------------------------------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA 237 (314)
Q Consensus 198 ~~~----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
+.+ ......||+.|+|||++ ....++.
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-------------~r~g~~q 850 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-------------ARTGYTQ 850 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-------------cccCccc
Confidence 100 00123689999999665 4666788
Q ss_pred ccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 238 KCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 238 ~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
-+|.||.||++|+|+.|..||.....++.+.+
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~k 882 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYK 882 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceee
Confidence 89999999999999999999988776665443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=222.69 Aligned_cols=226 Identities=25% Similarity=0.339 Sum_probs=184.6
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
.....+....+..||+|++|.|-+-++ .+|+..|+|.++...+ +...+...|+++..+. .+|++++|||...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444566777788999999999988884 5899999999987643 4456677788887766 689999999999999999
Q ss_pred eEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 114 ALVLELMPNGSLENWLY---SHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
++.||.+. .||..+-. ..+...+|..+.+++..++.||.|||+ +..++|||+||+|||++.+|.+|+||||.+
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 99999984 47776644 346668999999999999999999997 788999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
..+.+. .......|+..|+|||.+.. +. ....|+.++||||||+++.||.+++.||+.....-.++..
T Consensus 197 G~L~dS---iAkt~daGCkpYmaPEri~~--------e~-n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 197 GYLVDS---IAKTMDAGCKPYMAPERINP--------EL-NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred eeehhh---hHHHHhcCCCccCChhhcCc--------cc-CcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 887442 23444568889999998753 22 2337899999999999999999999999988777777776
Q ss_pred hhhccCCc
Q 047043 271 WVNESLPH 278 (314)
Q Consensus 271 ~~~~~~~~ 278 (314)
.+.+.-|.
T Consensus 265 vVeep~P~ 272 (282)
T KOG0984|consen 265 VVEEPSPQ 272 (282)
T ss_pred HhcCCCCC
Confidence 66544433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=239.52 Aligned_cols=239 Identities=25% Similarity=0.303 Sum_probs=189.4
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++.+.+..||.|+||+|++..++ +|+..|||.++.... ....++..|.+...+- +.||||++||.+-.+...++-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 45567788999999999999954 799999999987754 5556777787776655 68999999999988888999999
Q ss_pred ecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 119 LMPNGSLENWLYS----HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 119 ~~~~~sL~~~i~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
.+. .+|..+-.. .+..++|..+..+....+.||.||-. ...++|||+||+|||++..|.+||||||.+..+.
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 984 476654332 24558999999999999999999987 7889999999999999999999999999987763
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNE 274 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~ 274 (314)
+ +..+....|...|+|||.+.+ ....|+.+|||||||+++||+.||..||....+.-.++...+..
T Consensus 220 ~---SiAkT~daGCrpYmAPERi~p-----------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 220 D---SIAKTVDAGCRPYMAPERIDP-----------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred H---HHHhhhccCCccccChhccCC-----------ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 3 334555678999999988742 22358899999999999999999999998765543333333322
Q ss_pred ------------cCCchhhhhc------cccCCCCHHHHHHH
Q 047043 275 ------------SLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 275 ------------~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.++..+.+++ |...||...++.++
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2344455544 88999999988763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=245.72 Aligned_cols=204 Identities=28% Similarity=0.401 Sum_probs=167.8
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHh--CCCCCcceeecccccCC----cee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN--VHHRNLLKIFSSCSNPD----FKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~ 114 (314)
....+..+.+|+|+||.||+|.. +++.||||++... ..+.+.+|-++.+. +.|+||++|++.-+.+. .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 56677888999999999999997 5699999999865 45778888888875 48999999999877665 889
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH-----GHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~-----~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
+|++|.+.|+|.+++..+- .++....+++..++.||+|||+ .+.+.+|+|||||.+||||..+++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999998765 7999999999999999999995 23377899999999999999999999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
+..+......-......||.+|+|||++.... + ...+..-.+.||||+|.++|||+++..-
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgai------n-l~d~~Afkr~DvYamgLVLWEi~SRC~~ 423 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI------N-LQDRDAFKRIDVYAMGLVLWEIASRCTD 423 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhc------c-cccHHHHHHHHHHHHHHHHHHHHhhccc
Confidence 99886433322233367999999999875321 1 1113344579999999999999986543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=257.79 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=203.9
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccc--
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCS-- 108 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 108 (314)
.++.+-...+.|++.+.||.|.+|.||+++ .++++..|+|+....... ..++..|.++++.. .|||++.+|+++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444456789999999999999999999 568999999998877443 36788899999987 6999999999874
Q ss_pred ---cCCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 109 ---NPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 109 ---~~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
.++.++||||||.+||..|+++.. +..+.|..+..++..++.|+.+|| .+.++|||||-.||+++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEE
Confidence 467999999999999999999764 566899999999999999999999 999999999999999999999999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~ 264 (314)
+|||.+..++... -......|||.|+|||++.+ +......|+.++|+||||++..||--|.+|+-++.+.
T Consensus 165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac--------~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIAC--------DESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCCcccccceeeec--------ccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 9999988775432 23455789999999999986 4456677889999999999999999999998877654
Q ss_pred hhhhhhh--------hhccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 265 EISLKNW--------VNESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 265 ~~~~~~~--------~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
..-+... .+..-++.+.++ + |-..||+..+++++
T Consensus 235 raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 3322111 112222333333 3 88999999988874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=264.26 Aligned_cols=146 Identities=29% Similarity=0.441 Sum_probs=132.3
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||.|+||.||+|... +++.||+|+++... ......+..|+.+++.++||||+++++.+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999954 79999999997542 23346788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
|||+.+++|.+++...+. +++..++.++.||+.||.||| .+|++|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~-l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976554 789999999999999999999 8999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=243.30 Aligned_cols=217 Identities=29% Similarity=0.453 Sum_probs=178.2
Q ss_pred hhhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccH-------HHHHHHHHHHHHHhCCCCCcceeec
Q 047043 34 YLDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR-------AFRSFDSECEVLRNVHHRNLLKIFS 105 (314)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (314)
|.+-....++|-++.+||+|||+.||+|. ...++.||+|+-.....+ ......+|.++.+.|+||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 44445567889999999999999999999 446889999987554321 2344568999999999999999999
Q ss_pred ccc-cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---CCCc
Q 047043 106 SCS-NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD---ENMV 181 (314)
Q Consensus 106 ~~~-~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~---~~~~ 181 (314)
+|. +.+.++-|+|||+|.+|.-++....- +++..+..|..|+++||.||... +..|+|.||||.|||+- .-|.
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccce
Confidence 986 56688899999999999888877654 89999999999999999999965 67899999999999994 4578
Q ss_pred EEEEeeecceecCCCCCcce-----eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCC
Q 047043 182 ARVSDFGISKLLGDGEDSVT-----QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK 256 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~ 256 (314)
+||+|||++..++++..... .....||..|++||++.. ....+.++.++||||.|||+|+++.|+.
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvV---------gkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVV---------GKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeec---------CCCCCccccceeeEeeehhhhhhhccCC
Confidence 99999999999876543322 122458999999999852 2346678999999999999999999999
Q ss_pred CCCccc
Q 047043 257 PTDEMF 262 (314)
Q Consensus 257 Pf~~~~ 262 (314)
||....
T Consensus 683 PFGhnq 688 (775)
T KOG1151|consen 683 PFGHNQ 688 (775)
T ss_pred CCCCch
Confidence 998643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=257.28 Aligned_cols=243 Identities=30% Similarity=0.428 Sum_probs=199.7
Q ss_pred ccccceeeecCceEEEEEEe-CCC----CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDG----NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
....+.||+|+||+||+|.| ..| -+||+|++.... .+....+.+|+-+|.+++|||++++++++..+. +.+|+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45567899999999999995 233 478999987553 344578899999999999999999999998876 67899
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
+++++|+|.++++..+..+.....+.|..||++||.||| .++++||||..+|+||.+-..+|+.|||++..+....
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999988877999999999999999999999 9999999999999999999999999999999886655
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhhhhc--
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNWVNE-- 274 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~~~~-- 274 (314)
.........-.+.|+|-|. ...+.++.++|||||||++||++| |..|++++...++......+.
T Consensus 853 ~ey~~~~gK~pikwmale~-------------i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL 919 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALES-------------IRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL 919 (1177)
T ss_pred ccccccccccCcHHHHHHH-------------hhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC
Confidence 4443333334556777744 467889999999999999999999 999999988777654443333
Q ss_pred ----cCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 275 ----SLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 275 ----~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.++..+..++ |++.||+++++.+.+..+..
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 3344433332 99999999999998887653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=232.57 Aligned_cols=204 Identities=24% Similarity=0.323 Sum_probs=169.6
Q ss_pred HHhcCccccceeeecCceEEEEEE-eCC----CCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeeccccc-C
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGI-LSD----GNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSN-P 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~-~~~----~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 110 (314)
.....|+.++.||+|.+|.||+|. .++ ...+|+|.++.+.+ .......+|+-.++.++|||++.+..+|.. .
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 456789999999999999999997 332 22689998876532 223556789999999999999999999876 7
Q ss_pred CceeEEEEecCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC----CcE
Q 047043 111 DFKALVLELMPNGSLENWLYSH----NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN----MVA 182 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~----~~i 182 (314)
..+++++||.+. +|...|.-. ...++...+..+++||++|++||| ++-+.||||||.||+|..+ |.+
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccCee
Confidence 899999999976 999988632 345888999999999999999999 8999999999999999777 899
Q ss_pred EEEeeecceecCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 183 RVSDFGISKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
||+|||+++.+.+.-... ......-|..|.|||.++ ....|+.+.||||.|||+.||++-+..|.
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL------------Ga~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLL------------GARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhc------------ccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999999886543333 222345799999998876 56679999999999999999999877664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=212.40 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=171.0
Q ss_pred CccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 43 GFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
+|.-.+.||.|.+|+||+|+ +.+++.||+|..+.+.+. .-....+|+-+++.+.|.||++++++....+.+-+|+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677899999999999999 668999999999876432 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
|. .+|..+..+.+..++.+.+..++.|++.|+.++| ++.+.|||+||.|.+|+.+|.+||.|||+++-++-+...
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 95 5999999988878999999999999999999999 899999999999999999999999999999988765433
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~ 261 (314)
.. -..-|..|.+|.++. ...-|+...|+||-||++.|+.. |...|.+.
T Consensus 158 ys--aevvtlwyrppdvlf------------gakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 158 YS--AEVVTLWYRPPDVLF------------GAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ee--ceeeeeeccCcceee------------eeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 32 245788899995543 34557888999999999999988 55556543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=232.07 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=172.9
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCcee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (314)
...+|++++.||+|++++|-+++ .++.+.+|+|+++++. ++..+-...|-.++.+. +||.++-++.+|++...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 35689999999999999999999 5689999999998763 22223334566666666 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+|.||++||+|.-.+++... ++++.+..+-..|..||.||| ..||++||||.+|+++|..|++||+|+|.+..--
T Consensus 328 fvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999887776554 899999999999999999999 9999999999999999999999999999988754
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
.+.. .....+|||.|+|||++ .+..|+..+|.|+||++++||+.|+.||+
T Consensus 403 ~~gd--~tstfcgtpnyiapeil-------------rgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 403 GPGD--TTSTFCGTPNYIAPEIL-------------RGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCc--ccccccCCCcccchhhh-------------cccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 4333 34557899999999665 57789999999999999999999999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=253.04 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=167.2
Q ss_pred HhcCccccceeeecCceEEEEEEe-CC----CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecc------cc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SD----GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS------CS 108 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 108 (314)
..++|++.+.||+|+||.||+|.. .+ +..||+|.+...... ....++ .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999995 45 789999987643211 111111 1222222233322222 24
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHNYF-------------------LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~~~-------------------~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl 169 (314)
.....++++||+++++|.+++...... ..+..+..++.|++.||+||| +.|++||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcC
Confidence 566889999999999999998754311 123446789999999999999 899999999
Q ss_pred CCCceEecC-CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcc---------cCCCCCCCCccc
Q 047043 170 KPSNILLDE-NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA---------KFGSEGIISAKC 239 (314)
Q Consensus 170 kp~Nili~~-~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~---------~~~~~~~~~~~~ 239 (314)
||+|||++. ++.+||+|||++..+...... ......+++.|+|||.+.......... .......++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 679999999999765432221 223346889999999654221110000 000112345678
Q ss_pred ceehhhHHHHHHhcCCCCCCccccc--------hh---hhhhhhhccCC------------------chhhhhc--cccC
Q 047043 240 DVYSFGVLLMETFTGKKPTDEMFTG--------EI---SLKNWVNESLP------------------HALTDVV--DANL 288 (314)
Q Consensus 240 Dv~slG~il~~ll~g~~Pf~~~~~~--------~~---~~~~~~~~~~~------------------~~l~~ll--dp~~ 288 (314)
|||||||++|+|+++..|++..... .. .+.....+..+ +.+..|+ ||.+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999999988776532110 00 11111111110 3555666 9999
Q ss_pred CCCHHHHHHHHHhhhhheeee
Q 047043 289 RVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 289 Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
|||+.++++ |+|+..
T Consensus 441 R~ta~e~L~------Hpff~~ 455 (566)
T PLN03225 441 RISAKAALA------HPYFDR 455 (566)
T ss_pred CCCHHHHhC------CcCcCC
Confidence 999999998 666643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=252.38 Aligned_cols=248 Identities=28% Similarity=0.427 Sum_probs=198.6
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC--C------CCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS--D------GNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSC 107 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~--~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (314)
....++..+.+.||.|.||.|++|... . ...||+|..+... ..+.+.+..|+.+++.+ .|+|++.+.|++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334455567779999999999999832 1 3468999987654 34667899999999998 799999999999
Q ss_pred ccCCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCC
Q 047043 108 SNPDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172 (314)
Q Consensus 108 ~~~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~ 172 (314)
......++|+||+..|+|.++++..+ ..++..+.+.++.|++.|++||+ +.+++||||..+
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaR 447 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAAR 447 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhh
Confidence 99999999999999999999998776 34888899999999999999999 899999999999
Q ss_pred ceEecCCCcEEEEeeecceecCCCCCcceeeccc--ceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHH
Q 047043 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTMTM--ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250 (314)
Q Consensus 173 Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ 250 (314)
||++..+..+||+|||+++.......... .... -+..|+|||.+ ....++.+|||||||+++||
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl-------------~~~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESL-------------FDRVFTSKSDVWSFGILLWE 513 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHh-------------ccCcccccchhhHHHHHHHH
Confidence 99999999999999999986543332221 1112 35569999765 35778999999999999999
Q ss_pred Hhc-CCCCCCccc-cchhhhh-------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 251 TFT-GKKPTDEMF-TGEISLK-------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 251 ll~-g~~Pf~~~~-~~~~~~~-------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
+++ |..||.+.. ..+. .. ...+..+++.+.+++ +|.+||++.++.+.+.....
T Consensus 514 ifsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HhhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999 999998854 2222 22 123445566665444 99999999999999998543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=228.40 Aligned_cols=205 Identities=21% Similarity=0.367 Sum_probs=170.9
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccH--HHHHHHHHHHHHHhCCCCCcceeeccccc-------
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNVHHRNLLKIFSSCSN------- 109 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 109 (314)
..+.|+-..+||+|.||+||+|+ .++|+.|++|..-.+..+ .-....+|+++|..+.|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 46788999999999999999999 457888888865432211 12345789999999999999999998753
Q ss_pred -CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 110 -PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 110 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
...+|+|+++|+. +|..++......++...+.+++.++.+||.|+| .+.|+|||+|+.|++|+.+|.++|+|||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 3458999999976 999999887777999999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCCcce--eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 189 ISKLLGDGEDSVT--QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+++.+....+... .....-|..|++||.++ ....|+++.|||.-||++.+|++|.+-+++.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllL------------G~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLL------------GDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhh------------cccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 9977754433222 22345699999998876 5667889999999999999999999988764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=223.05 Aligned_cols=223 Identities=31% Similarity=0.402 Sum_probs=180.6
Q ss_pred CceEEEEEEeC-CCCeEEEEEeeecccHH-HHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHHHHhh
Q 047043 54 SFGIVYKGILS-DGNNVAIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYS 131 (314)
Q Consensus 54 ~~g~V~~a~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~ 131 (314)
+||.||+|... +++.+++|++....... ...+.+|++.+++++|++++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 68999999998765433 67889999999999999999999999999999999999999999999877
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeee
Q 047043 132 HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211 (314)
Q Consensus 132 ~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y 211 (314)
... ++...++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 654 789999999999999999999 8999999999999999999999999999988765432 12234577889
Q ss_pred ecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhc------c---CCchhhh
Q 047043 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNE------S---LPHALTD 282 (314)
Q Consensus 212 ~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~------~---~~~~l~~ 282 (314)
++||.. ....++.++|+||||++++++++|..||................ . ++..+.+
T Consensus 153 ~~pE~~-------------~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVL-------------LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred CCHHHH-------------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHH
Confidence 999765 24556779999999999999999999997733322211111100 0 4443444
Q ss_pred ----hc--cccCCCCHHHHHH
Q 047043 283 ----VV--DANLRVSMKDVAA 297 (314)
Q Consensus 283 ----ll--dp~~Rpt~~~~~~ 297 (314)
++ +|..||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 44 8999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=231.52 Aligned_cols=201 Identities=25% Similarity=0.325 Sum_probs=166.9
Q ss_pred HHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC--CC----Ccceeeccccc
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH--HR----NLLKIFSSCSN 109 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~----~i~~~~~~~~~ 109 (314)
.....++|.++..+|.|.||.|-.+. ..++..||+|+++.- ....+...-|+++++++. .| .++.+.++|+.
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34457899999999999999999999 557899999998754 233345566899999883 23 37888899999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC----------
Q 047043 110 PDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---------- 178 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---------- 178 (314)
.+..++|+|.+ |.|+.+++..++ ..++...+..+++|+++++++|| +.+++|.||||+||++.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccC
Confidence 99999999988 669999998764 45788999999999999999999 999999999999999821
Q ss_pred ----------CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHH
Q 047043 179 ----------NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248 (314)
Q Consensus 179 ----------~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il 248 (314)
+..|+++|||.++.-.+.. .....|..|.|||++ .+-.++.++||||+|||+
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEVi-------------LgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVI-------------LGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchhe-------------eccCcCCccCceeeeeEE
Confidence 2358999999998754433 345689999999766 466788899999999999
Q ss_pred HHHhcCCCCCCcc
Q 047043 249 METFTGKKPTDEM 261 (314)
Q Consensus 249 ~~ll~g~~Pf~~~ 261 (314)
+|+.+|...|+.-
T Consensus 300 ~ElytG~~LFqtH 312 (415)
T KOG0671|consen 300 VELYTGETLFQTH 312 (415)
T ss_pred EEeeccceecccC
Confidence 9999999988753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=217.29 Aligned_cols=207 Identities=21% Similarity=0.416 Sum_probs=169.6
Q ss_pred CcccceehhhHHHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceee
Q 047043 27 ATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIF 104 (314)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 104 (314)
-+|..-++..-+...++|++++.+|+|.+++||.|. ..++++++||++++- ....+.+|+.+|+.+. +|||++++
T Consensus 23 eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~ 99 (338)
T KOG0668|consen 23 EYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLL 99 (338)
T ss_pred hhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehh
Confidence 333333333334457889999999999999999999 567899999999865 3367889999999997 99999999
Q ss_pred cccccC--CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-Cc
Q 047043 105 SSCSNP--DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MV 181 (314)
Q Consensus 105 ~~~~~~--~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ 181 (314)
++..+. ....+|+|++...+...+... ++..++...+.+++.||.|+| +.||.|||+||.|++||.. -.
T Consensus 100 DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 100 DIVKDPESKTPSLIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhhcCccccCchhHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhhce
Confidence 998764 566799999988776665443 778889999999999999999 9999999999999999854 57
Q ss_pred EEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
++|+|||+|..+...... .....+..|--||.+. .-..|+..-|+|||||++..|+..+.||-
T Consensus 172 LrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLV------------dy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV------------DYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eeeeecchHhhcCCCcee---eeeeehhhcCCchhee------------echhccccHHHHHHHHHHHHHHhccCccc
Confidence 999999999988654432 2345677788898765 34567788999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=239.99 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=166.8
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--------HHHHHHHHHHHHHHhCC---CCCcceeecccc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--------RAFRSFDSECEVLRNVH---HRNLLKIFSSCS 108 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 108 (314)
..+|..++.+|.|+||.|++|.++ +...|++|.+.++.- +.....--|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 446899999999999999999966 466799999877631 11122345999999996 999999999999
Q ss_pred cCCceeEEEEec-CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 109 NPDFKALVLELM-PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 109 ~~~~~~lv~e~~-~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
+.+++|+.||.. ++.+|.++|..... ++|..+..++.|++.|+++|| ++||+|||||-+|+.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeec
Confidence 999999999986 45689999987655 899999999999999999999 999999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
|.+.+...+. .....||..|.|||++. ...+.+...|||+||+++|.+...+.||-
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~------------g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLG------------GEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhC------------CCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9988764432 23456999999997764 23344667899999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-29 Score=231.03 Aligned_cols=216 Identities=21% Similarity=0.257 Sum_probs=150.9
Q ss_pred HhcCccccceeeecCceEEEEEEe-----------------CCCCeEEEEEeeecccHHHHH--------------HHHH
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-----------------SDGNNVAIKVFKLQLGRAFRS--------------FDSE 88 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e 88 (314)
..++|++.+.||+|+||.||+|.. ..++.||||.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235679999987543222222 2335
Q ss_pred HHHHHhCCCCC-----cceeeccccc--------CCceeEEEEecCCCCHHHHHhhcC----------------------
Q 047043 89 CEVLRNVHHRN-----LLKIFSSCSN--------PDFKALVLELMPNGSLENWLYSHN---------------------- 133 (314)
Q Consensus 89 ~~~l~~l~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~i~~~~---------------------- 133 (314)
+.++.+++|.+ ++++++++.. ....++|+||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66666665544 4566676642 356789999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeee
Q 047043 134 -YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212 (314)
Q Consensus 134 -~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 212 (314)
..+++..+..++.|++.+|.||| +.+++|+||||+||+++.++.++|+|||++......... ......+++.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 11345678889999999999999 899999999999999999999999999998655332111 111223578999
Q ss_pred cCccccccccccCccc--C-------CCCCCCCcccceehhhHHHHHHhcCCC-CCCc
Q 047043 213 APVSQLFDILKPKNAK--F-------GSEGIISAKCDVYSFGVLLMETFTGKK-PTDE 260 (314)
Q Consensus 213 aPE~~~~~~~~~~~~~--~-------~~~~~~~~~~Dv~slG~il~~ll~g~~-Pf~~ 260 (314)
|||.+..........- . ........+.|+||+||++|+|++|.. ||..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9998753211000000 0 000011234799999999999999886 7654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=208.37 Aligned_cols=200 Identities=31% Similarity=0.458 Sum_probs=171.4
Q ss_pred ccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecC
Q 047043 44 FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
|++.+.||.|++|.||++... +++.+++|.+...... ....+.+|++.++.++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 677889999999999999954 5899999999876554 56788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce
Q 047043 122 NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT 201 (314)
Q Consensus 122 ~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~ 201 (314)
+++|.+++......+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 99999999875433788999999999999999999 899999999999999999999999999998877544211 1
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.....++..|++||... ....++.++|+|+||+++++|++|..||..
T Consensus 156 ~~~~~~~~~~~~pe~~~------------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLL------------GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhc------------CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12234677899997642 345566689999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=241.35 Aligned_cols=232 Identities=28% Similarity=0.474 Sum_probs=178.1
Q ss_pred ccccceeeecCce-EEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEecC
Q 047043 44 FNECNLLGTGSFG-IVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 44 y~~~~~lg~G~~g-~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
|...+.+|.|+.| .||+|.. .|+.||||.+-.+. .....+|+..++.- +||||+++|+.-.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4445678889887 6899997 68899999876543 34567899999887 69999999999999999999999996
Q ss_pred CCCHHHHHhhcCC--C-CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---C--CcEEEEeeecceec
Q 047043 122 NGSLENWLYSHNY--F-LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---N--MVARVSDFGISKLL 193 (314)
Q Consensus 122 ~~sL~~~i~~~~~--~-~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~--~~ikl~Dfg~~~~~ 193 (314)
- +|.+++...+. . ......+.++.|+++||++|| ..+|+||||||.||||+. + .+++|+|||++..+
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 99999987411 1 122456889999999999999 999999999999999965 3 46899999999998
Q ss_pred CCCCCccee-ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC-CCCCCccccchhhhh--
Q 047043 194 GDGEDSVTQ-TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-KKPTDEMFTGEISLK-- 269 (314)
Q Consensus 194 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-~~Pf~~~~~~~~~~~-- 269 (314)
..+.....+ ....||.+|.|||++.. ..-+.++|||||||++|+.++| .+||......+....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~-------------~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~ 728 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE-------------DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG 728 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc-------------cccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC
Confidence 765544433 44569999999988752 2234489999999999999884 899987554432211
Q ss_pred -----hhhh-c--cCCchhhhhc--cccCCCCHHHHHH
Q 047043 270 -----NWVN-E--SLPHALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 270 -----~~~~-~--~~~~~l~~ll--dp~~Rpt~~~~~~ 297 (314)
...+ . .-.+.+.+|+ ||..||++.+++.
T Consensus 729 ~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 729 NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 1 1223455555 9999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=211.36 Aligned_cols=205 Identities=20% Similarity=0.332 Sum_probs=165.9
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecc-cccCCce
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSS-CSNPDFK 113 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~ 113 (314)
.....+.|.+.+.+|.|.||.+-+++++ +++.+++|.+..... ...+|.+|+..--.| .|.||+.-|++ |++.+.+
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3446788999999999999999999954 788999999887643 347788888776666 48899988865 7888899
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec--CCCcEEEEeeecce
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD--ENMVARVSDFGISK 191 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~--~~~~ikl~Dfg~~~ 191 (314)
+++|||++.|+|.+-+...+ +.|....+++.|+++|+.|+| +..++|||||.+||||- +..++||||||...
T Consensus 98 vF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999999888765 789999999999999999999 89999999999999993 44589999999887
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
..+.-.. ....+..|.+||...- -....-...+.+|+|.||+++|.+++|..||+..
T Consensus 172 k~g~tV~-----~~~~~~~y~~pe~~~~--------~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 172 KVGTTVK-----YLEYVNNYHAPELCDT--------VVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ccCceeh-----hhhhhcccCCcHHHhh--------ccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 6543221 2234567899987641 1112233566899999999999999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=202.97 Aligned_cols=209 Identities=36% Similarity=0.552 Sum_probs=173.9
Q ss_pred eeecCceEEEEEEeC-CCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHH
Q 047043 50 LGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLEN 127 (314)
Q Consensus 50 lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 127 (314)
||.|++|.||++... +++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999954 5899999999876432 34678899999999999999999999999999999999999899999
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeecceecCCCCCcceeeccc
Q 047043 128 WLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDGEDSVTQTMTM 206 (314)
Q Consensus 128 ~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~~~~~~~~~~~~~~~ 206 (314)
++......++...+..++.+++.++.+|| ..|++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 99876444889999999999999999999 899999999999999998 89999999999887654321 122234
Q ss_pred ceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhccCCchhhhhc--
Q 047043 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVV-- 284 (314)
Q Consensus 207 ~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~l~~ll-- 284 (314)
+...|.+||.... ....+.++|+|++|++++++ ..+.+.+..++
T Consensus 155 ~~~~~~~pe~~~~------------~~~~~~~~D~~~lg~~~~~l----------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 155 GTPAYMAPEVLLG------------KGYYSEKSDIWSLGVILYEL----------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCCccChhHhcc------------cCCCCchhhhHHHHHHHHHH----------------------HHHHHHHHHHhhC
Confidence 6778999976531 13667789999999999999 33344555555
Q ss_pred cccCCCCHHHHHHH
Q 047043 285 DANLRVSMKDVAAK 298 (314)
Q Consensus 285 dp~~Rpt~~~~~~~ 298 (314)
+|..||++.++++.
T Consensus 201 ~p~~R~~~~~l~~~ 214 (215)
T cd00180 201 DPEKRPSAKEILEH 214 (215)
T ss_pred CcccCcCHHHHhhC
Confidence 89999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=217.24 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=200.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeeccc-cc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSC-SN 109 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 109 (314)
.....+++....+..|.||.||.|.|. +.+.|.+|..+.... -+...+..|.-.+..+.|||+..+.+++ ++
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 334556888888999999999999653 244667777665432 3456677888888888999999999985 45
Q ss_pred CCceeEEEEecCCCCHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 110 PDFKALVLELMPNGSLENWLYSH-------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~-------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
....+++..+...|+|..++... ...++..+...++.|++.|++||| +.|++|.||..+|.+||+.-.+
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhheeE
Confidence 66778888988889999999832 234677788999999999999999 9999999999999999999999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~ 261 (314)
||+|=.+++-+-.............+..|++||.+. +..|+.++|+||||+++|||++ |+.|+...
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-------------n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-------------NSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHh-------------hhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 999998887664443333344455788899997664 5567889999999999999999 99999988
Q ss_pred ccchhh------hhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 262 FTGEIS------LKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 262 ~~~~~~------~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.+.+.. .+...+-+||+.+..++ .|.+||+++++..-|.++...+
T Consensus 503 DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 503 DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 765542 22334567888877765 9999999999999998876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=212.63 Aligned_cols=130 Identities=25% Similarity=0.353 Sum_probs=112.1
Q ss_pred cCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-----C---CCcceeeccccc---
Q 047043 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-----H---RNLLKIFSSCSN--- 109 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~--- 109 (314)
++|.+.++||-|-|++||+|. ....+.||+|+.+... -..+....|+++|++++ | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 689999999999999999999 5678899999998762 23355678999999883 3 358999999864
Q ss_pred -CCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe
Q 047043 110 -PDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL 176 (314)
Q Consensus 110 -~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili 176 (314)
+..++||+|++ |.+|..+|...+ +.++...+.+|+.|++.||.|||. .+||+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~---ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR---ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH---hcCccccCCCcceeee
Confidence 56889999999 779999998753 448899999999999999999997 8999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=217.36 Aligned_cols=204 Identities=23% Similarity=0.295 Sum_probs=170.6
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC------CCcceeeccccc
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH------RNLLKIFSSCSN 109 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~ 109 (314)
....-++|++....|+|-|++|-.|.. ..|+.||||+|..... ....=..|+++|++|+. .++++++..|.+
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 444567899999999999999999994 4688999999987632 22444679999999952 379999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEe
Q 047043 110 PDFKALVLELMPNGSLENWLYSHNY--FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSD 186 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~~--~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~D 186 (314)
.+.++||+|.+ ..+|.+++.+.+. .+....+..++.||.-||..|- ++|++|.||||+||||+.+. .+||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeecc
Confidence 99999999998 5699999988653 3667889999999999999999 99999999999999998664 579999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
||.|...++....+ ..-+..|.|||++ .+.+|+...|+||.||++|||.||+..|.+..+
T Consensus 581 fGSA~~~~eneitP----YLVSRFYRaPEIi-------------LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 581 FGSASFASENEITP----YLVSRFYRAPEII-------------LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred CccccccccccccH----HHHHHhccCccee-------------ecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 99998876654332 2345669999766 578889999999999999999999999987544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=228.08 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=199.6
Q ss_pred HHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...++|+.+..+|+|.+|.||+|+ ..+++..|+|+++.+....+..+.+|+-+++.++||||+.+++.+.....+++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 456789999999999999999999 4579999999999988778888899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|||.+|+|++.-.-.+. +++.++..+++..+.+++||| ..|-+|||||-.||++++.|.+|+.|||.+..++..-
T Consensus 92 EycgggslQdiy~~Tgp-lselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGP-LSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EecCCCcccceeeeccc-chhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999997655554 899999999999999999999 8999999999999999999999999999887765422
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh-hh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-KN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-~~------ 270 (314)
......+||+.|+|||+.. +...+.|...+|+|++|+...|+---+.|.....+....+ ..
T Consensus 167 --~KrksfiGtpywmapEvaa----------verkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp 234 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAA----------VERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP 234 (829)
T ss_pred --hhhhcccCCccccchhHHH----------HHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC
Confidence 2344568999999999863 4567788899999999999999987777743322211111 00
Q ss_pred --h-hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 --W-VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 --~-~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
. -...-++.+.+++ +|+.||++..++.
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0 0112344555555 9999999988776
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=205.83 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=163.6
Q ss_pred CccccceeeecCceEEEEEE-eCCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCC-----cee
Q 047043 43 GFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-----FKA 114 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (314)
+.+.-+.||-|+||.||.+. -.+|+.|++|.+..-.. .....+-+|+.++..++|.|++..+++.+-.+ .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34566889999999999999 45899999998764322 22356778999999999999999998876543 457
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++|.+. .+|...|-+-+. ++...+.-+..||+.||.||| +.+|.||||||-|.++++|..+||||||+++...
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~-Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQA-LTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHH-hhhhheeccCCC-CCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEecccccccccc
Confidence 8888884 488877765443 788889999999999999999 8999999999999999999999999999998654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.+. ........-|..|.|||+++ ....|+.+.||||.||++.|++.++..|+...
T Consensus 208 ~d~-~~hMTqEVVTQYYRAPEiLM------------GaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 208 QRD-RLNMTHEVVTQYYRAPELLM------------GARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhh-hhhhHHHHHHHHhccHHHhh------------cchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 332 22333456789999998876 56678899999999999999999999987643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=198.41 Aligned_cols=198 Identities=25% Similarity=0.326 Sum_probs=161.8
Q ss_pred HHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC----
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP---- 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (314)
.....+|.-++.+|.|.- .|-.|- ...+++|++|...... ....++..+|+..+..++|+||++++.+|.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 345678888999999998 566666 3478999999775442 22345677899999999999999999998543
Q ss_pred --CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 111 --DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 111 --~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
...|+|||++. .+|...+.- .++...+.+++.|++.|+.||| +.||+||||||+||++..++.+||.|||
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccch
Confidence 46789999994 599988873 3678899999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
++..-... ........|..|.|||++. +..+...+||||+||++.||++|...|.+
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil-------------~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVIL-------------GMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchhee-------------ccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 98764332 2334456888999997764 33388899999999999999999998864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=192.31 Aligned_cols=204 Identities=21% Similarity=0.301 Sum_probs=177.6
Q ss_pred HhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..-.|++.++||+|+||..|.|+ .-++++||||.-.... ...+++.|.+..+.|. .++|..+|-+...+..-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 45579999999999999999999 5689999999876542 3356788999999884 799999999999888889999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-----CCcEEEEeeeccee
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-----NMVARVSDFGISKL 192 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-----~~~ikl~Dfg~~~~ 192 (314)
|.+ |.+|+|++.-+++.++..++..++.|++.-++++| .+.+|+|||||+|+||.. ...+.++|||++..
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 988 88999999988888999999999999999999999 899999999999999953 34689999999999
Q ss_pred cCCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 193 LGDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 193 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
+.++.... .+....||.+|++= +.+.+.+-+.+.|+-|||-++++.|.|..||++...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSI-------------NTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSI-------------NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEe-------------eccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 87654432 24456799999988 778888999999999999999999999999998653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=183.60 Aligned_cols=207 Identities=24% Similarity=0.296 Sum_probs=174.1
Q ss_pred HHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC-CCcceeecccccCCceeEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-RNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 116 (314)
...++|.+++.||+|+||.+|+|. ..+|..||||+-...... ..+.-|.++...+++ ..|..+..+..+.+.-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 346899999999999999999999 668999999997765322 456678899999974 7899999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---CCCcEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~---~~~~ikl~Dfg~~~~~ 193 (314)
|+.+ |.+|++++.-....++..++.-++-|++.-++|+| ..+.+||||||+|++.. ....+.|+|||++..+
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9988 78999999877777999999999999999999999 99999999999999985 4457999999999988
Q ss_pred CCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 194 GDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 194 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
-+..... ......||..|.+- ....+..-+.+.|+-|+|.++.....|..||+++....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASi-------------nAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASI-------------NAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccccccccCccccCCccceeeeehhh-------------hhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 5433221 12234689999877 55666777889999999999999999999999876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=197.18 Aligned_cols=170 Identities=21% Similarity=0.175 Sum_probs=131.5
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC--CCCeEEEEEeeec-----ccHHHHHHHHHHHHHHhCCCCCcce-eecc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS--DGNNVAIKVFKLQ-----LGRAFRSFDSECEVLRNVHHRNLLK-IFSS 106 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~ 106 (314)
++.....++|++.+.||+|+||+||+|.++ +++.+|+|.+... .......+.+|+++++.++|+|++. +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 345567789999999999999999999853 5777899986533 1223456889999999999999884 5442
Q ss_pred cccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC-CCCceEecCCCcEEEE
Q 047043 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL-KPSNILLDENMVARVS 185 (314)
Q Consensus 107 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl-kp~Nili~~~~~ikl~ 185 (314)
...++||||++|++|.. +.. .. ...++.+++.+|.||| +.|++|||| ||+||+++.++.++|+
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEE
Confidence 35789999999999963 211 11 1467889999999999 999999999 9999999999999999
Q ss_pred eeecceecCCCCCcce------eecccceeeeecCcccccc
Q 047043 186 DFGISKLLGDGEDSVT------QTMTMATIGYMAPVSQLFD 220 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~ 220 (314)
|||++..+........ -....+++.|.|||.+..+
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999998754332111 0234578889999887643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=193.81 Aligned_cols=205 Identities=25% Similarity=0.318 Sum_probs=167.2
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-C---CCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCC
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-S---DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPD 111 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 111 (314)
...+.+.|.++..||.|.|++||+|.. . ..+.||+|.+.... ...++.+|+++|..+- +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 444677899999999999999999983 3 46789999887653 2367889999999994 899999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-CCCcEEEEeeecc
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGIS 190 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-~~~~ikl~Dfg~~ 190 (314)
...+|+||+++.+..++... ++-.++..+++.++.||.++| .+||+||||||+|++.+ ..+.-.|+|||++
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999999888765 567889999999999999999 99999999999999997 5577899999998
Q ss_pred eecCCCC------------Ccc------------------------------eeecccceeeeecCccccccccccCccc
Q 047043 191 KLLGDGE------------DSV------------------------------TQTMTMATIGYMAPVSQLFDILKPKNAK 228 (314)
Q Consensus 191 ~~~~~~~------------~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~ 228 (314)
....... ... .+-...||++|.|||++.
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~---------- 250 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF---------- 250 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh----------
Confidence 7221000 000 011235899999998876
Q ss_pred CCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 229 FGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 229 ~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
.-+.-+.++||||.|+++..++++..||-...+
T Consensus 251 --k~~~QttaiDiws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 251 --RCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred --hccCcCCccceeeccceeehhhccccccccCcc
Confidence 344456789999999999999999999865443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-24 Score=188.70 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=186.8
Q ss_pred CccccceeeecCceEEEEEEeCC--CCeEEEEEeeecccHHHHHHHHHHHHHHhCC----CCCcceeeccc-ccCCceeE
Q 047043 43 GFNECNLLGTGSFGIVYKGILSD--GNNVAIKVFKLQLGRAFRSFDSECEVLRNVH----HRNLLKIFSSC-SNPDFKAL 115 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 115 (314)
+|.+.+.||+|+||.||.+.... ...+|+|+...........+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999544 3478999887653322226777888888886 36888999888 57888899
Q ss_pred EEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-----CcEEEEeeec
Q 047043 116 VLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-----MVARVSDFGI 189 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-----~~ikl~Dfg~ 189 (314)
||+.+ |.+|.++..... ..++..++..++.|++.+|.+|| +.|++||||||+|+.+... -.+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999886554 67999999999999999999999 9999999999999999754 3699999999
Q ss_pred ce--ecCCCCCc---ce---eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 190 SK--LLGDGEDS---VT---QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 190 ~~--~~~~~~~~---~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
++ .+...... .. .....||..|.++ +.+.+...+++.|+||++.++.+++.|..||...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~-------------~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI-------------NVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccH-------------HHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 98 43222211 11 1234599999999 6778888899999999999999999999999775
Q ss_pred ccchh--hhhhhh-----h---ccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 262 FTGEI--SLKNWV-----N---ESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 262 ~~~~~--~~~~~~-----~---~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..... ...... . ...+..+..+. +...+|....+.+.++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 241 EMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 53221 111110 1 11223333332 678899999888887766544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=174.58 Aligned_cols=151 Identities=22% Similarity=0.208 Sum_probs=116.0
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
|+|.+++...+..+++.+++.++.|++.||.||| +.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH----RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999876666999999999999999999999 666 999999999999999 99887654321
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhh---------
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN--------- 273 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~--------- 273 (314)
..||+.|+|||++ .+..++.++|||||||++|+|++|..||...............
T Consensus 64 --~~g~~~y~aPE~~-------------~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (176)
T smart00750 64 --SRVDPYFMAPEVI-------------QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD 128 (176)
T ss_pred --CCCcccccChHHh-------------cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc
Confidence 2478999999765 3456778999999999999999999999754322111111100
Q ss_pred ----c------cCCchhhhhc--cccCCCCHHHHHHHHHhhhhh
Q 047043 274 ----E------SLPHALTDVV--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 274 ----~------~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
. .+.+.+..++ +|..||++.++++++..+..+
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0 1223344444 999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=212.32 Aligned_cols=245 Identities=22% Similarity=0.234 Sum_probs=187.5
Q ss_pred CccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc----HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
+|...+.||++.|=+|.+|++..|. |++|++-+..+ +.+.+...|++ ...+++||++++.-+.+..+..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7889999999999999999986777 99999976642 22333334444 455689999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec--CCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL--GDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~--~~~ 196 (314)
|.. .+|+|.+..+.. +...+...++.||+.|+..+| +.|++|||||.+||||++-+.+.|+||...+.. ..+
T Consensus 102 yvk-hnLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHh-hhhhhhhccchH-HHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 995 499999987664 788889999999999999999 999999999999999999999999999876543 111
Q ss_pred C---CcceeecccceeeeecCccccccccccCcccCCCCCC-CCcccceehhhHHHHHHhc-CCCCCCcc----------
Q 047043 197 E---DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGI-ISAKCDVYSFGVLLMETFT-GKKPTDEM---------- 261 (314)
Q Consensus 197 ~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~~~Dv~slG~il~~ll~-g~~Pf~~~---------- 261 (314)
. ......+...-.+|+|||.+.... .+.......+ .+++-||||+||++.||++ |.+||.-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~---~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSAL---GKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccc---cccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 1 112233445677899999987432 1112222333 7889999999999999988 78888631
Q ss_pred ccchhhhhhhhhccCCchhhhhc--cccCCCCHHHHHHH
Q 047043 262 FTGEISLKNWVNESLPHALTDVV--DANLRVSMKDVAAK 298 (314)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~l~~ll--dp~~Rpt~~~~~~~ 298 (314)
.+.+..+..+.+..+.+.+..|| ||..|-+++|.++.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22333444445555566666666 99999999999987
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-25 Score=216.61 Aligned_cols=187 Identities=21% Similarity=0.277 Sum_probs=127.6
Q ss_pred hCCC-CCcceeeccc-------ccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 047043 94 NVHH-RNLLKIFSSC-------SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165 (314)
Q Consensus 94 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~ 165 (314)
.++| +||++++++| .....+++++|++ +++|.+++......+++..+..++.||+.||+||| ++||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCee
Confidence 3345 5777788876 2334677888987 56999999765556899999999999999999999 99999
Q ss_pred ecCCCCCceEecCCCcEE-------------------EEeeecceecCCCCC--------------cceeecccceeeee
Q 047043 166 HCDLKPSNILLDENMVAR-------------------VSDFGISKLLGDGED--------------SVTQTMTMATIGYM 212 (314)
Q Consensus 166 H~dlkp~Nili~~~~~ik-------------------l~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~y~ 212 (314)
||||||+|||++..+.++ ++|||++........ ........+|+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996655554 555554432210000 00011134788899
Q ss_pred cCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-hhhc----cCCc---hhhhhc
Q 047043 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-WVNE----SLPH---ALTDVV 284 (314)
Q Consensus 213 aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-~~~~----~~~~---~l~~ll 284 (314)
|||++ .+..++.++|||||||++|||++|..|+............ ..++ ..++ .+..++
T Consensus 183 APE~~-------------~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 249 (793)
T PLN00181 183 SPEED-------------NGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLL 249 (793)
T ss_pred Chhhh-------------ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhC
Confidence 99765 3456788999999999999999999887643211111110 0111 1111 223334
Q ss_pred --cccCCCCHHHHHHH
Q 047043 285 --DANLRVSMKDVAAK 298 (314)
Q Consensus 285 --dp~~Rpt~~~~~~~ 298 (314)
+|..||++.+++++
T Consensus 250 ~~~P~~Rps~~eil~h 265 (793)
T PLN00181 250 HPEPSCRPSMSELLQS 265 (793)
T ss_pred CCChhhCcChHHHhhc
Confidence 99999999999873
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=179.26 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=186.3
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..+...+.+|....+|+.|+|+| .|..++.|+++... .+..++|.+|+..++.+.||||..+++.|....++.+|..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 34556677889999999999998 56678888887653 3455789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|++.|+|+..+... +.-.+..++.+++.+++.|++|||+- ..-+.---|+..+++||++.+.+|. ++-..+
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris-mad~kf----- 339 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS-MADTKF----- 339 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee-ccccee-----
Confidence 99999999999765 34467789999999999999999953 1224455688999999999877764 221111
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------- 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------- 270 (314)
+.......-.|.|++||.++... ....-.+.|+|||++++||+.|++.||....+.+.....
T Consensus 340 -sfqe~gr~y~pawmspealqrkp----------ed~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv 408 (448)
T KOG0195|consen 340 -SFQEVGRAYSPAWMSPEALQRKP----------EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV 408 (448)
T ss_pred -eeeccccccCcccCCHHHHhcCc----------hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc
Confidence 11122234577899998875321 112234789999999999999999999988877654433
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.+++.++.....++ ||.+||.+..++-.|++++
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34566666666665 9999999999988887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=174.82 Aligned_cols=176 Identities=15% Similarity=0.146 Sum_probs=133.1
Q ss_pred hhhHHH--HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHH---HH------HHHHHHHHHhCCCCCcce
Q 047043 34 YLDIQR--ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAF---RS------FDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 34 ~~~~~~--~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~---~~------~~~e~~~l~~l~h~~i~~ 102 (314)
|.++.. +.++|++.+.+|.|+||.||++.. ++..+|+|+++....... .. +.+|++.+.++.||+|..
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 555555 478999999999999999999776 577899999976543221 22 678999999999999999
Q ss_pred eecccccC--------CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 103 IFSSCSNP--------DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 103 ~~~~~~~~--------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
+.+++... ...+++|||++|.+|.+... +++ ....+++.++..+| ..|++|+|++|+||
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Ni 166 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNF 166 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHE
Confidence 98875532 35789999999999988632 333 24569999999999 99999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
+++.+| ++|+|||.......... . +. ......+..++|+|+||+++...
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a---~------------d~------------~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKA---K------------DR------------IDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhh---H------------HH------------HHHHhHhcccccccceeEeehHH
Confidence 999888 99999997765422110 0 00 01122244689999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=168.63 Aligned_cols=139 Identities=18% Similarity=0.165 Sum_probs=108.0
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccHH--------------------------HHHHHHHHHHHHhCCCCCc
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRA--------------------------FRSFDSECEVLRNVHHRNL 100 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~i 100 (314)
...||+|++|.||+|...+|+.||+|+++...... ......|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999997689999999998653210 0122348899999987766
Q ss_pred ceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCeeecCCCCCceEecCC
Q 047043 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYL-HHGHSSAPIVHCDLKPSNILLDEN 179 (314)
Q Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~L-H~~~~~~~i~H~dlkp~Nili~~~ 179 (314)
.....+.. ...++||||++++++....... ..+++..+..++.|++.+|.++ | ..|++|+||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H----~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ----DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEE-C
Confidence 43332221 2237999999887776554333 3488899999999999999999 7 88999999999999998 4
Q ss_pred CcEEEEeeecceec
Q 047043 180 MVARVSDFGISKLL 193 (314)
Q Consensus 180 ~~ikl~Dfg~~~~~ 193 (314)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=161.35 Aligned_cols=142 Identities=20% Similarity=0.181 Sum_probs=110.2
Q ss_pred ccceeeecCceEEEEEEeCCCCeEEEEEeeecccH--------------------------HHHHHHHHHHHHHhCCCCC
Q 047043 46 ECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR--------------------------AFRSFDSECEVLRNVHHRN 99 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~ 99 (314)
+.+.||+|++|.||+|...+|+.||+|+++..... .......|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999668999999999865211 0112357888899998887
Q ss_pred cceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecC
Q 047043 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDE 178 (314)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~ 178 (314)
+.....+... ..++||||++|+++....... ..+++..+..++.|++.++.++| . .|++|+||||+||+++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH----~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLY----QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCChhhEEEE-
Confidence 7443333222 247999999887554432222 23778889999999999999999 7 9999999999999998
Q ss_pred CCcEEEEeeecceecCC
Q 047043 179 NMVARVSDFGISKLLGD 195 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~ 195 (314)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-23 Score=193.73 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=179.1
Q ss_pred Cc-cccceeeecCceEEEEEE-eCCCCeEEEEEeee----c-ccHHHH-HHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 43 GF-NECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKL----Q-LGRAFR-SFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 43 ~y-~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~----~-~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.| .....+|.|++|.|+.+. ......+..|.++. . ...... .+..|+-+-..+.|||++.......+.....
T Consensus 318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 35 456689999999888887 33444455554431 1 111222 2556777777889999988888777766555
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
-.||||++ +|..++...+. +...++-.++.|++.|+.|+| ..|+.|||+|++|++++.+|.+||+|||.+..+.
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~-~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGK-LTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcccc-cchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 56999998 99999987643 788889999999999999999 9999999999999999999999999999988775
Q ss_pred CCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCC-CcccceehhhHHHHHHhcCCCCCCccccchhh----
Q 047043 195 DGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGII-SAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS---- 267 (314)
Q Consensus 195 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~---- 267 (314)
..... .......|+..|+|||... +..| .+..||||.|++++.|.+|+.||......+..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~-------------~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~ 538 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLT-------------GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN 538 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCccccc-------------ccccCcchhhhhhccceEEEEecCCCccccccccccchhhh
Confidence 44433 3445567999999997654 3333 34689999999999999999998654332211
Q ss_pred --------------hhhhhhccCCchhhhhc--cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 268 --------------LKNWVNESLPHALTDVV--DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 268 --------------~~~~~~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
+....+......+.+++ ||.+|.|+.++++ .+|++...
T Consensus 539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~------d~W~~~i~ 592 (601)
T KOG0590|consen 539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN------DEWIRSIE 592 (601)
T ss_pred ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh------ChHhhhcc
Confidence 11112222333455555 9999999999998 66665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-21 Score=169.17 Aligned_cols=203 Identities=36% Similarity=0.503 Sum_probs=169.2
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeecccH---HHHHHHHHHHHHHhCCCC-CcceeecccccCCceeEEEEe
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR---AFRSFDSECEVLRNVHHR-NLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 119 (314)
|++.+.||.|+||.||.+... ..+++|.+...... ....+.+|..+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788899999999999999965 78899998776432 467788999999999887 799999999777778999999
Q ss_pred cCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecceecCCC
Q 047043 120 MPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLGDG 196 (314)
Q Consensus 120 ~~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~~~~ 196 (314)
+.++++.+++.... ..+.+.....++.|++.++.++| ..|++|||+||+||+++..+ .++++|||.+..+...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999997776654 25889999999999999999999 89999999999999999888 7999999998866543
Q ss_pred CCcc----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 197 EDSV----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 197 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.... ......++..|.|||.+... .........|+|++|+++++++.|..||....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~----------~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGL----------SLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CccccccccccccccccccCCHHHhcCC----------CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 23456799999999765310 01567788999999999999999999977655
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=187.15 Aligned_cols=203 Identities=23% Similarity=0.255 Sum_probs=161.7
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC---CCCcceeeccccc
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH---HRNLLKIFSSCSN 109 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 109 (314)
+-.........|.|.+.||.|++|+||.|...+|+.||+|+-++.....+ -=-.+++.+|+ -+.|.++......
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34455566788999999999999999999976799999999887754321 11122333333 3567777777778
Q ss_pred CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-------CCCcE
Q 047043 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-------ENMVA 182 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-------~~~~i 182 (314)
.+.-++|+||.+.|+|.+++...+. +++..++.+..|++..+++|| ..+||||||||+|+++. ....+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~-m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKV-MDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCC-CCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccce
Confidence 8888899999999999999985554 899999999999999999999 99999999999999992 34469
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCC
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK 256 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~ 256 (314)
+|+|||.+.-+.-..+........+|..|-++ |+..+.+++...|.|.|+.+++.||.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~-------------EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCI-------------EMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhH-------------HHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999987655433333344556788899999 55578899999999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=154.76 Aligned_cols=189 Identities=15% Similarity=0.062 Sum_probs=139.4
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeecccH----HHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEE
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR----AFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..+...|++|+||+|+.+.. .+.+++.+.+...... ....+.+|+++|+++. ++++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999997776 7888888877765321 1125789999999995 5789999886 34689999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC-CCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL-KPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl-kp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+.|.+|...... . ...++.|++.++.++| .+|++|+|| ||+||+++.++.++|+|||++.......
T Consensus 79 yI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh-------h-hHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999888654321 1 1357789999999999 999999999 7999999999999999999998655433
Q ss_pred Cc----ce-------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 198 DS----VT-------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 198 ~~----~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.. .. ......++.+++|+... .....--.+.+.++.|+-+|.++|+..|+-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~-----------~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERR-----------VLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHh-----------hhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 21 00 11223577788885432 1111111356889999999999999988644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=149.60 Aligned_cols=137 Identities=20% Similarity=0.310 Sum_probs=106.2
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-----CCCCcceeecccccCC---c-ee
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-----HHRNLLKIFSSCSNPD---F-KA 114 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~ 114 (314)
+.-.+.||+|++|.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++++++++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999995 3234444 69988765444457789999999999 5799999999998864 3 33
Q ss_pred EEEEe--cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCCeeecCCCCCceEecC----CCcEEEEe-
Q 047043 115 LVLEL--MPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL-EYLHHGHSSAPIVHCDLKPSNILLDE----NMVARVSD- 186 (314)
Q Consensus 115 lv~e~--~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l-~~LH~~~~~~~i~H~dlkp~Nili~~----~~~ikl~D- 186 (314)
+|+|| +.+++|.+++.+.. +++. ..++.+++.++ +||| +++|+|+||||+||+++. ++.++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 55789999997642 5555 35577777777 9999 999999999999999973 34799999
Q ss_pred eecc
Q 047043 187 FGIS 190 (314)
Q Consensus 187 fg~~ 190 (314)
||..
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=152.59 Aligned_cols=145 Identities=19% Similarity=0.145 Sum_probs=113.2
Q ss_pred hcCccccceeeecCceEEEEEE--eCCCCeEEEEEeeecccH------------------------HHHHHHHHHHHHHh
Q 047043 41 TEGFNECNLLGTGSFGIVYKGI--LSDGNNVAIKVFKLQLGR------------------------AFRSFDSECEVLRN 94 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~ 94 (314)
..-|++.+.||.|++|.||+|. ..+|+.||+|+++..... ....+..|++.+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458999999999999999998 458999999999754210 11235679999999
Q ss_pred CCCC--CcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-eeecCCCC
Q 047043 95 VHHR--NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP-IVHCDLKP 171 (314)
Q Consensus 95 l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~-i~H~dlkp 171 (314)
+.+. .+.++++. ...++||||+++.+|........ ......+..++.|++.++.+|| ..| ++|+||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCCh
Confidence 8653 34444443 23479999999888876543332 3566677899999999999999 899 99999999
Q ss_pred CceEecCCCcEEEEeeecceecCC
Q 047043 172 SNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 172 ~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+||+++ ++.++|+|||.+...+.
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999998875543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=153.53 Aligned_cols=225 Identities=18% Similarity=0.261 Sum_probs=136.6
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCC---C-------Ccceeecc--
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHH---R-------NLLKIFSS-- 106 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h---~-------~i~~~~~~-- 106 (314)
.+...+.||.|+++.||.+.+ .+++.+++|++..... ...+.+.+|......+.+ | .++--++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456677899999999999995 4799999999976542 234556666554444321 1 11111111
Q ss_pred -------ccc---CC-----ceeEEEEecCCCCHHHHHhh---cCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 047043 107 -------CSN---PD-----FKALVLELMPNGSLENWLYS---HNY---FLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165 (314)
Q Consensus 107 -------~~~---~~-----~~~lv~e~~~~~sL~~~i~~---~~~---~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~ 165 (314)
+.. .+ +.+++|+.. .++|.+++.. ... .+.......+..|++..+++|| ..|++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceE
Confidence 111 11 235677766 4588887653 221 1222334566689999999999 99999
Q ss_pred ecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhh
Q 047043 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFG 245 (314)
Q Consensus 166 H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG 245 (314)
|+||+|+|++++.+|.++|+||+.....+.... . ...+..|.+||....... .......++.+.|.|+||
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~-----~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQ-----FGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTS-----CHHSEEEE-HHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcc-----cCcccceeeeccCHHHHH
Confidence 999999999999999999999998776543211 1 234566888876542110 001334578899999999
Q ss_pred HHHHHHhcCCCCCCccccchhh---hhhhhhccCCchhhhhc
Q 047043 246 VLLMETFTGKKPTDEMFTGEIS---LKNWVNESLPHALTDVV 284 (314)
Q Consensus 246 ~il~~ll~g~~Pf~~~~~~~~~---~~~~~~~~~~~~l~~ll 284 (314)
+++|.|.++..||+........ +.... .+|+.++.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~~~~f~~C~--~~Pe~v~~LI 277 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADPEWDFSRCR--DMPEPVQFLI 277 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTSGGGGTTSS-----HHHHHHH
T ss_pred HHHHHHHHccCCCCCCCccccccccchhcC--CcCHHHHHHH
Confidence 9999999999999976543322 22222 5666666666
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-21 Score=175.19 Aligned_cols=185 Identities=30% Similarity=0.325 Sum_probs=155.9
Q ss_pred eeecCceEEEEEE-e---CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEEecCC
Q 047043 50 LGTGSFGIVYKGI-L---SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 50 lg~G~~g~V~~a~-~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+|.|.+|.|++++ . ..|..+++|+.++... ........|..++...+ ||.+++++-.++.....++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999987 2 2477889998876532 11224556777787776 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
+.|...+..... +++..+..+...++-+++++| +.|++|+|+|++||+++.+|++++.|||+.....+...
T Consensus 82 g~lft~l~~~~~-f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVM-FDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred chhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 999888776654 788888899999999999999 99999999999999999999999999999887644322
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.+||..|+|||++. ....++|.||||+++++|++|..||..
T Consensus 153 --~cgt~eymApEI~~---------------gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN---------------GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh---------------ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27899999998753 234578999999999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=145.18 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=112.6
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeeccc--H------HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG--R------AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~--~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++.||+|++|.||+|.. +|..+++|....... . ....+.+|++++..+.|+++.....++.+.+..+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999997 778899998664321 1 12456789999999999888777767667778899999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
|++|++|.+.+.... . ....++.+++.++.++| ..|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999886532 2 77889999999999999 99999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=141.44 Aligned_cols=138 Identities=20% Similarity=0.180 Sum_probs=109.0
Q ss_pred CccccceeeecCceEEEEEEeCCCCeEEEEEeeecccH----------------------HHHHHHHHHHHHHhCCCCC-
Q 047043 43 GFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR----------------------AFRSFDSECEVLRNVHHRN- 99 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~- 99 (314)
.|.+.+.||+|++|.||++...+|+.||+|+++..... .......|+.++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 48999999999999999999778999999998754210 0112566888888887663
Q ss_pred -cceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 100 -LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 100 -i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
++..++ ....+++|||++|++|...... .....++.+++.++.++| ..|++|+||+|+||+++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEEEcC
Confidence 344443 2345899999999998765321 345678899999999999 899999999999999999
Q ss_pred CCcEEEEeeecceecCC
Q 047043 179 NMVARVSDFGISKLLGD 195 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~ 195 (314)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=157.70 Aligned_cols=205 Identities=27% Similarity=0.349 Sum_probs=151.5
Q ss_pred HHhCCCCCcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCC
Q 047043 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKP 171 (314)
Q Consensus 92 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp 171 (314)
|+.+.|.|+.+++|.+.++...+.|.+||.-|+|.|.+......++......+..+++.||.|||+ ...-.|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 356789999999999999999999999999999999999877778999999999999999999994 23339999999
Q ss_pred CceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 172 SNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 172 ~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
+|.+++..+.+||+|||+....................-|.|||.+...... ......+.+.|+||||++++|+
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~------~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ------SLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccc------cccccccccCCeehHHHHHHHH
Confidence 9999999999999999988766431111112222244569999987632111 1112356789999999999999
Q ss_pred hcCCCCCCccccch----hhhhhh------hhc------cCCchh----hhhc--cccCCCCHHHHHHHHHhhhhh
Q 047043 252 FTGKKPTDEMFTGE----ISLKNW------VNE------SLPHAL----TDVV--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 252 l~g~~Pf~~~~~~~----~~~~~~------~~~------~~~~~l----~~ll--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
++...||+...... ...... ..+ .+++.+ +++. +|..||++.++...++.+...
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99999998633221 111100 001 222222 2222 999999999999998887664
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.6e-18 Score=140.21 Aligned_cols=130 Identities=25% Similarity=0.307 Sum_probs=104.8
Q ss_pred eeeecCceEEEEEEeCCCCeEEEEEeeecc---c-----HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 49 LLGTGSFGIVYKGILSDGNNVAIKVFKLQL---G-----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.||+|++|.||+|.+ ++..+++|...... . .....+.+|++++..++++++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999995 67889999865421 1 12355678999999998876554444445566678999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
+|++|.+.+..... .++.+++.+|.+|| ..|++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 78999999999999 99999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=156.97 Aligned_cols=145 Identities=21% Similarity=0.236 Sum_probs=114.3
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeec--cc------HHHHHHHHHHHHHHhCCCCCcceee
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQ--LG------RAFRSFDSECEVLRNVHHRNLLKIF 104 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~--~~------~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (314)
+|.........|...+.||+|+||.||++.+... .+++|..... .. .....+.+|+++++.++|++++...
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3444444455667889999999999999986433 3444432211 11 1235678899999999999998877
Q ss_pred cccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
.++.+....+++|||+++++|.+++. ....++.+++.++.+|| +.|++||||||+||++ .++.++|
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEE
Confidence 77777777889999999999999875 34678999999999999 9999999999999999 6789999
Q ss_pred Eeeeccee
Q 047043 185 SDFGISKL 192 (314)
Q Consensus 185 ~Dfg~~~~ 192 (314)
+|||++..
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99998865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=144.61 Aligned_cols=188 Identities=23% Similarity=0.269 Sum_probs=131.2
Q ss_pred CCCCcceeecccc---------------------------cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Q 047043 96 HHRNLLKIFSSCS---------------------------NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148 (314)
Q Consensus 96 ~h~~i~~~~~~~~---------------------------~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l 148 (314)
.||||+.++..|- ++..+|+||...+. +|..++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 4999999988652 24578899998865 9999998765 4666777889999
Q ss_pred HHHHHHHhcCCCCCCeeecCCCCCceEe--cCCC--cEEEEeeecceecCCCCC---cc-eeecccceeeeecCcccccc
Q 047043 149 WLALEYLHHGHSSAPIVHCDLKPSNILL--DENM--VARVSDFGISKLLGDGED---SV-TQTMTMATIGYMAPVSQLFD 220 (314)
Q Consensus 149 ~~~l~~LH~~~~~~~i~H~dlkp~Nili--~~~~--~ikl~Dfg~~~~~~~~~~---~~-~~~~~~~t~~y~aPE~~~~~ 220 (314)
++|+.||| ++|+.|||+|.+||++ |+++ .+++.|||++---...+- .. ..-...|....+|||+..-
T Consensus 351 LEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta- 425 (598)
T KOG4158|consen 351 LEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA- 425 (598)
T ss_pred HHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc-
Confidence 99999999 9999999999999999 3333 579999997643221100 00 0112346777899998631
Q ss_pred ccccCcccCCCCC---CCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-------hhccCCchhhhhc------
Q 047043 221 ILKPKNAKFGSEG---IISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------ 284 (314)
Q Consensus 221 ~~~~~~~~~~~~~---~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------ 284 (314)
..++ ..-.+.|.|+.|.+.||+++...||-.........+.+ .++.++..+++++
T Consensus 426 ---------~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 426 ---------VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred ---------CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcC
Confidence 1111 12337899999999999999999997632222222211 2345565666655
Q ss_pred cccCCCCHHHHHHHHH
Q 047043 285 DANLRVSMKDVAAKLK 300 (314)
Q Consensus 285 dp~~Rpt~~~~~~~l~ 300 (314)
||.+|+++.-....++
T Consensus 497 ~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVLN 512 (598)
T ss_pred CccccCCccHHHhHHH
Confidence 9999999876555444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=131.40 Aligned_cols=137 Identities=21% Similarity=0.252 Sum_probs=97.2
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccH--HHHH----------------------HHHHHHHHHhCCCC--Cc
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR--AFRS----------------------FDSECEVLRNVHHR--NL 100 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--~i 100 (314)
.+.||+|+||.||+|...+++.||+|+++..... .... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5679999999999999768999999998764321 1111 12445555554332 23
Q ss_pred ceeecccccCCceeEEEEecCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecC
Q 047043 101 LKIFSSCSNPDFKALVLELMPNGSLEN-WLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDE 178 (314)
Q Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~sL~~-~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~ 178 (314)
.+.++. ...+++|||++++++.. .+.... . ...+..++.+++.++.++| . .|++|+||+|+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh----~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY----REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh----hccCcCcCCCChhhEEEE-
Confidence 333333 23589999998854322 111111 1 1567889999999999999 7 9999999999999999
Q ss_pred CCcEEEEeeecceecCC
Q 047043 179 NMVARVSDFGISKLLGD 195 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~ 195 (314)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-17 Score=159.10 Aligned_cols=172 Identities=27% Similarity=0.346 Sum_probs=124.3
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...+|+.++++..|++|.||.++++ +.+.+|+|+ .++. --+++ ++.....|.++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~----lilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----LILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc----hhhhc---cccccCCccee-----------------
Confidence 4578999999999999999999965 678898854 2221 11111 22222344333
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+..+.+...+. ++. +++.+++||| .-|++|+|+||+|.+|+.-|++|++|||+.........
T Consensus 136 ----gDc~tllk~~g~-lPv--------dmvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP-LPV--------DMVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcccCCC-Ccc--------hhhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 455555554433 322 2388999999 99999999999999999999999999998765321111
Q ss_pred cc-------------eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 199 SV-------------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 199 ~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
.. .....+||+.|+|||++ ....|+..+|.|++|+++|+.+.|+.||.+..+++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi-------------lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI-------------LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhh-------------hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 10 11234799999999554 56678889999999999999999999999876555
Q ss_pred h
Q 047043 266 I 266 (314)
Q Consensus 266 ~ 266 (314)
+
T Consensus 266 l 266 (1205)
T KOG0606|consen 266 L 266 (1205)
T ss_pred H
Confidence 4
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=1e-15 Score=120.63 Aligned_cols=135 Identities=21% Similarity=0.248 Sum_probs=111.6
Q ss_pred ccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC--CCcceeecccccCCceeEEEEecCCC
Q 047043 46 ECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH--RNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
+++.||.|.++.||++.... ..+++|....... ...+.+|...++.+++ ..+++++.+...++..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999744 7899999876543 3568889999999975 58899999888888999999999887
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 124 SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 124 sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
++..+ +......++.+++.++..+|... ..+++|+|++|+||+++..+.++++||+.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76554 44556778899999999999321 25799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.9e-15 Score=138.55 Aligned_cols=168 Identities=18% Similarity=0.231 Sum_probs=133.8
Q ss_pred eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHH
Q 047043 63 LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL 142 (314)
Q Consensus 63 ~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~ 142 (314)
..++.+|.+..++...........+.+..++.++||+|+++++.++....+|+|+|.+. .|..++... +...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 45788999999887766556778899999999999999999999999999999999983 788888764 366788
Q ss_pred HHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCcccccccc
Q 047043 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222 (314)
Q Consensus 143 ~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 222 (314)
.-++||+.||.|||. +++++|+||..+.|+|+..|.+||++|.++........ .......-..|..|+.+.
T Consensus 108 ~Gl~qIl~AL~FL~~---d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~---- 178 (690)
T KOG1243|consen 108 LGLFQILAALSFLND---DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID---- 178 (690)
T ss_pred HHHHHHHHHHHHHhc---cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC----
Confidence 889999999999985 88999999999999999999999999998876544322 112222333466664321
Q ss_pred ccCcccCCCCCCCCcccceehhhHHHHHHhcCCC
Q 047043 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK 256 (314)
Q Consensus 223 ~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~ 256 (314)
.+ +...|.|.|||++++++.|..
T Consensus 179 --------~s---~~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 179 --------PS---EWSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --------cc---ccchhhhhHHHHHHHHhCccc
Confidence 11 135699999999999999933
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.5e-15 Score=127.94 Aligned_cols=135 Identities=19% Similarity=0.192 Sum_probs=102.7
Q ss_pred ceee-ecCceEEEEEEeCCCCeEEEEEeeecc-------------cHHHHHHHHHHHHHHhCCCCCc--ceeecccccC-
Q 047043 48 NLLG-TGSFGIVYKGILSDGNNVAIKVFKLQL-------------GRAFRSFDSECEVLRNVHHRNL--LKIFSSCSNP- 110 (314)
Q Consensus 48 ~~lg-~G~~g~V~~a~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~- 110 (314)
..|| .||.|+||.+.. .+..+++|.+.... ......+.+|++++..++|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 788899998886 47789999885421 0122456789999999988775 5666654332
Q ss_pred Cc---eeEEEEecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 111 DF---KALVLELMPN-GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 111 ~~---~~lv~e~~~~-~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
.. .++|||+++| .+|.+++... .+++. .+.+++.++.+|| +.|++|+||||.||+++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2499999997 6898887653 24443 3578999999999 99999999999999999989999999
Q ss_pred eecceec
Q 047043 187 FGISKLL 193 (314)
Q Consensus 187 fg~~~~~ 193 (314)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9987753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.1e-17 Score=154.52 Aligned_cols=211 Identities=22% Similarity=0.292 Sum_probs=169.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC--CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCC-CCCcceeecccccCCcee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS--DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 114 (314)
....|.+.+.||+|.++.|-++... ....++.|.+.... ......+..|..+-..+. |.|++++++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3456788888999999999988842 34456676665442 233345556777777776 999999999999999999
Q ss_pred EEEEecCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeeccee
Q 047043 115 LVLELMPNGSLENWL-YSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKL 192 (314)
Q Consensus 115 lv~e~~~~~sL~~~i-~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~ 192 (314)
+++++..|+++.+.+ .......+...+...+.|+..++.|+|. ..++.|+|+||+|.+++..+ .+++.|||++..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999988 4443246777888999999999999996 68899999999999999999 999999999998
Q ss_pred cCC-CCCcceeecccc-eeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 193 LGD-GEDSVTQTMTMA-TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 193 ~~~-~~~~~~~~~~~~-t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
+.. .+........+| ++.|.|||.... ........|+||.|+++..+++|..|++......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~------------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSG------------KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccc------------hhhcCCCcccccccccccccccCCCCcccccccc
Confidence 876 444445555678 999999977542 2455678999999999999999999988755433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8e-17 Score=144.87 Aligned_cols=165 Identities=24% Similarity=0.364 Sum_probs=119.2
Q ss_pred CceeEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 111 DFKALVLELMPNGSLENWLYSH--NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
.++|+.|++|...+|.+++... ....+......++.|++.++.| +|.+|+|+||.||++..+..+||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-------ccchhhhccccccccccchhhhhhhhh
Confidence 3678999999999999999743 2334566778899999999886 679999999999999999999999999
Q ss_pred cceecCCCC----CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcccc
Q 047043 189 ISKLLGDGE----DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFT 263 (314)
Q Consensus 189 ~~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~ 263 (314)
+........ ....+....||..|++||++ .+..|+.++||||||++++|++. =..+|.....
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi-------------~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t 468 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI-------------RGQQYSEKVDIYALGLILAELLIQFSTQFERIAT 468 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHH-------------hhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh
Confidence 988775544 22234556799999999766 56778999999999999999996 3333332221
Q ss_pred chh----hhhhhhhccCCc---hhhhhc--cccCCCCHHHH
Q 047043 264 GEI----SLKNWVNESLPH---ALTDVV--DANLRVSMKDV 295 (314)
Q Consensus 264 ~~~----~~~~~~~~~~~~---~l~~ll--dp~~Rpt~~~~ 295 (314)
... .++.....++|. .+..++ .|..||++.+.
T Consensus 469 ~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 111 111111122332 455555 99999955444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.2e-16 Score=131.67 Aligned_cols=210 Identities=20% Similarity=0.249 Sum_probs=145.1
Q ss_pred HHHHHhCCCCCcceeecccccCC-----ceeEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047043 89 CEVLRNVHHRNLLKIFSSCSNPD-----FKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHS 160 (314)
Q Consensus 89 ~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~ 160 (314)
+.-+.++.|.|+++++.+|.+.+ ...++.||+..|++..++++. +..+......+|+-|+++||.|||++
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--
Confidence 34444556999999999987644 567999999999999999864 44577888899999999999999976
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeecceecCC---CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCc
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD---GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA 237 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
...++|+++..+.|++..+|.+|++--. ...... ......+....+-++|.+| +.+.....+-
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~-------------~sg~~tn~~~ 261 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAP-------------ESGTTTNTTG 261 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccC-------------CcCccccccc
Confidence 6779999999999999999999884211 111100 0000111223356789999 4445555667
Q ss_pred ccceehhhHHHHHHhcCCCCCCccccc---hhhhhhh----hhccCCchhhhhc--cccCCCCHHHHHHHHHhhhhheee
Q 047043 238 KCDVYSFGVLLMETFTGKKPTDEMFTG---EISLKNW----VNESLPHALTDVV--DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 238 ~~Dv~slG~il~~ll~g~~Pf~~~~~~---~~~~~~~----~~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
++|||+||.+..+|..+...-...... +...... -++.=...+..++ .|..||++++++.+.-.+....++
T Consensus 262 a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 262 ASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLK 341 (458)
T ss_pred chhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecchHH
Confidence 899999999999999887652221111 1111111 0111122344455 899999999999988877777777
Q ss_pred eecccC
Q 047043 309 DVAATS 314 (314)
Q Consensus 309 ~~~~~~ 314 (314)
..+++|
T Consensus 342 ll~ahc 347 (458)
T KOG1266|consen 342 LLMAHC 347 (458)
T ss_pred HHhhHh
Confidence 776664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-14 Score=132.89 Aligned_cols=141 Identities=20% Similarity=0.243 Sum_probs=98.2
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHH----------------------------------------HHHH
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFR----------------------------------------SFDS 87 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~----------------------------------------~~~~ 87 (314)
+.||.|++|.||+|+.++|+.||||+.++...+... ++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999889999999998765311100 1333
Q ss_pred HHHHHHhC----CCCCcceeecc-cccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHHHhcCCCC
Q 047043 88 ECEVLRNV----HHRNLLKIFSS-CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL-ALEYLHHGHSS 161 (314)
Q Consensus 88 e~~~l~~l----~h~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~-~l~~LH~~~~~ 161 (314)
|++.+.++ ++.+-+.+-.+ +......+++|||++|.+|.+......... ....++..++. .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~----~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL----R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH----h
Confidence 44444443 12222222222 223445689999999999988765322112 23445666665 467889 8
Q ss_pred CCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 162 ~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
.|++|+|++|.||+++.++.++++|||++..++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=128.26 Aligned_cols=145 Identities=19% Similarity=0.237 Sum_probs=94.1
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeCC-CCeEEEEEeeecccHH----------------------------------
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRA---------------------------------- 81 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~-~~~vaiK~~~~~~~~~---------------------------------- 81 (314)
+......|+. +.||+|++|+||.|+.++ |+.||||+.++...+.
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 3344556777 799999999999999765 9999999998652111
Q ss_pred HHHHHHHHHHHHhCCCCCcceeecccc-------------cCCceeEEEEecCCCCHHHHH--hhcCC---CCCHHHHHH
Q 047043 82 FRSFDSECEVLRNVHHRNLLKIFSSCS-------------NPDFKALVLELMPNGSLENWL--YSHNY---FLDTLERLN 143 (314)
Q Consensus 82 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-------------~~~~~~lv~e~~~~~sL~~~i--~~~~~---~~~~~~~~~ 143 (314)
.+.+.+|++..... +|+.++...+. .....+++|||+.|+++.+.- ...+. .+.+..+..
T Consensus 194 ~~~l~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 194 EKTLHDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 11122223222222 23333322222 244556999999999998753 22221 122222222
Q ss_pred HHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC----cEEEEeeecceecCC
Q 047043 144 IMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----VARVSDFGISKLLGD 195 (314)
Q Consensus 144 i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----~ikl~Dfg~~~~~~~ 195 (314)
++ ..+. ..|++|+|++|.||+++.++ .++++|||++..++.
T Consensus 272 ~~-------~Qif----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FF-------TQVF----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HHHH----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 32 3345 68999999999999999887 999999999887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.2e-13 Score=106.90 Aligned_cols=128 Identities=18% Similarity=0.207 Sum_probs=94.8
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEecCCCCH
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
++.++.|.++.||++.. .+..+++|+...... ....+..|+.+++.+.+.++ .+++.... ...++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 46788999999999986 477899999765532 12346788999988854443 44554433 335799999999877
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-----eeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP-----IVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~-----i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+. . . .....+.+++.+++.|| ..+ ++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~----~--~---~~~~~~~~l~~~l~~LH----~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D--F---SDPENLEKIAKLLKKLH----SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c--c---cCHHHHHHHHHHHHHHh----CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 1 11235678999999999 666 59999999999998 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=6e-12 Score=102.99 Aligned_cols=137 Identities=20% Similarity=0.195 Sum_probs=99.0
Q ss_pred cceeeecCceEEEEEEeCC-------CCeEEEEEeeeccc----------------------HHHHHHH----HHHHHHH
Q 047043 47 CNLLGTGSFGIVYKGILSD-------GNNVAIKVFKLQLG----------------------RAFRSFD----SECEVLR 93 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~-------~~~vaiK~~~~~~~----------------------~~~~~~~----~e~~~l~ 93 (314)
...||.|--+.||.|...+ +..+|+|+++.... .....+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998432 47999999964310 0111222 7899998
Q ss_pred hCCC--CCcceeecccccCCceeEEEEecCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCeeecCC
Q 047043 94 NVHH--RNLLKIFSSCSNPDFKALVLELMPNGSLEN-WLYSHNYFLDTLERLNIMIDVWLALEYL-HHGHSSAPIVHCDL 169 (314)
Q Consensus 94 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~i~~~~~~~~~~~~~~i~~~l~~~l~~L-H~~~~~~~i~H~dl 169 (314)
++.. -+++..+++ +..++||||+.+..+.. .+.. ..+++.....+..+++.+|..+ | +.|++|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H----~~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK----ECNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH----hCCeecCCC
Confidence 8853 455666654 45679999996643322 1221 1245566778889999999988 8 899999999
Q ss_pred CCCceEecCCCcEEEEeeecceecC
Q 047043 170 KPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 170 kp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++.||+++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999996 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.3e-13 Score=123.01 Aligned_cols=198 Identities=25% Similarity=0.311 Sum_probs=157.2
Q ss_pred hcCccccceeee--cCceEEEEEEe--C-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCc
Q 047043 41 TEGFNECNLLGT--GSFGIVYKGIL--S-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 41 ~~~y~~~~~lg~--G~~g~V~~a~~--~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (314)
...+.+.+.+|. |.+|.+|.+.. . ++..+|+|.-+... +.....=.+++...++. .|++.++.+..++.++.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345778888999 99999999986 3 57888998743322 12222234566666666 48999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL----ALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDF 187 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~----~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Df 187 (314)
.++-+|++ +.+|.++.......+++..++....+... |+.++| .++++|-|++|.||+...+ ...+++||
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheecccccceeecCCc
Confidence 99999998 57999888777666888999999999999 999999 8999999999999999988 88999999
Q ss_pred ecceecCCCCCcceee---cccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 188 GISKLLGDGEDSVTQT---MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
|+...+++........ ...+..-|.+||.. .+.++...|+|+||.++.+..++..+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--------------~~l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL--------------NGLATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh--------------ccccchHhhhcchhhhhHhhHhhccc
Confidence 9999887655322211 22577789999874 45577889999999999988776654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.8e-11 Score=108.13 Aligned_cols=242 Identities=14% Similarity=0.093 Sum_probs=158.9
Q ss_pred ccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcce--------eecccccCCceeEE
Q 047043 46 ECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLK--------IFSSCSNPDFKALV 116 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~--------~~~~~~~~~~~~lv 116 (314)
..+.||+|+-+.+|-.-. -...+.|++.........+ ....|... .||-+-. ++|- ..+....+.
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence 456799999999985441 1224678877654332222 23333333 3443221 1111 122336788
Q ss_pred EEecCCC-CHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 117 LELMPNG-SLENWLYSH-----NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 117 ~e~~~~~-sL~~~i~~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
|..+++. .+..+.... -....+......+..++.+.+.|| ..|.+-||++++|+++++++.+.|.|-+..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH----~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH----EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH----hcCCcccccCccceeeecCceEEEEcccce
Confidence 8888764 333333321 234678899999999999999999 999999999999999999999999997754
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC-CCCCCccccc-----
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-KKPTDEMFTG----- 264 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-~~Pf~~~~~~----- 264 (314)
..-.+ ...+....|..+|++||..... ...+...+..+|.|.||+++++++.| ..||.+....
T Consensus 165 qi~~n---g~~~~cpVg~~eftPPElQ~~~--------sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~ 233 (637)
T COG4248 165 QINAN---GTLHLCPVGVSEFTPPELQTLP--------SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN 233 (637)
T ss_pred eeccC---CceEecccCccccCCHHHhccc--------cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence 43322 2234556799999999875421 12345567789999999999999885 9999864311
Q ss_pred --hhhh------------h-------hhhhccCCchhhhhc--------cccCCCCHHHHHHHHHhhhhheee
Q 047043 265 --EISL------------K-------NWVNESLPHALTDVV--------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 265 --~~~~------------~-------~~~~~~~~~~l~~ll--------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
+... . .+....++..+..+. .+.-|||++.++..|..++..+.+
T Consensus 234 p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 234 PLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred cchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 1000 0 011123344444443 567999999999999999988764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.6e-11 Score=94.16 Aligned_cols=142 Identities=19% Similarity=0.217 Sum_probs=102.8
Q ss_pred ccceeeecCceEEEEEEeCCCCeEEEEE-eeecc--c-----HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 46 ECNLLGTGSFGIVYKGILSDGNNVAIKV-FKLQL--G-----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~~~~vaiK~-~~~~~--~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
....+-+|+-+.|+++.+ .|+..+||- +.+.. + -...+..+|++.+.++.--.|.--.=++.+.+...++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 677899999999999997 677766664 32221 1 12345678999999886444433333455555566899
Q ss_pred EecCC-CCHHHHHhhcCCCCCHH-HHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEEEEeeeccee
Q 047043 118 ELMPN-GSLENWLYSHNYFLDTL-ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VARVSDFGISKL 192 (314)
Q Consensus 118 e~~~~-~sL~~~i~~~~~~~~~~-~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ikl~Dfg~~~~ 192 (314)
||++| .++.+++...-....+. ....++..+-..+.-|| .++++||||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48888887653223333 33788999999999999 99999999999999996544 458999998764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.4e-11 Score=95.05 Aligned_cols=131 Identities=23% Similarity=0.277 Sum_probs=97.0
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeec-c--cHH-----HHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQ-L--GRA-----FRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~-~--~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..+++|+-+.++.+.+. |.++++|.-.++ . ++. ..+-.+|++++.++.-..+..-.=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999863 344666653222 1 121 23456799999988654554444455566667799999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
++|..|.+.+.... ..++..+-.-+.-|| ..|++|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~--------~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR--------PDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc--------hHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99989998887651 445777778889999 99999999999999997664 99999998863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-10 Score=104.69 Aligned_cols=208 Identities=20% Similarity=0.223 Sum_probs=146.2
Q ss_pred CceEEEEEE-eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc----cCCceeEEEEecCC-CCHHH
Q 047043 54 SFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS----NPDFKALVLELMPN-GSLEN 127 (314)
Q Consensus 54 ~~g~V~~a~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~sL~~ 127 (314)
...+.|++. ..+|..|++|.+.............-+++++++.|+|+|++.++|. +...+++|.+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 457889999 5589999999995433222223344688899999999999999886 34578899999875 57777
Q ss_pred HHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 128 WLYSH--------------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 128 ~i~~~--------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+-... +...+|..+|.++.||+.||.++| +.|+...-|.+.+|+++.+.+++|..+|....+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 64321 334678999999999999999999 999999999999999999999999988876655
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhh
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN 273 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~ 273 (314)
..+. .+| + + --.+-|.-.||.++..|.+|..--.............+.
T Consensus 444 ~~d~--------------~~~--l----------e------~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~ 491 (655)
T KOG3741|consen 444 QEDP--------------TEP--L----------E------SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT 491 (655)
T ss_pred cCCC--------------Ccc--h----------h------HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh
Confidence 3322 122 0 0 012468999999999999997653332222222233344
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..++..+++++ .+.. -+..+++.+
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 55666666554 2222 556665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-10 Score=98.43 Aligned_cols=144 Identities=22% Similarity=0.251 Sum_probs=108.6
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCC--CCcceeecccccC---CceeEEEEec
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHH--RNLLKIFSSCSNP---DFKALVLELM 120 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~ 120 (314)
++.|+.|.++.+|++...+|..+++|....... .....+..|.++++.+.+ ..+.+++.+.... +..+++||++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999975668899999765432 134567889999999865 3456777776654 3668999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH----------------------------------------- 159 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----------------------------------------- 159 (314)
+|.++.+.+.. ..+++.+...++.+++.++..||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775532 23667777778888888888888411
Q ss_pred -----------CCCCeeecCCCCCceEecC--CCcEEEEeeeccee
Q 047043 160 -----------SSAPIVHCDLKPSNILLDE--NMVARVSDFGISKL 192 (314)
Q Consensus 160 -----------~~~~i~H~dlkp~Nili~~--~~~ikl~Dfg~~~~ 192 (314)
....++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0356899999999999988 56789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-10 Score=92.65 Aligned_cols=126 Identities=25% Similarity=0.287 Sum_probs=83.1
Q ss_pred EEEEEEeCCCCeEEEEEeeeccc--------------------------HHHHHHHHHHHHHHhCCCC--Ccceeecccc
Q 047043 57 IVYKGILSDGNNVAIKVFKLQLG--------------------------RAFRSFDSECEVLRNVHHR--NLLKIFSSCS 108 (314)
Q Consensus 57 ~V~~a~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 108 (314)
.||.|...+|..+|+|+.+.... .......+|++.|.++... ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999987899999999864310 0122355799999999754 456666553
Q ss_pred cCCceeEEEEecC--CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 109 NPDFKALVLELMP--NGSLENWLYSHNYFLDTLERLNIMIDVWLALEY-LHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 109 ~~~~~~lv~e~~~--~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~-LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
...+||||++ |..+..+.... ++......++.+++..+.. +| ..|++||||++.||+++.+ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-eEEEE
Confidence 3369999998 54554433221 1234566777888885444 68 9999999999999999887 99999
Q ss_pred eeecceecC
Q 047043 186 DFGISKLLG 194 (314)
Q Consensus 186 Dfg~~~~~~ 194 (314)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.5e-11 Score=108.08 Aligned_cols=199 Identities=23% Similarity=0.211 Sum_probs=146.5
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe--CCCCeEEEEEeeecccHHHHH--HHHHHHHHHhC-CCCCcceeecccccCC
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL--SDGNNVAIKVFKLQLGRAFRS--FDSECEVLRNV-HHRNLLKIFSSCSNPD 111 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~--~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (314)
.....++|..+..||.|.|+.|+.... .++..+++|-..........+ -..|+.+...+ .|.+.+..+..|..-.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 455678999999999999999998873 356678887665442221122 22455555555 5888898888888888
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEeeecc
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDFGIS 190 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Dfg~~ 190 (314)
..|+-.|||+++++...+.... .+++...+.+..|++.++.++| ....+|+|++|+||++..+ +..+++|||..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~-~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQ-MLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhHHHH-hcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhccccccc
Confidence 8888899999988887764333 3788889999999999999999 9999999999999999775 77899999988
Q ss_pred eecCCCCCcceeecccceeeeec-CccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMA-PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
+.+.-. .........+.+ +|+ ......+..+.|++|||.-+.+..++...
T Consensus 415 t~~~~~-----~~~~~~~~r~~p~~~~------------~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 415 TRLAFS-----SGVFHHIDRLYPIAEI------------LLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccee-----cccccccccccccchh------------hccccccccccccccccccccccccCccc
Confidence 643211 111222333332 333 23455667789999999999999988653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.5e-09 Score=91.42 Aligned_cols=139 Identities=16% Similarity=0.108 Sum_probs=97.8
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeecccH-HHH----------HHHHHHHHHHhCCCCCc--ceeeccccc-----
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR-AFR----------SFDSECEVLRNVHHRNL--LKIFSSCSN----- 109 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~~i--~~~~~~~~~----- 109 (314)
+.+.......|.+... .|+.+.+|........ ..+ ...+|++.+..+...+| +....+.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444445555666665 6778999977433211 111 36788888888853333 333334332
Q ss_pred CCceeEEEEecCCC-CHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-------CC
Q 047043 110 PDFKALVLELMPNG-SLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-------NM 180 (314)
Q Consensus 110 ~~~~~lv~e~~~~~-sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-------~~ 180 (314)
...-++|||++++. +|.+++... ....+......++.+++..+..|| ..|++|+|++++||+++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCCCCCc
Confidence 23567999999875 899988642 223456677889999999999999 999999999999999975 46
Q ss_pred cEEEEeeecce
Q 047043 181 VARVSDFGISK 191 (314)
Q Consensus 181 ~ikl~Dfg~~~ 191 (314)
.+.|+||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.3e-09 Score=88.17 Aligned_cols=136 Identities=24% Similarity=0.208 Sum_probs=99.1
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeecccH----------------------HHHHHHHHHHHHHhCCCC--C
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR----------------------AFRSFDSECEVLRNVHHR--N 99 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--~ 99 (314)
+.+...||-|--|.||.|....|.++++|.=+....+ ......+|.++|+.|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5677899999999999999888999999975332100 112345788999888654 5
Q ss_pred cceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC
Q 047043 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN 179 (314)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~ 179 (314)
+++.+++ +...+|||+++|..|...- ++....-.++..|+.-+..+- ..|++|||+++-||+++.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~----~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY----RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH----HcCccccCCchheEEEecC
Confidence 5555444 3446999999886665432 123344555666666666666 6899999999999999999
Q ss_pred CcEEEEeeecceec
Q 047043 180 MVARVSDFGISKLL 193 (314)
Q Consensus 180 ~~ikl~Dfg~~~~~ 193 (314)
|.+.++||..+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999876644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6e-10 Score=108.23 Aligned_cols=210 Identities=23% Similarity=0.280 Sum_probs=147.5
Q ss_pred HHHhcCccccceeeecCceEEEEEE-eCCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
+.-.+.+.+.+.+.+|.++.++.+. ..+|...+.|+..... ....+....+-.++-.-.+|.++..+..+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3456778888999999999999998 4467655565544331 11112222222222222356666666666677788
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++++|..+++|...+...+. .++.........+..+.++|| ...+.|+|++|.|.++..++..++.||+.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~----s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH----SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc----cchhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998887764 555566667778889999999 677899999999999999999999999733222
Q ss_pred CC------C---------------C--------CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehh
Q 047043 194 GD------G---------------E--------DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244 (314)
Q Consensus 194 ~~------~---------------~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~sl 244 (314)
+- . . +........+|+.|.+||.. .+.......|.|++
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-------------lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-------------LGRRHGSAADWWSS 1021 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc-------------ccccCCCcchhhhh
Confidence 10 0 0 00111223589999999664 34455667899999
Q ss_pred hHHHHHHhcCCCCCCccccch
Q 047043 245 GVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 245 G~il~~ll~g~~Pf~~~~~~~ 265 (314)
|+++++.++|..||+......
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhh
Confidence 999999999999998755433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.4e-08 Score=93.34 Aligned_cols=150 Identities=18% Similarity=0.249 Sum_probs=93.8
Q ss_pred HHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHH----------------------------------
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRS---------------------------------- 84 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~---------------------------------- 84 (314)
.....|+. +.|+.++-|.||.|+.++|+.||||+.++...+....
T Consensus 123 e~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~ 201 (517)
T COG0661 123 ELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR 201 (517)
T ss_pred HHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence 33444444 5799999999999998899999999997653221110
Q ss_pred ------HHHHHHHHHhC----C-CCCcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Q 047043 85 ------FDSECEVLRNV----H-HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153 (314)
Q Consensus 85 ------~~~e~~~l~~l----~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~ 153 (314)
+..|..-+.++ + .+++.--.=+++..+.-.++|||++|..+.+.........+...+.....++. +.
T Consensus 202 l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~ 279 (517)
T COG0661 202 LREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LR 279 (517)
T ss_pred HHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HH
Confidence 11222222222 1 22221111123344556799999999999888432222244333322222211 22
Q ss_pred HHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 154 ~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
.+- ..|.+|+|..|-||+++.+|.+.+.|||+...++.
T Consensus 280 q~~----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLL----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHH----hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 223 57899999999999999999999999999887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=8e-08 Score=79.10 Aligned_cols=159 Identities=17% Similarity=0.086 Sum_probs=112.6
Q ss_pred ccceehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc------cHHHHHHHHHHHHHHhCCCCC--c
Q 047043 29 WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRN--L 100 (314)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~--i 100 (314)
....+|+.++....+|-..---|+||-+.|+.... .|+.+-+|.-.... +-....+.+|+..+..+...+ +
T Consensus 5 ~~~~~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPV 83 (216)
T PRK09902 5 AKYDEFNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIV 83 (216)
T ss_pred chhhhHHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 34556777777777776655667799999999886 34467777654111 112356889999999985322 3
Q ss_pred ceeeccc--cc--CCceeEEEEecCC-CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 101 LKIFSSC--SN--PDFKALVLELMPN-GSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 101 ~~~~~~~--~~--~~~~~lv~e~~~~-~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
++..... .. ...-++|+|.+++ .+|.+++.... ...++.....++.+++.++.-|| ..|+.|+|+.+.||
T Consensus 84 P~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khI 159 (216)
T PRK09902 84 PKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHI 159 (216)
T ss_pred CccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhhe
Confidence 3333111 11 2245699998854 48888876532 23567777899999999999999 99999999999999
Q ss_pred EecCCCc--EEEEeeeccee
Q 047043 175 LLDENMV--ARVSDFGISKL 192 (314)
Q Consensus 175 li~~~~~--ikl~Dfg~~~~ 192 (314)
+++.++. +.++||.-+..
T Consensus 160 ll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 160 YVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eecCCCCeeEEEEEhhccch
Confidence 9986666 99999985543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.2e-09 Score=100.47 Aligned_cols=135 Identities=21% Similarity=0.307 Sum_probs=89.1
Q ss_pred HHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceee-------cccceeeeecCcccc
Q 047043 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT-------MTMATIGYMAPVSQL 218 (314)
Q Consensus 146 ~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~-------~~~~t~~y~aPE~~~ 218 (314)
.+.++|+.++|. +.+++|++|.|++|.++.++.+||+.|+++............. .......|.|||++.
T Consensus 106 ~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344599999996 7889999999999999999999999999876654422221111 112456799996653
Q ss_pred ccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccch-hhh--------hhhhhccCCchhhhhc----
Q 047043 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGE-ISL--------KNWVNESLPHALTDVV---- 284 (314)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~-~~~--------~~~~~~~~~~~l~~ll---- 284 (314)
+...+.++|+||+|+++|.+.. |+.-+....... ... ....+..+|+.+++.+
T Consensus 183 -------------~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 -------------GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred -------------cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 4556778999999999999995 444444321110 000 0112244555555544
Q ss_pred --cccCCCCHHHHH
Q 047043 285 --DANLRVSMKDVA 296 (314)
Q Consensus 285 --dp~~Rpt~~~~~ 296 (314)
+...||+...+.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 888899665554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.6e-08 Score=81.00 Aligned_cols=106 Identities=23% Similarity=0.258 Sum_probs=81.3
Q ss_pred HHHHHHHHHHHhCCCCC--cceeecccccC----CceeEEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 047043 83 RSFDSECEVLRNVHHRN--LLKIFSSCSNP----DFKALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYL 155 (314)
Q Consensus 83 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~L 155 (314)
....+|.+.+..+...+ .++.+++.+.. ...++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35667888777774322 34444444432 2457999999874 79998876443 56667888999999999999
Q ss_pred hcCCCCCCeeecCCCCCceEecCCC---cEEEEeeecceec
Q 047043 156 HHGHSSAPIVHCDLKPSNILLDENM---VARVSDFGISKLL 193 (314)
Q Consensus 156 H~~~~~~~i~H~dlkp~Nili~~~~---~ikl~Dfg~~~~~ 193 (314)
| ..|++|+|+++.|||++.++ .+.++||+-+...
T Consensus 135 H----~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H----DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H----HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 99999999999999998877 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.5e-07 Score=78.67 Aligned_cols=154 Identities=22% Similarity=0.228 Sum_probs=99.1
Q ss_pred ceehhhHHHHhcCccccceee---ecCceEEEEEEeCCCCeEEEEEeeecccHHH--HH---------------------
Q 047043 31 RTSYLDIQRATEGFNECNLLG---TGSFGIVYKGILSDGNNVAIKVFKLQLGRAF--RS--------------------- 84 (314)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~--~~--------------------- 84 (314)
.-+..++....++..+....| +|.-+.||+|...++..+|+|+++....... ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345567777778877777666 4666799999977899999999986532110 00
Q ss_pred -HHHHHHHHHhCCC--CCcceeecccccCCceeEEEEecCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047043 85 -FDSECEVLRNVHH--RNLLKIFSSCSNPDFKALVLELMPNGSLEN-WLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160 (314)
Q Consensus 85 -~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~ 160 (314)
-..|+.-|+++.. -.+++-+.+. ...++|||+.....-. .+. ...+...++..+..+++..+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~--- 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYK--- 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHH---
Confidence 1134444444421 1222222222 2359999985421100 111 1112333677788888888888872
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
..+++|+||+.-|||+. ++.+.++|++.+....
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 49999999999999998 8899999999887553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.4e-07 Score=76.58 Aligned_cols=143 Identities=17% Similarity=0.211 Sum_probs=93.5
Q ss_pred hhhHHH--HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHH---------HHHHHHHhCCC---CC
Q 047043 34 YLDIQR--ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFD---------SECEVLRNVHH---RN 99 (314)
Q Consensus 34 ~~~~~~--~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~---------~e~~~l~~l~h---~~ 99 (314)
|..+.. ..++|.+.+.+-......|.+... +|..+++|..+.......+.+. +.+..+..+.. ..
T Consensus 21 y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~ 99 (229)
T PF06176_consen 21 YLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE 99 (229)
T ss_pred HHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence 444444 456788888888877777776665 6789999998776433222222 23333333322 22
Q ss_pred cceeecc-----cccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 100 LLKIFSS-----CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 100 i~~~~~~-----~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
...++-+ +......+++|||++|..|.+... +++ .+...+.+++..|| +.|+.|+|..|.|+
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH----~~G~~HGD~hpgNF 166 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH----KHGFYHGDPHPGNF 166 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH----HcCCccCCCCcCcE
Confidence 2232222 223345568999999988766532 233 24456778899999 99999999999999
Q ss_pred EecCCCcEEEEeeecce
Q 047043 175 LLDENMVARVSDFGISK 191 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~ 191 (314)
+++.+ .++++|++...
T Consensus 167 lv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 167 LVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEECC-cEEEEECcccc
Confidence 99855 59999997544
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.4e-07 Score=75.68 Aligned_cols=133 Identities=14% Similarity=0.149 Sum_probs=86.0
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--cceeecccccCCceeEEEEecCCCC-
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--LLKIFSSCSNPDFKALVLELMPNGS- 124 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~s- 124 (314)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++..+.+..+++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999973 25568899887643 2245688999999886433 4677888888778889999998863
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHhcCCCCCCee
Q 047043 125 LENWLYSHNYFLDTLERLNIMIDVWLAL---------------------------------------EYLHHGHSSAPIV 165 (314)
Q Consensus 125 L~~~i~~~~~~~~~~~~~~i~~~l~~~l---------------------------------------~~LH~~~~~~~i~ 165 (314)
+...+.. +......++.+++..+ .+|........++
T Consensus 82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 2211110 0000111111111111 2222111244578
Q ss_pred ecCCCCCceEecCCCcEEEEeeecce
Q 047043 166 HCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 166 H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
|+|+.|.||+++.++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-06 Score=72.65 Aligned_cols=142 Identities=20% Similarity=0.254 Sum_probs=82.6
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCC--Ccceeeccc---ccCCceeEEEEecC
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR--NLLKIFSSC---SNPDFKALVLELMP 121 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~ 121 (314)
++.++.|..+.||.....+ ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999756 68999997765 3446777888888887432 355666533 22335689999999
Q ss_pred CCCHHH----------------HHhh---cC-C--CCCHHH---------HHHH------------HHHHHH-HHHHHhc
Q 047043 122 NGSLEN----------------WLYS---HN-Y--FLDTLE---------RLNI------------MIDVWL-ALEYLHH 157 (314)
Q Consensus 122 ~~sL~~----------------~i~~---~~-~--~~~~~~---------~~~i------------~~~l~~-~l~~LH~ 157 (314)
|.++.. .+.. .. . .+.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887777 1110 00 0 000000 0000 011111 2222321
Q ss_pred ---CCCCCCeeecCCCCCceEec-CCCcEEEEeeecce
Q 047043 158 ---GHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISK 191 (314)
Q Consensus 158 ---~~~~~~i~H~dlkp~Nili~-~~~~ikl~Dfg~~~ 191 (314)
......++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 01256799999999999999 66667799998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.7e-07 Score=70.58 Aligned_cols=131 Identities=19% Similarity=0.244 Sum_probs=93.4
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEecCC
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
-++.+.|++|.+|.||++.+ .|..+|+|+-+.+.+ ...+..|++++..++..++ .++|.+..+. +.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcC
Confidence 35677899999999999998 556899998776643 3678889999999976544 4555555443 44999998
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCC-CCceEecCCCcEEEEeeecceec
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLK-PSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlk-p~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
-+|.+..... +... ...+++.-.-|. ..||-|+.|. |...++-.++.+.|+||..|+.-
T Consensus 97 ~~L~~~~~~~----~rk~----l~~vlE~a~~LD----~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIGG----DRKH----LLRVLEKAYKLD----RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhcc----cHHH----HHHHHHHHHHHH----HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8888765431 2222 334455555566 7889999886 45555555559999999988743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.6e-06 Score=66.77 Aligned_cols=128 Identities=23% Similarity=0.305 Sum_probs=91.4
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecc----------------cHHHHHHHHHHHHHHhCC------CCCcceee
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL----------------GRAFRSFDSECEVLRNVH------HRNLLKIF 104 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~ 104 (314)
...||+|+.-.||.- ......+||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 457999999999843 345667999988765 112355566666665554 77899999
Q ss_pred cccccCCceeEEEEecC------CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 105 SSCSNPDFKALVLELMP------NGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 105 ~~~~~~~~~~lv~e~~~------~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
|+.++..-..+|+|.+. ..+|.+++.... +++ .....+.++.. +|- ...|+.+|++|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f~~---~l~----~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEFKR---YLL----DHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHHHH---HHH----HcCCeecCCCcccEEEEe
Confidence 99999999999999863 247888886544 555 45555555544 444 677999999999999942
Q ss_pred C---C-cEEEEe
Q 047043 179 N---M-VARVSD 186 (314)
Q Consensus 179 ~---~-~ikl~D 186 (314)
+ . .++|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.5e-06 Score=70.85 Aligned_cols=76 Identities=14% Similarity=0.090 Sum_probs=54.5
Q ss_pred eeeecCc-eEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEEecCCCCHH
Q 047043 49 LLGTGSF-GIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLELMPNGSLE 126 (314)
Q Consensus 49 ~lg~G~~-g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 126 (314)
.|..|.+ +.||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 789998853 4788899876542 245677888888874 344667787777666788999999987776
Q ss_pred HH
Q 047043 127 NW 128 (314)
Q Consensus 127 ~~ 128 (314)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.1e-06 Score=77.75 Aligned_cols=137 Identities=19% Similarity=0.339 Sum_probs=87.2
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeecccHH-------------------------------HHHHHHHHHHHHh--
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRA-------------------------------FRSFDSECEVLRN-- 94 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~-------------------------------~~~~~~e~~~l~~-- 94 (314)
+.||..+.|.|++|+.++|+.||||+-++..... .+.+..|++....
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4799999999999998899999999987653211 0111112222211
Q ss_pred --------CCCCC------cceeecccccCCceeEEEEecCCCCHHHH--HhhcCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 047043 95 --------VHHRN------LLKIFSSCSNPDFKALVLELMPNGSLENW--LYSHNYFLDTLERLNIMIDVWLALEYLHHG 158 (314)
Q Consensus 95 --------l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~--i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~ 158 (314)
+.|-+ |+++|. .......|+|||++|..+.|. +.+.+ ++...+..-+.+... +.|=
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~--~qIf-- 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYL--EQIF-- 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHH--HHHH--
Confidence 12322 223222 223456799999999877765 33433 555544433333322 2222
Q ss_pred CCCCCeeecCCCCCceEecC----CCcEEEEeeecceecC
Q 047043 159 HSSAPIVHCDLKPSNILLDE----NMVARVSDFGISKLLG 194 (314)
Q Consensus 159 ~~~~~i~H~dlkp~Nili~~----~~~ikl~Dfg~~~~~~ 194 (314)
..|.+|+|=.|-||++.. ++.+.+.|+|+.....
T Consensus 319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 578999999999999983 6789999999887654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.9e-05 Score=66.07 Aligned_cols=74 Identities=7% Similarity=0.069 Sum_probs=47.2
Q ss_pred cceeeecCce-EEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCC---CcceeecccccC---CceeEEEEe
Q 047043 47 CNLLGTGSFG-IVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR---NLLKIFSSCSNP---DFKALVLEL 119 (314)
Q Consensus 47 ~~~lg~G~~g-~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~ 119 (314)
++.++.|+.. .||+. +..+++|+.+... ....+.+|.+.+..+... .+..+++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4567877776 48865 2357788765432 235688899999887532 344555444332 244789999
Q ss_pred cCCCCHH
Q 047043 120 MPNGSLE 126 (314)
Q Consensus 120 ~~~~sL~ 126 (314)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.5e-05 Score=77.38 Aligned_cols=78 Identities=14% Similarity=0.280 Sum_probs=55.7
Q ss_pred cceeeecCceEEEEEEeCCC---CeEEEEEeeecc-cHHHHHHHHHHHHHHhCC-CCCc--ceeecccccC---CceeEE
Q 047043 47 CNLLGTGSFGIVYKGILSDG---NNVAIKVFKLQL-GRAFRSFDSECEVLRNVH-HRNL--LKIFSSCSNP---DFKALV 116 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv 116 (314)
++.++.|.+..+|+.....+ ..+++|...... ......+.+|+++++.+. |+++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788899999999886443 467777764432 112346788999999985 5554 7778877664 457899
Q ss_pred EEecCCCC
Q 047043 117 LELMPNGS 124 (314)
Q Consensus 117 ~e~~~~~s 124 (314)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.2e-05 Score=62.68 Aligned_cols=125 Identities=26% Similarity=0.417 Sum_probs=88.6
Q ss_pred cCccccceeeecCc-eEEEEEEeCCCCeEEEEEeee---cc--------c----------HHHHHHHHHHHHHHhCC---
Q 047043 42 EGFNECNLLGTGSF-GIVYKGILSDGNNVAIKVFKL---QL--------G----------RAFRSFDSECEVLRNVH--- 96 (314)
Q Consensus 42 ~~y~~~~~lg~G~~-g~V~~a~~~~~~~vaiK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 96 (314)
.+++.++.||.|.- |.||+++. +|+.+|+|+++. .. . .....|..|++...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999997 678999999422 10 0 12356788999888885
Q ss_pred CCCc--ceeecccccC------------------CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Q 047043 97 HRNL--LKIFSSCSNP------------------DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156 (314)
Q Consensus 97 h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH 156 (314)
+.++ ++++|+..-. ....+|-|+.+... .+... -+.+|.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 3344 8888875211 11236777765432 12222 3456677778899
Q ss_pred cCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 157 ~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+.||+-+|+++.|.. .-+|+|||.+
T Consensus 182 ----k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 ----KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ----HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 4588899853
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.8e-05 Score=63.63 Aligned_cols=102 Identities=23% Similarity=0.285 Sum_probs=79.9
Q ss_pred HHHHHHHHhCCC-CCcceeecccccCCceeEEEEecCCCCHHHH---HhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 047043 86 DSECEVLRNVHH-RNLLKIFSSCSNPDFKALVLELMPNGSLENW---LYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161 (314)
Q Consensus 86 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~ 161 (314)
.+|.-+++.+++ +++++++|+|-+ ++++||.+.+++... +... ...++....+++.++++.+.+|+++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~- 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPL- 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCC-
Confidence 357888888875 689999999965 578999976655421 1111 125788999999999999999996542
Q ss_pred CCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 162 APIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 162 ~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
..+.-+|++++|+-+++++++|++|.+.+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 44899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=8.1e-05 Score=63.18 Aligned_cols=74 Identities=15% Similarity=0.235 Sum_probs=48.9
Q ss_pred cceeeecCceEEEEEEeCC--CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCC-CcceeecccccCCceeEEEEecCCC
Q 047043 47 CNLLGTGSFGIVYKGILSD--GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR-NLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
++.|..|-...+|+....+ +..|++|+...... ..-...+|..+++.+... -.++++..+.. .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence 4567778888999998653 67899998765422 222335688888888432 23455544432 4799999886
Q ss_pred CH
Q 047043 124 SL 125 (314)
Q Consensus 124 sL 125 (314)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00021 Score=63.06 Aligned_cols=80 Identities=13% Similarity=0.122 Sum_probs=57.7
Q ss_pred CccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC---CCcceeeccccc---CCceeEE
Q 047043 43 GFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH---RNLLKIFSSCSN---PDFKALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv 116 (314)
.-.-.+.||.|..+.||.....++ .+++|..+... ....+..|.+.++.+.. ..++++++++.+ .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 334456799999999999985445 47778754321 22578889999988853 357788877654 3567999
Q ss_pred EEecCCCCH
Q 047043 117 LELMPNGSL 125 (314)
Q Consensus 117 ~e~~~~~sL 125 (314)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.6e-06 Score=81.15 Aligned_cols=193 Identities=18% Similarity=0.137 Sum_probs=130.4
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC-cceeecccccCCcee
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN-LLKIFSSCSNPDFKA 114 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 114 (314)
++..-.+.|+...-+++|+.+++++.+....+....+++... ....-++++|.+++||| .+..++-++.+...+
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 334444556777788999999999888322222335554433 44566899999999999 556666667777888
Q ss_pred EEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 115 LVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 115 lv~e~~~~~-sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+.++++.++ +-........-.+.+.+.......-+.+++++| +..-+|+| ||+.. ++..+..||+....+
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~----~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH----SSYKVHRD----NILGS-EEEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc----cccccCcc----ccccc-ccccccccccCCccc
Confidence 999998766 222222222222444455666777778899999 55457777 66554 468899999988776
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCC
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT 258 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf 258 (314)
...- ......+++.++|||.. ....+....|.|++|.-..++--|..|-
T Consensus 382 ~~~~---~~~t~~~~~~~~~pev~-------------~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 382 TRTM---KPRTAIGTPEPLAPEVI-------------QENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred Cccc---ccccCCCCCCCCCchhh-------------cccccccCCCccCCCcchhhcCCCCCCC
Confidence 5432 33445689999999654 4555666789999998777777776663
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=8.7e-05 Score=63.98 Aligned_cols=138 Identities=12% Similarity=0.062 Sum_probs=77.4
Q ss_pred eeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEecCCCCHHH
Q 047043 49 LLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELMPNGSLEN 127 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~ 127 (314)
.+..|-...+|+... ++..+++|+.........-...+|.++++.+...++ .+++.... .++|+||++|.++..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677889998874 567888997654422211245778899988854322 34444332 368999998866532
Q ss_pred H--------------Hhh---c---CCCCCHH-HHHHHHHHH---------HHHHHHHhcC----CCCCCeeecCCCCCc
Q 047043 128 W--------------LYS---H---NYFLDTL-ERLNIMIDV---------WLALEYLHHG----HSSAPIVHCDLKPSN 173 (314)
Q Consensus 128 ~--------------i~~---~---~~~~~~~-~~~~i~~~l---------~~~l~~LH~~----~~~~~i~H~dlkp~N 173 (314)
. +.+ . +..++.. .+..+..++ ...+..+-.. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 110 0 0111111 111111111 1111112110 002358999999999
Q ss_pred eEecCCCcEEEEeeeccee
Q 047043 174 ILLDENMVARVSDFGISKL 192 (314)
Q Consensus 174 ili~~~~~ikl~Dfg~~~~ 192 (314)
|+++.++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9998876 78999997763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00054 Score=60.28 Aligned_cols=142 Identities=13% Similarity=0.117 Sum_probs=81.7
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--cceeecc------cccCCceeEEEE
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--LLKIFSS------CSNPDFKALVLE 118 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e 118 (314)
++.+..|....+|+... ++..+++|+.... ....+..|++++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677777789998875 3456888987652 2245667788887774322 3444332 122345679999
Q ss_pred ecCCCCHHH----HHhh------------cCCCC--------CHHHH--H--------HHHHHHHHHHHHHhc---CCCC
Q 047043 119 LMPNGSLEN----WLYS------------HNYFL--------DTLER--L--------NIMIDVWLALEYLHH---GHSS 161 (314)
Q Consensus 119 ~~~~~sL~~----~i~~------------~~~~~--------~~~~~--~--------~i~~~l~~~l~~LH~---~~~~ 161 (314)
+++|.++.. .... .+... ..... . .....+..++.++.. ....
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866432 1110 00000 00000 0 011112233444431 0113
Q ss_pred CCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 162 APIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 162 ~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999887778999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00057 Score=60.57 Aligned_cols=156 Identities=17% Similarity=0.195 Sum_probs=87.2
Q ss_pred ehhhHHHHhcCccc-----cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--cceeec
Q 047043 33 SYLDIQRATEGFNE-----CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--LLKIFS 105 (314)
Q Consensus 33 ~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~ 105 (314)
+-.++.....+|.+ ++.++.|....+|+....+| .+++|+...... ......+.+++..+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 33555566566654 44566677789998875444 578898765321 134455667776664222 344443
Q ss_pred cc------ccCCceeEEEEecCCCCHH----HHHhh------------cCCCCC--H---HHHH----------------
Q 047043 106 SC------SNPDFKALVLELMPNGSLE----NWLYS------------HNYFLD--T---LERL---------------- 142 (314)
Q Consensus 106 ~~------~~~~~~~lv~e~~~~~sL~----~~i~~------------~~~~~~--~---~~~~---------------- 142 (314)
.. ...+..++++++++|..+. +.... .+...+ . ...+
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 2234568999999874431 11111 010000 0 0000
Q ss_pred HHHHHHHHHHHHHhcC---CCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 143 NIMIDVWLALEYLHHG---HSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 143 ~i~~~l~~~l~~LH~~---~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.....+...++++... ....+++|+|+.+.|++++.++...++||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 0011123344445310 114789999999999999988777899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=6.6e-05 Score=65.47 Aligned_cols=149 Identities=19% Similarity=0.214 Sum_probs=101.2
Q ss_pred cceehhhHHHHhcC---ccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc--------H------------HHH--H
Q 047043 30 RRTSYLDIQRATEG---FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG--------R------------AFR--S 84 (314)
Q Consensus 30 ~~~~~~~~~~~~~~---y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~--------~------------~~~--~ 84 (314)
...+|+-+.....+ +.+...||-|.-+.+|.+-...|++.++|+=+.... + ... .
T Consensus 77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla 156 (465)
T KOG2268|consen 77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA 156 (465)
T ss_pred ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence 34566666665444 688889999999999999988899999996432210 0 011 1
Q ss_pred HHHHHHHHHhCCCC--CcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 047043 85 FDSECEVLRNVHHR--NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162 (314)
Q Consensus 85 ~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~ 162 (314)
..+|+..|+.+... -+++.+++ +..++|||++.|.+|...-.- .+ +-.+...+..-+--|. .+
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d---~~~ly~~lm~~Iv~la----~~ 221 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----ED---PPTLYDDLMGLIVRLA----NH 221 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec----CC---hHHHHHHHHHHHHHHH----Hc
Confidence 23466666666421 23333333 445699999988887654321 12 2234445555566677 89
Q ss_pred CeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 163 PIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 163 ~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|++|||.+--||++++++.++++||..+...
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhhcc
Confidence 9999999999999999999999999865544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0016 Score=57.94 Aligned_cols=155 Identities=12% Similarity=0.113 Sum_probs=80.7
Q ss_pred ehhhHHHHhcCccc-----cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--cceeec
Q 047043 33 SYLDIQRATEGFNE-----CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--LLKIFS 105 (314)
Q Consensus 33 ~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~ 105 (314)
|-.++......|.+ ++.++.|....+|.....+| .+++|++. ... ......+...+..+...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~--~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT--AEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCC--hHHhHHHHHHHHHHHHCCCCCCccee
Confidence 33445555566655 34566677778999886455 68889876 211 133334555555553111 333332
Q ss_pred c------cccCCceeEEEEecCCCCHH-----------HHHhh---cCCCC--------C---HHHH-HH----------
Q 047043 106 S------CSNPDFKALVLELMPNGSLE-----------NWLYS---HNYFL--------D---TLER-LN---------- 143 (314)
Q Consensus 106 ~------~~~~~~~~lv~e~~~~~sL~-----------~~i~~---~~~~~--------~---~~~~-~~---------- 143 (314)
. ....+..++++++++|..+. ..+.+ ....+ . .... .+
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1 12245568999999886431 11110 00000 0 0000 00
Q ss_pred -HHHH-HHHHHHHHhcC---CCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 144 -IMID-VWLALEYLHHG---HSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 144 -i~~~-l~~~l~~LH~~---~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
...+ +...+..+.+. .-..|++|+|+.|.||+++.+...-++||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11111222210 014589999999999999866556899999775
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00028 Score=62.64 Aligned_cols=142 Identities=19% Similarity=0.173 Sum_probs=92.5
Q ss_pred cccceeeecCceEEEEEEeCCCCeEEEEEeeecc------------------------cH-HHHH-HHHHHHHHHhCCCC
Q 047043 45 NECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL------------------------GR-AFRS-FDSECEVLRNVHHR 98 (314)
Q Consensus 45 ~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~------------------------~~-~~~~-~~~e~~~l~~l~h~ 98 (314)
++-.+|..|--+.||.|...+|..+|||+++... ++ .... ...|.+-|++++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4445788899999999998899999999996531 11 0111 22466666666554
Q ss_pred CcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 99 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
.|.----+ .- ....|||+++.. +-...=.-....++...+..+-.+++.-|.-|-+ .+++||.||+--|+|+ .
T Consensus 227 GIP~PePI-lL-k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~---~c~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 227 GIPCPEPI-LL-KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ---KCRLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCCCce-ee-ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHH---HhceeccchhhhhheE-E
Confidence 43311111 11 234699999842 2111111112336666777888888888887765 8999999999999988 5
Q ss_pred CCcEEEEeeecceec
Q 047043 179 NMVARVSDFGISKLL 193 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~ 193 (314)
+|.+.++|-+.+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 568889998866543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00042 Score=61.25 Aligned_cols=74 Identities=23% Similarity=0.346 Sum_probs=48.3
Q ss_pred ceeeecCceEEEEEEeCC-------CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC-cceeecccccCCceeEEEEe
Q 047043 48 NLLGTGSFGIVYKGILSD-------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN-LLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 119 (314)
+.+..|-.-.+|+....+ ++.+++|+..... .......+|.+++..+...+ ..++++.+.. .+|+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 455667777899888544 5789999976643 22345677888888885322 3455555543 357888
Q ss_pred cCCCCHH
Q 047043 120 MPNGSLE 126 (314)
Q Consensus 120 ~~~~sL~ 126 (314)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8876654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0027 Score=58.03 Aligned_cols=76 Identities=16% Similarity=0.235 Sum_probs=53.3
Q ss_pred cceeeecCceEEEEEEeCCC-CeEEEEEeeecc-------cHHHHHHHHHHHHHHhCC---CCCcceeecccccCCceeE
Q 047043 47 CNLLGTGSFGIVYKGILSDG-NNVAIKVFKLQL-------GRAFRSFDSECEVLRNVH---HRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~-~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 115 (314)
.+.||.|.+..||++...+| +.++||.-.+.. +-...+...|.+.|+.+. ...+++++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 35789999999999997666 589999754221 113456677888888763 345777777744 45679
Q ss_pred EEEecCCCC
Q 047043 116 VLELMPNGS 124 (314)
Q Consensus 116 v~e~~~~~s 124 (314)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00029 Score=70.63 Aligned_cols=198 Identities=22% Similarity=0.209 Sum_probs=121.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeecccccCC----ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 047043 83 RSFDSECEVLRNVHHRNLLKIFSSCSNPD----FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158 (314)
Q Consensus 83 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~ 158 (314)
....-|.+.+....|+|++.++.+..... ...+..+++...++...++..+. .+...+..+..++..|+.++|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h-- 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLH-- 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHH--
Confidence 34455777888889999999988864432 22355688888899888887765 778888899999999999999
Q ss_pred CCCCCeeecCCCCC---ceEecCCCcEEEE--eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCC
Q 047043 159 HSSAPIVHCDLKPS---NILLDENMVARVS--DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEG 233 (314)
Q Consensus 159 ~~~~~i~H~dlkp~---Nili~~~~~ikl~--Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~ 233 (314)
...+.|.-+..+ +.-++..+...++ ||+....+.+...... ...+..+.+||... ....
T Consensus 304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~-----------~~~~ 367 (1351)
T KOG1035|consen 304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLK-----------ENTA 367 (1351)
T ss_pred --HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccc-----------cccc
Confidence 565555544444 3334555566666 8887776654432221 22344455664422 1233
Q ss_pred CCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhhccCCchhhhhc--cccCCCCHHHHHHHH
Q 047043 234 IISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVV--DANLRVSMKDVAAKL 299 (314)
Q Consensus 234 ~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~l~~ll--dp~~Rpt~~~~~~~l 299 (314)
......|+|++|.....+..|..+-........-+........-..+..+. +...|+++.+++++.
T Consensus 368 ~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 368 KKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhHHHHHHHHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 344567999999999999887665222111110000000001111222233 577788887777643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0032 Score=55.60 Aligned_cols=142 Identities=15% Similarity=0.123 Sum_probs=88.7
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeee--cccHHHHHHHHHHHHHHhCCC--CCcceeecccccCC--ceeEEE
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKL--QLGRAFRSFDSECEVLRNVHH--RNLLKIFSSCSNPD--FKALVL 117 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~ 117 (314)
..+++.+..|..-.+|.... +++.++++ ... ..........+|+++++.+.. .-....+++|.++. ..+.+|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34444554444445555553 37888888 332 223455677788999988742 33456677777666 778999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHH-HHHHHHHHHHhc---------------------------------------
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIM-IDVWLALEYLHH--------------------------------------- 157 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~-~~l~~~l~~LH~--------------------------------------- 157 (314)
++++|....+..... .....++ ..+++.|.-||+
T Consensus 105 ~~veGe~~~~~~~~~------~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 105 EWVEGEVVWSALPPE------SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEecceeccCcCCcc------cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 999885332222111 0011122 255555555553
Q ss_pred -----------CC----CCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 158 -----------GH----SSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 158 -----------~~----~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
.. ....++|+|+.+.|++++.++.+=+.||+.+..-
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 10 1455899999999999998888999999988753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0037 Score=56.32 Aligned_cols=141 Identities=15% Similarity=0.145 Sum_probs=81.0
Q ss_pred cceeeecCceEEEEEEeCC-----CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEec
Q 047043 47 CNLLGTGSFGIVYKGILSD-----GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 120 (314)
++.+..|-.-.+|++...+ ++.|++|+...... ..-...+|..+++.+...++ .++++.+..+ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455557778999987432 36899998876532 22234678999888854333 4556666443 578998
Q ss_pred CCCCHHHH-------H-------hh---cC---CC-CC-HHHHHHHHHH-----------------HHHHHHHH----hc
Q 047043 121 PNGSLENW-------L-------YS---HN---YF-LD-TLERLNIMID-----------------VWLALEYL----HH 157 (314)
Q Consensus 121 ~~~sL~~~-------i-------~~---~~---~~-~~-~~~~~~i~~~-----------------l~~~l~~L----H~ 157 (314)
++.++... . .+ .. .. .. ...+.++..+ +...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665421 0 00 01 00 11 1122222211 11112222 11
Q ss_pred CCCCCCeeecCCCCCceEecC-CCcEEEEeeeccee
Q 047043 158 GHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKL 192 (314)
Q Consensus 158 ~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~ 192 (314)
......++|+|+++.||++++ ++.+.++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111456899999999999976 46899999987764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0023 Score=53.07 Aligned_cols=117 Identities=17% Similarity=0.080 Sum_probs=72.4
Q ss_pred cCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCCCCHHHHHhhc
Q 047043 53 GSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH 132 (314)
Q Consensus 53 G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~ 132 (314)
++.++.-.++.+-|..+..|+-....--...-+.++.++++++. +|+++..- +...+.+|.|+|-....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 44444444443345554444433332213355678888988875 56666632 55567799999843111
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 133 NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 133 ~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
...-.+.. =+++|.-+|+. ..+..|||..|+||+-|+.|-+||.|-+.
T Consensus 142 ------~~~N~i~a-gi~~L~~fH~~--~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------NFSNFITA-GIKDLMDFHSE--NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------chhHHHHH-hHHHHHHhhcc--CCCeecCCCChhheeecCCCCEEecChhh
Confidence 11111111 13556677842 67799999999999999999999999774
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0081 Score=52.38 Aligned_cols=31 Identities=35% Similarity=0.606 Sum_probs=25.5
Q ss_pred CCeeecCCCCCceEecCCCc-EEEEeeeccee
Q 047043 162 APIVHCDLKPSNILLDENMV-ARVSDFGISKL 192 (314)
Q Consensus 162 ~~i~H~dlkp~Nili~~~~~-ikl~Dfg~~~~ 192 (314)
..++|+|+.+.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 44899999999999987555 46999997764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.018 Score=50.41 Aligned_cols=75 Identities=21% Similarity=0.233 Sum_probs=47.5
Q ss_pred cccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC---CCCcceeecccccCCceeEEEEecC
Q 047043 45 NECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH---HRNLLKIFSSCSNPDFKALVLELMP 121 (314)
Q Consensus 45 ~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (314)
+-.+.++.|....+|+.. .+++.+.+|+-.... ...+..|.+-|+.|. .-.+++.+++....+.-+++||+++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 444578889999999888 477889999877332 256777888887773 4567788888777777799999986
Q ss_pred CC
Q 047043 122 NG 123 (314)
Q Consensus 122 ~~ 123 (314)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 54
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.054 Score=49.63 Aligned_cols=74 Identities=12% Similarity=0.123 Sum_probs=49.2
Q ss_pred ccceeeecCceEEEEEEeCCCCeEEEEEeeeccc-------HHHHHHHHHHHHHHhCC---CCCcceeecccccCCceeE
Q 047043 46 ECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG-------RAFRSFDSECEVLRNVH---HRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 115 (314)
..+.||.|..-.||+... .+..++||.-..... -...+-..|.+.|+.+. ...+++++.++.+. .++
T Consensus 36 ~~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence 356789999999999886 345688987652211 02233444566666553 34788888888844 567
Q ss_pred EEEecCC
Q 047043 116 VLELMPN 122 (314)
Q Consensus 116 v~e~~~~ 122 (314)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999966
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0082 Score=50.03 Aligned_cols=32 Identities=28% Similarity=0.500 Sum_probs=22.3
Q ss_pred CCCeeecCCCCCceEe-cCCCcEEEEeeeccee
Q 047043 161 SAPIVHCDLKPSNILL-DENMVARVSDFGISKL 192 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili-~~~~~ikl~Dfg~~~~ 192 (314)
..-++|.|+.+.||++ +.++.++|+||..+..
T Consensus 142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 3458999999999999 8899999999997764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.023 Score=50.87 Aligned_cols=73 Identities=11% Similarity=0.230 Sum_probs=45.5
Q ss_pred ceeeecCceEEEEEEeCC----CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILSD----GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.|..|-.-.+|+..... +..|++|+...... ..-...+|..+++.+...++ +++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 345447777888887432 24899998865432 22334678888888854443 4555555433 57888876
Q ss_pred CCH
Q 047043 123 GSL 125 (314)
Q Consensus 123 ~sL 125 (314)
.++
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.067 Score=47.41 Aligned_cols=32 Identities=25% Similarity=0.312 Sum_probs=28.6
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
..+++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 56899999999999999999999999997763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.054 Score=48.77 Aligned_cols=72 Identities=15% Similarity=0.181 Sum_probs=45.2
Q ss_pred eeeecCceEEEEEEeCCC-CeEEEEEeeecc-------cHHHHHHHHHHHHHHhCC--CC-CcceeecccccCCceeEEE
Q 047043 49 LLGTGSFGIVYKGILSDG-NNVAIKVFKLQL-------GRAFRSFDSECEVLRNVH--HR-NLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 49 ~lg~G~~g~V~~a~~~~~-~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 117 (314)
.||.|....||++...+| +.|+||.-.+.. +-...+..-|.+.|+... .| .++++|.+-. ....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--ccceehH
Confidence 478899999999996543 589998653221 122344556777776653 34 4555555433 3445889
Q ss_pred EecCC
Q 047043 118 ELMPN 122 (314)
Q Consensus 118 e~~~~ 122 (314)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.022 Score=50.96 Aligned_cols=74 Identities=22% Similarity=0.250 Sum_probs=56.8
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
...+.|++|++. |+++.-. .. -...++..++++.+..+.-+.. +-..-|||+...||+|+ .|.|.|+||.
T Consensus 297 e~~y~yl~~kdh-gt~is~i-k~----~~~~e~lsff~s~~sil~~lek---kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII-KA----DRSEEELSFFWSCISILDILEK---KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeeee-ec----ccHHHHHHHHHHHHHHHhhhhh---cCCcccccccccceeee-cCceEEEEee
Confidence 344667788876 5555432 11 3456788889988888888875 66788999999999999 9999999999
Q ss_pred ccee
Q 047043 189 ISKL 192 (314)
Q Consensus 189 ~~~~ 192 (314)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9884
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.055 Score=46.42 Aligned_cols=75 Identities=23% Similarity=0.267 Sum_probs=52.9
Q ss_pred ceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHH---HHHHhCCCCCcceeecccccCCceeEEEEec-CCC
Q 047043 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSEC---EVLRNVHHRNLLKIFSSCSNPDFKALVLELM-PNG 123 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 123 (314)
..+..|..+.|+.++..+|.+.++|+..+.. ....|. ..|+..+-...+++++.-... ..+++|.+ ++.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~-----~~~~E~~g~~~L~~w~G~GaVrll~~d~~~--~AlLLErl~~g~ 80 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHA-----EAEHEARGEAALRWWNGRGAVRLLAADPER--GALLLERLDPGR 80 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcc-----cchhhhhHHhHhheeCCCCceeeecccccc--chhhhhhccCCC
Confidence 3456789999999998899999999987552 122233 557777777888988876443 34678887 455
Q ss_pred CHHHHH
Q 047043 124 SLENWL 129 (314)
Q Consensus 124 sL~~~i 129 (314)
+|.+.-
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 666554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.16 Score=45.33 Aligned_cols=135 Identities=21% Similarity=0.269 Sum_probs=76.7
Q ss_pred CceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC------cceeec----ccccCCceeEEEEecCCC
Q 047043 54 SFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN------LLKIFS----SCSNPDFKALVLELMPNG 123 (314)
Q Consensus 54 ~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~----~~~~~~~~~lv~e~~~~~ 123 (314)
.--.+|+....+|+. ++|+.... .....+..|...+..+...+ +...=| ....+.....+.+|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888766665 99999886 23356677888887773211 222211 122223667788999887
Q ss_pred CHHH-H----Hhh------------cCCC---------CCHH-------------HHHHHHHHHHHHHHHHhc----CCC
Q 047043 124 SLEN-W----LYS------------HNYF---------LDTL-------------ERLNIMIDVWLALEYLHH----GHS 160 (314)
Q Consensus 124 sL~~-~----i~~------------~~~~---------~~~~-------------~~~~i~~~l~~~l~~LH~----~~~ 160 (314)
.+.. . +.. .+.. ..+. .-.....++...+..+.. .-.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7662 1 000 0100 0000 001122233333443331 111
Q ss_pred CCC--eeecCCCCCceEecCCCc-EEEEeeecce
Q 047043 161 SAP--IVHCDLKPSNILLDENMV-ARVSDFGISK 191 (314)
Q Consensus 161 ~~~--i~H~dlkp~Nili~~~~~-ikl~Dfg~~~ 191 (314)
..+ ++|+|+.|.||+++.+.. +.++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 333 999999999999998875 8999999665
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.65 Score=41.51 Aligned_cols=97 Identities=13% Similarity=0.051 Sum_probs=53.8
Q ss_pred CcccceehhhHHHHhcCcccc---cee-eecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--c
Q 047043 27 ATWRRTSYLDIQRATEGFNEC---NLL-GTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--L 100 (314)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~~~---~~l-g~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i 100 (314)
.+.++.+-..+......+-+. +.. =.+.--.||+....++..+++|+.+... .....+..|.+.+..+.... +
T Consensus 6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv 84 (325)
T PRK11768 6 FPFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV 84 (325)
T ss_pred CCCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence 344455555566655555332 111 1234456899887678889999987543 23355667777777763211 1
Q ss_pred ceee---c--ccccCCceeEEEEecCCCC
Q 047043 101 LKIF---S--SCSNPDFKALVLELMPNGS 124 (314)
Q Consensus 101 ~~~~---~--~~~~~~~~~lv~e~~~~~s 124 (314)
+... | ....++..+.++++++|..
T Consensus 85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 2111 1 1122345667888887643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.0026 Score=65.94 Aligned_cols=177 Identities=12% Similarity=-0.060 Sum_probs=115.0
Q ss_pred eEEEEEeeeccc-----HHHHHHHHHHHHHHhCCCCCcceeeccccc--CCceeEEEEecCCCCHHHHHhhcC---CCCC
Q 047043 68 NVAIKVFKLQLG-----RAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFKALVLELMPNGSLENWLYSHN---YFLD 137 (314)
Q Consensus 68 ~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~---~~~~ 137 (314)
.+.+|+.+...- ...+....|.+..+.+.|+++...+.-... ....+..++++.+|.+.+.+.+.- ..+.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 456666653321 122333445555556678888776655443 345577889999999999987652 2244
Q ss_pred HHHHHHHHHHHHHHHHHHhcC-CCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCcc
Q 047043 138 TLERLNIMIDVWLALEYLHHG-HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216 (314)
Q Consensus 138 ~~~~~~i~~~l~~~l~~LH~~-~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 216 (314)
+..+.....+.+....-+|.. ...+--+|.++++.|.+|..+..++++++|+.+.... .....+...+++-|+.|++
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHH
Confidence 444444444445555555521 1134478999999999999999999999999873211 1122344557777888855
Q ss_pred ccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
.. .-.++.++|+|..|+-+|....|..+|-
T Consensus 1412 ~N-------------~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1412 KN-------------EIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HH-------------HHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 42 3345666999999999999999988863
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.28 Score=44.85 Aligned_cols=75 Identities=17% Similarity=0.196 Sum_probs=46.5
Q ss_pred cceeeecCceEEEEEEeCCC--Ce-----EEEEEeeecccHHHHHHHHHHHHHHhCCCC-CcceeecccccCCceeEEEE
Q 047043 47 CNLLGTGSFGIVYKGILSDG--NN-----VAIKVFKLQLGRAFRSFDSECEVLRNVHHR-NLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 118 (314)
++.|..|-...+|++...++ .. |++++.... ....-+..+|.++++.+... .-.++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34565688889999874332 22 444443222 22223346789999998644 44567777764 58999
Q ss_pred ecCCCCHH
Q 047043 119 LMPNGSLE 126 (314)
Q Consensus 119 ~~~~~sL~ 126 (314)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99886654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.2 Score=46.77 Aligned_cols=75 Identities=15% Similarity=0.224 Sum_probs=47.1
Q ss_pred ccceeeecCceEEEEEEeCC---------CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeE
Q 047043 46 ECNLLGTGSFGIVYKGILSD---------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKAL 115 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~l 115 (314)
.++.|..|-.-.+|++...+ ++.|++++........ -...+|..+++.+...++ .++++.+.. +.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~g----g~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFSG----GR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeCC----CE
Confidence 34456567677888887432 4579999886654332 244668888887754443 355555542 46
Q ss_pred EEEecCCCCH
Q 047043 116 VLELMPNGSL 125 (314)
Q Consensus 116 v~e~~~~~sL 125 (314)
|.+|++|-+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899887533
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.12 Score=47.09 Aligned_cols=74 Identities=18% Similarity=0.200 Sum_probs=47.1
Q ss_pred cceeeecCceEEEEEEeCC-CCeEEEEEeeecc------cHHHHHHHHHHHHHHhCC--CC-CcceeecccccCCceeEE
Q 047043 47 CNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQL------GRAFRSFDSECEVLRNVH--HR-NLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~-~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 116 (314)
.+.||.|...-||++...+ ++.|+||.-.+.. +-..++..-|.+.|+... .| .++++|.+-. ....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 5678999999999999643 5679998643221 123455566777777663 34 4555655433 334577
Q ss_pred EEecCC
Q 047043 117 LELMPN 122 (314)
Q Consensus 117 ~e~~~~ 122 (314)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887743
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.11 Score=47.23 Aligned_cols=60 Identities=20% Similarity=0.081 Sum_probs=43.5
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
.++-+|.+|.++..++.... .++....+++.-.++|+..+-- -.+.+|.|+.|.||++-.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~---vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI---VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH---hhcceecccCCCcEEEEe
Confidence 45667788889998887654 3555666666666666654432 567999999999999943
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.44 Score=49.37 Aligned_cols=94 Identities=16% Similarity=0.214 Sum_probs=52.0
Q ss_pred ceehhhHHH-HhcCcccc---ceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-------CCC
Q 047043 31 RTSYLDIQR-ATEGFNEC---NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-------HRN 99 (314)
Q Consensus 31 ~~~~~~~~~-~~~~y~~~---~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-------h~~ 99 (314)
..|-.+... ....|-+. +.|+ |..-.+|+....+|..+++|+....... .....|...+..+. -|.
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~ 86 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPR 86 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCe
Confidence 344444444 34445443 3454 4456789888767889999999865332 23344555555442 222
Q ss_pred cceee-c----ccc--cCC-ceeEEEEecCCCCHHH
Q 047043 100 LLKIF-S----SCS--NPD-FKALVLELMPNGSLEN 127 (314)
Q Consensus 100 i~~~~-~----~~~--~~~-~~~lv~e~~~~~sL~~ 127 (314)
+++-. + ... ++. ..+.+++|++|..+.+
T Consensus 87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence 22221 1 111 121 4567899999877755
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.017 Score=43.48 Aligned_cols=54 Identities=26% Similarity=0.432 Sum_probs=39.5
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHh
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN 94 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~ 94 (314)
+......|+ -+.||.|+.|.||+|+.++|+.||||+.++... ..+..++.+++.
T Consensus 7 ~~~~F~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~---~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 7 IDEIFDEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGIE---EQIEADLRILRR 60 (119)
T ss_pred HHHHHHHCC-cchhhheehhhheeeeecccchhhhhhcchHHH---HHHHHHHHHHHH
Confidence 344555566 368999999999999988899999999887643 344445555543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 314 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-31 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-77
Identities = 93/269 (34%), Positives = 136/269 (50%), Gaps = 23/269 (8%)
Query: 29 WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAF-RSFDS 87
+R S ++Q A++ F+ N+LG G FG VYKG L+DG VA+K K + + F +
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 88 ECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLE---RLNI 144
E E++ HRNLL++ C P + LV M NGS+ + L L+ R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
+ L YLH H I+H D+K +NILLDE A V DFG++KL+ + VT T
Sbjct: 137 ALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TA 194
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264
TIG++AP ++ S G S K DV+ +GV+L+E TG++ D
Sbjct: 195 VRGTIGHIAP-------------EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 265 E---ISLKNWVNESLPH-ALTDVVDANLR 289
+ L +WV L L +VD +L+
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-75
Identities = 85/265 (32%), Positives = 129/265 (48%), Gaps = 22/265 (8%)
Query: 30 RRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSEC 89
R +D++ AT F+ L+G G FG VYKG+L DG VA+K + + F++E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 90 EVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLY---SHNYFLDTLERLNIMI 146
E L H +L+ + C + L+ + M NG+L+ LY + +RL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
L YLH I+H D+K NILLDEN V +++DFGISK + + + T+
Sbjct: 147 GAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF-TGE 265
T+GY+ P ++ +G ++ K DVYSFGV+L E + +
Sbjct: 203 GTLGYIDP-------------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249
Query: 266 ISLKNWVNESLPH-ALTDVVDANLR 289
++L W ES + L +VD NL
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLA 274
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-66
Identities = 79/274 (28%), Positives = 120/274 (43%), Gaps = 40/274 (14%)
Query: 33 SYLDIQRATEGFNE------CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRA----F 82
S+ +++ T F+E N +G G FG+VYKG + + VA+K +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 83 RSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF--LDTLE 140
+ FD E +V+ H NL+++ S+ D LV MPNGSL + L + L
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 141 RLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200
R I + +LH +H D+K +NILLDE A++SDFG+++ +V
Sbjct: 135 RCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSE---GIISAKCDVYSFGVLLMETFTGKKP 257
+ + T YMAP E G I+ K D+YSFGV+L+E TG
Sbjct: 191 MTSRIVGTTAYMAP-----------------EALRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 258 TDEMFTGEISLKNWVNESL--PHALTDVVDANLR 289
DE L + E + D +D +
Sbjct: 234 VDEHR-EPQLLLDIKEEIEDEEKTIEDYIDKKMN 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-58
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 52/283 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQ-------LGRAFRSFDSECEVLRNVHHRNLL 101
+G G FG+V+KG + D + VAIK L + F+ F E ++ N++H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
K++ NP +V+E +P G L + L + + +L +M+D+ L +EY+ + +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ--NQN 142
Query: 162 APIVHCDLKPSNILLDE-----NMVARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAP 214
PIVH DL+ NI L + A+V+DFG+S+ +++ +MAP
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLLGNFQWMAP 195
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN- 273
+ + + + + K D YSF ++L TG+ P DE G+I N +
Sbjct: 196 -----ETIGAEEESY------TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 274 --------ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
E P L +V+ D R + +L ++
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-58
Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 38/274 (13%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
L G ++KG GN++ +KV K++ R R F+ EC LR H N+L + +C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 108 SNPDFK--ALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+P L+ MP GSL N L+ N+ +D + + +D+ + +LH I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT--LEPLI 134
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
L ++++DE+M AR+S + S M ++AP + L+
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP-----EALQK 182
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN-------ESLP 277
K D++SF VLL E T + P ++ EI +K + +
Sbjct: 183 KPEDTNRR-----SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 278 HALTDVV------DANLRVSMKDVAAKLKKIRVK 305
++ ++ D R + L+K++ K
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-58
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 29/272 (10%)
Query: 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEV- 91
++ + + G FG V+K L VA+K+F +Q +S+ +E EV
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---DKQSWQNEYEVY 70
Query: 92 -LRNVHHRNLLKIFSSCSNPDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMI 146
L + H N+L+ + L+ GSL ++L + E +I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAE 128
Query: 147 DVWLALEYLH------HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200
+ L YLH I H D+K N+LL N+ A ++DFG++ G+ +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
+ T YMAP ++L + + D+Y+ G++L E + D
Sbjct: 189 DTHGQVGTRRYMAP-----EVL---EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 261 MFTG-EISLKNWVNE--SLPHALTDVVDANLR 289
+ + + + SL VV R
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR 272
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-57
Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 35/270 (12%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
+G GSFG V++ G++VA+K+ Q F E +++ + H N++ +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 108 SNPDFKALVLELMPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
+ P ++V E + GSL L+ LD RL++ DV + YLH+ + PIV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIV 161
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
H +LK N+L+D+ +V DFG+S+L S T +MAP ++L+ +
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAP-----EVLRDE 214
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM----FTGEISLKNW---VNESLPH 278
+ + K DVYSFGV+L E T ++P + + K + +L
Sbjct: 215 PS--------NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 279 ALTDVV------DANLRVSMKDVAAKLKKI 302
+ ++ + R S + L+ +
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-56
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
+G G+FG+V K +VAIK + + ++F E L V+H N++K++ +C N
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 110 PDFKALVLELMPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
P LV+E GSL N L+ + ++ + + YLH ++H
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS-MQPKALIHR 129
Query: 168 DLKPSNILLDENM-VARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAPVSQLFDILKP 224
DLKP N+LL V ++ DFG + + MT + +MAP ++ +
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACD-------IQTHMTNNKGSAAWMAP-----EVFEG 177
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESL-------- 276
N S KCDV+S+G++L E T +KP DE+ + V+
Sbjct: 178 SNY--------SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 277 PHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306
P + ++ D + R SM+++ + + F
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-55
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
+G+GSFG VYKG +VA+K+ + + ++F +E VLR H N+L
Sbjct: 32 IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ P A+V + SL + L++ + + ++I ++YLH + I+H
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHR 144
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DLK +NI L E+ ++ DFG++ S +I +MAP ++++ +++
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP-----EVIRMQDS 199
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
S + DVY+FG++L E TG+ P +
Sbjct: 200 NPYSF-----QSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-54
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 48/279 (17%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQ----LGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G G FG VY+ G+ VA+K + + + + E ++ + H N++ +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
C LV+E G L L + +N + + + YLH + PI+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHD-EAIVPII 130
Query: 166 HCDLKPSNILLDE--------NMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVS 216
H DLK SNIL+ + N + +++DFG+++ T M+ A +MAP
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAP-- 183
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN--- 273
++ + + F S DV+S+GVLL E TG+ P + ++ +N
Sbjct: 184 EVI-----RASMF------SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 274 ----ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
+ P ++ D + R S ++ +L I
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-54
Identities = 54/277 (19%), Positives = 106/277 (38%), Gaps = 37/277 (13%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS 105
L+G G FG VY G VAI++ ++ ++F E R H N++
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
+C +P A++ L +L + + LD + I ++ + YLH + I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGIL 152
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA---TIGYMAPVSQLFDIL 222
H DLK N+ D V ++DFG+ + G + + + ++AP +I+
Sbjct: 153 HKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP-----EII 206
Query: 223 KPKNAKFGSEGII-SAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV--------- 272
+ + + + S DV++ G + E + P I W
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---WQMGTGMKPNL 263
Query: 273 -NESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
+ ++D++ + R + + L+K+
Sbjct: 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 66/281 (23%), Positives = 101/281 (35%), Gaps = 37/281 (13%)
Query: 24 LPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFR 83
LP+ R T IQ +G G +G V+ G G VA+KVF
Sbjct: 27 LPLLVQR-TIAKQIQ-------MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEA 74
Query: 84 SFDSECEV--LRNVHHRNLLKIFSSCSNPDFK----ALVLELMPNGSLENWLYSHNYFLD 137
S+ E E+ + H N+L ++ L+ + NGSL ++L + LD
Sbjct: 75 SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLD 132
Query: 138 TLERLNIMIDVWLALEYLH----HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193
L + L +LH I H DLK NIL+ +N ++D G++
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 194 GDGEDSVTQTMTMA--TIGYMAP-VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
+ V T YM P V L + L + + D+YSFG++L E
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEV--LDESLNRNHFQS------YIMADMYSFGLILWE 244
Query: 251 TFTGKKPTDEMFTGEISLKNWVNE--SLPHALTDVVDANLR 289
+ ++ + V S V LR
Sbjct: 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-49
Identities = 60/300 (20%), Positives = 111/300 (37%), Gaps = 58/300 (19%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEV--LRNVHHRNLLKIFS 105
+G G +G V++G G NVA+K+F + +S+ E E+ + H N+L +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 106 SCSNPDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH----H 157
S + L+ GSL ++L LDT+ L I++ + L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAPV 215
I H DLK NIL+ +N ++D G++ + + + T YMAP
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP- 186
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM------FTGEISL- 268
++L + D+++FG++L E + F +
Sbjct: 187 ----EVL--DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 269 --------------------KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
W ++ +L ++ + + R++ + L KI
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-49
Identities = 61/284 (21%), Positives = 102/284 (35%), Gaps = 50/284 (17%)
Query: 50 LGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
LG G FG K G + +K R+F E +V+R + H N+LK
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168
+ E + G+L + S + +R++ D+ + YLH S I+H D
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRD 133
Query: 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA------------TIGYMAP-- 214
L N L+ EN V+DFG+++L+ D + ++ +MAP
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 215 -VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN 273
+ +D K DV+SFG++L E + + V
Sbjct: 194 INGRSYDE----------------KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
Query: 274 ESL--------PHALTDV------VDANLRVSMKDVAAKLKKIR 303
L P + + +D R S + L+ +R
Sbjct: 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-47
Identities = 66/281 (23%), Positives = 107/281 (38%), Gaps = 35/281 (12%)
Query: 32 TSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEV 91
+ + + L+G G +G VYKG L D VA+KVF ++F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58
Query: 92 --LRNVHHRNLLKIFSSCSNPDFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLNI 144
+ + H N+ + LV+E PNGSL +L H D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 145 MIDVWLALEYLH-----HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL------ 193
V L YLH H I H DL N+L+ + +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
GE+ + TI YMAP ++L+ + D+Y+ G++ E F
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP-----EVLE-GAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 254 GKK---PTDEMFTGEISLKNWV--NESLPHALTDVVDANLR 289
P + + +++ + V + + V R
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-46
Identities = 58/257 (22%), Positives = 104/257 (40%), Gaps = 29/257 (11%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEV--LRNVHHRNLLKIFS 105
+G G FG V++G G VA+K+F + RS+ E E+ + H N+L +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103
Query: 106 SCSNPDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH----H 157
+ + + LV + +GSL ++L + Y + + + + L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAP- 214
I H DLK NIL+ +N ++D G++ D++ T YMAP
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV-- 272
V L D + K+ + + D+Y+ G++ E ++ + V
Sbjct: 222 V--LDDSINMKHFES------FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 273 NESLPHALTDVVDANLR 289
+ S+ V + LR
Sbjct: 274 DPSVEEMRKVVCEQKLR 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
LG+G+FG VYKG+ VAIK + +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
C + L+ +LMP G L +++ H + + LN + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDRR 137
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+VH DL N+L+ +++DFG++KLLG E I +MA S L
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH---- 193
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
I + + DV+S+GV + E T G KP D + EI
Sbjct: 194 ---------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 50 LGTGSFGIVYKGILSDGN-NVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIFSSC 107
+G G+FG V+ G L N VA+K + L ++ F E +L+ H N++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ +V+EL+ G +L + L L ++ D +EYL S +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHR 237
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N L+ E V ++SDFG+S+ DG + + + + + AP + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-------- 289
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
G S++ DV+SFG+LL ETF+ G P
Sbjct: 290 -----GRYSSESDVWSFGILLWETFSLGASP 315
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDSECEVLRNVHHRNLLKIFS- 105
+LG G+ V++G G+ AIKVF + R E EVL+ ++H+N++K+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 106 -SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLHHGHSSA 162
+ K L++E P GSL L + E L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 163 PIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQ 217
IVH ++KP NI+ D V +++DFG ++ L D E Q +++ T Y+ P
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHP--- 184
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
D+ + + + A D++S GV TG P
Sbjct: 185 --DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN---VAIKVFKL-QLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
LG G+FG V +G+ VAIKV K E +++ + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
C LV+E+ G L +L + ++ V + ++YL V
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFV 132
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDILKP 224
H DL N+LL A++SDFG+SK LG + ++ + + AP F
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF----- 187
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
KF S++ DV+S+GV + E + G+KP +M
Sbjct: 188 --RKF------SSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIF 104
+G+G G V G L VAIK K R R F SE ++ H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ +V E M NGSL+ +L +H+ ++ + ++ V + YL S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDLGY 172
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILK 223
VH DL N+L+D N+V +VSDFG+S++L D D+ T T I + AP + F
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF---- 228
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
F S+ DV+SFGV++ E G++P M
Sbjct: 229 ---RTF------SSASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDSECEVLRNVHHRNLLKIFS- 105
+LG G+ V++G G+ AIKVF + R E EVL+ ++H+N++K+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 106 -SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSS 161
+ K L++E P GSL L + E L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 162 APIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVS 216
IVH ++KP NI+ D V +++DFG ++ L D E Q +++ T Y+ P
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHP-- 184
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
D+ + + + A D++S GV TG P
Sbjct: 185 ---DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-37
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLK 102
F ++LG G+ G + + D +VA+K + F D E ++LR H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
F + + F+ + +EL +L+ ++ ++ LE + ++ L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SL 137
Query: 163 PIVHCDLKPSNILLDE-----NMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVS 216
IVH DLKP NIL+ + A +SDFG+ K L G S ++ + T G++AP
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP-- 195
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L + + D++S G + +
Sbjct: 196 ---EMLSEDCKENPTY-----TVDIFSAGCVFYYVISEGSH 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-37
Identities = 64/226 (28%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFK---LQLGRAFRSFDSECEVLRNVHHRNLLK 102
LG GSFG+V +G + VA+K K L A F E + ++ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
++ P K +V EL P GSL + L H + V + YL S
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL----ESK 140
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDI 221
+H DL N+LL + ++ DFG+ + L +D V Q + AP S
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-- 198
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
F S D + FGV L E FT G++P + +I
Sbjct: 199 -----RTF------SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 50 LGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G+FG V + G VA+K + R F+ E E+L+++ H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 105 SSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
C + + L++E +P GSL ++L H +D ++ L + +EYL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL----GTK 164
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDI 221
+H DL NIL++ ++ DFG++K+L ++ + + I + AP S
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-- 222
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
S DV+SFGV+L E FT
Sbjct: 223 -----------SKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-36
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 50 LGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G+FG V + G VA+K + R F+ E E+L+++ H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 105 SSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
C + + L++E +P GSL ++L H +D ++ L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDI 221
+H DL NIL++ ++ DFG++K+L ++ + + I + AP S
Sbjct: 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-- 191
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
S DV+SFGV+L E FT
Sbjct: 192 -----------SKFSVASDVWSFGVVLYELFT 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN---VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIFS 105
LG G+FG V +G+ VAIKV K +A E +++ + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
C LV+E+ G L +L + ++ V + ++YL V
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFV 458
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDILKP 224
H +L N+LL A++SDFG+SK LG + ++ + + AP F
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF----- 513
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
KF S++ DV+S+GV + E + G+KP +M
Sbjct: 514 --RKF------SSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
LG+G FG V+KG+ V IKV + + G ++F++ + ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
C + LV + +P GSL + + H L LN + + + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL----EEHG 135
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+VH +L N+LL +V+DFG++ LL + + + I +MA S F
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF---- 191
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
G + + DV+S+GV + E T G +P + E+
Sbjct: 192 ---------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 29/267 (10%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNL--LKI 103
+G+G V++ + AIK L+ + S+ +E L + + +++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSA 162
+ + +V+E N L +WL D ER + ++ A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
IVH DLKP+N L+ + M+ ++ DFGI+ + SV + + T+ YM P + +
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP--EAIKDM 203
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-------TDEMF-----TGEISLKN 270
S+ IS K DV+S G +L GK P ++ EI +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 271 WVNESLPHALTD--VVDANLRVSMKDV 295
+ L L D R+S+ ++
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G+FG V + VA+K + R F E ++L+ +H ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 105 SSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
P ++ LV+E +P+G L ++L H LD L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDI 221
VH DL NIL++ +++DFG++KLL +D V + + I + AP S
Sbjct: 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-- 204
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I S + DV+SFGV+L E FT K
Sbjct: 205 -----------NIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIF 104
+G G FG V G L + VAIK K+ + R F E ++ H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ +V E M NGSL+++L H+ ++ + ++ + ++YL S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDMGY 168
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILK 223
VH DL NIL++ N+V +VSDFG+ ++L D ++ T I + +P + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY---- 224
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
++ DV+S+G++L E + G++P EM
Sbjct: 225 ---------RKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 56/296 (18%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH 97
R F E +LG G+FG V K D AIK + + SE +L +++H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 98 RNLLKIFSSCSNPDFKA-------------LVLELMPNGSLENWLYSHNYFLDTLERLNI 144
+ +++ +++ + +E NG+L + ++S N E +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
+ AL Y+H I+H DLKP NI +DE+ ++ DFG++K + D +
Sbjct: 122 FRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 205 TMA------------TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME-- 250
T Y+A ++L G + K D+YS G++ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVAT-----EVLDGT-------GHYNEKIDMYSLGIIFFEMI 225
Query: 251 --TFTGK---KPTDEMFTGEISLKNWVNESLPHALTDVV------DANLRVSMKDV 295
TG ++ + I +++ ++ D N R + +
Sbjct: 226 YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNV--HHRNLLKI 103
+G+G V++ + AIK L+ + S+ +E L + H ++++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSA 162
+ + +V+E N L +WL D ER + ++ A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
IVH DLKP+N L+ + M+ ++ DFGI+ + SV + + T+ YM P + +
Sbjct: 129 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP--EAIKDM 184
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-------TDEMF-----TGEISLKN 270
S+ IS K DV+S G +L GK P ++ EI +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 271 WVNESLPHALTD--VVDANLRVSMKDV 295
+ L L D R+S+ ++
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 27/232 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
LG G FG V + VA+K K + G E E+LRN++H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 104 FSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
C+ L++E +P+GSL+ +L + ++ ++L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFD 220
VH DL N+L++ ++ DFG++K + ++ + + + + AP +
Sbjct: 147 --YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ- 203
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW 271
DV+SFGV L E T + M +
Sbjct: 204 ------------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
+G+G FG+V+ G + + VAIK + + + F E EV+ + H L++++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
LV E M +G L ++L + L + +DV + YL A ++H DL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL----EEACVIHRDL 130
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
N L+ EN V +VSDFG+++ + D + + T T + + +P F
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSF---------- 179
Query: 230 GSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
S+K DV+SFGVL+ E F+ GK P +
Sbjct: 180 ---SRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-36
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
LG+G+FG VYKG+ VAIK + +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
C + L+ +LMP G L +++ H + + LN + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDRR 137
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+VH DL N+L+ +++DFG++KLLG E I +MA S L
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH---- 193
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI 266
I + + DV+S+GV + E T G KP D + EI
Sbjct: 194 ---------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG G FG V+ G + VAIK K + +F E +V++ + H L+++++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 107 CS-NPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
S P + +V E M GSL ++L +L + +++ + + Y+
Sbjct: 331 VSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----ERMNY 384
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
VH DL+ +NIL+ EN+V +V+DFG+++L+ D E + Q I + AP + L+
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY----- 438
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
G + K DV+SFG+LL E T G+ P M
Sbjct: 439 --------GRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 50 LGTGSFGIVYKGILSDGN---NVAIKVFK--LQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG+G+FG V KG VA+K+ K +E V++ + + ++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
C + LV+E+ G L +L + + + + ++ V + ++YL +
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL----EESNF 138
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDILK 223
VH DL N+LL A++SDFG+SK L E+ QT + + AP +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY---- 194
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
KF S+K DV+SFGVL+ E F+ G+KP M
Sbjct: 195 ---YKF------SSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
+G G FG VYKG+L + VAIK K + F E ++ H N++++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
S ++ E M NG+L+ +L + L+ + ++ + ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL----ANMN 167
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM-TMATIGYMAPVSQLFDIL 222
VH DL NIL++ N+V +VSDFG+S++L D ++ T I + AP + +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--- 224
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
++ DV+SFG+++ E T G++P E+
Sbjct: 225 ----------RKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 65/307 (21%), Positives = 113/307 (36%), Gaps = 59/307 (19%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLR-NVHHRNLLKIFSS 106
+LG GS G V G VA+K + E ++L + H N+++ + S
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL------NIMIDVWLALEYLH-HGH 159
+ F + LEL N +L++ + S N + L+ +++ + + +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 160 SSAPIVHCDLKPSNILLD-------------ENMVARVSDFGISKLLGDGEDSVTQTMTM 206
I+H DLKP NIL+ EN+ +SDFG+ K L G+ S +
Sbjct: 136 ----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 207 A--TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP------- 257
T G+ AP ++L+ N ++ D++S G + + K
Sbjct: 192 PSGTSGWRAP-----ELLEESNNLQTKRR-LTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 258 -TDEMFTGEISLKNWVNESLPHALTD---------VVDANLRVSMKDVAA----KLKKIR 303
+ G SL + + D R + V K +
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
Query: 304 VKFLYDV 310
++FL V
Sbjct: 306 LEFLLKV 312
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-35
Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 29/267 (10%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNL--LKI 103
+G+G V++ + AIK L+ + S+ +E L + + +++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSA 162
+ + +V+E N L +WL D ER + ++ A+ +H HG
Sbjct: 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
IVH DLKP+N L+ + M+ ++ DFGI+ + SV + + + YM P + +
Sbjct: 176 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP--EAIKDM 231
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-------TDEMF-----TGEISLKN 270
S+ IS K DV+S G +L GK P ++ EI +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 271 WVNESLPHALTD--VVDANLRVSMKDV 295
+ L L D R+S+ ++
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG G FG V+ + VA+K K + +F +E V++ + H L+K+ +
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 107 CS-NPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPI 164
+ P + ++ E M GSL ++L S L +L + + + ++
Sbjct: 252 VTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI----EQRNY 305
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
+H DL+ +NIL+ ++V +++DFG+++++ D E + + I + AP + F
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINF----- 359
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
G + K DV+SFG+LLME T G+ P M
Sbjct: 360 --------GSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 26/230 (11%)
Query: 37 IQRATEGFNECNLLGTGSFGIVYKGILSDGNN----VAIKVFKLQLG-RAFRSFDSECEV 91
I + ++G G FG+VY G D AIK + +F E +
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 92 LRNVHHRNLLKIFSSCSNPD-FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL 150
+R ++H N+L + P+ ++L M +G L ++ S + ++ + V
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT-- 208
+EYL + VH DL N +LDE+ +V+DFG+++ + D E Q A
Sbjct: 136 GMEYL----AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ + A S L + K DV+SFGVLL E T G P
Sbjct: 192 VKWTALES-LQT------------YRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIF 104
+G G FG V++GI N VAIK K F E +R H +++K+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 105 SSCS-NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ NP + +++EL G L ++L Y LD + + AL YL S
Sbjct: 83 GVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL----ESKR 136
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
VH D+ N+L+ N ++ DFG+S+ + D + I +MAP S F
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF---- 191
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
++ DV+ FGV + E G KP +
Sbjct: 192 ---------RRFTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 48 NLLGTGSFGIVYKGILSDGNN----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLK 102
++G G FG VY G L D + A+K F +E ++++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 103 IFSSCSNPDFKAL-VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ C + L VL M +G L N++ + + + + + V +++L +S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 210
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT--IGYMAPVSQLF 219
VH DL N +LDE +V+DFG+++ + D E T A + +MA S L
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-LQ 269
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ K DV+SFGVLL E T G P
Sbjct: 270 T------------QKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG G FG V+ G + VAIK K + +F E +V++ + H L+++++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 107 CS-NPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
S P + +V E M GSL ++L +L + +++ + + Y+
Sbjct: 248 VSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV----ERMNY 301
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
VH DL+ +NIL+ EN+V +V+DFG+++L+ D E + Q I + AP + L+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY----- 355
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
G + K DV+SFG+LL E T G+ P M
Sbjct: 356 --------GRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 48 NLLGTGSFGIVYKGILSDGNN----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLK 102
++G G FG VY G L D + A+K F +E ++++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 103 IFSSCSNPDFKAL-VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ C + L VL M +G L N++ + + + + + V ++YL +S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 146
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT--IGYMAPVSQLF 219
VH DL N +LDE +V+DFG+++ + D E T A + +MA S L
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-LQ 205
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ K DV+SFGVLL E T G P
Sbjct: 206 T------------QKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-35
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 50 LGTGSFGIVYKGILSDGNN-----VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKI 103
LG G FG V N+ VA+K K G + + E ++LR ++H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 104 FSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
C + + LV+E +P GSL ++L H+ L L L + + YLH H
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL--LLFAQQICEGMAYLHAQH-- 154
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFD 220
+H DL N+LLD + + ++ DFG++K + +G + + + + + AP
Sbjct: 155 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE- 211
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
DV+SFGV L E T
Sbjct: 212 ------------YKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-35
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LGTG FG+V G +VAIK+ K + + F E +V+ N+ H L++++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
++ E M NG L N+L + T + L + DV A+EYL S +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDL 146
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
N L+++ V +VSDFG+S+ + D ++ + + + + P ++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMY---------- 195
Query: 230 GSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
S+K D+++FGVL+ E ++ GK P +
Sbjct: 196 ---SKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
LG+G FG+V G +VA+K+ K + + F E + + + H L+K + CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169
+V E + NG L N+L SH L+ + L + DV + +L S +H DL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHRDL 130
Query: 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229
N L+D ++ +VSDFG+++ + D + + T + + AP +
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-TKFPVKWSAPEVFHY---------- 179
Query: 230 GSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
S+K DV++FG+L+ E F+ GK P D
Sbjct: 180 ---FKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFKL-QLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G FG VY+G+ ++ VA+K K F SE +++N+ H +++K+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 105 SSCS-NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
P + +++EL P G L ++L + L L + + + A+ YL S
Sbjct: 80 GIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL----ESIN 133
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
VH D+ NIL+ ++ DFG+S+ + D ED ++T I +M+P S F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESINF---- 188
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261
+ DV+ F V + E + GK+P +
Sbjct: 189 ---------RRFTTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 53/211 (25%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS- 108
LG G FG V+ G + VA+K K Q + +F +E +++ + H+ L+++++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPIVHC 167
P + ++ E M NGSL ++L + + T+ +L ++ + + ++ +H
Sbjct: 80 EPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI----EERNYIHR 133
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL+ +NIL+ + + +++DFG+++L+ D + + I + AP + +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINY-------- 184
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
G + K DV+SFG+LL E T G+ P
Sbjct: 185 -----GTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
+LG G++GIVY G LS+ +AIK + R + E + +++ H+N+++ S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL--NIMIDVWLALEYLHHGHSSAPIV 165
S F + +E +P GSL L S L E+ + L+YLH IV
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IV 144
Query: 166 HCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
H D+K N+L++ + V ++SDFG SK L G + T+T T T+ YMAP +I+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT-GTLQYMAP-----EIID- 196
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
D++S G ++E TGK P
Sbjct: 197 -----KGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 47 CNLLGTGSFGIVYKGILSDGN-NVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+ LG G +G VY+G+ + VA+K K F E V++ + H NL+++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLG 283
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHGHSSAPI 164
C+ ++ E M G+L ++L N + L + + A+EYL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL----EKKNF 339
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
+H +L N L+ EN + +V+DFG+S+L+ + I + AP S +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAY----- 393
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
S K DV++FGVLL E T G P
Sbjct: 394 --------NKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKI 103
LG G FG V +G L + VA+K KL R F SE +++ H N++++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 104 FSSCSNPDFKA-----LVLELMPNGSLENWLYSH-----NYFLDTLERLNIMIDVWLALE 153
C + ++L M G L +L + L M+D+ L +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YL S+ +H DL N +L ++M V+DFG+SK + G+ + + ++A
Sbjct: 162 YL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
S L D + ++K DV++FGV + E T G P
Sbjct: 218 IES-LAD------------RVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 35/226 (15%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFK--LQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G FG V + L + VA+K+ K + F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 104 FSSCSNPDFKA------LVLELMPNGSLENWLYSH-----NYFLDTLERLNIMIDVWLAL 152
K ++L M +G L +L + + L + M+D+ +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
EYL SS +H DL N +L E+M V+DFG+S+ + G+ + + ++
Sbjct: 151 EYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
A S L D + + DV++FGV + E T G+ P
Sbjct: 207 ALES-LAD------------NLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 50 LGTGSFGIVYKGILSDGNN----VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIF 104
+G G FG V++GI N VAIK K F E +R H +++K+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 105 SSCS-NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ NP + +++EL G L ++L + LD + + AL YL S
Sbjct: 458 GVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL----ESKR 511
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
VH D+ N+L+ N ++ DFG+S+ + D + I +MAP S F
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF---- 566
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
++ DV+ FGV + E G KP
Sbjct: 567 ---------RRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
+G G FG V G GN VA+K K ++F +E V+ + H NL+++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 110 --PDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+V E M GSL ++L S L L +DV A+EYL VH
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFVH 312
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKN 226
DL N+L+ E+ VA+VSDFG++K E S TQ + + AP +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE------- 360
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
S K DV+SFG+LL E ++ G+ P
Sbjct: 361 ------KKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 50 LGTGSFGIVYKGILSDGN-NVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
LG G +G VY+G+ + VA+K K F E V++ + H NL+++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
++ E M G+L ++L N + + L + + A+EYL +H
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL----EKKNFIHR 135
Query: 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNA 227
DL N L+ EN + +V+DFG+S+L+ + I + AP S +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAY-------- 186
Query: 228 KFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
S K DV++FGVLL E T G P
Sbjct: 187 -----NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 28/215 (13%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
+G GSFG V++ G A+K +L+ E + ++ ++ +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGA 118
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ + +EL+ GSL + + + LEYLH + I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLH----TRRILH 173
Query: 167 CDLKPSNILLDEN-MVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQLFDIL 222
D+K N+LL + A + DFG + L + G +MAP +++
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP-----EVV 228
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
K AK D++S +++ G P
Sbjct: 229 MGKPC--------DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 42/242 (17%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH 96
+R F E L+G+G FG V+K DG IK K +A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 97 HRNLLKIFSSCSNPDFKA----------------LVLELMPNGSLENWLYSHN-YFLDTL 139
H N++ D+ + +E G+LE W+ LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
L + + ++Y+H +++ DLKPSNI L + ++ DFG+ L +
Sbjct: 123 LALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259
T+ YM+P + + ++ + D+Y+ G++L E
Sbjct: 179 TRSK---GTLRYMSP-----EQISSQD--------YGKEVDLYALGLILAELLHVCDTAF 222
Query: 260 EM 261
E
Sbjct: 223 ET 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 66/284 (23%), Positives = 110/284 (38%), Gaps = 43/284 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G F V L DG+ A+K + E ++ R +H N+L++ + C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 108 SNPDFKA----LVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHS 160
L+L G+L N + FL + L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---- 151
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-------TIGYMA 213
+ H DLKP+NILL + + D G + Q +T+ TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN 273
P +LF ++ +I + DV+S G +L G+ P D +F S+ V
Sbjct: 212 P--ELFS-VQSHC-------VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 274 ESL--------PHALTD------VVDANLRVSMKDVAAKLKKIR 303
L AL VD + R + + ++L+ ++
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 49 LLGTGSFGIVYKG---ILSDGNNVAIKVFKLQLGR--AFRS-FDSECEVLRNVHHRNLLK 102
LG G VY IL VAIK + F+ E + H+N++
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ D LV+E + +L ++ SH L +N + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT-MTMATIGYMAPVSQLFDI 221
IVH D+KP NIL+D N ++ DFGI+K L + S+TQT + T+ Y +P
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSP------- 181
Query: 222 LKPKNAKFGSE----GIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE----ISLKNWVN 273
E D+YS G++L E G+ P F GE I++K+ +
Sbjct: 182 ----------EQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQ 226
Query: 274 ESLPHALTDVV 284
+S+P+ TDV
Sbjct: 227 DSVPNVTTDVR 237
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-32
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 33/221 (14%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIF--- 104
LGTG FG V + I G VAIK + +L + + E ++++ ++H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 105 ---SSCSNPDFKALVLELMPNGSLENWLYSH--NYFLDTLERLNIMIDVWLALEYLHHGH 159
+ D L +E G L +L L ++ D+ AL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 160 SSAPIVHCDLKPSNILLD---ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
I+H DLKP NI+L + ++ ++ D G +K L GE + T+ Y+AP
Sbjct: 142 ----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYLAP-- 192
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L+ K K+ D +SFG L E TG +P
Sbjct: 193 ---ELLEQK--KYT------VTVDYWSFGTLAFECITGFRP 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 58/273 (21%), Positives = 98/273 (35%), Gaps = 40/273 (14%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNV 95
+ F + LG GS+G V+K DG A+K + +E V
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 96 -HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
H +++ + L EL SL+ + L + + D LAL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
LH +VH D+KP+NI L ++ DFG+ L G + YMAP
Sbjct: 173 LHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMAP 225
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP------TDEMFTGEISL 268
++L +G+ DV+S G+ ++E + ++ G +
Sbjct: 226 -----ELL---QGSYGT------AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP 271
Query: 269 KNWVNESLPHALTDVV------DANLRVSMKDV 295
+ L L V+ D LR + + +
Sbjct: 272 EFT--AGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
+G G FG V G GN VA+K K ++F +E V+ + H NL+++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 108 S-NPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
+V E M GSL ++L S L L +DV A+EYL V
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFV 139
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
H DL N+L+ E+ VA+VSDFG++K E S TQ + + AP +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE------ 188
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
S K DV+SFG+LL E ++ G+ P
Sbjct: 189 -------KKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 29/249 (11%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKL--QLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G GSF VYKG+ VA + + F E E+L+ + H N+++ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 106 SCSNPDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
S + LV ELM +G+L+ +L + R + + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHT--RT 149
Query: 162 APIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
PI+H DLK NI + ++ D G++ L S + + + T +MAP +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAP-----E 200
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHAL 280
+ + K DVY+FG+ ++E T + P E + + P +
Sbjct: 201 MYEEK---------YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251
Query: 281 TDVVDANLR 289
V ++
Sbjct: 252 DKVAIPEVK 260
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G GSFG DG IK + + E VL N+ H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
S +V++ G L + + + L+ + + LAL+++H I
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----I 146
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
+H D+K NI L ++ ++ DFGI+++L + + + T Y++P +I +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACI-GTPYYLSP-----EICEN 199
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
K + K D+++ G +L E T K
Sbjct: 200 KPY--------NNKSDIWALGCVLYELCTLKHA 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 39/225 (17%)
Query: 50 LGTGSFGIVYKGILSDGNN--------VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLL 101
LG G+F ++KG+ + + V +KV SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ C D LV E + GSL+ +L + ++ L +L + + A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL----EE 131
Query: 162 APIVHCDLKPSNILLD--------ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
++H ++ NILL ++SD GIS + + + I ++
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVP 185
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
P + D +SFG L E + G KP
Sbjct: 186 PECIEN------PKNL------NLATDKWSFGTTLWEICSGGDKP 218
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 28/226 (12%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS 105
+GTGS+G K SDG + K + SE +LR + H N+++ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 106 SCSNPDFKAL--VLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ L V+E G L + + +LD L +M + LAL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 161 SA-PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
++H DLKP+N+ LD ++ DFG++++L +T T YM+P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFV-GTPYYMSP----- 185
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+ + + + K D++S G LL E P FT
Sbjct: 186 EQMNRMS--------YNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 63/290 (21%)
Query: 49 LLGTGSFGIVYKG---ILSDGNNVAIKVFKLQLGR--AFRS-FDSECEVLRNVHHRNLLK 102
+LG G V+ +VA+KV + L R +F F E + ++H ++
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 103 IFSSCSNPDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
++ + +V+E + +L + +++ + + ++ D AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN 135
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT-MTMATIGYMAPVSQ 217
I+H D+KP+NI++ +V DFGI++ + D +SVTQT + T Y++P
Sbjct: 136 G----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP--- 188
Query: 218 LFDILKPKNAKFGSE----GIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE----ISLK 269
E + A+ DVYS G +L E TG+ P FTG+ ++ +
Sbjct: 189 --------------EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ 230
Query: 270 ---------NWVNESLPHALTDVV------DANLR-VSMKDVAAKLKKIR 303
+ +E L L VV + R + ++ A L ++
Sbjct: 231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIK---VFKLQLGRAFRSFDSECEVLRNVHH 97
F +G G F VY+ L DG VA+K +F L +A E ++L+ ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEY 154
N++K ++S + +VLEL G L + + + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
+H ++H D+KP+N+ + V ++ D G+ + + + ++ T YM+P
Sbjct: 152 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSP 205
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + + K D++S G LL E + P
Sbjct: 206 -----ERIHENGY--------NFKSDIWSLGCLLYEMAALQSP 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 31 RTSYLDIQRATEGFNE----CNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSF 85
R + L +T GF E +LG G +V + I A+K+ + G +F +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 86 D---------SECEVLRNV-HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF 135
+ E ++LR V H N++++ + F LV +LM G L ++L
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 136 LDTLER--LNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192
E+ IM + + LH IVH DLKP NILLD++M +++DFG S
Sbjct: 122 S---EKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 193 LGDGEDSVTQTMTMA-TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
L GE + + T Y+AP +I++ + + D++S GV++
Sbjct: 174 LDPGE----KLREVCGTPSYLAP-----EIIECSM--NDNHPGYGKEVDMWSTGVIM 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 47/257 (18%), Positives = 85/257 (33%), Gaps = 38/257 (14%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN------VAIKVFKLQLGRAFRSFDSE 88
+ Q ++ +LLG G+F VY+ D N+ +KV K F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF----LDTLERLNI 144
E L+ +K +S+ + LV EL G+L N + + + ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILL-----------DENMVARVSDFGISKLL 193
+ + +E +H I+H D+KP N +L D + + D G S +
Sbjct: 178 AMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
T T G+ ++L K + + D + +
Sbjct: 234 KLFPKGTIFTAKCETSGFQCV-----EMLSNKPWNY--------QIDYFGVAATVYCMLF 280
Query: 254 GKKPTDEMFTGEISLKN 270
G + GE +
Sbjct: 281 GTYMKVKNEGGECKPEG 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 43/238 (18%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFRSFDSECEVLRNVH 96
R F LG G FG+V++ D N AIK +L A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 97 HRNLLKIFSS----------CSNPDFKAL--VLELMPNGSLENWLYSHN--YFLDTLERL 142
H +++ F++ + L ++L +L++W+ + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202
+I + + A+E+LH ++H DLKPSNI + V +V DFG+ + E+ T
Sbjct: 122 HIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 203 TMTMATIG----------YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
M YM+P + + + S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSP-----EQIHGNS--------YSHKVDIFSLGLILFE 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 33/224 (14%)
Query: 49 LLGTGSFGIVYKG---ILSDGNNVAIKVFKLQLGR--AFRS-FDSECEVLRNVHHRNLLK 102
L+G G G VY+ + VA+K+ L FR+ E + +++
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
I + + L+ L L L + I+ + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--- 154
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT-MTMATIGYMAPVSQLFDI 221
H D+KP NIL+ + A + DFGI+ D +TQ T+ T+ YMAP +
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDE--KLTQLGNTVGTLYYMAP-ERF--- 207
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
SE + + D+Y+ +L E TG P + G+
Sbjct: 208 ---------SESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLK 102
LG GSFG+VY+G+ VAIK R F +E V++ + ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH---------NYFLDTLERLNIMIDVWLALE 153
+ S +++ELM G L+++L S + + + ++ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YL ++ VH DL N ++ E+ ++ DFG+++ + + + + + +M+
Sbjct: 153 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
P S L D G+ + DV+SFGV+L E T ++P
Sbjct: 209 PES-LKD------------GVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 45/227 (19%), Positives = 81/227 (35%), Gaps = 44/227 (19%)
Query: 49 LLGTGSFGIVYKG---ILSDGNNVAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKIF 104
+ G G +Y + +G V +K ++ +E + L V H ++++IF
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 105 SSCSNPDFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+ + D +V+E + SL+ L E + ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT-MTMATIGYMAPVSQL 218
S +V+ DLKP NI+L E + ++ D G + T G+ AP +
Sbjct: 200 -SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS-------RINSFGYLYGTPGFQAP-EIV 249
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+ D+Y+ G L G
Sbjct: 250 -------------RTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 39/230 (16%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG V+ + + VA+K K A + F E E+L N+ H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNIMIDV 148
+ C + D +V E M +G L +L +H L + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL +S VH DL N L+ N++ ++ DFG+S+ + + TM
Sbjct: 143 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I +M P S + + + DV+SFGV+L E FT GK+P
Sbjct: 199 IRWMPPES-IMY------------RKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFK-LQLGRAFRSFDSECEVLRNVHHRNLLK 102
LG G+FG VY+G +S N VA+K + + F E ++ +H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH------NYFLDTLERLNIMIDVWLALEYLH 156
+ +++ELM G L+++L L L+ L++ D+ +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 157 HGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
+H D+ N LL VA++ DFG+++ + M + +M
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
P + + GI ++K D +SFGVLL E F+ G P
Sbjct: 214 PEA-FME------------GIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 39/287 (13%), Positives = 91/287 (31%), Gaps = 66/287 (22%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG---------------------------- 79
+LG + G + + V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 80 RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMP-----NGSLENWLYSH-- 132
+ F +++++ + ++++ + + L P + L SH
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF-LYPRMQSNLQTFGEVLLSHSS 203
Query: 133 -NYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190
+ L RL + + V L LH +G +VH L+P +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEG--IISAKCDVYSFGVLL 248
G ++ G+ P + + FG +++ D ++ G+ +
Sbjct: 259 VRDGAS------AVSPIGRGFAPP-----ETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
Query: 249 METFTGKKPTDEMFTGE--ISLKNWV---NESLPHALTDVVDANLRV 290
+ P T + + W+ +++P + +++ LR
Sbjct: 308 YWIWCADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRY 350
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-29
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
+LG+G+F V+ G A+K K S ++E VL+ + H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL--NIMIDVWLALEYLH-HGHSSAPI 164
+ LV++L+ G L + + + E+ ++ V A++YLH +G I
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVY---TEKDASLVIQQVLSAVKYLHENG-----I 127
Query: 165 VHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLFD 220
VH DLKP N+L +EN ++DFG+SK+ +G T T GY+AP +
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAP-----E 177
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+L K + D +S GV+
Sbjct: 178 VLAQKP--YSKA------VDCWSIGVIT 197
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-29
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 48 NLLGTGSFGIVYKGILSDGN---NVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLK 102
+++G G+FG V K + + AIK K R F E EVL + HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------------LDTLERLNIMID 147
+ +C + + L +E P+G+L ++L L + + L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
V ++YL S +H DL NIL+ EN VA+++DFG+S+ E V +TM
Sbjct: 151 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MA S L + + DV+S+GVLL E + G P
Sbjct: 204 PVRWMAIES-LNY------------SVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 54/245 (22%), Positives = 93/245 (37%), Gaps = 47/245 (19%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKV-FKLQLGRAFRSFDS----------------ECEVL 92
L G F + D A+K K L + S E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 93 RNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF-------LDTLERLNIM 145
++ + L +N D ++ E M N S+ + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
V + Y+H+ + I H D+KPSNIL+D+N ++SDFG S+ + D + +
Sbjct: 158 KSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-S 210
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
T +M P + +++ G AK D++S G+ L F P F+ +
Sbjct: 211 RGTYEFMPP-----EFFSNESSYNG------AKVDIWSLGICLYVMFYNVVP----FSLK 255
Query: 266 ISLKN 270
ISL
Sbjct: 256 ISLVE 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFK-LQLGRAFRSFDSECEVLRNVHHRNLLK 102
LG G+FG VY+G +S N VA+K + + F E ++ +H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH------NYFLDTLERLNIMIDVWLALEYLH 156
+ ++LELM G L+++L L L+ L++ D+ +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 157 HGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
+H D+ N LL VA++ DFG+++ + M + +M
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
P + + GI ++K D +SFGVLL E F+ G P
Sbjct: 255 PEA-FME------------GIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+FG V+ + VA+K K A + F E E+L + H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYF--------------LDTLERLNIMIDVW 149
F C+ +V E M +G L +L SH L + L + V
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
+ YL + VH DL N L+ + +V ++ DFG+S+ + + TM I
Sbjct: 169 AGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+M P S + + + DV+SFGV+L E FT GK+P
Sbjct: 225 RWMPPES-ILY------------RKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-28
Identities = 35/253 (13%), Positives = 83/253 (32%), Gaps = 52/253 (20%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF-------------------KLQLGRAFRS---- 84
+LG + G + + V +L+L R ++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 85 -----FDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM----PNGSLENWLYSH--- 132
F +++++ + ++++ + + + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 133 NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192
+ L RL + + V L LHH +VH L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252
G + ++ + G+ P +L + +++ D ++ G+++ +
Sbjct: 256 DG------ARVVSSVSRGFEPP--ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 253 TGKKPTDEMFTGE 265
P T +
Sbjct: 308 CADLP----ITKD 316
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDS-----ECEVLRNVHHRNL 100
LG+G+ G V VAI++ K +G A + + E E+L+ ++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL--NIMIDVWLALEYLH-H 157
+KI + D+ +VLELM G L + + + E + LA++YLH +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 258
Query: 158 GHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
G I+H DLKP N+LL +E+ + +++DFG SK+LG+ + +T+ T Y+AP
Sbjct: 259 G-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTL-CGTPTYLAP 310
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
++L + D +S GV+L
Sbjct: 311 -----EVLVSVGTAGYNR-----AVDCWSLGVIL 334
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 40/231 (17%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLK 102
LG FG VYKG L VAIK K + G F E + + H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNIMID 147
+ + +++ +G L +L L+ + ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+ +EYL SS +VH DL N+L+ + + ++SD G+ + + + ++
Sbjct: 137 IAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I +MAP + + G S D++S+GV+L E F+ G +P
Sbjct: 193 PIRWMAPEA-IMY------------GKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLL 101
LG G+FG V + + VA+K+ K R+ SE ++L ++ HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 102 KIFSSCSNPDFKALV-LELMPNGSLENWLYSH---------------NYFLDTLERLNIM 145
+ +C+ P +V +E G+L +L S FL +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
V +E+L +S +H DL NILL E V ++ DFG+++ + D V +
Sbjct: 155 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP + +FD + + + DV+SFGVLL E F+ G P
Sbjct: 211 RLPLKWMAPET-IFD------------RVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-28
Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 45/267 (16%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKV-FKLQLGRA--FRSFDSECEVLRNVHHRNLLKI 103
LG G FG VY +A+KV FK QL +A E E+ ++ H N+L++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ + L+LE P G++ L + F + + ++ AL Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR---- 129
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAP---VSQLF 219
++H D+KP N+LL +++DFG S + + T+ Y+ P ++
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMH 184
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFT----GEISLKN 270
D K D++S GVL E GK P E + E + +
Sbjct: 185 D----------------EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 228
Query: 271 WVNESLPHALTD--VVDANLRVSMKDV 295
+V E ++ + + R +++V
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 39/216 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF--------KLQLGRAFRSFDSECEVLRNVH-HRN 99
+G G +V + + + G+ A+K+ QL + E +LR V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH- 156
++ + S + F LV +LM G L ++L E+ +IM + A+ +LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS---EKETRSIMRSLLEAVSFLHA 218
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI----GYM 212
+ IVH DLKP NILLD+NM R+SDFG S L GE + + GY+
Sbjct: 219 NN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCGTPGYL 266
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
AP +ILK + + D+++ GV+L
Sbjct: 267 AP-----EILKCS--MDETHPGYGKEVDLWACGVIL 295
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 48/239 (20%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLK 102
LG G FG V K VA+K+ K R SE VL+ V+H +++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH-----------------------NYFLDTL 139
++ +CS L++E GSL +L L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
+ ++ + ++YL + +VH DL NIL+ E ++SDFG+S+ + + +
Sbjct: 151 DLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
V ++ + +MA S LFD I + + DV+SFGVLL E T G P
Sbjct: 207 VKRSQGRIPVKWMAIES-LFD------------HIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDS-----ECEVLRNVHHRNL 100
LG+G+ G V VAIK+ K +G A + + E E+L+ ++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL--NIMIDVWLALEYLH-H 157
+KI + D+ +VLELM G L + + + E + LA++YLH +
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 133
Query: 158 GHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMA 213
G I+H DLKP N+LL +E+ + +++DFG SK+LG+ T+ T Y+A
Sbjct: 134 G-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLA 184
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
P ++L + D +S GV+L
Sbjct: 185 P-----EVLVSVGTAGYNR-----AVDCWSLGVIL 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 37/225 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIFS 105
LG GSFG V G A+KV +++ S E ++L+ + H N++K++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL--NIMIDVWLALEYLHHGHSSAP 163
+ + LV E+ G L + + S F E I+ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIRQVLSGITYMH----KNK 146
Query: 164 IVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
IVH DLKP N+LL ++ R+ DFG+S + + T Y+AP +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAP-----E 198
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+L G KCDV+S GV+L +G P F G
Sbjct: 199 VLH---------GTYDEKCDVWSTGVILYILLSGCPP----FNGA 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 42/212 (19%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF--KLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG GSFG V K A+KV + + E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSAP 163
+ +V EL G L + + F E I+ V+ + Y+H H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYMHKHN----- 141
Query: 164 IVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATI----GYMAPVS 216
IVH DLKP NILL +++ ++ DFG+S M Y+AP
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTAYYIAP-- 192
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
++L+ + KCDV+S GV+L
Sbjct: 193 ---EVLRGTYDE---------KCDVWSAGVIL 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 25/244 (10%), Positives = 54/244 (22%), Gaps = 55/244 (22%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
L G +V+ + + A+KVF + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 105 SSC----------------------SNPDFKA----LVLELM-----PNGSLENWLYSHN 133
D+ L++ S +++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 134 YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193
L + + L +VH P N+ + + + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253
G + + Y L A F + + G+ + +
Sbjct: 245 GT-----RGPASSVPVTYAPRE-----FLNASTATFT------HALNAWQLGLSIYRVWC 288
Query: 254 GKKP 257
P
Sbjct: 289 LFLP 292
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 54/234 (23%), Positives = 102/234 (43%), Gaps = 43/234 (18%)
Query: 50 LGTGSFGIVYKGILSDGNN--------VAIKVFK-LQLGRAFRSFDSECEVLRNV-HHRN 99
LG G+FG V + VA+K+ K + SE E+++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNI 144
++ + +C+ +++E G+L +L + + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
+ +EYL +S +H DL N+L+ EN V +++DFG+++ + + + T
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP + LFD + + + DV+SFGVL+ E FT G P
Sbjct: 219 GRLPVKWMAPEA-LFD------------RVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG+G++G V AIK+ + + E VL+ + H N++K++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLHHGHSSAPI 164
+ LV+E G L + + F E I+ V + YLH I
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAAVIIKQVLSGVTYLH----KHNI 157
Query: 165 VHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
VH DLKP N+LL +++ + ++ DFG+S + + + + + T Y+AP ++
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---LGTAYYIAP-----EV 209
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
L+ KCDV+S GV+L G P F G+
Sbjct: 210 LR---------KKYDEKCDVWSIGVILFILLAGYPP----FGGQ 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 41 TEGFNE----CNLLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQL-GRAFRSFDSECEVLR 93
+ F++ LG G+F +V + + + G A K+ +L R F+ + E + R
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLA 151
+ H N++++ S F LV +L+ G L + + ++ E + + + +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILES 117
Query: 152 LEYLH-HGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+ Y H +G IVH +LKP N+LL + +++DFG++ + D E A
Sbjct: 118 IAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFA 168
Query: 208 -TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
T GY++P ++LK + D+++ GV+L
Sbjct: 169 GTPGYLSP-----EVLKKD--PYSKP------VDIWACGVIL 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 51/242 (21%), Positives = 86/242 (35%), Gaps = 37/242 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSS 106
+L G F VY+ + G A+K R+ E ++ + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 107 CS-------NPDFKALVLELMPNGSLENWL--YSHNYFLDTLERLNIMIDVWLALEYLHH 157
S + L+L + G L +L L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA---------- 207
PI+H DLK N+LL ++ DFG + + D A
Sbjct: 155 --QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267
T Y P ++ D+ S I K D+++ G +L + P F
Sbjct: 213 TPMYRTP--EIIDLY--------SNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAK 258
Query: 268 LK 269
L+
Sbjct: 259 LR 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 61/267 (22%), Positives = 102/267 (38%), Gaps = 47/267 (17%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKV-FKLQLGRA--FRSFDSECEVLRNVHHRNLLKIF 104
LG G FG VY + +A+KV FK QL + E E+ ++ H N+L+++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ + L+LE P G L L H F + M ++ AL Y H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERK----V 135
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM--TMATIGYMAP---VSQLF 219
+H D+KP N+L+ +++DFG S +TM T+ Y+ P +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLD---YLPPEMIEGKTH 189
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF----TGEISLKN 270
D K D++ GVL E G P E ++
Sbjct: 190 D----------------EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233
Query: 271 WVNESLPHALTD--VVDANLRVSMKDV 295
++++ ++ R+ +K V
Sbjct: 234 FLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 48/239 (20%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFK-LQLGRAFRSFDSECEVLRNVHHRNLLK 102
+G G+FG V++ VA+K+ K F E ++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSH-----------------------NYFLDTL 139
+ C+ L+ E M G L +L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
E+L I V + YL S VH DL N L+ ENMV +++DFG+S+ + +
Sbjct: 175 EQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
I +M P S +F + + DV+++GV+L E F+ G +P
Sbjct: 231 KADGNDAIPIRWMPPES-IFY------------NRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 43/234 (18%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLL 101
LG G+FG V + VA+K+ K + SE +VL + +H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSH-----------------NYFLDTLERLNI 144
+ +C+ ++ E G L N+L LD + L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
V + +L +S +H DL NILL + ++ DFG+++ + + + V +
Sbjct: 151 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP S +F+ + + + DV+S+G+ L E F+ G P
Sbjct: 207 ARLPVKWMAPES-IFN------------CVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 52/232 (22%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 48 NLLGTGSFGIVYKGILSDGNN------VAIKVFKLQ-LGRAFRSFDSECEVLRNV-HHRN 99
LG G+FG V + VA+K+ K + SE +++ ++ H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-------------NYFLDTLERLNIMI 146
++ + +C++ ++ E G L N+L N T + L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
V + +L +S +H D+ N+LL VA++ DFG+++ + + + + +
Sbjct: 172 QVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP S +FD + + + DV+S+G+LL E F+ G P
Sbjct: 228 LPVKWMAPES-IFD------------CVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG GSFG V K A+KV K + + E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLHHGHSSAPI 164
+ +V EL G L + + F E I+ V+ + Y+H I
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYMH----KHNI 142
Query: 165 VHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
VH DLKP NILL +++ ++ DFG+S + + T Y+AP ++
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAP-----EV 194
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
L+ G KCDV+S GV+L +G P F G+
Sbjct: 195 LR---------GTYDEKCDVWSAGVILYILLSGTPP----FYGK 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 50 LGTGSFGIVYKGILSDGNN--------VAIKVFK-LQLGRAFRSFDSECEVLRNV-HHRN 99
LG G FG V + VA+K+ K + SE E+++ + H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNI 144
++ + +C+ +++E G+L +L + + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
+ +EYL +S +H DL N+L+ EN V +++DFG+++ + + + T
Sbjct: 209 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP + LFD + + + DV+SFGVL+ E FT G P
Sbjct: 265 GRLPVKWMAPEA-LFD------------RVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 43/234 (18%)
Query: 50 LGTGSFGIVYKGILSDGNN--------VAIKVFK-LQLGRAFRSFDSECEVLRNV-HHRN 99
LG G+FG V + VA+K+ K + SE E+++ + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH---------------NYFLDTLERLNI 144
++ + +C+ +++E G+L +L + L + + ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
V +EYL +S +H DL N+L+ E+ V +++DFG+++ + + T
Sbjct: 197 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP + LFD I + + DV+SFGVLL E FT G P
Sbjct: 253 GRLPVKWMAPEA-LFD------------RIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 53/226 (23%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 37 IQRATEGFNE----CNLLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQL-GRAFRSFDSEC 89
+ A+ F++ LG G+F +V + + + G A K+ +L R F+ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 90 EVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMID 147
+ R + H N++++ S F LV +L+ G L + + ++ E + +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQ 136
Query: 148 VWLALEYLH-HGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQT 203
+ ++ Y H +G IVH +LKP N+LL + +++DFG++ + D E
Sbjct: 137 ILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AW 187
Query: 204 MTMA-TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
A T GY++P ++LK + D+++ GV+L
Sbjct: 188 HGFAGTPGYLSP-----EVLKKD--PYSKP------VDIWACGVIL 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDS------------ECEVLR 93
LG+G++G V + + AIKV K Q + S D+ E +L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLA 151
++ H N++K+F + + LV E G L + + + F E NIM +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF---DECDAANIMKQILSG 158
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YLH IVH D+KP NILL + + ++ DFG+S + + T
Sbjct: 159 ICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGT 211
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
Y+AP ++LK + KCDV+S GV++ G P F G+
Sbjct: 212 AYYIAP-----EVLK---------KKYNEKCDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 28 TWRRTSYLDIQRATEGFNE----CNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAF 82
W++ ++ + LG+G+FG+V++ + + G K
Sbjct: 33 IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92
Query: 83 RSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL 142
+ +E ++ +HH L+ + + + L+LE + G L + + + +Y + E +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 143 NIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILL--DENMVARVSDFGISKLLGDGEDS 199
N M L+++H H IVH D+KP NI+ + ++ DFG++ L E
Sbjct: 153 NYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+T AT + AP +I+ + + D+++ GVL
Sbjct: 206 -IVKVTTATAEFAAP-----EIVDREP--------VGFYTDMWAIGVLG 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-26
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSS 106
+LG G+ V I L A+K+ + Q G E E+L HRN+L++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSAP 163
D LV E M GS+ + ++ +F E ++ DV AL++LH G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFN---ELEASVVVQDVASALDFLHNKG----- 131
Query: 164 IVHCDLKPSNILL---DENMVARVSDFGISKLLGDGED-SVTQTMTMATI----GYMAPV 215
I H DLKP NIL ++ ++ DF + + D S T + T YMAP
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP- 190
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
++++ + + +CD++S GV+L
Sbjct: 191 ----EVVEAFSEEASIYD---KRCDLWSLGVIL 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 53/264 (20%), Positives = 99/264 (37%), Gaps = 39/264 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G F ++ A K+ L E + R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ DF +VLEL SL + R + + L +YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 162
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM--TMATIGYMAPVSQLFDIL 222
+H DLK N+ L+E++ ++ DFG++ + + + + + T Y+AP ++L
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAP-----EVL 213
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFT----GEISLKNWVN 273
K S + DV+S G ++ GK P E + E S+ +N
Sbjct: 214 SKKGH--------SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 265
Query: 274 ESLPHALTD--VVDANLRVSMKDV 295
+ D R ++ ++
Sbjct: 266 PVAASLIQKMLQTDPTARPTINEL 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 49/247 (19%), Positives = 96/247 (38%), Gaps = 31/247 (12%)
Query: 11 RKRSAKIIAPIDLLPVATWRRTSYLDIQRATEGFNE----CNLLGTGSFGIVYKGI-LSD 65
+ + + D W++ ++ + + LGTG+FG+V++ +
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 66 GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL 125
GNN A K + E + + + H L+ + + + + ++ E M G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILL---DENMV 181
+ + + E + M V L ++H + VH DLKP NI+ N +
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNEL 296
Query: 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDV 241
++ DFG++ L + +T T + AP ++ + K + D+
Sbjct: 297 -KLIDFGLTAHLDPKQSV---KVTTGTAEFAAP-----EVAEGKP--------VGYYTDM 339
Query: 242 YSFGVLL 248
+S GVL
Sbjct: 340 WSVGVLS 346
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 38/264 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LLG GSF VY+ + G VAIK+ + + +E ++ + H ++L+++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ + ++ LVLE+ NG + +L + E + M + + YLH I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG----I 133
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM--TMATIGYMAPVSQLFDIL 222
+H DL SN+LL NM +++DFG++ L T+ T Y++P +I
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPN---YISP-----EIA 184
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFT----GEISLKNWVN 273
+ DV+S G + G+ P + + ++++
Sbjct: 185 TRSAH--------GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236
Query: 274 ESLPHALTD--VVDANLRVSMKDV 295
+ + R+S+ V
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSV 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 36/239 (15%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNV 95
R T F+E +G+G FG V+K + DG AIK K L ++ E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 96 -HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTL---ERLNIMIDVWLA 151
H ++++ FS+ + D + E GSL + + + + E ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL----------LGDGEDSVT 201
L Y+H +VH D+KPSNI + + + + +GD
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 202 QTMTMATIG---YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ G ++A ++L+ K D+++ + ++ +
Sbjct: 184 ISSPQVEEGDSRFLAN-----EVLQENYTH-------LPKADIFALALTVVCAAGAEPL 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 40/210 (19%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
+G GS+G V + A K F E E+++++ H N+++++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSAPIV 165
+ LV+EL G L + F E IM DV A+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVF---RESDAARIMKDVLSAVAYCHKLN-----VA 128
Query: 166 HCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATI----GYMAPVSQL 218
H DLKP N L + ++ DFG++ G+ M T Y++P
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYYVSP---- 177
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+L+ +CD +S GV++
Sbjct: 178 -QVLEGLYGP---------ECDEWSAGVMM 197
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 48/239 (20%)
Query: 50 LGTGSFGIVYKGILSDGNN------VAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLL 101
LG+G+FG V + VA+K+ K + + SE +++ + H N++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSH----------------------NYFLDTL 139
+ +C+ L+ E G L N+L S L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
+ L V +E+L VH DL N+L+ V ++ DFG+++ + +
Sbjct: 173 DLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
V + + +MAP S LF+ GI + K DV+S+G+LL E F+ G P
Sbjct: 229 VVRGNARLPVKWMAPES-LFE------------GIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 53/264 (20%), Positives = 99/264 (37%), Gaps = 39/264 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG G F ++ A K+ L E + R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ DF +VLEL SL + R + + L +YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 136
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM--TMATIGYMAPVSQLFDIL 222
+H DLK N+ L+E++ ++ DFG++ + + + + + T Y+AP ++L
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAP-----EVL 187
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFT----GEISLKNWVN 273
K S + DV+S G ++ GK P E + E S+ +N
Sbjct: 188 SKKGH--------SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 239
Query: 274 ESLPHALTD--VVDANLRVSMKDV 295
+ D R ++ ++
Sbjct: 240 PVAASLIQKMLQTDPTARPTINEL 263
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 58/249 (23%), Positives = 93/249 (37%), Gaps = 66/249 (26%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFD-----SECEVLRNVHHRNLLKI 103
+G GS+G+V I AIK+ R D +E +++ +HH N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL--------------------- 142
+ + + LV+EL G L + L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 143 ------------------NIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILL--DENMV 181
NIM ++ AL YLH G I H D+KP N L +++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208
Query: 182 ARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAPVSQLFDILKPKNAKFGSEGIISAKC 239
++ DFG+SK + MT T ++AP ++L N +G + C
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP-----EVLNTTNESYGPK------C 257
Query: 240 DVYSFGVLL 248
D +S GVLL
Sbjct: 258 DAWSAGVLL 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLK 102
++ +LG G FG V+K + G +A K+ K + + +E V+ + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSS 161
++ + + + LV+E + G L + + +Y L L+ + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--- 207
Query: 162 APIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
I+H DLKP NIL D + ++ DFG+++ E + T ++AP
Sbjct: 208 --ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPRE---KLKVNFGTPEFLAP---- 257
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+++ +S D++S GV+
Sbjct: 258 -EVVNYDF--------VSFPTDMWSVGVIA 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 43/214 (20%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG+G+FG V+ S G IK K + ++E EVL+++ H N++KIF
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 108 SNPDFKALVLELMPNGSL-----ENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGH 159
+ +V+E G L E +M + AL Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144
Query: 160 SSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAP 214
+VH DLKP NIL + ++ DFG+++L + T A T YMAP
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTALYMAP 195
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
++ K ++ KCD++S GV++
Sbjct: 196 -----EVFK---------RDVTFKCDIWSAGVVM 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 36/208 (17%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVL-RNVHHRNLLKIFSSC 107
+G GS+ + + I + A+K+ E E+L R H N++ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSAPI 164
+ + +V ELM G L + + +F ER ++ + +EYLH G +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFS---EREASAVLFTITKTVEYLHAQG-----V 137
Query: 165 VHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
VH DLKPSNIL R+ DFG +K L E+ + T T ++AP +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP-CYTANFVAP-----E 190
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+L+ + + + CD++S GVLL
Sbjct: 191 VLERQ--GYDAA------CDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G+ IVY+ A+KV K + + +E VL + H N++K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSAPI 164
P +LVLEL+ G L + + Y+ ER + + + A+ YLH +G I
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYY---SERDAADAVKQILEAVAYLHENG-----I 169
Query: 165 VHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLFD 220
VH DLKP N+L + +++DFG+SK++ T+ T GY AP +
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAP-----E 220
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLL 248
IL+ +G E D++S G++
Sbjct: 221 ILRGCA--YGPE------VDMWSVGIIT 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 47/211 (22%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 47 CNLLGTGSFGIVYKGI-LSDGNNVAIKVF--KLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LG G+F +V + + + G A + K R + + E + R + H N++++
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHS 160
S S L+ +L+ G L + + Y+ E + + + A+ + H G
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYY---SEADASHCIQQILEAVLHCHQMG-- 130
Query: 161 SAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
+VH +LKP N+LL + +++DFG++ + +GE T GY++P
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGF-AGTPGYLSP--- 182
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
++L+ +G D+++ GV+L
Sbjct: 183 --EVLRKD--PYGKP------VDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 36/212 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFD-----SECEVLRNVHHRNLLK 102
LG+G F IV K S G A K K Q + R E +LR V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLHHGHS 160
+ N L+LEL+ G L ++L E + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLHTKK- 135
Query: 161 SAPIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
I H DLKP NI+L ++ DFG++ + DG T ++AP
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAP-- 187
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+I+ + + + D++S GV+
Sbjct: 188 ---EIVNYEP--------LGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 36/212 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFD-----SECEVLRNVHHRNLLK 102
LG+G F IV K S G A K K Q + R E +LR V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLHHGHS 160
+ N L+LEL+ G L ++L E + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLHTKK- 135
Query: 161 SAPIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
I H DLKP NI+L ++ DFG++ + DG T ++AP
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAP-- 187
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+I+ + + + D++S GV+
Sbjct: 188 ---EIVNYEP--------LGLEADMWSIGVIT 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA-FRSFDSECEV-LRNVHHRNLLKIFSS 106
+G G++G V K + G +A+K + + + + +V +R+ +++ + +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLN------IMIDVWLALEYLHHGHS 160
+ +ELM + S + + + + + I + AL +L
Sbjct: 90 LFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
I+H D+KPSNILLD + ++ DFGIS L DS+ +T YMAP +
Sbjct: 147 ---IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAP-----E 195
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ P ++ G + DV+S G+ L E TG+ P
Sbjct: 196 RIDPSASRQG----YDVRSDVWSLGITLYELATGRFP 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 23/267 (8%)
Query: 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSF-DSECEVLRNVHHRN 99
+ F + + LG G+ G+V+K G +A K+ L++ A R+ E +VL +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ + + + ++ +E M GSL+ + + + I V L YL H
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I+H D+KPSNIL++ ++ DFG+S L DS+ + T YM+P
Sbjct: 152 K---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMSP----- 199
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHA 279
+ L+ + S + D++S G+ L+E G+ P E+ L A
Sbjct: 200 ERLQGTH--------YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 280 LTDVVDANLRVSMKDVAAKLKKIRVKF 306
T + + F
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIF 278
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-24
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 38/213 (17%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFD-----SECEVLRNVHHRNLLK 102
LG+G F IV K G A K K +L + R E +LR + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGH 159
+ N L+LEL+ G L ++L E + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDEATQFLKQILDGVHYLHSKR- 128
Query: 160 SSAPIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV 215
I H DLKP NI+L N ++ DFGI+ + G + + T ++AP
Sbjct: 129 ----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNI-FGTPEFVAP- 180
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+I+ + + + D++S GV+
Sbjct: 181 ----EIVNYEP--------LGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 26/203 (12%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108
LG G FGIV++ + S K K++ G E +L HRN+L + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH-HGHSSAPIVHC 167
+ + ++ E + + + + + L+ E ++ + V AL++LH H I H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN-----IGHF 126
Query: 168 DLKPSNILL--DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
D++P NI+ + ++ +FG ++ L G+ + Y AP ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAP-----EVHQHD 178
Query: 226 NAKFGSEGIISAKCDVYSFGVLL 248
+S D++S G L+
Sbjct: 179 V--------VSTATDMWSLGTLV 193
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 51/250 (20%), Positives = 94/250 (37%), Gaps = 55/250 (22%)
Query: 25 PVATWRRTSYLDIQRATEGFNE----CNLLGTGSFGIVYKGI-LSDGNNVAIKV-----F 74
P + LD+ F + C ++G G F +V + I G A+K+ F
Sbjct: 3 PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKF 62
Query: 75 KLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSL--------- 125
G + E + + H +++++ + S+ +V E M L
Sbjct: 63 TSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122
Query: 126 ENWLYSHNYFLDTLERL--NIMIDVWLALEYLH-HGHSSAPIVHCDLKPSNILL---DEN 179
++YS E + + M + AL Y H + I+H D+KP +LL + +
Sbjct: 123 AGFVYS--------EAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENS 169
Query: 180 MVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLFDILKPKNAKFGSEGIISAK 238
++ FG++ LG+ T +MAP +++K +
Sbjct: 170 APVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAP-----EVVKRE--------PYGKP 213
Query: 239 CDVYSFGVLL 248
DV+ GV+L
Sbjct: 214 VDVWGCGVIL 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-24
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
E + LG G+FG VYK G A KV + + + E E+L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++K+ + + +++E P G+++ + + L + + + AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVS 216
I+H DLK N+L+ R++DFG+S ++ + + IG +MAP
Sbjct: 138 ----IIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAP-- 186
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261
++ K+ + K D++S G+ L+E + P E+
Sbjct: 187 EVVMCETMKDTPYDY------KADIWSLGITLIEMAQIEPPHHEL 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 40/210 (19%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKV-FKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSS 106
LG GSF I K + A+K+ K + E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK----EITALKLCEGHPNIVKLHEV 74
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSAP 163
+ LV+EL+ G L + +F E IM + A+ ++H G
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFS---ETEASYIMRKLVSAVSHMHDVG----- 126
Query: 164 IVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA--TIGYMAPVSQL 218
+VH DLKP N+L ++N+ ++ DFG ++L Q + T+ Y AP
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----NQPLKTPCFTLHYAAP---- 178
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
++L + CD++S GV+L
Sbjct: 179 -ELLNQN--GYDES------CDLWSLGVIL 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 38/213 (17%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFD-----SECEVLRNVHHRNLLK 102
LG+G F +V K S G A K K + + R E +L+ + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGH 159
+ N L+LEL+ G L ++L E + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLHSLQ- 134
Query: 160 SSAPIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV 215
I H DLKP NI+L ++ DFG++ + G T ++AP
Sbjct: 135 ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAP- 186
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+I+ + + + D++S GV+
Sbjct: 187 ----EIVNYEP--------LGLEADMWSIGVIT 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 56/245 (22%), Positives = 96/245 (39%), Gaps = 33/245 (13%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFD---SECEVLRNVHHRN 99
F +LG GSF V + AIK+ + + E +V+ + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+K++ + + + L NG L ++ F +T R ++ ALEYLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG 150
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQL 218
I+H DLKP NILL+E+M +++DFG +K+L + T Y++P
Sbjct: 151 ----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSP---- 201
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF----TGEISLK 269
++L K+A D+++ G ++ + G P +F E
Sbjct: 202 -ELLTEKSA--------CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP 252
Query: 270 NWVNE 274
Sbjct: 253 EKFFP 257
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-23
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA-FRSFDSECEVL-RNVHHRNLLKIFSS 106
+G+G+ G V+K G+ +A+K + + + + +V+ ++ +++ F +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ +ELM E + + + + AL YL H ++H
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIH 148
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKN 226
D+KPSNILLDE ++ DFGIS L D + + YMAP + D P
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAP--ERIDPPDPTK 203
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + DV+S G+ L+E TG+ P
Sbjct: 204 PDY------DIRADVWSLGISLVELATGQFP 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-23
Identities = 41/218 (18%), Positives = 78/218 (35%), Gaps = 28/218 (12%)
Query: 51 GTGSFGIVYKGI-LSDGNNVAIKVFKL--QLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
G V G V ++ L E V + +H N++ ++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI---DVWLALEYLHHGHSSAPI 164
+ +V M GS ++ + +F+D + L I V AL+Y+HH
Sbjct: 96 IADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHHMG----Y 149
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGED--SVTQTMTMATIG---YMAPVSQLF 219
VH +K S+IL+ + +S + + V ++ +++P
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP----- 204
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L+ + + K D+YS G+ E G P
Sbjct: 205 EVLQQNLQGYDA------KSDIYSVGITACELANGHVP 236
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFR-SFDSECEVLRNV-HHRNLLKIFS 105
LG G F +V + I S G A K K + G+ R E VL ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLER--LNIMIDVWLALEYLH-HGHSSA 162
N L+LE G + + + + E + ++ + + YLH +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVS-ENDVIRLIKQILEGVYYLHQNN---- 151
Query: 163 PIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
IVH DLKP NILL ++ DFG+S+ +G + + M T Y+AP
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI-MGTPEYLAP----- 202
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLL 248
+IL I+ D+++ G++
Sbjct: 203 EILNYDP--------ITTATDMWNIGIIA 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA-FRSFDSECEV-LRNVHHRNLLKIFSS 106
LG G++G+V K + G +A+K + + + + ++ +R V + + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLN------IMIDVWLALEYLHHGHS 160
+ +ELM + SL+ + +D + + I + + ALE+LH S
Sbjct: 75 LFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
++H D+KPSN+L++ ++ DFGIS L D V + + YMAP +
Sbjct: 131 ---VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAP-----E 179
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ P+ + G S K D++S G+ ++E + P
Sbjct: 180 RINPELNQKGY----SVKSDIWSLGITMIELAILRFP 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 49/223 (21%), Positives = 98/223 (43%), Gaps = 32/223 (14%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
+ +G GS GIV G VA+K+ L+ + +E ++R+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+++++ S + +++E + G+L + + S L+ + + V AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVR-LNEEQIATVCEAVLQALAYLHAQG 161
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAP-- 214
++H D+K +ILL + ++SDFG + V + ++ +G +MAP
Sbjct: 162 ----VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAPEV 212
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+S+ + D++S G++++E G+ P
Sbjct: 213 ISR-----SLYA----------TEVDIWSLGIMVIEMVDGEPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
+ + +G G+ G VY + ++ G VAI+ LQ +E V+R + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ S D +V+E + GSL + + +D + + + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAP--VS 216
++H D+K NILL + +++DFG + ++ TM T +MAP V+
Sbjct: 137 ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ K K D++S G++ +E G+ P
Sbjct: 190 R-----KAYG----------PKVDIWSLGIMAIEMIEGEPP 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 61/267 (22%), Positives = 103/267 (38%), Gaps = 43/267 (16%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFK------------LQLGRAFRSFDSECEVLRNVH 96
LG+G+FG V+ + V +K K +LG+ E +L V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGS-LENWLYSHNYFLDTLERLNIMIDVWLALEYL 155
H N++K+ N F LV+E +G L ++ H LD I + A+ YL
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYL 146
Query: 156 HHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV 215
I+H D+K NI++ E+ ++ DFG + L G+ T TI Y AP
Sbjct: 147 RLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAP- 198
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---TDEMFTGEISLKNWV 272
++L G + +++S GV L + P +E I V
Sbjct: 199 ----EVLMGN----PYRG---PELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 273 NESLPHALTD--VVDANLRVSMKDVAA 297
++ L ++ R +++ +
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK---LQLGRAFRSFDSECEVLRNVH--- 96
F+ ++G G FG VY +D + A+K +++ + +E +L V
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
++ + + PD + +L+LM G L L H F + R ++ L LE++H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH 309
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPV 215
+ +V+ DLKP+NILLDE+ R+SD G++ + T GYMAP
Sbjct: 310 ----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP- 359
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP--------TDEMF 262
++L+ K + S D +S G +L + G P E+
Sbjct: 360 ----EVLQ-KGVAYDSS------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 35/230 (15%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSEC-----EVLRNVHH 97
F + +LG G FG V + + A K L+ R + ++L V+
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALEYLH 156
R ++ + + D LVL LM G L+ +Y R ++ LE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPV 215
IV+ DLKP NILLD++ R+SD G++ + +G+ T+GYMAP
Sbjct: 304 ----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP- 354
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+++ KN ++ D ++ G LL E G+ P F
Sbjct: 355 ----EVV--KNERYTFS------PDWWALGCLLYEMIAGQSP----FQQR 388
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-21
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 60/222 (27%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEV---LRNVHHRNLLKIF 104
+LG G G V + G A+K+ S + EV + +++ I
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 105 SSCSNPDFKA----LVLELMPNGSL-------ENWLYSHNYFLDTLER--LNIMIDVWLA 151
N +++E M G L + ++ ER IM D+ A
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT--------EREAAEIMRDIGTA 140
Query: 152 LEYLH-HGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMA 207
+++LH H I H D+KP N+L +++ V +++DFG +K T
Sbjct: 141 IQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPC 190
Query: 208 -TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
T Y+AP ++L P+ CD++S GV++
Sbjct: 191 YTPYYVAP-----EVLGPEK--------YDKSCDMWSLGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 60/264 (22%), Positives = 110/264 (41%), Gaps = 42/264 (15%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVF------KLQLGRAFRSFDSECEVLRNVHHRNLLK 102
+G G+F V + G VAIK+ L + FR E +++ ++H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+F L++E G + ++L +H + E + + A++Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
IVH DLK N+LLD +M +++DFG S G Y AP ++
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAP-----ELF 185
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE---------MFTGEISLKNWVN 273
+ K +G + DV+S GV+L +G P D + G+ + +++
Sbjct: 186 QGK----KYDG---PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238
Query: 274 ESLPHALTD--VVDANLRVSMKDV 295
+ L V++ R +++ +
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQI 262
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-21
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDS---ECEVLRNVH 96
+ F++ +G GSFG VY + + VAIK ++ + E L+ +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
H N ++ LV+E GS + L H L +E + L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMA 213
S ++H D+K NILL E + ++ DFG + ++ + +G +MA
Sbjct: 172 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSF--VGTPYWMA 218
Query: 214 P-VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
P V IL ++ K DV+S G+ +E K P
Sbjct: 219 PEV-----ILAMDEGQYDG------KVDVWSLGITCIELAERKPP 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQL---GRAFRSFDSECEVLRNVHHRN 99
F +G GSFG V +D + A+K Q R+ E ++++ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
L+ ++ S + + +V++L+ G L L + +F + +L I ++ +AL+YL +
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR 135
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQL 218
I+H D+KP NILLDE+ ++DF I+ +L TQ TMA T YMAP
Sbjct: 136 ----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAP---- 183
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++ + S + D +S GV E G++P
Sbjct: 184 -EMFSSRKGAGYSFAV-----DWWSLGVTAYELLRGRRP 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-21
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
E F+ LG GS+G VYK I G VAIK ++ + E +++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++K + S +V+E GS+ + + N L E I+ LEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAP-V 215
+H D+K NILL+ A+++DFG++ L D++ + T+ IG +MAP V
Sbjct: 146 ----KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEV 196
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
Q E + D++S G+ +E GK P
Sbjct: 197 IQ--------------EIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNVHHR 98
F ++G G+FG V L + + V A+K+ L+ F E +VL N +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSK 134
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHH 157
+ + + + + LV++ G L L + + + R + ++ +A++ +H
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH- 192
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
VH D+KP NIL+D N R++DFG L + + + T Y++P
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISP--- 245
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+IL+ G G +CD +S GV + E G+ P E +
Sbjct: 246 --EILQAMEGGKGRYG---PECDWWSLGVCMYEMLYGETPFYAESLVETY 290
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH 97
++ + C ++G GSFG+V++ L + + VAIK R E +++R V H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 98 RNLLK----IFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNI---MIDV 148
N++ +S+ D LVLE +P ++ + T+ L I M +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLGDGEDSVTQTMTMA 207
+L Y+H S I H D+KP N+LLD V ++ DFG +K+L GE +V+ +
Sbjct: 151 LRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY---IC 203
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ Y AP +++ FG+ + D++S G ++ E G+
Sbjct: 204 SRYYRAP-----ELI------FGATN-YTTNIDIWSTGCVMAELMQGQ 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 59/224 (26%), Positives = 89/224 (39%), Gaps = 40/224 (17%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIK--VFKLQLGRAFRSFDS---------ECEVLRNVHHR 98
+ +GS+G V G+ S+G VAIK + GR E +L + HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 99 N---LLKIFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
N L IF P LV ELM L ++ + M + L L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGY 211
LH A +VH DL P NILL +N + DF +++ ED+ T + Y
Sbjct: 149 VLH----EAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVTHRWY 199
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
AP +++ K ++ + D++S G ++ E F K
Sbjct: 200 RAP-----ELV--MQFKGFTKLV-----DMWSAGCVMAEMFNRK 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGILSD-GNNVAIK-VFKLQLGRAFRSFDSECEVLRNV 95
++ + F + G G+FG V G G +VAIK V R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 96 HHRN---LLKIFSSCSNPDFK----ALVLELMPNGSLENWLYSHNYFLDTLERLNI---M 145
HH N L F + D + +V+E +P+ +L ++ + I +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTM 204
+ ++ LH S + H D+KP N+L++ + ++ DFG +K L E +V
Sbjct: 136 FQLIRSIGCLHL--PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--- 190
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ + Y AP +++ FG++ + D++S G + E G+
Sbjct: 191 YICSRYYRAP-----ELI------FGNQH-YTTAVDIWSVGCIFAEMMLGE 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 30/221 (13%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLKIFSSC 107
+G+G+ +V VAIK L+ + E + + HH N++ ++S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 108 SNPDFKALVLELMPNGSLENWL-YSHNYFLDTLERLN------IMIDVWLALEYLHHGHS 160
D LV++L+ GS+ + + + L+ I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAP-VS 216
+H D+K NILL E+ +++DFG+S L G D + +G +MAP V
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV- 197
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + + F K D++SFG+ +E TG P
Sbjct: 198 ----MEQVRGYDF--------KADIWSFGITAIELATGAAP 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNVHHR 98
+ ++G G+FG V V A+K+ ++ + F E +++ +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSP 129
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
++++F + + + +V+E MP G L N + +++ + R +V LAL+ +H
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA-EVVLALDAIH-- 185
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
S +H D+KP N+LLD++ +++DFG + T T Y++P
Sbjct: 186 --SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP---- 238
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
++LK + G +G +CD +S GV L E G P +
Sbjct: 239 -EVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 42/191 (21%), Positives = 71/191 (37%), Gaps = 31/191 (16%)
Query: 85 FDSECEVLRNVHHRNLLKIFSSCSNPDFKAL--VLELMPNGSLENWLYSHNY--FLDTLE 140
++ R + + L ++L +L++W+ +
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 141 RLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200
L+I I + A+E+LH S ++H DLKPSNI + V +V DFG+ + E+
Sbjct: 166 CLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 201 TQTMTMA----------TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250
T M T YM+P + + N S K D++S G++L E
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSP-----EQIHGNN--------YSHKVDIFSLGLILFE 268
Query: 251 TFTGKKPTDEM 261
E
Sbjct: 269 LLYSFSTQMER 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 2/76 (2%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFRSFDSECEVLRNVH 96
R F +G G FG+V++ D N AIK +L A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 97 HRNLLKIFSSCSNPDF 112
H +++ F++
Sbjct: 63 HPGIVRYFNAWLETPP 78
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 60/276 (21%), Positives = 102/276 (36%), Gaps = 55/276 (19%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFK----LQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LLG GS+G V + + A+K+ K ++ + E ++LR + H+N++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 104 FS--SCSNPDFKALVLELMPNGSLENWLY----------SHNYFLDTLERLNIMIDVWLA 151
+V+E G E +H YF +ID
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ-------LID---G 121
Query: 152 LEYLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
LEYLH G IVH D+KP N+LL ++S G+++ L T + +
Sbjct: 122 LEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE---------M 261
+ P +I G + K D++S GV L TG P + +
Sbjct: 177 FQPP-----EIAN------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
Query: 262 FTGEISLKNWVNESLPHALTD--VVDANLRVSMKDV 295
G ++ L L + R S++ +
Sbjct: 226 GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFRSFDSECEVLRNVHHR 98
E F + +G GSFG V+KGI VAIK+ L + E VL
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
+ K + S +++E + GS + L LD + I+ ++ L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 138
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAP- 214
+H D+K +N+LL E+ +++DFG++ L D+ + T +G +MAP
Sbjct: 139 K----KIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAPE 189
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
V + + +K D++S G+ +E G+ P
Sbjct: 190 VIK--------------QSAYDSKADIWSLGITAIELARGEPP 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 46/224 (20%), Positives = 83/224 (37%), Gaps = 65/224 (29%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEV---LRNVHHRNLLKIF- 104
LG G G V + A+K+ + + EV R ++++I
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 105 ---SSCSNPDFKALVLELMPNGSL-------ENWLYSHNYFLDTLER--LNIMIDVWLAL 152
+ + +V+E + G L + ++ ER IM + A+
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--------EREASEIMKSIGEAI 174
Query: 153 EYLH-HGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+YLH I H D+KP N+L N + +++DFG +K ++ T
Sbjct: 175 QYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTT 222
Query: 209 I----GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248
Y+AP ++L P+ CD++S GV++
Sbjct: 223 PCYTPYYVAP-----EVLGPEK--------YDKSCDMWSLGVIM 253
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-20
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 39/237 (16%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG G++G V + VA+K+ + + E + + ++H N++K +
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 107 CSNPDFKALVLELMPNGSLENWLYSH---------NYFLDTLERLNIMIDVWLALEYLH- 156
+ + L LE G L + + +F ++ + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-------LMA---GVVYLHG 123
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
G I H D+KP N+LLDE ++SDFG++ + T+ Y+AP
Sbjct: 124 IG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP-- 176
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN 273
++LK + DV+S G++L G+ P D+ +W
Sbjct: 177 ---ELLKRR----EFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-20
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 24/230 (10%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNVHHR 98
F ++G G+F V + V A+K+ L+ G F E +VL N R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV-SCFREERDVLVNGDRR 121
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALEYLHH 157
+ ++ + + ++ LV+E G L L + E + ++ +A++ +H
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVH- 179
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
VH D+KP NILLD R++DFG L + + T Y++P
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-VGTPDYLSP--- 232
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+IL+ G G +CD ++ GV E F G+ P T E +
Sbjct: 233 --EILQAVGGGPG-TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-20
Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 47/268 (17%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQ----LGRAFRSFDSECEVLRNVHHRNL 100
LG G+FG V G G+ VA+K+ K++ +G+ R E + L+ H ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+K++ S P +V+E + G L +++ H ++ +E + + A++Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
+VH DLKP N+LLD +M A+++DFG+S ++ DGE T + + Y AP +
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAP-----E 180
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE---------MFTGEISLKNW 271
++ + G + D++S GV+L G P D+ + G + +
Sbjct: 181 VISGR----LYAG---PEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233
Query: 272 VNES----LPHALTDVVDANLRVSMKDV 295
+N S L H L VD R ++KD+
Sbjct: 234 LNRSVATLLMHML--QVDPLKRATIKDI 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-20
Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 35/249 (14%)
Query: 29 WRRTSYLDIQRA---TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRS 84
R +D+ F L+G G++G VYKG + G AIKV + G
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEE 66
Query: 85 FDSECEVLRNV-HHRNLLKIFSSCSNPDFKA------LVLELMPNGSLENWLYSH-NYFL 136
E +L+ HHRN+ + + + LV+E GS+ + + + L
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 137 DTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196
I ++ L +LH ++H D+K N+LL EN ++ DFG+S L
Sbjct: 127 KEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--- 179
Query: 197 EDSVTQTMTMATIG---YMAP-VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252
+ +V + T IG +MAP V + K D++S G+ +E
Sbjct: 180 DRTVGRRNTF--IGTPYWMAPEVIA---------CDENPDATYDFKSDLWSLGITAIEMA 228
Query: 253 TGKKPTDEM 261
G P +M
Sbjct: 229 EGAPPLCDM 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 35/223 (15%)
Query: 44 FNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLK 102
+ + ++G GSFG+VY+ L D G VAIK R E +++R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 103 ----IFSSCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTLERLNI---MIDVWLALE 153
+SS D L VL+ +P ++ ++ TL + + M ++ +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
Y+H S I H D+KP N+LLD + V ++ DFG +K L GE +V+ + + Y
Sbjct: 171 YIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 223
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
AP +++ FG+ ++ DV+S G +L E G+
Sbjct: 224 AP-----ELI------FGATD-YTSSIDVWSAGCVLAELLLGQ 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 60/291 (20%), Positives = 109/291 (37%), Gaps = 64/291 (21%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDS------------------- 87
+G GS+G+V +D A+KV K +L R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 88 ------ECEVLRNVHHRNLLKIFSSCSNPDFKAL--VLELMPNGSLENWLYSHNYFLDTL 139
E +L+ + H N++K+ +P+ L V EL+ G + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLSED 137
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
+ D+ +EYLH+ I+H D+KPSN+L+ E+ +++DFG+S D+
Sbjct: 138 QARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-DA 192
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259
+ T+ T +MAP + L F G DV++ GV L G+ P
Sbjct: 193 LLSN-TVGTPAFMAP-----ESLSETRKIF--SG---KALDVWAMGVTLYCFVFGQCPFM 241
Query: 260 -----EMF----TGEISLKNWVNES------LPHALTDVVDANLRVSMKDV 295
+ + + + + + + L + R+ + ++
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRML--DKNPESRIVVPEI 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 53/271 (19%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQ----LGRAFRSFDSECEVLRNVHHRNL 100
LG G+FG V G G+ VA+K+ K++ +G+ R E + L+ H ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+K++ S P +V+E + G L +++ + LD E + + ++Y H
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHM- 136
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG---YMAPVSQ 217
+VH DLKP N+LLD +M A+++DFG+S ++ DGE T + G Y AP
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAP--- 184
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE---------MFTGEISL 268
+++ + G + D++S GV+L G P D+ + G
Sbjct: 185 --EVISGR----LYAG---PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235
Query: 269 KNWVNES----LPHALTDVVDANLRVSMKDV 295
++N S L H L VD R ++KD+
Sbjct: 236 PQYLNPSVISLLKHML--QVDPMKRATIKDI 264
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 39/237 (16%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF-KLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG G++G V + VA+K+ + + E + + ++H N++K +
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 107 CSNPDFKALVLELMPNGSLENWLYSH---------NYFLDTLERLNIMIDVWLALEYLH- 156
+ + L LE G L + + +F ++ + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-------LMA---GVVYLHG 123
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
G I H D+KP N+LLDE ++SDFG++ + T+ Y+AP
Sbjct: 124 IG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP-- 176
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN 273
++LK + DV+S G++L G+ P D+ +W
Sbjct: 177 ---ELLKRR----EFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 41/238 (17%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSEC-----EVLRNVHH 97
F + +LG G FG V+ + + A K L R + + ++L VH
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLD--TLERLNIMI-DVWLALEY 154
R ++ + + LV+ +M G + +Y+ + R + LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMA 213
LH I++ DLKP N+LLD++ R+SD G++ L G+ T A T G+MA
Sbjct: 305 LH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMA 357
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---------TDEMF 262
P ++L ++ D ++ GV L E + P E+
Sbjct: 358 P-----ELL--LGEEYDFS------VDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 49/269 (18%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIK-VFKLQLGRAFRSFDS-----ECEVLRNVHHR--N 99
LLG+G FG VY GI +SD VAIK V K ++ + E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 100 LLKIFSSCSNPDFKALVLEL-MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
++++ PD L+LE P L +++ L + V A+ + H+
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC 168
Query: 159 HSSAPIVHCDLKPSNILLDEN-MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
++H D+K NIL+D N ++ DFG LL D + T Y P
Sbjct: 169 G----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPP--- 217
Query: 218 LFDILKPKNAKFGSEGIISAKC------DVYSFGVLLMETFTGKKP---TDEMFTGEISL 268
E I V+S G+LL + G P +E+ G++
Sbjct: 218 --------------E-WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262
Query: 269 KNWVNESLPHALTD--VVDANLRVSMKDV 295
+ V+ H + + + R + +++
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-19
Identities = 61/269 (22%), Positives = 105/269 (39%), Gaps = 53/269 (19%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR------AFRSFDSECEV 91
Q E + + +G G++G+VYK S G VA+K +L A R E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA 151
L+ +HH N++ + + LV E M L+ L + L + + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATI 209
+ + H I+H DLKP N+L++ + +++DFG+++ G ++ T + T+
Sbjct: 132 VAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIP----VRSYTHEVVTL 183
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK-------------- 255
Y AP D+L GS+ S D++S G + E TGK
Sbjct: 184 WYRAP-----DVL------MGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231
Query: 256 ------KPTDEMFTGEISLKNWVNESLPH 278
P + L W +
Sbjct: 232 IFSILGTPNPREWPQVQELPLWKQRTFQV 260
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 59/269 (21%), Positives = 94/269 (34%), Gaps = 47/269 (17%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFK----------LQLGRAFRSFDSECEVLRNVH- 96
LLG G FG V+ G L+D VAIKV E +L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93
Query: 97 ---HRNLLKIFSSCSNPDFKALVLEL-MPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
H ++++ + LVLE +P L +++ L V A+
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAI 152
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
++ H +VH D+K NIL+D A++ DFG LL D + T Y
Sbjct: 153 QHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVY 204
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---TDEMFTGEISL 268
P + + V+S G+LL + G P E+ E+
Sbjct: 205 SPP-----EWISRH----QYHA---LPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252
Query: 269 KNWVNESLPHALTD--VVDANLRVSMKDV 295
V+ + + R S++++
Sbjct: 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK---LQLGRAFRSFDSECEVLRNVHHRN 99
F LLG G+FG V A+K+ K + +E VL+N H
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
L + S D V+E G L L F + R ++ AL+YLH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEK 268
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
+ +V+ DLK N++LD++ +++DFG+ K G + + +T T Y+AP
Sbjct: 269 N---VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAP----- 318
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
++L+ + D + GV++ E G+ P +++F
Sbjct: 319 EVLEDNDYGRA--------VDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFD---SECEVLRNVHHRN 99
F+ LGTGSFG V + N A+K+ Q + + +E +L+ V+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
L+K+ S + +V+E + G + + L F + R + L EYLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD 161
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQL 218
+++ DLKP N+L+D+ +V+DFG +K + +T T+ T +AP
Sbjct: 162 ----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAP---- 207
Query: 219 FDILKPKNAKFGSEGIISAK-----CDVYSFGVLLMETFTGKKP-----TDEMF 262
E II +K D ++ GVL+ E G P +++
Sbjct: 208 -------------E-IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 51/226 (22%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK---VFKLQLG--RAFRSFDSECEVLRNVHHRN---L 100
+G G++G+V + VAIK F+ Q R R E ++L H N +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 101 LKIFSSCSNPDFKA--LVLELMPNGSLENWLYS-------HNYFLDTLERLNIMIDVWLA 151
I + + K +V +LM L L + YFL + R
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR---------G 140
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATI 209
L+Y+H SA ++H DLKPSN+LL+ ++ DFG++++ D + T +T +AT
Sbjct: 141 LKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYVATR 195
Query: 210 GYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
Y AP +I+ N+K ++ I D++S G +L E + +
Sbjct: 196 WYRAP-----EIM--LNSKGYTKSI-----DIWSVGCILAEMLSNR 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 51/220 (23%), Positives = 82/220 (37%), Gaps = 34/220 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
+G+G+FG+ VA+K R E R++ H N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNI--MIDVWLALEYLHHGHSSA 162
P A+++E G L + + F + R ++ + Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---GVSYCHSMQ--- 136
Query: 163 PIVHCDLKPSNILLDENMVAR--VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
I H DLK N LLD + R + DFG SK + T+ T Y+AP +
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAP-----E 187
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
+L + +G DV+S GV L G P ++
Sbjct: 188 VLLRQ----EYDG---KIADVWSCGVTLYVMLVGAYPFED 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 8e-18
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFD---SECEVLRNVHHRN 99
F LGTGSFG V+ A+KV K ++ + + E +L V H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+++++ + + ++++ + G L + L F + + + +V LALEYLH
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD 126
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM-ATIGYMAPVSQL 218
I++ DLKP NILLD+N +++DFG +K + D T T+ T Y+AP
Sbjct: 127 ----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAP---- 172
Query: 219 FDILKPKNAKFGSEGIISAK-----CDVYSFGVLLMETFTGKKP-----TDEMF 262
E ++S K D +SFG+L+ E G P T + +
Sbjct: 173 -------------E-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 60/264 (22%), Positives = 114/264 (43%), Gaps = 40/264 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVF---KLQLGRAFRSFDSECEVLRNVHHRNLLKIF 104
LG GSFG V VA+K L+ + E L+ + H +++K++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 105 SSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPI 164
+ P +V+E G L +++ + E + A+EY H I
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHK----I 129
Query: 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKP 224
VH DLKP N+LLD+N+ +++DFG+S ++ DG T + + Y AP +++
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAP-----EVING 181
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE---------MFTGEISLKNWVNES 275
K G + DV+S G++L G+ P D+ + + + ++++
Sbjct: 182 K----LYAG---PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234
Query: 276 ----LPHALTDVVDANLRVSMKDV 295
+ + V D R++++++
Sbjct: 235 AQSLIRRMI--VADPMQRITIQEI 256
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-17
Identities = 51/233 (21%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR------AFRSFDSECEVLRN 94
+ + + +G G++G V+K VA+K +L A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
+ H+N++++ + LV E L+ + S N LD + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYM 212
H + ++H DLKP N+L++ N ++++FG+++ G + + + T+ Y
Sbjct: 117 CHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFGI----PVRCYSAEVVTLWYR 168
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
P D+L FG++ + S D++S G + E +P +F G
Sbjct: 169 PP-----DVL------FGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 44 FNECNLLGTGSFGIVY---KGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNV 95
F +LGTG++G V+ K D + A+KV K +Q + +E +VL ++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 96 -HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALE 153
L+ + + L+L+ + G L L F T + I + ++ LALE
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVLALE 173
Query: 154 YLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
+LH G I++ D+K NILLD N ++DFG+SK E TI YM
Sbjct: 174 HLHKLG-----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYM 227
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270
AP DI++ ++ D +S GVL+ E TG P FT + +
Sbjct: 228 AP-----DIVRGGDSGHDKA------VDWWSLGVLMYELLTGASP----FTVDGEKNS 270
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VF--KLQLGRAFRSFDSECEVLRNVHHRN--- 99
+GTGS+G V + + VAIK VF + R R E +L ++H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 100 LLKIFSSCSNPDFKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
+L I F +VLE+ + + + Y + + ++ ++ + ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
SA I+H DLKP+N L++++ +V DFG+++ + E+ +Q M V+
Sbjct: 174 ---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 24/218 (11%), Positives = 50/218 (22%), Gaps = 57/218 (26%)
Query: 49 LLGTGSFGIVYKGILSD---GNNVAIKVFKLQLGRA--FRS-FDSECEVLRNVHHRNLLK 102
G ++ + D VA+ Q S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ +V E + GSL+ + + + M + A + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR----A 148
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDIL 222
+ PS + + + ++ M +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDAN------ 180
Query: 223 KPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260
+ D+ G L + P E
Sbjct: 181 --------------PQDDIRGIGASLYALLVNRWPLPE 204
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 41/193 (21%), Positives = 70/193 (36%), Gaps = 38/193 (19%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VFKLQLG--RAFRSFDSECEVLRNVHHRN--- 99
+G GS+G VY + NVAIK +F+ + R R E +L +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 100 LLKIFSSCSNPDFKA--LVLELMPNGSLENWLYSHN--------YFLDTLERLNIMIDVW 149
L + F +VLE+ + L+ + L L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL-------- 140
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATI 209
++H + I+H DLKP+N LL+++ +V DFG+++ + +D+
Sbjct: 141 -GENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 210 GYMAPVSQLFDIL 222
L L
Sbjct: 196 EPGPHNKNLKKQL 208
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 41/248 (16%)
Query: 44 FNECNLLGTGSFGIVY---KGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNV 95
F +LG G +G V+ K ++ + A+KV K ++ + +E +L V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALEY 154
H ++ + + L+LE + G L L F + + ++ +AL +
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLAEISMALGH 136
Query: 155 LH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
LH G I++ DLKP NI+L+ +++DFG+ K + +VT T TI YMA
Sbjct: 137 LHQKG-----IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC-GTIEYMA 189
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF----TG 264
P +IL D +S G L+ + TG P +
Sbjct: 190 P-----EILMRS--GHNRA------VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 265 EISLKNWV 272
+++L ++
Sbjct: 237 KLNLPPYL 244
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 5e-17
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 35/232 (15%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFR-SFDS----E 88
LD++ + + + + LG G F VYK + VAIK KL + + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 89 CEVLRNVHHRN---LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIM 145
++L+ + H N LL F SN +LV + M LE + ++ L M
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSN---ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
+ LEYLH I+H DLKP+N+LLDEN V +++DFG++K G + T
Sbjct: 119 LMTLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP----NRAYT 170
Query: 206 --MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ T Y AP ++L FG+ + D+++ G +L E
Sbjct: 171 HQVVTRWYRAP-----ELL------FGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK---VFKLQLG--RAFRSFDSECEVLRNVHHRN---L 100
LG G++G+V G VAIK F L R R E ++L++ H N +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 101 LKIFSSCSNPDFKA--LVLELMP--------NGSLENWLYSH-NYFLDTLERLNIMIDVW 149
I S +F ++ ELM L + H YF+ R
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQTLR-------- 123
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT------ 203
A++ LH + ++H DLKPSN+L++ N +V DFG+++++ + ++
Sbjct: 124 -AVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 204 MT--MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
M +AT Y AP +++ + S + DV+S G +L E F +
Sbjct: 179 MVEFVATRWYRAP-----EVM--LTSAKYSRAM-----DVWSCGCILAELFLRR 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 8e-17
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 35/232 (15%)
Query: 44 FNECNLLGTGSFGIVY---KGILSDGNNV-AIKVFKLQLGRAFRSFDSECE--VLRNVHH 97
F +LG GSFG V+ K SD + A+KV K + ++ E +L V+H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALEYLH 156
++K+ + L+L+ + G L L F T E + + ++ LAL++LH
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELALALDHLH 143
Query: 157 -HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV 215
G I++ DLKP NILLDE +++DFG+SK + + T+ YMAP
Sbjct: 144 SLG-----IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC-GTVEYMAP- 195
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+++ + D +SFGVL+ E TG P E
Sbjct: 196 ----EVVNRR--GHTQS------ADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR------AFRSFDSECEVLRNV 95
E ++ +G G++G+VYK + G A+K +L+ R E +L+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYL 155
H N++K++ LV E + L+ L L+++ + ++ + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 156 HHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMA 213
H ++H DLKP N+L++ +++DFG+++ G + T + T+ Y A
Sbjct: 117 HDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIP----VRKYTHEIVTLWYRA 168
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
P D+L GS+ S D++S G + E G
Sbjct: 169 P-----DVL------MGSK-KYSTTIDIWSVGCIFAEMVNGT 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 53/263 (20%), Positives = 98/263 (37%), Gaps = 61/263 (23%)
Query: 41 TEGFNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
++ ++ LGTGSFGIV + + G A+K R E ++++ + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 100 ---LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYL- 155
L+ F + + + K N +N+ + + + + +EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 156 --------HHGHS------------------------SAPIVHCDLKPSNILLD-ENMVA 182
S S I H D+KP N+L++ ++
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVY 242
++ DFG +K L E S + + Y AP +++ G+ + D++
Sbjct: 182 KLCDFGSAKKLIPSEPS---VAYICSRFYRAP-----ELM------LGATE-YTPSIDLW 226
Query: 243 SFGVLLMETFTGKKPTDEMFTGE 265
S G + E G KP +F+GE
Sbjct: 227 SIGCVFGELILG-KP---LFSGE 245
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 60/235 (25%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIK--VFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIF 104
LG G G+V+ + +D VAIK V A R E +++R + H N++K+F
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 105 ------------SSCSNPDFKA--LVLELMPNGSLENWLYSHN-------YFLDTLERLN 143
S + + +V E M L N L F+ L R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR-- 131
Query: 144 IMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQ 202
L+Y+H SA ++H DLKP+N+ ++ E++V ++ DFG+++++ D S
Sbjct: 132 -------GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKG 179
Query: 203 TMT--MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
++ + T Y +P +L + ++ I D+++ G + E TGK
Sbjct: 180 HLSEGLVTKWYRSP-----RLL--LSPNNYTKAI-----DMWAAGCIFAEMLTGK 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 31/229 (13%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVLRNVHHR 98
F+ LLG G+FG V A+K+ + + + +E VL+N H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHP 65
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
L + + D V+E G L L F + R ++ ALEYLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH-- 122
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
S +V+ D+K N++LD++ +++DFG+ K G + + +T T Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAP---- 174
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
++L+ + D + GV++ E G+ P + +F
Sbjct: 175 -EVLEDNDYGRA--------VDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 58/227 (25%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VFKLQLG--RAFRSFDSECEVLRNVHHRN--- 99
+G+G++G V I G VAIK F+ ++ RA+R E +L+++ H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 100 LLKIFSSCSNPD-FKA--LVLELMPNGSLENWLYS------HNYFLDTLERLNIMIDVWL 150
LL +F+ S+ F LV+ M L+ + Y + + +
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--------- 137
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MAT 208
L+Y+H SA +VH DLKP N+ ++E+ ++ DFG+++ MT + T
Sbjct: 138 GLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVT 186
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
Y AP +++ + ++ + D++S G ++ E TGK
Sbjct: 187 RWYRAP-----EVI--LSWMHYNQTV-----DIWSVGCIMAEMLTGK 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 65/231 (28%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIK----VFKLQLG--RAFRSFDSECEVLRNVHHRN--- 99
+G+G+ GIV + NVAIK F+ Q RA+R E +++ V+H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 100 LLKIFSSCSNPD-FKA--LVLELMPNGSLENWLYS------HNYFLDTLERLNIMIDVWL 150
LL +F+ + + F+ +V+ELM +L + +Y L +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--------- 138
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MAT 208
+++LH SA I+H DLKPSNI++ + ++ DFG+++ G + MT + T
Sbjct: 139 GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVT 189
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKC----DVYSFGVLLMETFTGK 255
Y AP E I+ D++S G ++ E G
Sbjct: 190 RYYRAP-----------------EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 30/231 (12%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDS---ECEVL-RNVH 96
FN +LG GSFG V + + A+K+ K + + E VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
L ++ S D V+E + G L + F + ++ + L +L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 459
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
S I++ DLK N++LD +++DFG+ K + T+T T Y+AP
Sbjct: 460 ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYIAP-- 511
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+I+ + D ++FGVLL E G+ P DE+F
Sbjct: 512 ---EIIAYQPYGKS--------VDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 43/173 (24%), Positives = 68/173 (39%), Gaps = 18/173 (10%)
Query: 86 DSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIM 145
D + ++ R S S L E + FL +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
V +E+L +S +H DL NILL E V ++ DFG+++ + D V +
Sbjct: 200 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257
+ +MAP + +FD + + + DV+SFGVLL E F+ G P
Sbjct: 256 RLPLKWMAPET-IFD------------RVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 18/166 (10%)
Query: 50 LGTGSFGIVYKGIL------SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLL 101
LG G+FG V + + VA+K+ K R+ SE ++L ++ HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 102 KIFSSCSNPDFKALV-LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ +C+ P +V +E G+L +L S N + G
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------NEFVPYKTKGARFRQGKD 140
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTM 206
+ DLK + + + S F K L D E+
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 53/225 (23%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VFKLQLG--RAFRSFDSECEVLRNVHHRN--- 99
+G+G+ GIV NVAIK F+ Q RA+R E +++ V+H+N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 100 LLKIFSSCSNPD-FKA--LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
LL +F+ + F+ LV+ELM +L + LD ++ + +++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH 181
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMAP 214
SA I+H DLKPSNI++ + ++ DFG+++ G + MT + T Y AP
Sbjct: 182 ----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAP 232
Query: 215 VSQLFDILKPKNAKFGSEGIISAKC----DVYSFGVLLMETFTGK 255
E I+ D++S G ++ E K
Sbjct: 233 -----------------EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 59/228 (25%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIK----VFKLQLG--RAFRSFDSECEVLRNVHHRN--- 99
+G+G++G V + G VA+K F+ + R +R E +L+++ H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 100 LLKIFSSCSNPD-FKA--LVLELMPNGSLENWLYS-------HNYFLDTLERLNIMIDVW 149
LL +F+ + + F LV LM L N + + + + R
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-------- 143
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MA 207
L+Y+H SA I+H DLKPSN+ ++E+ ++ DFG+++ MT +A
Sbjct: 144 -GLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
T Y AP +I+ + + D++S G ++ E TG+
Sbjct: 192 TRWYRAP-----EIM-------LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 51/261 (19%), Positives = 92/261 (35%), Gaps = 62/261 (23%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLLK 102
+G GS+G+V+K G VAIK F A R E +L+ + H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
+ LV E + ++ + L + + +I A+ + H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH----KH 121
Query: 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMAPVSQLFD 220
+H D+KP NIL+ ++ V ++ DFG ++LL + +AT Y +P +
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATRWYRSP-----E 172
Query: 221 ILKPKNAKFGSE----GIISAKCDVYSFGVLLMETFTGK--------------------K 256
+L G + DV++ G + E +G
Sbjct: 173 LL------VGDTQYGPPV-----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221
Query: 257 PTDEMFTGEISLKNWVNESLP 277
+ + + +P
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIP 242
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 52/275 (18%), Positives = 104/275 (37%), Gaps = 54/275 (19%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDS----ECEVLR 93
+ + +G G+FG V+K G VA+K K+ + F E ++L+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQ 71
Query: 94 NVHHRN---LLKIFSSCSNPDFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLNIM 145
+ H N L++I + ++P + LV + + L L + E +M
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
+ L Y+H I+H D+K +N+L+ + V +++DFG+++ ++S T
Sbjct: 131 QMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 206 --MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK-------- 255
+ T+ Y P ++L G D++ G ++ E +T
Sbjct: 187 NRVVTLWYRPP-----ELL------LGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 256 ------------KPTDEMFTGEISLKNWVNESLPH 278
T E++ + + + L
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVK 269
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 60/265 (22%), Positives = 107/265 (40%), Gaps = 53/265 (20%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNV 95
E + + + LG G++ VYKG N VA+K +L+ A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYL 155
H N++ + LV E + L+ +L ++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 156 HHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMA 213
H ++H DLKP N+L++E +++DFG+++ T+T + T+ Y
Sbjct: 117 HRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIP----TKTYDNEVVTLWYRP 168
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK------------------ 255
P DIL GS S + D++ G + E TG+
Sbjct: 169 P-----DIL------LGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216
Query: 256 --KPTDEMFTGEISLKNWVNESLPH 278
PT+E + G +S + + + P
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPK 241
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 59/228 (25%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VFKLQLG--RAFRSFDSECEVLRNVHHRN--- 99
+G+G++G V + G VAIK F+ +L RA+R E +L+++ H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 100 LLKIFSSCSNPD-FKA--LVLELMPNGSLENWLYS-------HNYFLDTLERLNIMIDVW 149
LL +F+ D F LV+ M L + + + + +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MA 207
L Y+H +A I+H DLKP N+ ++E+ ++ DFG+++ MT +
Sbjct: 140 -GLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMTGYVV 187
Query: 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
T Y AP +++ N ++ + D++S G ++ E TGK
Sbjct: 188 TRWYRAP-----EVI--LNWMRYTQTV-----DIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 41/163 (25%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEV---LRNVHHRNLLKIF- 104
LG G G V + A+K+ + + EV R ++++I
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 105 ---SSCSNPDFKALVLELMPNGSL-------ENWLYSHNYFLDTLER--LNIMIDVWLAL 152
+ + +V+E + G L + ++ ER IM + A+
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--------EREASEIMKSIGEAI 130
Query: 153 EYLH-HGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISK 191
+YLH I H D+KP N+L N + +++DFG +K
Sbjct: 131 QYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 58/271 (21%), Positives = 99/271 (36%), Gaps = 58/271 (21%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR------AFRSFDSECEV 91
++ E + L+G GS+G+V K G VAIK F A R E ++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA 151
L+ + H NL+ + C LV E + + ++ + L LD + +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
+ + H + I+H D+KP NIL+ ++ V ++ DFG ++ L + +AT Y
Sbjct: 137 IGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD--EVATRWY 190
Query: 212 MAPVSQLFDILKPKNAKFGSE----GIISAKCDVYSFGVLLMETFTGK------------ 255
AP ++L G + DV++ G L+ E F G+
Sbjct: 191 RAP-----ELL------VGDVKYGKAV-----DVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 256 --------KPTDEMFTGEISLKNWVNESLPH 278
+ LP
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPE 265
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-15
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFK----LQLGRAFRSFDSECEVL-RNVHH 97
F +LG GSFG V+ N AIK K L + E VL H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEH 77
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH- 156
L +F + + V+E + G L + S + F + ++ L L++LH
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLHS 136
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
G IV+ DLK NILLD++ +++DFG+ K D+ T T T Y+AP
Sbjct: 137 KG-----IVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFC-GTPDYIAP-- 187
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+IL + D +SFGVLL E G+ P +E+F
Sbjct: 188 ---EILLGQKYNHS--------VDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 35/185 (18%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIK----VF--KLQLGRAFRSFDSECEVLRNVH-HRNLL 101
LG G++GIV+K I G VA+K F R FR E +L + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 102 KIFSSCSNPDFKA--LVLELMPNGSLENWLYS-------HNYFLDTLERLNIMIDVWLAL 152
+ + + + LV + M L + + Y + L + +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK---------VI 122
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
+YLH S ++H D+KPSNILL+ +V+DFG+S+ +
Sbjct: 123 KYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 213 APVSQ 217
Sbjct: 179 NFDDD 183
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSECE-------VLRNV 95
F +LG GSFG V + + ++ A+KV K + D + E +L
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK----KDVILQDDDVECTMTEKRILSLA 80
Query: 96 -HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
+H L ++F PD V+E + G L + F + R ++ AL +
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
LH I++ DLK N+LLD +++DFG+ K G T T T Y+AP
Sbjct: 140 LH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFC-GTPDYIAP 193
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+IL+ D ++ GVLL E G P D++F
Sbjct: 194 -----EILQEMLYGPA--------VDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 65/229 (28%), Positives = 92/229 (40%), Gaps = 30/229 (13%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDS---ECEVL-RNVHHR 98
F+ ++G GSFG V A+KV + + + E VL +NV H
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
L+ + S D VL+ + G L L FL+ R ++ AL YLH
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH-- 156
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
S IV+ DLKP NILLD ++DFG+ K +S T T T Y+AP
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFC-GTPEYLAP---- 208
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
++L + D + G +L E G P T EM+
Sbjct: 209 -EVLHKQPYDRT--------VDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 46/236 (19%)
Query: 39 RATEGFNECNLLGTGSFGIVYKG--ILSDGNNVAIKVFKLQLGR------AFRSFDSECE 90
RA + + +G G++G V+K + + G VA+K ++Q G R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 91 V-----LRNVHHRN---LLKIFSSCSNPDFKA--LVLELMPNGSLENWLYSH-NYFLDTL 139
V L H N L + + LV E + L +L + T
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199
++M + L++LH +VH DLKP NIL+ + +++DFG++++
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQ 173
Query: 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ T + T+ Y AP ++L S + D++S G + E F K
Sbjct: 174 MALTSVVVTLWYRAP-----EVL------LQSS--YATPVDLWSVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 34/231 (14%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSEC-----EVL-RNVH 96
FN +LG GSFG V + + A+K+ L+ + D EC VL
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
L ++ S D V+E + G L + F + ++ + L +L
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 138
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
S I++ DLK N++LD +++DFG+ K + T+T T Y+AP
Sbjct: 139 ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYIAP-- 190
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMF 262
+I+ + D ++FGVLL E G+ P DE+F
Sbjct: 191 ---EIIAYQPYGKS--------VDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 48/238 (20%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR---------AFRSFDSE 88
AT + +G G++G VYK G+ VA+K ++ G R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60
Query: 89 CEV-----LRNVHHRN---LLKIFSSCSNPDFKA--LVLELMPNGSLENWLYSHN-YFLD 137
EV L H N L+ + ++ LV E + L +L L
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 138 TLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197
++M L++LH IVH DLKP NIL+ +++DFG++++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYS--- 171
Query: 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ T + T+ Y AP ++L S + D++S G + E F K
Sbjct: 172 YQMALTPVVVTLWYRAP-----EVL------LQST--YATPVDMWSVGCIFAEMFRRK 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 40 ATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-----GRAFRSFDSECEVLR 93
++ F + LG G++ VYKG+ + G VA+K KL A R E +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF-----LDTLERLNIMIDV 148
+ H N+++++ + LV E M N L+ ++ S L+ +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--M 206
L + H I+H DLKP N+L+++ ++ DFG+++ G T + +
Sbjct: 118 LQGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFSSEV 169
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
T+ Y AP D+L GS S D++S G +L E TGK
Sbjct: 170 VTLWYRAP-----DVL------MGSR-TYSTSIDIWSCGCILAEMITGK 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 40/231 (17%)
Query: 39 RATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR------AFRSFDSECEV 91
+ + + LG G++G VYK I VAIK +L+ A R E +
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86
Query: 92 LRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLA 151
L+ + HRN++++ S + L+ E N L+ ++ + + + + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLING 144
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILLDENMVAR-----VSDFGISKLLGDGEDSVTQTMT- 205
+ + H +H DLKP N+LL + + + DFG+++ G + T
Sbjct: 145 VNFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPIRQFTH 196
Query: 206 -MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ T+ Y P +IL GS S D++S + E
Sbjct: 197 EIITLWYRPP-----EIL------LGSR-HYSTSVDIWSIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 46/252 (18%), Positives = 92/252 (36%), Gaps = 57/252 (22%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFK------------LQLGRAFRSFDSECEVLRNV 95
LG G F V+ + + +VA+K+ + ++L + D+ E
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 96 HH-RNLLKIFS-SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLAL 152
+H LL F+ N +V E++ +L + + + L + I + L L
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVA------RVSDFGISKLLGDGEDSVTQTMTM 206
+Y+H I+H D+KP N+L++ +++D G + + + QT
Sbjct: 145 DYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE- 200
Query: 207 ATIGYMAPVSQLFDILKPKNAKFGSEGII----SAKCDVYSFGVLLMETFTGKKPTDEMF 262
Y +P E ++ D++S L+ E TG +F
Sbjct: 201 ----YRSP-----------------EVLLGAPWGCGADIWSTACLIFELITGDF----LF 235
Query: 263 TGEISLKNWVNE 274
+ ++ +
Sbjct: 236 EPD-EGHSYTKD 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 31/238 (13%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDS---ECEVL-RNVHHR 98
F+ ++G GS+ V L + + A++V K +L D E V + +H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI-DVWLALEYLHH 157
L+ + S V+E + G L + E ++ LAL YLH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISLALNYLH- 170
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
I++ DLK N+LLD +++D+G+ K G T T T Y+AP
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC-GTPNYIAP--- 222
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNES 275
+IL+ ++ F D ++ GVL+ E G+ P F S N +
Sbjct: 223 --EILRGEDYGFS--------VDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNT 266
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFRSFDSECEVLRNV-HHRNLLKIFSS 106
LG G + V++ I +++ V +K+ K + + R E ++L N+ N++ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 107 CSNPDFK--ALVLELMPNGSLENWLYSHNYFLDTLERLNI---MIDVWLALEYLHHGHSS 161
+P + ALV E + N + TL +I M ++ AL+Y H S
Sbjct: 100 VKDPVSRTPALVFEHVNNTDF------KQLY-QTLTDYDIRFYMYEILKALDYCH----S 148
Query: 162 APIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMAPVSQL 218
I+H D+KP N+++D E+ R+ D+G L + Q +A+ + P
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHP-GQEYNVRVASRYFKGP---- 199
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
++L + + + D++S G +L K+P
Sbjct: 200 -ELL--VDYQMYDYSL-----DMWSLGCMLASMIFRKEP 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 54/238 (22%), Positives = 90/238 (37%), Gaps = 60/238 (25%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR------NLL 101
++G GSFG V K +VA+K+ + R R E +L ++ + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 102 KIFSS-------CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALE 153
+ + C + EL+ + +L + + + +L + + L+
Sbjct: 163 HMLENFTFRNHIC-------MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVA--RVSDFGISKLLGDGEDSVTQTMTMATIGY 211
LH I+HCDLKP NILL + + +V DFG S + Q+ Y
Sbjct: 215 ALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----Y 265
Query: 212 MAPVSQLFDILKPKNAKFGSEGII----SAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
AP E I+ D++S G +L E TG + GE
Sbjct: 266 RAP-----------------EVILGARYGMPIDMWSLGCILAELLTGY----PLLPGE 302
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 33/239 (13%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNV-AIKVFKLQLGRAFRSFDSEC-----EVL-RNVH 96
F+ ++G GS+ V L + + A+KV ++ D + V + +
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
H L+ + S V+E + G L + + R ++ LAL YLH
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 127
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
I++ DLK N+LLD +++D+G+ K G T T T Y+AP
Sbjct: 128 ----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC-GTPNYIAP-- 179
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNES 275
+IL+ ++ F D ++ GVL+ E G+ P F S N +
Sbjct: 180 ---EILRGEDYGFS--------VDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNT 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-RNLLKIFSSC 107
+G G+FG + G L VAIK+ ++ E + + + +++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 108 SNPDFKALVLELMPNG-SLEN-WLYSHNYF-LDTLERLNI-MIDVWLALEYLHHGHSSAP 163
+ A+VLEL+ G SLE+ + F L T+ + I +I +EY+H S
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLIS---RMEYVH----SKN 125
Query: 164 IVHCDLKPSNILL------DENMVARVSDFGISK 191
+++ D+KP N L+ + ++ + DF ++K
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 34/151 (22%), Positives = 61/151 (40%), Gaps = 18/151 (11%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-RNLLKIFSSC 107
+G GSFG++++G L + VAIK + E + + + ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 108 SNPDFKALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
LV++L+ G SLE+ L + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVY 129
Query: 167 CDLKPSNILL------DENMVARVSDFGISK 191
D+KP N L+ + NM+ V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIY-VVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 35/168 (20%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKL------QLGRAFRSF-----DSECEVLRNVH 96
+G+G FG++Y + A V K+ L + + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 97 HRNLLKI-------FSSCSNPDFKALVLELMPNG-SLENWLYSHNYF-LDTLERLNI-MI 146
+ L I + ++ +V+E + G L+ + F T+ +L I M+
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISK 191
DV LEY+H VH D+K +N+LL + + V D+G+S
Sbjct: 162 DV---LEYIHENE----YVHGDIKAANLLLGYKNPDQVYLA-DYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-RNLLKIFSSC 107
+G+GSFG +Y G ++ G VAIK+ ++ E ++ + + + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 108 SNPDFKALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ D+ +V+EL+ G SLE+ + L + + +EY+H S +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIH 128
Query: 167 CDLKPSNILL----DENMVARVSDFGISK 191
D+KP N L+ N+V + DFG++K
Sbjct: 129 RDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 49/231 (21%), Positives = 88/231 (38%), Gaps = 51/231 (22%)
Query: 50 LGTGSFGIVYKGILSDGNN---VAIKVFKLQLGR---AFRSFDSECEVLRNVHHRN---L 100
+G G++G VYK DG + A+K + G A R E +LR + H N L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACR----EIALLRELKHPNVISL 83
Query: 101 LKIFSSCSNP-----------DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVW 149
K+F S ++ D + ++ L +++ +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHI-IKFHRASKANK----KPVQLPRGMVKSLLYQIL 138
Query: 150 LALEYLHHGHSSAPIVHCDLKPSNILL----DENMVARVSDFGISKLLGDGEDSVTQ-TM 204
+ YLH ++H DLKP+NIL+ E +++D G ++L +
Sbjct: 139 DGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255
+ T Y AP ++L G+ + D+++ G + E T +
Sbjct: 195 VVVTFWYRAP-----ELL------LGAR-HYTKAIDIWAIGCIFAELLTSE 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR------NL 100
+L+G GSFG V K + VAIK+ K + E +L ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 101 LKIFSSCSNPDFKA---LVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLH 156
+ + F+ LV E++ + +L + L + N+ +L + AL +L
Sbjct: 119 VHLKRHF---MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 157 HGHSSAPIVHCDLKPSNILL--DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
I+HCDLKP NILL + ++ DFG S LG Q+ Y +P
Sbjct: 175 TPE--LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 227
Query: 215 VSQLFDILKPKNAKFGSEGII----SAKCDVYSFGVLLMETFTGK 255
E ++ D++S G +L+E TG+
Sbjct: 228 -----------------EVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSC 107
+G+GSFG +Y G + VAIK+ ++ E ++ R + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 108 SNPDFKALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
D+ LV++L+ G SLE+ + L L + + +E++H S +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLH 126
Query: 167 CDLKPSNILLDENMVAR---VSDFGISK 191
D+KP N L+ A + DFG++K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 3e-10
Identities = 33/205 (16%), Positives = 54/205 (26%), Gaps = 55/205 (26%)
Query: 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKL--------QLGRAFRSFDSECEV 91
TE C +G G FG V++ I D VAIK+ + + F E +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 92 LRNVH---------HRNLLKIFSSC------------------------------SNPDF 112
+ + + + S D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 113 KALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKP 171
+VLE G LE +I+ + +L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHW 190
Query: 172 SNILLDENMVARVSDFGISKLLGDG 196
N+LL + + ++ K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 57/255 (22%), Positives = 89/255 (34%), Gaps = 58/255 (22%)
Query: 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDS---ECEVLRNV---------- 95
LG G F V+ + VA+KV K A ++ E +L++V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK----SAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 96 -HHRNLLKIFSSCS-NPDFKALVLELMPNG-SLENWLYSHNYFLDTLERL-NIMIDVWLA 151
LL F N +V E++ G L W+ NY L + I+ V
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 152 LEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLG----DGEDSVTQTM 204
L+YLH + I+H D+KP NILL ++ + ++ + G G T
Sbjct: 159 LDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGS--------------------EGII----SAKCD 240
T + + LK K A G+ E +I + D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 241 VYSFGVLLMETFTGK 255
++S + E TG
Sbjct: 276 IWSTACMAFELATGD 290
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 53/241 (21%), Positives = 87/241 (36%), Gaps = 60/241 (24%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-----HHRNLLK 102
+G G+FG V + + A+KV + + + RS E ++L+ + ++ N++K
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 103 IFSSCSNPDFKA---LVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLHHG 158
+ L+ E + SL + +NY +E + I++ AL YL
Sbjct: 101 YHGKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
+ H DLKP NILLD+ + G T I +L
Sbjct: 157 S----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST--GI-------KL 203
Query: 219 FDILKPKNAKFGS--------------------EGII----SAKCDVYSFGVLLMETFTG 254
D FG E I+ D++SFG +L E +TG
Sbjct: 204 ID--------FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 255 K 255
Sbjct: 256 S 256
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 31/170 (18%), Positives = 67/170 (39%), Gaps = 36/170 (21%)
Query: 49 LLGTGSFGIVYKGILSDGNNVAIK---VFKL------QLGRAFRSF-----DSECEVLRN 94
+G G FG +Y ++ +V V K+ L + + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 95 VHHRNLLKI-------FSSCSNPDFKALVLELMPNG-SLEN-WLYSHNYF-LDTLERLNI 144
L + + ++ ++++ G L+ + + F T+ +L++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 145 -MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV--SDFGISK 191
++D+ LEY+H VH D+K SN+LL+ +V D+G++
Sbjct: 160 RILDI---LEYIHEHE----YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 49/242 (20%), Positives = 88/242 (36%), Gaps = 66/242 (27%)
Query: 49 LLGTGSFGIVYKGI--LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR------NL 100
LG G+FG V + + + VA+K+ + +G+ + E VL+ + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR-NVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 101 LKIFSSCSNPDFKA---LVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLH 156
+ + +F + EL+ + +L +N+ L + ++ + AL +LH
Sbjct: 85 VLMSDWF---NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVA-------------------RVSDFGISKLLGDGE 197
+ H DLKP NIL + RV+DFG + +
Sbjct: 141 ENQ----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196
Query: 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGII----SAKCDVYSFGVLLMETFT 253
++ T Y P E I+ + CDV+S G +L E +
Sbjct: 197 TTIVATRH-----YRPP-----------------EVILELGWAQPCDVWSIGCILFEYYR 234
Query: 254 GK 255
G
Sbjct: 235 GF 236
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 27/170 (15%), Positives = 57/170 (33%), Gaps = 38/170 (22%)
Query: 50 LGTGSFGIVYKGI---------LSDGNNVAIKV--FKLQLGRAFRSFDSECEV------- 91
+ GI+Y+ ++K+ +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 92 -LRNVHHRNLLKIFSSCSN-PDFKALVLELMPNG-SLE---NWLYSHNYFLDTLERLNI- 144
L + + + ++ LVL + G SL+ + H ++ ++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISK 191
++D ALE+LH VH ++ NI + D++ V +G +
Sbjct: 168 LLD---ALEFLHENE----YVHGNVTAENIFVDPEDQSQVTLA-GYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 51/242 (21%), Positives = 94/242 (38%), Gaps = 66/242 (27%)
Query: 49 LLGTGSFGIVYKGI--LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR------NL 100
LG G+FG V + I + G +VA+K+ K + R + SE +VL +++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 101 LKIFSSCSNPDFKA---LVLELMPNGSLENWLYSHNYFLDTLERL-NIMIDVWLALEYLH 156
+++ + +V EL+ S +++ + + L+ + + + ++ +LH
Sbjct: 80 VQMLEWF---EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVA-------------------RVSDFGISKLLGDGE 197
+ H DLKP NIL ++ +V DFG + +
Sbjct: 136 SNK----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGII----SAKCDVYSFGVLLMETFT 253
++ T Y AP E I+ S CDV+S G +L+E +
Sbjct: 192 STLVSTRH-----YRAP-----------------EVILALGWSQPCDVWSIGCILIEYYL 229
Query: 254 GK 255
G
Sbjct: 230 GF 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.34 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.11 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.59 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.33 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=393.75 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=214.5
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||+||+|++ .+|+.||+|++++.. ......+.+|++++++++||||+++++++++.+.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999995 579999999998652 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||++||+|.+++.+.+. +++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||++..+...
T Consensus 111 mEy~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999987665 899999999999999999999 899999999999999999999999999999987654
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
.........+||+.|+|||++. +..|+.++|||||||++|+|++|..||......+..... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~-------------~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLT-------------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHH-------------HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCcccccCcccCcccCCHHHHc-------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 4333344567999999998764 456788999999999999999999999875543332111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
.+..+++.+++++ ||.+|||+.|++.+-....|+|++++.
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 2344566555555 999999999998888888899997653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=381.24 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=204.7
Q ss_pred HHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
....+++++.+.||+|+||+||+|+++. .||||+++... .+..+.+.+|++++++++||||+++++++.. +.+++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3456789999999999999999999643 59999987543 3456789999999999999999999998865 56899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999999877667999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
...........||+.|+|||++.. .....++.++|||||||++|||++|..||....+........
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~----------~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRM----------QDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp ---------CCCCTTSCCHHHHHC----------CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred CCcceeecccccCCCccCHHHhhc----------cCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 333333344679999999998742 234568999999999999999999999998765433211111
Q ss_pred -------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 272 -------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 272 -------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
.+..+++.+.+++ ||.+|||+.++++.++.+++.+-+
T Consensus 255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 1234566666665 999999999999999999987643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=385.27 Aligned_cols=243 Identities=22% Similarity=0.311 Sum_probs=204.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
...|++++.||+|+||+||+|++ .+|+.||||+++.......+.+.+|+++++.++||||+++++++.+++.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 35699999999999999999995 47999999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
|+||+|.+++.+.. +++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 153 ~~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 153 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999997643 899999999999999999999 89999999999999999999999999999988754332
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--------W 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--------~ 271 (314)
.....+||+.|+|||++ .+..|+.++|||||||++|+|++|..||.+....+.-... .
T Consensus 226 -~~~~~~GTp~YmAPEvl-------------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~ 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELI-------------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHH-------------TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS
T ss_pred -cccccccCcCcCCHHHH-------------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence 23346799999999876 3556889999999999999999999999875443321111 0
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
....+++.+++++ ||.+|||+.|+++ |+|+++.
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~------Hp~~~~~ 330 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK------HPFLAKA 330 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhcCC
Confidence 1234566566655 9999999999876 7777643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=372.00 Aligned_cols=241 Identities=24% Similarity=0.395 Sum_probs=186.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||+||+|++ .+|+.||+|+++... ......+.+|+++++.++||||+++++++++.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47999999999999999999995 579999999997653 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+ +|+|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 92 mEy~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EECC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EeCC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 9999 6799999987665 999999999999999999999 899999999999999999999999999999876443
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
. .....+||+.|+|||++. ....++.++|||||||++|+|++|..||............ .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~------------~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~ 230 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVIS------------GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT 230 (275)
T ss_dssp ------------CTTSCHHHHS------------SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred C---ccCCeeECcccCChhhhc------------CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2 223467999999998764 2233467899999999999999999999875433321111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
.+..+++.+++++ ||.+|||+.|+++ |+|++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hpw~k 267 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ------DDWFK 267 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH------CHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc------Ccccc
Confidence 2234555555555 9999999999987 56654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=375.32 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=206.3
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|.+.+.||+|+||+||+|++. ++..||||.++.......+.+.+|++++++++||||+++++++.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 468999999999999999999853 46789999998766666788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 115 LVLELMPNGSLENWLYSHN------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
+||||+++|+|.+++.+.+ ..+++.++..++.|++.||+||| +++++||||||+|||++.++.+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcE
Confidence 9999999999999997642 35899999999999999999999 8999999999999999999999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCcc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEM 261 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~ 261 (314)
||+|||+++...............||+.|+|||++. +..++.++|||||||++|||+| |..||...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-------------~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-------------YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHc-------------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999998664433322233346899999998764 4568899999999999999998 89999987
Q ss_pred ccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 262 FTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 262 ~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
...+..... ..+..+|+.+.+++ ||.+|||+.++.+.|+.+..
T Consensus 235 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 235 SNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 655432211 12345666666665 99999999999999887754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=383.13 Aligned_cols=239 Identities=23% Similarity=0.329 Sum_probs=195.1
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.++|++++.||+|+||+||+|++ .+|+.||||+++... ......+.+|++++++++||||+++++++++.+.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 37899999999999999999995 479999999998653 345577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 118 ELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 118 e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+||+|.+++... +..+++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999764 345789999999999999999999 899999999999999999999999999999876432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
. ......+||+.|+|||++ .+..|+.++|||||||++|+|++|..||......+......
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l-------------~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~ 243 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEIC-------------ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred c--ccccccCCCccccCHHHH-------------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence 1 112345799999999876 35568899999999999999999999998765444322211
Q ss_pred -hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 -VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 -~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.+..+++.+++++ ||.+|||+.|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234566566655 99999999999873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=375.36 Aligned_cols=247 Identities=29% Similarity=0.389 Sum_probs=200.0
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......+.|.+|++++++++||||+++++++.+++.++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467888899999999999999853 47789999998766666788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 115 LVLELMPNGSLENWLYSHN--------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~--------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
+||||+++|+|.+++.+.+ ..+++.++..++.|++.||+||| +++++||||||+|||++.++
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTT
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCC
Confidence 9999999999999997642 34889999999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~ 259 (314)
.+||+|||+++...............||+.|+|||++ .+..++.++|||||||++|||+| |+.||.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-------------~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-------------LYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhh-------------cCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 9999999999876543333333445689999999775 45678899999999999999999 899998
Q ss_pred ccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 260 EMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 260 ~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.....+..... ..+..+++.+.+++ ||.+|||+.|+++.|+.+.+
T Consensus 263 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 263 QLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp SSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 86654432111 12345666666665 99999999999999998765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=377.92 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=202.2
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..+.|++.+.||+|+||.||+|++ .+|+.||||+++.+. ...+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 346789999999999999999995 479999999998653 22469999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~~~~~ 197 (314)
|++||+|.+++.+.+. +++..+..++.|++.||+||| ++||+||||||+|||++.+| .+||+|||++..+....
T Consensus 131 y~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999987664 899999999999999999999 99999999999999999887 69999999998875432
Q ss_pred Ccc---eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh----
Q 047043 198 DSV---TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 198 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---- 270 (314)
... .....+||+.|+|||++. +..|+.++|||||||++|+|++|..||............
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~-------------~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 272 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVM-------------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP 272 (336)
T ss_dssp --------CCCCCCGGGCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC
T ss_pred cccceecCCccccCccccCHHHHC-------------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC
Confidence 211 122346999999997763 556889999999999999999999999875544322111
Q ss_pred ----hhhccCCchhhhhc------cccCCCCHHHHHHHHHh-------hhhheeee
Q 047043 271 ----WVNESLPHALTDVV------DANLRVSMKDVAAKLKK-------IRVKFLYD 309 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~-------~~~~~~~~ 309 (314)
..++.+++.+.+++ ||.+|||+.|+++++.. +.|+|+..
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 12345666666665 99999999999988765 45666654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=363.80 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=193.4
Q ss_pred cCc-cccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc----CCce
Q 047043 42 EGF-NECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN----PDFK 113 (314)
Q Consensus 42 ~~y-~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 113 (314)
++| ++.+.||+|+||+||+|.+ .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+ .+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 444 6777899999999999995 479999999997653 3345678999999999999999999999864 4568
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEec-CCCcEEEEeeecc
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLD-ENMVARVSDFGIS 190 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~-~~~~ikl~Dfg~~ 190 (314)
|+||||+++|+|.+++.+.+. +++..+..++.|++.||+||| ++| |+||||||+|||++ .++.+||+|||++
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~ylH----~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999999987654 899999999999999999999 777 99999999999997 4789999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
...... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||....+...-...
T Consensus 180 ~~~~~~----~~~~~~GTp~YmAPE~~~--------------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~ 241 (290)
T 3fpq_A 180 TLKRAS----FAKAVIGTPEFMAPEMYE--------------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241 (290)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGG--------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred EeCCCC----ccCCcccCccccCHHHcC--------------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH
Confidence 754322 223457999999998752 24788999999999999999999999765433221111
Q ss_pred --------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 271 --------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 --------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
..+..+++.+++++ ||.+|||+.|+++ |+|+++
T Consensus 242 i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~------Hp~~~~ 288 (290)
T 3fpq_A 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQE 288 (290)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC-
T ss_pred HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc------CccccC
Confidence 12233444455554 9999999999876 788765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=383.28 Aligned_cols=242 Identities=22% Similarity=0.314 Sum_probs=204.0
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.+.|++++.||+|+||.||+|++ .+|+.||||+++.......+.+.+|+.+|+.++||||+++++++.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35699999999999999999995 47999999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
|+||+|.+++.... +++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 230 ~~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 230 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 99999999997643 899999999999999999999 89999999999999999999999999999988754322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------- 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-------- 271 (314)
.....+||+.|+|||++ .+..|+.++|||||||++|+|++|..||.+....+......
T Consensus 303 -~~~~~~GTp~YmAPEvl-------------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~ 368 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELI-------------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK 368 (423)
T ss_dssp -CBCCCEECTTTCCHHHH-------------TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred -cccccccCcCcCCHHHH-------------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc
Confidence 23346799999999876 35568899999999999999999999998754433211110
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
....+++.++++| ||.+|||+.|+++ |+|++.
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~------Hp~~~~ 406 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK------HPFLAK 406 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGGG
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CHHhcC
Confidence 1234555555555 9999999999876 777764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=367.65 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=202.7
Q ss_pred hcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
..++++.+.||+|+||+||+|++. +++.||||.++... ....+.|.+|+.++++++||||+++++++.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 456788899999999999999852 46789999997553 33457899999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 114 ALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+|||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECC
Confidence 99999999999999996532 34889999999999999999999 899999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCC
Q 047043 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~P 257 (314)
++.+||+|||+++...............||+.|+|||++. +..++.++|||||||++|||+| |..|
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-------------~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-------------YGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh-------------CCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 9999999999998764433322334457999999998764 4568899999999999999998 8999
Q ss_pred CCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 258 TDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 258 f~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
|.+....+..... ..+..+|+.+.+++ ||.+|||+.|+++.|+.+
T Consensus 248 f~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 248 YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9987654432211 12345666666665 999999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=369.06 Aligned_cols=243 Identities=27% Similarity=0.325 Sum_probs=192.7
Q ss_pred cCccccceeeecCceEEEEEEeC----CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
++|++++.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++++.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999852 47889999997542 1223467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||++||+|.+++.+.+. +++..+..++.|++.||+||| ++||+||||||+|||++.+|.+||+|||++.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999987664 899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN----- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~----- 270 (314)
... .....+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....+.....
T Consensus 179 ~~~--~~~~~~GT~~YmAPE~~~-------------~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 179 HEK--KAYSFCGTVEYMAPEVVN-------------RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp --C--CCCSCCCCGGGCCHHHHH-------------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCc--cccccccCcccCCHHHhc-------------cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 222 223457999999998764 456788999999999999999999999876544332111
Q ss_pred hhhccCCchhhhhc------cccCCCCH-----HHHHHHHHhhhhheeeee
Q 047043 271 WVNESLPHALTDVV------DANLRVSM-----KDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~-----~~~~~~l~~~~~~~~~~~ 310 (314)
..+..+++.+++++ ||.+|||+ +|+++ |+|+++.
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~------Hp~f~~i 288 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR------HSFFSTI 288 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT------SGGGTTC
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc------CccccCC
Confidence 12344566555655 99999985 56654 7777653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=352.33 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=183.7
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCC-------
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD------- 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 111 (314)
.++|++++.||+|+||+||+|++ .+|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46799999999999999999995 4799999999986543 34467889999999999999999999987544
Q ss_pred -----ceeEEEEecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 112 -----FKALVLELMPNGSLENWLYSHNY--FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 112 -----~~~lv~e~~~~~sL~~~i~~~~~--~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
.+|++||||++|+|.+++..... ..++..+..++.|++.||+||| ++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEE
Confidence 36899999999999999987543 2345668899999999999999 899999999999999999999999
Q ss_pred EeeecceecCCCCCcc----------eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC
Q 047043 185 SDFGISKLLGDGEDSV----------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g 254 (314)
+|||++..+....... .....+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~-------------~~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-------------HGNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHH-------------TTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHH-------------cCCCCCCHHHHHHHHHHHHHHcc-
Confidence 9999998775432211 12234699999999776 35568899999999999999996
Q ss_pred CCCCCccccchhhhhhhhhccCC-----------chhhhhc--cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 255 KKPTDEMFTGEISLKNWVNESLP-----------HALTDVV--DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 255 ~~Pf~~~~~~~~~~~~~~~~~~~-----------~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
||.................+| +.+..++ ||.+|||+.|+++ |+|+++..
T Consensus 226 --Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~------h~~~~~~~ 287 (299)
T 4g31_A 226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE------NAVFEDLD 287 (299)
T ss_dssp --CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGCCC-
T ss_pred --CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhCCCC
Confidence 886543222222222222222 1344455 9999999999877 67766543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=360.24 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=205.3
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeC-C-----CCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCC-CCcceeecccc
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILS-D-----GNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHH-RNLLKIFSSCS 108 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 108 (314)
+....++|++.+.||+|+||+||+|.+. . ++.||+|.++.... ...+.+.+|++++.++.| |||++++++|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 3445789999999999999999999843 2 35799999976543 345678999999999965 89999999986
Q ss_pred c-CCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCC
Q 047043 109 N-PDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172 (314)
Q Consensus 109 ~-~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~ 172 (314)
. ++.+++|||||++|+|.+++.+.. ..+++..+..++.|++.||+||| +++++||||||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~ 214 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAAR 214 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCcc
Confidence 5 567899999999999999997532 34789999999999999999999 899999999999
Q ss_pred ceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 173 Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
|||++.++.+||+|||+++.+.............||+.|+|||++. +..++.++|||||||++|||+
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-------------~~~y~~ksDVwS~Gv~l~El~ 281 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------------DRVYTIQSDVWSFGVLLWEIF 281 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHT
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh-------------cCCCCCcccEeehHHHHHHHH
Confidence 9999999999999999998775544443444567899999998764 456889999999999999999
Q ss_pred c-CCCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 253 T-GKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 253 ~-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
| |..||.+....+.-.... .+..+++.+.+++ ||.+|||+.+++++|+.+.+
T Consensus 282 t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 282 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 8 999998765433222111 2334566666655 99999999999999988764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=353.49 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=187.6
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC----ceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD----FKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 116 (314)
.++|.+.+.||+|+||+||+|++ +|+.||||+++...... .....|+..+.+++||||+++++++.+.+ .+++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46788999999999999999997 68999999997653221 22334555566789999999999987653 57899
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH----SSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
|||+++|+|.+++...+ +++..+.+++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||++..
T Consensus 80 ~Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999998654 889999999999999999999310 012899999999999999999999999999987
Q ss_pred cCCCCCcc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch-----
Q 047043 193 LGDGEDSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE----- 265 (314)
Q Consensus 193 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~----- 265 (314)
........ ......||+.|+|||++... .......++.++|||||||++|||++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~-------~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDS-------INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTC-------SCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ccCCCCceeeecccccccccccCHHHhccc-------ccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 75433221 12235699999999987521 01123357889999999999999999987664322111
Q ss_pred -----h---hhhh-h----hhccCC---------chhhhh----c--cccCCCCHHHHHHHHHhhhhh
Q 047043 266 -----I---SLKN-W----VNESLP---------HALTDV----V--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 266 -----~---~~~~-~----~~~~~~---------~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
. .... . ..+.+| +.+.++ + ||.+|||+.++++.|+++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0 0110 0 011222 123333 3 999999999999999988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=364.63 Aligned_cols=204 Identities=25% Similarity=0.336 Sum_probs=172.5
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc------CC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN------PD 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 111 (314)
.++|++++.||+|+||+||+|++ .+|+.||||+++... ......+.+|+++|+.++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999995 579999999997543 2345678899999999999999999998653 46
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.+|+||||++ |+|.+++.+.+. +++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~-l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999996 689999987654 999999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCC--cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 192 LLGDGED--SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 192 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.+..... .......+||+.|+|||++. ....++.++||||+||++|+|++|..||.+..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~------------~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELML------------SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHT------------TCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ecccCccccccccccceeChHhcCHHHhc------------CCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 7643211 11233467999999998764 23457889999999999999999999998644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=356.97 Aligned_cols=205 Identities=21% Similarity=0.291 Sum_probs=171.8
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC----CCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeeccccc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN 109 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (314)
..+..+.++|++.+.||+|+||+||+|+.+ +++.||+|.+..... ...+.+|+++++.+ +||||+++++++.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 334456789999999999999999999842 467899999876533 35678899999998 69999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEeee
Q 047043 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDFG 188 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Dfg 188 (314)
.+.+|+||||+++++|.+++.. +++..+..++.|++.||+||| ++||+||||||+|||++.+ +.+||+|||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCEEEEEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999842 899999999999999999999 9999999999999999876 799999999
Q ss_pred cceecCCCCCc--------------------------ceeecccceeeeecCccccccccccCcccCCCCCCCCccccee
Q 047043 189 ISKLLGDGEDS--------------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVY 242 (314)
Q Consensus 189 ~~~~~~~~~~~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~ 242 (314)
+|......... ......+||+.|+|||++. ....++.++|||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~------------~~~~y~~~~DiW 231 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT------------KCPNQTTAIDMW 231 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT------------TCSCCCTHHHHH
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc------------CCCCCCCccchh
Confidence 99865432211 0112346999999998764 234578899999
Q ss_pred hhhHHHHHHhcCCCCCCcc
Q 047043 243 SFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 243 slG~il~~ll~g~~Pf~~~ 261 (314)
|+||++|+|++|..||...
T Consensus 232 SlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCC
T ss_pred hhHHHHHHHHHCCCCCCCC
Confidence 9999999999999999543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=372.58 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=197.1
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHH---HHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSF---DSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
.++|++++.||+|+||+||+|+. .+|+.||+|++++... ...... ..++.+++.++||||++++++|++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 57899999999999999999995 4799999999976421 111223 3345666677899999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+||||++||+|.+++.+.+. +++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||++..+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999987665 899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-hh-h--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-SL-K-- 269 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-~~-~-- 269 (314)
.... ....+||+.|+|||++. .+..|+.++|+|||||++|+|++|..||.+...... .. .
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~------------~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i 406 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQ------------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHS------------TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH
T ss_pred CCCC----CCCccCCcCccCHHHHh------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Confidence 5432 23357999999998763 345688999999999999999999999976443221 11 1
Q ss_pred ----hhhhccCCchhhhhc------cccCCCC-----HHHHHHHHHhhhhheeeee
Q 047043 270 ----NWVNESLPHALTDVV------DANLRVS-----MKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 270 ----~~~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~~l~~~~~~~~~~~ 310 (314)
...+..+++.+++++ ||.+|++ +.|+++ |+|++..
T Consensus 407 ~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~------HpfF~~i 456 (689)
T 3v5w_A 407 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------SPFFRSL 456 (689)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT------SGGGTTC
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc------CccccCC
Confidence 112345666666665 9999998 677665 7777653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=366.33 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=206.6
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..++|++.+.||+|+||.||+|+. .+|+.||+|++..........+.+|+++|+.++||||+++++++.+.+.+|+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 457899999999999999999995 4799999999987765566788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC--CcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN--MVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~--~~ikl~Dfg~~~~~~~~ 196 (314)
|++||+|.+++......+++..+..++.||+.||.||| ++||+||||||+|||++.+ +.+||+|||++..+...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999999766556999999999999999999999 8999999999999999754 89999999999987544
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------- 269 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------- 269 (314)
. .....+||+.|+|||++ .+..|+.++|||||||++|+|++|..||.+....+....
T Consensus 311 ~---~~~~~~GT~~y~APEv~-------------~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~ 374 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVA-------------EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 374 (573)
T ss_dssp S---EEEEECSSGGGCCHHHH-------------TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred C---ceeeeEECccccCHHHh-------------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC
Confidence 3 23345799999999776 355688899999999999999999999987654433111
Q ss_pred --hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 270 --NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 --~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
......+++.++++| ||.+|||+.|+++ |+|++.
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~------Hpw~~~ 416 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTP 416 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcCcCC
Confidence 112234566555554 9999999999987 677664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=326.97 Aligned_cols=242 Identities=23% Similarity=0.347 Sum_probs=199.1
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
+.+...++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 3344578999999999999999999995 589999999997653 3445678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEEEEECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 9999999999999999987654 899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~- 271 (314)
...... .....||+.|+|||++. .....+.++|||||||++|+|++|..||.............
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 228 (328)
T 3fe3_A 164 FTVGGK---LDAFCGAPPYAAPELFQ------------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228 (328)
T ss_dssp GSSSCG---GGTTSSSGGGCCHHHHH------------TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCCc---cccccCCcceeCccccc------------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 644322 23356999999998864 12233578999999999999999999998765443322211
Q ss_pred ----hhccCCchhhhh----c--cccCCCCHHHHHH
Q 047043 272 ----VNESLPHALTDV----V--DANLRVSMKDVAA 297 (314)
Q Consensus 272 ----~~~~~~~~l~~l----l--dp~~Rpt~~~~~~ 297 (314)
.+..++..+.++ + ||.+|||+.++++
T Consensus 229 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 229 GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 122344444444 4 9999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=319.23 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=204.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
....++|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.+++..++|
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34568999999999999999999994 57999999999876555567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|.+++.... +++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EECCTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EECCCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999997753 899999999999999999999 899999999999999999999999999998876543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
.. ......||+.|+|||++. +..++.++||||||+++|+|++|..||.............
T Consensus 170 ~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 234 (297)
T 3fxz_A 170 QS--KRSTMVGTPYWMAPEVVT-------------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234 (297)
T ss_dssp TC--CBCCCCSCGGGCCHHHHH-------------CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC
T ss_pred cc--ccCCccCCcCccChhhhc-------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 32 223356899999998763 4457889999999999999999999998754433211111
Q ss_pred ---hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 272 ---VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.+..+++.+.+++ ||.+|||+.|+++ |+|++.
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~------h~~~~~ 275 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ------HQFLKI 275 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGGG
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh------Chhhcc
Confidence 1234555555554 9999999999987 566543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=321.02 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=202.7
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
+-...+...++|++++.||+|+||.||+|+..+++.||+|+++.... .....+.+|+++++.++||||+++++++.+.
T Consensus 12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp ---CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred cceeecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 33455678899999999999999999999987899999999975532 2346778999999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+..++||||+++ +|.+.+......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCc
Confidence 999999999975 899988877767999999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
........ ......+|+.|+|||++. ....++.++|||||||++|+|++|..||......+.....
T Consensus 167 ~~~~~~~~--~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 167 RAFGIPVR--SYTHEVVTLWYRAPDVLM------------GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp EETTSCCC-----CCCCCCTTCCHHHHT------------TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred eecCCCcc--cccCCcccCCcCCHHHhc------------CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 87654322 223346899999998763 2345788999999999999999999999865443321110
Q ss_pred h-----------------------------------hhccCCch----hhhhc--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 271 W-----------------------------------VNESLPHA----LTDVV--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 ~-----------------------------------~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
. ..+.+++. +..++ ||.+|||+.|+++ |+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~ 306 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN------HPYFKD 306 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTT
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc------Cccccc
Confidence 0 11223333 44444 9999999999987 788776
Q ss_pred ec
Q 047043 310 VA 311 (314)
Q Consensus 310 ~~ 311 (314)
..
T Consensus 307 ~~ 308 (311)
T 3niz_A 307 LD 308 (311)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=317.75 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=208.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 57899999999999999999995 47999999998766566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++......+++..+..++.|++.||+||| +.|++|+||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999986667999999999999999999999 899999999999999999999999999999876443221
Q ss_pred ce------------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-
Q 047043 200 VT------------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI- 266 (314)
Q Consensus 200 ~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~- 266 (314)
.. .....||+.|+|||++ .+..++.++||||||+++|+|++|..||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMI-------------NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHH-------------TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred ccccccccccccccccccCCCcceeCHHHh-------------cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 11 1134689999999775 345678899999999999999999999876433221
Q ss_pred -------hhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 267 -------SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 267 -------~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
......+..+++.+.+++ ||.+|||+.++++.|+.++..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111222455666666655 99999999999999999987653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=322.76 Aligned_cols=258 Identities=33% Similarity=0.529 Sum_probs=208.9
Q ss_pred cceehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc
Q 047043 30 RRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109 (314)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (314)
..+++.++....++|++.+.||+|+||.||+|..++++.||+|.+..........+.+|+++++.++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 44566677778899999999999999999999987899999999887665566788999999999999999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 110 PDFKALVLELMPNGSLENWLYSHN---YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999987543 34889999999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++................||+.|+|||.+. +..++.++||||||+++|+|++|..||......+.
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFI-------------KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHH-------------HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred cccccccccccccccccccCCCccccCHHHhc-------------CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 99998764433322233345899999998764 34577899999999999999999999976433221
Q ss_pred h-hh-------------hhhh--------ccCC----chhhhhc--cccCCCCHHHHHHHHHhhhh
Q 047043 267 S-LK-------------NWVN--------ESLP----HALTDVV--DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 267 ~-~~-------------~~~~--------~~~~----~~l~~ll--dp~~Rpt~~~~~~~l~~~~~ 304 (314)
. .. .... +.++ +.+..++ ||.+|||+.++++.++.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 0 00 0000 1111 2233444 99999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.12 Aligned_cols=246 Identities=21% Similarity=0.358 Sum_probs=198.5
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4689999999999999999999954 799999999976532 23366889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+....
T Consensus 85 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp ECCTTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EcCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999876544 899999999999999999999 8999999999999999999999999999998764333
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh-----
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV----- 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~----- 272 (314)
.........||+.|+|||++. .....+.++|||||||++|+|++|..||............+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLK------------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHH------------CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred cccccCCCccCcCccCcHHhc------------cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence 222233456899999998864 223346789999999999999999999987554333222221
Q ss_pred ---hccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhheee
Q 047043 273 ---NESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 273 ---~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
...+++.+.++ + ||.+|||+.|+++ ++|+.
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~------h~~~~ 266 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK------DRWYN 266 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh------Chhhc
Confidence 13345544444 4 9999999999976 56654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=310.33 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=206.1
Q ss_pred HHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...++|++.+.||+|+||.||+|..+++..||+|+++..... ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 346789999999999999999999888888999999865432 3668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++++|.+++...+..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999999887666899999999999999999999 89999999999999999999999999999987654332
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------ 271 (314)
. ......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFH-------------YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHH-------------HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred h-cccCCCcCcccCCHHHHh-------------ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC
Confidence 2 222344677899998764 3446779999999999999999 999998765544322211
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+..+++.+.+++ ||.+|||+.++++.++.++.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1223455455544 999999999999999998765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.21 Aligned_cols=237 Identities=24% Similarity=0.294 Sum_probs=196.1
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++++.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|.++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 478999999999999999999954 79999999998652 23446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999987654 899999999999999999999 899999999999999999999999999998764322
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
.. ......||+.|+|||++ .+..++.++|+|||||++|+|++|..||.............
T Consensus 159 ~~--~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 223 (337)
T 1o6l_A 159 GA--TMKTFCGTPEYLAPEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGG-------------SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred CC--cccccccChhhCChhhh-------------cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 21 22345699999999775 34567889999999999999999999998754433221111
Q ss_pred hhccCCchhhhhc------cccCCC-----CHHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRV-----SMKDVAA 297 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~ 297 (314)
.+..+++.+.+++ ||.+|| ++.++++
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1234455555544 999999 8998877
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=320.59 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=202.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH------HHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
..+.++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 346788999999999999999999954 7999999999865321 246788999999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC----cEEEEe
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----VARVSD 186 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----~ikl~D 186 (314)
+..++||||+++++|.+++...+ .+++..+..++.|++.||.||| ++|++|+||||+||+++.++ .+||+|
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999999997655 4899999999999999999999 89999999999999998776 799999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||......+.
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~ 226 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVN-------------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHc-------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999987754322 23356999999997753 45678899999999999999999999987544332
Q ss_pred hh---------hhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 267 SL---------KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 267 ~~---------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.. .......+++.+++++ ||.+|||+.|+++ |+|+..
T Consensus 227 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~~ 278 (361)
T 2yab_A 227 LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR------HPWITP 278 (361)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------STTTSC
T ss_pred HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc------CcCcCC
Confidence 11 1112234566555555 9999999999886 566553
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=316.33 Aligned_cols=237 Identities=21% Similarity=0.336 Sum_probs=199.3
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
+.++|++.+.||+|+||.||+|... +++.+|+|.++... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4689999999999999999999954 68899999997653 344668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC--CCcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE--NMVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~--~~~ikl~Dfg~~~~~~~~ 196 (314)
|+++++|.+++...+..+++..+..++.|++.||.||| ++|++|+||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999999877666999999999999999999999 899999999999999986 789999999999877543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------- 269 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------- 269 (314)
. ......+|+.|+|||++. +..++.++||||||+++|+|++|..||...........
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 221 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQ-------------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHT-------------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred C---ccccccCChhhcCcHHhc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence 2 223456899999997753 44567899999999999999999999987554332111
Q ss_pred --hhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 270 --NWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 270 --~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
......+++.+.+++ ||.+|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234566555554 9999999999988
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=314.45 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=197.4
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
+........++|++.+.||+|+||.||+|+. +++.||+|++.... ......+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344445578999999999999999999987 68899999987653 34456788999999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEecCCCcEEEEe
Q 047043 111 DFKALVLELMPNGSLENWLYSHNY--FLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~--~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~~~~~ikl~D 186 (314)
+..++||||+++++|.+++...+. .+++..++.++.|++.||+||| +.| ++||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999986542 3889999999999999999999 889 99999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++........ ......||+.|+|||++. +..++.++||||||+++|+|++|..||........
T Consensus 183 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~ 247 (309)
T 3p86_A 183 FGLSRLKASTFL--SSKSAAGTPEWMAPEVLR-------------DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247 (309)
T ss_dssp CC-------------------CCTTSCHHHHT-------------TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred CCCCcccccccc--ccccCCCCccccChhhhc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999875433211 223356899999997763 45567899999999999999999999987655433
Q ss_pred hhhh-------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 267 SLKN-------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 267 ~~~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.... ..+..+++.+.+++ ||.+|||+.++++.|+.+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 2211 12234555555554 9999999999999999887654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=311.92 Aligned_cols=203 Identities=23% Similarity=0.399 Sum_probs=172.7
Q ss_pred cCccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++.+.||+|+||.||+|+..+++.||+|.++.... .....+.+|+++++.++||||+++++++.+.+..++|||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999987899999999976532 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++ +|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 999999876666899999999999999999999 89999999999999999999999999999876643221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
......+|+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 156 -~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLM------------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp -------CCCTTCCHHHHT------------TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -ccccccccccccCchhee------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 122346899999998763 234578899999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=322.54 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=204.2
Q ss_pred HhcCccccceeeecCceEEEEEEeC--------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccccc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS--------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN 109 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|++. ++..||+|+++... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999842 34579999997653 33457789999999999 89999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 110 PDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.||| ++|++||||||+||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NI 234 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNV 234 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhE
Confidence 999999999999999999998653 23788999999999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT- 253 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~- 253 (314)
+++.++.+||+|||++................+|+.|+|||++. +..++.++|||||||++|+|++
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-------------DRVYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-------------TCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-------------CCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999999998765433322223345788999998763 4567889999999999999999
Q ss_pred CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 254 GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
|..||......+..... ..+..+++.+.+++ ||.+||++.++++.|+.+....
T Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 302 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 99999876544332111 12234555555554 9999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.89 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=204.8
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
.+.+.....++|++.+.||+|+||.||+|.+.++..||+|+++..... ...+.+|+++++.++||||+++++++.+.+.
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 344445667899999999999999999999888889999999865322 3668899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999999875556999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~ 271 (314)
...... .......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 170 ~~~~~~-~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 235 (283)
T 3gen_A 170 VLDDEY-TSSVGSKFPVRWSPPEVLM-------------YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235 (283)
T ss_dssp BCCHHH-HSTTSTTSCGGGCCHHHHH-------------HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cccccc-ccccCCccCcccCCHHHhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence 543211 1122234678899998764 3356789999999999999998 999998765443322111
Q ss_pred ------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 272 ------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 272 ------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+..+++.+.+++ ||.+|||+.+++++++++..+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1223445455544 999999999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.88 Aligned_cols=240 Identities=24% Similarity=0.331 Sum_probs=195.8
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++++.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 468899999999999999999995 478999999997653 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+.+++|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EECCCTTEEHHHHHHTTCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999987554 899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh--hhh---
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS--LKN--- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~--~~~--- 270 (314)
.. ......||+.|+|||++. ...+..++.++|||||||++|+|++|..||......... ...
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~----------~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~ 234 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFS----------SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTC----------CCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred CC---ceeccCCCccccCCeeec----------cCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence 32 223456999999998863 123456788999999999999999999999754322111 111
Q ss_pred ---hhhccCCchhhhhc------cccCCCC-HHHHHH
Q 047043 271 ---WVNESLPHALTDVV------DANLRVS-MKDVAA 297 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt-~~~~~~ 297 (314)
..+..+++.+.+++ ||.+||+ +.++.+
T Consensus 235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11234455454544 9999998 666554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.53 Aligned_cols=199 Identities=23% Similarity=0.366 Sum_probs=171.4
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999995 479999999997653 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++ ++.+.+...+..+++..+..++.|++.||+||| ++|++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9975 777777766666999999999999999999999 89999999999999999999999999999987654322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
......+|+.|+|||++. ....++.++|||||||++|+|++|..||-
T Consensus 157 --~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLF------------GAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHT------------TCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred --cccCCccccCCcChHHHc------------CCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 223346899999998763 23347889999999999999999888853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=325.65 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=206.8
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
....++|++.+.||+|+||.||+|.++ +++.||+|+++.... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344678999999999999999999965 799999999876532 344678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++...+..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999877666899999999999999999999 89999999999999999999999999999886543
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~---- 270 (314)
...........++..|+|||.+. ...++.++||||||+++|+|++ |..||............
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 332 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALN-------------YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG 332 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC
T ss_pred CceeecCCCCCCCcCcCCHhHhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 22111112223577899998764 3457789999999999999998 99999876554332111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.++.+.
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 11234555555554 9999999999999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=309.94 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=204.3
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 35789999999999999999999878889999999865432 36688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++......+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 9999999999877667899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------V 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~ 272 (314)
.......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||......+...... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFS-------------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred ccccCcccccccCCHHHhc-------------CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence 1122234677899998763 3457789999999999999999 999998765443322111 1
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+..+++.+.+++ ||.+||++.+++++++++...
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 223454455544 999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.49 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=197.1
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC----ceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD----FKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 115 (314)
..++|++.+.||+|+||.||+|++ .++.||+|+++... ........|+.++++++||||+++++++.+.. .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 457899999999999999999997 47899999997653 33345566888899999999999999988754 3699
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC----------CeeecCCCCCceEecCCCcEEEE
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA----------PIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~----------~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
||||+++++|.+++.... +++..++.++.|++.||+||| +. |++|+||||+||+++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999997754 899999999999999999999 78 99999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
|||++................||+.|+|||++... ......++.++|||||||++|+|++|..||.......
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA--------INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC--------CCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccc--------cccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 99999877654433333345689999999887421 1112356678999999999999999999997643211
Q ss_pred h--------------hhhhhh-----hcc-------------CCchhhhhc--cccCCCCHHHHHHHHHhhhhh
Q 047043 266 I--------------SLKNWV-----NES-------------LPHALTDVV--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 266 ~--------------~~~~~~-----~~~-------------~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
. ...... .+. +.+.+..++ ||.+|||+.++++.|+.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000000 011 222344444 999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=309.02 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=201.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
+.++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 467899999999999999999995 479999999986532 3445778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 89 v~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999987654 899999999999999999999 89999999999999999999999999999876643
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh------
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------ 269 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------ 269 (314)
.... ......||+.|+|||.+. +..++.++||||||+++|+|++|..||...........
T Consensus 164 ~~~~-~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 164 TSLT-QTNHVLGTVQYFSPEQAK-------------GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp ------------CCSSCCHHHHH-------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred cccc-ccCccccCccccCHhHhc-------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 3221 223346899999998763 44567889999999999999999999987654332211
Q ss_pred ----hhhhccCCchhhhhc------cccCCC-CHHHHHHHHHhhhhhe
Q 047043 270 ----NWVNESLPHALTDVV------DANLRV-SMKDVAAKLKKIRVKF 306 (314)
Q Consensus 270 ----~~~~~~~~~~l~~ll------dp~~Rp-t~~~~~~~l~~~~~~~ 306 (314)
......+++.+.+++ ||.+|| ++.++.+.+..+..+-
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 122345666666665 999998 9999999998876554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=325.79 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=201.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|..+++.++||||+++++++.+.+.+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999954 689999999976421 122457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++.....
T Consensus 147 V~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999999997643 899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
... .......||+.|+|||++.. ......++.++|||||||++|+|++|..||.............
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~---------~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKS---------QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHT---------TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred CCc-ccccCCcCCccccCHHHhhc---------cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 322 12234579999999998752 1223347889999999999999999999998754433211111
Q ss_pred -----hhccCCchhhhhc------cccC--CCCHHHHHHHHHhhhhheeeee
Q 047043 272 -----VNESLPHALTDVV------DANL--RVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 -----~~~~~~~~l~~ll------dp~~--Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
....++..+++++ +|.. ||++.|+++ |+|+++.
T Consensus 291 ~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~------Hp~f~~~ 336 (410)
T 3v8s_A 291 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR------HLFFKND 336 (410)
T ss_dssp HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT------SGGGCCS
T ss_pred cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc------CccccCC
Confidence 1124555555555 6777 999999887 6777653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=311.55 Aligned_cols=240 Identities=27% Similarity=0.367 Sum_probs=198.7
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 578999999999999999999954 79999999998653 12346678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.+|.+||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999987654 899999999999999999999 999999999999999999999999999999876432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
.....||+.|+|||++. +..++.++|+|||||++|+|++|..||.............
T Consensus 160 -----~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 221 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVS-------------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 221 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHT-------------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred -----cccccCCccccCHhHhc-------------CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 12346899999997763 4557889999999999999999999998754433211111
Q ss_pred hhccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 272 VNESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
.+..+++.+.+++ ||.+|| ++.++++ |+|++.
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~------hp~f~~ 264 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN------HPWFKE 264 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT------SGGGSS
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc------CccccC
Confidence 1233455455544 999999 8888876 666654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.53 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=203.2
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CC---CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DG---NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..++|++.+.||+|+||.||+|.+. ++ ..||+|+++... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 4678999999999999999999963 33 359999998653 344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+++++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999877666999999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh-
Q 047043 195 DGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 195 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~- 271 (314)
...... ......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIA-------------FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred cCccceeeccCCCCcccccCHhHhc-------------CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 432221 122234577899998764 3457789999999999999999 999998765544322211
Q ss_pred -----hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 272 -----VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 272 -----~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.+..+++.+.+++ ||.+||++.++++.|+.+....
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 2234555555554 9999999999999999987543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=309.19 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=192.1
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
.....+...++|++.+.||+|+||.||+|+.. ..+|+|+++... ......+.+|+.+++.++||||++++++. ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 33444566789999999999999999999853 359999997653 34457789999999999999999999965 44
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
...++||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceec
Confidence 5678999999999999999877667999999999999999999999 899999999999999999999999999998
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
................||+.|+|||.+. ......++.++||||||+++|+|++|..||......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 237 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIR----------MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237 (289)
T ss_dssp ----------------CCCTTCCHHHHC--------------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH
T ss_pred cccccccccccccccCCCccccCchhhc----------ccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 7664433222333456899999998863 123556788999999999999999999999876543322221
Q ss_pred h-----------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 271 W-----------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 271 ~-----------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
. ....+++.+.+++ ||.+||++.++++.|+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 1124455555554 99999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.17 Aligned_cols=257 Identities=22% Similarity=0.283 Sum_probs=204.6
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
.++....++|++.+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|..++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344445689999999999999999999965 688999999986421 1223488899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+..++||||+++|+|.+++.+....+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999886566999999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
......... ......||+.|+|||++... ......++.++|||||||++|+|++|..||......+.....
T Consensus 223 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~--------~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 223 LKLMEDGTV-QSSVAVGTPDYISPEILQAM--------EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EECCTTSCE-ECCSCCSCGGGCCHHHHHHH--------HTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred hhcccCCCc-ccccccCCcCeeChHHHhhc--------ccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 876543322 22335799999999987521 112456788999999999999999999999875543322111
Q ss_pred h-------hh---ccCCchhhhhc------cccC--CCCHHHHHHHHHhhhhheeeee
Q 047043 271 W-------VN---ESLPHALTDVV------DANL--RVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 271 ~-------~~---~~~~~~l~~ll------dp~~--Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
. .+ ..+++.+++++ +|.. ||++.|+++ |+|++..
T Consensus 294 ~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~------Hpff~~i 345 (437)
T 4aw2_A 294 MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK------HPFFSGI 345 (437)
T ss_dssp HTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT------SGGGTTC
T ss_pred hhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC------CCccCCC
Confidence 1 01 12455555544 6666 899999887 6676543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=320.07 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=193.9
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++++.||+|+||.||+|+.+ +++.||+|+++... ......+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34689999999999999999999954 79999999998652 22345677899999988 799999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+||||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999987654 899999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-- 271 (314)
.... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||......+......
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 239 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQ-------------EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239 (353)
T ss_dssp CC-----------CCGGGCCHHHHH-------------HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccCC--ccccccCCCcCeEChhhcC-------------CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 3221 1233456999999998764 3346779999999999999999999998765443322111
Q ss_pred ---hhccCCchhhhhc------cccCCCCH------HHHHHHHHhhhhheeee
Q 047043 272 ---VNESLPHALTDVV------DANLRVSM------KDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt~------~~~~~~l~~~~~~~~~~ 309 (314)
.+..+++.+.+++ ||.+||++ .++++ |+|+++
T Consensus 240 ~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~------hp~f~~ 286 (353)
T 3txo_A 240 EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR------HPFFKE 286 (353)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT------SGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh------CCcccC
Confidence 1223444444444 99999998 66655 666654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=318.39 Aligned_cols=236 Identities=25% Similarity=0.419 Sum_probs=193.3
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 468999999999999999999995 5899999999976431 123468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+ +|+|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EEECC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99999 6799998877654 899999999999999999999 89999999999999999999999999999886644
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCC-CCcccceehhhHHHHHHhcCCCCCCccccchhhh-----h
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGI-ISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-----K 269 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-----~ 269 (314)
... .....||+.|+|||++. +.. .+.++||||||+++|+|++|..||.......... .
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~-------------~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~ 224 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVIN-------------GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSC-------------CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC
T ss_pred Ccc---cccccCCcCcCCHHHHc-------------CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC
Confidence 322 23356999999997753 233 3678999999999999999999998654322211 1
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+..+++.+.+++ ||.+|||+.|+++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112233455444444 9999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.42 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=199.7
Q ss_pred HhcCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc--CCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 112 (314)
..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+++++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 468899999999999999999983 2588999999987766667789999999999999999999998854 456
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||+++++|.+++...+..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 89999999999999999887666899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh----
Q 047043 193 LGDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS---- 267 (314)
Q Consensus 193 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~---- 267 (314)
....... .......++..|+|||.+. +..++.++||||||+++|+|++|..||.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 230 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLT-------------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230 (295)
T ss_dssp ------------CTTCGGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT
T ss_pred ccCCcceeeeccCCCCccceeCcHHhc-------------CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC
Confidence 6543221 1122334677899998764 345788999999999999999999998754221100
Q ss_pred ----------hh--------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 268 ----------LK--------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 268 ----------~~--------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.. ...+..+++.+.+++ ||.+|||+.++++.++.++..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 001234555555555 9999999999999999998765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=318.31 Aligned_cols=239 Identities=22% Similarity=0.329 Sum_probs=199.6
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 3567899999999999999999995 479999999998765555567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC--CCcEEEEeeecceecCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE--NMVARVSDFGISKLLGD 195 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~--~~~ikl~Dfg~~~~~~~ 195 (314)
||+++++|.+++...+..+++..+..++.|++.||.||| ++|++|+||||+||+++. ++.+||+|||++.....
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999877666999999999999999999999 899999999999999974 56799999999987754
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
... .....||+.|+|||++. +..++.++|||||||++|+|++|..||......+......
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~ 267 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVD-------------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHT-------------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred Ccc---eeeeccCCCccCchhcc-------------CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 322 23346899999997753 4557889999999999999999999998754432211110
Q ss_pred -----hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 -----VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 -----~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
....+++.+.+++ ||.+|||+.++++
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1123455555554 9999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=312.10 Aligned_cols=205 Identities=25% Similarity=0.409 Sum_probs=160.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|++++.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999995 4799999999976532 23356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 118 ELMPNGSLENWLYSHN-----YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
||++ ++|.+++.... ..+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9997 59999887542 34889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
...... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 158 ~~~~~~--~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 158 FGIPVN--TFSSEVVTLWYRAPDVLM------------GSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp TTSCCC--CCCCCCSCCTTCCHHHHT------------TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCcc--cCCCCcccccccCchHhh------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 654322 122346899999998763 234578899999999999999999999976543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=316.95 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=207.2
Q ss_pred ceehhhHHHHhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCcce
Q 047043 31 RTSYLDIQRATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLK 102 (314)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~ 102 (314)
.++..++....++|++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 444555566789999999999999999999983 2467899999986532 3456789999999999 7899999
Q ss_pred eecccccCC-ceeEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q 047043 103 IFSSCSNPD-FKALVLELMPNGSLENWLYSHNY----------------------------------------------- 134 (314)
Q Consensus 103 ~~~~~~~~~-~~~lv~e~~~~~sL~~~i~~~~~----------------------------------------------- 134 (314)
+++++.+.+ ..+++|||+++++|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987754 48999999999999999976532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 135 ------------------FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 135 ------------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
.+++..++.++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1889999999999999999999 899999999999999999999999999999876554
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~---- 271 (314)
..........+|+.|+|||++. +..++.++||||||+++|+|++ |..||.............
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 313 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIF-------------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred ccchhccccCCCceeEChhhhc-------------CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC
Confidence 4433444556888999998764 3457789999999999999998 999998765433222211
Q ss_pred ---hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 272 ---VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+..+++.+.+++ ||.+|||+.+++++|+.+...
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1223444455544 999999999999999988754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=309.98 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=206.7
Q ss_pred HHHhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
.-..++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 33468899999999999999999985 235789999997653 34557788999999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeec
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-----------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~ 167 (314)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| ++|++|+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~ 174 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHR 174 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCccc
Confidence 99999999999999999998643 23789999999999999999999 8999999
Q ss_pred CCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHH
Q 047043 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL 247 (314)
Q Consensus 168 dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i 247 (314)
||||+||+++.++.++|+|||++................+|+.|+|||.+. +..++.++||||||++
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-------------DHIYTTQSDVWSFGVL 241 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-------------HCEECHHHHHHHHHHH
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-------------CCCcCchhhHHHHHHH
Confidence 999999999999999999999998775543333333345788899998764 3456789999999999
Q ss_pred HHHHhc-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 248 LMETFT-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 248 l~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
+|+|++ |..||............ ..+..+++.+.+++ ||.+||++.++++.++.+..+.
T Consensus 242 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 999999 99999876544332111 11234555555554 9999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=311.28 Aligned_cols=238 Identities=23% Similarity=0.352 Sum_probs=197.1
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH------HHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||+|..+ +++.||+|+++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35678999999999999999999954 7999999999865321 3467889999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC----cEEEEee
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----VARVSDF 187 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----~ikl~Df 187 (314)
..++||||+++++|.+++...+ .+++..+..++.|++.||.||| ++|++|+||||+||+++.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999997654 4899999999999999999999 89999999999999998877 8999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..||......+..
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 226 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIV-------------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHH-------------TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred CCCeECCCCCc---cccccCCcCcCCceee-------------cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 99987754322 2234689999999775 3456788999999999999999999999765433221
Q ss_pred h---------hhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 268 L---------KNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 268 ~---------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
. .......+++.+.+++ ||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 227 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1112234555555544 9999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=323.07 Aligned_cols=243 Identities=19% Similarity=0.331 Sum_probs=198.2
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.+.....++|++.+.||+|+||.||+|.. .+|+.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp ---CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 34556788999999999999999999995 479999999998654 234567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---CCCcEEEEeee
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD---ENMVARVSDFG 188 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~---~~~~ikl~Dfg 188 (314)
..++||||+++++|.+.+...+. +++..+..++.|++.||.||| ++|++||||||+||+++ .++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 99999999999999999987655 899999999999999999999 89999999999999998 46789999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||..........
T Consensus 159 ~a~~~~~~~~--~~~~~~gt~~Y~APE~l~-------------~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~ 223 (444)
T 3soa_A 159 LAIEVEGEQQ--AWFGFAGTPGYLSPEVLR-------------KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223 (444)
T ss_dssp SCBCCCTTCC--BCCCSCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred eeEEecCCCc--eeecccCCcccCCHHHhc-------------CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 9977654322 122356999999997753 4567889999999999999999999997755433211
Q ss_pred hhh---------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 269 KNW---------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 269 ~~~---------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
... ....+++.+.+++ ||.+|||+.|+++
T Consensus 224 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 1124555555555 9999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=309.61 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=199.6
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC--ceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD--FKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 115 (314)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4578999999999999999999954 69999999997643 233566789999999999999999999987654 7799
Q ss_pred EEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe----cCCCcEEEEeeec
Q 047043 116 VLELMPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL----DENMVARVSDFGI 189 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili----~~~~~ikl~Dfg~ 189 (314)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999998653 23899999999999999999999 8999999999999999 7888899999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh---
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--- 266 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--- 266 (314)
+........ .....||+.|+|||++..... ....+..++.++|||||||++|+|++|..||........
T Consensus 163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVL-----RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHTS-----CCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ceecCCCCc---eeecccCCCccCHHHhhhccc-----cccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 987754432 223458999999998753211 111256788899999999999999999999975332111
Q ss_pred hhhhhh-----------------------------------hccCCchhhhhc--cccCCCCHHHHHHHHHhhhhh
Q 047043 267 SLKNWV-----------------------------------NESLPHALTDVV--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 267 ~~~~~~-----------------------------------~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
...... +..+.+.++.++ ||.+|||+.|++++..+..++
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 010100 111122334444 999999999999999877654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=317.73 Aligned_cols=236 Identities=22% Similarity=0.344 Sum_probs=191.0
Q ss_pred cCccc--cceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNE--CNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~--~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
+.|++ .+.||+|+||.||+|.. .+|+.||+|+++.........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34444 56899999999999995 5799999999988765566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe--cCCCcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL--DENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili--~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|+++++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++......
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999999999876666899999999999999999999 8999999999999999 56789999999999877543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
.. .....||+.|+|||++ ....++.++|||||||++|+|++|..||......+.....
T Consensus 243 ~~---~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 306 (373)
T 2x4f_A 243 EK---LKVNFGTPEFLAPEVV-------------NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD 306 (373)
T ss_dssp CB---CCCCCSSCTTCCHHHH-------------TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred cc---cccccCCCcEeChhhc-------------cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Confidence 32 2234689999999775 3456788999999999999999999999876543321111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.....+++.+.+++ ||.+|||+.|+++
T Consensus 307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11134555555554 9999999999988
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.60 Aligned_cols=259 Identities=35% Similarity=0.506 Sum_probs=206.2
Q ss_pred CCcccceehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccH-HHHHHHHHHHHHHhCCCCCcceee
Q 047043 26 VATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR-AFRSFDSECEVLRNVHHRNLLKIF 104 (314)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~ 104 (314)
......+++.++....++|++.+.||+|+||.||+|+..+++.||+|++...... ....+.+|+++++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3445678899999999999999999999999999999778999999999765322 223678999999999999999999
Q ss_pred cccccCCceeEEEEecCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC---CeeecCCCCCceEecC
Q 047043 105 SSCSNPDFKALVLELMPNGSLENWLYSHN---YFLDTLERLNIMIDVWLALEYLHHGHSSA---PIVHCDLKPSNILLDE 178 (314)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~---~~~~~~~~~~i~~~l~~~l~~LH~~~~~~---~i~H~dlkp~Nili~~ 178 (314)
+++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +. |++|+||||+||+++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH----DHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH----HSSSSCEECCCCSGGGEEECT
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCeEeCCCchhhEEECC
Confidence 99999999999999999999999998643 34889999999999999999999 77 9999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCC
Q 047043 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT 258 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf 258 (314)
++.++|+|||++......... ......||+.|+|||.+. +..++.++||||||+++|+|++|..||
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLS-------------TGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHH-------------HSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred CCCEEeccCccccccCccccc-ccccccCCcCccCHHHhc-------------cCCCCccccchhHHHHHHHHHhCCCcc
Confidence 999999999999876543322 223345899999998764 344678999999999999999999999
Q ss_pred Ccccc---chhhhhhhh-------------------------hccCCchhhhhc--cccCCCCHHHHHHHHHhh
Q 047043 259 DEMFT---GEISLKNWV-------------------------NESLPHALTDVV--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 259 ~~~~~---~~~~~~~~~-------------------------~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~ 302 (314)
+.... .......+. ...+.+.+..++ ||.+|||+.+++++|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 63211 000000000 011112233344 999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=313.08 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=201.3
Q ss_pred HHhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (314)
...++|++.+.||+|+||.||+|.. .++..||+|+++... ......+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3568899999999999999999995 235689999997543 23446788999999999 899999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecC
Q 047043 111 DFKALVLELMPNGSLENWLYSHNY----------------------FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~----------------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~d 168 (314)
+..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.|++|+|
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~D 197 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRD 197 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETT
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCC
Confidence 999999999999999999986542 2688999999999999999999 89999999
Q ss_pred CCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHH
Q 047043 169 LKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLL 248 (314)
Q Consensus 169 lkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il 248 (314)
|||+||+++.++.++|+|||++................+|+.|+|||.+. +..++.++||||||+++
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-------------EGIYTIKSDVWSYGILL 264 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-------------cCCCChhHhHHHHHHHH
Confidence 99999999999999999999998775544333344456788899998764 34578899999999999
Q ss_pred HHHhc-CCCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 249 METFT-GKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 249 ~~ll~-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
|+|++ |..||............. .+..+++.+.+++ ||..||++.++++.++.+......
T Consensus 265 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred HHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 99998 999998765433211111 1223455555554 999999999999999988765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=307.48 Aligned_cols=204 Identities=24% Similarity=0.313 Sum_probs=170.3
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 578999999999999999999954 699999999865532 33466789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhcC-CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999888888765544 899999999999999999999 8999999999999999999999999999998765332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
. ......+|+.|+|||.+. ....++.++||||||+++|+|++|..||.....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLV------------GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp -----------GGGCCHHHHH------------TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c--ccCCCcCCccccChHHHh------------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 123346899999998764 234578899999999999999999999987544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=303.36 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=201.3
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 5688999999999999999999954 79999999997653 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhccC-CCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999876543 899999999999999999999 8999999999999999999999999999988764332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh-----
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV----- 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~----- 272 (314)
.........+++.|+|||.+. .....+.++||||||+++|+|++|..||............+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLK------------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGT------------CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT
T ss_pred chhcccCCccccCccChHHHh------------cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc
Confidence 222233456899999998753 122346789999999999999999999987654332222211
Q ss_pred ---hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 273 ---NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 273 ---~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
...+++.+.+++ ||.+|||+.|+++ ++|+.+.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~~ 268 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK------DRWYNKP 268 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTTCC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc------CccccCh
Confidence 134555555554 9999999999987 5665543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=314.92 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=206.0
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (314)
.+....++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445789999999999999999999953 34789999998653 334577899999999999999999999999
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHN-----------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~ 165 (314)
+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| ++|++
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~iv 196 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFV 196 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCee
Confidence 9999999999999999999998642 45899999999999999999999 89999
Q ss_pred ecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhh
Q 047043 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFG 245 (314)
Q Consensus 166 H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG 245 (314)
|+||||+||+++.++.+||+|||++................+|+.|+|||.+. +..++.++||||||
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG 263 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------------YNRYTTESDVWAYG 263 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-------------HCCCCHHHHHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-------------cCCcCcccccHHHH
Confidence 99999999999999999999999987664433222233456788999998764 33477899999999
Q ss_pred HHHHHHhc-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 246 VLLMETFT-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 246 ~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
+++|+|++ |..||......+..... ..+..++..+.+++ ||.+||++.++++.|+.+..++...
T Consensus 264 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred HHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 99999999 99999876544332111 11234555555554 9999999999999999998877543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=314.34 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=199.8
Q ss_pred cccceehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-----cHHHHHHHHHHHHHHhCCCCCcc
Q 047043 28 TWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLL 101 (314)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~ 101 (314)
+....+.-++..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+
T Consensus 12 ~~~~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp --CCCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 334445566778889999999999999999999995 578999999997642 23456788999999999999999
Q ss_pred eeecccccCCceeEEEEecCCCCHHHHHhhc---------------------------------------CCCCCHHHHH
Q 047043 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSH---------------------------------------NYFLDTLERL 142 (314)
Q Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~---------------------------------------~~~~~~~~~~ 142 (314)
++++++.+.+..++||||+++++|.+++... ...+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 9999999999999999999999999988521 1123577888
Q ss_pred HHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC--cEEEEeeecceecCCCCCc--ceeecccceeeeecCcccc
Q 047043 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM--VARVSDFGISKLLGDGEDS--VTQTMTMATIGYMAPVSQL 218 (314)
Q Consensus 143 ~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~--~ikl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~ 218 (314)
.++.|++.||+||| +.|++|+||||+||+++.++ .+||+|||++..+...... .......||+.|+|||.+.
T Consensus 172 ~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 172 NIMRQIFSALHYLH----NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHH----HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 99999999999999 89999999999999998776 8999999999876432221 1223456899999998763
Q ss_pred ccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---------hhccCCchhhhhc-----
Q 047043 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---------VNESLPHALTDVV----- 284 (314)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---------~~~~~~~~l~~ll----- 284 (314)
.....++.++||||||+++|+|++|..||......+...... ....+++.+.+++
T Consensus 248 -----------~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 248 -----------TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp -----------CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred -----------cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcC
Confidence 123567889999999999999999999998765443322111 1123455555554
Q ss_pred -cccCCCCHHHHHH
Q 047043 285 -DANLRVSMKDVAA 297 (314)
Q Consensus 285 -dp~~Rpt~~~~~~ 297 (314)
||.+||++.++++
T Consensus 317 ~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 317 RNVDERFDAMRALQ 330 (345)
T ss_dssp SCTTTSCCHHHHHH
T ss_pred CChhHCCCHHHHhc
Confidence 9999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=315.90 Aligned_cols=238 Identities=25% Similarity=0.371 Sum_probs=182.6
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.....++|++.+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3456788999999999999999999964 68899999998653 23567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcEEEEeeeccee
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVARVSDFGISKL 192 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~ikl~Dfg~~~~ 192 (314)
||||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++. ++.+||+|||++..
T Consensus 126 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EECCCCSCBHHHHHTTCSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEeCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999999977654 899999999999999999999 899999999999999975 88999999999886
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV 272 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~ 272 (314)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..............
T Consensus 201 ~~~~~---~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~ 264 (349)
T 2w4o_A 201 VEHQV---LMKTVCGTPGYCAPEILR-------------GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264 (349)
T ss_dssp ---------------CGGGSCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH
T ss_pred cCccc---ccccccCCCCccCHHHhc-------------CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH
Confidence 54322 122346899999997753 44578899999999999999999999976554432222221
Q ss_pred h----------ccCCchhhhhc------cccCCCCHHHHHH
Q 047043 273 N----------ESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 273 ~----------~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
. ..++..+.+++ ||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 265 NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 23455455544 9999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.12 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=195.4
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++++.||+|+||.||+|+.+ +++.||+|+++... ......+.+|..++.++ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34678999999999999999999954 68899999998653 22334577899999877 899999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++||||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++...
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEcCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999999987654 899999999999999999999 899999999999999999999999999998753
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc--------h
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG--------E 265 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~--------~ 265 (314)
..... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||...... .
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~-------------~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~ 268 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILR-------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred ccCCC--ccccccCCcccCCchhhc-------------CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence 32221 233457999999997763 456788999999999999999999999643211 1
Q ss_pred hhhhhh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 266 ISLKNW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 266 ~~~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
...... .+..++..+.+++ ||.+||++......-+.+.|+|+++.
T Consensus 269 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 111111 1233455445544 99999996311111222337776543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=312.97 Aligned_cols=235 Identities=26% Similarity=0.307 Sum_probs=196.6
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++++.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|.++++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3578999999999999999999954 79999999997653 2234678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++.+.+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999987654 899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
.. ....||+.|+|||++. +..++.++|||||||++|+|++|..||.............
T Consensus 194 ~~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T 1rdq_E 194 RT-----WTLCGTPEALAPEIIL-------------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred Cc-----ccccCCccccCHHHhc-------------CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 32 2346899999998763 4457889999999999999999999998754433211111
Q ss_pred -hhccCCchhhhhc------cccCCCC-----HHHHHH
Q 047043 272 -VNESLPHALTDVV------DANLRVS-----MKDVAA 297 (314)
Q Consensus 272 -~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~ 297 (314)
.+..++..+.+++ ||.+||+ +.|+++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1234555555554 9999998 888876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=305.11 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=197.4
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CC-------CeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DG-------NNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||+|... ++ ..||+|+++.......+.+.+|+.+++.++||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3578999999999999999999943 44 469999998766666678999999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc--------EE
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV--------AR 183 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~--------ik 183 (314)
..++||||+++++|.+++...+..+++..+..++.|++.||.||| ++|++|+||||+||+++.++. ++
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999887666899999999999999999999 899999999999999988876 99
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC-CCCCCccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-KKPTDEMF 262 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-~~Pf~~~~ 262 (314)
|+|||++..... .....+|+.|+|||.+. ....++.++||||||+++|+|++| ..||....
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIE------------NPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHH------------CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhC------------CCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 999998865422 12245788899998764 124577899999999999999995 45555433
Q ss_pred cchhhhh----hhhhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhheeeeecc
Q 047043 263 TGEISLK----NWVNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKFLYDVAA 312 (314)
Q Consensus 263 ~~~~~~~----~~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~~~~~~~ 312 (314)
....... ...+...++.+.++ + ||.+|||+.++++.|+.+...-.....+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 224 SQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp HHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred hHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 3222111 11123334444444 4 9999999999999999988765554443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.23 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=195.8
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--------HHHHHHHHHHHHHHhCCCCCcceeecccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--------RAFRSFDSECEVLRNVHHRNLLKIFSSCS 108 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (314)
....++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678999999999999999999995 5789999999986531 12345678999999999999999999999
Q ss_pred cCCceeEEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 109 NPDFKALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
+.+..++|||++.++ +|.+++...+. +++..+..++.|++.||.||| ..|++|+||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999998666 99999887654 899999999999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++........ .....||+.|+|||++. .....+.++||||||+++|+|++|..||....... .
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~ 238 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLM------------GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-E 238 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHT------------TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-T
T ss_pred ccceECCCCCc---eeccCCCccccChhhhc------------CCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-h
Confidence 99987654332 22346899999998764 22233778999999999999999999998643321 1
Q ss_pred hhhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 268 LKNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 268 ~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.....+..+++.+.+++ ||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122333555555554 9999999999988
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=308.12 Aligned_cols=246 Identities=21% Similarity=0.313 Sum_probs=200.9
Q ss_pred ceehhhHHHHhcC----------ccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC
Q 047043 31 RTSYLDIQRATEG----------FNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99 (314)
Q Consensus 31 ~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ 99 (314)
.+++.++....+. |+..+.||+|+||.||+|+.. +|+.||+|+++.........+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666655443 788889999999999999965 79999999998765555677889999999999999
Q ss_pred cceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC
Q 047043 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN 179 (314)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~ 179 (314)
|+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999998754 3899999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 180 MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 180 ~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
+.+||+|||++........ ......||+.|+|||.+. +..++.++||||||+++|+|++|..||.
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVIS-------------RSLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999887654322 123356899999997753 4567889999999999999999999997
Q ss_pred ccccchhhhhh--------hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 260 EMFTGEISLKN--------WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 260 ~~~~~~~~~~~--------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
........... .....+++.+.+++ ||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 243 SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 65432221110 01123455455544 9999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=307.46 Aligned_cols=240 Identities=23% Similarity=0.314 Sum_probs=188.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--------------------------HHHHHHHHHHHHH
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--------------------------RAFRSFDSECEVL 92 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l 92 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 358999999999999999999995 4789999999976431 1235678999999
Q ss_pred HhCCCCCcceeeccccc--CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCC
Q 047043 93 RNVHHRNLLKIFSSCSN--PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLK 170 (314)
Q Consensus 93 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlk 170 (314)
+.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.|++|+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlk 164 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIK 164 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCC
Confidence 99999999999999876 5688999999999999886543 34899999999999999999999 8999999999
Q ss_pred CCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHH
Q 047043 171 PSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250 (314)
Q Consensus 171 p~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ 250 (314)
|+||+++.++.+||+|||++........ ......||+.|+|||.+.. .....++.++||||||+++|+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~----------~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSE----------TRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCT----------TCCCEESHHHHHHHHHHHHHH
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhcc----------CCCCCCCchhhhHhHHHHHHH
Confidence 9999999999999999999987654322 2233568999999987631 111224678999999999999
Q ss_pred HhcCCCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 251 TFTGKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 251 ll~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
|++|..||............. ....+++.+.+++ ||.+||++.|+++
T Consensus 233 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999998654332211110 1124555555554 9999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.70 Aligned_cols=240 Identities=31% Similarity=0.508 Sum_probs=197.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH-------HHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR-------AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 47899999999999999999995 57999999998654321 1157889999999999999999999997765
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEecCCCc-----EEEE
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLDENMV-----ARVS 185 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~~~~~-----ikl~ 185 (314)
++||||+++++|.+.+......+++..++.++.|++.||+||| +.| ++|+||||+||+++.++. ++|+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6899999999999999877767999999999999999999999 888 999999999999987776 9999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
|||++..... ......+|+.|+|||.+. .....++.++||||||+++|+|++|..||.......
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~-----------~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIG-----------AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSS-----------CSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred CCCccccccc-----cccccCCCccccCchhhc-----------cCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 9999875433 223356899999998752 134557789999999999999999999998765444
Q ss_pred hhhhhh---------hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 266 ISLKNW---------VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 266 ~~~~~~---------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
...... .+..+++.+.+++ ||.+|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 322111 2234555556655 999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=306.69 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=207.2
Q ss_pred HHhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCcceeecccccC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (314)
...++|++.+.||+|+||.||+|.+ .+++.||+|+++.... ...+.+.+|+.+++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3467999999999999999999984 2467899999986543 3457788999999999 899999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNY-----------------FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSN 173 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~-----------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~N 173 (314)
+..++||||+++++|.+++..... .+++..++.++.|++.||.||| ++|++|+||||+|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~N 175 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARN 175 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGG
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccce
Confidence 999999999999999999986542 3899999999999999999999 8999999999999
Q ss_pred eEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 174 ILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 174 ili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
|+++.++.+||+|||++................+|+.|+|||.+. +..++.++||||||+++|+|++
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt 242 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------------NCVYTFESDVWSYGIFLWELFS 242 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc-------------CCCCChHHHHHHHHHHHHHHHh
Confidence 999999999999999998776554433334455788899998764 3457789999999999999998
Q ss_pred -CCCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 254 -GKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 254 -g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
|..||............. .+..+++.+.+++ ||.+|||+.++++.|+++..+.
T Consensus 243 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999998765433211111 1234555555554 9999999999999999887654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=302.57 Aligned_cols=244 Identities=21% Similarity=0.334 Sum_probs=202.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..+.++|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 456788999999999999999999954 6889999999876555567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~~~~~ 193 (314)
|||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999999877654 899999999999999999999 8999999999999999 78889999999999876
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-- 271 (314)
..... .....+|+.|+|||.+. +.++.++||||||+++|+|++|..||......+......
T Consensus 160 ~~~~~---~~~~~~t~~y~aPE~~~--------------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (277)
T 3f3z_A 160 KPGKM---MRTKVGTPYYVSPQVLE--------------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG 222 (277)
T ss_dssp CTTSC---BCCCCSCTTTCCHHHHT--------------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cCccc---hhccCCCCCccChHHhc--------------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 54332 23346899999998752 237789999999999999999999998765443322111
Q ss_pred -------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 272 -------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 -------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
....+++.+.+++ ||.+|||+.++++ |+|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~------h~~~~~ 267 (277)
T 3f3z_A 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE------HEWFEK 267 (277)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT------SHHHHH
T ss_pred CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc------CHHHhc
Confidence 1124555555554 9999999999876 555544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=315.33 Aligned_cols=239 Identities=27% Similarity=0.354 Sum_probs=193.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (314)
....++|++.+.||+|+||.||+|+.+ +++.||+|+++... .........|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456789999999999999999999964 78999999998653 22345677889999876 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||+++++|.+++.+.+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999987654 899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~- 271 (314)
...... ......||+.|+|||++. +..++.++|+|||||++|+|++|..||......+......
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILL-------------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCCC--cccCCCCCcccCChhhhc-------------CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 432211 223456999999997763 4457889999999999999999999998755433221111
Q ss_pred ----hhccCCchhhhhc------cccCCCCHH-HHH
Q 047043 272 ----VNESLPHALTDVV------DANLRVSMK-DVA 296 (314)
Q Consensus 272 ----~~~~~~~~l~~ll------dp~~Rpt~~-~~~ 296 (314)
.+..++..+.+++ ||.+||++. +++
T Consensus 233 ~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1223455455544 999999987 444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=299.56 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=199.6
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC--CceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 115 (314)
..++|++.+.||+|+||.||+|++ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467899999999999999999997 48899999998653 34456788999999999999999999999876 78899
Q ss_pred EEEecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 116 VLELMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
+|||+++++|.+++..... .+++..++.++.|++.||.||| +.| ++|+||||+||+++.++.++|+|||+...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999987643 4899999999999999999999 888 99999999999999999999999987654
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~- 271 (314)
... ....+|+.|+|||.+... ....++.++||||||+++|+|++|..||.............
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~----------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 225 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKK----------PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSC----------GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH
T ss_pred ecc-------cCccCCccccChhhhccC----------CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh
Confidence 322 224578999999887421 12233457999999999999999999998765544322221
Q ss_pred ------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 272 ------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 272 ------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+..+++.+.+++ ||.+|||+.++++.|+.+.++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~~ 271 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 2234555555555 999999999999999988653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=314.02 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=195.7
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 578999999999999999999954 68999999998653 23456678899999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999987654 899999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc--------hhh
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG--------EIS 267 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~--------~~~ 267 (314)
... ......||+.|+|||++. +..++.++|+|||||++|+|++|..||...... ...
T Consensus 163 ~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 227 (345)
T 3a8x_A 163 PGD--TTSTFCGTPNYIAPEILR-------------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred CCC--cccccCCCccccCccccC-------------CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence 221 223356999999998763 456788999999999999999999999753211 111
Q ss_pred hhhh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 268 LKNW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 268 ~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.... .+..++..+.+++ ||.+||++......-+.+.|+|+++
T Consensus 228 ~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 228 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 1111 1233454444544 9999999631111122334777654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.09 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=206.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-C-------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCcceeeccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-S-------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLKIFSSC 107 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (314)
....++|++.+.||+|+||.||+|+. . .+..||+|+++.... .....+.+|+++++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34568999999999999999999994 2 235799999976543 3457788999999999 899999999999
Q ss_pred ccCCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCC
Q 047043 108 SNPDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPS 172 (314)
Q Consensus 108 ~~~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~ 172 (314)
.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++||||||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAAR 220 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcc
Confidence 99999999999999999999998753 34899999999999999999999 899999999999
Q ss_pred ceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 173 NILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 173 Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
||+++.++.+||+|||++................+|+.|+|||++. +..++.++|||||||++|+|+
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------------DRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-------------SCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-------------CCCCCchhHHHHHHHHHHHHH
Confidence 9999999999999999998765433322333345788999998763 456788999999999999999
Q ss_pred c-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 253 T-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 253 ~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
+ |..||......+..... ..+..+++.+.+++ ||.+|||+.++++.|+.+....
T Consensus 288 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 9 99999876544322111 11234555555554 9999999999999999987644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.58 Aligned_cols=240 Identities=21% Similarity=0.388 Sum_probs=198.0
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
....++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 456788999999999999999999954 79999999997653 344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEEEEeeecce
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VARVSDFGISK 191 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ikl~Dfg~~~ 191 (314)
+||||+++++|.+.+...+. +++..+..++.|++.||.||| ++|++|+||||+||+++.++ .+||+|||++.
T Consensus 105 lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999999876654 899999999999999999999 89999999999999997654 59999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh--
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-- 269 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-- 269 (314)
....... .....||+.|+|||++. +..++.++|||||||++|+|++|..||...........
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~ 243 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVLK-------------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 243 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EecCCcc---cccCCCCccccCHHHHc-------------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 7654322 22346899999997753 44678899999999999999999999987544332111
Q ss_pred -------hhhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 270 -------NWVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 270 -------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
......+++.+.+++ ||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111234555555554 99999999998874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=315.18 Aligned_cols=209 Identities=19% Similarity=0.241 Sum_probs=177.9
Q ss_pred HHhcCccccceeeec--CceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTG--SFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G--~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++.+.||+| +||.||+|+.+ +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 356789999999999 99999999965 79999999998654 34456788899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 114 ALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
++||||+++++|.+++... ...+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999765 344899999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCCc-----ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 193 LGDGEDS-----VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 193 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
....... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ-----------NLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHST-----------TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eccccccccccccccccccccccccCHHHHhc-----------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5322111 11122468899999987641 12467889999999999999999999997644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=301.47 Aligned_cols=258 Identities=31% Similarity=0.507 Sum_probs=208.2
Q ss_pred CcccceehhhHHHHhcCcccc------ceeeecCceEEEEEEeCCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhCC
Q 047043 27 ATWRRTSYLDIQRATEGFNEC------NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNVH 96 (314)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~ 96 (314)
.....+++.++....++|... +.||+|+||.||+|.. +++.||+|.+.... ......+.+|+.+++.++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345677888888888888776 8999999999999996 68899999987532 234577889999999999
Q ss_pred CCCcceeecccccCCceeEEEEecCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSH--NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 97 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~--~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
||||+++++++.+.+..+++|||+++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHE
Confidence 999999999999999999999999999999998743 345899999999999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG 254 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g 254 (314)
+++.++.++|+|||++................||+.|+|||.+. +.++.++||||||+++|+|++|
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------------~~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR--------------GEITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT--------------TEECTHHHHHHHHHHHHHHHHC
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc--------------CCCCccchhHHHHHHHHHHHHC
Confidence 99999999999999998765543333333456899999998753 2367799999999999999999
Q ss_pred CCCCCccccchhh-------------hhhhhhcc-----------CCchhhhhc--cccCCCCHHHHHHHHHhhh
Q 047043 255 KKPTDEMFTGEIS-------------LKNWVNES-----------LPHALTDVV--DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 255 ~~Pf~~~~~~~~~-------------~~~~~~~~-----------~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~ 303 (314)
..||......... ...+.... +.+.+..++ ||..|||+.++++.|+.+.
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred CCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 9999865432211 01111111 112334444 9999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=304.81 Aligned_cols=245 Identities=28% Similarity=0.356 Sum_probs=195.6
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..+.++|++.+.||+|+||.||+|.. .++..+|+|++..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 45678999999999999999999995 4799999999986542 235678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeec
Q 047043 116 VLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGI 189 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~ 189 (314)
||||+++++|.+.+... +..+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 99999999999988643 355899999999999999999999 8999999999999999 4567899999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
+........ .....+|+.|+|||.+. ..++.++||||||+++|+|++|..||......+....
T Consensus 174 a~~~~~~~~---~~~~~~t~~y~aPE~~~--------------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~ 236 (285)
T 3is5_A 174 AELFKSDEH---STNAAGTALYMAPEVFK--------------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236 (285)
T ss_dssp CCC-------------CTTGGGCCHHHHT--------------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ceecCCccc---CcCcccccCcCChHHhc--------------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence 976544321 23346899999998752 2467899999999999999999999987654443222
Q ss_pred hhh--------hccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 270 NWV--------NESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 ~~~--------~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
... ...+++.+.++ + ||.+|||+.|+++ ++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~f~~ 284 (285)
T 3is5_A 237 ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH------HEWFKQ 284 (285)
T ss_dssp HHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT------SGGGGC
T ss_pred hccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc------CHHhhc
Confidence 211 11234444444 4 9999999999987 677653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=301.19 Aligned_cols=248 Identities=17% Similarity=0.219 Sum_probs=204.7
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+++++.+ +|++++++++++.+....+++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 467899999999999999999995 579999999987553 235678899999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc-----EEEEeeeccee
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV-----ARVSDFGISKL 192 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~-----ikl~Dfg~~~~ 192 (314)
||+ +++|.+++...+..+++..+..++.|++.||.||| ++|++|+||||+||+++.++. ++|+|||++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999 89999999887666999999999999999999999 999999999999999987766 99999999987
Q ss_pred cCCCCCc-----ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh-
Q 047043 193 LGDGEDS-----VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI- 266 (314)
Q Consensus 193 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~- 266 (314)
....... .......||+.|+|||.+ .+..++.++||||||+++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 227 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTH-------------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 227 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred cccccccccccccCccCCCCCcccCCchhh-------------cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH
Confidence 7543321 112345689999999775 345578899999999999999999999987432211
Q ss_pred -hhh-----------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 267 -SLK-----------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 267 -~~~-----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
... ......+++.+.+++ ||.+||++.++++.++.+..+.-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 228 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 000 011235666666665 99999999999999999887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=312.76 Aligned_cols=203 Identities=23% Similarity=0.364 Sum_probs=167.7
Q ss_pred cCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHH-HHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRA-FRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++++.||+|+||.||+|+.. +++.||+|+++...... ...+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999964 79999999997653221 12445799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++ ++|.+++...+..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 97 5999999887777999999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
......+|+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 156 -~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILL------------GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp --------CGGGCCHHHHT------------TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -ccccccCcccccChhhhc------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 223346899999998753 234578899999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.66 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=192.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC----CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..++|++.+.||+|+||.||+|+.+ ++..||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3568999999999999999999853 57789999998653 344567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+++++|.+++...+..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999887767999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh-
Q 047043 195 DGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 195 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~- 271 (314)
...... ......++..|+|||.+. +..++.++||||||+++|+|++ |..||......+......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIA-------------YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ---------------CTTSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred cCCccceeccCCCcCCCccChhhhc-------------cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 432211 112223567899998764 3457789999999999999998 999998765443321111
Q ss_pred -----hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 272 -----VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 272 -----~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+..++..+.+++ ||.+||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1223444455544 999999999999999988653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=321.62 Aligned_cols=238 Identities=26% Similarity=0.433 Sum_probs=197.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4688999999999999999999964 799999999976532 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 94 v~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEECCSSEEHHHHTTSSSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999976554 899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW---- 271 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~---- 271 (314)
.. ......||+.|+|||++. .....+.++|||||||++|+|++|..||.............
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVIS------------GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHT------------TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC
T ss_pred cc---cccccCCCcCeEChhhcc------------CCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc
Confidence 32 223356999999998764 12234678999999999999999999998754433211111
Q ss_pred -hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 -VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 -~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.+..++..+.+++ ||.+|||+.++++
T Consensus 234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1223444444444 9999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=313.63 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=190.1
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.......++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 34455678999999999999999999995 4799999999976532 23456778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-----CCCcEEEEe
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-----ENMVARVSD 186 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-----~~~~ikl~D 186 (314)
..++||||+++ +|.+++...+. +++..+..++.|++.||.||| ++|++|+||||+||+++ .++.+||+|
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEEecCCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 99999999974 99999987654 899999999999999999999 89999999999999994 455699999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++........ ......+|+.|+|||++. ....++.++|||||||++|+|++|..||......+.
T Consensus 181 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 246 (329)
T 3gbz_A 181 FGLARAFGIPIR--QFTHEIITLWYRPPEILL------------GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246 (329)
T ss_dssp TTHHHHHC-------------CCTTCCHHHHT------------TCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCccccCCccc--ccCCCcCCccccCHHHhc------------CCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH
Confidence 999987643322 223345799999998764 234578899999999999999999999976543222
Q ss_pred hhhh-----------------------------------hhhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhh
Q 047043 267 SLKN-----------------------------------WVNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 267 ~~~~-----------------------------------~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.... .....+++.+.++ + ||.+|||+.|+++ |+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp 320 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE------HP 320 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SG
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC------Cc
Confidence 1111 1112244444444 4 9999999999987 78
Q ss_pred eeeee
Q 047043 306 FLYDV 310 (314)
Q Consensus 306 ~~~~~ 310 (314)
|+.+.
T Consensus 321 ~f~~~ 325 (329)
T 3gbz_A 321 YFSHN 325 (329)
T ss_dssp GGSSS
T ss_pred ccCCC
Confidence 87654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.12 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=188.2
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC-CCC---eEEEEEeeec--ccHHHHHHHHHHHHHHhCCCCCcceeeccccc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS-DGN---NVAIKVFKLQ--LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~---~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (314)
+.....++|++.+.||+|+||.||+|... +++ .||+|+++.. .....+.+.+|+++++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34445678999999999999999999954 343 7999999765 23456788999999999999999999999887
Q ss_pred CCce------eEEEEecCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC
Q 047043 110 PDFK------ALVLELMPNGSLENWLYSHN-----YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 110 ~~~~------~lv~e~~~~~sL~~~i~~~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~ 178 (314)
.+.. +++|||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcC
Confidence 6655 89999999999999986532 24899999999999999999999 899999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCC
Q 047043 179 NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~P 257 (314)
++.+||+|||++................+++.|+|||.+. +..++.++|||||||++|+|++ |..|
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ell~~g~~p 239 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA-------------DNLYTVHSDVWAFGVTMWEIMTRGQTP 239 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhc-------------CCCCCCccchhhHHHHHHHHHhCCCCC
Confidence 9999999999998765443322333345678899998764 3457789999999999999999 9999
Q ss_pred CCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 258 TDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 258 f~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
|......+..... ..+..+++.+.+++ ||.+|||+.++++.++++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 240 YAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9876554432221 12234555555554 9999999999999999886543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=319.40 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=203.6
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
...++|++.+.||+|+||.||+|+. .+++.||+|++++.. ......+.+|..++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3468899999999999999999996 479999999997642 123345788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+++++|.+++.+.+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999999999999876656999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--- 271 (314)
..... ......||+.|+|||++.... .......++.++|||||||++|+|++|..||......+......
T Consensus 214 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~------~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 214 ADGTV-RSLVAVGTPDYLSPEILQAVG------GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTSCE-ECSSCCSCGGGCCHHHHHHHH------TCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred CCCcc-ccceeccccCcCCHHHHhhcc------cCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 43321 222356999999999875211 01123467889999999999999999999998755433211111
Q ss_pred -------hhccCCchhhhhc-----cccCC---CCHHHHHHHHHhhhhheeeee
Q 047043 272 -------VNESLPHALTDVV-----DANLR---VSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 -------~~~~~~~~l~~ll-----dp~~R---pt~~~~~~~l~~~~~~~~~~~ 310 (314)
....++..+++++ +|..| |++.|+++ |+|++..
T Consensus 287 ~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~------Hpff~~i 334 (412)
T 2vd5_A 287 EHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRT------HPFFFGL 334 (412)
T ss_dssp HHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHT------SGGGTTC
T ss_pred cCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhc------CCCcCCC
Confidence 1134566555555 78777 68888866 6776543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=311.74 Aligned_cols=239 Identities=20% Similarity=0.319 Sum_probs=194.7
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-----HHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999995 4799999999975421 1346788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc---EEEEee
Q 047043 114 ALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV---ARVSDF 187 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~---ikl~Df 187 (314)
++||||+++++|.+.+... +..+++..+..++.|++.||.||| ++|++|+||||+||+++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999887643 345899999999999999999999 899999999999999986654 999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVK-------------REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHc-------------CCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH
Confidence 99987754322 123356999999998763 445788999999999999999999999874322111
Q ss_pred h--------hhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 268 L--------KNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 268 ~--------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
. .......+++.+.+++ ||.+|||+.++++
T Consensus 243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 1111234566555554 9999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=301.68 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=203.5
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++.+.||+|+||.||+|.+.+++.||+|+++.... ..+.+.+|+++++.++||||+++++++.+.+..+++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3578999999999999999999987888999999987643 236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 9999999999887666899999999999999999999 89999999999999999999999999999876533211
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~ 272 (314)
.......++..|+|||.+. +..++.++||||||+++|+|++ |..||............ ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 226 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFS-------------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred cccccccccccccChhhhc-------------CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 1112234678899998763 3456789999999999999999 89999875443322111 11
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+..++..+.+++ ||..||++.++++.|+.+...
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 223445455544 999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.34 Aligned_cols=217 Identities=25% Similarity=0.298 Sum_probs=183.4
Q ss_pred CCCCCCcccceehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC----
Q 047043 22 DLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH---- 96 (314)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---- 96 (314)
.+...-....+++.+.....++|++.+.||+|+||.||+|+. .+++.||+|+++.. .........|.++++.++
T Consensus 15 ~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~ 93 (360)
T 3llt_A 15 YFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDI 93 (360)
T ss_dssp -----CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCST
T ss_pred eeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCC
Confidence 334445566678888888899999999999999999999995 57899999999754 234466778999999986
Q ss_pred -CCCcceeecccccCCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 97 -HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 97 -h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
||||+++++++...+..++|||++ +++|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NI 168 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENI 168 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGE
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccE
Confidence 999999999999999999999999 889999998754 34899999999999999999999 89999999999999
Q ss_pred EecC-------------------------CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccC
Q 047043 175 LLDE-------------------------NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKF 229 (314)
Q Consensus 175 li~~-------------------------~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~ 229 (314)
+++. ++.+||+|||++....... ....||+.|+|||++.
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~----------- 232 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVIL----------- 232 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHT-----------
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHc-----------
Confidence 9975 7889999999998754432 2345899999997763
Q ss_pred CCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 230 GSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 230 ~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+..++.++|||||||++|+|++|..||....
T Consensus 233 --~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 233 --NLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp --TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --CCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 4567889999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=307.69 Aligned_cols=244 Identities=24% Similarity=0.318 Sum_probs=189.3
Q ss_pred HhcCccccceeeecCceEEEEEEe----CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 457899999999999999999995 478999999997642 223456778999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..++||||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGI-FMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999987654 889999999999999999999 8999999999999999999999999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
....... ......||+.|+|||++. +..++.++||||||+++|+|++|..||............
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILM-------------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHT-------------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCCc--cccccCCCcCccCHhhCc-------------CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5432221 122346899999998763 345678999999999999999999999875543321111
Q ss_pred ----hhhccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 271 ----WVNESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
..+..+++.+.+++ ||..|| ++.++++ |+|++.
T Consensus 235 ~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~------hp~f~~ 282 (327)
T 3a62_A 235 KCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA------HPFFRH 282 (327)
T ss_dssp HTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH------SGGGSS
T ss_pred hCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc------CCcccC
Confidence 12234555555554 999999 7778776 566543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=315.12 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=201.2
Q ss_pred HhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|.+. +++.||+|.++... ......+.+|+.+++.++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3578999999999999999999942 46689999997543 3344578899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEE
Q 047043 113 KALVLELMPNGSLENWLYSHN------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VAR 183 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ik 183 (314)
.++||||+++++|.+++...+ ..+++..++.++.|++.||+||| ++|++||||||+||+++.++ .+|
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999998653 34889999999999999999999 89999999999999998555 599
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMF 262 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~ 262 (314)
|+|||++................+|+.|+|||++. +..++.++|||||||++|+|++ |..||....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhc-------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999987653322222333456789999998764 3457889999999999999998 999998765
Q ss_pred cchhhhhhh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 263 TGEISLKNW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 263 ~~~~~~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+...... .+..++..+.+++ ||.+||++.++++.++.+...
T Consensus 292 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 292 NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 543322111 1234555555554 999999999999999887653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=311.74 Aligned_cols=239 Identities=23% Similarity=0.252 Sum_probs=194.0
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+..|.+++..+ +||+|+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34689999999999999999999965 58899999998653 22345677899999887 799999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+||||+++++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999987654 899999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-- 271 (314)
..... ......||+.|+|||++. +..++.++|+|||||++|+|++|..||......+......
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 236 (353)
T 2i0e_A 172 IWDGV--TTKTFCGTPDYIAPEIIA-------------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236 (353)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHT-------------TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccCCc--ccccccCCccccChhhhc-------------CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence 32221 223456999999997763 4557889999999999999999999998755433221111
Q ss_pred ---hhccCCchhhhhc------cccCCCC-----HHHHHH
Q 047043 272 ---VNESLPHALTDVV------DANLRVS-----MKDVAA 297 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~ 297 (314)
.+..++..+.+++ ||.+||+ +.++++
T Consensus 237 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1234555555544 9999995 466665
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=314.88 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=183.6
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...++|++++.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 45689999999999999999999954 799999999976532 2256788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc--EEEEeeecceecCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV--ARVSDFGISKLLGD 195 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~--ikl~Dfg~~~~~~~ 195 (314)
||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++. +||+|||++.....
T Consensus 96 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 96 EYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EeCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999977654 899999999999999999999 899999999999999987765 99999999874432
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh---hhhh
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL---KNWV 272 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~---~~~~ 272 (314)
.. ......||+.|+|||++. .....+.++|||||||++|+|++|..||.......... ....
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLL------------RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp -------------CTTSCHHHHH------------CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred cC---CCCCCcCCCCcCChhhhc------------CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 22 223346999999998764 12223445899999999999999999998754322111 1111
Q ss_pred --------hccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 273 --------NESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 273 --------~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
...+++.+.+++ ||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 113455455544 99999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.75 Aligned_cols=257 Identities=23% Similarity=0.260 Sum_probs=201.6
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc----cCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS----NPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~ 112 (314)
....++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+++++.++||||+++++++. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34567899999999999999999995 579999999998766666778899999999999999999999986 3457
Q ss_pred eeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 113 KALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
.+++|||+++++|.+++.. .+..+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 8899999999999999876 3455899999999999999999999 89999999999999999999999999998
Q ss_pred ceecCCCCCcce-------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 190 SKLLGDGEDSVT-------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 190 ~~~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+........... .....||+.|+|||.+.. .....++.++||||||+++|+|++|..||....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV----------QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSC----------CSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhcc----------CCCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 876532111100 012346899999987531 112236789999999999999999999997532
Q ss_pred cchhhhhh--------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 263 TGEISLKN--------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 263 ~~~~~~~~--------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
........ .....++..+.+++ ||.+||++.++++.++.+....-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 251 QKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred cccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 21111110 01123455555554 999999999999999998766543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.17 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=192.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEeCC----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILSD----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
....++|++.+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.+++.++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4456899999999999999999999532 4469999987543 334567889999999999999999999985 456
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||+++++|.+++...+..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 78999999999999999877666899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh-
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~- 270 (314)
....... ......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~ 231 (281)
T 1mp8_A 166 MEDSTYY-KASKGKLPIKWMAPESIN-------------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231 (281)
T ss_dssp --------------CCGGGCCHHHHH-------------HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred cCccccc-ccccCCCcccccChhhcc-------------cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence 6443221 122234677899998763 3456789999999999999996 99999876554332111
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
..+..+++.+.+++ ||.+||++.++++.++.+..+.
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 232 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 12234555555554 9999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.88 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=206.2
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC-CC-----CeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS-DG-----NNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSC 107 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (314)
......++|++.+.||+|+||.||+|... ++ ..||+|.++... ......+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44456789999999999999999999953 33 379999997653 23456788999999999 899999999999
Q ss_pred ccCCceeEEEEecCCCCHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 108 SNPDFKALVLELMPNGSLENWLYSH-------------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 108 ~~~~~~~lv~e~~~~~sL~~~i~~~-------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+||| +.|++|+||||+||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNV 195 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGC
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceE
Confidence 9999999999999999999998753 234789999999999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT- 253 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~- 253 (314)
+++.++.++|+|||++................+|+.|+|||.+. +..++.++||||||+++|+|++
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHTTT
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc-------------cCCCChHHHHHHHHHHHHHHHcC
Confidence 99999999999999998765444333333455788899998764 3457789999999999999998
Q ss_pred CCCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 254 GKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
|..||............. .+..+++.+.+++ ||..|||+.++++.|+.+..+..
T Consensus 263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 263 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp SCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 999998755433211111 1223455455544 99999999999999999877654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=308.37 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=200.8
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+|+++++.+ +||||+++++++..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 357899999999999999999995 5799999999876532 24688899999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc-----EEEEeeeccee
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV-----ARVSDFGISKL 192 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~-----ikl~Dfg~~~~ 192 (314)
||+ +++|.+++...+..+++..+..++.|++.||+||| +.|++||||||+||+++.++. +||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999 89999999876666999999999999999999999 899999999999999998887 99999999987
Q ss_pred cCCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 193 LGDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 193 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
+....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~ 226 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTH-------------LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHH-------------cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH
Confidence 65433211 12345689999999775 3456788999999999999999999999875432211
Q ss_pred --hhhh-----------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 268 --LKNW-----------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 268 --~~~~-----------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.... ....+| .+.+++ ||..||++.++.+.++.+..+.
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 227 ERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1110 011233 444443 9999999999999999887654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=309.60 Aligned_cols=208 Identities=27% Similarity=0.398 Sum_probs=169.4
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH-----HHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR-----AFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
.....++|++.+.||+|+||.||+|.. .+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 445678999999999999999999995 47999999999754321 124677899999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+..++||||+++ +|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999999975 999998877666899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
........ ......+|+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLF------------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHT------------TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccCCcc--cCCcccccccccCchHhh------------CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 87644322 223346899999998763 234478899999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=322.61 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=195.9
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-------------HHHHHHHHHHHHHHhCCCCCcce
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-------------RAFRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 102 (314)
...+.++|++++.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 345788999999999999999999995 4789999999976431 22467889999999999999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC--
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-- 180 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-- 180 (314)
+++++.++...++||||+++++|.+.+...+. +++..+..++.|++.||.||| +.|++||||||+||+++.++
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCC
Confidence 99999999999999999999999999877654 899999999999999999999 89999999999999998765
Q ss_pred -cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 181 -VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 181 -~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~--------------~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK--------------KKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp SSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT--------------TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc--------------cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 699999999987754322 23356999999998752 247789999999999999999999998
Q ss_pred ccccchhhhhh---------hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 260 EMFTGEISLKN---------WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 260 ~~~~~~~~~~~---------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.....+..... .....+++.+.+++ ||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 249 GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 76544321111 11234566555554 99999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=306.29 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=193.7
Q ss_pred HhcCcccc-ceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEE
Q 047043 40 ATEGFNEC-NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~-~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 116 (314)
..++|++. +.||+|+||.||+|.. .+++.||+|+++.........+.+|++++.++ .||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 46789986 7899999999999994 57999999999876555567788999999985 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc---EEEEeeecceec
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV---ARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~---ikl~Dfg~~~~~ 193 (314)
|||+++++|.+++...+. +++..+..++.|++.||+||| ++|++|+||||+||+++.++. +||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999987654 899999999999999999999 899999999999999987766 999999998765
Q ss_pred CCCCCc-----ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch---
Q 047043 194 GDGEDS-----VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--- 265 (314)
Q Consensus 194 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--- 265 (314)
...... .......||+.|+|||++... ......++.++|||||||++|+|++|..||......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAF--------SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHT--------SHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcc--------cccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 322111 111234589999999987521 0011346779999999999999999999997653221
Q ss_pred -----------hhhhh----------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 266 -----------ISLKN----------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 266 -----------~~~~~----------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
..... .....++..+.+++ ||.+|||+.|+++ |+|+...
T Consensus 237 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~ 302 (316)
T 2ac3_A 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ------HPWVQGC 302 (316)
T ss_dssp ----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------STTCC--
T ss_pred cccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc------ChhhcCC
Confidence 00000 11123555555554 9999999999987 7777654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.13 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=192.9
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCe----EEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNN----VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||+|+||.||+|++. +++. |++|.++... ......+.+|+.++++++||||+++++++.+++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 578999999999999999999953 5554 5777765432 234567889999999999999999999998765 67
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+++|++++++|.+++......+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 899999999999999887777999999999999999999999 8999999999999999999999999999998776
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
............+|..|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESIL-------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred CCcccccccCCCccccccChHHhc-------------cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence 544433333445688999998764 4557889999999999999999 999998765544322111
Q ss_pred ----hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 272 ----VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ----~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..++..+.+++ ||.+||++.++++.++.+..
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1223444444444 99999999999999988764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=306.20 Aligned_cols=195 Identities=22% Similarity=0.400 Sum_probs=169.1
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeeccccc--CCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSN--PDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 115 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ...+.+|+.+++.++ ||||+++++++.+ ....++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 357899999999999999999995 579999999998543 356889999999997 9999999999987 667899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~~ 194 (314)
+|||+++++|.+++.. +++..+..++.|++.||+||| ++|++|+||||+||+++.++ .++|+|||++....
T Consensus 111 v~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999998854 789999999999999999999 89999999999999999776 89999999998765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.... .....++..|+|||.+. ....++.++|||||||++|+|++|..||..
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLV------------DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHT------------TCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCc---cccccccccccChhhhc------------CCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4332 23346889999998753 235578899999999999999999999954
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=298.57 Aligned_cols=238 Identities=21% Similarity=0.390 Sum_probs=196.9
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 3568999999999999999999995 469999999997653 3445778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc---EEEEeeeccee
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV---ARVSDFGISKL 192 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~---ikl~Dfg~~~~ 192 (314)
+|||+++++|.+.+...+. +++..+..++.|++.||.||| +.|++|+||||+||+++.++. ++|+|||++..
T Consensus 83 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999998877654 899999999999999999999 899999999999999976655 99999999987
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW- 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~- 271 (314)
...... .....+|+.|+|||.+. +..++.++||||||+++|+|++|..||.............
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLK-------------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCcc---ccCCCCCcCCcCchhhc-------------CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence 654332 22346899999997753 4557889999999999999999999997755433221111
Q ss_pred --------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 --------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 --------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
....+++.+.+++ ||.+|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1124455555554 9999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=304.95 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=209.5
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
+|.+.....++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+++++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34555667889999999999999999999964 68899999998653 34577889999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 112 FKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 999999999999999999864 345899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK 269 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~ 269 (314)
........ .......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||...........
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~ 224 (288)
T 3kfa_A 159 RLMTGDTY-TAHAGAKFPIKWTAPESLA-------------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224 (288)
T ss_dssp GTSCSSSS-EEETTEEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred eeccCCcc-ccccCCccccCcCChhhhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 87654332 2233345678899998764 3456789999999999999999 9999987554332211
Q ss_pred h------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 270 N------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 270 ~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
. ..+..+++.+.+++ ||.+||++.++++.++.+..+.
T Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 11234555555554 9999999999999999887653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=315.01 Aligned_cols=206 Identities=26% Similarity=0.364 Sum_probs=164.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeec--ccHHHHHHHHHHHHHHhCC-CCCcceeecccccC--C
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ--LGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNP--D 111 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~ 111 (314)
....++|++++.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35678999999999999999999995 57999999998643 2344567788999999997 99999999998654 4
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..|+||||++ ++|.+++... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 7899999997 5999998764 3899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCC-------------------cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 192 LLGDGED-------------------SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 192 ~~~~~~~-------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
.+..... ........||+.|+|||++. ....++.++|||||||++|+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL------------GSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT------------TCCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhc------------CCCCCCChhhHHHHHHHHHHHH
Confidence 7643111 11122346899999998764 2356788999999999999999
Q ss_pred cCCCCCCccc
Q 047043 253 TGKKPTDEMF 262 (314)
Q Consensus 253 ~g~~Pf~~~~ 262 (314)
+|..||.+..
T Consensus 226 ~g~~pf~~~~ 235 (388)
T 3oz6_A 226 CGKPIFPGSS 235 (388)
T ss_dssp HSSCSCCCSS
T ss_pred hCCCCCCCCC
Confidence 9999997644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=309.62 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=209.2
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeec
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFS 105 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (314)
...++....++|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33455667789999999999999999999843 467899999975532 34456889999999999999999999
Q ss_pred ccccCCceeEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe
Q 047043 106 SCSNPDFKALVLELMPNGSLENWLYSHN---------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL 176 (314)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili 176 (314)
++.+.+..++||||+++++|.+++...+ ..+++..++.++.|++.||.||| ++|++|+||||+||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMV 171 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEE
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEE
Confidence 9999999999999999999999987632 34688999999999999999999 8999999999999999
Q ss_pred cCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CC
Q 047043 177 DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GK 255 (314)
Q Consensus 177 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~ 255 (314)
+.++.+||+|||++................+|+.|+|||.+. +..++.++||||||+++|+|++ |.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-------------DGVFTTYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc-------------cCCCCchhhHHHHHHHHHHHHhcCC
Confidence 999999999999987654332222222345688899998763 3457789999999999999999 89
Q ss_pred CCCCccccchhhhhhh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 256 KPTDEMFTGEISLKNW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 256 ~Pf~~~~~~~~~~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.||............. .+..+++.+.+++ ||..|||+.++++.++.+..++++.
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 239 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 9998765443221111 1234555555554 9999999999999999987776543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.14 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=196.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 467889999999999999999999954 79999999997542 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---CCCcEEEEeeecce
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISK 191 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~---~~~~ikl~Dfg~~~ 191 (314)
+||||+.+++|.+.+...+. +++..+..++.|++.||.||| ++|++||||||+||+++ .++.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEcCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999999877654 899999999999999999999 89999999999999995 45679999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||......+.....
T Consensus 173 ~~~~~~---~~~~~~gt~~y~aPE~~~--------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 173 CFQQNT---KMKDRIGTAYYIAPEVLR--------------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGG--------------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ECCCCC---ccCCCcCCCCCCCHHHhC--------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 664432 223356999999998753 23778999999999999999999999875543321111
Q ss_pred --------hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 271 --------WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 271 --------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.....+++.+++++ ||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred hCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11234555555554 99999999999883
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.19 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=195.1
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCe----EEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNN----VAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||+|+||.||+|.+ .+++. |++|.+.... ......+.+|+.+++.++||||+++++++.+ +..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 46899999999999999999995 45654 7777765432 2233566789999999999999999999874 5688
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+++++|.+++...+..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999876656899999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
............+|..|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIH-------------FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred cccccccccCCCCcccccChHHhc-------------cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 544333334456788999998764 3457889999999999999999 999998765443322111
Q ss_pred ----hhccCCc----hhhhhc--cccCCCCHHHHHHHHHhhhh
Q 047043 272 ----VNESLPH----ALTDVV--DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ----~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..++. .+..++ ||.+||++.++++.++.+..
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122333 444444 99999999999999988753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=303.97 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=201.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH------HHHHHHHHHHHHHhCCCCCcceeecccccC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVHHRNLLKIFSSCSNP 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (314)
....++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345688999999999999999999954 7999999999865321 246788999999999999999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC----cEEEEe
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----VARVSD 186 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----~ikl~D 186 (314)
+..++||||+++++|.+++...+ .+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999999998654 4899999999999999999999 89999999999999999887 799999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++........ .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||......+.
T Consensus 163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 226 (321)
T 2a2a_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIV-------------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226 (321)
T ss_dssp CTTCEECCTTCC---CCCCCSCGGGCCHHHH-------------TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred CccceecCcccc---ccccCCCCCccCcccc-------------cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999987654322 2234589999999775 345678899999999999999999999987544322
Q ss_pred hhh---------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 267 SLK---------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 267 ~~~---------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
... ......+++.+.+++ ||.+|||+.++++ |+|+..
T Consensus 227 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~------hp~~~~ 278 (321)
T 2a2a_A 227 LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR------HPWITP 278 (321)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH------STTTSC
T ss_pred HHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc------CccccC
Confidence 111 112234555555554 9999999999987 566543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=311.89 Aligned_cols=249 Identities=16% Similarity=0.223 Sum_probs=194.9
Q ss_pred HhcCccccceeeecCceEEEEEEeCC------CCeEEEEEeeecccHHH-----------HHHHHHHHHHHhCCCCCcce
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSD------GNNVAIKVFKLQLGRAF-----------RSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~ 102 (314)
..++|++.+.||+|+||.||+|.+.. ++.||+|++........ .....|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999643 47899999876542111 11334556667778999999
Q ss_pred eecccccC----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-
Q 047043 103 IFSSCSNP----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD- 177 (314)
Q Consensus 103 ~~~~~~~~----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~- 177 (314)
+++++... ...++||||+ +++|.+++...+..+++..+..++.|++.||.||| +.|++||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEec
Confidence 99998764 4589999999 89999999887667999999999999999999999 89999999999999998
Q ss_pred -CCCcEEEEeeecceecCCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 178 -ENMVARVSDFGISKLLGDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 178 -~~~~ikl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
.++.+||+|||++..+....... ......||+.|+|||++ .+..++.++|||||||++|+|
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-------------NGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-------------CCCCCCchhhHHHHHHHHHHH
Confidence 88999999999998764332111 11233489999999765 345578899999999999999
Q ss_pred hcCCCCCCccccchhh-----------hhhhh-----hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 252 FTGKKPTDEMFTGEIS-----------LKNWV-----NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 252 l~g~~Pf~~~~~~~~~-----------~~~~~-----~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
++|..||......... ..... ...+++.+.+++ ||.+||++.++++.++.+....
T Consensus 255 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 255 LTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 9999999864322211 11111 134566666665 9999999999999999887653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=317.89 Aligned_cols=206 Identities=23% Similarity=0.358 Sum_probs=169.7
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC--
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-- 110 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 110 (314)
+...+.++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 3445678999999999999999999995 478899999997542 33456788999999999999999999998765
Q ss_pred ---CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 111 ---DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 111 ---~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
+..|+|||++. ++|.+++.... .+++..+..++.||+.||.||| +.|++||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccC
Confidence 57899999986 59999997654 4899999999999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCc--------------------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHH
Q 047043 188 GISKLLGDGEDS--------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL 247 (314)
Q Consensus 188 g~~~~~~~~~~~--------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i 247 (314)
|++......... .......||+.|+|||++. ....++.++|||||||+
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~------------~~~~~~~~~DiwSlG~i 241 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL------------LQENYTKSIDIWSTGCI 241 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHT------------TCSCCCTHHHHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh------------cCCCCCcccccchHHHH
Confidence 999876543221 1123456899999998753 34567889999999999
Q ss_pred HHHHhcCCCCCC
Q 047043 248 LMETFTGKKPTD 259 (314)
Q Consensus 248 l~~ll~g~~Pf~ 259 (314)
+|+|++|..||.
T Consensus 242 l~ell~g~~p~~ 253 (432)
T 3n9x_A 242 FAELLNMLQSHI 253 (432)
T ss_dssp HHHHHTTCTTTC
T ss_pred HHHHHhcccccc
Confidence 999998655543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=306.37 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=204.2
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--------cHHHHHHHHHHHHHHhC-CCCCcce
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--------GRAFRSFDSECEVLRNV-HHRNLLK 102 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~ 102 (314)
.+.......++|++.+.||.|++|.||+|... +|+.||||+++... ......+.+|+.+++.+ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34444556788999999999999999999964 79999999997653 12245678899999999 7999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
+++++...+..++||||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||||+||+++.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999986544 899999999999999999999 8999999999999999999999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+|+|||++........ .....||+.|+|||++.... ......++.++|||||||++|+|++|..||....
T Consensus 240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSM-------DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTT-------CTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEecCcccccCCCcc---cccCCCCCCccChhhccccc-------cccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999987754322 22356899999999875311 1123457889999999999999999999997644
Q ss_pred cchhhhh---------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 263 TGEISLK---------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 263 ~~~~~~~---------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
....... ......++..+.+++ ||.+|||+.++++ ++|+.
T Consensus 310 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~ 364 (365)
T 2y7j_A 310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ------HPFFE 364 (365)
T ss_dssp HHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGC
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CcccC
Confidence 3221110 111234455455544 9999999999987 66653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=304.03 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=207.8
Q ss_pred eehhhHHHHhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCccee
Q 047043 32 TSYLDIQRATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLKI 103 (314)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 103 (314)
++........++|++.+.||+|+||.||+|++ .+++.||+|+++.... .....+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678999999999999999999983 2467899999986543 3456788999999999 78999999
Q ss_pred ecccccCC-ceeEEEEecCCCCHHHHHhhcCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeec
Q 047043 104 FSSCSNPD-FKALVLELMPNGSLENWLYSHNYF---------------LDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167 (314)
Q Consensus 104 ~~~~~~~~-~~~lv~e~~~~~sL~~~i~~~~~~---------------~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~ 167 (314)
++++...+ ..+++|||+++++|.+++...... +++..++.++.|++.||.||| +.|++|+
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~ 172 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHR 172 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCS
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccc
Confidence 99987654 589999999999999999875432 788999999999999999999 8999999
Q ss_pred CCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHH
Q 047043 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL 247 (314)
Q Consensus 168 dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i 247 (314)
||||+||+++.++.+||+|||++................+|+.|+|||++. +..++.++||||||++
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~i 239 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------------DRVYTIQSDVWSFGVL 239 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHH
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-------------cccccchhHHHHHHHH
Confidence 999999999999999999999998765544333344456788999998764 3457789999999999
Q ss_pred HHHHhc-CCCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 248 LMETFT-GKKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 248 l~~ll~-g~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
+|+|++ |..||............. .+..+++.+.+++ ||.+|||+.+++++++.+.+...
T Consensus 240 l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 240 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 999998 999998755433221111 1223454555554 99999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=305.33 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=203.8
Q ss_pred HHhcCccccceeeecCceEEEEEEe--------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccc
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL--------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCS 108 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~--------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|++ .++..||+|+++... ......+.+|+++++.+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3468999999999999999999985 246789999998653 34457788999999999 8999999999999
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCc
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHNY---------------FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSN 173 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~~---------------~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~N 173 (314)
+.+..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.|++|+||||+|
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARN 187 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGG
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccce
Confidence 99999999999999999999986532 3788999999999999999999 8999999999999
Q ss_pred eEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 174 ILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 174 ili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
|+++.++.+||+|||++................+|+.|+|||++. +..++.++||||||+++|+|++
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-------------DRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-------------HCEECHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc-------------CCCcChHHHHHHHHHHHHHHHh
Confidence 999999999999999998775543322233345678899998764 3456789999999999999999
Q ss_pred -CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 254 -GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 254 -g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
|..||......+..... ..+..++..+.+++ ||..||++.++++.|+.+....
T Consensus 255 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 255 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp TSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 99999876543322111 11234455555554 9999999999999999987644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=315.57 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=189.3
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--------cHHHHHHHHHHHHHHhCCCCCcceeecccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--------GRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (314)
....++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678999999999999999999995 578999999997642 112335789999999999999999999986
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEEEE
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VARVS 185 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ikl~ 185 (314)
.+ ..++||||+++++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++ .+||+
T Consensus 211 ~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AE-DYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SS-EEEEEEECCTTCBGGGGTSSSCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cC-ceEEEEEcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEe
Confidence 54 57899999999999998876554 899999999999999999999 89999999999999997544 59999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
|||++....... ......||+.|+|||++.. .....++.++|||||||++|+|++|..||.......
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVS----------VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC--------------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeec----------CCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 999998764332 2233568999999987531 124567889999999999999999999997643322
Q ss_pred hhhh----------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 266 ISLK----------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 266 ~~~~----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.... ......+++.+.+++ ||.+|||+.++++ |+|+.+
T Consensus 352 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~ 405 (419)
T 3i6u_A 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR------HPWLQD 405 (419)
T ss_dssp CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGCC
T ss_pred HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC------CcccCC
Confidence 1111 112234555555554 9999999999987 677654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=311.46 Aligned_cols=204 Identities=23% Similarity=0.316 Sum_probs=168.2
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC-
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP- 110 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 110 (314)
.+.....++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++...
T Consensus 18 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 18 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 34455678999999999999999999995 579999999986532 23456788999999999999999999998765
Q ss_pred -----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 111 -----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 111 -----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
..+++||||+ +++|.+++... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~ 170 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKIL 170 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEE
Confidence 3469999999 78999998764 3899999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
|||++...... .....+|+.|+|||++. ....++.++|||||||++|+|++|..||.+..
T Consensus 171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 171 DFGLARQADSE-----MTGYVVTRWYRAPEVIL------------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CCTTCEECCSS-----CCSSCSCGGGCCTHHHH------------TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecccccccc-----cCcCcCCCCcCCHHHHh------------CCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876432 12345899999998764 22457889999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=297.07 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=182.0
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 457899999999999999999995 5799999999976532 224678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999887666899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-----h
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-----N 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-----~ 270 (314)
... ......+|+.|+|||.+ .+..++.++||||||+++|+|++|..||........... .
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIA-------------TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229 (278)
T ss_dssp ------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC
T ss_pred CCC--cceeccCCCCcCCcchh-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc
Confidence 322 12234589999999765 344567899999999999999999999976443221110 0
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
..+..++..+.+++ ||.+||++.++++ ++|+.+.
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~------h~~~~~~ 269 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD------HPFMSRN 269 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------STTTC--
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc------CccccCC
Confidence 11233444444444 9999999999887 6666543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=304.66 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=185.7
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeeccc------
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSC------ 107 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~------ 107 (314)
++.....+|++.+.||+|+||.||+|++ .+++.||+|++..........+.+|+.+++++. ||||+++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3344566899999999999999999995 479999999997776666678899999999996 99999999987
Q ss_pred --ccCCceeEEEEecCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEecCCCc
Q 047043 108 --SNPDFKALVLELMPNGSLENWLYS--HNYFLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLDENMV 181 (314)
Q Consensus 108 --~~~~~~~lv~e~~~~~sL~~~i~~--~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~~~~~ 181 (314)
......+++|||+. ++|.+++.. ....+++..++.++.|++.||.||| ..| ++|+||||+||+++.++.
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCC
Confidence 34456889999995 699998865 3445899999999999999999999 888 999999999999999999
Q ss_pred EEEEeeecceecCCCCCcc----------eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHH
Q 047043 182 ARVSDFGISKLLGDGEDSV----------TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMET 251 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~l 251 (314)
+||+|||++.......... ......+|+.|+|||++. ...+..++.++||||||+++|+|
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID----------LYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp EEBCCCTTCBCCSSCC-----------------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh----------ccccCCCChHHhHHHHHHHHHHH
Confidence 9999999998765432211 111345899999998762 22455678899999999999999
Q ss_pred hcCCCCCCccccchhhhhh---hhhccCCchh----hhhc--cccCCCCHHHHHHHHHhhhhh
Q 047043 252 FTGKKPTDEMFTGEISLKN---WVNESLPHAL----TDVV--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 252 l~g~~Pf~~~~~~~~~~~~---~~~~~~~~~l----~~ll--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
++|..||............ ......+..+ ..++ ||.+||++.++++.++.+...
T Consensus 247 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 247 CFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp HHSSCCC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999764432221111 1122333334 4444 999999999999999988764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=312.74 Aligned_cols=249 Identities=26% Similarity=0.280 Sum_probs=190.6
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHH-HHhCCCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEV-LRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++++.||+|+||.||+|+.+ +++.||+|+++.... .....+..|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34678999999999999999999954 689999999986532 223445566665 4567999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+||||+++++|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.+|.+||+|||++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999999987654 889999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-- 271 (314)
..... ......||+.|+|||++. +..++.++|+|||||++|+|++|..||......+......
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLH-------------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred ccCCC--ccccccCCccccCHHHhC-------------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 32221 223456999999998763 4557889999999999999999999998755433322111
Q ss_pred ---hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 272 ---VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.+..++..+++++ ||.+||++.+.++. ...|+|++.
T Consensus 255 ~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~--i~~h~~f~~ 299 (373)
T 2r5t_A 255 PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME--IKSHVFFSL 299 (373)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH--HHTSGGGTT
T ss_pred ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH--HhCCccccC
Confidence 1234555555554 99999998643332 234566543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=296.93 Aligned_cols=239 Identities=24% Similarity=0.416 Sum_probs=186.2
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc----HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG----RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|.+ +++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 357899999999999999999997 488999999876532 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC---eeecCCCCCceEecC--------CCcEEE
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP---IVHCDLKPSNILLDE--------NMVARV 184 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~---i~H~dlkp~Nili~~--------~~~ikl 184 (314)
||||+++++|.+++... .+++..++.++.|++.||.||| +.| ++|+||||+||+++. ++.++|
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH----~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH----DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH----HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999998643 4899999999999999999999 777 899999999999985 778999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG 264 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~ 264 (314)
+|||++........ ....+|+.|+|||.+. +..++.++||||||+++|+|++|..||......
T Consensus 158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIR-------------ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHH-------------HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred ccCCcccccccccc----cCCCCccceeCHHHhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999876643321 2346899999998763 345678999999999999999999999876544
Q ss_pred hhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 265 EISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 265 ~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
....... .+..+++.+.+++ ||.+|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 3322211 1234555555554 999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=305.72 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=191.2
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCC-----
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD----- 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (314)
...++|++.+.||+|+||.||+|+.+ +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45688999999999999999999965 799999999986532 34577899999999999999999999875433
Q ss_pred ----------------------------------------------------ceeEEEEecCCCCHHHHHhhcCC--CCC
Q 047043 112 ----------------------------------------------------FKALVLELMPNGSLENWLYSHNY--FLD 137 (314)
Q Consensus 112 ----------------------------------------------------~~~lv~e~~~~~sL~~~i~~~~~--~~~ 137 (314)
..+++|||+++++|.+++..... ..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 37899999999999999987542 245
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc----------ceeecccc
Q 047043 138 TLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS----------VTQTMTMA 207 (314)
Q Consensus 138 ~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~----------~~~~~~~~ 207 (314)
+..++.++.|++.||+||| ++|++|+||||+||+++.++.+||+|||++......... .......|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hHHHHHHHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 5678999999999999999 899999999999999999999999999999887554221 11233468
Q ss_pred eeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--------hhhccCCch
Q 047043 208 TIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--------WVNESLPHA 279 (314)
Q Consensus 208 t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--------~~~~~~~~~ 279 (314)
|+.|+|||.+. +..++.++||||||+++|+|++|..|+............ ...+.+.+.
T Consensus 239 t~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 239 TKLYMSPEQIH-------------GNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305 (332)
T ss_dssp CGGGSCHHHHH-------------CCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHH
T ss_pred CcCccChHHhc-------------CCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHH
Confidence 99999998763 345788999999999999999998875432211110000 011112224
Q ss_pred hhhhc--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 280 LTDVV--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 280 l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
+..++ ||.+|||+.|+++ ++|+.+
T Consensus 306 i~~~l~~~p~~Rps~~~~l~------~~~f~~ 331 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE------NAIFEN 331 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH------STTCCC
T ss_pred HHHHccCCCCcCCCHHHHhh------chhhhc
Confidence 44555 9999999999987 677654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.22 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=195.0
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 35688999999999999999999964 69999999998765555678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999998876666999999999999999999999 8999999999999999999999999999875432110
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
.......+|+.|+|||.+... ......++.++||||||+++|+|++|..||.............
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCE--------TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHH--------HTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred --cccccccCChhhcCCeeeccc--------cCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc
Confidence 112234589999999987531 1234567889999999999999999999998765433221111
Q ss_pred --hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 --VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.+..++..+.+++ ||..|||+.++++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1234455555544 9999999999877
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=297.16 Aligned_cols=240 Identities=27% Similarity=0.457 Sum_probs=189.0
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
....++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345689999999999999999999965 799999999976531 2345788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+++|||+++++|.+++...+. +++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEEeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999999987654 899999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
.... ......+++.|+|||.+. .....+.++||||||+++|+|++|..||............
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVIS------------GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG 226 (276)
T ss_dssp CC----------------CCTGGGT------------TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CCCc---ceecccCCccccCHHHHc------------CCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 4432 122346899999998753 1223467899999999999999999999875433221111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+..++..+.+++ ||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11233445455544 9999999999988
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=306.53 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=177.7
Q ss_pred hcCcccc---ceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeE
Q 047043 41 TEGFNEC---NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~---~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++. +.||+|+||.||+|.. .+++.||+|++... ......+|+.+++.+. ||||+++++++.+....++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 3556664 7899999999999995 47999999999764 2356778999999997 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC---cEEEEeeeccee
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM---VARVSDFGISKL 192 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~---~ikl~Dfg~~~~ 192 (314)
||||+++++|.+++...+. +++..+..++.|++.||.||| ++|++||||||+||+++.++ .+||+|||++..
T Consensus 84 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EECCCCSCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999987654 899999999999999999999 89999999999999997665 899999999986
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch------h
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE------I 266 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~------~ 266 (314)
...... ......+|+.|+|||++ .+..++.++||||||+++|+|++|..||....... .
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~-------------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 223 (325)
T 3kn6_A 159 KPPDNQ--PLKTPCFTLHYAAPELL-------------NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223 (325)
T ss_dssp CCC-------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH
T ss_pred cCCCCC--cccccCCCcCccCHHHh-------------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH
Confidence 644322 22335689999999765 34567889999999999999999999998643210 0
Q ss_pred hhhh----------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 267 SLKN----------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 267 ~~~~----------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.... .....+++.+.+++ ||.+|||+.++++ |+|+.+.
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~------h~w~~~~ 277 (325)
T 3kn6_A 224 IMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY------NEWLQDG 277 (325)
T ss_dssp HHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT------CGGGCTT
T ss_pred HHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc------ChhhccC
Confidence 0111 11134566555555 9999999999865 7777643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=301.61 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=196.1
Q ss_pred CCCCcccceehhhHHHHhcCccccceeeecCceEEEEEEeC----CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCC
Q 047043 24 LPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHH 97 (314)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h 97 (314)
.......+....+.....++|++.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++|
T Consensus 16 ~~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h 95 (313)
T 3brb_A 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95 (313)
T ss_dssp --------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC
T ss_pred cCchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC
Confidence 33344444555666667889999999999999999999843 34589999997653 3445678899999999999
Q ss_pred CCcceeecccccCC-----ceeEEEEecCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeec
Q 047043 98 RNLLKIFSSCSNPD-----FKALVLELMPNGSLENWLYS-----HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167 (314)
Q Consensus 98 ~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~i~~-----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~ 167 (314)
|||+++++++.+.+ ..+++|||+++++|.+++.. ....+++..++.++.|++.||.||| ++|++|+
T Consensus 96 ~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~ 171 (313)
T 3brb_A 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHR 171 (313)
T ss_dssp TTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCC
T ss_pred CCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccC
Confidence 99999999987654 45899999999999999853 2345899999999999999999999 8999999
Q ss_pred CCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHH
Q 047043 168 DLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL 247 (314)
Q Consensus 168 dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i 247 (314)
||||+||+++.++.+||+|||++................+++.|+|||.+. +..++.++||||||++
T Consensus 172 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~i 238 (313)
T 3brb_A 172 DLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------------DRVYTSKSDVWAFGVT 238 (313)
T ss_dssp CCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHH-------------SSCCCHHHHHHHHHHH
T ss_pred CCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhc-------------CCCccchhhhHHHHHH
Confidence 999999999999999999999988765433222233345788899997763 4557889999999999
Q ss_pred HHHHhc-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 248 LMETFT-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 248 l~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
+|+|++ |..||............ ..+..+++.+.+++ ||..||++.++++.|+.+...+
T Consensus 239 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999 99999876554332211 12234555555554 9999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=297.74 Aligned_cols=237 Identities=25% Similarity=0.349 Sum_probs=192.5
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 357899999999999999999995 4688999999976432 224568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999987654 899999999999999999999 99999999999999999999999999998865433
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN----- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~----- 270 (314)
.. .....+++.|+|||.+ .+..++.++||||||+++|+|++|..||............
T Consensus 162 ~~----~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 224 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMI-------------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224 (279)
T ss_dssp ----------CCCCTTCCHHHH-------------TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred cc----ccccCCCCCccCHhHh-------------ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC
Confidence 21 2334689999999775 3455678999999999999999999999875443321111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..+..+++.+.+++ ||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11233445455544 99999999999983
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=308.84 Aligned_cols=207 Identities=22% Similarity=0.325 Sum_probs=173.6
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeeccccc-------
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSN------- 109 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 109 (314)
..++|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 358999999999999999999995 5799999999865532 223467789999999999999999999876
Q ss_pred -CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 110 -PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 110 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
.+..++||||+++ +|.+.+......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999975 888888776666999999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 189 ISKLLGDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 189 ~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
++..+...... .......+|+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLL------------GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHT------------TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hcccccccccccccccCCcccccCccCchhhc------------CCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99876532221 1223346899999998763 234578899999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=319.74 Aligned_cols=197 Identities=25% Similarity=0.390 Sum_probs=155.2
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccc-----cC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCS-----NP 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 110 (314)
.+.++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++. ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3457899999999999999999995 479999999986542 334567889999999999999999999984 34
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+.+|+|||++ +++|.+++.... .+++..+..++.||+.||.||| +.|++||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 6789999998 569999987654 4899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCc-------------------------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhh
Q 047043 191 KLLGDGEDS-------------------------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFG 245 (314)
Q Consensus 191 ~~~~~~~~~-------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG 245 (314)
......... .......||+.|+|||++. ....++.++||||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------------~~~~~~~~~DiwSlG 271 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL------------LQENYTEAIDVWSIG 271 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT------------TCCCCCTHHHHHHHH
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh------------CCCCCCcHhHHHHHH
Confidence 876432211 0122346799999998653 345688899999999
Q ss_pred HHHHHHhc
Q 047043 246 VLLMETFT 253 (314)
Q Consensus 246 ~il~~ll~ 253 (314)
|++|||++
T Consensus 272 ~il~ellt 279 (458)
T 3rp9_A 272 CIFAELLN 279 (458)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.80 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=202.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---------cHHHHHHHHHHHHHHhCC-CCCcceeecc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---------GRAFRSFDSECEVLRNVH-HRNLLKIFSS 106 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 106 (314)
....++|++.+.||+|+||.||+|..+ +++.||+|+++... ....+.+.+|+++++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 346789999999999999999999964 78999999997542 123456788999999995 9999999999
Q ss_pred cccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEe
Q 047043 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 107 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~D 186 (314)
+.+.+..++||||+++++|.+++..... +++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999987543 899999999999999999999 89999999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++........ .....+++.|+|||.+.... ......++.++||||||+++|+|++|..||........
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-------~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSM-------NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHH-------CTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhcccc-------ccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 999987654322 22345899999999875321 11345578899999999999999999999976543322
Q ss_pred hhhh---------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 267 SLKN---------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 267 ~~~~---------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.... .....+++.+.+++ ||.+|||+.++++ ++|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~ 290 (298)
T 1phk_A 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA------HPFFQQY 290 (298)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT------SGGGCTT
T ss_pred HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh------ChHhhhc
Confidence 1111 11134555555554 9999999999987 6666554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=311.40 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=190.1
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCC--CCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVH--HRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999997779999999997653 345577899999999996 59999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|| +.+++|.+++...+ .+++..+..++.|++.||.||| +.|++||||||+||+++ ++.+||+|||++..+...
T Consensus 135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 55789999998765 4889999999999999999999 99999999999999995 579999999999876543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV---- 272 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~---- 272 (314)
..........||+.|+|||++....... ........++.++|||||||++|+|++|..||.........+....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSR--ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC--------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CccccCCCCCcCCCccChHHhhhccccc--cccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 3322233456999999999875211000 0011234688899999999999999999999987544322222221
Q ss_pred ----hccCCchhhhh----c--cccCCCCHHHHHHH
Q 047043 273 ----NESLPHALTDV----V--DANLRVSMKDVAAK 298 (314)
Q Consensus 273 ----~~~~~~~l~~l----l--dp~~Rpt~~~~~~~ 298 (314)
+...+..+.++ + ||.+||++.+++++
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 12223344444 4 99999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.43 Aligned_cols=238 Identities=24% Similarity=0.282 Sum_probs=187.2
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 457899999999999999999995 479999999998642 2334567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||||+++++|.+++...+. +++..+..++.|++.||+||| + .|++||||||+||+++.++.+||+|||++....
T Consensus 226 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHh----hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999977654 899999999999999999999 7 899999999999999999999999999987543
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--- 271 (314)
.... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.............
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 365 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLE-------------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHH-------------TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCc--ccccccCCccccCHhhcC-------------CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 3221 223356999999998763 4567889999999999999999999998755433221111
Q ss_pred --hhccCCchhhhhc------cccCCC-----CHHHHHH
Q 047043 272 --VNESLPHALTDVV------DANLRV-----SMKDVAA 297 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~ 297 (314)
.+..+++.+.+++ ||.+|| ++.|+++
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1233455555544 999999 9999887
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=306.48 Aligned_cols=238 Identities=25% Similarity=0.302 Sum_probs=195.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.+.|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999995 579999999997542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+. |+|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 99997 5899888766666899999999999999999999 899999999999999999999999999998765432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
....||+.|+|||++.. .....++.++|||||||++|+|++|..||............
T Consensus 208 ------~~~~gt~~y~aPE~~~~----------~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 271 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILA----------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 271 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHT----------TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ------CcccCCcceeCHhhhcc----------ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence 22458999999988631 13456788999999999999999999999775443221111
Q ss_pred -hhhccCCchhhhhc------cccCCCCHHHHHHHH
Q 047043 271 -WVNESLPHALTDVV------DANLRVSMKDVAAKL 299 (314)
Q Consensus 271 -~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l 299 (314)
.....+++.+.+++ ||.+|||+.+++++.
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11223455555554 999999999998743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=298.81 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=192.2
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeec---ccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ---LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
...++|++.+.||+|+||.||+|.. .+++.||+|+++.. .......+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4567899999999999999999995 57999999999753 2345577889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 115 LVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
++|||+++++|.+++.. .+..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 99999999999999864 3455899999999999999999999 8999999999999999999999999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~ 271 (314)
....... ......+++.|+|||.+. +..++.++||||||+++|+|++|..||.............
T Consensus 185 ~~~~~~~--~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 249 (310)
T 2wqm_A 185 FFSSKTT--AAHSLVGTPYYMSPERIH-------------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249 (310)
T ss_dssp ----------------CCSSCCHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH
T ss_pred eecCCCc--cccccCCCeeEeChHHhC-------------CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH
Confidence 6643321 122345899999997753 4457889999999999999999999997643222111111
Q ss_pred ---------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 272 ---------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 272 ---------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
....+++.+.+++ ||..||++.++++.++++....-
T Consensus 250 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1134555555554 99999999999999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=302.06 Aligned_cols=246 Identities=23% Similarity=0.404 Sum_probs=196.4
Q ss_pred hcCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccC--Cc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DF 112 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 112 (314)
.++|++.+.||+|+||.||+|++ .+++.||+|+++... ......+.+|+++++.++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 56799999999999999999983 368899999997553 23346788999999999999999999998876 67
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|||+++++|.+++......+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 89999999999999999776666999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc-------
Q 047043 193 LGDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG------- 264 (314)
Q Consensus 193 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~------- 264 (314)
....... .......+|..|+|||.+. +..++.++||||||+++|+|++|..|+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLM-------------QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred ccCCCcceeccCCCCCCccccCCeeec-------------CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 7554322 1223345788899998764 345677899999999999999999986532110
Q ss_pred ---hhhh---hh-h-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 265 ---EISL---KN-W-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 265 ---~~~~---~~-~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.... .. . .+..+++.+.+++ ||.+|||+.++++.++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 00 0 1234555555554 9999999999999998874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.23 Aligned_cols=242 Identities=23% Similarity=0.390 Sum_probs=188.9
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc-
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF- 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 112 (314)
..+.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34678999999999999999999995 578999999997653 2345678899999999999999999999876543
Q ss_pred ---eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 113 ---KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 113 ---~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
.++||||+++++|.+++...+. +++..++.++.|++.||+||| ++|++|+||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred CcccEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4899999999999999987654 899999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 190 SKLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 190 ~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
+.......... ......||+.|+|||++. +..++.++||||||+++|+|++|..||..........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 229 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQAR-------------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229 (311)
T ss_dssp C------------------CCTTCCHHHHH-------------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhc-------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 98765432221 222345899999998763 4457889999999999999999999998765544322
Q ss_pred hhh---------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 269 KNW---------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 269 ~~~---------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
... ....+++.+.+++ ||.+||+..+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 230 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 221 1234565555554 9999997766654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=314.67 Aligned_cols=241 Identities=31% Similarity=0.454 Sum_probs=199.0
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC-ceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-FKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 118 (314)
..++|++.+.||+|+||.||+|.+ .++.||+|+++... ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467899999999999999999997 47799999998653 3467889999999999999999999976654 7899999
Q ss_pred ecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++...+. .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999987643 3689999999999999999999 8999999999999999999999999999988543221
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------ 270 (314)
....++..|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 344 -----~~~~~~~~y~aPE~~~-------------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 405 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALR-------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 405 (450)
T ss_dssp --------CCCTTTSCHHHHH-------------SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC
T ss_pred -----cCCCCCcceeCHHHhc-------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 1224678899998763 4457889999999999999998 99999876554432111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12344566666655 999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=304.56 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=191.7
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeE----EEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNV----AIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~v----aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
.++|++.+.||+|+||.||+|.+ .+++.+ ++|.+.... ......+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 57899999999999999999995 456654 666654332 234577889999999999999999999998765 77
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++++++.+++|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 899999999999999887767999999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh--
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~-- 271 (314)
............+|+.|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESIL-------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp -----------CCCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred CccccccccCCCccccccCHHHHc-------------CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 544333333445678899998764 4457889999999999999999 999998765544322111
Q ss_pred ----hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 272 ----VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ----~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..++..+.+++ ||.+||++.++++.++.+..
T Consensus 236 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1223444455544 99999999999999998874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=299.19 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=200.2
Q ss_pred HHhcCccccceeeecCceEEEEEEeCC----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeeccc-ccCCc
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSD----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSC-SNPDF 112 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 112 (314)
....+|++.+.||+|+||.||+|.... +..+++|.+.... ......+.+|+.++++++||||+++++++ ...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 345679999999999999999999532 2258899887543 34457788999999999999999999985 55678
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECccccccc
Confidence 89999999999999999877666899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh
Q 047043 193 LGDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK 269 (314)
Q Consensus 193 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~ 269 (314)
....... .......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||......+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQ-------------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred ccccchhccccccCCCCCccccChHHhc-------------CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 6443211 1222345778899998763 3457789999999999999999 6667766544333221
Q ss_pred hh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 270 NW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 270 ~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
.. .+..+++.+.+++ ||.+||++.++++.++.+...+..
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 245 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11 1234455555554 999999999999999999887754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=305.00 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=193.7
Q ss_pred cceehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeeccc
Q 047043 30 RRTSYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSC 107 (314)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (314)
...++..+....++|++.+.||+|+||.||+|++ .+++.||+|++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4455666677889999999999999999999995 5799999999976532 336788899999998 799999999998
Q ss_pred cc------CCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 108 SN------PDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 108 ~~------~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
.. .+..++||||+++++|.+++... +..+++..+..++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCC
Confidence 76 46889999999999999999864 245899999999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
.++|+|||++........ ......+|+.|+|||++... ......++.++||||||+++|+|++|..||..
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--------~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACD--------ENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC----------------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccc--------cccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876643221 12234689999999987521 11245678899999999999999999999987
Q ss_pred cccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 261 MFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 261 ~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
........... ....++..+.+++ ||..||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 237 MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 55433221111 1233455555554 9999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.35 Aligned_cols=243 Identities=25% Similarity=0.290 Sum_probs=190.0
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
....++|++.+.||+|+||+||+|+.. +++.||+|++.... .........|...+..+ +||||+++++++.+++..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 335578999999999999999999965 79999999986542 22333444555555554 899999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++|||++ +++|.+++...+..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.+||+|||++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999 67999999887767999999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch-hh---hh
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE-IS---LK 269 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~-~~---~~ 269 (314)
..... .....||+.|+|||++. +.++.++|||||||++|+|++|..|+....... .. ..
T Consensus 208 ~~~~~---~~~~~gt~~y~aPE~~~--------------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 270 (311)
T 3p1a_A 208 GTAGA---GEVQEGDPRYMAPELLQ--------------GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP 270 (311)
T ss_dssp C---------CCCCCGGGCCGGGGG--------------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCC
T ss_pred ccCCC---CcccCCCccccCHhHhc--------------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCC
Confidence 44322 23345899999998753 247789999999999999999976654422211 10 11
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
......+++.+.+++ ||.+|||+.++++ ++|++
T Consensus 271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~------hp~~~ 309 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA------LPVLR 309 (311)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGS
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh------Ccccc
Confidence 122344566555554 9999999999987 66664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=298.04 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=202.9
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.....++|++.+.||+|+||.||+|...+++.||+|.++.... ..+.+.+|+++++.++||||+++++++.+ +..+++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 3445689999999999999999999987788999999976532 34678899999999999999999999875 457899
Q ss_pred EEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 117 LELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|||+++++|.+++.... ..+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999987542 24899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~---- 270 (314)
.... ......++..|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 227 (279)
T 1qpc_A 162 NEYT-AREGAKFPIKWTAPEAIN-------------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227 (279)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred cccc-cccCCCCccCccChhhhc-------------cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc
Confidence 3211 122334677899998763 3456788999999999999999 99999876543321111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
..+..+++.+.+++ ||.+|||+.++++.++.+......
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 11234555555554 999999999999999998776543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=297.43 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=188.5
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-----HHHHHHHHHHHHHHhC---CCCCcceeeccccc
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-----RAFRSFDSECEVLRNV---HHRNLLKIFSSCSN 109 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~ 109 (314)
...++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4568999999999999999999995 5799999999975431 1123455667766665 59999999999876
Q ss_pred CC-----ceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEE
Q 047043 110 PD-----FKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 110 ~~-----~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ik 183 (314)
.. ..+++||++. ++|.+++.... ..+++..+..++.|++.||+||| ++|++|+||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEE
Confidence 54 5789999996 59999998754 33899999999999999999999 89999999999999999999999
Q ss_pred EEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 184 VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
|+|||++........ .....+|+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLL-------------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHH-------------TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHc-------------CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976643322 23356899999998764 34578899999999999999999999976544
Q ss_pred chhhhhhh--------------------------------hhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhh
Q 047043 264 GEISLKNW--------------------------------VNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 264 ~~~~~~~~--------------------------------~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+...... ..+.+++.+.++ + ||.+|||+.|+++ |+
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------h~ 298 (308)
T 3g33_A 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ------HS 298 (308)
T ss_dssp HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT------ST
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc------Cc
Confidence 33211110 112344444444 4 9999999999887 78
Q ss_pred eeeeec
Q 047043 306 FLYDVA 311 (314)
Q Consensus 306 ~~~~~~ 311 (314)
|+....
T Consensus 299 ~~~~~~ 304 (308)
T 3g33_A 299 YLHKDE 304 (308)
T ss_dssp TC----
T ss_pred cccCCC
Confidence 876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.68 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=207.1
Q ss_pred hhhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 34 YLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
+..+....++|++.+.||+|+||.||+|.++ ++..||+|.++.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3444556788999999999999999999965 588999999986532 35778999999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 113 KALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.++||||+++++|.+++... ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999999999999864 345899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~ 270 (314)
....... .......++..|+|||.+. ...++.++||||||+++|+|++ |..||............
T Consensus 367 ~~~~~~~-~~~~~~~~~~~y~aPE~~~-------------~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~ 432 (495)
T 1opk_A 367 LMTGDTY-TAHAGAKFPIKWTAPESLA-------------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432 (495)
T ss_dssp CCTTCCE-ECCTTCCCCGGGCCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred eccCCce-eecCCCcCCcceeCHhHHh-------------cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7643321 1222334677899998764 3457789999999999999999 99999876544332111
Q ss_pred ------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 ------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.+...
T Consensus 433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 12334566555555 999999999999999887543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=298.85 Aligned_cols=238 Identities=26% Similarity=0.370 Sum_probs=194.0
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..+.++|++.+.||+|+||.||+|+.. +|+.||+|+++.........+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 346789999999999999999999954 7999999999876444446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~~~~~ 193 (314)
|||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 85 MQLVSGGELFDRILERGV-YTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp ECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEcCCCccHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999999876654 899999999999999999999 8999999999999999 78889999999998754
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--- 270 (314)
... ......+|+.|+|||.+ .+..++.++||||||+++|+|++|..||............
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVL-------------AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTB-------------SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred CCC----ccccccCCCCccChHHh-------------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 322 12234589999999765 3456788999999999999999999999875443321111
Q ss_pred ------hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 ------WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 ------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.....+++.+.+++ ||.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 223 YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11234555555555 9999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=319.94 Aligned_cols=239 Identities=25% Similarity=0.375 Sum_probs=192.8
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..+.++|++++.||+|+||.||+|+.+ ++..||+|+++... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 346778999999999999999999954 79999999997653 223466889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC---CcEEEEeeecce
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN---MVARVSDFGISK 191 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~---~~ikl~Dfg~~~ 191 (314)
+||||+++++|.+.+..... +++..+..++.|++.||.||| +.|++||||||+||+++.. +.+||+|||++.
T Consensus 113 lv~e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999998877654 899999999999999999999 8999999999999999764 459999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||......+.....
T Consensus 188 ~~~~~~~---~~~~~gt~~y~aPE~l~--------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 188 VFENQKK---MKERLGTAYYIAPEVLR--------------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp ECBTTBC---BCCCCSCTTTCCHHHHT--------------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ECCCCcc---ccccCCCcCeeCHHHHc--------------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7754322 23356999999998752 34778999999999999999999999876554332111
Q ss_pred --------hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 271 --------WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 271 --------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.....+++.+.+++ ||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11234555555554 99999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.09 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=204.7
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..+....++|++.+.||+|+||.||+|.++++..||+|.++... ...+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44455678899999999999999999998788899999998653 23578899999999999999999999987 56789
Q ss_pred EEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 115 LVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+||||+++++|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++...
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999997542 34788999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN-- 270 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-- 270 (314)
..... .......+|..|+|||.+. ...++.++||||||+++|+|++ |..||......+.....
T Consensus 335 ~~~~~-~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 400 (454)
T 1qcf_A 335 EDNEY-TAREGAKFPIKWTAPEAIN-------------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400 (454)
T ss_dssp CCHHH-HTTCSSSSCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH
T ss_pred CCCce-eccCCCcccccccCHHHhc-------------cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 43211 1112234677899998764 3457889999999999999999 99999876554432211
Q ss_pred ----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 ----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.+...
T Consensus 401 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11234566666655 999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=303.97 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=201.0
Q ss_pred hcCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc--cCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS--NPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 113 (314)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+++++.++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999983 358899999998776666678999999999999999999999875 55678
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++||||+++++|.+++......+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999999876556899999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh------
Q 047043 194 GDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI------ 266 (314)
Q Consensus 194 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~------ 266 (314)
....... ......+|..|+|||.+. +..++.++||||||+++|+|++|..||........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLS-------------DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred ccCCccceeeccCCccccccCHHHhc-------------cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 5433221 122345788899998764 34467899999999999999999999865432211
Q ss_pred -------hhhh--------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 267 -------SLKN--------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 267 -------~~~~--------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
.... ..+..+++.+.+++ ||.+|||+.++++.|+.+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0000 01234555555554 99999999999999998865443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.12 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=194.2
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCcee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (314)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35688999999999999999999964 79999999998642 33456778899999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC------------
Q 047043 115 LVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN------------ 179 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~------------ 179 (314)
+||||+++++|.+++... ...+++..++.++.|++.||.||| ++|++|+||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999764 244899999999999999999999 8999999999999999844
Q ss_pred -------CcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 180 -------MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 180 -------~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
..++|+|||.+....... ...+|+.|+|||.+. ....++.++||||||+++|+|+
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQ------------ENYTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHT------------TCCTTHHHHHHHHHHHHHHHHT
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhc------------CCCCCCchhhHHHHHHHHHHHh
Confidence 479999999988765432 234899999998764 2335667999999999999999
Q ss_pred cCCCCCCccccchhhhh---hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 253 TGKKPTDEMFTGEISLK---NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 253 ~g~~Pf~~~~~~~~~~~---~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
+|..|+........... ...+..+++.+.+++ ||.+|||+.++++ |+|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~ 287 (289)
T 1x8b_A 226 GAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK------HSVLLSAS 287 (289)
T ss_dssp TCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT------CTTC----
T ss_pred cCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh------ChHhhhhc
Confidence 99987654322111110 112234555555555 9999999999987 77776643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.46 Aligned_cols=235 Identities=21% Similarity=0.304 Sum_probs=182.8
Q ss_pred HHhcCcccc-ceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHh-CCCCCcceeeccccc----CC
Q 047043 39 RATEGFNEC-NLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRN-VHHRNLLKIFSSCSN----PD 111 (314)
Q Consensus 39 ~~~~~y~~~-~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~ 111 (314)
...++|.+. +.||.|+||.||+|..+ +++.||+|+++.. ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 456788887 68999999999999954 7999999999744 346678888754 489999999998865 66
Q ss_pred ceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcEEEEee
Q 047043 112 FKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVARVSDF 187 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~ikl~Df 187 (314)
.+++||||+++++|.+++...+ ..+++..+..++.|++.||.||| ++|++||||||+||+++. ++.+||+||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEec
Confidence 7899999999999999998653 35899999999999999999999 899999999999999987 788999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 272 (400)
T 1nxk_A 209 GFAKETTSHN---SLTTPCYTPYYVAPEVL-------------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_dssp TTCEECC--------------CTTCCGGGS-------------CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred ccccccCCCC---ccccCCCCCCccCHhhc-------------CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence 9998764322 22345689999999765 4556788999999999999999999999764432210
Q ss_pred ---hhh----------hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 268 ---LKN----------WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 268 ---~~~----------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
... .....+++.+.+++ ||.+|||+.+++++
T Consensus 273 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 273 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 01134555555554 99999999999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=296.48 Aligned_cols=243 Identities=27% Similarity=0.432 Sum_probs=191.0
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||+|+||.||+|++ .++.||+|.+... .....+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 57899999999999999999997 4788999998754 344678899999999999999999999874 478999999
Q ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc-EEEEeeecceecCCCC
Q 047043 121 PNGSLENWLYSHNY--FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV-ARVSDFGISKLLGDGE 197 (314)
Q Consensus 121 ~~~sL~~~i~~~~~--~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~-ikl~Dfg~~~~~~~~~ 197 (314)
++++|.+++..... .+++..++.++.|++.||+|||+.+ .+|++|+||||+||+++.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 99999999986542 3688899999999999999999211 189999999999999988876 7999999987653321
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
....||+.|+|||++. +..++.++||||||+++|+|++|..||.............
T Consensus 161 -----~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (307)
T 2eva_A 161 -----TNNKGSAAWMAPEVFE-------------GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR 222 (307)
T ss_dssp ---------CCTTSSCHHHHT-------------CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC
T ss_pred -----ccCCCCCceEChhhhC-------------CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC
Confidence 2235899999997753 4567889999999999999999999998654332211111
Q ss_pred --hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 272 --VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
....++..+.+++ ||.+|||+.++++.++.+...+-
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1234555555554 99999999999999999876653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.78 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=197.5
Q ss_pred HHHhcCccccceeeecCceEEEEEEeCC----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILSD----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
....++|++.+.||+|+||.||+|.+.. +..||+|.++... ....+.+.+|+.+++.++||||+++++++.++ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence 3456889999999999999999998432 3359999988653 34457788999999999999999999998765 4
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++||++++++|.+++...+..+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 68999999999999999877666899999999999999999999 89999999999999999999999999999887
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~ 271 (314)
....... ......+++.|+|||.+. +..++.++||||||+++|+|++ |..||.............
T Consensus 163 ~~~~~~~-~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~ 228 (281)
T 3cc6_A 163 IEDEDYY-KASVTRLPIKWMSPESIN-------------FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228 (281)
T ss_dssp C----------CCCCCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH
T ss_pred ccccccc-ccccCCCCcceeCchhhc-------------cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh
Confidence 6443221 122344678899998763 3456789999999999999998 999997654443321111
Q ss_pred ------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 272 ------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..+++.+.+++ ||..||++.++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1233455555554 99999999999999998865
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.24 Aligned_cols=210 Identities=24% Similarity=0.299 Sum_probs=171.6
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc-----------HHHHHHHHHHHHHHhCCCCCcc
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG-----------RAFRSFDSECEVLRNVHHRNLL 101 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~ 101 (314)
...++....++|++.+.||+|+||.||+|...+++.||+|.+..... ...+.+.+|+++++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45667788899999999999999999999977899999999865321 2246788999999999999999
Q ss_pred eeecccc-----cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe
Q 047043 102 KIFSSCS-----NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL 176 (314)
Q Consensus 102 ~~~~~~~-----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili 176 (314)
++++++. .....++||||+. ++|.+.+...+..+++..+..++.|++.||.||| +.|++|+||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEE
Confidence 9999983 3457899999997 5999988877667999999999999999999999 8999999999999999
Q ss_pred cCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCC
Q 047043 177 DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK 256 (314)
Q Consensus 177 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~ 256 (314)
+.++.++|+|||++....... ......+|+.|+|||.+. ....++.++|||||||++|+|++|..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVM------------QFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHT------------TCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhc------------CCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 999999999999987543322 223346889999998764 22457889999999999999999999
Q ss_pred CCCccc
Q 047043 257 PTDEMF 262 (314)
Q Consensus 257 Pf~~~~ 262 (314)
||....
T Consensus 233 pf~~~~ 238 (362)
T 3pg1_A 233 LFRGST 238 (362)
T ss_dssp SCCCSS
T ss_pred CCCCCC
Confidence 998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.83 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=192.9
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
.....++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3455789999999999999999999954 78899999997653 2334678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 9999999999999999987654 899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh----
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL---- 268 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~---- 268 (314)
....... ......+++.|+|||.+ .+..++.++||||||+++|+|++|..||..........
T Consensus 184 ~~~~~~~-~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (309)
T 2h34_A 184 TTDEKLT-QLGNTVGTLYYMAPERF-------------SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ 249 (309)
T ss_dssp --------------CCGGGCCGGGT-------------CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS
T ss_pred ccccccc-cccccCCCcCccCHHHH-------------cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc
Confidence 6443211 12234589999999765 34567789999999999999999999998754332111
Q ss_pred ----hhhhhccCCchhhhhc------cccCCC-CHHHHHHHHHhhhhhe
Q 047043 269 ----KNWVNESLPHALTDVV------DANLRV-SMKDVAAKLKKIRVKF 306 (314)
Q Consensus 269 ----~~~~~~~~~~~l~~ll------dp~~Rp-t~~~~~~~l~~~~~~~ 306 (314)
.......++..+.+++ ||.+|| ++.++++.++......
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1112334565555555 999999 9999999998876544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=298.31 Aligned_cols=241 Identities=23% Similarity=0.282 Sum_probs=181.0
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 468899999999999999999995 5799999999976532 2233444555567788999999999999999999999
Q ss_pred EEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 117 LELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
|||+++ +|.+++.. .+..+++..+..++.|++.||.||| ++ |++|+||||+||+++.++.++|+|||++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999974 88887754 3456899999999999999999999 76 999999999999999999999999999877
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV 272 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~ 272 (314)
..... ......+|+.|+|||.+.. ......++.++||||||+++|+|++|..||..............
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~---------~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 160 LVDDV---AKDIDAGCKPYMAPERINP---------ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp -------------CCCCCCSCHHHHSC---------CTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred ccccc---cccccCCCccccChhhcCh---------hhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence 64432 2223468999999988631 12455678899999999999999999999986443332222221
Q ss_pred --------hccCCchhhhhc------cccCCCCHHHHHH
Q 047043 273 --------NESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 273 --------~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+++.+.+++ ||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 123555555554 9999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=296.22 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=203.6
Q ss_pred HhcCccccc-eeeecCceEEEEEEeC---CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 40 ATEGFNECN-LLGTGSFGIVYKGILS---DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~-~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..++|.+.+ .||+|+||.||+|... ++..||+|+++... ......+.+|+++++.++||||+++++++. .+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence 457788887 9999999999999843 57789999998753 345677889999999999999999999994 55689
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+|||++++++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999999876666999999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh--
Q 047043 195 DGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN-- 270 (314)
Q Consensus 195 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-- 270 (314)
....... .....+|+.|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECIN-------------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred cCcceeeccccccccccccCHHHhc-------------cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 4332211 22234678899998763 3456789999999999999998 99999876543322111
Q ss_pred ----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 271 ----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
..+..+++.+.+++ ||.+||++.++++.++.+....-.
T Consensus 229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 12234556555554 999999999999999998765443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=292.52 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=193.7
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc----CCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN----PDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 112 (314)
..+.|++.+.||+|+||.||+|.. .++..|++|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345589999999999999999995 478899999997653 3455778899999999999999999998764 456
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEec-CCCcEEEEeeec
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLD-ENMVARVSDFGI 189 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~-~~~~ikl~Dfg~ 189 (314)
.++||||+++++|.+++...+. +++..+..++.|++.||.||| +.| ++|+||||+||+++ .++.++|+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEEecCCCCHHHHHHHccC-CCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 8999999999999999987554 899999999999999999999 888 99999999999997 789999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
+...... ......+|+.|+|||.+. ..++.++||||||+++|+|++|..||...........
T Consensus 179 ~~~~~~~----~~~~~~~t~~y~aPE~~~--------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 240 (290)
T 1t4h_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYE--------------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGG--------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred ccccccc----ccccccCCcCcCCHHHHh--------------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH
Confidence 8754332 122345899999998652 2367899999999999999999999987544332221
Q ss_pred hh--------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 270 NW--------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 ~~--------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.. .+...++.+.+++ ||..|||+.++++ |+|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~------h~~f~~ 288 (290)
T 1t4h_A 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQE 288 (290)
T ss_dssp HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC-
T ss_pred HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh------Cccccc
Confidence 11 2223334444444 9999999999987 677665
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=303.32 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=179.4
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
.+.....++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34455678999999999999999999994 578999999987543 2334667889999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 113 KALVLELMPNGSLENWLYS-------HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~-------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
.++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEE
Confidence 9999999999999999874 2345899999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCC---cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 186 DFGISKLLGDGED---SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 186 Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
|||++........ ........+|+.|+|||.+.. ...++.++||||||+++|+|++|..||....
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ------------VRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHH------------HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhcc------------ccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 9999876543221 111223468999999987641 1236778999999999999999999998754
Q ss_pred cchhhhhhh---------------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 263 TGEISLKNW---------------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 263 ~~~~~~~~~---------------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
......... ....++..+.+++ ||..||++.++++ ++|+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~ 294 (303)
T 2vwi_A 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR------HKFFQKA 294 (303)
T ss_dssp GGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT------STTC---
T ss_pred hhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh------ChhhhcC
Confidence 433211111 0123344444444 9999999999987 6666543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=294.66 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=198.8
Q ss_pred CccccceeeecCceEEEEEEe-CCCC---eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce-eEE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGN---NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK-ALV 116 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv 116 (314)
.|++.+.||+|+||.||+|.+ .+++ .+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 466779999999999999994 3333 79999987543 34557788999999999999999999999876655 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+.+++|.+++...+..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999886667899999999999999999999 899999999999999999999999999998765432
Q ss_pred CC--cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC-CCccccchhhhhh---
Q 047043 197 ED--SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-TDEMFTGEISLKN--- 270 (314)
Q Consensus 197 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P-f~~~~~~~~~~~~--- 270 (314)
.. ........+|+.|.|||.+ .+..++.++||||||+++|+|++|..| |............
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESL-------------QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred cccccccCcCCCCCccccChhhh-------------ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence 21 1122234578899999765 345678899999999999999995554 5544333221111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
..+..+++.+.+++ ||.+|||+.++++.++.+...+....
T Consensus 245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 11233455555554 99999999999999999998877654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=322.10 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=199.0
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|.++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 356799999999999999999995 479999999997652 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||||++|++|.+++...+ ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999997653 34899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch--hhhh-h-
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--ISLK-N- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--~~~~-~- 270 (314)
.... .....||+.|+|||++. +..++.++|||||||++|+|++|..||....... .... .
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~-------------~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i 401 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVK-------------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHT-------------TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH
T ss_pred cCcc---ccccCCCccccCHHHHc-------------CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh
Confidence 4322 23357999999998763 4457889999999999999999999998753211 1111 1
Q ss_pred -----hhhccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 271 -----WVNESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
..+..++..+++++ ||.+|| ++.|+++ |+|++.
T Consensus 402 ~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~------HpfF~~ 450 (576)
T 2acx_A 402 KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE------HPLFKK 450 (576)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT------SGGGTT
T ss_pred hcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh------Chhhcc
Confidence 11234555555554 999999 7788876 556554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.04 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=190.4
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCC--CCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHH--RNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+.++..++| |||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999998789999999997653 3345778899999999976 999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
|||+ .+++|.+++...+. +++..+..++.|++.||.||| +.|++||||||+||+++ ++.+||+|||++.....
T Consensus 87 v~e~-~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EECC-CSEEHHHHHHHSCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEeC-CCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9995 57899999987654 899999999999999999999 89999999999999997 67899999999987654
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhh---
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV--- 272 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~--- 272 (314)
...........||+.|+|||++....... ........++.++|||||||++|+|++|..||..............
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSR--ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccc--cccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 43332333456999999999875311110 0111236678899999999999999999999987544332222221
Q ss_pred -----hccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 273 -----NESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 273 -----~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
+...+..+.+++ ||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 122333444443 99999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=319.80 Aligned_cols=238 Identities=26% Similarity=0.408 Sum_probs=198.0
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46688999999999999999999954 79999999997542 234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeecce
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISK 191 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~~~ 191 (314)
+||||+.+++|.+.+...+. +++..+..++.|++.||.||| ++|++||||||+||++ +.++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999987654 899999999999999999999 8999999999999999 567899999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
....... .....||+.|+|||++. +.++.++|||||||++|+|++|..||......+.....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~--------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 240 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLH--------------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHH--------------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred Ecccccc---cccCCCCccccCceeec--------------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 7654332 23356999999998753 24678999999999999999999999876543321111
Q ss_pred --------hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 271 --------WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 271 --------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.....+++.+++++ ||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11234566555554 99999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.24 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=204.6
Q ss_pred CCCCcccceehhhHHH-HhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC
Q 047043 24 LPVATWRRTSYLDIQR-ATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV 95 (314)
Q Consensus 24 ~~~~~~~~~~~~~~~~-~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l 95 (314)
.+.....+.+..++.. ..++|++.+.||+|+||.||+|++ .+++.||+|.+.... ......+.+|+.+++.+
T Consensus 11 ~~~~~~~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 90 (327)
T 2yfx_A 11 NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90 (327)
T ss_dssp CEEETTEEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC
T ss_pred CccccCCccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC
Confidence 3444444555555543 468999999999999999999983 257789999997543 33456788999999999
Q ss_pred CCCCcceeecccccCCceeEEEEecCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC
Q 047043 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHN------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169 (314)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl 169 (314)
+||||+++++++.+....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||
T Consensus 91 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dl 166 (327)
T 2yfx_A 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDI 166 (327)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCC
T ss_pred CCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcC
Confidence 99999999999999999999999999999999998753 34788999999999999999999 899999999
Q ss_pred CCCceEecC---CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhH
Q 047043 170 KPSNILLDE---NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGV 246 (314)
Q Consensus 170 kp~Nili~~---~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~ 246 (314)
||+||+++. +..++|+|||++................+|+.|+|||.+. +..++.++||||||+
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~ 233 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-------------EGIFTSKTDTWSFGV 233 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH-------------HCCCCHHHHHHHHHH
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc-------------CCCCCchhhHHHHHH
Confidence 999999984 4469999999987654433322333456788999998764 345778999999999
Q ss_pred HHHHHhc-CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 247 LLMETFT-GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 247 il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
++|+|++ |..||............ ..+..++..+.+++ ||.+||++.++++.++.+...
T Consensus 234 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 234 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 9999998 99999875443321111 11234555555554 999999999999999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=301.18 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=190.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--------cHHHHHHHHHHHHHHhCCCCCcceeecccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--------GRAFRSFDSECEVLRNVHHRNLLKIFSSCS 108 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (314)
....++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 45678999999999999999999995 468899999987542 122345789999999999999999999987
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc---EEEE
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV---ARVS 185 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~---ikl~ 185 (314)
..+ .++||||+++++|.+++...+ .+++..+..++.|++.||.||| ++|++|+||||+||+++.++. +||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 765 789999999999999887654 4899999999999999999999 899999999999999987664 9999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~ 265 (314)
|||++....... ......||+.|+|||++.. .....++.++||||||+++|+|++|..||.......
T Consensus 160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~----------~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVS----------VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHH----------TTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred cCccceeccccc---ccccccCCcCccCchhhcc----------CCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 999998764322 1223458999999987631 134557889999999999999999999997644321
Q ss_pred hhhh----------hhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 266 ISLK----------NWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 266 ~~~~----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.... ......+++.+.+++ ||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111 111234555555554 9999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.66 Aligned_cols=200 Identities=25% Similarity=0.309 Sum_probs=165.3
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP----- 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (314)
...++|++++.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4568999999999999999999995 479999999997642 34456788999999999999999999998654
Q ss_pred -CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 111 -DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 111 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||+
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 456999999965 67776643 3889999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+..
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVIL-------------GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHT-------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc---ccCCCcccccccCHHHHc-------------CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98764432 223356899999998763 4467889999999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.02 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=189.3
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHh--CCCCCcceeeccccc----CCce
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN--VHHRNLLKIFSSCSN----PDFK 113 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~ 113 (314)
..++|++.+.||+|+||.||+|++ +++.||+|++.... ...+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 568999999999999999999997 78899999997653 2445566777666 789999999998543 4568
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH----SSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
++||||+++++|.+++... .+++..++.++.|++.||+|||+.. .+.|++||||||+||+++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999999999654 4899999999999999999999311 147899999999999999999999999999
Q ss_pred ceecCCCCCcce--eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC----------CCC
Q 047043 190 SKLLGDGEDSVT--QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG----------KKP 257 (314)
Q Consensus 190 ~~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g----------~~P 257 (314)
+........... .....||+.|+|||++.... ......++.++||||||+++|+|++| ..|
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI-------QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC-------CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eeecccccccccccccccccccceeChhhhcCcC-------CCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 987654332211 22336899999998875210 00011456789999999999999999 888
Q ss_pred CCccccchhhhhhh-----------------hh----ccCCchhhhhc--cccCCCCHHHHHHHHHhh
Q 047043 258 TDEMFTGEISLKNW-----------------VN----ESLPHALTDVV--DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 258 f~~~~~~~~~~~~~-----------------~~----~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~ 302 (314)
|............. .. ..+.+.+..++ ||.+|||+.++++.|+.+
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 86543322111110 01 11222344444 999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=290.60 Aligned_cols=237 Identities=24% Similarity=0.357 Sum_probs=193.3
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccH------HHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4578999999999999999999965 7999999999765321 24678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC----cEEEEeee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----VARVSDFG 188 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----~ikl~Dfg 188 (314)
.+++|||+++++|.+++..... +++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999976544 899999999999999999999 89999999999999998777 89999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
++........ .....+++.|+|||.+ .+..++.++||||||+++|+|++|..||......+...
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 221 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIV-------------NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHH-------------TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cceeccCCCc---ccccCCCcCccCccee-------------cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 9987644322 2234589999999775 34557889999999999999999999998754432211
Q ss_pred ---------hhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 269 ---------KNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 269 ---------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.......+++.+.+++ ||.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 222 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1112234555555544 9999999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=302.85 Aligned_cols=206 Identities=24% Similarity=0.334 Sum_probs=173.2
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----C
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-----D 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 111 (314)
...++|++++.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3457999999999999999999995 478899999997543 33446788999999999999999999998654 4
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..+++||++. ++|.+++.... +++..+..++.|++.||+||| ++|++|+||||+||+++.++.++|+|||++.
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 6899999996 59999987643 899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 192 LLGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 192 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
......... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIML------------NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHH------------TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred ecCCCCCccccccccccccCCCCCHHhc------------CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 765332211 112346899999998754 344578899999999999999999999976543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.73 Aligned_cols=248 Identities=19% Similarity=0.179 Sum_probs=196.1
Q ss_pred HHHhcCccccceeeecCceEEEEEE------eCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC---CCCcceeecccc
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGI------LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH---HRNLLKIFSSCS 108 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 108 (314)
....++|++.+.||+|+||.||+|. ..+++.||+|+++.... ..+..|.+++..++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3345779999999999999999993 45789999999986543 45677788887776 899999999999
Q ss_pred cCCceeEEEEecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC------
Q 047043 109 NPDFKALVLELMPNGSLENWLYS----HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE------ 178 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~------ 178 (314)
..+..++||||+++++|.+++.. ....+++..++.++.|++.||+||| ++|++||||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC-
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCcc
Confidence 99999999999999999999975 2445899999999999999999999 999999999999999988
Q ss_pred -----CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 179 -----NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 179 -----~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
++.+||+|||++..+.............||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-------------SNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-------------TTCCBSTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-------------cCCCCCccccHHHHHHHHHHHHh
Confidence 899999999999776433333344456799999999776 34558899999999999999999
Q ss_pred CCCCCCccccchhhhhh-----hhhccCCchhhhhc--cccCC-CCHHHHHHHHHhhhhh
Q 047043 254 GKKPTDEMFTGEISLKN-----WVNESLPHALTDVV--DANLR-VSMKDVAAKLKKIRVK 305 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~-----~~~~~~~~~l~~ll--dp~~R-pt~~~~~~~l~~~~~~ 305 (314)
|..||............ ...+.+.+.+..++ +|..| |++.++.+.++.+...
T Consensus 281 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 281 GTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp SSCCCEEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCccccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 99999765443222111 11122233344444 77777 6788888888776654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=292.28 Aligned_cols=235 Identities=25% Similarity=0.337 Sum_probs=195.1
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 578999999999999999999954 688999999976431 2245788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999987654 899999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
. .....+++.|+|||.+. +..++.++||||||+++|+|++|..||......+......
T Consensus 168 ~----~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIE-------------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHT-------------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred c----cccccCCCCcCCHHHhc-------------cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC
Confidence 2 22346899999997753 4456789999999999999999999998754433221111
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.+..++..+.+++ ||.+||++.++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1234455555554 9999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=293.81 Aligned_cols=248 Identities=20% Similarity=0.295 Sum_probs=195.6
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccc-ccCCceeEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC-SNPDFKALV 116 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 116 (314)
...++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3568899999999999999999995 5789999998765532 24678899999999887776666554 677788999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~~~~~ 193 (314)
|||+ +++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 88999999876666999999999999999999999 8999999999999999 78899999999999877
Q ss_pred CCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--
Q 047043 194 GDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-- 266 (314)
Q Consensus 194 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-- 266 (314)
....... ......+|+.|+|||.+. +..++.++|||||||++|+|++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHL-------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhc-------------CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 5443211 122356899999997753 45578899999999999999999999987543211
Q ss_pred hhh-----------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 267 SLK-----------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 267 ~~~-----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
... ......+++.+.+++ ||.+|||+.++++.++.+..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 226 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000 011144566666655 9999999999999999987764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.51 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=189.3
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHH--HHhCCCCCcceeeccc-----ccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEV--LRNVHHRNLLKIFSSC-----SNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~-----~~~~~ 112 (314)
..++|++.+.||+|+||.||+|+. +++.||+|+++.... ..+..|.++ +..++||||+++++.+ .....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 468999999999999999999986 788999999986532 333444444 4457999999999743 34446
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---------CeeecCCCCCceEecCCCcEE
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA---------PIVHCDLKPSNILLDENMVAR 183 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~---------~i~H~dlkp~Nili~~~~~ik 183 (314)
+++||||+++++|.+++.... .++..+..++.|++.||.||| +. |++||||||+||+++.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcEE
Confidence 789999999999999997665 588899999999999999999 77 999999999999999999999
Q ss_pred EEeeecceecCCCCCc------ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 184 VSDFGISKLLGDGEDS------VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 184 l~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
|+|||++..+...... .......||+.|+|||++..... ......++.++|||||||++|+|++|..|
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN------LRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC------GGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc------cccccccccccchHHHHHHHHHHHhcCCc
Confidence 9999999876543211 11223468999999988742100 00113466789999999999999999776
Q ss_pred CCcccc-chh---------------hhhhh-----hhcc--------------CCchhhhhc--cccCCCCHHHHHHHHH
Q 047043 258 TDEMFT-GEI---------------SLKNW-----VNES--------------LPHALTDVV--DANLRVSMKDVAAKLK 300 (314)
Q Consensus 258 f~~~~~-~~~---------------~~~~~-----~~~~--------------~~~~l~~ll--dp~~Rpt~~~~~~~l~ 300 (314)
|..... ... ..... ..+. +.+.+..++ ||.+|||+.|+++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 532111 100 00000 0111 122334444 9999999999999999
Q ss_pred hhhhheeeeec
Q 047043 301 KIRVKFLYDVA 311 (314)
Q Consensus 301 ~~~~~~~~~~~ 311 (314)
.+.+.|.++..
T Consensus 315 ~ll~~~~~~~~ 325 (336)
T 3g2f_A 315 ELMMIWERNKS 325 (336)
T ss_dssp HHHHCCCC---
T ss_pred HHHHHHHhccc
Confidence 99999988754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.27 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=202.9
Q ss_pred HhcCccccceeeecCceEEEEEEe-----CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccC--Cc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--DF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 112 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++||||+++++++... ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 467899999999999999999983 36889999999877666678899999999999999999999988654 37
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 89999999999999999887666899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch------
Q 047043 193 LGDGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE------ 265 (314)
Q Consensus 193 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~------ 265 (314)
......... .....++..|+|||.+. +..++.++||||||+++|+|++|..||.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~ 261 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLT-------------ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCT
T ss_pred ccccccccccccCCCCceeEECchhhc-------------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcc
Confidence 754432211 12234677899998764 3346789999999999999999999986432110
Q ss_pred -----h---hhhhh--------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 266 -----I---SLKNW--------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 266 -----~---~~~~~--------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
. ..... .+..+++.+.+++ ||.+||++.++++.++.++..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 00000 1234555555554 9999999999999999998765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.54 Aligned_cols=205 Identities=26% Similarity=0.373 Sum_probs=170.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4678999999999999999999954 699999999865432 3345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++++|.+++...+ .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 103 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999888887765544 4899999999999999999999 899999999999999999999999999998766443
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
.. ......+|+.|+|||.+. ....++.++||||||+++|+|++|..||.....
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLV------------GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp --------CCCCCTTCCHHHHT------------TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc--ccCCCcCCccccCccccc------------CCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 22 223346899999998763 234578899999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=298.45 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=190.7
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC--CCCCcceeecccccC
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV--HHRNLLKIFSSCSNP 110 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~ 110 (314)
+........++|++.+.||+|+||.||+|+. +++.||+|++..... .....|.+++... +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3445566788999999999999999999997 488999999875532 3444556666554 899999999998776
Q ss_pred ----CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--------CeeecCCCCCceEecC
Q 047043 111 ----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA--------PIVHCDLKPSNILLDE 178 (314)
Q Consensus 111 ----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~--------~i~H~dlkp~Nili~~ 178 (314)
...++||||+++++|.+++.... +++..++.++.|++.||+||| .. |++|+||||+||+++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH----TEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----SCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH----HhhhhhccCCCEEecccchHHEEECC
Confidence 78899999999999999997653 899999999999999999999 77 9999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcce--eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC--
Q 047043 179 NMVARVSDFGISKLLGDGEDSVT--QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-- 254 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-- 254 (314)
++.+||+|||++........... .....||+.|+|||++.... .......+.++|||||||++|+|++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-------NRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-------CTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-------CCccccCccccchHHHHHHHHHHHhccC
Confidence 99999999999977644322211 12346899999998864210 00111122358999999999999999
Q ss_pred --------CCCCCccccchhhhh---hh--------------hhccCCc----hhhhhc--cccCCCCHHHHHHHHHhhh
Q 047043 255 --------KKPTDEMFTGEISLK---NW--------------VNESLPH----ALTDVV--DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 255 --------~~Pf~~~~~~~~~~~---~~--------------~~~~~~~----~l~~ll--dp~~Rpt~~~~~~~l~~~~ 303 (314)
..||........... .. ....+++ .+..++ ||.+|||+.+++++|+.+.
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 667655332211110 00 0112222 333344 9999999999999999887
Q ss_pred hh
Q 047043 304 VK 305 (314)
Q Consensus 304 ~~ 305 (314)
..
T Consensus 331 ~~ 332 (337)
T 3mdy_A 331 ES 332 (337)
T ss_dssp HT
T ss_pred hh
Confidence 54
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=307.09 Aligned_cols=236 Identities=23% Similarity=0.353 Sum_probs=185.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc--------
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS-------- 108 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------- 108 (314)
....++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ....+|+++++.++||||+++++++.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567999999999999999999995 579999999987553 22346999999999999999999883
Q ss_pred ------------------------------cCCceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 047043 109 ------------------------------NPDFKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYL 155 (314)
Q Consensus 109 ------------------------------~~~~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~L 155 (314)
+....++||||++ ++|.+.+.. .+..+++..+..++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3345889999997 488877753 345589999999999999999999
Q ss_pred hcCCCCCCeeecCCCCCceEec-CCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCC
Q 047043 156 HHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGI 234 (314)
Q Consensus 156 H~~~~~~~i~H~dlkp~Nili~-~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~ 234 (314)
| +.|++||||||+||+++ .++.+||+|||++........ .....+|+.|+|||.+. ....
T Consensus 158 H----~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~------------~~~~ 218 (383)
T 3eb0_A 158 H----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELML------------GATE 218 (383)
T ss_dssp H----TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHT------------TCSS
T ss_pred H----HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhc------------CCCC
Confidence 9 99999999999999997 688999999999987654332 22345899999998753 2345
Q ss_pred CCcccceehhhHHHHHHhcCCCCCCccccchhhh----------------------------------hhhhhccCCchh
Q 047043 235 ISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL----------------------------------KNWVNESLPHAL 280 (314)
Q Consensus 235 ~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~----------------------------------~~~~~~~~~~~l 280 (314)
++.++|||||||++|+|++|..||......+... ....+..+++.+
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 7889999999999999999999998754332211 111222345445
Q ss_pred hhhc------cccCCCCHHHHHH
Q 047043 281 TDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 281 ~~ll------dp~~Rpt~~~~~~ 297 (314)
.+++ ||.+|||+.|+++
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 5554 9999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=299.88 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=200.4
Q ss_pred HhcCc-cccceeeecCceEEEEEEe-----CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeeccccc--C
Q 047043 40 ATEGF-NECNLLGTGSFGIVYKGIL-----SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSN--P 110 (314)
Q Consensus 40 ~~~~y-~~~~~lg~G~~g~V~~a~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 110 (314)
+.++| ++++.||+|+||.||++.+ .+++.||+|+++.... .....+.+|+++++.++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34455 9999999999999998864 2578999999986643 445778999999999999999999999876 4
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
...++||||+++++|.+++...+ +++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred ceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 67899999999999999997654 899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh---
Q 047043 191 KLLGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--- 266 (314)
Q Consensus 191 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--- 266 (314)
.......... ......+|..|+|||.+. +..++.++||||||+++|+|++|..||........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~ 248 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLK-------------EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhc-------------CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh
Confidence 8875543221 123345788899998764 34567789999999999999999999875432210
Q ss_pred ----------hhhhh--------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 267 ----------SLKNW--------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 267 ----------~~~~~--------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
..... .+..++..+.+++ ||.+|||+.++++.|+.+..++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 249 GIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 00000 1234555555554 999999999999999999887753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=294.48 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=191.1
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhCCCCCcceeeccc--ccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNVHHRNLLKIFSSC--SNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 112 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 568999999999999999999995 578999999997653 23356788999999999999999999998 45668
Q ss_pred eeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 113 KALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.++||||++++ |.+++... ...+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999765 77777653 345899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
...............+|+.|+|||++.. ....++.++||||||+++|+|++|..||............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~ 226 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANG-----------LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG 226 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTC-----------CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccCccccccccccCCCCCCCcChhhccC-----------cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh
Confidence 7654333333344568999999987531 1233467899999999999999999999875433221111
Q ss_pred ----hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 271 ----WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..+..++..+.+++ ||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11234455555544 99999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.41 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=198.1
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc-------
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN------- 109 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 109 (314)
....++|++.+.||+|+||.||+|... +++.||+|.++... ..+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 346688999999999999999999965 79999999998653 356789999999999999999998754
Q ss_pred ---------CCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC
Q 047043 110 ---------PDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN 179 (314)
Q Consensus 110 ---------~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~ 179 (314)
....+++|||+++++|.+++... +..+++..++.++.|++.||.||| +.|++|+||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCC
Confidence 45688999999999999999754 345899999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 180 MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 180 ~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
+.++|+|||++........ .....+|+.|+|||.+. +..++.++||||||+++|+|++|..||.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQIS-------------SQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHH-------------CSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCEEECcchhheecccccc---ccccCCcccccChhhhc-------------cCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999999987754332 22345899999998763 3456789999999999999999999875
Q ss_pred ccccchhhh-hhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 260 EMFTGEISL-KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 260 ~~~~~~~~~-~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
......... ....+..++..+.+++ ||.+||++.++++.+..+.....++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 223 ETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp HHHHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred hHHHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 432111111 1112234455444544 999999999999999999877665543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=306.56 Aligned_cols=237 Identities=26% Similarity=0.383 Sum_probs=190.2
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (314)
....++|++.+.||+|+||.||+|..+ +++.||+|+++.... ...+|++++.++ +||||+++++++.+++..++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 346788999999999999999999954 789999999986532 345688888887 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC----CcEEEEeeecce
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN----MVARVSDFGISK 191 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~----~~ikl~Dfg~~~ 191 (314)
||||+++++|.+.+...+. +++..+..++.|++.||.||| ++|++||||||+||++..+ +.+||+|||++.
T Consensus 94 v~E~~~gg~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHHTCTT-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999987654 899999999999999999999 8999999999999998432 359999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch--hhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--ISLK 269 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--~~~~ 269 (314)
....... ......+|+.|+|||++. +..++.++|||||||++|+|++|..||....... ....
T Consensus 169 ~~~~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~ 233 (342)
T 2qr7_A 169 QLRAENG--LLMTPCYTANFVAPEVLE-------------RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233 (342)
T ss_dssp ECBCTTC--CBCCSSCCSSCCCHHHHH-------------HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH
T ss_pred cCcCCCC--ceeccCCCccccCHHHhc-------------CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH
Confidence 7654322 123356899999998864 2346778999999999999999999998632211 1111
Q ss_pred hh----------hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 270 NW----------VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 270 ~~----------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.. ....+++.+.+++ ||.+||++.+++++
T Consensus 234 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1134556555554 99999999998773
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=298.55 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=194.2
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CC----CeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DG----NNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
..++|++.+.||+|+||.||+|... ++ ..||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3567888999999999999999853 22 3599999986532 3456788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999877666999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh
Q 047043 194 GDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 194 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~ 271 (314)
....... ......+|..|+|||.+. +..++.++||||||+++|+|++ |..||......+......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAIS-------------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp -------------CCCGGGSCHHHHH-------------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccccccccccCCCCccccccCchhcc-------------cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 5432211 112234577899998763 4457789999999999999998 999998765433221111
Q ss_pred ------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 272 ------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 272 ------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.+..+++.+.+++ ||..||++.++++.++.+...
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1223445555544 999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.51 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=199.2
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.+....++|++.+.||+|+||.||+|.++.+..||+|+++.... ..+.+.+|++++++++||||+++++++.+ +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 33445678999999999999999999987777899999986532 23678999999999999999999999876 67899
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||||+++++|.+++... +..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999999753 344899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
..... ......++..|+|||.+. ...++.++||||||+++|+|++ |..||......+.....
T Consensus 332 ~~~~~-~~~~~~~~~~y~aPE~~~-------------~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 332 DNEYT-ARQGAKFPIKWTAPEAAL-------------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp ------------CCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CCcee-cccCCcccccccCHhHHh-------------cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 33211 222334678899998764 3457889999999999999999 99999876554432211
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.+...
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 12345666666655 999999999999999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=293.56 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=199.4
Q ss_pred HHHhcCccccc-eeeecCceEEEEEEe---CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 38 QRATEGFNECN-LLGTGSFGIVYKGIL---SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 38 ~~~~~~y~~~~-~lg~G~~g~V~~a~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
....++|++.+ .||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34467899998 999999999999963 347889999997653 23457789999999999999999999999 556
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..++||||+++++|.+++...+. +++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhCcC-CCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 78899999999999999987654 899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh
Q 047043 192 LLGDGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK 269 (314)
Q Consensus 192 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~ 269 (314)
.......... .....+++.|+|||.+. +..++.++||||||+++|+|++ |..||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 232 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECIN-------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhc-------------cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 7754432211 12234568899998764 3346778999999999999999 9999987654433211
Q ss_pred hh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 270 NW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 270 ~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.. .+..+++.+.+++ ||.+||++.++++.|+.+....
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 233 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11 1234555555555 9999999999999999886643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=301.94 Aligned_cols=255 Identities=23% Similarity=0.244 Sum_probs=182.7
Q ss_pred CCCCCCCcccceehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc------HHHHHHHHHHHHHH
Q 047043 21 IDLLPVATWRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG------RAFRSFDSECEVLR 93 (314)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~ 93 (314)
+...|.++.+.....+.....++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.++.
T Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~ 89 (312)
T 2iwi_A 10 PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89 (312)
T ss_dssp -----------------------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHH
T ss_pred CCCCCCCCCCCCCccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHH
Confidence 3344555555556667777889999999999999999999995 5789999999976532 12344567899998
Q ss_pred hC----CCCCcceeecccccCCceeEEEEe-cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecC
Q 047043 94 NV----HHRNLLKIFSSCSNPDFKALVLEL-MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCD 168 (314)
Q Consensus 94 ~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~d 168 (314)
++ +||||+++++++.+.+..+++||+ +.+++|.+++...+. +++..++.++.|++.||.||| +.|++|+|
T Consensus 90 ~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~d 164 (312)
T 2iwi_A 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH----SRGVVHRD 164 (312)
T ss_dssp HHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HHTEECCC
T ss_pred hhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeecC
Confidence 88 899999999999999999999999 788999999987654 899999999999999999999 89999999
Q ss_pred CCCCceEec-CCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHH
Q 047043 169 LKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL 247 (314)
Q Consensus 169 lkp~Nili~-~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i 247 (314)
|||+||+++ .++.++|+|||++....... .....++..|+|||++.. ....+.++||||||++
T Consensus 165 lkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~------------~~~~~~~~Di~slG~i 228 (312)
T 2iwi_A 165 IKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISR------------HQYHALPATVWSLGIL 228 (312)
T ss_dssp CSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHH------------SCBCHHHHHHHHHHHH
T ss_pred CChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeec------------CCCCCccchHHHHHHH
Confidence 999999998 88999999999998765432 223458999999987641 2233458999999999
Q ss_pred HHHHhcCCCCCCccccchhhhhhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 248 LMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 248 l~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
+|+|++|..||....... ......+..++..+.+++ ||..||++.++++
T Consensus 229 l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 229 LYDMVCGDIPFERDQEIL-EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHSSCSCCSHHHHH-HTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCChHHHh-hhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999997643211 111112234555555544 9999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=326.01 Aligned_cols=245 Identities=22% Similarity=0.254 Sum_probs=198.9
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCce
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (314)
...++|++++.||+|+||.||+|+. .+++.||+|+++... ......+..|.+++..+ +||+|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3467899999999999999999995 478999999998642 22345677889999887 799999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+||||+++++|.+++...+. +++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999987654 899999999999999999999 899999999999999999999999999999864
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-- 271 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~-- 271 (314)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|..||......+......
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l-------------~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 557 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEII-------------AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHH-------------TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS
T ss_pred ccCCc--ccccccCCCcccCHhhh-------------cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence 33222 23345799999999776 34567889999999999999999999998765443322211
Q ss_pred ---hhccCCchhhhhc------cccCCCCH-----HHHHHHHHhhhhheeee
Q 047043 272 ---VNESLPHALTDVV------DANLRVSM-----KDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ---~~~~~~~~l~~ll------dp~~Rpt~-----~~~~~~l~~~~~~~~~~ 309 (314)
.+..++..+.+++ ||.+||++ .|+++ |+|++.
T Consensus 558 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~------h~ff~~ 603 (674)
T 3pfq_A 558 NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE------HAFFRY 603 (674)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS------SGGGSS
T ss_pred CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc------CccccC
Confidence 2234555555554 99999997 56554 666654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.68 Aligned_cols=245 Identities=13% Similarity=0.162 Sum_probs=195.1
Q ss_pred hcCccccceeeecCceEEEEEEeC---------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCccee--------
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS---------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI-------- 103 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-------- 103 (314)
.++|++.+.||+|+||.||+|+.. +++.||+|++... ..+.+|+++++.++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 478999999999999999999964 3789999998865 467889999999999999884
Q ss_pred -------eccccc-CCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 104 -------FSSCSN-PDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 104 -------~~~~~~-~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
++++.. .+..++||||+ +++|.+++... +..+++..+..++.|++.||.||| ++|++|+||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHE
Confidence 444444 67889999999 89999999875 345899999999999999999999 89999999999999
Q ss_pred EecCCC--cEEEEeeecceecCCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHH
Q 047043 175 LLDENM--VARVSDFGISKLLGDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL 247 (314)
Q Consensus 175 li~~~~--~ikl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i 247 (314)
+++.++ .++|+|||++..+....... ......||+.|+|||++. +..++.++||||||++
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~i 257 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-------------GCGPSRRSDLQSLGYC 257 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-------------TCCCCHHHHHHHHHHH
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-------------cCCCCchhhHHHHHHH
Confidence 999998 89999999998764332111 112346899999997753 4467889999999999
Q ss_pred HHHHhcCCCCCCccccchhhhhhhh----h------------ccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 248 LMETFTGKKPTDEMFTGEISLKNWV----N------------ESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 248 l~~ll~g~~Pf~~~~~~~~~~~~~~----~------------~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
+|+|++|..||.............. . ..+++.+.+++ ||.+||++.++++.|+.+..+
T Consensus 258 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 258 MLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999987642221111110 0 13456556655 999999999999999998876
Q ss_pred eee
Q 047043 306 FLY 308 (314)
Q Consensus 306 ~~~ 308 (314)
+-.
T Consensus 338 ~~~ 340 (352)
T 2jii_A 338 LRV 340 (352)
T ss_dssp TTC
T ss_pred cCC
Confidence 543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=308.92 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=173.7
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 568999999999999999999954 79999999998763 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++...+. +++..+..++.|++.||.||| .. |++|+||||+||+++.++.++|+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999987654 899999999999999999999 64 9999999999999999999999999988655322
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......||+.|+|||++. +..++.++||||||+++|+|++|..||....
T Consensus 186 ---~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQ-------------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ---C----CCCCTTCCHHHHT-------------TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ---cccCCCCCCCeECHHHHc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 122346899999997753 4567889999999999999999999997644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=292.43 Aligned_cols=239 Identities=21% Similarity=0.327 Sum_probs=196.8
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999999964 68899999997653 2345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
+|||+++++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEECCTTCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999998876554 899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN----- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~----- 270 (314)
... ......+|+.|+|||.+. +..++.++||||||+++|+|++|..||......+.....
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLS-------------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHT-------------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred Ccc--ccccccCCCCcCCcchhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC
Confidence 322 122346899999997753 445678999999999999999999999875543321111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..+..++..+.+++ ||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11233444444444 99999999998873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=301.14 Aligned_cols=239 Identities=21% Similarity=0.333 Sum_probs=196.9
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
...++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999954 68899999997652 234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|||+++++|.+++...+. +++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999999876544 899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh----
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~---- 270 (314)
.... ......+|+.|+|||++. +..++.++||||||+++|+|++|..||......+.....
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 257 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLS-------------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHH-------------TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred cCcc--cccccCCCccccCHHHhc-------------cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC
Confidence 3322 123346899999998764 344678999999999999999999999875443321111
Q ss_pred -hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 -WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 -~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+..++..+.+++ ||.+||++.++++
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233444444444 9999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.06 Aligned_cols=242 Identities=30% Similarity=0.447 Sum_probs=191.7
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc-CCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-PDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 118 (314)
..++|++.+.||+|+||.||+|.. +++.||+|+++... ..+.+.+|+++++.++||||+++++++.. .+..+++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 468999999999999999999987 58899999997653 34678899999999999999999998654 457899999
Q ss_pred ecCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~-~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++++|.+++...+. .+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999976532 3788999999999999999999 8999999999999999999999999999987654321
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------ 270 (314)
....+++.|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 172 -----~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 233 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALR-------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 233 (278)
T ss_dssp ---------CCTTTSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred -----cCCCccccccCHHHhC-------------CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 2234678899998763 3456789999999999999998 99999875543322111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
..+..+++.+.+++ ||.+||++.++++.|+.++..-
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 12234555555554 9999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.58 Aligned_cols=249 Identities=19% Similarity=0.280 Sum_probs=200.1
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccc-ccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC-SNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 117 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 467899999999999999999995 5799999999876532 24678899999999988766655554 6677889999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeecceecC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLG 194 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~~~~~~ 194 (314)
||+ +++|.+++......+++..+..++.|++.||+||| ++|++|+||||+||++ +.++.+||+|||++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 88999999866666999999999999999999999 8999999999999999 488899999999998775
Q ss_pred CCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--h
Q 047043 195 DGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--S 267 (314)
Q Consensus 195 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--~ 267 (314)
...... ......||+.|+|||.+ .+..++.++||||||+++|+|++|..||........ .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTH-------------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred ccccccccccccccccccccccCChhhh-------------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence 443211 12334689999999775 345578899999999999999999999986432210 0
Q ss_pred hh-----------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 268 LK-----------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 268 ~~-----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
.. ......+++.+.+++ ||.+||++.++++.++.+..+.-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 227 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00 011245666666655 999999999999999998876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=299.37 Aligned_cols=249 Identities=28% Similarity=0.404 Sum_probs=197.8
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeE--EEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNV--AIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~v--aiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|+. .++..+ ++|.++... ......+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 47899999999999999999995 466654 999887532 23456788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 116 VLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
||||+++++|.+++...+ ..+++..++.++.|++.||.||| ++|++|+||||+||+++.++
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGG
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCC
Confidence 999999999999997653 35899999999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~ 259 (314)
.+||+|||++....... ......+++.|+|||.+. +..++.++||||||+++|+|++ |..||.
T Consensus 180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLN-------------YSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred eEEEcccCcCccccccc---cccCCCCCccccChhhhc-------------cccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 99999999987432211 122234678899998763 3446789999999999999998 999998
Q ss_pred ccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 260 EMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 260 ~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.....+..... ..+..+++.+.+++ ||.+||++.++++.++.+..+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 244 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp TCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred CCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 76543322111 11233455555554 9999999999999999988765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=304.71 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=192.6
Q ss_pred cCccccceeeecCceEEEEEEeC-C-C--CeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccc-cCCceeE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-D-G--NNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCS-NPDFKAL 115 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~-~--~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 115 (314)
..|++.+.||+|+||.||+|... + + ..||+|.++... ......+.+|+.++++++||||+++++++. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999953 2 2 368999886543 345678899999999999999999999864 5568899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++...+..+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999999877666899999999999999999999 89999999999999999999999999999986643
Q ss_pred CCCcc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh--
Q 047043 196 GEDSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN-- 270 (314)
Q Consensus 196 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-- 270 (314)
..... ......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~ 311 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQ-------------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311 (373)
T ss_dssp -------------CCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT
T ss_pred cccccccccCCCCCcccccChHHhc-------------CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc
Confidence 32111 122345678899998763 3457889999999999999999 77888765543332111
Q ss_pred ----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 271 ----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 271 ----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
..+..+++.+.+++ ||.+||++.++++.|+.+...+..+.
T Consensus 312 ~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 11234555555555 99999999999999999988776543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.73 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=201.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC--ceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD--FKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 115 (314)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4578999999999999999999954 69999999997643 233466789999999999999999999987654 7799
Q ss_pred EEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe----cCCCcEEEEeeec
Q 047043 116 VLELMPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL----DENMVARVSDFGI 189 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili----~~~~~ikl~Dfg~ 189 (314)
||||+++++|.+++.... ..+++..++.++.|++.||+||| ++|++||||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999997643 23899999999999999999999 8999999999999999 7788899999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh---
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--- 266 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--- 266 (314)
+........ .....||+.|+|||++....... .....++.++|||||||++|+|++|..||........
T Consensus 163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRK-----DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CEECCCGGG---SSCSSSCCTTCCHHHHHHHCC-------CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ceEccCCCc---cccccCCccccCHHHhhcccccc-----ccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 987654322 22346899999999875311100 0124567789999999999999999999975332110
Q ss_pred hhhhh-----------------------------------hhccCCchhhhhc--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 267 SLKNW-----------------------------------VNESLPHALTDVV--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 267 ~~~~~-----------------------------------~~~~~~~~l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
..... .+..+.+.++.++ ||.+||++.++++.++.+.++-...
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~~~ 314 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH 314 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEEEE
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceEEE
Confidence 00000 0111122344444 9999999999999999988876544
Q ss_pred e
Q 047043 310 V 310 (314)
Q Consensus 310 ~ 310 (314)
.
T Consensus 315 ~ 315 (396)
T 4eut_A 315 V 315 (396)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=302.68 Aligned_cols=246 Identities=16% Similarity=0.220 Sum_probs=190.0
Q ss_pred HhcCccccceeeecCceEEEEEEeC----CCCeEEEEEeeecccHH-----------HHHHHHHHHHHHhCCCCCcceee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS----DGNNVAIKVFKLQLGRA-----------FRSFDSECEVLRNVHHRNLLKIF 104 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~----~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~ 104 (314)
..++|++.+.||+|+||.||+|... ++..+|+|++....... ...+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 4578999999999999999999954 67899999987653211 12355788888999999999999
Q ss_pred ccccc----CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 105 SSCSN----PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 105 ~~~~~----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
+++.. ....++||||+ +++|.+++...+ .+++..++.++.|++.||+||| +.|++|+||||+||+++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCC
Confidence 99877 77899999999 899999998765 5899999999999999999999 89999999999999998777
Q ss_pred --cEEEEeeecceecCCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc
Q 047043 181 --VARVSDFGISKLLGDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT 253 (314)
Q Consensus 181 --~ikl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~ 253 (314)
.+||+|||++..+....... ......||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-------------GVALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-------------TCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc-------------CCCCCchhhHHHHHHHHHHHHh
Confidence 99999999998764322111 112346899999998763 4467889999999999999999
Q ss_pred CCCCCCccccchhhhhh-------hhh---------ccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 254 GKKPTDEMFTGEISLKN-------WVN---------ESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~-------~~~---------~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
|..||............ ..+ ..+++.+.+++ ||.+||++.++++.|+.+.-
T Consensus 256 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 256 GKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp SSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99999653322211110 001 15666666665 99999999999999988654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=297.70 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=201.5
Q ss_pred eehhhHHHHhcCcccc-ceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhC-CCCCcceeecc
Q 047043 32 TSYLDIQRATEGFNEC-NLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNV-HHRNLLKIFSS 106 (314)
Q Consensus 32 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (314)
..|.......++|.+. +.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++.+ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3456667888999998 89999999999999954 799999999976432 2346788999999999 56999999999
Q ss_pred cccCCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcE
Q 047043 107 CSNPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVA 182 (314)
Q Consensus 107 ~~~~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~i 182 (314)
+.+.+..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.|++|+||||+||+++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998653 345899999999999999999999 899999999999999987 7899
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
||+|||++........ .....+|+.|+|||++ .+..++.++||||||+++|+|++|..||....
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEIL-------------NYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHH-------------TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeee-------------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987654322 2234689999999775 34567889999999999999999999998765
Q ss_pred cchhhhhh---------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 263 TGEISLKN---------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 263 ~~~~~~~~---------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
..+..... .....+++.+.+++ ||.+|||+.++++ ++|+++.
T Consensus 238 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~------h~~~~~~ 294 (327)
T 3lm5_A 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS------HSWLQQW 294 (327)
T ss_dssp HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------CGGGCCC
T ss_pred chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC------CHhhccc
Confidence 43332111 11123455555544 9999999999876 6776543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.96 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=187.9
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc--------
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-------- 109 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 109 (314)
...++|++.+.||+|+||.||+|+. .+++.||+|+++.. ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3567899999999999999999995 47999999999764 3445778899999999999999999998754
Q ss_pred -----CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEE
Q 047043 110 -----PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARV 184 (314)
Q Consensus 110 -----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl 184 (314)
.+..+++|||+++++|.+++...+..+++..++.++.|++.||+||| ++|++|+||||+||+++.++.++|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEE
Confidence 45788999999999999999877666889999999999999999999 899999999999999999999999
Q ss_pred EeeecceecCCCCC------------cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHh
Q 047043 185 SDFGISKLLGDGED------------SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETF 252 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll 252 (314)
+|||++........ ........+|+.|+|||.+. ....++.++||||||+++|+|+
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD------------GTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHT------------SCSCCCTHHHHHHHHHHHHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCccccc------------CCCCCcchhhHHHHHHHHHHHH
Confidence 99999876543211 11122345899999998763 2335788999999999999999
Q ss_pred cCCCCCCccccchhhhhhh----------hhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhheeee
Q 047043 253 TGKKPTDEMFTGEISLKNW----------VNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 253 ~g~~Pf~~~~~~~~~~~~~----------~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
+ ||............. .....+..+.++ + ||.+|||+.++++ ++|++.
T Consensus 226 ~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~ 289 (303)
T 1zy4_A 226 Y---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN------SGWLPV 289 (303)
T ss_dssp S---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH------SSCSCC
T ss_pred h---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC------CCCcCC
Confidence 8 555322211111111 112223334444 3 9999999999987 677654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.62 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=194.3
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|.....||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34566666999999999999995 57899999999877666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeecceecCCC
Q 047043 120 MPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGISKLLGDG 196 (314)
Q Consensus 120 ~~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~~~~~~~~ 196 (314)
+++++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999998653 23568889999999999999999 899999999999999987 899999999999876432
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
.. ......+++.|+|||.+... ...++.++||||||+++|+|++|..||............
T Consensus 177 ~~--~~~~~~~~~~y~aPE~~~~~-----------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (295)
T 2clq_A 177 NP--CTETFTGTLQYMAPEIIDKG-----------PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHG-----------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC
T ss_pred CC--cccccCCCccccChhhhcCC-----------CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc
Confidence 21 12234589999999886421 123677899999999999999999999765433221111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
..+..+++.+.+++ ||..||++.++++ ++|++.
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------~~~~~~ 284 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV------DEFLKV 284 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT------SGGGCC
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc------Chhhhh
Confidence 11234555555554 9999999999986 666553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.24 Aligned_cols=242 Identities=26% Similarity=0.316 Sum_probs=192.4
Q ss_pred HhcCccccceeeecCceEEEEEEe----CCCCeEEEEEeeecc----cHHHHHHHHHHHHHHhC-CCCCcceeecccccC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFKLQL----GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNP 110 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+++++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 357899999999999999999996 368999999987542 12335567899999999 699999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+..++||||+++++|.+++...+. +++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999987654 899999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--hh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI--SL 268 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~--~~ 268 (314)
..+...... ......||+.|+|||++.. ....++.++|||||||++|+|++|..||........ ..
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~ 274 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRG-----------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTT-----------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred eecccCCCC-cccCcccCcCccChhhhcC-----------CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH
Confidence 876433221 1223468999999988641 123467899999999999999999999975432111 11
Q ss_pred h-h------hhhccCCchhhhhc------cccCCC-----CHHHHHHH
Q 047043 269 K-N------WVNESLPHALTDVV------DANLRV-----SMKDVAAK 298 (314)
Q Consensus 269 ~-~------~~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~ 298 (314)
. . ..+..++..+.+++ ||.+|| ++.+++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 275 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1 1 11233444444444 999999 99999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.49 Aligned_cols=238 Identities=26% Similarity=0.345 Sum_probs=190.8
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
...++|++.+.||.|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999954 69999999998653 2366888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999865566899999999999999999999 8999999999999999999999999999998765432
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------ 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------ 271 (314)
. ......+++.|+|||.+. +..++.++||||||+++|+|++|..||.............
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQ-------------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT 244 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHS-------------SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred c--ccCccCCCCCccChhhcC-------------CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc
Confidence 2 122346899999997753 3457889999999999999999999998754432211110
Q ss_pred --hhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 272 --VNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 272 --~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.+..++..+.+++ ||..|||+.++++
T Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1223455555544 9999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=296.42 Aligned_cols=266 Identities=20% Similarity=0.301 Sum_probs=202.8
Q ss_pred ccceehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHh--CCCCCcceeecc
Q 047043 29 WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRN--VHHRNLLKIFSS 106 (314)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~ 106 (314)
....+......+.++|++.+.||+|+||.||+|+. +++.||+|++.... ...+.+|.+++.. ++||||++++++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 33445566677889999999999999999999997 58899999997542 3566778888887 689999999999
Q ss_pred cccCC----ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeecCCCCCceEecC
Q 047043 107 CSNPD----FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH----SSAPIVHCDLKPSNILLDE 178 (314)
Q Consensus 107 ~~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----~~~~i~H~dlkp~Nili~~ 178 (314)
+.... ..++||||+++++|.+++.+.. +++..++.++.|++.||.|||+.. .+.|++|+||||+||+++.
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 88765 7899999999999999997653 899999999999999999999210 1368999999999999999
Q ss_pred CCcEEEEeeecceecCCCCCcc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC--
Q 047043 179 NMVARVSDFGISKLLGDGEDSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-- 254 (314)
Q Consensus 179 ~~~ikl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-- 254 (314)
++.+||+|||++.......... ......+|+.|+|||++.... ......++.++||||||+++|+|++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI-------NMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCC-------CTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccc-------cccccccCCcccHHHHHHHHHHHHhccC
Confidence 9999999999998765443221 123346899999998874210 00111344689999999999999999
Q ss_pred --------CCCCCccccchh---hhhh-h----hhccCC---------c----hhhhhc--cccCCCCHHHHHHHHHhhh
Q 047043 255 --------KKPTDEMFTGEI---SLKN-W----VNESLP---------H----ALTDVV--DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 255 --------~~Pf~~~~~~~~---~~~~-~----~~~~~~---------~----~l~~ll--dp~~Rpt~~~~~~~l~~~~ 303 (314)
..||........ .... . ..+.++ + .+..++ ||.+|||+.+++++|+.+.
T Consensus 256 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 788876432211 1111 0 111122 2 333333 9999999999999999998
Q ss_pred hhee
Q 047043 304 VKFL 307 (314)
Q Consensus 304 ~~~~ 307 (314)
.+..
T Consensus 336 ~~~~ 339 (342)
T 1b6c_B 336 QQEG 339 (342)
T ss_dssp HTTC
T ss_pred HHhc
Confidence 7653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=316.66 Aligned_cols=244 Identities=24% Similarity=0.343 Sum_probs=197.5
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+|.++++.++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999964 799999999976532 2345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 117 LELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|||++|++|.+++... ...+++..+..++.|++.||.||| ++|++||||||+||+++.+|.+||+|||++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999998764 345899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccc----hhhhh
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTG----EISLK 269 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~----~~~~~ 269 (314)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .....
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~-------------~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~ 404 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLL-------------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 404 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH
T ss_pred cCCCc--ccccccCCccccChhhhc-------------CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH
Confidence 54322 122346999999998763 456788999999999999999999999865321 11111
Q ss_pred h-----hhhccCCchhhhhc------cccCCCCH-----HHHHHHHHhhhhheeee
Q 047043 270 N-----WVNESLPHALTDVV------DANLRVSM-----KDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 ~-----~~~~~~~~~l~~ll------dp~~Rpt~-----~~~~~~l~~~~~~~~~~ 309 (314)
. ..+..++..+.+++ ||.+||++ .++++ |+|+++
T Consensus 405 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~------Hpff~~ 454 (543)
T 3c4z_A 405 VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT------HPLFRD 454 (543)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT------SGGGTT
T ss_pred HhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc------CccccC
Confidence 1 11234555555554 99999975 55554 555544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.44 Aligned_cols=240 Identities=26% Similarity=0.383 Sum_probs=196.1
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
......++|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 34556789999999999999999999964 79999999997653 2345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC---CcEEEEeeec
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN---MVARVSDFGI 189 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~---~~ikl~Dfg~ 189 (314)
.+++||++++++|.+.+...+. +++..++.++.|++.||.||| +.|++|+||||+||+++.+ +.++|+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 9999999999999998876554 899999999999999999999 8999999999999999754 4699999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
+........ .....+++.|+|||.+. +.++.++||||||+++|+|++|..||...........
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~--------------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (287)
T 2wei_A 171 STCFQQNTK---MKDRIGTAYYIAPEVLR--------------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233 (287)
T ss_dssp GGTBCCCSS---CSCHHHHHTTCCHHHHT--------------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ceeecCCCc---cccccCcccccChHHhc--------------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 876644322 12345889999998753 2367899999999999999999999987544332111
Q ss_pred h---------hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 270 N---------WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 270 ~---------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
. .....+++.+.+++ ||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1 11134455555554 9999999999988
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.80 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=185.7
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccc---------
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCS--------- 108 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------- 108 (314)
...++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 35689999999999999999999964 69999999998776666788899999999999999999998763
Q ss_pred -----cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-CCCcE
Q 047043 109 -----NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVA 182 (314)
Q Consensus 109 -----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-~~~~i 182 (314)
+.+..++||||++ ++|.+++... .+++..+..++.|++.||+||| ++|++|+||||+||+++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 5999998653 3889999999999999999999 89999999999999997 56799
Q ss_pred EEEeeecceecCCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 183 RVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
||+|||++......... .......+|..|+|||.+. ....++.++||||||+++|+|++|..||...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------------~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL------------SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHH------------CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhc------------CcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999998876432111 1122345788999998764 2345788999999999999999999999875
Q ss_pred ccchhhhhh-----------------------------------hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 262 FTGEISLKN-----------------------------------WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 262 ~~~~~~~~~-----------------------------------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+..... ...+.+++.+.+++ ||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 229 HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 432211000 01123555555554 9999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=290.54 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=198.3
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
..+.|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 456799999999999999999995 479999999997653 334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++++|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 100 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp ECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999998753 4899999999999999999999 8999999999999999999999999999998765432
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------h
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------W 271 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------~ 271 (314)
. ......+|+.|+|||.+. +..++.++||||||+++|+|++|..||............ .
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIK-------------QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT 238 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred c--ccCccCCCcCccCHHHHh-------------cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC
Confidence 1 123346899999997753 455778999999999999999999999875543322111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
....++..+.+++ ||..|||+.+++++..
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1234455555554 9999999999988543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=291.77 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=191.1
Q ss_pred HhcCccccceeeecCceEEEEEEeC--CCC--eEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS--DGN--NVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~--~~~--~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 4678999999999999999999842 333 68999987642 345678889999999999999999999998765
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++||++++++|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 78999999999999999876666899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh
Q 047043 193 LGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN 270 (314)
Q Consensus 193 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~ 270 (314)
........ ......+|..|+|||.+. +..++.++||||||+++|+|++ |..||............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLK-------------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccchhhhccCCCCceeeCchhhc-------------CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 75433221 122345677899998764 3346789999999999999999 99999876543322111
Q ss_pred h-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 W-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
. ....+++.+.+++ ||.+||++.++++.++++...
T Consensus 238 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1 1234555555554 999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.36 Aligned_cols=202 Identities=26% Similarity=0.362 Sum_probs=155.8
Q ss_pred HHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC---
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP--- 110 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 110 (314)
.....++|++++.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 345568999999999999999999994 579999999987542 23456788999999999999999999988653
Q ss_pred ---CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 111 ---DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 111 ---~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
...++++|++ +++|.+++... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp GGCCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred ccCCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999998 67999988763 4899999999999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
|++...... .....+|+.|+|||++. ....++.++|||||||++|+|++|..||.+..
T Consensus 177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 177 GLARHTADE-----MTGYVATRWYRAPEIML------------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp -------------------CCCTTCCHHHHT------------TCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccc-----CCCcCcCcCccChHHHc------------CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765432 22346899999998764 23567889999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=298.30 Aligned_cols=205 Identities=26% Similarity=0.358 Sum_probs=170.9
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccC-----C
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-----D 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 111 (314)
.+.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 45689999999999999999999954 78999999997543 33456778999999999999999999987653 6
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..+++||++. ++|.+++... .+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++.
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 7899999996 5999998764 3899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcce--------eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 192 LLGDGEDSVT--------QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 192 ~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
.......... .....||+.|+|||++. .+..++.++|||||||++|+|++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML------------TSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHH------------SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeec------------cCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7653321111 11235799999998754 23567889999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.97 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=197.0
Q ss_pred hcCccccc-eeeecCceEEEEEEeC---CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECN-LLGTGSFGIVYKGILS---DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~-~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++... ......+.+|++++++++||||+++++++.+ +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 7999999999999853 45679999998653 2345788999999999999999999999976 56899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++++|.+++......+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999999877667999999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 196 GEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 196 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
..... ......+|+.|+|||++. ...++.++|||||||++|||++ |..||......+.....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~-------------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECIN-------------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555 (613)
T ss_dssp -------------CCTTSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred CCceeeeccCCCCccceeCHhhhc-------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 32211 112233567899998763 3457889999999999999998 99999886654432211
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
..+..+++.+.+++ ||.+||++.++++.|+.+....-
T Consensus 556 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 12344666666655 99999999999999998765543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=292.07 Aligned_cols=242 Identities=24% Similarity=0.346 Sum_probs=194.0
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccc--ccCCcee
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSC--SNPDFKA 114 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 114 (314)
..++|++.+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|+.++++++||||+++++++ ......+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3578999999999999999999954 79999999998653 34456788999999999999999999987 4567899
Q ss_pred EEEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-----eeecCCCCCceEecCCCcEEEEe
Q 047043 115 LVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGHSSAP-----IVHCDLKPSNILLDENMVARVSD 186 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~-----i~H~dlkp~Nili~~~~~ikl~D 186 (314)
+||||+++++|.+++... +..+++..++.++.|++.||+||| +.| ++|+||||+||+++.++.++|+|
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH----RRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh----cccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 999999999999999753 334899999999999999999999 777 99999999999999999999999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++........ ......+++.|+|||.+. +..++.++||||||+++|+|++|..||........
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 224 (279)
T 2w5a_A 160 FGLARILNHDTS--FAKTFVGTPYYMSPEQMN-------------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224 (279)
T ss_dssp CCHHHHC---CH--HHHHHHSCCTTCCHHHHH-------------CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred Cchheeeccccc--cccccCCCccccChHHhc-------------cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH
Confidence 999876543221 122346899999998763 34577899999999999999999999987654332
Q ss_pred hhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 267 SLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 267 ~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
.... ..+..+++.+.+++ ||.+||++.++++++.
T Consensus 225 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 2111 11234555555554 9999999999998543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=300.11 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=197.2
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccH-----------------HHHHHHHHHHHHHhCCCCCcce
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGR-----------------AFRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~ 102 (314)
..++|++.+.||+|+||.||+|.. +++.||+|++...... ....+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 468999999999999999999999 9999999999765321 1267889999999999999999
Q ss_pred eecccccCCceeEEEEecCCCCHHHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCce
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENW------LYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNI 174 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~------i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Ni 174 (314)
+++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.||| + +|++|+||+|+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH----NEKNICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTSCEECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh----ccCCEeecCCChHhE
Confidence 99999999999999999999999998 5542 455899999999999999999999 7 9999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCc-ccceehhhHHHHHHhc
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISA-KCDVYSFGVLLMETFT 253 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~-~~Dv~slG~il~~ll~ 253 (314)
+++.++.++|+|||++...... ......+++.|+|||.+. ....++. ++||||||+++|+|++
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~------------~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFS------------NESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGS------------SCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhc------------CCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999876443 233456899999998753 1224444 8999999999999999
Q ss_pred CCCCCCccccchhhhhhhh------h-------------------ccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 254 GKKPTDEMFTGEISLKNWV------N-------------------ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~~~------~-------------------~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
|..||.............. + ..++..+.+++ ||.+||++.++++
T Consensus 248 g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~----- 322 (348)
T 2pml_X 248 NVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK----- 322 (348)
T ss_dssp SSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT-----
T ss_pred CCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc-----
Confidence 9999987544211111110 0 34555555554 9999999999987
Q ss_pred hhheeee
Q 047043 303 RVKFLYD 309 (314)
Q Consensus 303 ~~~~~~~ 309 (314)
|+|+.+
T Consensus 323 -hp~f~~ 328 (348)
T 2pml_X 323 -HEWLAD 328 (348)
T ss_dssp -SGGGTT
T ss_pred -CccccC
Confidence 566544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=308.80 Aligned_cols=202 Identities=24% Similarity=0.315 Sum_probs=171.6
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC------CCCCcceeecccccC
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV------HHRNLLKIFSSCSNP 110 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 110 (314)
.....+|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+++++.+ .|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 34567899999999999999999995 468999999997652 3345677788888776 477999999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc--EEEEee
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV--ARVSDF 187 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~--ikl~Df 187 (314)
+..+++||++. ++|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||+++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999995 69999988754 34899999999999999999999 899999999999999998887 999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
|++....... ....+|+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 247 G~a~~~~~~~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 247 GSSCYEHQRV-----YTYIQSRFYRAPEVIL-------------GARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHH-------------TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceecCCcc-----cccCCCCCccChHHHh-------------CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9997654322 2346899999998764 34578899999999999999999999976543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.03 Aligned_cols=203 Identities=24% Similarity=0.322 Sum_probs=169.1
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.+.+...++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 35 ~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 35 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp TEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 34455678999999999999999999995 479999999997643 234567889999999999999999999998776
Q ss_pred ce------eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 112 FK------ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 112 ~~------~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
.. +++|||+. ++|.+.+.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred CcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEE
Confidence 54 99999996 588887643 3899999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
|||++...... .....+|+.|+|||.+. ....++.++|||||||++|+|++|..||....
T Consensus 187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 187 DFGLARHADAE-----MTGYVVTRWYRAPEVIL------------SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp STTCC-------------CTTCCCTTSCHHHHS------------CCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecCcccccccC-----cCCcccCccccCHHHhc------------CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765432 22345899999998764 22567889999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=307.44 Aligned_cols=243 Identities=14% Similarity=0.167 Sum_probs=180.8
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeec---ccHHHHHHHHHHHH---HHhCCCCCcceee-------cc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQ---LGRAFRSFDSECEV---LRNVHHRNLLKIF-------SS 106 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~---l~~l~h~~i~~~~-------~~ 106 (314)
.++|++.+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+.+ ++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999994 57999999999753 23455778899954 4455799999998 44
Q ss_pred cccCC-----------------ceeEEEEecCCCCHHHHHhhcCCCCC-------HHHHHHHHHHHHHHHHHHhcCCCCC
Q 047043 107 CSNPD-----------------FKALVLELMPNGSLENWLYSHNYFLD-------TLERLNIMIDVWLALEYLHHGHSSA 162 (314)
Q Consensus 107 ~~~~~-----------------~~~lv~e~~~~~sL~~~i~~~~~~~~-------~~~~~~i~~~l~~~l~~LH~~~~~~ 162 (314)
+.+.+ ..+++|||+ +|+|.+++...+. ++ +..++.++.|++.||+||| ++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~ 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLH----HY 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHH----HT
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHH----hC
Confidence 44432 378999999 5799999986543 33 4788889999999999999 89
Q ss_pred CeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCccccee
Q 047043 163 PIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVY 242 (314)
Q Consensus 163 ~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~ 242 (314)
|++||||||+||+++.++.+||+|||++..... ......| +.|+|||++...... .........++.++|||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~--~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATI--SYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTST--HHHHCCEEECCHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccc--cccccccccCChhhhHH
Confidence 999999999999999999999999999986432 2233456 899999987532000 00001112578899999
Q ss_pred hhhHHHHHHhcCCCCCCccccchhhhhh-hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 243 SFGVLLMETFTGKKPTDEMFTGEISLKN-WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 243 slG~il~~ll~g~~Pf~~~~~~~~~~~~-~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
||||++|+|++|..||............ .....+++.+.+++ ||.+|||+.++++
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999999765433221111 11245666655555 9999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=299.32 Aligned_cols=263 Identities=20% Similarity=0.297 Sum_probs=198.6
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
.......++|++.+.||+|+||.||+|.... .+++|+++... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3334457899999999999999999999643 59999987543 2233557789999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++|||+++++|.+++...+..+++..++.++.|++.||.||| +.|++|+||||+||+++ ++.++|+|||++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999999999999999877666899999999999999999999 89999999999999998 67999999998765
Q ss_pred cCCCCC---cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 193 LGDGED---SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 193 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
...... ........|++.|+|||.+...... .......++.++||||||+++|+|++|..||...........
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~----~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD----TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC------CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhcccc----ccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 532111 1112234588999999987532111 111245678899999999999999999999987654433221
Q ss_pred hh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 270 NW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 270 ~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
.. ....++..+.+++ ||.+|||+.++++.++.+..+...
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11 1123455555555 999999999999999999877543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.33 Aligned_cols=199 Identities=25% Similarity=0.314 Sum_probs=162.0
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC-----
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD----- 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 468999999999999999999995 478999999997642 334567889999999999999999999987654
Q ss_pred -ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 112 -FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 112 -~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 77999999964 88888753 3889999999999999999999 899999999999999999999999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
....... ......+|+.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVIL-------------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------------CTTCCHHHHT-------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc---ccCCceecCCccCHHHhc-------------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8654322 122346899999998763 4457889999999999999999999997654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.90 Aligned_cols=201 Identities=27% Similarity=0.411 Sum_probs=163.8
Q ss_pred HHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccC------C
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP------D 111 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 111 (314)
.....+|++.+.||+|+||.||+|+...+..+|+|.+.... ....+|+++++.++||||+++++++... .
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34567899999999999999999997666668888876542 2234699999999999999999998543 2
Q ss_pred ceeEEEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-CCCcEEEEee
Q 047043 112 FKALVLELMPNGSLENWLY---SHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDF 187 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-~~~~ikl~Df 187 (314)
..++||||+++ ++...+. .....+++..+..++.|++.||+||| +.|++||||||+||+++ .++.+||+||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 47899999976 5544433 23445899999999999999999999 89999999999999998 7999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
|++........ .....+|+.|+|||++. ....++.++|||||||++|+|++|..||.+..
T Consensus 187 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 187 GSAKILIAGEP---NVSYICSRYYRAPELIF------------GATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp TTCEECCTTCC---CCSSCSCGGGCCHHHHT------------TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccccCCCC---CcccccCcCccCHHHHc------------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987644332 22346899999998763 23457889999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=317.39 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=203.0
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.+....++|++.+.||+|+||.||+|.+..+..||+|+++.... ..+.+.+|++++++++||||+++++++.+ +..++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 34455778999999999999999999987778899999986532 23678999999999999999999999876 67899
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
||||+++++|.+++... +..+++..+..++.|++.||+||| ++|++||||||+|||++.++.+||+|||++....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999999753 344899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
... ........++..|+|||.+. ...++.++||||||+++|+|++ |..||......+.....
T Consensus 415 ~~~-~~~~~~~~~~~~y~aPE~~~-------------~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 415 DNE-YTARQGAKFPIKWTAPEAAL-------------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp CHH-HHTTCSTTSCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CCc-eecccCCcCcccccCHHHhc-------------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 321 11112234678899998764 3457889999999999999999 99999876554432111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.+...
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11234566566655 999999999999999887543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.94 Aligned_cols=210 Identities=22% Similarity=0.302 Sum_probs=159.7
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCC--
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD-- 111 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (314)
.......++|++.+.||+|+||.||+|+. .+++.||+|.+.... .......++++.+..++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 44567789999999999999999999995 479999999986542 22245667788888899999999999986533
Q ss_pred -----ceeEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcE
Q 047043 112 -----FKALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVA 182 (314)
Q Consensus 112 -----~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~i 182 (314)
..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||.. ++|++|+||||+||+++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcE
Confidence 27899999975 66655442 344588999999999999999999932 578999999999999986 8999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
||+|||++........ .....||+.|+|||++. ....++.++|||||||++|+|++|..||....
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIF------------GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHT------------TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHc------------CCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999999987654332 22346899999998763 23457889999999999999999999998754
Q ss_pred c
Q 047043 263 T 263 (314)
Q Consensus 263 ~ 263 (314)
.
T Consensus 237 ~ 237 (360)
T 3e3p_A 237 S 237 (360)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=302.74 Aligned_cols=198 Identities=28% Similarity=0.411 Sum_probs=163.1
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc------CCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN------PDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~ 113 (314)
..+|++.+.||+|+||.||+|++. +++.||||.+.... ....+|+++++.++||||+++++++.. ...+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 347999999999999999999964 79999999987542 233469999999999999999998743 2246
Q ss_pred eEEEEecCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-CcEEEEeeec
Q 047043 114 ALVLELMPNGSLENWLYS---HNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-MVARVSDFGI 189 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~---~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-~~ikl~Dfg~ 189 (314)
++||||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.|++||||||+||+++.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 789999975 77766643 3455899999999999999999999 9999999999999999955 5789999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+..+..... .....+|+.|+|||++. ....++.++|||||||++|+|++|..||.+..
T Consensus 204 a~~~~~~~~---~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 204 AKQLVRGEP---NVSYICSRYYRAPELIF------------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp CEECCTTCC---CCSCCSCTTSCCHHHHT------------TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhcccCCC---ceeeeeCCCcCCHHHHc------------CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 987654322 22346899999998763 23357889999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.15 Aligned_cols=199 Identities=23% Similarity=0.290 Sum_probs=168.0
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC--------CCCcceeecccc--
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH--------HRNLLKIFSSCS-- 108 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~-- 108 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|+++.. ......+.+|+++++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 468999999999999999999995 47889999999765 334567888999999885 788999999987
Q ss_pred --cCCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEecCCC----
Q 047043 109 --NPDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLDENM---- 180 (314)
Q Consensus 109 --~~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~~~~---- 180 (314)
++...++|||++ +++|.+.+... ...+++..+..++.|++.||.||| ++ |++||||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccchhhh
Confidence 667889999999 56777766554 355899999999999999999999 77 999999999999998775
Q ss_pred ---------------------------------------------cEEEEeeecceecCCCCCcceeecccceeeeecCc
Q 047043 181 ---------------------------------------------VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPV 215 (314)
Q Consensus 181 ---------------------------------------------~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 215 (314)
.+||+|||++....... ....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCCh
Confidence 79999999998764432 2245899999998
Q ss_pred cccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
++. +..++.++|||||||++|+|++|..||....
T Consensus 264 ~~~-------------~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 264 VLI-------------GSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHH-------------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hhc-------------CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 764 3457889999999999999999999997543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.09 Aligned_cols=246 Identities=20% Similarity=0.276 Sum_probs=199.8
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC-CCcceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-RNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 117 (314)
..++|++.+.||+|+||.||+|++ .+++.||||++...... ..+..|+++++.++| +++..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 457899999999999999999995 57999999998765332 457889999999976 55666666777888899999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe---cCCCcEEEEeeecceecC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLG 194 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili---~~~~~ikl~Dfg~~~~~~ 194 (314)
||+ +++|.+++......+++..++.++.||+.||.||| .+|++||||||+|||+ +.++.+||+|||++..+.
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999 88999999876666999999999999999999999 8999999999999999 588999999999998875
Q ss_pred CCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh--
Q 047043 195 DGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS-- 267 (314)
Q Consensus 195 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~-- 267 (314)
...... ......||+.|+|||.+ .+..++.++|||||||++|+|++|..||.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-------------~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTH-------------LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred CCccccccccccccccCCCccccCHHHh-------------cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence 543211 12245689999999775 3456788999999999999999999999875442210
Q ss_pred hh-----------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 268 LK-----------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 268 ~~-----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.. ......+++.+.+++ ||.+||++.++++.|+.+..+
T Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 225 YEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 00 112245666666655 999999999999999988654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.64 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=192.8
Q ss_pred eehhhHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCC--CCCcceeeccc
Q 047043 32 TSYLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVH--HRNLLKIFSSC 107 (314)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~ 107 (314)
.++.++....++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|++++..++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34444555678899999999999999999998789999999997643 345577889999999996 59999999999
Q ss_pred ccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 108 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
.+.+..+++|| +.+++|.+++...+. +++..+..++.|++.||.||| +.|++|+||||+||+++. +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 557899999987654 899999999999999999999 899999999999999964 89999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++................||+.|+|||.+....... ........++.++||||||+++|+|++|..||.........
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR--ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC------------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhccccc--ccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 9998765443322233456899999999875211000 01112346788999999999999999999999875443322
Q ss_pred hhhhh--------hccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 268 LKNWV--------NESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 268 ~~~~~--------~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..... +...++.+.+++ ||.+||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 22221 122344444444 99999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=302.78 Aligned_cols=236 Identities=12% Similarity=0.099 Sum_probs=173.1
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc---HHHHHHHHHHHHHHhC--CCCCcceeec-------cc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG---RAFRSFDSECEVLRNV--HHRNLLKIFS-------SC 107 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~~-------~~ 107 (314)
..+|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999954 799999999987542 3455677785555554 6999887553 32
Q ss_pred ccC-----------------CceeEEEEecCCCCHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCCe
Q 047043 108 SNP-----------------DFKALVLELMPNGSLENWLYSHNYFLDTLER------LNIMIDVWLALEYLHHGHSSAPI 164 (314)
Q Consensus 108 ~~~-----------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~------~~i~~~l~~~l~~LH~~~~~~~i 164 (314)
... ...++||||++ ++|.+++...+..+++... ..++.|++.||+||| ++|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCC
Confidence 221 34799999998 7999999876544566666 678899999999999 8999
Q ss_pred eecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehh
Q 047043 165 VHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSF 244 (314)
Q Consensus 165 ~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~sl 244 (314)
+||||||+||+++.++.+||+|||++...+.. .....+|+.|+|||++.. ....++.++|||||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~-----------~~~~~~~~~DiwSl 279 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNA-----------STATFTHALNAWQL 279 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTC-----------SEEECCHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccC-----------CCCCcCccccHHHH
Confidence 99999999999999999999999999876432 223457799999987631 12467889999999
Q ss_pred hHHHHHHhcCCCCCCccccchh--------------hhhhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 245 GVLLMETFTGKKPTDEMFTGEI--------------SLKNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 245 G~il~~ll~g~~Pf~~~~~~~~--------------~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
||++|+|++|..||........ .........+++.+.+++ ||.+|||+.++++
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999987633211 000011134556555555 9999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=316.57 Aligned_cols=240 Identities=28% Similarity=0.423 Sum_probs=191.6
Q ss_pred ceeeecCceEEEEEEe---CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGIL---SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||.||+|.+ ++++.||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 346789999998653 2345789999999999999999999999975 457899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc-ce
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VT 201 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~-~~ 201 (314)
++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++..+...... ..
T Consensus 454 g~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999976554 899999999999999999999 899999999999999999999999999999876543321 11
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh------hhc
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW------VNE 274 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~------~~~ 274 (314)
.....+|+.|+|||++. +..++.++||||||+++|+|++ |..||......+...... .+.
T Consensus 529 ~~~~~~t~~y~APE~~~-------------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 595 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECIN-------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 595 (635)
T ss_dssp ------CGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccCCCCceeeeChhhhc-------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 22234678899998763 4457889999999999999998 999998876544322111 233
Q ss_pred cCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 275 ~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.+++.+.+++ ||.+||++.++++.|+.+...+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 4566566655 9999999999999999887654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=296.78 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=196.2
Q ss_pred ehhhHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH------HHHHHHHHHHHHHhCC--CCCccee
Q 047043 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR------AFRSFDSECEVLRNVH--HRNLLKI 103 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~ 103 (314)
+........++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.+++.++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3345556788999999999999999999995 57899999999765321 2245667999999996 5999999
Q ss_pred ecccccCCceeEEEEecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec-CCCc
Q 047043 104 FSSCSNPDFKALVLELMPN-GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMV 181 (314)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~-~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~-~~~~ 181 (314)
++++.+.+..+++||++.+ ++|.+++...+. +++..++.++.|++.||.||| +.|++|+||||+||+++ .++.
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTE
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999999975 899999987554 899999999999999999999 89999999999999998 7889
Q ss_pred EEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 182 ARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
+||+|||++....... .....||+.|+|||++.. ....+.++||||||+++|+|++|..||...
T Consensus 189 ~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~------------~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY------------HRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHH------------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEEeeCcccccccccc----ccCCCCCccCCChHHhcc------------CCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 9999999998765432 223458999999987642 223467899999999999999999999764
Q ss_pred ccchhhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 262 FTGEISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
... ..........+++.+.+++ ||.+|||+.++++ ++|+.+.
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------hp~~~~~ 300 (320)
T 3a99_A 253 EEI-IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN------HPWMQDV 300 (320)
T ss_dssp HHH-HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSSC
T ss_pred hhh-hcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc------CHhhcCc
Confidence 321 1111122344555555554 9999999999987 5555543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.36 Aligned_cols=203 Identities=22% Similarity=0.277 Sum_probs=155.1
Q ss_pred HhcCcccc-ceeeecCceEEEEEEeC---CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccc--ccCCce
Q 047043 40 ATEGFNEC-NLLGTGSFGIVYKGILS---DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC--SNPDFK 113 (314)
Q Consensus 40 ~~~~y~~~-~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 113 (314)
..+.|++. +.||+|+||.||+|+++ +++.||+|++..... ...+.+|+.+++.++||||+++++++ ......
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 44567774 47999999999999954 578999999976532 24678899999999999999999998 457789
Q ss_pred eEEEEecCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe----cCCCc
Q 047043 114 ALVLELMPNGSLENWLYSH--------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL----DENMV 181 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili----~~~~~ 181 (314)
++||||+. ++|.+++... ...+++..+..++.||+.||.||| +.|++||||||+||++ +.++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCc
Confidence 99999996 5888887632 123899999999999999999999 8999999999999999 67789
Q ss_pred EEEEeeecceecCCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 182 ARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 182 ikl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
+||+|||++......... .......||+.|+|||++. ....++.++|||||||++|+|++|..||..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL------------GARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHT------------TCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhc------------CCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999876543211 1223356899999998764 234578899999999999999999999964
Q ss_pred c
Q 047043 261 M 261 (314)
Q Consensus 261 ~ 261 (314)
.
T Consensus 239 ~ 239 (405)
T 3rgf_A 239 R 239 (405)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.02 Aligned_cols=206 Identities=25% Similarity=0.312 Sum_probs=171.6
Q ss_pred hhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CC-----Ccceeeccc
Q 047043 35 LDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HR-----NLLKIFSSC 107 (314)
Q Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~ 107 (314)
.......++|++.+.||+|+||.||+|... +++.||+|+++.. ......+..|+++++.++ |+ +++++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 444556789999999999999999999954 7889999999854 234466777888888774 44 489999999
Q ss_pred ccCCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec--CCCcEEE
Q 047043 108 SNPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD--ENMVARV 184 (314)
Q Consensus 108 ~~~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~--~~~~ikl 184 (314)
...+..++|||++. ++|.+++.... ..+++..+..++.|++.||.|||+. ..|++||||||+||+++ .++.+||
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999996 59999998754 4589999999999999999999932 36899999999999994 5778999
Q ss_pred EeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 185 SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+|||++....... ....+|+.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 203 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 203 VDFGSSCQLGQRI-----YQYIQSRFYRSPEVLL-------------GMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCTTCEETTCCC-----CSSCSCGGGCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeccCceeccccc-----ccccCCccccChHHHc-------------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998764432 2346899999997763 4457889999999999999999999998644
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.84 Aligned_cols=201 Identities=25% Similarity=0.359 Sum_probs=171.2
Q ss_pred HHhcCccccceeeecCceEEEEEEe-C-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCC------CcceeecccccC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-S-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR------NLLKIFSSCSNP 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~ 110 (314)
...++|++.+.||+|+||.||+|.. . +++.||+|+++.. ......+.+|+++++.++|+ +++++++++.+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4567999999999999999999985 3 6889999999754 33456788899999888654 599999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-----------
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE----------- 178 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~----------- 178 (314)
+..++||||+ +++|.+++...+ ..+++..+..++.|++.||+||| ++|++|+||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 789999998764 34789999999999999999999 899999999999999987
Q ss_pred --------CCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHH
Q 047043 179 --------NMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250 (314)
Q Consensus 179 --------~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ 250 (314)
++.++|+|||++....... ....+|+.|+|||++. +..++.++|||||||++|+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVIL-------------ALGWSQPCDVWSIGCILIE 226 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHT-------------TSCCCTHHHHHHHHHHHHH
T ss_pred ccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhh-------------CCCCCcchhhHHHHHHHHH
Confidence 6689999999998654322 2345899999997753 4457889999999999999
Q ss_pred HhcCCCCCCcccc
Q 047043 251 TFTGKKPTDEMFT 263 (314)
Q Consensus 251 ll~g~~Pf~~~~~ 263 (314)
|++|..||.....
T Consensus 227 l~~g~~pf~~~~~ 239 (339)
T 1z57_A 227 YYLGFTVFPTHDS 239 (339)
T ss_dssp HHHSSCSCCCSCH
T ss_pred HHhCCCCCCCCCh
Confidence 9999999986543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.27 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=170.1
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHH-HHHhCCCCCcceeecccccCCceeEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECE-VLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+..|.. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 458999999999999999999996 4799999999986532 23344555555 66677999999999999999999999
Q ss_pred EEecCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 117 LELMPNGSLENWLYS----HNYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~----~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
|||+++ +|.+++.. ....+++..+..++.|++.||.||| +. |++|+||||+||+++.++.+||+|||++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 999975 88887763 2445899999999999999999999 77 99999999999999999999999999987
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~ 271 (314)
...... ......||+.|+|||.+.. ...+..++.++||||||+++|+|++|..||.............
T Consensus 175 ~~~~~~---~~~~~~gt~~y~aPE~~~~---------~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (327)
T 3aln_A 175 QLVDSI---AKTRDAGCRPYMAPERIDP---------SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242 (327)
T ss_dssp C------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred eccccc---ccccCCCCccccCceeecc---------ccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence 664332 1222368999999987631 1134557889999999999999999999997643221111110
Q ss_pred -----------hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 272 -----------VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 272 -----------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
....++..+.+++ ||.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1123455555544 99999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=287.88 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=169.0
Q ss_pred HHhcCccccceeeecCceEEEEEEe--CCCCeEEEEEeeecccH--HHHHHHHHHHHHHhC---CCCCcceeecccc---
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL--SDGNNVAIKVFKLQLGR--AFRSFDSECEVLRNV---HHRNLLKIFSSCS--- 108 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~--~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~--- 108 (314)
...++|++.+.||+|+||.||+|+. .+++.||+|+++..... ....+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3568999999999999999999996 35789999999765321 123456677777666 8999999999986
Q ss_pred --cCCceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 109 --NPDFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 109 --~~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
.....+++|||+. ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEe
Confidence 5678899999997 59999998653 34899999999999999999999 8999999999999999999999999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcccc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~ 263 (314)
|||++....... ......+|+.|+|||.+. +..++.++||||||+++|+|++|..||.....
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~-------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLL-------------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCcccccccCCC---CccccccccceeCHHHHh-------------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999987654322 122345899999997763 44578899999999999999999999986543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=290.53 Aligned_cols=200 Identities=24% Similarity=0.329 Sum_probs=166.8
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc--
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF-- 112 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 112 (314)
....++|.+.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 34568999999999999999999995 479999999997643 2345678899999999999999999999887654
Q ss_pred ----eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 113 ----KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 113 ----~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
.+++|||+. ++|.+++.. .+++..+..++.|++.||.||| ++|++|+||||+||+++.++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred cceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 489999996 588877643 3899999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
++...... .....+|+.|+|||.+. ....++.++||||||+++|+|++|..||....
T Consensus 172 ~~~~~~~~-----~~~~~~t~~y~aPE~~~------------~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 172 LARHADAE-----MTGYVVTRWYRAPEVIL------------SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CTTC-------------CCSBCCSCHHHHS------------CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cccCCCCC-----ccccccCcCcCCHHHHh------------CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765332 22345899999998763 22457789999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.10 Aligned_cols=245 Identities=23% Similarity=0.271 Sum_probs=176.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
....++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.++..+++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 445789999999999999999999964 799999999986532 22334445556677889999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
+||||+ ++.+..+.......+++..+..++.|++.||.||| .. |++|+||||+||+++.++.++|+|||++...
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999999 55666666655556899999999999999999999 74 9999999999999999999999999998765
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhhhh
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN 273 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~~~ 273 (314)
.... ......+|+.|+|||.+.. .......++.++||||||+++|+|++|..||...............
T Consensus 176 ~~~~---~~~~~~~~~~y~aPE~~~~--------~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (318)
T 2dyl_A 176 VDDK---AKDRSAGCAAYMAPERIDP--------PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244 (318)
T ss_dssp --------------CCTTCCHHHHC----------------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred cCCc---cccccCCCccccChhhccc--------ccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence 4322 1223458999999988742 1113455788999999999999999999999874433222221111
Q ss_pred ---------ccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 274 ---------ESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 274 ---------~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
..++..+.+++ ||.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12445455544 99999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=311.54 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=199.1
Q ss_pred HHHHhcCccccceeeecCceEEEEEEeCC----CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 37 IQRATEGFNECNLLGTGSFGIVYKGILSD----GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 37 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
.....++|++.+.||+|+||.||+|.+.. +..||+|.++... ......+.+|+.++++++||||+++++++.+ +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 33446789999999999999999999532 4579999887643 3345678899999999999999999999854 5
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..++||||+++++|.+++...+..+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 688999999999999999877666899999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~ 270 (314)
........ ......+|+.|+|||.+. +..++.++||||||+++|+|++ |..||......+.....
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i 605 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESIN-------------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhc-------------CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 76443221 122334678899998763 3457789999999999999997 99999876544332111
Q ss_pred ------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 ------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 ------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..+..+++.+.+++ ||..||++.++++.|+.+..+
T Consensus 606 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12334555555555 999999999999999988654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.63 Aligned_cols=235 Identities=22% Similarity=0.309 Sum_probs=166.5
Q ss_pred HHHhcCccccc-eeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc----CC
Q 047043 38 QRATEGFNECN-LLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN----PD 111 (314)
Q Consensus 38 ~~~~~~y~~~~-~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 111 (314)
....++|++.+ .||+|+||.||+|..+ +++.||+|++.... ....+....++.+.||||+++++++.. +.
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 34678999966 5999999999999965 79999999997642 112223334566799999999999875 45
Q ss_pred ceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcEEEEee
Q 047043 112 FKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVARVSDF 187 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~ikl~Df 187 (314)
..++||||+++++|.+++...+ ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 6899999999999999998754 35899999999999999999999 899999999999999976 445999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS 267 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~ 267 (314)
|++....... .....+|+.|+|||.+ .+..++.++||||||+++|+|++|..||.........
T Consensus 176 g~~~~~~~~~----~~~~~~t~~y~aPE~~-------------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 238 (336)
T 3fhr_A 176 GFAKETTQNA----LQTPCYTPYYVAPEVL-------------GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 238 (336)
T ss_dssp TTCEEC---------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccc----cccCCCCcCccChhhh-------------CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh
Confidence 9998654322 2234689999999765 3556778999999999999999999999765432210
Q ss_pred -------------hhhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 268 -------------LKNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 268 -------------~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
........+++.+.+++ ||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 239 PGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00011134555555554 9999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.47 Aligned_cols=201 Identities=26% Similarity=0.365 Sum_probs=169.0
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CC-CeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC------cceeecccccC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DG-NNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN------LLKIFSSCSNP 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~ 110 (314)
...++|++.+.||+|+||.||+|... ++ +.||+|+++.. ......+.+|+.+++.++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 35689999999999999999999954 45 68999999754 234467788999999886554 88999999999
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEe-------------
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILL------------- 176 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili------------- 176 (314)
+..++|||++ ++++.+.+.... ..+++..+..++.|++.||.||| ++|++|+||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecccccccccccc
Confidence 9999999999 567777776553 45899999999999999999999 9999999999999999
Q ss_pred ------cCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHH
Q 047043 177 ------DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLME 250 (314)
Q Consensus 177 ------~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ 250 (314)
+.++.+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVIL-------------ELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHT-------------TCCCCTHHHHHHHHHHHHH
T ss_pred cccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeee-------------cCCCCCccchHHHHHHHHH
Confidence 567899999999998654332 2346899999997763 4557889999999999999
Q ss_pred HhcCCCCCCcccc
Q 047043 251 TFTGKKPTDEMFT 263 (314)
Q Consensus 251 ll~g~~Pf~~~~~ 263 (314)
|++|..||.....
T Consensus 232 l~~g~~pf~~~~~ 244 (355)
T 2eu9_A 232 YYRGFTLFQTHEN 244 (355)
T ss_dssp HHHSSCSCCCSSH
T ss_pred HHhCCCCCCCCCH
Confidence 9999999986543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=280.80 Aligned_cols=217 Identities=13% Similarity=0.108 Sum_probs=180.3
Q ss_pred HHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45688999999999999999999964 69999999998653 234577889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
+||||+++++|.+++... .....+..++.|++.||.||| ++|++|+||||+||+++.++.++|++++
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999998543 456678999999999999999 8999999999999999999999987432
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccch---------
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE--------- 265 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~--------- 265 (314)
|.+| ++.++|||||||++|+|++|..||.......
T Consensus 175 ----------------~~~~--------------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 218 (286)
T 3uqc_A 175 ----------------TMPD--------------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218 (286)
T ss_dssp ----------------CCTT--------------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT
T ss_pred ----------------ccCC--------------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh
Confidence 3333 4668999999999999999999998754322
Q ss_pred ---hhhhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 266 ---ISLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 266 ---~~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..........+++.+.+++ ||..| |+.++++.|+.+...
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0111123345666666665 99999 999999999987654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.54 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=180.9
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
...+|++.+.||+|+||+|+.....+++.||||.+..... ....+|+++++.+ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456999999999999997655556899999999875432 3456799999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-----CcEEEEeeecceec
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-----MVARVSDFGISKLL 193 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-----~~ikl~Dfg~~~~~ 193 (314)
++. ++|.+++........+..+..++.|++.||.||| +.|++||||||+||+++.+ ..++|+|||++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 996 5999999877655667778899999999999999 8999999999999999532 35889999999876
Q ss_pred CCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhhh
Q 047043 194 GDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKNW 271 (314)
Q Consensus 194 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~~ 271 (314)
...... .......||+.|+|||++.. .....++.++|||||||++|+|++ |..||.............
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~----------~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~ 243 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSE----------DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243 (432)
T ss_dssp ------------CCSCTTSCCGGGTSC----------C---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhc----------ccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc
Confidence 543221 12233568999999987641 123456779999999999999999 999997543322211110
Q ss_pred ------------hhccCCchhhhhc--cccCCCCHHHHHH
Q 047043 272 ------------VNESLPHALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 272 ------------~~~~~~~~l~~ll--dp~~Rpt~~~~~~ 297 (314)
.+..+.+.+..++ ||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111223445555 9999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.84 Aligned_cols=198 Identities=21% Similarity=0.323 Sum_probs=165.2
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-----------CCCcceeeccc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-----------HRNLLKIFSSC 107 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357899999999999999999995 578999999998542 33466788999988875 78999999998
Q ss_pred ccCC----ceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeecCCCCCceEec----
Q 047043 108 SNPD----FKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSA-PIVHCDLKPSNILLD---- 177 (314)
Q Consensus 108 ~~~~----~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~-~i~H~dlkp~Nili~---- 177 (314)
...+ ..+++||++ +++|.+++... ...+++..+..++.|++.||.||| ++ |++|+||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCC
Confidence 7543 788999999 88999999864 344899999999999999999999 77 999999999999994
Q ss_pred --CCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCC
Q 047043 178 --ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255 (314)
Q Consensus 178 --~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~ 255 (314)
..+.+||+|||++....... ....+|+.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~-------------~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLL-------------GAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHH-------------TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHh-------------CCCCCchHhHHHHHHHHHHHHhCC
Confidence 44489999999998765432 2245899999998764 345788999999999999999999
Q ss_pred CCCCcc
Q 047043 256 KPTDEM 261 (314)
Q Consensus 256 ~Pf~~~ 261 (314)
.||...
T Consensus 233 ~pf~~~ 238 (373)
T 1q8y_A 233 FLFEPD 238 (373)
T ss_dssp CCC---
T ss_pred CCCCCC
Confidence 999854
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=275.49 Aligned_cols=214 Identities=21% Similarity=0.335 Sum_probs=172.9
Q ss_pred HHHhcCcccc-ceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHH-HhCCCCCcceeeccccc----C
Q 047043 38 QRATEGFNEC-NLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVL-RNVHHRNLLKIFSSCSN----P 110 (314)
Q Consensus 38 ~~~~~~y~~~-~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~ 110 (314)
....++|.+. +.||+|+||.||+|.. .+++.||+|+++.. ....+|+.++ +..+||||+++++++.. .
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567889988 7799999999999995 57999999999754 4566788887 55589999999999876 6
Q ss_pred CceeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcEEEEe
Q 047043 111 DFKALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVARVSD 186 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~ikl~D 186 (314)
...++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 78899999999999999998754 35899999999999999999999 899999999999999987 78899999
Q ss_pred eecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh
Q 047043 187 FGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI 266 (314)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~ 266 (314)
||++..... ..++.++|||||||++|+|++|..||........
T Consensus 164 fg~a~~~~~-------------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 164 FGFAKETTG-------------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp CTTCEECTT-------------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred ccccccccc-------------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 998764321 2245679999999999999999999975432211
Q ss_pred -------------hhhhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 267 -------------SLKNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 267 -------------~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.........+++.+.+++ ||.+|||+.|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111112234566555554 9999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=290.40 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=178.1
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.+.|.+.+.||+|+||+||.+...+|+.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.+++..++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34566678899999999987766689999999987653 34567899999876 899999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC-------------C
Q 047043 120 MPNGSLENWLYSHNYF------LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN-------------M 180 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~------~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~-------------~ 180 (314)
+. ++|.+++...... .++..++.++.|++.||+||| ++|++||||||+||+++.+ +
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCce
Confidence 96 5999999865421 133356789999999999999 8999999999999999754 4
Q ss_pred cEEEEeeecceecCCCCCcc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCC
Q 047043 181 VARVSDFGISKLLGDGEDSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKP 257 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~P 257 (314)
.+||+|||++.......... ......||+.|+|||++.... .......++.++|||||||++|+|++ |..|
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN------NLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCC------TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccc------ccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 89999999998875433221 122346999999999875210 11234568899999999999999999 9999
Q ss_pred CCccccchhhhhhh--------------hhccCCchhhhhc--cccCCCCHHHHHH
Q 047043 258 TDEMFTGEISLKNW--------------VNESLPHALTDVV--DANLRVSMKDVAA 297 (314)
Q Consensus 258 f~~~~~~~~~~~~~--------------~~~~~~~~l~~ll--dp~~Rpt~~~~~~ 297 (314)
|............. .+..+.+.+..++ ||.+|||+.++++
T Consensus 240 f~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 97654332211110 0111223344444 9999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.57 Aligned_cols=202 Identities=29% Similarity=0.431 Sum_probs=169.5
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeeccccc------C
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN------P 110 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 110 (314)
...++|++.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|+++++.++||||+++++++.. +
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3458999999999999999999995 579999999987653 3445678899999999999999999998765 6
Q ss_pred CceeEEEEecCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCc---EEEE
Q 047043 111 DFKALVLELMPNGSLENWLYSHN--YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMV---ARVS 185 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~--~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~---ikl~ 185 (314)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++. ++|+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 78899999999999999998653 25889999999999999999999 899999999999999987664 8999
Q ss_pred eeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 186 DFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
|||++........ .....||+.|+|||.+ .+..++.++||||||+++|+|++|..||..
T Consensus 167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l-------------~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 167 DLGYAKELDQGEL---CTEFVGTLQYLAPELL-------------EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp SCCCCCBTTSCCC---CCCCCSCCTTCSSCSS-------------CCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccccc---cccccCCcccCChHHh-------------ccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9999987654332 2335689999999654 456778899999999999999999999964
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=284.84 Aligned_cols=244 Identities=15% Similarity=0.145 Sum_probs=176.0
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---HHHHHHHHHHHHHHhCCC-CCcceee-----------
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---RAFRSFDSECEVLRNVHH-RNLLKIF----------- 104 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~~----------- 104 (314)
..+|...+.||+|+||.||+|.+ .+|+.||||+++.... ...+.+.+|+.+++.++| ++...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34588889999999999999994 5799999999884432 224678899999999876 3221111
Q ss_pred ----------ccccc-----CCceeEEEEecCCCCHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 047043 105 ----------SSCSN-----PDFKALVLELMPNGSLENWLYS------HNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163 (314)
Q Consensus 105 ----------~~~~~-----~~~~~lv~e~~~~~sL~~~i~~------~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~ 163 (314)
.++.. ....+++|+.. +++|.+++.. .+..+++..+..++.|++.||+||| ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ 231 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYG 231 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTT
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCC
Confidence 11111 22456777765 6799999852 2344678889999999999999999 899
Q ss_pred eeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceeh
Q 047043 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYS 243 (314)
Q Consensus 164 i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~s 243 (314)
++||||||+||+++.++.+||+|||++...... .....| +.|+|||++....... .......++.++||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~---~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPF---GQHHPTLMTFAFDTWT 302 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTT---GGGCCEEECHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhcccccc---ccccCcCCCchhhHHH
Confidence 999999999999999999999999998865432 233456 8999999874221000 0013445788999999
Q ss_pred hhHHHHHHhcCCCCCCccccchhhhhhh-hhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 244 FGVLLMETFTGKKPTDEMFTGEISLKNW-VNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 244 lG~il~~ll~g~~Pf~~~~~~~~~~~~~-~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
|||++|+|++|..||............. ....+++.+.+++ ||.+||++.+++++
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999998755433222111 1234666666655 99999998777653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=298.48 Aligned_cols=237 Identities=22% Similarity=0.294 Sum_probs=185.4
Q ss_pred HHhcCccccceeeecCceEEEEEEeC--CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc---
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS--DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF--- 112 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 112 (314)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34589999999999999999999964 68999999986543 3445678899999999999999999999987665
Q ss_pred --eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 113 --KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 113 --~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
.|+||||+++++|.+++.. .+++..+..++.|++.||.||| ++|++||||||+||+++.+ .+||+|||++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987754 4899999999999999999999 8999999999999999875 8999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh--
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-- 268 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-- 268 (314)
...... ....||+.|+|||++.. . ++.++|||||||++|+|++|..||..........
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~-------------~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 288 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRT-------------G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD 288 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHH-------------C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTC
T ss_pred hhcccC------CccCCCccccCHHHHcC-------------C-CCCceehhhhHHHHHHHHhCCCCCcccccccccccc
Confidence 876443 23458999999987641 1 2678999999999999999999987643222111
Q ss_pred -hhhhhccCCchhhhhc--cccCCCC-HHHHHHHHHhhh
Q 047043 269 -KNWVNESLPHALTDVV--DANLRVS-MKDVAAKLKKIR 303 (314)
Q Consensus 269 -~~~~~~~~~~~l~~ll--dp~~Rpt-~~~~~~~l~~~~ 303 (314)
....++.+.+.+..++ ||.+||+ ..++...+..+.
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0111223334555555 9999995 555666555543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=275.01 Aligned_cols=194 Identities=22% Similarity=0.258 Sum_probs=160.3
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--------cHHHHHHHHHHHHHHhCC---------------
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--------GRAFRSFDSECEVLRNVH--------------- 96 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~--------------- 96 (314)
..++|++.+.||+|+||.||+|++ +|+.||+|+++... ....+.+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999998 78999999998753 123467888999988886
Q ss_pred -----------CCCcceeeccccc-------------CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 047043 97 -----------HRNLLKIFSSCSN-------------PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152 (314)
Q Consensus 97 -----------h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l 152 (314)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..+..++.|++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 6666666776665 7889999999999977776644 3489999999999999999
Q ss_pred HHHhcCCCCCCeeecCCCCCceEecCCC--------------------cEEEEeeecceecCCCCCcceeecccceeeee
Q 047043 153 EYLHHGHSSAPIVHCDLKPSNILLDENM--------------------VARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212 (314)
Q Consensus 153 ~~LH~~~~~~~i~H~dlkp~Nili~~~~--------------------~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~ 212 (314)
+|||+ ++|++||||||+|||++.++ .+||+|||++...... ...||+.|+
T Consensus 175 ~~lH~---~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEA---SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM 244 (336)
T ss_dssp HHHHH---HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred HHHHH---hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence 99993 37899999999999999877 8999999999876432 236899999
Q ss_pred cCccccccccccCcccCCCCCCCCcccceehhhHH-HHHHhcCCCCCCc
Q 047043 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVL-LMETFTGKKPTDE 260 (314)
Q Consensus 213 aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~i-l~~ll~g~~Pf~~ 260 (314)
|||++. +.. +.++|||||+++ .++++.|..||..
T Consensus 245 aPE~~~-------------g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 245 DEDLFT-------------GDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CSGGGC-------------CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred Chhhhc-------------CCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 998763 222 678999998777 7888999999865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=251.28 Aligned_cols=184 Identities=17% Similarity=0.076 Sum_probs=131.1
Q ss_pred eeecCceEEEEEE-eCCCCeEEEEEeeecc----------cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeEEE
Q 047043 50 LGTGSFGIVYKGI-LSDGNNVAIKVFKLQL----------GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 50 lg~G~~g~V~~a~-~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
.+.|+.|....++ .-.|+.+++|++.... ....+.+.+|+++|+++ .|+||+++++++++++..|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666656 3468999999997642 23456789999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||++|++|.+.+...+. +++. .++.||++||+|+| ++||+||||||+|||++.+|.+||+|||+++......
T Consensus 322 Eyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999987654 5554 47899999999999 9999999999999999999999999999998765432
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P 257 (314)
. .....+||+.|+|||++. +.+..++|+||+|++++++.++..|
T Consensus 394 ~--~~~t~vGTp~YmAPE~l~--------------g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S--WPTNLVQSFFVFVNELFA--------------ENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C--CSHHHHHHHHHHHHHHC-------------------------------CCCCTTHHH
T ss_pred c--cccCceechhhccHHHhC--------------CCCCCcccccccccchhhhccccch
Confidence 2 233467999999998863 2345678999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=217.62 Aligned_cols=190 Identities=16% Similarity=0.100 Sum_probs=140.7
Q ss_pred cCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--------cHHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--------GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
..+...+.||+|+||.||+|.. .++.+++|...... ....+.+.+|++++++++||||+++..++...+..
T Consensus 336 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 414 (540)
T 3en9_A 336 KRKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK 414 (540)
T ss_dssp ------------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred ccCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence 3345567899999999999964 57888998864432 11235578999999999999999665555567778
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
++||||+++++|.+++.. +..++.|++.+|.||| ++|++||||||+||+++. .+||+|||++...
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999999875 5678999999999999 899999999999999998 9999999999887
Q ss_pred CCCCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCC
Q 047043 194 GDGEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT 258 (314)
Q Consensus 194 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf 258 (314)
....... ......||+.|+|||++... ...|+..+|+|+...-..+-..++-+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~-----------~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF-----------LEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH-----------HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHH-----------HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5432211 11245699999999987521 123566789999988887777666655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=178.57 Aligned_cols=135 Identities=19% Similarity=0.171 Sum_probs=110.6
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc------------------HHHHHHHHHHHHHHhCCCCCcce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG------------------RAFRSFDSECEVLRNVHHRNLLK 102 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~ 102 (314)
...|++.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+.+++.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 334666699999999999999987799999999975321 12456889999999998 4 66
Q ss_pred eecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
+.+++.. +..++||||++|++|.+ +.. .....++.|++.||.+|| +.|++|+||||+||+++ ++.+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-CCcE
Confidence 6665544 55689999999999988 421 234579999999999999 89999999999999999 9999
Q ss_pred EEEeeeccee
Q 047043 183 RVSDFGISKL 192 (314)
Q Consensus 183 kl~Dfg~~~~ 192 (314)
+|+|||++..
T Consensus 232 kl~DFG~a~~ 241 (282)
T 1zar_A 232 WIIDFPQSVE 241 (282)
T ss_dssp EECCCTTCEE
T ss_pred EEEECCCCeE
Confidence 9999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=7.4e-21 Score=163.22 Aligned_cols=137 Identities=21% Similarity=0.265 Sum_probs=107.2
Q ss_pred ccccceeeecCceEEEEEEe-CCCCe--EEEEEeeecccH------------------------HHHHHHHHHHHHHhCC
Q 047043 44 FNECNLLGTGSFGIVYKGIL-SDGNN--VAIKVFKLQLGR------------------------AFRSFDSECEVLRNVH 96 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 96 (314)
|++.+.||+|+||.||+|.. .+|+. ||+|+++..... ....+.+|++.+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999996 68989 999997654211 1135778999999998
Q ss_pred CCCc--ceeecccccCCceeEEEEecCC-C----CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC
Q 047043 97 HRNL--LKIFSSCSNPDFKALVLELMPN-G----SLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169 (314)
Q Consensus 97 h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl 169 (314)
|+++ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.+|.+||. .+|++||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCCC
Confidence 7754 334432 356899999942 3 67665432 2355678899999999999995 578999999
Q ss_pred CCCceEecCCCcEEEEeeecceec
Q 047043 170 KPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 170 kp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
||+||+++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=160.42 Aligned_cols=151 Identities=13% Similarity=0.159 Sum_probs=104.4
Q ss_pred ehhhHHHHhcC---ccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc--------------HHHHHHHHHHHHHHhC
Q 047043 33 SYLDIQRATEG---FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG--------------RAFRSFDSECEVLRNV 95 (314)
Q Consensus 33 ~~~~~~~~~~~---y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l 95 (314)
+|+-+....++ |++.+.||+|++|.||+|...+|+.||||+++.... ........+.++....
T Consensus 83 D~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~k 162 (397)
T 4gyi_A 83 DYLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIK 162 (397)
T ss_dssp HHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHH
Confidence 45555666555 999999999999999999988899999999864210 0011122222222222
Q ss_pred CCCCcceeeccccc------CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC
Q 047043 96 HHRNLLKIFSSCSN------PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169 (314)
Q Consensus 96 ~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl 169 (314)
.|+|+.+++..... .+..++||||++|++|..+. .......++.|++.+|.+|| ++|++||||
T Consensus 163 E~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH----~~gIVHrDL 231 (397)
T 4gyi_A 163 EFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLA----KHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHH----HTTEECSCC
T ss_pred HHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHH----HCCCcCCCC
Confidence 33343333322211 12336999999988876542 22345678899999999999 899999999
Q ss_pred CCCceEecCCC----------cEEEEeeecceecC
Q 047043 170 KPSNILLDENM----------VARVSDFGISKLLG 194 (314)
Q Consensus 170 kp~Nili~~~~----------~ikl~Dfg~~~~~~ 194 (314)
||.|||++.++ .+.|+||+.+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999998766 48999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-13 Score=116.94 Aligned_cols=147 Identities=16% Similarity=0.118 Sum_probs=114.3
Q ss_pred HHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 116 (314)
....+.|++...++.|+.+.||++.. .++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 45567899999999899999999985 36889999987532222346888999999884 66788899988888889999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH------------------------------------- 159 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------- 159 (314)
||+++|.+|.+.+. +......++.+++.++..||+..
T Consensus 89 ~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 89 MSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999887531 12234467889999999999510
Q ss_pred ------------------CCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 160 ------------------SSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 160 ------------------~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
....++|+|++|.||+++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799998664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=4e-12 Score=108.20 Aligned_cols=140 Identities=15% Similarity=0.078 Sum_probs=100.9
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--cceeecccccCCceeEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--LLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~ 117 (314)
....|.+....+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..+++|
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34556654444456669999998767888999997654 2256778999998885434 566888888877889999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------------
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS------------------------------------- 160 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~------------------------------------- 160 (314)
|+++|.++. ... .+ ...++.+++..+..||+...
T Consensus 95 e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998873 211 11 23567788888888884210
Q ss_pred -----------------CCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 161 -----------------SAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 161 -----------------~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.9e-10 Score=102.92 Aligned_cols=144 Identities=15% Similarity=0.205 Sum_probs=105.2
Q ss_pred cccceeeecCceEEEEEEeCCCCeEEEEEee--ecc-cHHHHHHHHHHHHHHhCC--CCCcceeecccccC---CceeEE
Q 047043 45 NECNLLGTGSFGIVYKGILSDGNNVAIKVFK--LQL-GRAFRSFDSECEVLRNVH--HRNLLKIFSSCSNP---DFKALV 116 (314)
Q Consensus 45 ~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv 116 (314)
..++.++.|.++.||++... +..+++|... ... ......+.+|..+++.+. +..+++++.++.+. ...++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678899999999999864 4678888876 332 122356788999999986 34578888887766 457899
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH------------------------------------- 159 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------- 159 (314)
||+++|.++.+... ..++......++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999877754211 22677788889999999999999521
Q ss_pred -----------------CCCCeeecCCCCCceEecCCCc--EEEEeeeccee
Q 047043 160 -----------------SSAPIVHCDLKPSNILLDENMV--ARVSDFGISKL 192 (314)
Q Consensus 160 -----------------~~~~i~H~dlkp~Nili~~~~~--ikl~Dfg~~~~ 192 (314)
...+++|+|+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 0256999999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=5.6e-10 Score=97.50 Aligned_cols=138 Identities=19% Similarity=0.231 Sum_probs=98.6
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCC--cceeecccccCC---ceeEEEEec
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRN--LLKIFSSCSNPD---FKALVLELM 120 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~ 120 (314)
++.++.|.+..||++. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 5578999999998753 56889986543 34467888999998873 322 345554443333 347899999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH----------------------------------------- 159 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----------------------------------------- 159 (314)
+|.++.+.... .++..+...++.+++..+..||+..
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888754332 2567777788888888888888411
Q ss_pred -------------CCCCeeecCCCCCceEecC--CCcEEEEeeecceec
Q 047043 160 -------------SSAPIVHCDLKPSNILLDE--NMVARVSDFGISKLL 193 (314)
Q Consensus 160 -------------~~~~i~H~dlkp~Nili~~--~~~ikl~Dfg~~~~~ 193 (314)
....++|+|++|.||+++. +..+.|+||+.+...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 0135899999999999987 556789999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=2.9e-07 Score=78.58 Aligned_cols=135 Identities=19% Similarity=0.133 Sum_probs=98.7
Q ss_pred eeeecCce-EEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEEEecCCCCH
Q 047043 49 LLGTGSFG-IVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 49 ~lg~G~~g-~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
.+..|.++ .||+.... .+..+++|+-+.. ....+.+|...++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44556665 68988844 5678999986643 3456788999998884 33367888888888899999999999888
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH---------------------------------------------- 159 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~---------------------------------------------- 159 (314)
.+..... ......+..+++..+..||+..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 8765432 2233456777888888888411
Q ss_pred --------CCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 160 --------SSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 160 --------~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237999999999999987767799998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=5.2e-07 Score=78.67 Aligned_cols=137 Identities=13% Similarity=0.085 Sum_probs=93.6
Q ss_pred cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCC---Ccceeecccc-cCCceeEEEEecCC
Q 047043 47 CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR---NLLKIFSSCS-NPDFKALVLELMPN 122 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~ 122 (314)
++.++.|....||+. +..+++|+-.. ......+..|.++++.+.+. .+.+.+.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 56788888432 23456788999999998642 3455555553 34567899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH------------------------------------------- 159 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~------------------------------------------- 159 (314)
.++.+..... ++..+...++.++...|..||+..
T Consensus 98 ~~l~~~~~~~---l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMAV---LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHTT---SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhhh---CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 8887632211 344455555556666665555311
Q ss_pred -------------CCCCeeecCCCCCceEecC---CCcE-EEEeeeccee
Q 047043 160 -------------SSAPIVHCDLKPSNILLDE---NMVA-RVSDFGISKL 192 (314)
Q Consensus 160 -------------~~~~i~H~dlkp~Nili~~---~~~i-kl~Dfg~~~~ 192 (314)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1345799999999999987 4554 8999997764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=7.8e-07 Score=79.11 Aligned_cols=80 Identities=10% Similarity=-0.061 Sum_probs=54.5
Q ss_pred ccee-eecCceEEEEEEeC-------CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCC-C--CCcceeecccccC--
Q 047043 47 CNLL-GTGSFGIVYKGILS-------DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVH-H--RNLLKIFSSCSNP-- 110 (314)
Q Consensus 47 ~~~l-g~G~~g~V~~a~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~-- 110 (314)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|..+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 77888999988753 26688999876432 001245677888888874 2 3466777776655
Q ss_pred -CceeEEEEecCCCCHH
Q 047043 111 -DFKALVLELMPNGSLE 126 (314)
Q Consensus 111 -~~~~lv~e~~~~~sL~ 126 (314)
...++|||+++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3567999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.2e-05 Score=70.58 Aligned_cols=31 Identities=32% Similarity=0.343 Sum_probs=28.0
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1e-05 Score=73.03 Aligned_cols=76 Identities=16% Similarity=0.187 Sum_probs=49.0
Q ss_pred ccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-------HHHHHHHHHHHHHHhCCC--C-CcceeecccccCCcee
Q 047043 46 ECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-------RAFRSFDSECEVLRNVHH--R-NLLKIFSSCSNPDFKA 114 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~ 114 (314)
..+.+|.|.++.||++... +++.+++|....... .....+..|.++++.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3567899999999999843 578899998653211 112345778888887732 3 34455544 334567
Q ss_pred EEEEecCCC
Q 047043 115 LVLELMPNG 123 (314)
Q Consensus 115 lv~e~~~~~ 123 (314)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00011 Score=63.05 Aligned_cols=79 Identities=14% Similarity=0.073 Sum_probs=56.6
Q ss_pred cCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC---CCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH---RNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e 118 (314)
.+..-++.+|.|..+.||+.+..+|+.|++|+...........+..|.+.|+.+.. --++++++.. .-+++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34566788999999999999988999999998765433333457789999988742 1244555442 2368999
Q ss_pred ecCCCC
Q 047043 119 LMPNGS 124 (314)
Q Consensus 119 ~~~~~s 124 (314)
+++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00014 Score=63.32 Aligned_cols=76 Identities=14% Similarity=0.124 Sum_probs=59.2
Q ss_pred ccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC---CCCcceeecccccCCceeEEEEecCC
Q 047043 46 ECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH---HRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 46 ~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
-.+.|+.|.+..+|+... ++..+++|+.... ....+..|.+.++.+. ...+++++.+....+..+++||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345788999999999985 5678899987654 2456788988888873 35677888887777889999999988
Q ss_pred CCH
Q 047043 123 GSL 125 (314)
Q Consensus 123 ~sL 125 (314)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00012 Score=63.37 Aligned_cols=74 Identities=7% Similarity=0.109 Sum_probs=46.9
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEec-C
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELM-P 121 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~ 121 (314)
+.-++.|+.|....+|+. +.+++|+...... ......+|...++.+...++ .+++.... +..++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence 444788999999999998 5689998865421 11234567877777742222 45555443 3346899999 6
Q ss_pred CCCH
Q 047043 122 NGSL 125 (314)
Q Consensus 122 ~~sL 125 (314)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00024 Score=64.53 Aligned_cols=32 Identities=19% Similarity=0.327 Sum_probs=28.1
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
...++|+|+++.||+++.++ +.++||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 67899999999999998776 999999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00031 Score=61.54 Aligned_cols=141 Identities=13% Similarity=0.061 Sum_probs=72.8
Q ss_pred cceeeecCceE-EEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC--CCcceeecccccCCceeEEEEecCCC
Q 047043 47 CNLLGTGSFGI-VYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH--RNLLKIFSSCSNPDFKALVLELMPNG 123 (314)
Q Consensus 47 ~~~lg~G~~g~-V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (314)
++.|+.|+... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+.... .+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 34566665554 6677653467788886554321 234456777666632 2345566553332 26899999776
Q ss_pred CHHHHHhhcC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHh--
Q 047043 124 SLENWLYSHN-------------------------YFLDTLERL-------NIM-------------IDVWLALEYLH-- 156 (314)
Q Consensus 124 sL~~~i~~~~-------------------------~~~~~~~~~-------~i~-------------~~l~~~l~~LH-- 156 (314)
++.+.+.... ..++..... .+. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654432210 001111100 000 01111222221
Q ss_pred -cCCCCCCeeecCCCCCceEecCC----CcEEEEeeecceec
Q 047043 157 -HGHSSAPIVHCDLKPSNILLDEN----MVARVSDFGISKLL 193 (314)
Q Consensus 157 -~~~~~~~i~H~dlkp~Nili~~~----~~ikl~Dfg~~~~~ 193 (314)
... ...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 178 ~~~~-~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEG-DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCS-CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccC-CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 111 4679999999999999874 67999999977643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00065 Score=59.07 Aligned_cols=158 Identities=8% Similarity=0.076 Sum_probs=84.7
Q ss_pred eehhhHHHHhcCccc-----cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC--cceee
Q 047043 32 TSYLDIQRATEGFNE-----CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN--LLKIF 104 (314)
Q Consensus 32 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~ 104 (314)
.+-.++.....+|.+ ++.|+.|....+|+....+| .+++|+..... ....+..|..++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344556666666765 23456677789999986555 68899887631 1134556777777663212 33333
Q ss_pred ccc------ccCCceeEEEEecCCCCHHH----H----------Hhhc--C--CC----CCHHHHHH-------------
Q 047043 105 SSC------SNPDFKALVLELMPNGSLEN----W----------LYSH--N--YF----LDTLERLN------------- 143 (314)
Q Consensus 105 ~~~------~~~~~~~lv~e~~~~~sL~~----~----------i~~~--~--~~----~~~~~~~~------------- 143 (314)
... ...+..++++++++|.++.. . +... + .. ........
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 221 12345688999998754311 0 1100 1 00 00000000
Q ss_pred --HHHHHHHHHHHHhcC---CCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 144 --IMIDVWLALEYLHHG---HSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 144 --i~~~l~~~l~~LH~~---~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
+...+...+..+... ....+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344444421 1135799999999999998876668999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0019 Score=56.23 Aligned_cols=91 Identities=11% Similarity=-0.025 Sum_probs=54.5
Q ss_pred eehhhHHHHhcCccc-----cceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCC--Ccceee
Q 047043 32 TSYLDIQRATEGFNE-----CNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHR--NLLKIF 104 (314)
Q Consensus 32 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~ 104 (314)
.+-..+......|.+ ++.++ |....||+....+|+.+++|+...... ....+..|..+++.+... .+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344445555455532 34566 788899988866677899999874321 124556677777777421 234444
Q ss_pred cc-----cccCCceeEEEEecCCCC
Q 047043 105 SS-----CSNPDFKALVLELMPNGS 124 (314)
Q Consensus 105 ~~-----~~~~~~~~lv~e~~~~~s 124 (314)
.. ....+..++++++++|.+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ecCCcEEEEECCEEEEEEEecCCCC
Confidence 33 112345578999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00091 Score=59.81 Aligned_cols=141 Identities=13% Similarity=0.141 Sum_probs=82.0
Q ss_pred cceeeecCceEEEEEEeC--------CCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEE
Q 047043 47 CNLLGTGSFGIVYKGILS--------DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++.+..|-...+|++... +++.+++|+..... .......+|.++++.+. +.-..++++.+.++ +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence 356777888899999853 24789999864321 12345568999998874 32235677776653 899
Q ss_pred EecCCCCHHHH--------------Hhh---c----CCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 047043 118 ELMPNGSLENW--------------LYS---H----NYFLD--TLERLNIMIDVWL-------------------ALEY- 154 (314)
Q Consensus 118 e~~~~~sL~~~--------------i~~---~----~~~~~--~~~~~~i~~~l~~-------------------~l~~- 154 (314)
||++|.+|..- +.+ . +.... ..++.++..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99987554311 000 0 11111 2344444443321 1222
Q ss_pred ---HhcCCCCCCeeecCCCCCceEecCC----CcEEEEeeeccee
Q 047043 155 ---LHHGHSSAPIVHCDLKPSNILLDEN----MVARVSDFGISKL 192 (314)
Q Consensus 155 ---LH~~~~~~~i~H~dlkp~Nili~~~----~~ikl~Dfg~~~~ 192 (314)
|........++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222224569999999999999876 7899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00031 Score=64.00 Aligned_cols=72 Identities=17% Similarity=0.211 Sum_probs=48.2
Q ss_pred cceeeecCceEEEEEEeCC--------CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC-cceeecccccCCceeEEE
Q 047043 47 CNLLGTGSFGIVYKGILSD--------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN-LLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 117 (314)
++.|+.|....+|++...+ ++.+++|+...... ...+..|..+++.+...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998542 57899999854211 134457888888874333 3566766554 3889
Q ss_pred EecCCCC
Q 047043 118 ELMPNGS 124 (314)
Q Consensus 118 e~~~~~s 124 (314)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9987633
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0021 Score=52.34 Aligned_cols=105 Identities=10% Similarity=-0.012 Sum_probs=68.4
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCccee
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~ 202 (314)
-+|.+.+...+.+++|+++|.++.|.+.+|.-+-. ...-...=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~---~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR---RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh---cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 48999999998889999999999999999887721 11111233456889999999888753 1100
Q ss_pred ecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 203 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
.....|.|||... ...+.+.-|||||+++|..+--..|=+
T Consensus 98 ---~~~~~~~~pe~~~--------------~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY--------------SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp ------------CCSS--------------SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ---ccccCCCChhhcc--------------ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 1223467885431 233456789999999999998666633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00074 Score=61.97 Aligned_cols=74 Identities=16% Similarity=0.187 Sum_probs=47.8
Q ss_pred cceeeecCceEEEEEEeCC-CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEEecCCCC
Q 047043 47 CNLLGTGSFGIVYKGILSD-GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLELMPNGS 124 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~s 124 (314)
++.|+.|-...+|++...+ +..+++|+....... .-....|..+++.+...++ .++++.+.+ .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4567778889999998654 478999987543211 1123578999988864444 567776643 36999998744
Q ss_pred H
Q 047043 125 L 125 (314)
Q Consensus 125 L 125 (314)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00075 Score=60.04 Aligned_cols=73 Identities=11% Similarity=0.177 Sum_probs=44.3
Q ss_pred cceeeecCceEEEEEEeCC---------CCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCC-cceeecccccCCceeEE
Q 047043 47 CNLLGTGSFGIVYKGILSD---------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN-LLKIFSSCSNPDFKALV 116 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 116 (314)
++.++.|..-.+|+....+ ++.+++|+...... .......|.++++.+...+ ..++++.+. .++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 4567778888999998543 26899998765422 1223467888888774323 345665442 3689
Q ss_pred EEecCCCC
Q 047043 117 LELMPNGS 124 (314)
Q Consensus 117 ~e~~~~~s 124 (314)
|++++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.011 Score=51.98 Aligned_cols=32 Identities=19% Similarity=0.343 Sum_probs=27.7
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45699999999999999888899999986653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.021 Score=51.66 Aligned_cols=74 Identities=11% Similarity=0.186 Sum_probs=48.3
Q ss_pred cceeeecCceEEEEEEeCC--------CCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEE
Q 047043 47 CNLLGTGSFGIVYKGILSD--------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++.+..|-.-.+|+....+ ++.+++|+..... ...-...+|.++++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999998642 5789999875432 22223467888888874 222355555443 26899
Q ss_pred EecCCCCH
Q 047043 118 ELMPNGSL 125 (314)
Q Consensus 118 e~~~~~sL 125 (314)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.70 E-value=0.014 Score=52.52 Aligned_cols=30 Identities=33% Similarity=0.397 Sum_probs=25.0
Q ss_pred CeeecCCCCCceEe------cCCCcEEEEeeeccee
Q 047043 163 PIVHCDLKPSNILL------DENMVARVSDFGISKL 192 (314)
Q Consensus 163 ~i~H~dlkp~Nili------~~~~~ikl~Dfg~~~~ 192 (314)
.++|+|+.+.||++ +.++.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 3456799999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.59 E-value=1.8 Score=35.09 Aligned_cols=82 Identities=10% Similarity=0.093 Sum_probs=56.0
Q ss_pred CCCCcceeecccccCCceeEEEEecCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCCeeecCCCCCc
Q 047043 96 HHRNLLKIFSSCSNPDFKALVLELMPNG-SLENWLYSHNYFLDTLERLNIMIDVWLALE-YLHHGHSSAPIVHCDLKPSN 173 (314)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~-~LH~~~~~~~i~H~dlkp~N 173 (314)
.||++ --.+-.+.+.+.+..+.-+++ ++.. +.+ ++....+.++.+|+.... +++ .-.|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~~----~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IRK----TTLLSRIRAAIHLVSKVKHHSA------RRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HHT----SCHHHHHHHHHHHHHHHSSCCS------SSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HHh----cCHHHHHHHHHHHHHHHHHhhh------CceeEEEeCce
Confidence 56766 333345566665555543232 3332 322 678889999999888776 444 34677899999
Q ss_pred eEecCCCcEEEEeeecc
Q 047043 174 ILLDENMVARVSDFGIS 190 (314)
Q Consensus 174 ili~~~~~ikl~Dfg~~ 190 (314)
++++.++.+++.-.|.-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999887753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.33 E-value=1.2 Score=35.92 Aligned_cols=125 Identities=13% Similarity=0.197 Sum_probs=79.5
Q ss_pred CCCCcceeecccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceE
Q 047043 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNIL 175 (314)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nil 175 (314)
.||+++.. .+.++.+.+.+..+.- .+..++-.-. ..+....+.++.+|+....+++ .=+|--|.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~~------~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDNIK--SFTKNEKLRYLLNIKNLEEVNR------TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGGGG--GSCHHHHHHHHHHGGGGGGGGG------SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHHHHH--hcCHHHHHHHHHHHHHHHHHhc------CceEEEEecceEE
Confidence 57777755 4555556554444432 2333322211 2678889999999998886555 2367889999999
Q ss_pred ecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCC
Q 047043 176 LDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK 255 (314)
Q Consensus 176 i~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~ 255 (314)
++.++.+++.-.|+-..+ +|. ..+...=.-..=|++..+++++
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~------------------~~~ee~fL~qyKAliiall~~K 154 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL------------------PVSEAEFLTRYKALVICAFNEK 154 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC------------------CCCHHHHHHHHHHHHHHHHCTT
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC------------------CCCHHHHHHHHHHHHHHHHcCC
Confidence 999999999877753322 220 0011111335667888999999
Q ss_pred CCCCccccchhhh
Q 047043 256 KPTDEMFTGEISL 268 (314)
Q Consensus 256 ~Pf~~~~~~~~~~ 268 (314)
..|+....+...+
T Consensus 155 ~~Fe~l~~G~lel 167 (215)
T 4ann_A 155 QSFDALVEGNLEL 167 (215)
T ss_dssp CCHHHHHHSCGGG
T ss_pred CCHHHHHcChHhh
Confidence 9998776655444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 314 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-62
Identities = 63/275 (22%), Positives = 115/275 (41%), Gaps = 36/275 (13%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G+GSFG VYKG VA+K+ + + ++F +E VLR H N+L
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
+ P A+V + SL + L+ + ++ ++I ++YLH I+
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA----KSII 126
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
H DLK +NI L E++ ++ DFG++ + S +I +MAP
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV--------- 177
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-----------VNE 274
+ + S + DVY+FG++L E TG+ P + + + V
Sbjct: 178 -IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIR 303
+ P A+ ++ + R + A ++ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-53
Identities = 57/275 (20%), Positives = 118/275 (42%), Gaps = 34/275 (12%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLL 101
E LG G FG V+ G + VA+K K + +F +E +++ + H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF-LDTLERLNIMIDVWLALEYLHHGHS 160
++++ + ++ E M NGSL ++L + + L + L++ + + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---- 126
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
+H DL+ +NIL+ + + +++DFG+++L+ D E + I + AP
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAP------ 179
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN------- 273
+ + G + K DV+SFG+LL E T + T ++N
Sbjct: 180 -------EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 274 ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
++ P L ++ R + + + L+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 23/234 (9%)
Query: 37 IQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRS-FDSECEVLRN 94
++ + F + + LG G+ G+V+K G +A K+ L++ A R+ E +VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEY 154
+ ++ + + + ++ +E M GSL+ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 155 LHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAP 214
L H I+H D+KPSNIL++ ++ DFG+S L D + T YM+P
Sbjct: 120 LREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268
S + D++S G+ L+E G+ P E+ L
Sbjct: 173 ERL-------------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 5e-52
Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 47/300 (15%)
Query: 33 SYLDIQRATEGFNEC---------NLLGTGSFGIVYKGILSDGNN----VAIKVFKLQLG 79
++ D A F + ++G G FG V G L VAIK K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 80 -RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDT 138
+ R F SE ++ H N++ + + ++ E M NGSL+++L ++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 139 LERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198
++ + ++ + ++YL + VH DL NIL++ N+V +VSDFG+S+ L D
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 199 SVTQTMT---MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-G 254
T T I + AP + ++ DV+S+G+++ E + G
Sbjct: 184 DPTYTSALGGKIPIRWTAP-------------EAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 255 KKPTDEMFTGEI------SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
++P +M ++ + P AL ++ D N R + L K+
Sbjct: 231 ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLL 101
E LG G FG V+ G + VAIK K + +F E +V++ + H L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTL-ERLNIMIDVWLALEYLHHGHS 160
++++ S +V E M GSL ++L L + +++ + + Y+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
VH DL+ +NIL+ EN+V +V+DFG+++L+ D E + Q I + AP + L
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAAL-- 187
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN------- 273
G + K DV+SFG+LL E T + L
Sbjct: 188 -----------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236
Query: 274 ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
P +L D++ + R + + + A L+
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-51
Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
LGTG FG+V G +VAIK+ K + F E +V+ N+ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ C+ ++ E M NG L N+L + T + L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES----KQ 120
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
+H DL N L+++ V +VSDFG+S+ + D E + + + + + P
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPP--------- 170
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI------SLKNWVNESL 276
+ S+K D+++FGVL+ E ++ GK P + E L+ +
Sbjct: 171 ----EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226
Query: 277 PHALTDVV------DANLRVSMKDVAAKLKKI 302
+ ++ A+ R + K + + + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-50
Identities = 61/273 (22%), Positives = 112/273 (41%), Gaps = 32/273 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
+G+G FG+V+ G + + VAIK + + F E EV+ + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ C LV E M +G L ++L + L + +DV + YL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---- 121
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
++H DL N L+ EN V +VSDFG+++ + D + + + + + +P
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASP--------- 171
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN-------ESL 276
+ S S+K DV+SFGVL+ E F+ K E + +++
Sbjct: 172 ----EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 277 PHALTDVV------DANLRVSMKDVAAKLKKIR 303
+ ++ R + + +L +I
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-50
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 50 LGTGSFGIVYKGILSDGNN---VAIKVFKLQLGRAFR-SFDSECEVLRNVHHRNLLKIFS 105
LG G+FG V +G+ VAIKV K +A E +++ + + ++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165
C LV+E+ G L +L + ++ V + ++YL V
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFV 131
Query: 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLFDILKP 224
H DL N+LL A++SDFG+SK LG + T + + AP
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP---------- 181
Query: 225 KNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI------SLKNWVNESLP 277
+ + S++ DV+S+GV + E + G+KP +M E+ + P
Sbjct: 182 ---ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238
Query: 278 HALTDVV------DANLRVSMKDVAAKLKKI 302
L ++ R V +++
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 2e-49
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 38/272 (13%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKL---QLGRAFRSFDSECEVLRNVH 96
+ F++ +G GSFG VY + + VAIK Q ++ E L+ +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
H N ++ LV+E + + H L +E + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
S ++H D+K NILL E + ++ DFG + ++ + T +MAP
Sbjct: 133 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEV 182
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNES- 275
L EG K DV+S G+ +E K P M NES
Sbjct: 183 ILAM----------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 276 ------LPHALTDVV------DANLRVSMKDV 295
+ V R + + +
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 73/275 (26%), Positives = 113/275 (41%), Gaps = 40/275 (14%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKI 103
+G G FG V G GN VA+K K ++F +E V+ + H NL+++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQL 65
Query: 104 FSSCSNPDFK-ALVLELMPNGSLENWLYSHNY-FLDTLERLNIMIDVWLALEYLHHGHSS 161
+V E M GSL ++L S L L +DV A+EYL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----G 121
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
VH DL N+L+ E+ VA+VSDFG++K TQ + + AP
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAP------- 169
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN-------E 274
+ E S K DV+SFG+LL E ++ + + + +
Sbjct: 170 ------EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223
Query: 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIR 303
P A+ +V+ DA +R S + +L+ I+
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-49
Identities = 54/243 (22%), Positives = 94/243 (38%), Gaps = 15/243 (6%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSS 106
LG G+FG VYK A KV + + E ++L + H N++K+ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ +++E G+++ + L + + AL YLH I+H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIH 133
Query: 167 CDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKN 226
DLK NIL + +++DFG+S + +MAP + + K +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--PYWMAPEVVMCETSKDRP 191
Query: 227 AKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALTDVVDA 286
K DV+S G+ L+E + P E+ + LK +E A +
Sbjct: 192 --------YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 287 NLR 289
N +
Sbjct: 244 NFK 246
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 36/275 (13%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHR 98
E + +GTGS+G K SDG + K + SE +LR + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 99 NLLKIFSSCSNPDFKAL--VLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALE 153
N+++ + + L V+E G L + + +LD L +M + LAL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 154 YLH-HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
H ++H DLKP+N+ LD ++ DFG++++L + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYM 181
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK--- 269
+P + + + K D++S G LL E P E++ K
Sbjct: 182 SP-------------EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
Query: 270 ---NWVNESLPHALTDVV------DANLRVSMKDV 295
+ L +++ R S++++
Sbjct: 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 6e-48
Identities = 66/295 (22%), Positives = 116/295 (39%), Gaps = 38/295 (12%)
Query: 34 YLDIQRATEGFNECNLLGTGSFGIVYKGILSDGNN----VAIKVFKLQLGRAFRS-FDSE 88
++ I ++ + ++G G FG VY G L D + A+K S F +E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKA-LVLELMPNGSLENWLYSHNYFLDTLERLNIMID 147
++++ H N+L + C + +VL M +G L N++ + + + + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 148 VWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-- 205
V +++L VH DL N +LDE +V+DFG+++ + D E T
Sbjct: 139 VAKGMKFLAS----KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+ +MA S + K DV+SFGVLL E T P
Sbjct: 195 KLPVKWMALES-------------LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 266 ISLKNWVN-------ESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307
+ E P L +V+ A +R S ++ +++ I F+
Sbjct: 242 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 7e-48
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 34/274 (12%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNN-VAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLK 102
+ LG G +G VY+G+ + VA+K K F E V++ + H NL++
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 103 IFSSCSNPDFKALVLELMPNGSLENWLYSHNYF-LDTLERLNIMIDVWLALEYLHHGHSS 161
+ C+ ++ E M G+L ++L N + + L + + A+EYL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----K 133
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
+H DL N L+ EN + +V+DFG+S+L+ G+ I + AP
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP------- 185
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN-------E 274
+ + S K DV++FGVLL E T + E
Sbjct: 186 ------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239
Query: 275 SLPHALTDVV------DANLRVSMKDVAAKLKKI 302
P + +++ + + R S ++ + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-47
Identities = 65/281 (23%), Positives = 118/281 (41%), Gaps = 37/281 (13%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNN-----VAIKVFKLQLGRAFR-SFDSECEVLRNV 95
++G G FG VYKG+L + VAIK K R F E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 96 HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYL 155
H N++++ S ++ E M NG+L+ +L + L+ + ++ + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 156 HHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV-TQTMTMATIGYMAP 214
+ VH DL NIL++ N+V +VSDFG+S++L D ++ T + I + AP
Sbjct: 127 A----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 215 VSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN- 273
+ S ++ DV+SFG+++ E T + + +K +
Sbjct: 183 -------------EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 274 ------ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
P A+ ++ + R D+ + L K+
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 53/270 (19%), Positives = 105/270 (38%), Gaps = 33/270 (12%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKL-QLGRAFRSFDSECEVLRNVHHRN 99
E ++ LG G++G V + VA+K+ + + + E + + ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++K + + + L LE G L + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I H D+KP N+LLDE ++SDFG++ + T+ Y+AP
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP----- 174
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN------ 273
++LK + DV+S G++L G+ P D+ +W
Sbjct: 175 ELLK-------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227
Query: 274 --ESLPHALTDVV------DANLRVSMKDV 295
+ + A ++ + + R+++ D+
Sbjct: 228 PWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-47
Identities = 53/297 (17%), Positives = 109/297 (36%), Gaps = 54/297 (18%)
Query: 50 LGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109
+G G FG V++G G VA+K+F + R++ ++E + H N+L ++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 110 PDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG----HSS 161
+ LV + +GSL ++L + Y + + + + L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIGYMAPVSQLF 219
I H DLK NIL+ +N ++D G++ D++ + T YMAP L
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP-EVLD 185
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWV------- 272
D + K+ + + D+Y+ G++ E ++ + V
Sbjct: 186 DSINMKHFES------FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 273 --------------------NESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303
+ + ++ + R++ + L ++
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-46
Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 38/276 (13%)
Query: 46 ECNLLGTGSFGIVYKGILSDGNN---VAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNL 100
E LG+G+FG V KG VA+K+ K + +E V++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+++ C + LV+E+ G L +L + + + + ++ V + ++YL +
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLF 219
VH DL N+LL A++SDFG+SK L E+ + + AP
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP----- 179
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI------SLKNWV 272
+ + S+K DV+SFGVL+ E F+ G+KP M E+ +
Sbjct: 180 --------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
P + D++ D R V +L+
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 4e-46
Identities = 61/313 (19%), Positives = 110/313 (35%), Gaps = 60/313 (19%)
Query: 33 SYLDIQRATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLGRAFRS-F 85
L ++ +G G+FG V++ VA+K+ K + ++ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 86 DSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------- 135
E ++ + N++K+ C+ L+ E M G L +L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 136 -------------LDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182
L E+L I V + YL VH DL N L+ ENMV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVV 179
Query: 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVY 242
+++DFG+S+ + + I +M P S + + DV+
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------------YNRYTTESDVW 226
Query: 243 SFGVLLMETFTGKKPTDEMFTGEISLKNWVN-------ESLPHALTDVV------DANLR 289
++GV+L E F+ E + + E+ P L +++ R
Sbjct: 227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286
Query: 290 VSMKDVAAKLKKI 302
S + L+++
Sbjct: 287 PSFCSIHRILQRM 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 9e-46
Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 29/248 (11%)
Query: 50 LGTGSFGIVYKGILSD-GNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSS 106
+G GSF VYKG+ ++ VA + + + F E E+L+ + H N+++ + S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 107 C----SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSA 162
LV ELM +G+L+ +L + + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTP-- 133
Query: 163 PIVHCDLKPSNILL-DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
PI+H DLK NI + ++ D G++ L S + + + T +MAP ++
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAP-----EM 184
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESLPHALT 281
+ K DVY+FG+ ++E T + P E + + P +
Sbjct: 185 YEEK---------YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235
Query: 282 DVVDANLR 289
V ++
Sbjct: 236 KVAIPEVK 243
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-45
Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 38/287 (13%)
Query: 35 LDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKV-----FKLQLGRAFRSFDSE 88
L I + TE F + +LG+G+FG VYKG+ + +G V I V + +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 89 CEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDV 148
V+ +V + ++ ++ C + L+ +LMP G L +++ H + + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 149 WLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMAT 208
+ YL +VH DL N+L+ +++DFG++KLLG E
Sbjct: 121 AKGMNYLED----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 209 IGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEI- 266
I +MA S L I + + DV+S+GV + E T G KP D + EI
Sbjct: 177 IKWMALESIL-------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 267 -----SLKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
+ + ++ DA+ R +++ + K+
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-45
Identities = 56/294 (19%), Positives = 107/294 (36%), Gaps = 56/294 (19%)
Query: 48 NLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNV-HHRN 99
LG G+FG V + VA+K+ K R + SE +VL + +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSH-----------------NYFLDTLERL 142
++ + +C+ ++ E G L N+L LD + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202
+ V + +L + +H DL NILL + ++ DFG+++ + + + V +
Sbjct: 149 SFSYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262
+ +MAP + + + + DV+S+G+ L E F+
Sbjct: 205 GNARLPVKWMAP-------------ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 263 TGEISLKNWVN--------ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
+ + E P + D++ D R + K + ++K
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 2e-45
Identities = 57/270 (21%), Positives = 103/270 (38%), Gaps = 36/270 (13%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRN 99
+ + +G G+ G VY + ++ G VAI+ LQ +E V+R + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++ S D +V+E + GSL + + + + + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
S ++H D+K NILL + +++DFG + + ++ + T +MAP
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAP----- 185
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN------ 273
+ + K D++S G++ +E G+ P N
Sbjct: 186 --------EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 274 --ESLPHALTDVV------DANLRVSMKDV 295
E L D + D R S K++
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-45
Identities = 66/282 (23%), Positives = 100/282 (35%), Gaps = 40/282 (14%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNN----VAIKVFKLQL---GRAFRSFDSECEVLRNVH 96
LG GSFG+V +G + VA+K K + A F E + ++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
HRNL++++ P K +V EL P GSL + L H + V + YL
Sbjct: 70 HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS-VTQTMTMATIGYMAPV 215
S +H DL N+LL + ++ DFG+ + L +D V Q + AP
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN-- 273
S S D + FGV L E FT + G L
Sbjct: 185 SLK-------------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231
Query: 274 ------ESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303
E P + +V+ R + + L + +
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 53/293 (18%)
Query: 44 FNECNLLGTGSFGIVYKGILSDGNN---VAIKVFKLQLGR-AFRSFDSECEVLRNV-HHR 98
+++G G+FG V K + AIK K + R F E EVL + HH
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------------LDTLERLN 143
N++ + +C + + L +E P+G+L ++L L + + L+
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 144 IMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203
DV ++YL +H DL NIL+ EN VA+++DFG+S+ E V +T
Sbjct: 132 FAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 184
Query: 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263
M + +MA + + + + DV+S+GVLL E + T
Sbjct: 185 MGRLPVRWMAI-------------ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 264 GEISLKNWVN-------ESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303
+ + + D++ R S + L ++
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-44
Identities = 58/296 (19%), Positives = 109/296 (36%), Gaps = 61/296 (20%)
Query: 49 LLGTGSFGIVYKGILSDGNN------VAIKVFKLQLGRAFR-SFDSECEVLRNV-HHRNL 100
+LG+G+FG V + VA+K+ K + + R + SE +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHN----------------------YFLDT 138
+ + +C+ L+ E G L N+L S L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 139 LERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198
+ L V +E+L VH DL N+L+ V ++ DFG+++ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT 258
V + + +MAP + EGI + K DV+S+G+LL E F+
Sbjct: 220 YVVRGNARLPVKWMAP-------------ESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 259 DEMFTGEISLKNWVN--------ESLPHALTDVV------DANLRVSMKDVAAKLK 300
+ + + + ++ D+ R S ++ + L
Sbjct: 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-44
Identities = 62/272 (22%), Positives = 104/272 (38%), Gaps = 37/272 (13%)
Query: 49 LLGTGSFGIVYKGILSDGNN----VAIKVFKLQLGRAFRS-FDSECEVLRNVHHRNLLKI 103
+G G FG V++GI N VAIK K + R F E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ + +++EL G L ++L Y LD + + AL YL S
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKR 128
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
VH D+ N+L+ N ++ DFG+S+ + D + I +MAP S
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI------ 181
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVN-------ESL 276
+ ++ DV+ FGV + E + + N +
Sbjct: 182 -------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 277 PHALTDVV------DANLRVSMKDVAAKLKKI 302
P L ++ D + R ++ A+L I
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-44
Identities = 60/269 (22%), Positives = 107/269 (39%), Gaps = 37/269 (13%)
Query: 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFK---LQLGRAFRSFDSECEVLRNVHH 97
E F LG G FG VY +A+KV L+ E E+ ++ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
N+L+++ + L+LE P G++ L + F D + ++ AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
S ++H D+KP N+LL +++DFG S +T T+ Y+ P
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP--- 173
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISLKNWV 272
++++ + K D++S GVL E GK P E + ++
Sbjct: 174 --EMIE--------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 223
Query: 273 NESLPHALTDVV------DANLRVSMKDV 295
+ + D++ + + R +++V
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-44
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 33/288 (11%)
Query: 38 QRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG---RAFRSFDSECEVLR 93
++ E F +LG GSF V L+ AIK+ + + E +V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 94 NVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
+ H +K++ + + + L NG L ++ F D ++ ALE
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALE 122
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
YLH I+H DLKP NILL+E+M +++DFG +K+L + T Y++
Sbjct: 123 YLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISL 268
P ++L K+ D+++ G ++ + G P +F I L
Sbjct: 179 P-----ELLTEKS--------ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL 225
Query: 269 KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310
+ E D+V DA R+ +++ F V
Sbjct: 226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (383), Expect = 5e-44
Identities = 51/265 (19%), Positives = 97/265 (36%), Gaps = 38/265 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LGTG+FG+V++ + GNN A K + E + + + H L+ + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ + ++ E M G L + + + E + M V L ++H + VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHL 148
Query: 168 DLKPSNILL--DENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
DLKP NI+ + ++ DFG++ L + T T + AP
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAE------- 198
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---------TDEMFTGEISLKNWVNESL 276
+ D++S GVL +G P + + + ++ + +
Sbjct: 199 ------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 277 PHALTDVV------DANLRVSMKDV 295
D + D N R+++
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (378), Expect = 3e-43
Identities = 53/265 (20%), Positives = 104/265 (39%), Gaps = 38/265 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG+G+FG+V++ + + G K + +E ++ +HH L+ + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ L+LE + G L + + + +Y + E +N M L+++H IVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHL 151
Query: 168 DLKPSNILLDENMVARV--SDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
D+KP NI+ + + V DFG++ L E +T AT + AP +I+ +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP-----EIVDRE 203
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---------TDEMFTGEISLKNWVNESL 276
+ D+++ GVL +G P + + S+
Sbjct: 204 P--------VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 277 PHALTDVV------DANLRVSMKDV 295
D + + R+++ D
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 141 bits (356), Expect = 7e-41
Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 43/280 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGR---AFRSFDSECEVLRNVHHRNLLKIF 104
+LG G V+ L +VA+KV + L R + F E + ++H ++ ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 105 SSCSNPDFKA----LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+ +V+E + +L + +++ + + ++ D AL + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---- 128
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMA-TIGYMAPVSQLF 219
I+H D+KP+NI++ +V DFGI++ + D +SVTQT + T Y++P Q
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP-EQAR 187
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW-------- 271
+ A+ DVYS G +L E TG+ P ++ ++
Sbjct: 188 G------------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
Query: 272 -VNESLPHALTDVVDANLRV-------SMKDVAAKLKKIR 303
+E L L VV L + ++ A L ++
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-41
Identities = 51/265 (19%), Positives = 100/265 (37%), Gaps = 39/265 (14%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G FGIV++ + S K K++ G E +L HRN+L + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 108 SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHC 167
+ + ++ E + + + + + L+ E ++ + V AL++LH S I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHF 126
Query: 168 DLKPSNILLD--ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPK 225
D++P NI+ + ++ +FG ++ L G+ + Y AP
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH-------- 175
Query: 226 NAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---------TDEMFTGEISLKNWVNESL 276
++S D++S G L+ +G P + + E + + +
Sbjct: 176 -----QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 277 PHALTDVV------DANLRVSMKDV 295
D V + R++ +
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 56/290 (19%), Positives = 120/290 (41%), Gaps = 46/290 (15%)
Query: 42 EGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQLGRAFR-SFDSECEVLRN 94
E LG GSFG+VY+G+ VAIK R F +E V++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 95 VHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------LDTLERLNIM 145
+ +++++ S +++ELM G L+++L S + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 146 IDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT 205
++ + YL+ + VH DL N ++ E+ ++ DFG+++ + + +
Sbjct: 140 GEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 206 MATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGE 265
+ + +M+P + +G+ + DV+SFGV+L E T + + + E
Sbjct: 196 LLPVRWMSP-------------ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 266 ISLKNWVN-------ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
L+ + ++ P L +++ + +R S ++ + +K+
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 5e-40
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 28/253 (11%)
Query: 44 FNECNLLGTGSFGIVYKGILSD-GNNVAIKVFKL------QLGRAFRSFDSECEVLRNVH 96
F+ ++G G FG VY +D G A+K Q + ++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
++ + + PD + +L+LM G L L H F + + ++ L LE++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 124
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
+ +V+ DLKP+NILLDE+ R+SD G++ + ++ T GYMAP
Sbjct: 125 NRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 176
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNWVNESL 276
+ D +S G +L + G P + T + + + ++
Sbjct: 177 LQ------------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
Query: 277 PHALTDVVDANLR 289
L D LR
Sbjct: 225 AVELPDSFSPELR 237
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 138 bits (349), Expect = 8e-40
Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 41/280 (14%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAF---------RSFDSECEV 91
E + +LG G +V + I A+K+ + G +F + E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 92 LRNVH-HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWL 150
LR V H N++++ + F LV +LM G L ++L L E IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121
Query: 151 ALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIG 210
+ LH IVH DLKP NILLD++M +++DFG S L GE T
Sbjct: 122 VICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE---------M 261
Y+AP + + + + D++S GV++ G P +
Sbjct: 175 YLAPE-------IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 262 FTGEISLKNWVNESLPHALTDVV------DANLRVSMKDV 295
+G + + + D+V R + ++
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-39
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 55/293 (18%)
Query: 48 NLLGTGSFGIVYKGIL--------SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HH 97
LG G+FG V + VA+K+ K + SE E+++ + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYF---------------LDTLERL 142
+N++ + +C+ +++E G+L +L + L + + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 143 NIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQ 202
+ V +EYL S +H DL N+L+ E+ V +++DFG+++ + +
Sbjct: 139 SCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 203 TMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262
T + +MAP + + I + + DV+SFGVLL E FT
Sbjct: 195 TNGRLPVKWMAP-------------EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 263 TGEISLKNWVN-------ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302
E K + + L ++ + R + K + L +I
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 6e-39
Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 46/287 (16%)
Query: 29 WRRTSYLDIQRATEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFR-SFD 86
W++ DI+ + ++ ++LGTG+F V VAIK + S +
Sbjct: 1 WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 87 SECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMI 146
+E VL + H N++ + + L+++L+ G L + + F + ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114
Query: 147 DVWLALEYLHHGHSSAPIVHCDLKPSNILL---DENMVARVSDFGISKLLGDGEDSVTQT 203
V A++YLH IVH DLKP N+L DE+ +SDFG+SK+ G +
Sbjct: 115 QVLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLS 167
Query: 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT----- 258
T GY+AP ++ S D +S GV+ G P
Sbjct: 168 TACGTPGYVAPEVL-------------AQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
Query: 259 ----DEMFTGEISLKNWVNESLPHALTDVV------DANLRVSMKDV 295
+++ E + + + + D + D R + +
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-37
Identities = 58/262 (22%), Positives = 99/262 (37%), Gaps = 35/262 (13%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRS------FDSECEVLRNVH--HRN 99
LLG+G FG VY GI +SD VAIK + + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++++ PD L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 160 SSAPIVHCDLKPSNILLDEN-MVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
+ ++H D+K NIL+D N ++ DFG LL D T T Y P
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPP---- 178
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---TDEMFTGEISLKNWVNES 275
+ ++ V+S G+LL + G P +E+ G++ + V+
Sbjct: 179 -EWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 230
Query: 276 LPHALTD--VVDANLRVSMKDV 295
H + + + R + +++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (333), Expect = 6e-37
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 36/246 (14%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKI 103
LGTGSFG V+ +G A+KV K ++ + + E +L V H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 104 FSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP 163
+ + + ++++ + G L + + +V LALEYLH S
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLH----SKD 124
Query: 164 IVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILK 223
I++ DLKP NILLD+N +++DFG +K + D T Y+AP
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAP--------- 170
Query: 224 PKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM---------FTGEISLKNWVNE 274
+ S + D +SFG+L+ E G P + E+ + NE
Sbjct: 171 ----EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226
Query: 275 SLPHAL 280
+ L
Sbjct: 227 DVKDLL 232
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-36
Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 55/293 (18%)
Query: 48 NLLGTGSFGIVYKGI------LSDGNNVAIKVFKLQLGRA-FRSFDSECEVL-RNVHHRN 99
LG G+FG V + + VA+K+ K + R+ SE ++L HH N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 100 LLKIFSSCSNPDFK-ALVLELMPNGSLENWLYSHNY---------------FLDTLERLN 143
++ + +C+ P +++E G+L +L S FL +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 144 IMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQT 203
V +E+L S +H DL NILL E V ++ DFG+++ + D V +
Sbjct: 139 YSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 204 MTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFT 263
+ +MAP + + + + + DV+SFGVLL E F+
Sbjct: 195 DARLPLKWMAP-------------ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 264 GEISLKNWVNESLPHALTDVV--------------DANLRVSMKDVAAKLKKI 302
+ + E D + + R + ++ L +
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-36
Identities = 65/269 (24%), Positives = 101/269 (37%), Gaps = 36/269 (13%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFK---LQLGRAFRSFDSECEVL-RNVH 96
E F +LG GSFG V+ AIK K + + E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 97 HRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLH 156
H L +F + + V+E + G L + S + F D ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVS 216
IV+ DLK NILLD++ +++DFG+ K G+ T Y+AP
Sbjct: 121 SKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 174
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISLKNW 271
L + D +SFGVLL E G+ P +E+F +
Sbjct: 175 LL-------------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221
Query: 272 VNESLPHALTDVV------DANLRVSMKD 294
L D++ + R+ ++
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 44 FNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLK 102
+ + ++G GSFG+VY+ L G VAIK R + E +++R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 103 IFSSCSNPD------FKALVLELMPNGSLENWLY--SHNYFLDTLERLNIMIDVWLALEY 154
+ + + LVL+ +P + L + M ++ +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 155 LHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
+H S I H D+KP N+LLD + V ++ DFG +K L GE +V+ + Y A
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRA 190
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
P ++ DV+S G +L E G+
Sbjct: 191 PELIF------------GATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-36
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 48 NLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL-----GRAFRSFDSECEVLRNVHHRNLL 101
+ LG G F VYK + VAIK KL R+ E ++L+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ + + +LV + M + ++ L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 162 APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDI 221
I+H DLKP+N+LLDEN V +++DFG++K G T + T Y AP ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAP-----EL 171
Query: 222 LKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
L + D+++ G +L E
Sbjct: 172 LFGAR-------MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (314), Expect = 2e-34
Identities = 46/218 (21%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRN 99
E ++ +G G++G+VYK + G A+K +L+ + E +L+ + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
++K++ LV E + + L+ L L+++ + ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
++H DLKP N+L++ +++DFG+++ G T + T+ Y AP +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLM- 173
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
S D++S G + E G
Sbjct: 174 -----------GSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-34
Identities = 45/222 (20%), Positives = 84/222 (37%), Gaps = 21/222 (9%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFR-SFDSECEVLRNVHHR 98
+ + +G G++G+V + VAIK + + E ++L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYS--HNYFLDTLERLNIMIDVWLALEYLH 156
N++ I P + + + + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 157 HGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT-MATIGYMAPV 215
SA ++H DLKPSN+LL+ ++ DFG++++ D +AT Y AP
Sbjct: 127 ----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 216 SQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + D++S G +L E + +
Sbjct: 183 I------------MLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-34
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 21/219 (9%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHR 98
E F + +G G++G+VYK G VA+K +L + E +L+ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG 158
N++K+ + LV E + + S + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 159 HSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
S ++H DLKP N+L++ +++DFG+++ G + T + + Y AP L
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILL 175
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
S D++S G + E T +
Sbjct: 176 ------------GCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 55/276 (19%), Positives = 101/276 (36%), Gaps = 54/276 (19%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVL-RNVHHRNLLKIFSS 106
+LG G G V + A+K+ + E E+ R ++++I
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 107 CSNPDFKA----LVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSS 161
N +V+E + G L + + + E IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----S 129
Query: 162 APIVHCDLKPSNILLD---ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQL 218
I H D+KP N+L N + +++DFG +K + T T Y+AP
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP---- 182
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP---------TDEMFT----GE 265
++L P+ CD++S GV++ G P + M T G+
Sbjct: 183 -EVLGPEK--------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 266 ISLKNWVNESLPHALTDVV------DANLRVSMKDV 295
N + + ++ + R+++ +
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-34
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 37 IQRATEGFNECNLLGTGSFGIVYKG--ILSDGNNVAIKVFKLQLG--RAFRSFDSECEVL 92
+ RA + + +G G++G V+K + + G VA+K ++Q G S E VL
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 93 R---NVHHRNLLKIFSSCSNPDFKA-----LVLELMPNGSLENWLYSHNYFLDTLERLNI 144
R H N++++F C+ LV E + + T ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 145 MIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTM 204
M + L++LH S +VH DLKP NIL+ + +++DFG++++ + T
Sbjct: 122 MFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 174
Query: 205 TMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ T+ Y AP L + + D++S G + E F K
Sbjct: 175 VVVTLWYRAPEVLL-------------QSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 8e-33
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 47/273 (17%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL------GRAFRSFDSECEVLRNVHHRNLL 101
LG+G F +V K S G A K K + G + + E +L+ + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 102 KIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS 161
+ N L+LEL+ G L ++L + E + + + YLH S
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLH----S 131
Query: 162 APIVHCDLKPSNILLDENMVAR----VSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
I H DLKP NI+L + V + + DFG++ + G + T ++AP
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAP--- 185
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD---------EMFTGEISL 268
+I+ + + + D++S GV+ +G P +
Sbjct: 186 --EIVNYEP--------LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 269 KNWVNESLPHALTDVV------DANLRVSMKDV 295
++ + D + D R++++D
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-32
Identities = 44/227 (19%), Positives = 86/227 (37%), Gaps = 30/227 (13%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNL 100
+ + +G G+FG V+K G VA+K ++ + E ++L+ + H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 101 LKIFSSCSNPDFKA--------LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
+ + C LV + + F E +M + L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQMLLNGL 130
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMT--MATIG 210
Y+H I+H D+K +N+L+ + V +++DFG+++ ++S T + T+
Sbjct: 131 YYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 211 YMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
Y P L E D++ G ++ E +T
Sbjct: 187 YRPPELLL------------GERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-32
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 24/218 (11%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRA---FRSFDSECEVLRNVHHRN 99
F+ LLG G+FG V + G A+K+ + ++ A +E VL+N H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 100 LLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
L + + D V+E G L L F + ++ ALEYLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLH--- 122
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
S +V+ D+K N++LD++ +++DFG+ K D T T Y+AP
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVL-- 177
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ D + GV++ E G+ P
Sbjct: 178 -----------EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-31
Identities = 39/217 (17%), Positives = 84/217 (38%), Gaps = 22/217 (10%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNL 100
+ + +G G++G V+K VA+K +L S E +L+ + H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHS 160
+++ + LV E + + + + + + L + H +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHSRN- 121
Query: 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFD 220
++H DLKP N+L++ N ++++FG+++ G + + T+ Y P
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLF-- 174
Query: 221 ILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ S D++S G + E +P
Sbjct: 175 ----------GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 2e-30
Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 30/231 (12%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
+G+GSFG +Y G ++ G VAIK+ ++ E ++ + + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 108 -SNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
+ D+ +V+EL+ + + + F L + + +EY+H S +H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIH----SKNFIH 126
Query: 167 CDLKPSNIL---LDENMVARVSDFGISKLLGDGEDSVTQTMTMA-----TIGYMAPVSQL 218
D+KP N L + + + DFG++K D T Y + + L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 219 FDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269
S + D+ S G +LM G P + K
Sbjct: 187 -------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (287), Expect = 4e-30
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 32/262 (12%)
Query: 42 EGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHH 97
+ F+ LGTGSFG V GN+ A+K+ Q + +E +L+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
L+K+ S + +V+E + G + + L F + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
S +++ DLKP N+L+D+ +V+DFG +K + T +AP
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAP--- 207
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-----TDEMFTGEISLKNWV 272
+ + D ++ GVL+ E G P +++ +S K
Sbjct: 208 ----------EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 273 NESLPHALTDVVDANLRVSMKD 294
L D++ L+V +
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTK 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 113 bits (283), Expect = 4e-30
Identities = 42/233 (18%), Positives = 76/233 (32%), Gaps = 32/233 (13%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSS 106
+G GSFG++++G L + VAIK + E + + + ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 107 CSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVH 166
LV++L+ SLE+ L + ++ +H +V+
Sbjct: 70 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVY 124
Query: 167 CDLKPSNILLDENM-----VARVSDFGISKLLGDGEDSVTQTMTMA-----TIGYMAPVS 216
D+KP N L+ + V DFG+ K D T YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI-- 182
Query: 217 QLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269
+ + S + D+ + G + M G P + K
Sbjct: 183 ---NTHLGREQ--------SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (276), Expect = 8e-29
Identities = 47/239 (19%), Positives = 97/239 (40%), Gaps = 37/239 (15%)
Query: 30 RRTSYLDIQRATEGFNECN------LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAF 82
R Y D + + + LG G + V++ I +++ V +K+ K +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 76
Query: 83 RSFDSECEVLRNV-HHRNLLKIFSSCSNPDFK--ALVLELMPNGSLENWLYSHNYFLDTL 139
+ E ++L N+ N++ + +P + ALV E + N + + L
Sbjct: 77 K---REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDY 129
Query: 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGED 198
+ M ++ AL+Y H I+H D+KP N+++D E+ R+ D+G+++ G+
Sbjct: 130 DIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184
Query: 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ +A+ + P + + D++S G +L K+P
Sbjct: 185 --EYNVRVASRYFKGPELLV------------DYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-29
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 26/225 (11%)
Query: 42 EGFNECNLLGTGSFGIVYKGIL----SDGNNVAIKVFK----LQLGRAFRSFDSECEVLR 93
E F +LGTG++G V+ G A+KV K +Q + +E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 94 NV-HHRNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
++ L+ + + L+L+ + G L L F + E + ++ LAL
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-EVQIYVGEIVLAL 142
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYM 212
E+LH I++ D+K NILLD N ++DFG+SK E
Sbjct: 143 EHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 213 APVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ + G + D +S GVL+ E TG P
Sbjct: 199 PDIVR------------GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 5e-27
Identities = 41/220 (18%), Positives = 81/220 (36%), Gaps = 27/220 (12%)
Query: 44 FNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNL 100
+ + +G+G++G V + G VAIK + E +L+++ H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 101 LKIFSSCSNPDFKALVLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHH 157
+ + + + + + L ++ + L Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQ 217
I+H DLKP N+ ++E+ ++ DFG+++ T + T Y AP
Sbjct: 140 AG----IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVI 190
Query: 218 LFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
L + + D++S G ++ E TGK
Sbjct: 191 L------------NWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-25
Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 41 TEGFNECNLLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHH 97
E + + +G+G++G V G VA+K + E +L+++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 98 RNLLKIFSSCSNP----DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALE 153
N++ + + +F + L G+ N + D ++ + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135
Query: 154 YLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMA 213
Y+H I+H DLKPSN+ ++E+ ++ DFG+++ D T +AT Y A
Sbjct: 136 YIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRA 186
Query: 214 PVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
P L + + D++S G ++ E TG+
Sbjct: 187 PEIML------------NWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (244), Expect = 3e-24
Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 33/218 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFS 105
+G+G+ GIV NVAIK + E +++ V+H+N++ + +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 106 SCSNPDFK------ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH 159
+ LV+ELM LD ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 160 SSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLF 219
I+H DLKPSNI++ + ++ DFG+++ G T + T Y AP
Sbjct: 140 ----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP----- 187
Query: 220 DILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+ D++S G ++ E K
Sbjct: 188 --------EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.8 bits (242), Expect = 8e-24
Identities = 42/226 (18%), Positives = 81/226 (35%), Gaps = 34/226 (15%)
Query: 49 LLGTGSFGIVYKGI-LSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSC 107
LG G F V+ + + +VA+K+ + + + E ++L+ V+ + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 108 SNPDFK---------------ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLAL 152
+N K +V E++ L + + + I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 153 EYLHHGHSSAPIVHCDLKPSNILLD-ENMVARVSDFGISKLLGDGEDSVTQTMTMATIGY 211
+Y+H I+H D+KP N+L++ + + I+ L T ++ T Y
Sbjct: 139 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 212 MAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP 257
+P + D++S L+ E TG
Sbjct: 196 RSP-------------EVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.1 bits (189), Expect = 1e-17
Identities = 25/157 (15%), Positives = 45/157 (28%), Gaps = 19/157 (12%)
Query: 48 NLLGTGSFGIVYKGILSDGNNVAIKVFKLQL----------GRAFRSFDSECEVLRNVHH 97
L+G G V+ +K K+ F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHH 157
R L K+ + ++ +E Y + ++ + + +H
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVL----MELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 158 GHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194
IVH DL N+L+ E + + DF S +G
Sbjct: 122 RG----IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.85 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.04 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=373.17 Aligned_cols=247 Identities=21% Similarity=0.355 Sum_probs=201.9
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++++.||+|+||+||+|++ .+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46899999999999999999996 4799999999976532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+++|+|.+++.+.+ .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999997655 4899999999999999999999 89999999999999999999999999999987754433
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW------- 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~------- 271 (314)
........||+.|+|||++. ....++.++|||||||++|+|++|..||.............
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~------------~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLK------------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHH------------CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS
T ss_pred cccccceeeCcCccCHhHhc------------CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 33344467999999998864 22334678999999999999999999998755433322221
Q ss_pred -hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 272 -VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 -~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
....+++.+.+++ ||.+|||+.|+++ |+|++..
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hpwf~~~ 266 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK------DRWYNKP 266 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTTCC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhCcC
Confidence 1234565555554 9999999999865 7887643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=368.68 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=207.0
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
+.|++++.||+|+||+||+|++ .+++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5699999999999999999995 479999999998776666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++|+|.+++.+.+..+++..+..++.|++.||.||| ++|++||||||+|||++.++.+||+|||++....... .
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence 999999998776666999999999999999999999 8999999999999999999999999999987653221 1
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh--------h
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW--------V 272 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~--------~ 272 (314)
......||+.|+|||++.. .......++.++|||||||++|+|++|..||.+....+.-.... .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~--------~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMC--------ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTT--------CSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred cccccccccccCCHHHHhh--------cccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 1223569999999998753 23345678899999999999999999999998765544322111 1
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
+..+++.+++++ ||.+|||+.|+++ |+|+.
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~------hp~~~ 273 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ------HPFVT 273 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------SGGGC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccC
Confidence 234566666655 9999999999876 66664
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=363.77 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=200.1
Q ss_pred HHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
...++|++.+.||+|+||+||+|+++ ..||||+++... ....+.+.+|+.++++++||||+++++++.. +.+++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34688999999999999999999853 359999997542 3456788999999999999999999998765 567899
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++|+|.+++...+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999999877667999999999999999999999 899999999999999999999999999999876543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
..........||+.|+|||++.. .....++.++|||||||++|||++|..||.+..........
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~----------~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRM----------QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTT----------CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred CCcccccccccCcccCCHHHHhc----------ccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 33333344568999999998742 23446788999999999999999999999876543321111
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
..+..+++.+.+++ ||.+|||+.|+++.|+.+..
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12234566666665 99999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=364.61 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=203.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
.++|++++.||+|+||+||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999995 57999999999876555557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+++|+|.+++.+. .+++..+..++.|++.||+||| ++|++||||||+|||++.++.+||+|||++..+.....
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999999988764 3899999999999999999999 89999999999999999999999999999988754332
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--------h
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN--------W 271 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~--------~ 271 (314)
......||+.|+|||++. +..++.++|||||||++|+|++|..||............ .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~-------------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVT-------------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHS-------------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS
T ss_pred -cccccccCCCccChhhhc-------------CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 233456999999998763 456788999999999999999999999875543321111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
.+..+++.+++++ ||.+|||+.|+++ |+|++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------Hp~~~ 274 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ------HQFLK 274 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT------CGGGG
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc------CHhhC
Confidence 2344666666665 9999999999876 67764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=368.67 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=207.7
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++|++.+.||+|+||+||+|++ .+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999996 479999999998643 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++|+|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++..+....
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999887665 899999999999999999999 8999999999999999999999999999998875443
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----hh
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----WV 272 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~~ 272 (314)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||......+..... ..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~-------------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLT-------------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHH-------------TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred cccccccccCCccccCceeec-------------cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence 333334457999999998764 456788999999999999999999999875443322111 12
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
+..+++.+++++ ||.+|||++|++.......|+|+.+.
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 345666555555 99999999999888888889988764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=360.70 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=201.9
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++.+.||+|+||+||+|+++ +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999964 79999999997542 22346688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++|+|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 85 mEy~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EeecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999987654 899999999999999999999 899999999999999999999999999999766433
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
. .....||+.|+|||++. +..++.++|||||||++|+|++|..||......+..... .
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~-------------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 222 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIE-------------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222 (263)
T ss_dssp C----CEETTEEGGGCCHHHHT-------------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred c----ccccCCCCcccCHHHHc-------------CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2 23356999999998763 456788999999999999999999999875543321111 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
.+..+++.+++++ ||.+|||+.|+++ |+|+..
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~------hp~~~~ 260 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE------HPWITA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT------CHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc------CcCcCC
Confidence 2334566666655 9999999999987 666643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=352.03 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=194.3
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||+|+||.||+|++.+++.||||.++... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 36899999999999999999998888899999997653 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++|+|.+++......+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 999999999887777899999999999999999999 899999999999999999999999999999876543322
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhh------hhhh
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLK------NWVN 273 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~------~~~~ 273 (314)
......||+.|+|||++. +..++.++|||||||++|||++ |..||......+.... ...+
T Consensus 158 ~~~~~~gt~~y~aPE~l~-------------~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFS-------------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224 (263)
T ss_dssp -------CTTSCCHHHHT-------------TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC
T ss_pred eecceecCcccCChHHhc-------------CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 222346899999998763 4568889999999999999999 5666665443322111 1123
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
..+++.+.+++ ||.+|||++|++++|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 34555566655 99999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-51 Score=363.50 Aligned_cols=238 Identities=22% Similarity=0.341 Sum_probs=202.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
..++|++++.||+|+||.||+|+. .+|+.||+|+++.........+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457899999999999999999995 5799999999987765556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec--CCCcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD--ENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~--~~~~ikl~Dfg~~~~~~~~ 196 (314)
|+++|+|.+.+...+..+++..+..++.||+.||.||| ++|++||||||+|||++ .++.+||+|||++..+...
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999999988777767999999999999999999999 89999999999999997 6789999999999987654
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------ 270 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------ 270 (314)
. ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+....+.....
T Consensus 183 ~---~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 246 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIV-------------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246 (352)
T ss_dssp S---CEEEECSSGGGCCHHHH-------------TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC
T ss_pred C---ceeeccCcccccCHHHH-------------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 3 23345689999999776 3556788999999999999999999999876544321111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.....+++.+.+++ ||.+|||+.|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234555555555 9999999999977
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-51 Score=363.81 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=204.9
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
+.++|++.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999995 4799999999987765566788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec--CCCcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD--ENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~--~~~~ikl~Dfg~~~~~~~~ 196 (314)
|+++|+|.+++......+++..+..++.||+.||.||| ++|++||||||+||+++ .++.+||+|||++..+...
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999999766656999999999999999999999 89999999999999995 4678999999999887544
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK------- 269 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~------- 269 (314)
. ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+.-..
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~-------------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAE-------------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHH-------------TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred c---ccceecCcccccCHHHHc-------------CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 3 233456899999998763 45678899999999999999999999987554332111
Q ss_pred --hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 270 --NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 --~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
......+++.+++++ ||.+|||+.|+++ |+|+..
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~~~~ 285 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTP 285 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH------STTTSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCC
Confidence 112234566555554 9999999999987 566543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-51 Score=361.68 Aligned_cols=239 Identities=24% Similarity=0.336 Sum_probs=184.4
Q ss_pred HHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
+.+.+.|++.+.||+|+||+||+|+++ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456778999999999999999999954 799999999986532 233567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEec---CCCcEEEEeeeccee
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLD---ENMVARVSDFGISKL 192 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~---~~~~ikl~Dfg~~~~ 192 (314)
||||++|++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||++. .++.+||+|||++..
T Consensus 85 vmE~~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EECCCCSCBHHHHHHTCSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEeccCCCcHHHhhhcccC-CCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999999987654 899999999999999999999 89999999999999994 578999999999986
Q ss_pred cCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--
Q 047043 193 LGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-- 270 (314)
Q Consensus 193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-- 270 (314)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+.....
T Consensus 160 ~~~~~---~~~~~~GT~~y~APE~~~-------------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 160 EDPGS---VLSTACGTPGYVAPEVLA-------------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp ----------------CTTSCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred ccCCC---eeeeeeeCccccCcHHHc-------------CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 64332 223356999999998763 456788999999999999999999999875543322111
Q ss_pred -------hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 -------WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 -------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
...+.+++.+.+++ ||.+|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11234566556655 9999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=347.08 Aligned_cols=238 Identities=24% Similarity=0.371 Sum_probs=192.0
Q ss_pred cCc-cccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc----CCce
Q 047043 42 EGF-NECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN----PDFK 113 (314)
Q Consensus 42 ~~y-~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 113 (314)
++| +..+.||+|+||+||+|.+ .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 6677899999999999995 478999999987653 3445678899999999999999999999864 4568
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeecCCCCCceEec-CCCcEEEEeeecc
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAP--IVHCDLKPSNILLD-ENMVARVSDFGIS 190 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~--i~H~dlkp~Nili~-~~~~ikl~Dfg~~ 190 (314)
++||||+++|+|.+++.+.+. +++..+..++.|++.||+||| +++ ++||||||+|||++ .++.+||+|||++
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~gl~yLH----~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCcHHHHHhcccc-ccHHHHHHHHHHHHHHHHHHH----HCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999999987654 899999999999999999999 777 99999999999996 5789999999999
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||....+.......
T Consensus 163 ~~~~~~----~~~~~~GT~~Y~aPE~~~--------------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~ 224 (270)
T d1t4ha_ 163 TLKRAS----FAKAVIGTPEFMAPEMYE--------------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 224 (270)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGG--------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred eeccCC----ccCCcccCccccCHHHhC--------------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH
Confidence 754332 223457999999998753 24788999999999999999999999865443322111
Q ss_pred --------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 271 --------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 271 --------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
..+..+++.+++++ ||.+|||+.|+++ |+|++
T Consensus 225 i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~------Hp~fk 270 (270)
T d1t4ha_ 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQ 270 (270)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC
T ss_pred HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC------CcccC
Confidence 12233455555555 9999999999977 66653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=353.16 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=185.5
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc--CCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN--PDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 115 (314)
.++|++++.||+|+||+||+|+. .+|+.||+|.++... ....+.+.+|++++++++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999995 479999999997653 3345678899999999999999999998864 467899
Q ss_pred EEEecCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 116 VLELMPNGSLENWLYSH---NYFLDTLERLNIMIDVWLALEYLHHGH-SSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~---~~~~~~~~~~~i~~~l~~~l~~LH~~~-~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
||||+++|+|.+++.+. +..+++..++.++.|++.||.|||+.+ ..++++||||||+|||++.++.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 455899999999999999999999321 12349999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
.+..... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......+.....
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l-------------~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQM-------------NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp HC-------------CCCSCCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecccCCC--ccccCCCCcccCCHHHH-------------cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 7654322 22345689999999776 3456788999999999999999999999876544332111
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+..+++.+.+++ ||..|||+.|+++
T Consensus 228 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12344666666665 9999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-51 Score=357.16 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=207.8
Q ss_pred ceehhhHHHHhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc
Q 047043 31 RTSYLDIQRATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN 109 (314)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (314)
+++|+++....++|++.+.||+|+||+||+|.++ +++.||||+++... ...+.+.+|++++++++||||+++++++.+
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3455555666789999999999999999999964 68899999987653 334678999999999999999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 110 PDFKALVLELMPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
++..+++|||+++|+|.+++... ...+++..+..++.|++.||+||| ++|++||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999998754 455899999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
++........ .......|++.|+|||++. +..++.++|||||||++|||++|..||....+.....
T Consensus 161 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~-------------~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~ 226 (287)
T d1opja_ 161 LSRLMTGDTY-TAHAGAKFPIKWTAPESLA-------------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226 (287)
T ss_dssp CTTTCCSSSS-EEETTEEECGGGCCHHHHH-------------HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ceeecCCCCc-eeeccccccccccChHHHc-------------CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence 9987654322 2233345788999998764 3467889999999999999999776654332222111
Q ss_pred hh-------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 269 KN-------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 269 ~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.. ..+..+++.+.+++ ||.+|||+.++++.|+.+..+
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11 12235666666665 999999999999999877543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-51 Score=357.79 Aligned_cols=235 Identities=23% Similarity=0.283 Sum_probs=195.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (314)
+.|+.++.||+|+||+||+|++ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999995 578999999997653 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 118 ELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 118 e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
||+++|+|..++...+ .+++..+..++.|++.||.||| ++|++||||||+|||++.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999988876665554 4899999999999999999999 899999999999999999999999999999865332
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------- 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------- 270 (314)
....||+.|+|||++.. .....++.++|||||||++|+|++|..||......+.-...
T Consensus 169 -----~~~~GT~~Y~APE~~~~----------~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~ 233 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILA----------MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTT----------TTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred -----CccccCccccCHHHHhc----------cCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 23469999999998741 12346888999999999999999999999875543321111
Q ss_pred hhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 271 WVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 271 ~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
..+..+++.+++++ ||..|||+.|+++
T Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 12234566666665 9999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=345.80 Aligned_cols=243 Identities=27% Similarity=0.425 Sum_probs=205.7
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||+|+||+||+|++++++.||||.++.... ..+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 468999999999999999999988888999999987533 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++|+|.+++......+++..+..++.|+++||.||| ++|++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999999998877667899999999999999999999 899999999999999999999999999999876543322
Q ss_pred eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhh
Q 047043 201 TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVN 273 (314)
Q Consensus 201 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~ 273 (314)
......+|+.|+|||.+. +..++.++||||||+++|||++ |+.||......+..... ..+
T Consensus 157 ~~~~~~~t~~y~aPE~~~-------------~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p 223 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLM-------------YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223 (258)
T ss_dssp CCCCSCCCGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred eecccCCCCCcCCcHHhc-------------CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 233356899999998764 3457889999999999999998 89999987665543221 122
Q ss_pred ccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 274 ESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 274 ~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
..+++.+.+++ ||.+|||+.+++++|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 34455555555 999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=349.24 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=202.8
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc------HHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG------RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
+.++|++.+.||+|+||+||+|++ .+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 557899999999999999999995 5799999999976431 235678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC----cEEEEeee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----VARVSDFG 188 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----~ikl~Dfg 188 (314)
+|+||||+++|+|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++ .+||+|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhccccc-cchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999987654 899999999999999999999 89999999999999998776 59999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS- 267 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~- 267 (314)
++........ .....+|+.|+|||++. +..++.++|||||||++|+|++|..||.+....+..
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~-------------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 226 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVN-------------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHc-------------CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9987754332 23356899999997763 456788999999999999999999999875543321
Q ss_pred --------hhhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 268 --------LKNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 268 --------~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
......+.+++.+++++ ||.+|||+.|+++ |+|++.
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~~ 276 (293)
T d1jksa_ 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIKP 276 (293)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTCC
T ss_pred HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCC
Confidence 11223345666555555 9999999999987 677754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=362.24 Aligned_cols=199 Identities=26% Similarity=0.369 Sum_probs=175.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++++.||+|+||+||+|++ .+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999995 479999999998653 3344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSS-APIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~-~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+++|+|.+++.+.+. +++..+..++.|++.||.||| + +||+||||||+|||++.++.+||+|||++.......
T Consensus 85 y~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH----~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999987654 899999999999999999999 5 599999999999999999999999999998664321
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 160 ----~~~~~GT~~Y~APEvl~-------------~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQ-------------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----C---CCSSCCCCHHHHH-------------CSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----cccccCCccccCchHHc-------------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22357999999998764 456889999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.3e-50 Score=345.28 Aligned_cols=248 Identities=26% Similarity=0.350 Sum_probs=205.6
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc---------HHHHHHHHHHHHHHhCC-CCCcceeeccccc
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG---------RAFRSFDSECEVLRNVH-HRNLLKIFSSCSN 109 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 109 (314)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++.... .....+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999995 4799999999976431 12346788999999996 9999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
++..|+||||+++|+|.+++...+. +++..+..++.||+.||+||| ++|++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999987654 899999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
+........ .....||+.|.|||.+... +......++.++||||+||++|+|++|..||...........
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~-------~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECS-------MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHH-------HCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhcc-------ccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 988755332 2335689999999998643 223455678899999999999999999999987654432111
Q ss_pred ---------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 270 ---------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 ---------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
......+++.+++++ ||.+|||+.|+++ |+|++.
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~------h~~~~~ 275 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA------HPFFQQ 275 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT------SGGGCT
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc------CHHHHH
Confidence 112235666666665 9999999998865 777653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-50 Score=351.11 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=191.6
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC---eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN---NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||+||+|+++ +++ .||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 467888999999999999999964 443 58888876543 3455679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++|+|.+++......+++.++..++.|++.||+||| ++|++||||||+|||++.++.+||+|||++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999887667999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcce---eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh-
Q 047043 196 GEDSVT---QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 196 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~- 270 (314)
...... .....+|+.|+|||.+. +..++.++|||||||++|||++ |..||......+.....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~-------------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQ-------------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ---------------CGGGSCHHHHH-------------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCCcceeeecccccCCccccCHHHHh-------------cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 322211 11235788999997753 4567889999999999999998 89999876554432111
Q ss_pred -----hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 271 -----WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 271 -----~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
..+..+++.+.+++ ||.+|||+.++++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 12334566666665 9999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=352.33 Aligned_cols=237 Identities=24% Similarity=0.294 Sum_probs=199.2
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++++.||+|+||.||+|+. .+|+.||+|++++.. ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999995 579999999998652 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++|+|.+++.+.+. +++..+..++.|++.||+||| ++|++||||||+||+++.+|.+||+|||++......
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999987665 899999999999999999999 899999999999999999999999999999876433
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
.. .....+||+.|+|||++ .+..++.++|||||||++|+|++|..||......+..... .
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~-------------~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~ 223 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGG-------------SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred Cc--ccccceeCHHHhhhhhc-------------cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC
Confidence 22 23345799999999765 4567889999999999999999999999876544332211 1
Q ss_pred hhccCCchhhhhc------cccCCCC-----HHHHHH
Q 047043 272 VNESLPHALTDVV------DANLRVS-----MKDVAA 297 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~ 297 (314)
.+..+++.++++| ||.+|++ +.|+++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2344566666655 9999995 777776
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=351.45 Aligned_cols=237 Identities=21% Similarity=0.336 Sum_probs=199.8
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
+.++|++.+.||+|+||+||+|.++ +++.||+|+++.... ....+.+|+++++.++||||+++++++++.+.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5689999999999999999999964 789999999987643 33567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCC--CcEEEEeeecceecCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDEN--MVARVSDFGISKLLGDG 196 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~--~~ikl~Dfg~~~~~~~~ 196 (314)
|++|++|.+++...+..+++.++..++.||+.||+||| ++|++||||||+||+++.+ +.++|+|||++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999999877766999999999999999999999 8999999999999999754 48999999999876443
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh--------
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-------- 268 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-------- 268 (314)
. ......+|+.|+|||.. .+..++.++|||||||++|+|++|..||......+...
T Consensus 158 ~---~~~~~~~t~~y~ape~~-------------~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 221 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVH-------------QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp C---EEEEEESCGGGSCHHHH-------------TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred C---cccccccccccccchhc-------------cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 2 23345689999999765 45567889999999999999999999998765433211
Q ss_pred -hhhhhccCCchhhhhc------cccCCCCHHHHHH
Q 047043 269 -KNWVNESLPHALTDVV------DANLRVSMKDVAA 297 (314)
Q Consensus 269 -~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~ 297 (314)
.......+++.+++++ ||.+|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122235666556555 9999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-49 Score=348.14 Aligned_cols=240 Identities=28% Similarity=0.371 Sum_probs=199.8
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++++.||+|+||+||+|++ .+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 36799999999999999999995 579999999998643 23356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||++|++|..++..... +++..+..++.|++.||+||| ++|++||||||+||+++.+|.+||+|||++......
T Consensus 83 mE~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999998887665 789999999999999999999 999999999999999999999999999999876543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
. ....||+.|+|||++ .+..++.++|||||||++|+|++|..||......+..... .
T Consensus 158 ~-----~~~~Gt~~Y~APE~l-------------~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 219 (316)
T d1fota_ 158 T-----YTLCGTPDYIAPEVV-------------STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 219 (316)
T ss_dssp B-----CCCCSCTTTCCHHHH-------------TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred c-----ccccCcccccCHHHH-------------cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC
Confidence 2 235699999999776 3456788999999999999999999999876544332211 1
Q ss_pred hhccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 272 VNESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
.++.+++.+++++ ||.+|+ |++++++ |+|+++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~------Hp~f~~ 262 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN------HPWFKE 262 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT------SGGGSS
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc------Cccccc
Confidence 2334555555554 888885 8999876 555543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-49 Score=356.31 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=195.9
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc------HHHHHHHHHHHHHHhCCCCCcceeecccccCCce
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG------RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFK 113 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (314)
.++|++.+.||+|+||.||+|+. .+|+.||+|++..... .......+++.+++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999995 4799999999975421 1112223456677777899999999999999999
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceec
Q 047043 114 ALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLL 193 (314)
Q Consensus 114 ~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~ 193 (314)
|+||||+++|+|.+++.+... +++..+..++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++..+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999987654 899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-hh---
Q 047043 194 GDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS-LK--- 269 (314)
Q Consensus 194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~-~~--- 269 (314)
.... .....||+.|+|||++. .+..++.++|||||||++|+|++|..||......... ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~------------~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 221 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQ------------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHS------------TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS
T ss_pred CCCc----ccccccccccchhHHhh------------cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 5432 22346999999998764 3456788999999999999999999999865433221 11
Q ss_pred ----hhhhccCCchhhhhc------cccCCCC-----HHHHHHHHHhhhhheeee
Q 047043 270 ----NWVNESLPHALTDVV------DANLRVS-----MKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 270 ----~~~~~~~~~~l~~ll------dp~~Rpt-----~~~~~~~l~~~~~~~~~~ 309 (314)
...+..+++.++++| ||.+||| +.|+++ |+|+++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~------Hp~f~~ 270 (364)
T d1omwa3 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------SPFFRS 270 (364)
T ss_dssp SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT------SGGGTT
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc------CccccC
Confidence 112345666666665 9999999 688876 566554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=344.81 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=203.2
Q ss_pred hcCccccce-eeecCceEEEEEEeC---CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNL-LGTGSFGIVYKGILS---DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~-lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|.+.+. ||+|+||.||+|.++ ++..||||+++... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777774 999999999999853 34579999997654 3455789999999999999999999999875 45789
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++|+|.+++...+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++..+..
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999998776666999999999999999999999 89999999999999999999999999999988755
Q ss_pred CCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh---
Q 047043 196 GEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN--- 270 (314)
Q Consensus 196 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~--- 270 (314)
..... ......||+.|+|||++. ...++.++|||||||++|||++ |..||......+.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~ 228 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECIN-------------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred cccccccccccccCccccChHHHh-------------CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 43222 222345889999998764 3457889999999999999998 99999886654432111
Q ss_pred ---hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheee
Q 047043 271 ---WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLY 308 (314)
Q Consensus 271 ---~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~ 308 (314)
..++.+|+.+.+++ ||.+|||+.++.+.|+.....+..
T Consensus 229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 12345666666665 999999999999998877654433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=348.66 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=198.4
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCC-----eEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGN-----NVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPD 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~-----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||+||+|++. +++ .||+|.+.... ......+.+|+.+++++ +||||+++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 4578999999999999999999953 332 68999886543 23345788999999998 8999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCC
Q 047043 112 FKALVLELMPNGSLENWLYSHN----------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDL 169 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dl 169 (314)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++|++||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDl 190 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDL 190 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTC
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccC
Confidence 9999999999999999997643 23788899999999999999999 899999999
Q ss_pred CCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHH
Q 047043 170 KPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLM 249 (314)
Q Consensus 170 kp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~ 249 (314)
||+||+++.++.+||+|||++................||+.|+|||++. +..++.++|||||||++|
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------------~~~~~~~~DiwS~Gvil~ 257 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-------------EGIYTIKSDVWSYGILLW 257 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHH
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-------------CCCCCcceeccchhHHHH
Confidence 9999999999999999999998766554443444556899999998764 456788999999999999
Q ss_pred HHhc-CCCCCCccccchhhhhh-------hhhccCCchhhhhc------cccCCCCHHHHHHHHH
Q 047043 250 ETFT-GKKPTDEMFTGEISLKN-------WVNESLPHALTDVV------DANLRVSMKDVAAKLK 300 (314)
Q Consensus 250 ~ll~-g~~Pf~~~~~~~~~~~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~ 300 (314)
||++ |..||.+......-... ..+..+++.+.+++ ||..|||+.|++++|.
T Consensus 258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 258 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9998 89999876543321111 12345666666665 9999999999999885
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=343.74 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=197.4
Q ss_pred HhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
..++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 467899999999999999999998888899999997653 234678999999999999999999998765 557899999
Q ss_pred cCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++|+|.+++... +..+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999977543 234899999999999999999999 89999999999999999999999999999987754322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCC-CCCccccchhhhh------hh
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKK-PTDEMFTGEISLK------NW 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~-Pf~~~~~~~~~~~------~~ 271 (314)
.......+|+.|+|||++. ...++.++|||||||++|||++|.. ||......+.... ..
T Consensus 165 -~~~~~~~gt~~y~APE~~~-------------~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 165 -TAREGAKFPIKWTAPEAIN-------------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp -ECCTTCCCCTTTSCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred -ccccccCCcccccChHHHh-------------CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 2233456889999998764 3457889999999999999999655 4544333222111 11
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.+..+++.+.+++ ||.+|||+.++++.|+.+.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2345666666665 9999999999999888754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-49 Score=349.11 Aligned_cols=240 Identities=25% Similarity=0.306 Sum_probs=199.7
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
.++|++++.||+|+||.||+|++ .+|+.||+|+++... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 36899999999999999999995 479999999997642 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+.+|+|.+++.+.+. +++..+..++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++......
T Consensus 120 ~e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999987664 899999999999999999999 899999999999999999999999999999887543
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-----h
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-----W 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-----~ 271 (314)
. ....||+.|+|||++. +..++.++|||||||++|+|++|..||.+.......... .
T Consensus 195 ~-----~~~~Gt~~Y~APE~~~-------------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 256 (350)
T d1rdqe_ 195 T-----WTLCGTPEALAPEIIL-------------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256 (350)
T ss_dssp B-----CCCEECGGGCCHHHHT-------------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred c-----ccccCccccCCHHHHc-------------CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC
Confidence 2 2356999999998763 456788999999999999999999999875443321111 1
Q ss_pred hhccCCchhhhhc------cccCC-----CCHHHHHHHHHhhhhheeee
Q 047043 272 VNESLPHALTDVV------DANLR-----VSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~R-----pt~~~~~~~l~~~~~~~~~~ 309 (314)
.+..+++.+.+++ ||.+| ||+.|+++ |+|+++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~------Hp~f~~ 299 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN------HKWFAT 299 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT------SGGGTT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc------CccccC
Confidence 2234555555554 88888 48999876 666543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=343.36 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=193.6
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++++.||+|+||+||+|++ .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999995 5799999999976532 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCC
Q 047043 119 LMPNGSLENWL-YSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGE 197 (314)
Q Consensus 119 ~~~~~sL~~~i-~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~ 197 (314)
|+.+ ++.+++ ......+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965 555544 444556999999999999999999999 8999999999999999999999999999998764432
Q ss_pred CcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-------
Q 047043 198 DSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN------- 270 (314)
Q Consensus 198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~------- 270 (314)
. ......||+.|+|||.+. ....++.++|||||||++|+|++|..||.+....+.-...
T Consensus 157 ~--~~~~~~gt~~y~apE~~~------------~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILL------------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHT------------TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred c--cceeecccceeeehhhhc------------cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 2 223356999999998754 2344678999999999999999999999764432211100
Q ss_pred ---------------------------hhhccCCch----hhhhc--cccCCCCHHHHHHHHHhhhhheeeeec
Q 047043 271 ---------------------------WVNESLPHA----LTDVV--DANLRVSMKDVAAKLKKIRVKFLYDVA 311 (314)
Q Consensus 271 ---------------------------~~~~~~~~~----l~~ll--dp~~Rpt~~~~~~~l~~~~~~~~~~~~ 311 (314)
.....+++. ++.|+ ||.+|||+.|+++ |+|+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~------H~ff~~~~ 290 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA------HPFFQDVT 290 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGTTCC
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC------CHhhccCC
Confidence 001123343 44444 9999999999987 67776554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-48 Score=337.80 Aligned_cols=246 Identities=22% Similarity=0.403 Sum_probs=196.4
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCC----
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD---- 111 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 111 (314)
+.++|++.+.||+|+||.||+|++ .+|+.||+|+++... ......+.+|+++++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 457899999999999999999995 579999999997653 234567899999999999999999999987543
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..|+||||++|++|.+++...+. +++.++..++.|++.||+||| ++|++||||||+||+++.++..+++|||.+.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred eEEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhh
Confidence 47899999999999999877654 899999999999999999999 8999999999999999999999999999887
Q ss_pred ecCCCCCc-ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh
Q 047043 192 LLGDGEDS-VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN 270 (314)
Q Consensus 192 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~ 270 (314)
........ .......||+.|+|||++ .+..++.++|||||||++|+|++|..||......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-------------~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~ 226 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQA-------------RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226 (277)
T ss_dssp ECC----------------TTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred hhccccccccccccccCcccccCHHHH-------------cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 65433222 223345699999999876 3456788999999999999999999999876544432221
Q ss_pred ---------hhhccCCchhhhhc------cccCCC-CHHHHHHHHHhhh
Q 047043 271 ---------WVNESLPHALTDVV------DANLRV-SMKDVAAKLKKIR 303 (314)
Q Consensus 271 ---------~~~~~~~~~l~~ll------dp~~Rp-t~~~~~~~l~~~~ 303 (314)
...+.+|+.+.+++ ||.+|| +++++++.+.+++
T Consensus 227 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 12345666666665 999999 8999999888775
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=341.50 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=188.9
Q ss_pred cccceeeecCceEEEEEEe-CCCCeEEEEEeeecccH-----HHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 45 NECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGR-----AFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 45 ~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
|.++.||+|+||+||+|+. .+|+.||||+++..... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3468899999999999995 57999999999765321 12467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
|+.++++..+. ..+..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 81 FMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99876665554 44455899999999999999999999 89999999999999999999999999999987654322
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh--------
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN-------- 270 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~-------- 270 (314)
......||+.|+|||++. ....++.++|||||||++|+|++|..||......+.-...
T Consensus 156 --~~~~~~gt~~y~aPE~~~------------~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLF------------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHT------------TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred --cccceecChhhccHHHHc------------cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC
Confidence 223356899999998764 3445788999999999999999999999765432211000
Q ss_pred -------------------------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 271 -------------------------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 271 -------------------------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
...+.+++.+.+++ ||.+|||+.|+++ |+|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~------Hp~f~~~ 286 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK------MKYFSNR 286 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT------SGGGTSS
T ss_pred hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC------CHhhCCC
Confidence 01123344444444 9999999999976 7887754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=335.30 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=192.4
Q ss_pred hcCccccceeeecCceEEEEEEeC-C---CCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-D---GNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|++. + +..||+|.++... ......+.+|++++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 578999999999999999999853 2 3468888876543 3345678999999999999999999999964 67899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
||||+++|+|.+++......+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999998877767999999999999999999999 89999999999999999999999999999987644
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~---- 270 (314)
.... ......+|+.|+|||.+. +..++.++|||||||++|||++ |..||......+.....
T Consensus 161 ~~~~-~~~~~~gt~~y~apE~l~-------------~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 161 STYY-KASKGKLPIKWMAPESIN-------------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp -----------CCGGGCCHHHHH-------------HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred Ccce-eccceecCcccchhhHhc-------------cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 3222 223345789999997763 4567889999999999999998 89999876655432211
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
..++.+|+.+.+++ ||.+|||+.|+++.|+.+.++
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12345666666665 999999999999999988664
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=335.43 Aligned_cols=237 Identities=28% Similarity=0.425 Sum_probs=190.7
Q ss_pred ceeeecCceEEEEEEeC---CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEecCC
Q 047043 48 NLLGTGSFGIVYKGILS---DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELMPN 122 (314)
Q Consensus 48 ~~lg~G~~g~V~~a~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (314)
+.||+|+||+||+|.++ +++.||+|+++... ....+.+.+|++++++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999853 35689999997542 33456799999999999999999999999754 56899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcce-
Q 047043 123 GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVT- 201 (314)
Q Consensus 123 ~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~- 201 (314)
|+|.+++..... +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++..+........
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999987654 899999999999999999999 89999999999999999999999999999987754433222
Q ss_pred eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------hhhc
Q 047043 202 QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------WVNE 274 (314)
Q Consensus 202 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~~~~ 274 (314)
.....||+.|+|||.+. +..++.++|||||||++|||++ |..||.+....+..... ..+.
T Consensus 167 ~~~~~gt~~y~APE~l~-------------~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 233 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECIN-------------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233 (277)
T ss_dssp ----CCCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccCCCceecCchhhc-------------CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 22346899999998764 3457889999999999999998 89999876554332111 1234
Q ss_pred cCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 275 SLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 275 ~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
.+|+.+.+++ ||.+|||+.++.+.|+.+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 5666666665 9999999999988876653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=334.65 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=191.6
Q ss_pred hcCccccceeeecCceEEEEEEeCC-C----CeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccccCCcee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSD-G----NNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~-~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (314)
..+|+..+.||+|+||.||+|.++. + ..||||.++.... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 3578899999999999999999543 2 3699999876533 34457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecC
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLG 194 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~ 194 (314)
++|||+.++++.+.+......+++..+..++.|++.||+||| +++++||||||+|||++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999998877777999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCC-cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCC-CCccccchhhhhhh-
Q 047043 195 DGED-SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKP-TDEMFTGEISLKNW- 271 (314)
Q Consensus 195 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~P-f~~~~~~~~~~~~~- 271 (314)
.... ........||+.|+|||++. +..++.++|||||||++|||++|..| +......+. ....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~-------------~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-~~~i~ 227 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAIS-------------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-MKAIN 227 (283)
T ss_dssp ------------CCCGGGSCHHHHH-------------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHc-------------cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-HHHHh
Confidence 4322 11223345789999998763 45678899999999999999996555 444333222 1111
Q ss_pred ------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 272 ------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..+++.+.+++ ||.+|||+.|+++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2234555566665 99999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=339.91 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=195.6
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeeccc------HHHHHHHHHHHHHHhCC--CCCcceeecccccCC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLG------RAFRSFDSECEVLRNVH--HRNLLKIFSSCSNPD 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||+||+|++ .+|+.||+|+++.... .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999995 5799999999975421 11234668999999986 899999999999999
Q ss_pred ceeEEEEecCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-CCcEEEEeeec
Q 047043 112 FKALVLELMPN-GSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-NMVARVSDFGI 189 (314)
Q Consensus 112 ~~~lv~e~~~~-~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-~~~ikl~Dfg~ 189 (314)
..++|||++.+ +++.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~-l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECcccc
Confidence 99999999975 578888776554 899999999999999999999 899999999999999985 47999999999
Q ss_pred ceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh
Q 047043 190 SKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK 269 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~ 269 (314)
+....... .....||+.|+|||++.. ...++.++|||||||++|+|++|..||..... .....
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~------------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-i~~~~ 220 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRY------------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-IIRGQ 220 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHH------------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-HHHCC
T ss_pred ceeccccc----ccccccCCCcCCHHHHcC------------CCCCCcccccccceeeehhHhhCCCCCCCchH-Hhhcc
Confidence 98754332 233569999999988752 23346789999999999999999999986432 11112
Q ss_pred hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 270 NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 270 ~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
...+..+++.+++++ ||.+|||+.|+++ |+|+++.
T Consensus 221 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~------hp~~~~~ 261 (273)
T d1xwsa_ 221 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN------HPWMQDV 261 (273)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSSC
T ss_pred cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc------CHhhCCC
Confidence 223455666666655 9999999999976 7777654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=341.59 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=195.6
Q ss_pred cCccccceeeecCceEEEEEEeC-CCC----eEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeE
Q 047043 42 EGFNECNLLGTGSFGIVYKGILS-DGN----NVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (314)
++|++++.||+|+||+||+|.+. +|+ +||+|.++... ....+.+.+|++++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999954 555 58888876442 23457789999999999999999999999875 4567
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGD 195 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~ 195 (314)
++|++.+++|.+.+......+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 88999999999999888777999999999999999999999 89999999999999999999999999999987755
Q ss_pred CCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh----
Q 047043 196 GEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN---- 270 (314)
Q Consensus 196 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~---- 270 (314)
...........||+.|+|||++. +..++.++|||||||++|||++ |..||+.....+.....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~-------------~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESIL-------------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred ccccccccccccCccccChHHHh-------------cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 44333333446899999998764 4467889999999999999998 89999876554432111
Q ss_pred --hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 271 --WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 271 --~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
..++.+++.+.+++ ||.+|||+.|+++++..+..
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 12334566666665 99999999999999887753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=342.17 Aligned_cols=236 Identities=27% Similarity=0.352 Sum_probs=193.4
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc---cHHHHHHHHHHHHHH-hCCCCCcceeecccccCCceeEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL---GRAFRSFDSECEVLR-NVHHRNLLKIFSSCSNPDFKALV 116 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 116 (314)
++|++.+.||+|+||+||+|++ .+++.||+|++++.. ......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999995 479999999998642 223345566666665 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCC
Q 047043 117 LELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDG 196 (314)
Q Consensus 117 ~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~ 196 (314)
|||+++|+|.+++...+. +++..+..++.|++.||+||| ++|++||||||+|||++.++.+||+|||++......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999987654 899999999999999999999 899999999999999999999999999999866433
Q ss_pred CCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhhh-----
Q 047043 197 EDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKNW----- 271 (314)
Q Consensus 197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~~----- 271 (314)
.. ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+...........
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~ 221 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAPEIL-------------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221 (320)
T ss_dssp TC--CBCCCCSCGGGCCHHHH-------------TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cc--cccccCCCCCcCCHHHH-------------cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 22 23345699999999776 35568899999999999999999999998765444322111
Q ss_pred hhccCCchhhhhc------cccCCCCHH-HHHH
Q 047043 272 VNESLPHALTDVV------DANLRVSMK-DVAA 297 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~-~~~~ 297 (314)
.+..+++.+.+++ ||.+||++. ++++
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1234556555554 999999985 6654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-48 Score=339.14 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=204.6
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeeccc-HHHHHHHHHHHHHHhCCCCCcceeecccc
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQLG-RAFRSFDSECEVLRNVHHRNLLKIFSSCS 108 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (314)
+++-..++|++.+.||+|+||+||+|+++ +++.||||+++.... .....+.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445788999999999999999999853 356899999976543 34567899999999999999999999999
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHN-----------------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIV 165 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~ 165 (314)
+.+..+++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~iv 162 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFV 162 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeE
Confidence 9999999999999999999997532 23788899999999999999999 89999
Q ss_pred ecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhh
Q 047043 166 HCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFG 245 (314)
Q Consensus 166 H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG 245 (314)
||||||+||+++.++.+||+|||++................+|+.|+|||.+. +..++.++||||||
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------~~~~t~ksDVwS~G 229 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------------YNRYTTESDVWAYG 229 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-------------HCCCCHHHHHHHHH
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-------------cCCCChhhhhccch
Confidence 99999999999999999999999998665443333344456889999998764 45688999999999
Q ss_pred HHHHHHhcCC-CCCCccccchhhhhhh------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 246 VLLMETFTGK-KPTDEMFTGEISLKNW------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 246 ~il~~ll~g~-~Pf~~~~~~~~~~~~~------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
|++|||++|. .||......+...... .+..+++.+.+++ ||.+|||+.++++.|+++.
T Consensus 230 vvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999985 6787765544322111 2335566666665 9999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=341.34 Aligned_cols=234 Identities=21% Similarity=0.313 Sum_probs=190.0
Q ss_pred HhcCccccc-eeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhC-CCCCcceeeccccc----CCc
Q 047043 40 ATEGFNECN-LLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN----PDF 112 (314)
Q Consensus 40 ~~~~y~~~~-~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 112 (314)
+.++|+++. .||+|+||.||+|++ .+++.||||+++.. ..+.+|+.++.++ +||||+++++++++ .+.
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 568999986 599999999999995 57999999999754 4567789887655 89999999999865 467
Q ss_pred eeEEEEecCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcEEEEeee
Q 047043 113 KALVLELMPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVARVSDFG 188 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~ikl~Dfg 188 (314)
+|+|||||+||+|.+++.+.+ ..+++.++..++.|++.||+||| ++|++||||||+||+++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccc
Confidence 899999999999999998653 45899999999999999999999 899999999999999975 4579999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-- 266 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-- 266 (314)
++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+......
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~-------------~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~ 223 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVL-------------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCC-------------CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----
T ss_pred eeeeccCCCc---cccccCCcccCCcHHH-------------cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH
Confidence 9987754332 2345699999999765 455678899999999999999999999976432211
Q ss_pred -----------hhhhhhhccCCchhhhhc------cccCCCCHHHHHHH
Q 047043 267 -----------SLKNWVNESLPHALTDVV------DANLRVSMKDVAAK 298 (314)
Q Consensus 267 -----------~~~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~ 298 (314)
.+.......+++.+.+++ ||.+|||+.|++++
T Consensus 224 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 224 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111122234566555554 99999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.8e-48 Score=335.12 Aligned_cols=202 Identities=22% Similarity=0.382 Sum_probs=170.5
Q ss_pred cCccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc--HHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEe
Q 047043 42 EGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG--RAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLEL 119 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (314)
++|++++.||+|+||+||+|++++|+.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999988999999999976532 2246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 120 MPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 120 ~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
+.++.+.. +......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHH-HHhhcCCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 97654444 4444455999999999999999999999 89999999999999999999999999999987654322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
......+++.|.|||.+. ....++.++|||||||++|+|++|..||....
T Consensus 156 -~~~~~~~~~~y~~pE~~~------------~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLM------------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp -------CCCTTCCHHHHT------------TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccceecccchhhhHHHHh------------CCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 223346899999998764 34567889999999999999999999997654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=335.03 Aligned_cols=244 Identities=28% Similarity=0.430 Sum_probs=192.3
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEEec
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLELM 120 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (314)
.++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 578999999999999999999987778899999976532 34678999999999999999999999865 5678999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCc
Q 047043 121 PNGSLENWLYSH-NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDS 199 (314)
Q Consensus 121 ~~~sL~~~i~~~-~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~ 199 (314)
++|+|..++... ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999988653 345899999999999999999999 89999999999999999999999999999987643322
Q ss_pred ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCC-Cccccchhhh------hhhh
Q 047043 200 VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPT-DEMFTGEISL------KNWV 272 (314)
Q Consensus 200 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf-~~~~~~~~~~------~~~~ 272 (314)
.......+|+.|+|||.+. .+.++.++|||||||++|||++|..|+ ......+... ....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~-------------~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~ 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAAL-------------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235 (285)
T ss_dssp -------CCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred eeeccccccccccChHHHh-------------CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 2233356899999997764 455788999999999999999966554 4433222111 1123
Q ss_pred hccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 273 NESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 273 ~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
+..+++.+++++ ||..||++.++++.|+.+..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 455666666665 99999999999998877553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=333.08 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=191.6
Q ss_pred HhcCccccceeeecCceEEEEEEeC--CCC--eEEEEEeeecc---cHHHHHHHHHHHHHHhCCCCCcceeecccccCCc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS--DGN--NVAIKVFKLQL---GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDF 112 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~--~~~--~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|++. +++ .||||+++... ....+.+.+|+.++++++||||+++++++.++ .
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence 3578999999999999999999842 233 68999987642 34457889999999999999999999999764 6
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.++||||++++++.+.+......+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 78999999999999988876666999999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCCcce-eecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh
Q 047043 193 LGDGEDSVT-QTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN 270 (314)
Q Consensus 193 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~ 270 (314)
......... .....+|..|+|||.+. +..++.++||||||+++|||++ |..||.+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-------------~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i 227 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLK-------------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHH-------------HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHh-------------CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence 755433222 22345788899998764 4457888999999999999998 89999876554432111
Q ss_pred -------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhh
Q 047043 271 -------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKI 302 (314)
Q Consensus 271 -------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~ 302 (314)
..++.+|+.+.+++ ||.+|||+.++.+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12345666666666 999999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=330.68 Aligned_cols=239 Identities=31% Similarity=0.459 Sum_probs=191.3
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc-CCceeEEEEe
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-PDFKALVLEL 119 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 119 (314)
.++|++.+.||+|+||.||+|++ .|..||+|.++.+. ..+.+.+|++++++++||||+++++++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46899999999999999999998 57789999997653 34678999999999999999999998854 5678999999
Q ss_pred cCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 120 MPNGSLENWLYSHN-YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 120 ~~~~sL~~~i~~~~-~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
+++|+|.+++.+.+ ..+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999997643 34899999999999999999999 899999999999999999999999999998865432
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-CCCCCCccccchhhhhh------h
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT-GKKPTDEMFTGEISLKN------W 271 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~-g~~Pf~~~~~~~~~~~~------~ 271 (314)
.....+|..|+|||.+. +..++.++||||||+++|||++ |..||......+..... .
T Consensus 157 ---~~~~~~~~~y~aPE~l~-------------~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~ 220 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALR-------------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 220 (262)
T ss_dssp --------CCTTTSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred ---CccccccccCCChHHHh-------------CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 22345788999998763 3467889999999999999998 78888876554432211 1
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.+..+++.+++++ ||.+|||+.+++++|+.++.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2344555666665 99999999999999998865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=332.12 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=211.5
Q ss_pred CcccceehhhHHH-HhcCccccceeeecCceEEEEEEe------CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CC
Q 047043 27 ATWRRTSYLDIQR-ATEGFNECNLLGTGSFGIVYKGIL------SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HH 97 (314)
Q Consensus 27 ~~~~~~~~~~~~~-~~~~y~~~~~lg~G~~g~V~~a~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h 97 (314)
+.+++.+|+.-+. ..++|++.+.||+|+||.||+|++ .+++.||||.++... ......+.+|+.+++.+ +|
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~H 86 (311)
T d1t46a_ 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86 (311)
T ss_dssp CCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred eCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCC
Confidence 3455666666554 468999999999999999999984 235689999997654 33456788999999999 69
Q ss_pred CCcceeecccccCCceeEEEEecCCCCHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047043 98 RNLLKIFSSCSNPDFKALVLELMPNGSLENWLYSHN-----------------YFLDTLERLNIMIDVWLALEYLHHGHS 160 (314)
Q Consensus 98 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~-----------------~~~~~~~~~~i~~~l~~~l~~LH~~~~ 160 (314)
|||+++++++.+++..+++|||+++|+|.+++.... ..+++..+..++.|++.||+|||
T Consensus 87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---- 162 (311)
T d1t46a_ 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---- 162 (311)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----
T ss_pred CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----
Confidence 999999999999999999999999999999987642 24889999999999999999999
Q ss_pred CCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccc
Q 047043 161 SAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCD 240 (314)
Q Consensus 161 ~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~D 240 (314)
++|++||||||+||+++.++.++++|||.+................||+.|+|||.+. ...++.++|
T Consensus 163 ~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------------~~~~~~~~D 229 (311)
T d1t46a_ 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------------NCVYTFESD 229 (311)
T ss_dssp HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-------------HCCCCHHHH
T ss_pred hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-------------CCCCCCccc
Confidence 8999999999999999999999999999998776554444445567899999997763 456788999
Q ss_pred eehhhHHHHHHhc-CCCCCCccccchhhhhh-------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhh
Q 047043 241 VYSFGVLLMETFT-GKKPTDEMFTGEISLKN-------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 241 v~slG~il~~ll~-g~~Pf~~~~~~~~~~~~-------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
||||||++|+|++ |..||......+.-... ..+..+++.+.+++ ||.+|||+.++++.|+++..+
T Consensus 230 IwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9999999999998 55666554443321111 12234566666665 999999999999999876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=328.90 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=189.3
Q ss_pred HhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeeccccc-C
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSN-P 110 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 110 (314)
..++|++.+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|...+.++ +|+||+.+++++.. .
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 4578999999999999999999842 24579999987543 23456677788888777 68999999998765 4
Q ss_pred CceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceE
Q 047043 111 DFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNIL 175 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nil 175 (314)
+.++++|||+++|+|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNIL 166 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCcccee
Confidence 57899999999999999997542 24789999999999999999999 899999999999999
Q ss_pred ecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC-
Q 047043 176 LDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG- 254 (314)
Q Consensus 176 i~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g- 254 (314)
++.++.+||+|||++................||+.|+|||.+. +..++.++|||||||++|||++|
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-------------~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------------DRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh-------------cCCCCcccceeehHHHHHHHHhCC
Confidence 9999999999999998765544333334456999999998764 45678899999999999999986
Q ss_pred CCCCCccccchhhhhhh-------hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 255 KKPTDEMFTGEISLKNW-------VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 255 ~~Pf~~~~~~~~~~~~~-------~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
..||........-.... .+..+++.+.+++ ||.+|||+.|++++|+.+.+
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 56787654433211111 2234555555555 99999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=329.78 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=198.9
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CC-------CeEEEEEeeeccc-HHHHHHHHHHHHHHhC-CCCCcceeeccccc
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DG-------NNVAIKVFKLQLG-RAFRSFDSECEVLRNV-HHRNLLKIFSSCSN 109 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~-------~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|+.. ++ ..||+|.++.... .....+.+|...+.++ +||||+++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4679999999999999999999842 22 3699999977653 3457788899999888 79999999999999
Q ss_pred CCceeEEEEecCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCce
Q 047043 110 PDFKALVLELMPNGSLENWLYSHN---------------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNI 174 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Ni 174 (314)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeecccce
Confidence 999999999999999999997543 34899999999999999999999 89999999999999
Q ss_pred EecCCCcEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhc-
Q 047043 175 LLDENMVARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFT- 253 (314)
Q Consensus 175 li~~~~~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~- 253 (314)
|++.++.+||+|||++................+|+.|+|||.+. +..++.++||||||+++|+|++
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-------------~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------------DRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-------------CCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999998776544433344456899999998764 4568899999999999999998
Q ss_pred CCCCCCccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhh
Q 047043 254 GKKPTDEMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIR 303 (314)
Q Consensus 254 g~~Pf~~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~ 303 (314)
|..||............ ..+..+++.+.+++ ||..|||+.|+++.|+.+.
T Consensus 234 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 234 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 78999876544331111 12334566666666 9999999999999998774
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=331.74 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=207.9
Q ss_pred HHhcCccccceeeecCceEEEEEEeC------CCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGILS------DGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD 111 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||+|.++ +++.||||.++... ......+.+|+.++++++||||+++++++...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34689999999999999999999852 35789999997543 234456889999999999999999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcE
Q 047043 112 FKALVLELMPNGSLENWLYSHN---------YFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVA 182 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~i 182 (314)
..++||||+++|+|.+++.... ..+++..+.+++.|++.||.||| +++++||||||+|||++.++.+
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceE
Confidence 9999999999999999986531 23688899999999999999999 8999999999999999999999
Q ss_pred EEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcC-CCCCCcc
Q 047043 183 RVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTG-KKPTDEM 261 (314)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g-~~Pf~~~ 261 (314)
||+|||++................+|+.|+|||.+. +..++.++||||||+++|||++| ..||...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-------------~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-------------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHc-------------cCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 999999998765544333334456899999997764 45677899999999999999997 5788776
Q ss_pred ccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeee
Q 047043 262 FTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 262 ~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~ 309 (314)
...+..... ..+..+++.+.+++ ||.+|||+.++++.|++..++.+++
T Consensus 240 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 240 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 544332111 12344566666665 9999999999999999998887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=325.24 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=197.2
Q ss_pred cceeeecCceEEEEEEeCC--C--CeEEEEEeeec-ccHHHHHHHHHHHHHHhCCCCCcceeeccccc-CCceeEEEEec
Q 047043 47 CNLLGTGSFGIVYKGILSD--G--NNVAIKVFKLQ-LGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-PDFKALVLELM 120 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~--~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 120 (314)
.+.||+|+||+||+|.+.. + ..||||.++.. .......+.+|++++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999532 2 26899998753 34456789999999999999999999999765 56889999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCCcc
Q 047043 121 PNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGEDSV 200 (314)
Q Consensus 121 ~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~~~ 200 (314)
++++|.+++.......++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||++..........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999877766888899999999999999999 8999999999999999999999999999998765432221
Q ss_pred --eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhh-------hh
Q 047043 201 --TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLK-------NW 271 (314)
Q Consensus 201 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~-------~~ 271 (314)
......||+.|+|||.+. ...++.++||||||+++|||++|..||........... ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~-------------~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~ 254 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQ-------------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHH-------------HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred ceecccccccccccChHHHh-------------cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 122345899999997763 45678899999999999999998887765332211111 11
Q ss_pred hhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 272 VNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 272 ~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.+..+++.+.+++ ||.+||++.|++++|+.+...+..+.
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 2344556666665 99999999999999999998877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=326.50 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=187.5
Q ss_pred hcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHH--HHHHHHhCCCCCcceeecccccCC----cee
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDS--ECEVLRNVHHRNLLKIFSSCSNPD----FKA 114 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 114 (314)
.++|.+.+.||+|+||.||+|+. +|+.||||.++.... ..... |+..+.+++||||+++++++.+.+ .++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 46788899999999999999996 688999999976532 33333 444445679999999999987543 578
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG----HSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~----~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+||||+++|+|.+++.+.. +++.....++.|++.||+|||+. ...+|++||||||+||+++.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999998754 88999999999999999999931 01369999999999999999999999999999
Q ss_pred eecCCCCCcc--eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchh--
Q 047043 191 KLLGDGEDSV--TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEI-- 266 (314)
Q Consensus 191 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~-- 266 (314)
.......... ......||+.|+|||++... .......++.++|||||||++|||++|..||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS-------INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTC-------SCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred ccccCCCcceeccccceecccCcCChhhcccc-------ccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 8775433221 22345699999999986521 111233467899999999999999999888753221110
Q ss_pred -----------hhhh-hh----hccCC---------chhhhh----c--cccCCCCHHHHHHHHHhhhhh
Q 047043 267 -----------SLKN-WV----NESLP---------HALTDV----V--DANLRVSMKDVAAKLKKIRVK 305 (314)
Q Consensus 267 -----------~~~~-~~----~~~~~---------~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~ 305 (314)
.... .. .+.++ ..+.++ + ||.+|||+.|+++.|+++..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0000 00 01111 123333 3 999999999999999988754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=328.57 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=190.8
Q ss_pred hcCccccceeeecCceEEEEEEe-CC-CCeEEEEEeeecccH--HHHHHHHHHHHHHhC---CCCCcceeecccc-----
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SD-GNNVAIKVFKLQLGR--AFRSFDSECEVLRNV---HHRNLLKIFSSCS----- 108 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~-~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~----- 108 (314)
.++|++++.||+|+||+||+|++ ++ ++.||||+++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999996 45 567999999765321 223456677777665 7999999999884
Q ss_pred cCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 109 NPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 109 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
.....+++||++.++++..........+++..+..++.|++.||+||| ++|++||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 345788999999887766665556666899999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL 268 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~ 268 (314)
++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||......+.-.
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~-------------~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLL-------------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHT-------------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred hhhhhcccc---cCCCcccChhhcCcchhc-------------CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 987653322 233457999999997763 4568889999999999999999999998654322110
Q ss_pred hh--------------------------------hhhccCCchhhhh----c--cccCCCCHHHHHHHHHhhhhheeeee
Q 047043 269 KN--------------------------------WVNESLPHALTDV----V--DANLRVSMKDVAAKLKKIRVKFLYDV 310 (314)
Q Consensus 269 ~~--------------------------------~~~~~~~~~l~~l----l--dp~~Rpt~~~~~~~l~~~~~~~~~~~ 310 (314)
.. .....+++.+.++ + ||.+|||+.|+++ |+|+++.
T Consensus 226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~------Hpff~~i 299 (305)
T d1blxa_ 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQDL 299 (305)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGTTC
T ss_pred HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------ChhhcCc
Confidence 00 0112344444444 4 9999999999877 7787665
Q ss_pred c
Q 047043 311 A 311 (314)
Q Consensus 311 ~ 311 (314)
.
T Consensus 300 ~ 300 (305)
T d1blxa_ 300 E 300 (305)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=330.55 Aligned_cols=206 Identities=23% Similarity=0.329 Sum_probs=168.9
Q ss_pred HHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc-cHHHHHHHHHHHHHHhCCCCCcceeecccccCC----c
Q 047043 39 RATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL-GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD----F 112 (314)
Q Consensus 39 ~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 112 (314)
.+.++|++++.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3457899999999999999999995 589999999997653 344567889999999999999999999986543 2
Q ss_pred eeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeeccee
Q 047043 113 KALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKL 192 (314)
Q Consensus 113 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~ 192 (314)
.+++++++.+++|.+++...+ +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++..
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 345556677899999997653 899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcc-eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 193 LGDGEDSV-TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 193 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
........ ......||+.|+|||++. ....++.++||||+||++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~------------~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIML------------NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTT------------TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCccceeeccccccceechHHHhh------------cCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 64432221 123456899999998764 34456789999999999999999999997643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=331.47 Aligned_cols=201 Identities=23% Similarity=0.329 Sum_probs=166.6
Q ss_pred HHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCC---
Q 047043 38 QRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPD--- 111 (314)
Q Consensus 38 ~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 111 (314)
+...++|++++.||+|+||+||+|.+ .+|+.||||+++... ....+.+.+|+++|+.++||||+++++++...+
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 34678999999999999999999995 579999999997543 234567889999999999999999999987654
Q ss_pred ---ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeee
Q 047043 112 ---FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFG 188 (314)
Q Consensus 112 ---~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg 188 (314)
.+++||||+ +.+|..++... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhccccccccccccc
Confidence 579999999 56788777554 3899999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 189 ISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
++....... ....+|+.|+|||.+. ....++.++|||||||++|+|++|..||....
T Consensus 167 ~a~~~~~~~-----~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 167 LARQADSEM-----TGYVVTRWYRAPEVIL------------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp TCEECCSSC-----CSSCSCGGGCCTHHHH------------TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceeccCCcc-----ccccccccccCHHHHc------------CCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 998765432 3356899999998764 23456889999999999999999999997643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=326.96 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=197.2
Q ss_pred hcCccccceeeecCceEEEEEEeC-CCC--eEEEEEeeecc-cHHHHHHHHHHHHHHhC-CCCCcceeecccccCCceeE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGILS-DGN--NVAIKVFKLQL-GRAFRSFDSECEVLRNV-HHRNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~~-~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (314)
.++|++.+.||+|+||.||+|.++ +|. .||||.++... ....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 478999999999999999999954 555 46777765432 33456789999999998 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC
Q 047043 116 VLELMPNGSLENWLYSH---------------NYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM 180 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~---------------~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~ 180 (314)
||||+++|+|.+++... ...+++..+..++.|++.||.||| ++|++||||||+|||++.++
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGG
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCC
Confidence 99999999999998653 345899999999999999999999 89999999999999999999
Q ss_pred cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCC-CCCC
Q 047043 181 VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGK-KPTD 259 (314)
Q Consensus 181 ~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~-~Pf~ 259 (314)
.+||+|||++........ .....+|..|+|||.+. ...++.++|||||||++|||++|. .||.
T Consensus 165 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-------------~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLN-------------YSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CEEECCTTCEESSCEECC---C----CCTTTCCHHHHH-------------HCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ceEEcccccccccccccc---ccceecCCcccchHHhc-------------cCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 999999999876533221 22345889999998764 456788999999999999999965 5787
Q ss_pred ccccchhhhhh------hhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhee
Q 047043 260 EMFTGEISLKN------WVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKFL 307 (314)
Q Consensus 260 ~~~~~~~~~~~------~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~~ 307 (314)
.....+..... ..+..+++.+.+++ ||.+|||+.+++++|+++.++..
T Consensus 229 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 65544432111 11234566666665 99999999999999999886544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=324.07 Aligned_cols=205 Identities=21% Similarity=0.316 Sum_probs=166.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeeccccc--------
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSN-------- 109 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 109 (314)
.++|++++.||+|+||+||+|++ .+|+.||||++.... ......+.+|+.+++.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 68999999999999999999995 589999999986553 2234567899999999999999999998754
Q ss_pred CCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeec
Q 047043 110 PDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGI 189 (314)
Q Consensus 110 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~ 189 (314)
.+..+++||++.++.+ .........+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~-~~~~~~~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHH-HHHTCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCcc-chhhhcccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecce
Confidence 4568899999976544 444444556899999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCc--ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 190 SKLLGDGEDS--VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 190 ~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
+......... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~------------~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLL------------GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHT------------TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecccccccccccccceecCHHHhhHHHHc------------CCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 9876543221 1223356899999998764 23457889999999999999999999997644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=317.53 Aligned_cols=200 Identities=21% Similarity=0.337 Sum_probs=172.1
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccCCceeEEEE
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (314)
++|++++.||+|+||+||+|++ .+++.||||+++... ......+.+|+.+++.++||||+++++++.+.+..+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999995 579999999997653 2346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecceecCCCCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISKLLGDGED 198 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~~~~~~~~ 198 (314)
++.++++..++...+ .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 998888877766554 4899999999999999999999 89999999999999999999999999999987754332
Q ss_pred cceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCc
Q 047043 199 SVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDE 260 (314)
Q Consensus 199 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~ 260 (314)
......+++.|.|||.+. ....++.++|||||||++|+|++|..||..
T Consensus 157 --~~~~~~~~~~~~~pe~~~------------~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLF------------GAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHT------------TCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred --cceeeccccchhhhhHhc------------cCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 222345677888997654 234467899999999999999999999643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=327.13 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=162.6
Q ss_pred CccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCcceeeccccc------CCceeE
Q 047043 43 GFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNLLKIFSSCSN------PDFKAL 115 (314)
Q Consensus 43 ~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~l 115 (314)
+|+.++.||+|+||+||+|++ .+|+.||||+++... ....+|++++++++||||+++++++.. ...+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 689999999999999999995 479999999997653 223479999999999999999998743 345789
Q ss_pred EEEecCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecce
Q 047043 116 VLELMPNGSLENWLY---SHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISK 191 (314)
Q Consensus 116 v~e~~~~~sL~~~i~---~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~ 191 (314)
||||++++ +.+.+. .....+++..+..++.|++.||+||| ++||+||||||+|||++.++ .+||+|||++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999764 443332 23445899999999999999999999 99999999999999999775 89999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccc
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMF 262 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~ 262 (314)
....... .....||+.|.|||.+. ....++.++|||||||++|+|++|..||....
T Consensus 172 ~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 172 QLVRGEP---NVSYICSRYYRAPELIF------------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp ECCTTSC---CCSCCSCTTSCCHHHHT------------TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred hccCCcc---cccccccccccChHHhh------------cccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 7754332 23356899999998654 34567889999999999999999999997654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-45 Score=323.11 Aligned_cols=196 Identities=22% Similarity=0.386 Sum_probs=167.0
Q ss_pred HhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeeccccc--CCceeE
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSN--PDFKAL 115 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 115 (314)
..++|++++.||+|+||+||+|+. .+|+.||+|+++... .+.+.+|+++++.++ ||||+++++++.. ....++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 357899999999999999999995 579999999997653 356788999999995 9999999999874 457899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-cEEEEeeecceecC
Q 047043 116 VLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM-VARVSDFGISKLLG 194 (314)
Q Consensus 116 v~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~-~ikl~Dfg~~~~~~ 194 (314)
||||+.+++|.... ..+++..+..++.||+.||.||| ++||+||||||+|||++.++ .++|+|||++....
T Consensus 110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999999987754 23899999999999999999999 89999999999999998654 68999999998775
Q ss_pred CCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 195 DGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
.... .....+|+.|+|||.+. ....++.++||||+||++|+|++|..||...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~------------~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLV------------DYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHT------------TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCc---ccccccCccccCccccc------------CCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 4332 23456899999998754 2345688999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=321.46 Aligned_cols=246 Identities=26% Similarity=0.310 Sum_probs=196.3
Q ss_pred hcCccccceeeecCceEEEEEEe-C---CCCeEEEEEeeecc----cHHHHHHHHHHHHHHhCCC-CCcceeecccccCC
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-S---DGNNVAIKVFKLQL----GRAFRSFDSECEVLRNVHH-RNLLKIFSSCSNPD 111 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~---~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 111 (314)
.++|++++.||+|+||+||+|+. . +|+.||+|+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47799999999999999999984 2 48899999986542 2234567889999999966 89999999999999
Q ss_pred ceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 112 FKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 112 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
..+++|||+.+++|.+++...+. +++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999987765 788999999999999999999 8999999999999999999999999999998
Q ss_pred ecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhhhh-
Q 047043 192 LLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISLKN- 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~~~- 270 (314)
.+...... ......|++.|.|||.+.. ....++.++|||||||++|+|++|..||............
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~-----------~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~ 245 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRG-----------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTT-----------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred hhcccccc-cccccccccccchhHHhhc-----------CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 76543322 2334568999999987641 2345678999999999999999999999875443321111
Q ss_pred --------hhhccCCchhhhhc------cccCCC-----CHHHHHHHHHhhhhheeee
Q 047043 271 --------WVNESLPHALTDVV------DANLRV-----SMKDVAAKLKKIRVKFLYD 309 (314)
Q Consensus 271 --------~~~~~~~~~l~~ll------dp~~Rp-----t~~~~~~~l~~~~~~~~~~ 309 (314)
..+..+++.+.+++ ||.+|| |++|+++ |+|++.
T Consensus 246 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~------Hpff~~ 297 (322)
T d1vzoa_ 246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE------HLFFQK 297 (322)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT------SGGGTT
T ss_pred HhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc------CHhhcC
Confidence 11234566555555 999999 4788765 666543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-44 Score=310.44 Aligned_cols=246 Identities=17% Similarity=0.230 Sum_probs=200.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC-CCcceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-RNLLKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||+|+||+||+|++ .+|+.||+|+++.... ...+.+|++.++.++| ++++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 47899999999999999999995 4789999999876532 2457789999999965 899999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC-----CCcEEEEeeecceec
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE-----NMVARVSDFGISKLL 193 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~-----~~~ikl~Dfg~~~~~ 193 (314)
++ +++|.+++...+..+++..+..++.|++.||+||| ++|++||||||+||+++. ++.++|+|||++..+
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 68999999887777999999999999999999999 999999999999999964 578999999999887
Q ss_pred CCCCCc-----ceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhh-
Q 047043 194 GDGEDS-----VTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEIS- 267 (314)
Q Consensus 194 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~- 267 (314)
...... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~-------------~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTH-------------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHH-------------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHh-------------cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 543221 122335699999999775 3556889999999999999999999999864432210
Q ss_pred -hh-----------hhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhhhe
Q 047043 268 -LK-----------NWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRVKF 306 (314)
Q Consensus 268 -~~-----------~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~~~ 306 (314)
.. ......+|+.+.+++ +|.+||+.+.+.+.++++..+.
T Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00 112245677666665 9999999999988888776543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=324.21 Aligned_cols=203 Identities=24% Similarity=0.345 Sum_probs=167.7
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccccC--
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCSNP-- 110 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 110 (314)
+.+.+.++|++++.||+|+||+||+|++ .+|+.||||+++... ......+.+|+++++.++|||++++++++...
T Consensus 12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 3445578999999999999999999995 579999999997653 23446788999999999999999999987532
Q ss_pred ---CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEee
Q 047043 111 ---DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDF 187 (314)
Q Consensus 111 ---~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Df 187 (314)
...+++++++.+++|.+++... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+|++||
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCcccccccccccccccc
Confidence 3445667778899999998654 3899999999999999999999 899999999999999999999999999
Q ss_pred ecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 188 GISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
|.+...... .....||+.|+|||... ....++.++|||||||++|+|++|..||.+.
T Consensus 166 g~a~~~~~~-----~~~~~g~~~y~apE~~~------------~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 166 GLARHTDDE-----MTGYVATRWYRAPEIML------------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ----CCTGG-----GSSSCHHHHTSCHHHHT------------TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chhcccCcc-----cccccccccccCchhhc------------CCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 998765332 23356899999998653 3445678999999999999999999999764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-44 Score=311.19 Aligned_cols=244 Identities=20% Similarity=0.248 Sum_probs=192.4
Q ss_pred hcCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc-ceeecccccCCceeEEEE
Q 047043 41 TEGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL-LKIFSSCSNPDFKALVLE 118 (314)
Q Consensus 41 ~~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 118 (314)
.++|++.+.||+|+||.||+|++ .+|+.||||++..... ...+..|+++++.++|+++ +.+.+++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46899999999999999999995 5789999999876532 2467889999999987665 555566678888999999
Q ss_pred ecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecC---CCcEEEEeeecceecCC
Q 047043 119 LMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDE---NMVARVSDFGISKLLGD 195 (314)
Q Consensus 119 ~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~---~~~ikl~Dfg~~~~~~~ 195 (314)
|+ ++++.+.+...+..+++..+..++.|++.||+||| ++|++||||||+||+++. +..++|+|||++..+..
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99 56888887776667999999999999999999999 899999999999999863 45799999999998754
Q ss_pred CCCcc-----eeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCccccchhhh--
Q 047043 196 GEDSV-----TQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEMFTGEISL-- 268 (314)
Q Consensus 196 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~~~~~~~~-- 268 (314)
..... ......||+.|+|||.+ .+..++.++|||||||++|+|++|..||..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~ 225 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTH-------------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHH-------------TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred cccccceeccccCCcCCCccccCHHHH-------------hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence 33221 22345699999999765 35568899999999999999999999997654322110
Q ss_pred -----------hhhhhccCCchhhhhc------cccCCCCHHHHHHHHHhhhh
Q 047043 269 -----------KNWVNESLPHALTDVV------DANLRVSMKDVAAKLKKIRV 304 (314)
Q Consensus 269 -----------~~~~~~~~~~~l~~ll------dp~~Rpt~~~~~~~l~~~~~ 304 (314)
.......+|+.+.+++ ||.+||++.++.+.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 226 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0112345677666665 99999999999887776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=314.81 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=158.4
Q ss_pred HhcCccccceeeecCceEEEEEEeC-CCCeEEEEEeeecc--cHHHHHHHHHHHHHHhCCCCCcceeecccc------cC
Q 047043 40 ATEGFNECNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL--GRAFRSFDSECEVLRNVHHRNLLKIFSSCS------NP 110 (314)
Q Consensus 40 ~~~~y~~~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 110 (314)
+.++|++++.||+|+||+||+|+++ +|+.||||+++... ......+.+|+.++++++||||+++++++. +.
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4578999999999999999999954 79999999998653 334467889999999999999999999985 44
Q ss_pred CceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecc
Q 047043 111 DFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGIS 190 (314)
Q Consensus 111 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~ 190 (314)
+.+|+||||+.+ ++.+.+. ..+++..+..++.|++.||.||| ++|++||||||+||+++.++.++++|||++
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhh
Confidence 688999999966 5555443 23899999999999999999999 899999999999999999999999999988
Q ss_pred eecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCCcc
Q 047043 191 KLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTDEM 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~~~ 261 (314)
....... ......+|+.|+|||.+. +..++.++||||+||++|+|++|..||.+.
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~-------------~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVIL-------------GMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -----------------CCTTCCHHHHT-------------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccccc---ccccccccccccChhhhc-------------CCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 7654432 233456899999997763 456788999999999999999999999653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-38 Score=284.48 Aligned_cols=198 Identities=21% Similarity=0.287 Sum_probs=155.3
Q ss_pred cCccccceeeecCceEEEEEEe-CCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-----------CCCcceeeccccc
Q 047043 42 EGFNECNLLGTGSFGIVYKGIL-SDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-----------HRNLLKIFSSCSN 109 (314)
Q Consensus 42 ~~y~~~~~lg~G~~g~V~~a~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 109 (314)
++|++++.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999995 579999999998663 23356778898888775 5789999988754
Q ss_pred --CCceeEEEEecCCCCH-HHH-HhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCC-----
Q 047043 110 --PDFKALVLELMPNGSL-ENW-LYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENM----- 180 (314)
Q Consensus 110 --~~~~~lv~e~~~~~sL-~~~-i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~----- 180 (314)
....+++++++..+.. ... .......+++..+..++.|++.|+.|||+ ..||+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCccccc
Confidence 3456666766644432 222 23344568999999999999999999993 38999999999999997654
Q ss_pred -cEEEEeeecceecCCCCCcceeecccceeeeecCccccccccccCcccCCCCCCCCcccceehhhHHHHHHhcCCCCCC
Q 047043 181 -VARVSDFGISKLLGDGEDSVTQTMTMATIGYMAPVSQLFDILKPKNAKFGSEGIISAKCDVYSFGVLLMETFTGKKPTD 259 (314)
Q Consensus 181 -~ikl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~Dv~slG~il~~ll~g~~Pf~ 259 (314)
.++++|||.+....... ....||+.|+|||++. ...++.++||||+||++++|++|..||.
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~-------------~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLL-------------GAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHH-------------TCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhcc-------------ccCCCccccccchHHHHHHHHHCCCCCC
Confidence 49999999988654322 2346899999998764 4457889999999999999999999997
Q ss_pred cc
Q 047043 260 EM 261 (314)
Q Consensus 260 ~~ 261 (314)
..
T Consensus 231 ~~ 232 (362)
T d1q8ya_ 231 PD 232 (362)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3.9e-23 Score=167.45 Aligned_cols=134 Identities=21% Similarity=0.234 Sum_probs=106.2
Q ss_pred ccccceeeecCceEEEEEEeCCCCeEEEEEeeeccc------------------HHHHHHHHHHHHHHhCCCCCcceeec
Q 047043 44 FNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLG------------------RAFRSFDSECEVLRNVHHRNLLKIFS 105 (314)
Q Consensus 44 y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (314)
+.+.+.||+|+||.||+|...+|+.||||+++.... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999987899999998764211 01223456888899999999988876
Q ss_pred ccccCCceeEEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEE
Q 047043 106 SCSNPDFKALVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVS 185 (314)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~ 185 (314)
+.. .+++||++++..+.+ ++...+..++.|++.++.+|| .+|++||||||+||+++++ .++|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCC-CEEEE
Confidence 543 369999998755432 455567789999999999999 8999999999999999865 58899
Q ss_pred eeecceecC
Q 047043 186 DFGISKLLG 194 (314)
Q Consensus 186 Dfg~~~~~~ 194 (314)
|||.+....
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.85 E-value=7.8e-09 Score=85.94 Aligned_cols=149 Identities=15% Similarity=0.120 Sum_probs=104.7
Q ss_pred hHHHHhcCccccceeeecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCcee
Q 047043 36 DIQRATEGFNECNLLGTGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKA 114 (314)
Q Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 114 (314)
++......|++++..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4556678888887766566678998874 56678888877654334456778888887774 333567777888888889
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 047043 115 LVLELMPNGSLENWLYSHNYFLDTLERLNIMIDVWLALEYLHHGH----------------------------------- 159 (314)
Q Consensus 115 lv~e~~~~~sL~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~~----------------------------------- 159 (314)
+||++++|.++.+..... .....++.+++..+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998876654221 123334566666666676310
Q ss_pred --------------------CCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 160 --------------------SSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 160 --------------------~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
....++|+|+.|.||++++++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 02237999999999999987666799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=1.3e-06 Score=71.73 Aligned_cols=131 Identities=15% Similarity=0.080 Sum_probs=86.6
Q ss_pred eeeecCc-eEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC--CCcceeecccccCCceeEEEEecCCCCH
Q 047043 49 LLGTGSF-GIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH--RNLLKIFSSCSNPDFKALVLELMPNGSL 125 (314)
Q Consensus 49 ~lg~G~~-g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL 125 (314)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..+++|++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444554 68899987778889999876543 2456778888877742 3356778888888888999999988655
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 047043 126 ENWLYSHNYFLDTLERLNIMIDVWLALEYLHHG----------------------------------------------- 158 (314)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~~l~~~l~~LH~~----------------------------------------------- 158 (314)
.+.. .... ..+.++...+..||+.
T Consensus 94 ~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3310 1111 1223344444444420
Q ss_pred -------CCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 159 -------HSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 159 -------~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.....++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 012348999999999999887667799998664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.81 E-value=4.1e-05 Score=66.82 Aligned_cols=77 Identities=17% Similarity=0.226 Sum_probs=48.3
Q ss_pred cceeeecCceEEEEEEeC-CCCeEEEEEeeecc-------cHHHHHHHHHHHHHHhCC-C--CCcceeecccccCCceeE
Q 047043 47 CNLLGTGSFGIVYKGILS-DGNNVAIKVFKLQL-------GRAFRSFDSECEVLRNVH-H--RNLLKIFSSCSNPDFKAL 115 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~-~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 115 (314)
.+.||.|..-.||++... +++.+++|.-.+.. +....+...|.+.++.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999843 57789999754321 112234556788877662 2 345566654 3445678
Q ss_pred EEEecCCCCH
Q 047043 116 VLELMPNGSL 125 (314)
Q Consensus 116 v~e~~~~~sL 125 (314)
+||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.32 E-value=0.00066 Score=57.27 Aligned_cols=65 Identities=11% Similarity=0.061 Sum_probs=43.0
Q ss_pred EEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCCCCc--ceeec-----ccccCCceeEEEEecCC
Q 047043 57 IVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHHRNL--LKIFS-----SCSNPDFKALVLELMPN 122 (314)
Q Consensus 57 ~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~-----~~~~~~~~~lv~e~~~~ 122 (314)
.||++...+|+.+++|+.++... ....+..|...+..|...++ +.... .+......+.++++++|
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 79999988999999999886532 23567778888887742222 11111 12345566788888765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.19 E-value=0.00084 Score=56.17 Aligned_cols=156 Identities=9% Similarity=-0.004 Sum_probs=79.9
Q ss_pred ehhhHHHHhcCccccceee-----ecCceEEEEEEeCCCCeEEEEEeeecccHHHHHHHHHHHHHHhCCC-----CCcce
Q 047043 33 SYLDIQRATEGFNECNLLG-----TGSFGIVYKGILSDGNNVAIKVFKLQLGRAFRSFDSECEVLRNVHH-----RNLLK 102 (314)
Q Consensus 33 ~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~a~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~i~~ 102 (314)
|-.++..+..+|.+.+... .|--=+.|+....+| .+++|++.... ....+..|.+++..+.. |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 3456777788887755443 344456798886555 58999986542 22345556667766632 22211
Q ss_pred ee-c--ccccCCceeEEEEecCCCCHH-----HH------H---hhc--C------------------------CCCCHH
Q 047043 103 IF-S--SCSNPDFKALVLELMPNGSLE-----NW------L---YSH--N------------------------YFLDTL 139 (314)
Q Consensus 103 ~~-~--~~~~~~~~~lv~e~~~~~sL~-----~~------i---~~~--~------------------------~~~~~~ 139 (314)
.- | +.........++.++.+.... .. + ... . ......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 011123334455554432111 00 0 000 0 000111
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCCeeecCCCCCceEecCCCcEEEEeeecce
Q 047043 140 ERLNIMIDVWLALEYLHHGHSSAPIVHCDLKPSNILLDENMVARVSDFGISK 191 (314)
Q Consensus 140 ~~~~i~~~l~~~l~~LH~~~~~~~i~H~dlkp~Nili~~~~~ikl~Dfg~~~ 191 (314)
.....+......+...+...-..|++|+|+.++|++++.+...-++||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1222233333333333322225779999999999999988777899999765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.04 E-value=0.00083 Score=58.27 Aligned_cols=73 Identities=16% Similarity=0.197 Sum_probs=49.4
Q ss_pred cceeeecCceEEEEEEeCC--------CCeEEEEEeeecccHHHHHHHHHHHHHHhCC-CCCcceeecccccCCceeEEE
Q 047043 47 CNLLGTGSFGIVYKGILSD--------GNNVAIKVFKLQLGRAFRSFDSECEVLRNVH-HRNLLKIFSSCSNPDFKALVL 117 (314)
Q Consensus 47 ~~~lg~G~~g~V~~a~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (314)
++.|+.|-.=.+|++...+ .+.|++++..... ......+|..+++.+. +.-..++++++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567778888999998543 3568888775322 2234567888888885 3334577787764 5889
Q ss_pred EecCCCCH
Q 047043 118 ELMPNGSL 125 (314)
Q Consensus 118 e~~~~~sL 125 (314)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99876443
|